data_2ka0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ka0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -74.86 159.4 31.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.446 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.1 t -153.74 120.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.459 1.903 . . . . 0.0 106.031 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -100.23 136.56 39.94 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.71 -1.244 . . . . 0.0 109.007 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.78 103.11 10.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.679 1.592 . . . . 0.0 106.906 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 143.13 30.64 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.54 -178.72 4.34 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.641 1.976 . . . . 0.0 107.67 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.44 -52.51 38.62 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.808 1.243 . . . . 0.0 110.387 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 m -70.67 -33.35 70.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.004 -0.435 . . . . 0.0 111.858 -173.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.23 -150.45 8.15 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -161.21 164.53 30.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.715 1.257 . . . . 0.0 110.658 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.8 p -146.8 175.47 10.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.564 . . . . 0.0 108.965 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.02 141.98 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.5 pt -129.93 147.73 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -132.94 125.88 30.8 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.26 131.1 53.75 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 125.265 1.603 . . . . 0.0 109.47 -163.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -69.94 122.07 18.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.947 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.86 9.35 1.54 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.138 1.375 . . . . 0.0 114.067 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.02 -6.52 56.57 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.091 -1.005 . . . . 0.0 110.39 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.22 132.96 55.93 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.255 1.022 . . . . 0.0 109.702 -164.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.88 -44.09 70.16 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.274 1.429 . . . . 0.0 111.159 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -54.06 -43.09 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.591 1.156 . . . . 0.0 112.358 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.56 -44.79 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.51 1.504 . . . . 0.0 108.643 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -61.3 -40.23 93.42 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.365 0.666 . . . . 0.0 111.041 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -79.01 -29.41 43.67 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.972 0.909 . . . . 0.0 111.046 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mt -60.97 -24.58 66.21 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.228 1.411 . . . . 0.0 111.363 168.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -64.33 -20.13 65.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.345 0.975 . . . . 0.0 111.177 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -81.89 -14.97 55.46 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.068 0.947 . . . . 0.0 112.251 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -124.33 28.93 6.51 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.294 1.038 . . . . 0.0 111.414 -166.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -131.81 141.26 40.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.0 158.35 74.35 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.075 1.063 . . . . 0.0 112.332 -8.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -150.31 166.0 31.33 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.31 0.644 . . . . 0.0 110.003 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.48 166.93 12.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.3 163.19 17.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.702 0.763 . . . . 0.0 111.736 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.96 131.85 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 164.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.6 99.96 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -85.59 154.85 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.4 p -129.6 150.91 50.72 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.627 1.171 . . . . 0.0 108.681 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -149.31 98.22 2.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.43 -87.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.2 29.61 1.81 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.292 1.837 . . . . 0.0 110.327 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -133.11 161.83 33.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.436 1.094 . . . . 0.0 108.589 168.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -127.3 143.22 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -148.69 166.9 26.99 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -154.38 155.64 35.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.759 -1.213 . . . . 0.0 108.584 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -83.02 86.55 6.98 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.541 0.737 . . . . 0.0 109.511 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.0 p -58.15 150.88 49.58 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 122.663 0.385 . . . . 0.0 111.874 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.85 -13.31 13.06 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.277 2.651 . . . . 0.0 112.647 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.81 158.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-N 119.092 0.86 . . . . 0.0 108.904 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.32 103.83 4.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.229 1.412 . . . . 0.0 107.879 172.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.55 147.12 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -125.47 -7.45 6.92 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -65.17 146.7 54.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.723 1.209 . . . . 0.0 107.778 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 18.0 ptp -144.81 104.35 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.24 1.416 . . . . 0.0 110.304 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.66 -30.34 59.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.156 -1.018 . . . . 0.0 113.221 -172.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -133.29 72.9 74.87 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 119.432 1.015 . . . . 0.0 110.522 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 56.3 Cg_endo -69.48 150.67 70.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.75 2.967 . . . . 0.0 112.113 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -140.13 173.36 11.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.494 1.917 . . . . 0.0 108.384 170.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.27 10.67 8.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 112.657 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.72 154.11 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 131.001 3.72 . . . . 0.0 107.004 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.14 -174.48 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.23 1.412 . . . . 0.0 109.575 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -90.94 175.84 6.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.698 0.761 . . . . 0.0 110.935 166.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.58 5.23 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.923 1.289 . . . . 0.0 110.68 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.17 30.91 1.6 Allowed Glycine 0 C--N 1.337 0.615 0 O-C-N 120.692 -1.255 . . . . 0.0 112.949 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -115.79 169.92 8.85 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.049 0.924 . . . . 0.0 109.462 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -136.99 140.99 41.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.703 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -127.03 176.82 17.64 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.875 1.226 . . . . 0.0 110.987 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -111.4 143.01 42.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 165.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -104.77 86.06 1.36 Allowed Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 125.631 1.572 . . . . 0.0 107.667 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.05 -43.39 42.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.359 2.039 . . . . 0.0 115.054 -172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.74 -22.65 43.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.639 2.226 . . . . 0.0 111.482 -165.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -115.76 15.13 16.95 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.763 1.649 . . . . 0.0 113.751 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 47.56 37.96 7.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.755 2.278 . . . . 0.0 113.024 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.83 160.95 15.34 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.724 -1.235 . . . . 0.0 110.531 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.07 -179.14 6.87 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 161.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.6 m -139.15 163.93 31.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.796 0.838 . . . . 0.0 109.777 154.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.5 mt -151.05 101.49 2.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 129.36 3.064 . . . . 0.0 105.066 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -99.97 119.88 38.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.73 1.56 2.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.14 -178.74 34.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 166.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -83.25 106.88 15.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -59.71 165.43 4.38 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 125.465 1.506 . . . . 0.0 110.961 169.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.41 1.48 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.333 2.022 . . . . 0.0 114.165 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ttp -107.17 58.31 0.63 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 120.208 1.367 . . . . 0.0 110.182 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 p -159.83 -178.63 7.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 122.161 0.982 . . . . 0.0 110.501 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.93 -62.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 154.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.39 -43.54 40.18 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.046 0.538 . . . . 0.0 112.022 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -149.68 161.98 41.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.957 1.303 . . . . 0.0 108.6 -162.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.78 80.54 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -167.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -79.85 141.85 55.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -89.26 177.29 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 124.494 3.463 . . . . 0.0 112.935 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.78 16.16 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.4 t -164.86 173.86 11.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.029 1.286 . . . . 0.0 109.783 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.57 78.8 0.58 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.8 148.92 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 25.7 p30 -64.97 158.59 25.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.213 0.53 . . . . 0.0 112.177 164.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.56 99.32 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 166.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.2 pt -113.47 -16.38 9.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.511 1.124 . . . . 0.0 111.408 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.1 175.56 20.03 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-O 122.061 0.811 . . . . 0.0 112.413 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -135.86 134.0 38.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.7 mt -73.76 95.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 165.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -76.62 -24.2 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.365 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -148.66 158.68 44.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 110.421 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.78 42.34 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.371 1.462 . . . . 0.0 112.569 160.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tp -67.63 -11.81 59.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -162.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -107.18 -35.27 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 119.258 0.935 . . . . 0.0 110.331 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.56 -18.21 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.484 0.713 . . . . 0.0 111.316 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mp -66.76 -29.09 68.97 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.088 -1.007 . . . . 0.0 112.314 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -67.22 -22.79 65.69 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.818 1.644 . . . . 0.0 112.87 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -99.16 5.77 46.69 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.932 -171.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.86 165.37 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 119.744 1.157 . . . . 0.0 108.741 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -109.39 172.84 6.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.29 35.8 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 112.735 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.45 51.97 0.04 OUTLIER Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.804 -1.185 . . . . 0.0 112.93 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -103.4 24.92 10.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.016 1.408 . . . . 0.0 113.302 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.6 mttt 44.19 88.25 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.452 1.901 . . . . 0.0 113.258 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.75 142.38 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -125.06 94.49 4.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.443 1.897 . . . . 0.0 106.826 162.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.28 140.39 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 128.724 2.81 . . . . 0.0 109.1 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -140.97 177.06 8.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.999 2.12 . . . . 0.0 109.61 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -78.71 -2.32 38.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.924 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.831 -160.655 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.977 0.894 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -62.57 160.59 13.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.932 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 36.8 t -151.11 149.69 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.494 1.518 . . . . 0.0 109.075 166.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -116.54 139.86 50.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.423 2.289 . . . . 0.0 106.229 166.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.8 mt -112.08 119.49 38.61 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 117' ' ' VAL . 3.5 tt -121.49 141.01 51.45 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -164.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.45 ' CE1' HG11 ' A' ' 117' ' ' VAL . 18.8 m-85 -128.98 166.45 19.15 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.3 1.409 . . . . 0.0 108.616 -172.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.11 -19.16 62.71 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.244 -0.91 . . . . 0.0 111.543 171.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -25.76 12.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -172.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.5 -156.37 18.11 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 126.379 1.942 . . . . 0.0 108.274 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 13.0 pttp -168.02 157.54 9.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.174 1.487 . . . . 0.0 111.695 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.3 p -136.31 175.24 9.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.36 1.064 . . . . 0.0 111.043 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 127.22 56.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 pt -121.65 129.01 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -96.14 133.65 40.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.127 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.4 mt -124.62 130.53 52.6 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.588 1.085 . . . . 0.0 110.574 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -71.35 135.97 47.58 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.868 1.667 . . . . 0.0 111.375 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -90.96 45.35 1.25 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 112.854 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -129.05 30.15 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.094 -1.628 . . . . 0.0 108.964 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -132.53 139.47 47.9 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.012 -1.055 . . . . 0.0 109.034 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -45.0 -62.76 1.11 Allowed 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 126.373 1.869 . . . . 0.0 109.609 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.33 -39.64 28.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 121.071 -1.018 . . . . 0.0 113.17 -171.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.8 -44.77 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.513 1.125 . . . . 0.0 109.247 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -52.05 -53.57 40.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -43.94 97.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.863 0.865 . . . . 0.0 109.424 -170.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.21 -29.05 20.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.392 1.877 . . . . 0.0 112.866 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -59.98 -29.44 68.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.009 0.822 . . . . 0.0 110.895 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -74.07 -35.62 64.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.04 0.448 . . . . 0.0 109.935 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.35 21.05 3.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.648 2.779 . . . . 0.0 111.407 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -128.26 137.71 31.45 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 121.187 1.812 . . . . 0.0 107.733 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.93 153.14 97.39 Favored 'Cis proline' 0 C--N 1.348 0.518 0 CA-C-N 119.161 0.736 . . . . 0.0 112.428 -5.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -139.75 167.48 22.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 122.667 0.387 . . . . 0.0 111.377 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.15 155.06 46.84 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 t -166.74 161.62 15.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.5 128.2 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.4 HG23 HG11 ' A' ' 117' ' ' VAL . 2.8 t -75.66 73.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -65.29 153.48 40.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -139.46 161.03 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.95 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -160.54 92.62 0.97 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.37 84.34 0.03 OUTLIER Glycine 0 C--O 1.212 -1.248 0 CA-C-O 119.194 -0.781 . . . . 0.0 114.577 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.36 25.23 7.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.095 2.958 . . . . 0.0 113.252 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -128.8 149.38 50.76 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.468 1.107 . . . . 0.0 109.099 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.7 mt -125.04 141.35 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.59 172.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 168.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -156.71 151.36 25.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -74.11 98.33 3.1 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.9 p -66.95 149.8 98.26 Favored Pre-proline 0 N--CA 1.437 -1.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.06 -3.03 12.87 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.389 3.392 . . . . 0.0 112.102 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.2 149.79 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 108.141 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.02 15.79 6.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.84 117.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 123.978 0.911 . . . . 0.0 110.019 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -94.73 2.04 55.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -81.61 96.39 7.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.498 2.319 . . . . 0.0 110.29 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.8 ptp -86.57 123.42 31.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.508 1.123 . . . . 0.0 110.378 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.88 -23.88 16.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -137.9 70.69 50.06 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.2 146.75 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.282 2.655 . . . . 0.0 109.87 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -135.76 174.92 10.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 164.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -125.3 7.05 7.76 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.223 1.009 . . . . 0.0 111.503 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -144.74 137.06 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -142.9 -179.56 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.057 1.343 . . . . 0.0 109.722 -173.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.37 -167.56 1.52 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.977 2.111 . . . . 0.0 111.438 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.19 45.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.429 1.891 . . . . 0.0 107.545 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.03 38.2 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.24 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -110.28 176.04 5.2 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.41 134.33 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.89 148.16 18.88 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -86.75 139.14 31.02 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 168.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -104.89 85.21 1.15 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -64.39 -36.68 43.47 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.167 1.245 . . . . 0.0 114.837 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.05 -21.04 18.61 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.266 1.977 . . . . 0.0 110.599 -167.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 22.17 7.58 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 118.05 -1.416 . . . . 0.0 113.352 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 46.21 49.59 12.56 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.766 1.783 . . . . 0.0 111.995 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.97 175.46 9.35 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 111.286 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.18 -169.66 2.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.141 1.376 . . . . 0.0 111.06 166.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -166.13 140.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.554 1.542 . . . . 0.0 110.371 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -137.36 124.12 21.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.413 2.285 . . . . 0.0 107.538 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.62 119.63 40.09 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.248 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -140.94 14.7 2.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.54 48.32 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 CA-C-N 119.755 1.161 . . . . 0.0 114.327 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.8 tttt 62.24 177.44 0.13 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.64 1.976 . . . . 0.0 109.844 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.2 p -149.25 165.54 17.42 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 120.119 1.327 . . . . 0.0 109.925 -172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.62 64.73 8.12 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.377 3.384 . . . . 0.0 111.462 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.23 -44.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.719 1.608 . . . . 0.0 108.753 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.79 154.74 23.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.479 1.511 . . . . 0.0 108.227 -159.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.73 -58.03 1.6 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.4 -49.42 55.41 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.194 0.521 . . . . 0.0 110.926 -167.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -135.89 166.09 24.12 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 127.005 2.122 . . . . 0.0 108.109 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.73 115.91 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -125.6 144.78 49.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.115 0.966 . . . . 0.0 111.139 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.5 173.56 14.08 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.305 3.336 . . . . 0.0 112.975 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.268 1.427 . . . . 0.0 114.346 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -147.86 173.37 12.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.569 1.547 . . . . 0.0 107.679 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.11 85.59 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 m -90.93 150.02 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -75.32 175.22 8.58 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.9 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.42 44.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.7 pt -64.65 -39.96 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.312 -1.492 . . . . 0.0 110.927 -174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.82 169.08 16.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -138.47 132.71 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.9 mt -73.62 90.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 103.687 -2.708 . . . . 0.0 103.687 167.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.9 m -72.65 -25.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.511 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 155.1 36.76 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.586 0.755 . . . . 0.0 112.23 -165.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.6 20.17 62.38 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.888 1.232 . . . . 0.0 113.897 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.02 -38.03 87.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.745 1.273 . . . . 0.0 111.542 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -76.39 -1.17 25.62 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.25 1.96 26.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.871 0.868 . . . . 0.0 113.024 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.1 mt -84.31 -41.97 16.28 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.622 1.169 . . . . 0.0 113.68 -172.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.55 -23.41 64.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.61 1.671 . . . . 0.0 111.135 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -69.07 -10.55 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.543 -1.348 . . . . 0.0 111.212 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -92.44 157.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 120.334 1.425 . . . . 0.0 109.634 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.42 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 16.5 mmtp -102.08 172.4 6.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.767 1.627 . . . . 0.0 108.013 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.31 25.24 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 128.492 2.717 . . . . 0.0 113.649 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.85 65.16 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 120.337 -1.477 . . . . 0.0 111.992 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 1.5 mm-40 -125.12 38.16 4.25 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.964 1.306 . . . . 0.0 110.465 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 mttt 42.24 87.26 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.542 1.937 . . . . 0.0 110.597 164.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.45 HG11 ' CE1' ' A' ' 7' ' ' PHE . 19.5 m -64.0 178.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -150.47 90.36 1.64 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.42 125.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -137.55 170.9 15.28 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.509 1.05 . . . . 0.0 109.69 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.11 -11.52 60.33 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.657 0 C-N-CA 128.652 2.781 . . . . 0.0 110.783 -173.111 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.413 0.625 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -72.38 167.44 20.51 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 t -147.62 130.19 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.15 1.38 . . . . 0.0 108.599 167.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.74 128.61 45.04 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -100.61 105.1 16.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.5 31.54 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 169.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.93 175.09 8.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.93 1.292 . . . . 0.0 109.383 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.97 -29.64 67.9 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.503 -1.373 . . . . 0.0 112.057 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.8 m -103.53 -3.0 25.87 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.31 -166.76 39.6 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 119.712 1.142 . . . . 0.0 111.266 -173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 150.34 25.53 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.808 0.304 . . . . 0.0 110.397 168.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.8 p -132.85 172.87 12.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.598 0.713 . . . . 0.0 109.385 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -135.06 146.85 29.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.5 pt -128.13 156.97 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -111.02 135.15 51.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.29 134.69 55.21 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.076 1.351 . . . . 0.0 108.781 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -86.66 118.53 26.12 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.778 0.831 . . . . 0.0 109.478 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -66.21 20.05 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.028 2.131 . . . . 0.0 114.64 -171.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.86 24.17 5.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.39 1.876 . . . . 0.0 109.511 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -129.92 147.81 51.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.438 2.295 . . . . 0.0 108.311 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.77 -46.49 59.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.701 2.0 . . . . 0.0 110.157 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.07 -46.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.337 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -72.16 -43.91 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -165.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -60.89 -24.62 66.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.966 1.307 . . . . 0.0 111.715 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.5 mt -90.18 -25.8 20.46 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.48 1.112 . . . . 0.0 112.501 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mt -70.11 -28.82 65.71 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 121.065 -1.022 . . . . 0.0 110.804 172.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.66 -36.68 47.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.337 0.655 . . . . 0.0 111.044 175.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -71.36 -17.51 62.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 112.17 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -123.13 12.46 9.59 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.902 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -106.01 135.76 19.39 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 121.003 1.729 . . . . 0.0 108.109 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.86 164.32 79.83 Favored 'Cis proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.911 1.004 . . . . 0.0 112.824 -6.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -147.54 168.58 21.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.713 1.258 . . . . 0.0 109.403 165.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 47.3 mp0 -130.71 154.51 47.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.174 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -165.2 -175.46 3.66 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.905 0.882 . . . . 0.0 111.551 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 t -93.26 142.19 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 128.017 2.527 . . . . 0.0 107.891 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -97.11 91.33 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -86.79 159.64 19.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.6 p -132.4 149.32 52.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.03 0.932 . . . . 0.0 110.561 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.0 t90 -166.91 103.3 0.56 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -172.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.41 20.09 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 160.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.357 17.2 pt-20 47.71 50.91 14.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.966 1.707 . . . . 0.0 111.234 -159.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -140.01 159.56 41.89 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 126.962 2.105 . . . . 0.0 107.615 168.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.99 139.64 50.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 127.513 2.325 . . . . 0.0 106.478 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -155.34 150.02 26.36 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.962 1.363 . . . . 0.0 111.263 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -135.64 151.76 50.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.163 1.385 . . . . 0.0 108.204 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -88.82 83.34 6.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -166.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -53.98 152.29 10.8 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.256 0.622 . . . . 0.0 111.971 -168.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -79.2 4.93 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.505 1 C-N-CA 125.41 4.073 . . . . 0.0 112.505 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.0 t -107.98 131.53 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.071 1.348 . . . . 0.0 110.421 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.46 66.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.31 1.444 . . . . 0.0 107.19 -171.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -110.49 128.99 66.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 124.48 1.112 . . . . 0.0 108.297 -175.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.98 45.07 2.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.584 1.153 . . . . 0.0 111.264 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -127.69 146.35 50.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.457 1.503 . . . . 0.0 108.405 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.62 110.48 2.45 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.154 1.782 . . . . 0.0 108.329 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -87.36 -25.48 23.83 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.633 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -123.35 65.68 31.51 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 120.138 1.336 . . . . 0.0 110.147 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.26 114.63 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.048 2.499 . . . . 0.0 110.391 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 131.42 55.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.544 1.537 . . . . 0.0 108.087 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -93.12 5.27 52.1 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -160.86 149.28 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 128.095 2.558 . . . . 0.0 109.648 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.0 m -140.95 174.18 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.053 1.741 . . . . 0.0 109.39 -165.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -94.51 170.03 9.77 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.86 0.838 . . . . 0.0 110.708 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.74 -7.42 8.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 124.965 1.306 . . . . 0.0 112.237 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.11 27.22 4.59 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.681 1.61 . . . . 0.0 112.596 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -103.8 175.78 5.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.016 0.908 . . . . 0.0 109.331 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.4 t -135.42 133.86 52.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.709 0.804 . . . . 0.0 109.639 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.74 156.66 21.54 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -103.64 143.37 32.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 163.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -109.33 85.66 3.69 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 124.699 1.2 . . . . 0.0 108.552 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.65 -29.84 90.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.265 1.31 . . . . 0.0 114.671 172.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -77.75 -9.0 17.07 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.509 2.139 . . . . 0.0 111.917 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.59 8.95 4.0 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 118.411 -1.216 . . . . 0.0 115.583 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 44.65 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.741 1.27 . . . . 0.0 109.971 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.49 165.69 20.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.534 -0.729 . . . . 0.0 111.611 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -84.0 178.15 7.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.409 166.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -151.26 108.93 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.082 1.753 . . . . 0.0 108.39 165.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.21 105.29 17.11 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -80.35 133.59 35.94 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -152.84 22.18 0.59 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.946 0.898 . . . . 0.0 110.955 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.2 -139.66 2.76 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.41 103.01 4.78 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -58.52 156.11 24.96 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.487 1.915 . . . . 0.0 111.166 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -3.0 11.89 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.059 3.173 . . . . 0.0 113.459 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.0 tpt -73.09 -8.79 57.33 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.777 -1.202 . . . . 0.0 112.336 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t -132.54 -177.46 4.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.497 1.142 . . . . 0.0 109.914 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -144.35 -42.68 0.25 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.96 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -71.5 -56.81 5.19 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.57 1.176 . . . . 0.0 108.147 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -133.11 -164.84 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.177 2.191 . . . . 0.0 107.41 -153.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.95 77.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.538 1.517 . . . . 0.0 107.662 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -76.14 142.74 72.51 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.59 179.74 6.22 Favored 'Trans proline' 0 CA--C 1.533 0.449 1 C-N-CA 126.925 5.083 . . . . 0.0 113.665 170.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.37 -14.01 62.39 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.32 -172.07 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.89 97.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.4 m -90.0 172.67 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -126.55 124.5 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.47 55.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.586 1.184 . . . . 0.0 109.256 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.6 pt -80.05 -14.57 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.236 1.014 . . . . 0.0 111.381 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.12 155.89 16.82 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -135.88 140.83 44.42 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.879 0.872 . . . . 0.0 108.659 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 97.1 mt -79.63 93.95 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 123.814 1.768 . . . . 0.0 108.634 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.48 -23.68 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.002 -163.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.04 159.71 44.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.252 2.621 . . . . 0.0 108.716 171.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.53 69.2 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-O 117.927 -1.485 . . . . 0.0 115.277 167.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.69 -49.99 73.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.188 1.994 . . . . 0.0 111.212 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.3 -25.6 66.11 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.814 -0.554 . . . . 0.0 110.956 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.9 -5.97 34.75 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.754 1.222 . . . . 0.0 112.164 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.5 mt -80.7 -44.41 18.77 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 119.028 0.831 . . . . 0.0 111.46 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -57.53 -22.92 47.32 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.03 -1.044 . . . . 0.0 113.147 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -91.82 16.59 10.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.386 1.474 . . . . 0.0 112.978 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.3 mm -113.3 148.13 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 121.156 1.798 . . . . 0.0 109.922 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -89.16 171.98 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.667 1.587 . . . . 0.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.05 40.14 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 130.127 3.371 . . . . 0.0 112.724 167.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.87 12.67 0.03 OUTLIER Glycine 0 CA--C 1.522 0.522 0 O-C-N 120.452 -1.405 . . . . 0.0 116.156 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.53 22.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.607 1.704 . . . . 0.0 114.34 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 33' ' ' GLU . 0.1 OUTLIER 64.87 152.95 0.05 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.003 2.121 . . . . 0.0 112.373 167.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.51 148.26 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 O-C-N 120.435 -1.416 . . . . 0.0 109.048 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.06 108.47 15.27 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.492 2.317 . . . . 0.0 107.14 160.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.8 t -86.51 124.38 40.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.788 2.435 . . . . 0.0 107.792 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -140.67 179.76 6.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.571 1.532 . . . . 0.0 110.17 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -81.31 -10.33 59.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.937 0 C-N-CA 127.545 2.338 . . . . 0.0 111.266 -169.271 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttp . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.62 152.14 39.72 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 50.8 t -153.82 147.85 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.546 1.939 . . . . 0.0 108.132 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -131.81 137.41 48.11 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.479 1.911 . . . . 0.0 107.528 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.1 mt -108.57 104.62 13.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.678 1.991 . . . . 0.0 105.857 -174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.67 103.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.56 173.45 9.57 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.931 0.892 . . . . 0.0 108.985 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.77 -42.22 95.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -80.82 -17.08 51.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.62 -161.79 34.09 Favored Glycine 0 N--CA 1.464 0.565 0 CA-C-N 121.11 1.777 . . . . 0.0 110.252 -165.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -159.33 159.92 34.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.203 1.501 . . . . 0.0 111.668 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.8 p -142.84 178.41 7.67 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.195 0.998 . . . . 0.0 109.877 170.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -132.92 129.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.62 144.71 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.401 1.08 . . . . 0.0 108.309 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -136.01 128.97 31.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.314 -0.866 . . . . 0.0 112.858 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.59 123.79 42.81 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 125.084 1.49 . . . . 0.0 108.824 -164.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.22 138.58 57.9 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.608 1.563 . . . . 0.0 111.462 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -97.2 50.26 1.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.518 0.727 . . . . 0.0 112.0 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.35 17.75 3.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.144 1.378 . . . . 0.0 111.85 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.68 144.76 50.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.376 1.47 . . . . 0.0 112.438 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -53.24 -50.58 64.47 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.326 1.451 . . . . 0.0 111.829 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.22 -44.74 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.0 -34.17 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -66.53 -48.94 68.13 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.17 0.988 . . . . 0.0 111.016 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.5 mt -70.96 -21.78 62.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.691 0.796 . . . . 0.0 110.515 -173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.2 -41.97 80.57 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.852 2.061 . . . . 0.0 111.608 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -56.0 -36.72 68.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.362 0.983 . . . . 0.0 110.0 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.86 -29.54 70.83 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -108.39 2.25 22.33 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.992 1.317 . . . . 0.0 112.04 -168.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.12 142.17 24.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.26 160.43 83.03 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 CA-C-N 119.421 0.829 . . . . 0.0 112.941 -7.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.86 175.45 12.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.933 1.693 . . . . 0.0 109.874 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 177.47 7.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.12 2.168 . . . . 0.0 110.728 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -162.63 -154.73 0.32 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.293 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 t -120.39 134.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.877 1.671 . . . . 0.0 107.661 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -88.09 77.03 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 118.995 0.816 . . . . 0.0 109.379 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.62 150.93 34.84 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.681 -1.262 . . . . 0.0 109.239 171.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.8 p -124.69 142.53 51.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.082 1.353 . . . . 0.0 108.886 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -153.36 107.26 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.87 22.13 70.01 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.939 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 75.52 28.38 0.96 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.846 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -115.47 153.26 31.43 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 155.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -124.48 123.97 67.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -138.24 132.4 31.69 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.088 1.755 . . . . 0.0 108.284 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -136.8 156.83 47.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.459 -1.401 . . . . 0.0 107.483 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.72 115.76 7.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.1 p -80.73 153.34 73.01 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 160.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.7 -0.77 10.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.12 3.213 . . . . 0.0 112.53 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.2 t -80.78 163.94 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 126.578 1.951 . . . . 0.0 108.722 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -143.07 21.93 1.92 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.83 155.71 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -135.13 -4.88 2.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.699 0.8 . . . . 0.0 112.445 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 55' ' ' GLU . 74.0 tttt -70.44 140.52 52.02 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.041 1.291 . . . . 0.0 109.914 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.24 131.01 46.97 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.345 1.458 . . . . 0.0 107.299 167.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 53' ' ' LYS . 71.8 mm-40 -87.45 -38.07 16.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.218 0.532 . . . . 0.0 109.679 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.65 62.02 12.83 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.344 1.857 . . . . 0.0 108.085 -161.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.87 125.75 15.35 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 108.022 -1.568 . . . . 0.0 108.022 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -117.22 145.77 43.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.221 1.009 . . . . 0.0 109.018 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.77 -1.64 27.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.883 1.273 . . . . 0.0 111.905 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.66 146.96 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 129.026 2.931 . . . . 0.0 108.438 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.98 -173.0 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 109.488 -166.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -105.43 159.09 16.19 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.16 1.384 . . . . 0.0 111.31 171.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 58.7 mt -73.37 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.36 0.82 0.5 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 119.033 -0.87 . . . . 0.0 113.975 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -100.48 175.57 5.64 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.764 1.782 . . . . 0.0 109.11 170.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -136.24 134.02 49.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.519 1.127 . . . . 0.0 108.157 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.78 -172.26 31.72 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.78 156.38 48.1 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 146.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -121.0 86.77 42.57 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.83 -46.39 31.87 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.253 1.968 . . . . 0.0 114.875 -167.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 -23.76 46.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.809 2.34 . . . . 0.0 111.636 -165.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.57 12.26 46.86 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.757 1.646 . . . . 0.0 113.983 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.458 ' N ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER 44.45 48.08 8.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.701 2.0 . . . . 0.0 110.776 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.41 157.03 27.96 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.09 0.948 . . . . 0.0 111.066 -172.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.53 172.56 12.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.641 161.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.53 105.27 3.29 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.872 1.669 . . . . 0.0 109.836 169.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -86.57 120.28 27.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 107.865 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -105.46 105.69 15.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.991 0.814 . . . . 0.0 109.325 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -136.25 9.24 3.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.46 -121.21 1.02 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 119.782 1.173 . . . . 0.0 110.65 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -156.56 121.77 4.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.375 1.087 . . . . 0.0 108.517 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -98.14 155.86 36.51 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.996 2.519 . . . . 0.0 112.079 -165.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.61 3.12 6.7 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.489 2.793 . . . . 0.0 115.39 -170.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.5 mmt -81.99 -32.16 30.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.596 1.544 . . . . 0.0 111.289 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -90.96 175.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.565 0.746 . . . . 0.0 110.087 -176.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 -62.77 0.44 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.16 -26.27 61.12 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.246 0.546 . . . . 0.0 112.395 -165.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -167.9 162.38 13.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 128.359 2.664 . . . . 0.0 107.119 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -75.76 84.19 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 119.534 1.061 . . . . 0.0 109.211 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.49 ' H ' ' HB3' ' A' ' 85' ' ' SER . 11.1 mt-30 -75.77 144.41 76.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.508 159.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.18 -177.36 3.82 Favored 'Trans proline' 0 C--N 1.346 0.44 1 C-N-CA 125.382 4.055 . . . . 0.0 112.003 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.701 167.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -166.36 179.85 5.38 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 126.099 1.76 . . . . 0.0 106.781 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.11 102.36 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.635 1.174 . . . . 0.0 112.17 -171.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.21 149.07 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.96 109.04 15.95 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 p -80.61 33.06 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 122.548 1.166 . . . . 0.0 112.347 -162.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.3 pt -63.88 -12.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.633 2.373 . . . . 0.0 115.431 -159.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.73 13.61 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 122.571 1.095 . . . . 0.0 111.825 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -117.42 140.81 49.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 163.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.4 mt -72.51 94.82 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 157.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -77.4 -32.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.725 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -153.77 163.45 40.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.821 0.819 . . . . 0.0 111.385 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.62 31.41 54.14 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.283 0.944 . . . . 0.0 112.361 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.77 -54.01 51.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.619 1.209 . . . . 0.0 111.268 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.72 -17.41 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.766 -0.584 . . . . 0.0 112.141 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.4 -11.75 25.39 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 124.008 0.923 . . . . 0.0 110.828 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.9 -25.76 32.17 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.704 1.138 . . . . 0.0 112.428 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.95 -20.79 62.42 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.711 -1.243 . . . . 0.0 111.485 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.57 28.85 5.23 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.634 2.773 . . . . 0.0 111.108 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.92 166.43 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 127.895 2.478 . . . . 0.0 107.276 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -127.27 -169.51 2.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.323 -1.486 . . . . 0.0 111.264 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -78.43 11.87 2.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.561 1.544 . . . . 0.0 113.854 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.89 79.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.576 0 O-C-N 120.423 -1.423 . . . . 0.0 111.496 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -130.52 40.14 3.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.95 2.1 . . . . 0.0 109.584 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 43.77 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.162 2.585 . . . . 0.0 114.047 163.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.5 p -81.8 111.14 17.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.7 13.4 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.1 t -86.17 126.16 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 127.717 2.407 . . . . 0.0 107.674 -168.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -135.92 172.12 13.47 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.533 1.97 . . . . 0.0 111.428 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -72.24 -11.1 60.57 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.04 0 C-N-CA 125.517 1.527 . . . . 0.0 114.249 179.022 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpp . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 121.359 0.599 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -78.9 163.62 25.12 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 123.067 0.547 . . . . 0.0 109.582 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.3 t -148.02 146.29 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.518 168.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -120.77 131.62 54.59 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.488 1.915 . . . . 0.0 105.844 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.3 mt -108.71 121.28 44.72 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 tt -123.66 142.13 51.35 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -167.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 11' ' ' LYS . 5.9 m-85 -134.32 172.13 13.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 119.674 1.125 . . . . 0.0 110.438 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.207 -0.308 . . . . 0.0 110.71 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 m -101.4 -5.65 25.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.02 -163.58 33.82 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 120.931 1.696 . . . . 0.0 111.476 -169.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -160.42 165.1 31.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.7 1.25 . . . . 0.0 110.261 173.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.7 p -146.73 178.0 8.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.469 1.108 . . . . 0.0 111.529 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -133.85 130.18 55.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.141 0.976 . . . . 0.0 108.585 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.9 pt -128.01 147.08 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.435 0.694 . . . . 0.0 109.173 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -131.11 127.77 38.78 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 116.188 1.921 . . . . 0.0 116.188 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.91 126.24 45.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.433 1.708 . . . . 0.0 111.563 -161.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -69.6 122.54 19.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.185 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.95 6.6 1.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -85.89 -5.82 59.17 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 120.943 -1.098 . . . . 0.0 110.57 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -105.24 143.14 33.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.09 0.956 . . . . 0.0 109.932 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -45.36 -58.84 3.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.889 1.676 . . . . 0.0 109.427 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.92 -35.87 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.749 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -63.42 -42.99 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.489 1.041 . . . . 0.0 108.909 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -61.53 -44.32 97.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.685 0.794 . . . . 0.0 111.599 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -37.61 78.38 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.338 -1.476 . . . . 0.0 110.905 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.76 -39.83 65.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.842 1.657 . . . . 0.0 110.483 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -62.43 -31.79 72.55 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 123.037 0.535 . . . . 0.0 111.368 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -72.17 -8.92 57.4 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.37 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -131.05 30.25 4.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.93 1.692 . . . . 0.0 110.296 -173.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.43 144.27 52.17 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -63.84 158.96 67.78 Favored 'Cis proline' 0 N--CA 1.459 -0.503 0 CA-C-N 119.029 0.689 . . . . 0.0 113.604 -8.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -150.16 160.85 43.36 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 124.068 0.947 . . . . 0.0 110.682 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -114.45 160.21 19.44 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.187 0.995 . . . . 0.0 108.356 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.56 172.5 10.68 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.536 -0.727 . . . . 0.0 110.297 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.15 124.03 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -81.57 74.97 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 123.574 0.749 . . . . 0.0 110.356 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -68.07 163.94 21.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.858 0.754 . . . . 0.0 110.251 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.3 p -137.51 155.64 49.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.42 . . . . 0.0 110.197 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -155.6 99.19 2.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.41 -62.27 2.69 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 124.25 0.928 . . . . 0.0 115.18 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -168.75 40.56 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.958 1.703 . . . . 0.0 109.246 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.78 167.05 31.65 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.8 mt -135.39 133.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.027 1.331 . . . . 0.0 109.357 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.95 159.25 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.968 0.907 . . . . 0.0 109.648 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -145.27 157.72 43.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.795 -1.191 . . . . 0.0 108.882 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -76.3 98.01 4.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.048 0.939 . . . . 0.0 109.4 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.1 p -68.93 144.79 96.16 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.142 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.7 -28.95 7.62 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.001 2.467 . . . . 0.0 111.003 175.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -67.25 140.21 19.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -121.66 114.98 21.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.94 154.18 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -134.71 21.37 3.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.604 0.761 . . . . 0.0 112.861 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -94.48 119.61 33.45 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.13 1.372 . . . . 0.0 110.94 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.81 112.87 14.02 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.588 1.155 . . . . 0.0 111.84 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.04 -25.95 36.74 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.504 1.122 . . . . 0.0 113.138 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -133.94 60.55 46.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 119.037 0.835 . . . . 0.0 110.675 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.4 95.38 0.61 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.924 2.416 . . . . 0.0 108.876 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.7 mtt-85 -85.35 169.31 13.84 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -123.94 4.71 8.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.743 0.417 . . . . 0.0 111.679 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.7 t -139.92 151.37 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.91 1.684 . . . . 0.0 106.659 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.47 -175.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.323 1.849 . . . . 0.0 109.503 -172.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -114.98 -179.3 3.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.272 1.029 . . . . 0.0 110.303 167.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.13 10.15 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 126.649 1.98 . . . . 0.0 110.999 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.39 32.26 1.87 Allowed Glycine 0 CA--C 1.524 0.65 0 O-C-N 120.165 -1.584 . . . . 0.0 112.371 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -123.5 169.74 11.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.35 1.075 . . . . 0.0 109.66 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -139.91 114.76 7.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 -177.46 48.69 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.103 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -131.11 138.7 49.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -116.46 82.63 12.37 Favored Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.55 -47.25 22.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.669 2.246 . . . . 0.0 114.449 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.26 -22.45 40.17 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.167 2.578 . . . . 0.0 111.141 -165.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.53 26.43 6.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.522 1.058 . . . . 0.0 113.165 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mttt 46.25 50.92 11.77 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.417 1.487 . . . . 0.0 112.174 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.7 -177.86 4.75 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.061 0.544 . . . . 0.0 110.973 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 2.7 tp -104.8 -170.96 1.84 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.047 1.739 . . . . 0.0 109.296 172.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.422 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -156.32 153.13 28.54 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.191 1.796 . . . . 0.0 110.05 158.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.57 102.37 4.59 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.986 2.514 . . . . 0.0 105.15 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -91.06 116.11 28.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.216 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -141.88 15.23 2.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.06 -146.1 4.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 104.75 8.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -69.28 166.27 31.19 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.502 2.321 . . . . 0.0 113.284 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.98 6.52 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 125.248 3.965 . . . . 0.0 113.419 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.89 136.38 53.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.164 1.785 . . . . 0.0 107.061 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.73 163.52 0.25 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 128.834 2.854 . . . . 0.0 109.679 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.67 -42.51 2.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.97 -81.25 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.428 0.632 . . . . 0.0 111.223 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -98.94 153.84 18.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 127.334 2.254 . . . . 0.0 107.859 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.9 126.81 15.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 124.358 1.063 . . . . 0.0 109.05 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -126.96 150.42 71.8 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.16 0.984 . . . . 0.0 113.064 167.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.3 -174.43 2.2 Favored 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 126.315 4.677 . . . . 0.0 113.284 174.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.03 -10.1 59.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 t -173.84 -176.52 1.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.86 1.264 . . . . 0.0 108.806 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.28 73.81 0.5 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.414 1.486 . . . . 0.0 111.766 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.4 141.56 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.548 . . . . 0.0 110.31 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -74.76 125.47 28.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.91 49.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.78 -21.77 29.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.684 -172.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.45 164.03 13.44 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 119.631 1.105 . . . . 0.0 112.275 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -129.65 145.63 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.528 1.131 . . . . 0.0 108.352 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mt -76.09 101.67 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.83 -22.23 6.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.972 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -155.63 159.07 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.908 0.883 . . . . 0.0 111.652 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.96 11.02 70.93 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 118.746 -1.03 . . . . 0.0 115.145 169.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 tp -51.74 -48.25 63.74 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.005 1.403 . . . . 0.0 111.369 -172.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -70.2 -19.37 63.17 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 120.785 -1.197 . . . . 0.0 111.971 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.2 -0.67 32.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.247 1.019 . . . . 0.0 111.784 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.89 -39.01 61.73 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 119.954 -1.717 . . . . 0.0 111.567 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.422 ' H ' ' HD2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -63.68 -23.74 67.5 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.995 -1.066 . . . . 0.0 111.91 -172.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -94.45 23.0 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 0.0 112.679 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.46 165.63 2.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.397 1.479 . . . . 0.0 107.168 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -125.86 171.08 11.0 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.91 1.684 . . . . 0.0 108.095 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.01 1.91 2.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.218 2.207 . . . . 0.0 114.738 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.41 74.79 0.12 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.74 29.98 5.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.056 2.143 . . . . 0.0 110.029 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.4 mttt 43.07 101.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.611 2.764 . . . . 0.0 113.937 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.2 167.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 116.126 -2.23 . . . . 0.0 105.325 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -135.47 109.82 8.42 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 154.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.9 t -78.53 126.26 38.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 125.337 1.455 . . . . 0.0 107.087 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 mtm105 -128.92 176.04 8.18 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 0.0 110.231 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -72.53 -6.94 47.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.781 0 C-N-CA 126.81 2.044 . . . . 0.0 112.419 -170.409 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 ttm . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -68.4 160.88 28.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.048 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.1 t -152.94 143.48 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 126.613 1.965 . . . . 0.0 107.126 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -135.93 112.55 10.06 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 119.889 -1.757 . . . . 0.0 108.499 -171.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.57 92.26 9.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 131.412 3.885 . . . . 0.0 108.631 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.61 152.4 40.56 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 164.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -131.63 177.82 7.22 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.879 1.672 . . . . 0.0 107.62 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.18 -44.56 83.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m -86.16 -15.4 41.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -172.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.93 -165.49 34.0 Favored Glycine 0 N--CA 1.467 0.717 0 CA-C-N 120.734 1.606 . . . . 0.0 110.942 -166.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 138.01 8.94 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.915 1.358 . . . . 0.0 110.259 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.515 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 24.1 m -140.11 164.2 30.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.607 1.163 . . . . 0.0 111.772 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.29 112.67 21.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.428 1.091 . . . . 0.0 108.64 -167.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 pt -101.63 139.28 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.12 110.34 21.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -109.82 122.78 48.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.534 1.134 . . . . 0.0 109.708 -167.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 49.6 t30 -84.64 125.3 32.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.52 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.54 -1.82 12.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.597 1.559 . . . . 0.0 113.538 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.2 -21.14 64.88 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.139 0.881 . . . . 0.0 109.638 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 16.2 m-85 -92.79 124.63 36.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.321 1.448 . . . . 0.0 110.049 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -47.4 -53.91 12.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.241 1.817 . . . . 0.0 111.495 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -44.65 -40.43 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -71.76 -42.09 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.023 1.283 . . . . 0.0 109.958 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -59.26 -37.73 78.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.662 0.785 . . . . 0.0 110.085 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.49 -34.9 54.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.007 1.323 . . . . 0.0 109.983 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.97 -23.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.493 1.117 . . . . 0.0 112.052 172.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -14.4 50.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.742 1.156 . . . . 0.0 111.993 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -86.57 -14.37 43.07 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 120.723 -1.236 . . . . 0.0 112.25 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -124.93 4.58 8.02 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.433 1.093 . . . . 0.0 113.205 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.6 mt -104.6 141.33 22.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 120.1 1.318 . . . . 0.0 107.507 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.32 159.35 94.26 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.294 -0.711 . . . . 0.0 112.589 -6.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -140.21 164.62 29.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 122.125 -0.359 . . . . 0.0 110.055 165.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -124.26 150.4 45.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.3 161.91 37.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.006 -172.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.01 123.07 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.69 98.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -85.77 155.14 21.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 165.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -131.79 144.55 51.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 108.731 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -154.1 102.63 2.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.47 19.76 79.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 116.45 -2.306 . . . . 0.0 116.674 154.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 76.94 37.96 0.27 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.851 2.826 . . . . 0.0 112.566 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -131.71 163.74 27.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.612 1.965 . . . . 0.0 106.187 150.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.0 mt -127.79 146.24 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 127.009 2.124 . . . . 0.0 107.097 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -134.95 169.32 17.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 122.678 1.228 . . . . 0.0 109.715 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -149.99 150.55 31.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -88.75 82.79 6.74 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -167.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 p -65.26 147.92 98.28 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -165.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.19 -26.22 12.86 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.623 2.216 . . . . 0.0 112.072 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.3 136.46 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -122.66 100.02 6.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.733 1.613 . . . . 0.0 107.38 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.04 171.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 129.034 2.934 . . . . 0.0 104.669 165.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.94 3.14 2.0 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 166.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -44.81 118.84 1.74 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.918 1.287 . . . . 0.0 111.053 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtm -108.72 90.59 3.34 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.78 2.032 . . . . 0.0 106.042 -171.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -67.94 -26.88 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.455 -0.778 . . . . 0.0 111.466 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -153.7 54.83 1.2 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.141 1.776 . . . . 0.0 113.692 -167.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.58 162.97 19.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.762 1.642 . . . . 0.0 111.993 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -146.63 -175.71 4.9 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 128.331 2.652 . . . . 0.0 106.489 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -120.28 1.15 10.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.322 1.049 . . . . 0.0 112.916 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.62 159.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.269 2.227 . . . . 0.0 108.998 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG23 ' CD2' ' A' ' 78' ' ' PHE . 24.6 m -141.3 -179.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.809 2.044 . . . . 0.0 109.233 -172.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -88.76 178.56 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 120.722 -1.236 . . . . 0.0 110.844 163.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.7 mt -76.56 4.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.489 1.516 . . . . 0.0 110.261 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 43.07 0.67 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -111.78 -154.47 0.54 Allowed 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 129.368 3.067 . . . . 0.0 103.412 161.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.536 ' CG1' ' HA3' ' A' ' 99' ' ' GLY . 4.9 p -158.72 177.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -143.89 152.26 24.06 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 119.641 -1.912 . . . . 0.0 111.55 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -105.22 123.84 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.321 1.048 . . . . 0.0 109.189 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -104.76 88.29 2.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 127.403 2.281 . . . . 0.0 109.246 -172.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -61.64 -31.15 86.55 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.033 1.822 . . . . 0.0 115.366 -171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.17 -36.7 20.65 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 123.48 2.278 . . . . 0.0 109.463 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.93 64.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.138 -1.368 . . . . 0.0 113.501 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 45.78 55.63 6.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.388 2.094 . . . . 0.0 108.904 -166.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.83 157.83 44.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.55 176.16 6.79 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.32 124.54 7.5 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.871 1.268 . . . . 0.0 108.855 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.19 115.17 29.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.72 2.408 . . . . 0.0 107.553 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.402 ' CD2' HG23 ' A' ' 61' ' ' VAL . 1.9 m-85 -107.73 110.45 22.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.862 1.21 . . . . 0.0 108.204 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -125.77 11.24 7.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.695 0.798 . . . . 0.0 112.826 -170.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.64 -128.6 0.96 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 165.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -132.77 107.91 8.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.119 1.459 . . . . 0.0 110.584 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -64.85 165.51 15.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 126.655 1.982 . . . . 0.0 113.383 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.93 7.49 1.31 Allowed 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.889 4.393 . . . . 0.0 114.523 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.1 mmt -116.08 81.37 1.6 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.529 -1.357 . . . . 0.0 109.505 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 p 174.92 -177.03 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.041 2.137 . . . . 0.0 107.632 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -127.94 -59.51 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 143.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -81.4 -37.34 28.3 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.43 162.36 34.65 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.427 1.491 . . . . 0.0 107.733 -165.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.13 83.97 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 121.373 1.897 . . . . 0.0 108.334 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.68 146.29 52.69 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 126.768 2.027 . . . . 0.0 109.923 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.53 -175.34 1.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.932 3.755 . . . . 0.0 112.043 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -38.98 61.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.145 1.378 . . . . 0.0 113.751 168.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.24 174.25 3.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.661 1.584 . . . . 0.0 109.118 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.37 103.02 0.05 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.6 1.56 . . . . 0.0 111.31 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.21 142.7 23.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.446 1.099 . . . . 0.0 109.734 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -79.58 125.45 29.62 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -90.06 71.06 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.5 pt -87.4 -32.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.536 ' HA3' ' CG1' ' A' ' 66' ' ' VAL . . . -75.74 169.41 54.77 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 161.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.63 147.56 35.23 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 101.948 -3.352 . . . . 0.0 101.948 131.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.99 83.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 156.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.4 -41.0 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 120.558 -1.339 . . . . 0.0 111.016 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.49 150.09 46.07 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 125.739 1.615 . . . . 0.0 108.713 -169.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.515 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 78.35 78.08 0.83 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tp -108.77 -60.52 1.73 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.164 1.786 . . . . 0.0 110.108 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.49 -23.22 58.83 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.47 -0.769 . . . . 0.0 110.439 -172.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -24.11 54.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.415 1.086 . . . . 0.0 111.085 173.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.46 -29.57 56.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.399 0.999 . . . . 0.0 112.027 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -72.4 17.85 0.1 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.952 -1.092 . . . . 0.0 112.74 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -147.85 23.34 1.1 Allowed 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 126.124 1.77 . . . . 0.0 112.437 -178.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.2 mm -105.82 141.05 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 43.3 mmtt -85.18 174.73 9.44 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.4 1.48 . . . . 0.0 109.842 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.61 43.2 0.73 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.674 1.59 . . . . 0.0 112.643 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.43 64.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.385 0 O-C-N 120.12 -1.613 . . . . 0.0 111.91 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 6.2 mm-40 -122.22 24.64 9.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.025 1.73 . . . . 0.0 112.405 -172.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mttp 43.41 86.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.632 2.373 . . . . 0.0 113.494 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.69 104.81 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.804 -0.56 . . . . 0.0 109.522 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.71 96.8 7.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.824 1.65 . . . . 0.0 109.59 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.1 t -77.42 117.64 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.779 2.432 . . . . 0.0 108.177 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.7 173.74 10.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.92 1.288 . . . . 0.0 109.821 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -79.55 -10.6 59.83 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 121.547 1.976 . . . . 0.0 115.602 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 127.016 2.126 . . . . 0.0 111.067 -175.591 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttm . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.674 1.225 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.9 mtm-85 -67.2 161.19 25.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.66 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 t -146.73 105.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.521 1.128 . . . . 0.0 107.978 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.78 142.15 34.05 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.636 -1.29 . . . . 0.0 109.403 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.98 97.69 5.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.044 0.938 . . . . 0.0 111.48 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 148.41 25.51 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.98 175.94 8.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.946 1.698 . . . . 0.0 110.36 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -78.2 -5.12 50.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -132.85 5.17 3.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -167.87 39.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -158.95 163.69 36.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.45 1.1 . . . . 0.0 108.25 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 p -161.73 179.87 7.78 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 130.198 3.399 . . . . 0.0 103.862 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.524 ' CG1' ' CG2' ' A' ' 102' ' ' VAL . 4.0 p -149.68 150.85 13.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 112.126 -2.306 . . . . 0.0 105.115 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -129.79 114.99 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 124.675 1.19 . . . . 0.0 109.246 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -89.45 107.52 19.12 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.7 -170.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.59 138.61 46.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.768 0.713 . . . . 0.0 110.586 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -87.98 149.51 23.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.742 -0.599 . . . . 0.0 109.69 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.38 -0.66 53.51 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.622 1.169 . . . . 0.0 114.135 -164.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -96.21 5.72 50.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.134 1.374 . . . . 0.0 109.024 -167.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -111.53 133.29 53.91 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.014 2.126 . . . . 0.0 109.178 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.71 -51.7 66.4 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.402 1.081 . . . . 0.0 110.218 -170.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -49.74 -36.06 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.452 1.501 . . . . 0.0 114.456 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.07 -39.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 119.786 1.175 . . . . 0.0 109.283 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.38 -37.5 80.97 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 0.0 110.427 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.0 -36.23 30.93 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.936 0.894 . . . . 0.0 110.735 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.08 -28.32 66.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.361 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -58.52 -26.91 64.0 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.677 0.671 . . . . 0.0 111.591 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -68.12 -26.13 65.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.989 0.813 . . . . 0.0 110.541 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -124.22 24.3 8.13 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 120.952 -1.093 . . . . 0.0 112.614 -160.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.7 mt -115.61 153.38 47.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.449 1.477 . . . . 0.0 108.335 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.26 160.83 23.75 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.067 -1.222 . . . . 0.0 111.341 -24.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -146.85 171.34 15.35 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.224 1.41 . . . . 0.0 109.756 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -122.25 162.58 21.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.252 1.021 . . . . 0.0 109.408 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 -179.92 6.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.063 0.545 . . . . 0.0 109.807 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.15 142.26 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG21 ' HB ' ' A' ' 117' ' ' VAL . 18.3 t -91.65 76.35 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.943 1.297 . . . . 0.0 107.803 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -69.82 156.48 38.98 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.899 -1.126 . . . . 0.0 108.912 175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.5 p -136.45 137.81 40.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.281 1.032 . . . . 0.0 109.956 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 67.9 t90 -142.58 75.6 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.454 1.502 . . . . 0.0 108.163 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.13 81.53 0.19 Allowed Glycine 0 C--O 1.218 -0.847 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.987 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 51.6 63.44 2.24 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 118.367 1.084 . . . . 0.0 109.253 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.9 154.87 15.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -131.66 144.09 38.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -148.74 170.62 17.79 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.332 1.453 . . . . 0.0 109.945 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.42 144.13 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.291 1.036 . . . . 0.0 109.256 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -74.85 84.95 2.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.796 2.038 . . . . 0.0 109.384 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 p -61.78 152.32 76.25 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-O 121.413 0.625 . . . . 0.0 111.869 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -81.18 0.23 10.11 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.13 3.22 . . . . 0.0 112.584 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.55 134.19 47.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 125.12 1.368 . . . . 0.0 108.541 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -114.97 18.03 16.59 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.92 0.888 . . . . 0.0 112.589 -168.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.33 150.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.739 0.781 . . . . 0.0 112.354 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -135.76 40.9 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.758 2.423 . . . . 0.0 108.586 -172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -121.61 105.84 10.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.105 2.162 . . . . 0.0 111.165 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -93.19 130.79 38.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.359 1.463 . . . . 0.0 109.716 171.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.32 -44.88 8.48 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.683 -0.636 . . . . 0.0 110.864 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -114.46 60.67 1.09 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.121 0.968 . . . . 0.0 109.581 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.12 144.67 42.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.36 2.04 . . . . 0.0 112.593 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -143.64 164.97 28.91 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.533 0.733 . . . . 0.0 109.751 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.07 12.98 18.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.414 1.886 . . . . 0.0 110.51 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -166.78 150.93 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 129.987 3.315 . . . . 0.0 110.016 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.09 -175.49 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.94 1.296 . . . . 0.0 111.74 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -94.58 175.48 6.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.821 1.248 . . . . 0.0 110.817 170.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.7 mt -81.44 33.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.692 1.597 . . . . 0.0 111.074 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.96 34.67 0.2 Allowed Glycine 0 CA--C 1.511 -0.207 0 O-C-N 120.369 -1.457 . . . . 0.0 111.888 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -121.6 -175.28 3.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.214 1.006 . . . . 0.0 108.35 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -139.12 164.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.182 1.793 . . . . 0.0 107.6 -168.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -165.34 129.12 1.89 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.49 144.5 49.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -114.34 86.79 12.57 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.424 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 68.8 Cg_endo -65.98 -22.23 55.68 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.243 2.629 . . . . 0.0 117.512 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 42.7 Cg_endo -80.48 -19.1 9.15 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 CA-C-N 123.007 2.11 . . . . 0.0 112.096 -171.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.35 -9.67 11.41 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.615 1.579 . . . . 0.0 114.137 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 58.83 84.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.094 2.157 . . . . 0.0 111.299 -164.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.28 175.92 13.23 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.457 HD11 ' H ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -87.14 -172.42 3.95 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.687 1.595 . . . . 0.0 110.928 162.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.457 ' H ' HD11 ' A' ' 75' ' ' LEU . 15.8 t -158.22 149.8 21.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.866 1.666 . . . . 0.0 109.09 161.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.46 128.86 47.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.99 2.516 . . . . 0.0 109.448 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.05 112.91 24.01 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 125.011 1.324 . . . . 0.0 109.363 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -134.33 5.55 3.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.767 2.427 . . . . 0.0 113.459 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.18 -168.32 40.43 Favored Glycine 0 CA--C 1.52 0.405 0 O-C-N 119.978 -1.701 . . . . 0.0 110.707 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.08 102.27 14.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -163.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.8 p -74.79 166.33 46.22 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 110.824 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.5 -19.88 48.31 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.362 2.708 . . . . 0.0 113.334 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.7 tpt -97.41 50.69 1.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.229 1.011 . . . . 0.0 110.317 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.0 p -158.93 177.84 10.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.147 0.579 . . . . 0.0 110.26 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.52 -62.46 0.87 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 148.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.05 -49.04 21.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.116 0.96 . . . . 0.0 111.912 -166.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -136.7 158.7 43.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.239 1.816 . . . . 0.0 108.205 -164.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mt -79.6 83.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.56 143.64 59.61 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.807 1.643 . . . . 0.0 111.398 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -81.97 174.99 9.67 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.436 3.424 . . . . 0.0 112.284 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.97 -20.5 65.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 m -156.93 170.35 22.7 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.81 2.444 . . . . 0.0 108.892 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.11 0.51 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.852 0.751 . . . . 0.0 109.848 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.89 -165.62 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 128.275 2.63 . . . . 0.0 107.396 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -139.8 127.37 21.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 112.511 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 32.75 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.432 -1.418 . . . . 0.0 111.1 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -61.25 -15.63 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 119.68 -1.887 . . . . 0.0 113.698 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.73 165.83 15.32 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -134.7 126.18 28.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 170.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.78 93.17 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 166.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.524 ' CG2' ' CG1' ' A' ' 13' ' ' VAL . 30.8 m -76.42 -63.32 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.405 ' H ' HG12 ' A' ' 13' ' ' VAL . 1.1 mm-40 -93.07 166.03 12.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -172.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.38 16.57 80.62 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-N 115.241 -0.89 . . . . 0.0 114.793 158.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.88 -62.61 1.55 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.162 0.985 . . . . 0.0 109.276 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.35 -21.2 62.92 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.176 -167.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.5 -19.83 64.55 Favored 'General case' 0 C--O 1.225 -0.23 0 O-C-N 121.67 -0.644 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.61 -18.52 65.38 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.618 -1.301 . . . . 0.0 113.44 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -59.11 -29.54 67.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.086 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 27.86 9.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.653 1.115 . . . . 0.0 112.879 -163.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.61 150.55 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.84 170.67 9.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.92 15.81 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.643 2.377 . . . . 0.0 112.932 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.71 54.67 0.09 OUTLIER Glycine 0 CA--C 1.533 1.173 0 O-C-N 119.206 -2.184 . . . . 0.0 114.758 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -100.3 32.35 3.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.938 1.295 . . . . 0.0 113.274 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.8 mttp 42.03 74.78 0.1 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.309 1.844 . . . . 0.0 112.619 171.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.407 ' HB ' HG21 ' A' ' 36' ' ' VAL . 7.5 p -68.14 105.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.25 88.91 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.39 1.476 . . . . 0.0 107.185 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.51 134.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 126.704 2.002 . . . . 0.0 108.648 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -141.93 -172.21 3.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.231 1.812 . . . . 0.0 110.332 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -99.9 0.1 40.62 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.262 0 C-N-CA 126.989 2.116 . . . . 0.0 112.718 -169.617 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.236 0.363 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 152.92 42.83 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.9 t -150.91 130.98 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.267 1.427 . . . . 0.0 107.613 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -115.56 120.53 39.77 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.516 2.326 . . . . 0.0 107.01 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.25 109.34 22.11 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 126.884 2.074 . . . . 0.0 106.903 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 126.94 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -110.11 173.03 6.51 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.069 0.948 . . . . 0.0 108.445 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.55 -17.66 62.3 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.046 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -115.48 4.59 14.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.594 1.557 . . . . 0.0 114.666 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.75 -164.98 38.38 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.642 -1.286 . . . . 0.0 110.724 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -157.83 158.63 35.53 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.067 0.947 . . . . 0.0 109.079 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -145.38 177.31 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.998 0.919 . . . . 0.0 108.971 174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 t -135.11 133.29 53.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.0 pt -122.66 166.32 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -144.7 135.99 25.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.32 114.93 19.55 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 126.686 1.994 . . . . 0.0 108.627 -168.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.92 132.25 52.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.381 0.673 . . . . 0.0 110.411 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.68 21.05 0.21 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.311 1.444 . . . . 0.0 113.842 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.0 10.24 22.16 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.329 1.052 . . . . 0.0 110.454 -173.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -122.72 137.33 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.589 1.156 . . . . 0.0 108.938 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.94 -53.67 30.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.963 0.905 . . . . 0.0 110.458 -173.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.37 -32.25 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.36 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.26 -50.45 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.855 1.262 . . . . 0.0 107.886 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -58.71 -43.83 90.19 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.155 0.582 . . . . 0.0 110.942 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -41.97 90.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.766 0.826 . . . . 0.0 109.351 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.34 -28.6 54.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.93 1.292 . . . . 0.0 111.112 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -60.74 -29.96 69.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.713 0.688 . . . . 0.0 110.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -72.35 -14.42 61.72 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.595 0.758 . . . . 0.0 111.863 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -125.29 24.47 7.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.769 1.628 . . . . 0.0 110.982 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mt -121.56 136.86 26.33 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.26 164.97 57.82 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 N-CA-C 114.772 1.028 . . . . 0.0 114.772 -7.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.26 165.49 35.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.686 0.794 . . . . 0.0 112.136 166.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -121.78 160.11 25.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.366 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -163.57 -159.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.432 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.12 134.49 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.075 1.35 . . . . 0.0 108.606 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.38 76.34 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 124.884 1.274 . . . . 0.0 108.111 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -69.31 144.96 53.39 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.256 -1.527 . . . . 0.0 107.615 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.5 p -129.07 147.31 50.92 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.624 0.647 . . . . 0.0 110.215 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -151.79 64.32 0.86 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.725 0.81 . . . . 0.0 109.685 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.91 77.72 0.48 Allowed Glycine 0 C--O 1.211 -1.298 0 O-C-N 120.98 -1.075 . . . . 0.0 111.581 170.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 62.06 23.0 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.106 1.453 . . . . 0.0 112.333 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -126.49 145.98 50.29 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.649 2.38 . . . . 0.0 107.317 171.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mt -122.73 144.48 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 163.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.08 158.17 43.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 166.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -141.89 153.85 44.7 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.2 t -79.91 104.54 10.55 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -68.43 149.64 97.96 Favored Pre-proline 0 N--CA 1.447 -0.588 0 O-C-N 121.813 -0.554 . . . . 0.0 110.008 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.72 -36.85 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.076 2.518 . . . . 0.0 110.793 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 149.36 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -132.2 121.87 24.35 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.539 1.936 . . . . 0.0 106.048 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.9 143.81 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -128.54 36.37 4.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.3 1.04 . . . . 0.0 111.31 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -128.91 114.87 17.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.093 2.557 . . . . 0.0 107.623 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 162.27 13.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.443 1.097 . . . . 0.0 109.933 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.2 -39.8 3.56 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.996 1.719 . . . . 0.0 110.517 166.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -122.0 60.85 12.65 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.174 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.61 131.49 29.74 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.007 1.138 . . . . 0.0 110.61 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -129.79 124.94 34.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -90.19 0.48 57.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.339 0.518 . . . . 0.0 111.919 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -137.29 135.58 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.65 173.27 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.959 -167.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -115.65 168.02 10.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.937 0.875 . . . . 0.0 112.866 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.2 mt -78.52 68.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.789 2.035 . . . . 0.0 106.85 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.77 -1.14 0.16 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.406 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.3 174.54 7.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.306 2.053 . . . . 0.0 109.564 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.29 146.55 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.181 1.392 . . . . 0.0 107.941 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.64 161.03 26.18 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.316 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -81.21 146.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 168.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -121.03 85.43 40.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.897 1.279 . . . . 0.0 108.382 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.05 -38.96 84.57 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.382 2.055 . . . . 0.0 115.854 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.5 -28.5 32.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.673 2.249 . . . . 0.0 109.814 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.82 4.52 75.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.028 -1.429 . . . . 0.0 114.535 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.96 25.84 4.29 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.47 2.135 . . . . 0.0 112.728 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.44 178.1 7.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.08 -158.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -172.97 4.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.166 166.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.7 m -148.25 158.37 44.04 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.888 2.475 . . . . 0.0 107.02 161.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mt -146.62 114.25 6.4 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.138 1.775 . . . . 0.0 109.488 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -102.73 106.22 16.81 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.103 0.961 . . . . 0.0 110.335 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -138.28 18.25 2.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.47 -134.25 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.148 0.885 . . . . 0.0 111.514 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -127.64 94.44 3.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.67 154.26 85.42 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.86 1.664 . . . . 0.0 111.222 -175.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.97 5.36 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 125.087 3.858 . . . . 0.0 113.685 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.98 24.75 12.3 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.379 1.472 . . . . 0.0 109.212 175.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.46 166.63 23.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.552 1.541 . . . . 0.0 107.985 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -153.17 -68.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -170.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -73.69 -50.83 18.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 122.206 1.003 . . . . 0.0 111.106 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.77 177.57 7.15 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 130.369 3.467 . . . . 0.0 107.187 -173.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -80.89 141.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.99 1.268 . . . . 0.0 108.62 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -141.46 144.87 35.43 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.02 0.928 . . . . 0.0 110.236 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.1 169.58 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.501 3.467 . . . . 0.0 113.911 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.16 64.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.7 p -164.52 -168.86 1.61 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.475 1.11 . . . . 0.0 108.195 165.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 76.9 0.12 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.697 0.761 . . . . 0.0 111.567 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.52 169.84 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.765 1.226 . . . . 0.0 109.242 165.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -114.71 129.16 56.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.866 1.266 . . . . 0.0 109.729 171.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.83 86.13 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.6 pt -103.73 -22.64 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 110.504 170.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.03 163.64 12.51 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -128.41 145.32 51.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.246 1.018 . . . . 0.0 108.596 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 91.9 mt -74.08 102.39 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 158.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -27.88 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 112.783 -2.008 . . . . 0.0 107.293 -167.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -155.86 161.45 40.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.022 2.529 . . . . 0.0 112.299 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.85 30.78 37.79 Favored Glycine 0 C--O 1.221 -0.674 0 CA-C-O 118.205 -1.331 . . . . 0.0 113.284 172.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.73 -41.36 97.53 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.142 1.971 . . . . 0.0 113.17 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.81 -19.87 47.46 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.121 -0.987 . . . . 0.0 111.246 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.3 -22.72 63.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.705 1.202 . . . . 0.0 110.371 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.04 -34.42 77.65 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.167 1.787 . . . . 0.0 110.285 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -67.56 -2.62 6.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -100.9 -16.03 17.35 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 123.929 0.892 . . . . 0.0 112.01 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.02 165.27 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.01 0.823 . . . . 0.0 109.65 -165.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -113.69 -179.76 3.73 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.202 1.401 . . . . 0.0 108.449 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.16 22.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.028 2.131 . . . . 0.0 114.876 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.99 26.81 0.03 OUTLIER Glycine 0 C--N 1.338 0.666 0 O-C-N 119.817 -1.802 . . . . 0.0 115.907 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.06 49.05 1.04 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.806 1.803 . . . . 0.0 112.052 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.2 mttt 42.98 82.53 0.03 OUTLIER 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.263 2.225 . . . . 0.0 114.161 157.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.73 104.09 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.415 1.486 . . . . 0.0 107.699 175.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.37 101.07 13.21 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.72 134.01 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 128.58 2.752 . . . . 0.0 107.632 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -138.98 175.36 9.62 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.194 2.598 . . . . 0.0 109.634 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -73.6 -10.2 59.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 121.025 1.739 . . . . 0.0 114.884 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.821 0 C-N-CA 126.097 1.759 . . . . 0.0 111.105 -154.055 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpp . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -112.82 179.68 3.9 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.51 1.924 . . . . 0.0 107.706 162.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.5 t -147.59 150.31 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.274 2.229 . . . . 0.0 106.838 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -125.23 145.71 49.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.705 2.002 . . . . 0.0 107.256 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.8 mt -121.98 111.96 17.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.99 122.17 44.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -106.8 172.08 7.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.4 -23.82 67.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.588 0.755 . . . . 0.0 111.562 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -125.26 8.74 7.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -167.79 40.84 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-O 119.527 -0.596 . . . . 0.0 111.816 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -159.2 153.66 24.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.831 0.815 . . . . 0.0 111.117 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.0 p -136.8 179.42 6.38 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.426 0.691 . . . . 0.0 110.595 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.61 135.22 49.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.51 124.45 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -96.31 117.89 31.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.986 1.314 . . . . 0.0 107.754 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -128.12 135.72 50.18 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 118.848 0.749 . . . . 0.0 109.715 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -101.04 106.78 18.1 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.01 1.71 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 1 C-N-CA 131.836 4.054 . . . . 0.0 117.151 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.76 -44.21 64.45 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.635 -1.29 . . . . 0.0 107.953 164.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -62.6 139.69 58.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 110.194 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.74 -56.35 16.19 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.283 1.833 . . . . 0.0 107.28 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -57.45 -38.64 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.042 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.36 -35.62 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.001 -170.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -61.25 -47.32 86.57 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.876 -0.515 . . . . 0.0 111.008 170.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -32.25 71.36 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.719 1.208 . . . . 0.0 110.417 -171.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' CD2' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -59.94 -40.99 90.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.389 1.876 . . . . 0.0 109.825 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -50.42 -36.19 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.897 0.879 . . . . 0.0 110.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -69.89 -23.83 63.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.615 0.766 . . . . 0.0 111.622 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -113.13 -10.35 13.43 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 111.336 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -83.21 143.57 45.47 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -70.17 149.72 90.02 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 125.47 -0.637 . . . . 0.0 112.229 -10.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -139.48 168.33 20.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.124 0.97 . . . . 0.0 109.802 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -114.13 166.0 12.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.32 161.24 39.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.603 -0.685 . . . . 0.0 109.928 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.76 128.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 t -77.62 107.45 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 167.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -96.61 151.23 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 163.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.4 p -122.46 149.97 43.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.214 1.006 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -149.43 92.88 1.99 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.2 -88.17 0.49 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 123.646 0.641 . . . . 0.0 111.758 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -141.43 36.74 1.68 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.972 1.709 . . . . 0.0 107.944 -173.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -133.17 163.84 28.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 109.681 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.0 mt -123.07 142.59 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -136.46 161.56 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.588 1.555 . . . . 0.0 107.303 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.39 142.83 27.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -75.2 93.33 2.81 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.566 1.146 . . . . 0.0 109.325 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.1 p -62.29 150.92 83.51 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -67.9 -39.04 11.91 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.107 2.538 . . . . 0.0 110.914 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.475 HG12 ' CD2' ' A' ' 26' ' ' LEU . 11.9 p -67.24 155.25 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.595 -0.69 . . . . 0.0 109.673 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -154.63 56.11 0.68 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.329 0.652 . . . . 0.0 112.464 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.12 173.3 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 0.0 110.103 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.0 14.03 2.26 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -69.94 127.76 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -136.03 93.99 2.99 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.827 1.251 . . . . 0.0 110.205 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -75.33 -43.54 50.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -117.19 66.35 4.25 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 111.635 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.31 155.39 69.46 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 120.759 0.972 . . . . 0.0 111.212 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -144.61 157.72 44.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.605 1.162 . . . . 0.0 108.911 168.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -119.63 5.48 11.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.85 1.26 . . . . 0.0 111.892 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.3 145.05 27.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.15 179.45 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.805 0.842 . . . . 0.0 110.115 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -87.88 -168.59 2.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 0.0 111.139 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.7 mt -90.79 -8.62 10.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 124.803 1.241 . . . . 0.0 110.917 161.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.68 83.22 0.25 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 105.663 -2.975 . . . . 0.0 105.663 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -141.15 -175.18 4.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.74 3.216 . . . . 0.0 105.884 152.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.96 163.3 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 131.312 3.845 . . . . 0.0 109.443 -166.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.91 144.25 9.3 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.87 163.52 27.19 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.169 0.984 . . . . 0.0 109.771 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -136.66 87.31 20.86 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 109.973 -172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.58 -27.53 69.6 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 121.465 1.443 . . . . 0.0 115.201 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.79 -28.39 16.88 Favored 'Trans proline' 0 C--N 1.354 0.822 0 CA-C-N 123.787 2.388 . . . . 0.0 111.362 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.28 9.93 26.63 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.736 -1.035 . . . . 0.0 113.737 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm 46.17 55.84 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.697 1.599 . . . . 0.0 110.814 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.93 176.94 7.47 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.699 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.0 174.49 6.53 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 125.784 1.633 . . . . 0.0 109.929 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.61 137.2 23.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.565 1.946 . . . . 0.0 109.861 162.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.64 109.7 14.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.745 3.618 . . . . 0.0 106.079 172.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.23 49.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.647 1.112 . . . . 0.0 108.632 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -147.01 34.57 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.93 -120.94 0.55 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.877 2.18 . . . . 0.0 108.135 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.81 5.8 7.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.667 1.733 . . . . 0.0 113.302 170.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.298 0.0 OUTLIER 62.93 167.72 0.1 Allowed Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.68 1.127 . . . . 0.0 113.858 167.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -91.41 6.15 3.7 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.973 3.115 . . . . 0.0 113.527 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -132.54 62.86 1.64 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.7 1.136 . . . . 0.0 108.277 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -156.62 175.0 14.62 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.343 1.457 . . . . 0.0 109.633 -174.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -148.38 -50.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 154.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.41 -58.98 2.97 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -132.2 168.46 18.0 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.228 2.611 . . . . 0.0 108.502 -167.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.73 122.06 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -129.77 144.32 52.51 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 123.413 0.445 . . . . 0.0 110.479 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.02 173.26 14.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.136 3.224 . . . . 0.0 112.717 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.12 -33.29 75.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.76 175.03 10.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.154 1.382 . . . . 0.0 107.511 172.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 100.33 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.18 -173.46 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -130.92 125.14 32.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.266 2.4 t -90.39 61.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.838 -163.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.3 pt -77.14 -10.48 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.715 2.006 . . . . 0.0 112.398 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.18 167.18 12.58 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 130.423 3.868 . . . . 0.0 112.268 -166.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -148.14 129.04 14.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.825 2.05 . . . . 0.0 106.751 150.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.8 mt -56.98 100.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 155.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 m -76.57 -36.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 118.903 0.774 . . . . 0.0 110.869 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -149.97 164.13 36.28 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.29 1.036 . . . . 0.0 111.142 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.5 33.05 71.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.994 1.283 . . . . 0.0 112.59 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.74 -52.33 66.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.332 1.053 . . . . 0.0 112.288 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.48 -21.26 56.06 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.001 -0.437 . . . . 0.0 111.316 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -9.89 6.63 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.021 1.328 . . . . 0.0 111.75 175.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.9 mt -79.78 -41.23 26.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.808 1.643 . . . . 0.0 111.611 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -65.23 -12.2 48.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.825 -1.172 . . . . 0.0 113.142 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -102.96 14.17 32.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.566 1.146 . . . . 0.0 112.125 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -107.3 127.47 63.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.253 1.421 . . . . 0.0 107.727 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -70.27 174.34 5.71 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.287 1.035 . . . . 0.0 110.471 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.34 49.57 0.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.929 1.692 . . . . 0.0 111.624 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.03 88.54 0.07 OUTLIER Glycine 0 C--O 1.231 -0.074 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -138.5 26.68 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 -173.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 mttm 43.41 75.33 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.013 2.125 . . . . 0.0 111.746 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.75 105.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.72 102.35 10.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.95 123.5 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 126.423 1.889 . . . . 0.0 107.669 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -132.97 172.43 12.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.14 1.336 . . . . 0.0 109.139 164.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -70.76 -12.49 61.58 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.774 0 C-N-CA 125.122 1.369 . . . . 0.0 109.969 -162.06 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttp . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -94.72 164.91 12.75 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.206 1.002 . . . . 0.0 109.821 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -149.27 132.5 7.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.06 140.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 mp -114.15 99.97 8.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.38 142.44 33.01 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -133.96 165.91 23.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.42 -17.16 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.912 -1.118 . . . . 0.0 112.332 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 m -115.61 -6.01 12.19 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.44 -169.01 39.93 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 120.633 1.56 . . . . 0.0 109.511 -172.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -169.95 113.29 0.48 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.002 0.906 . . . . 0.0 111.578 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.494 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 30.7 m -119.46 171.69 8.17 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.961 1.304 . . . . 0.0 108.713 -169.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 t -139.9 133.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -166.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.5 pt -123.36 160.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 123.386 1.565 . . . . 0.0 108.371 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -145.96 128.18 15.74 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.555 -164.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.85 149.19 51.69 Favored 'General case' 0 C--O 1.246 0.887 0 O-C-N 125.08 1.487 . . . . 0.0 110.291 -166.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -87.01 22.34 2.06 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 46.27 14.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.844 2.058 . . . . 0.0 116.215 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -116.18 10.53 14.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.013 -1.055 . . . . 0.0 110.084 -166.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -125.71 135.68 52.35 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -171.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -47.34 -51.31 19.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 110.152 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.279 7.5 p -48.86 -56.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.678 1.991 . . . . 0.0 112.376 172.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.74 -45.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 121.797 2.09 . . . . 0.0 110.74 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -65.51 -43.15 91.0 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.775 0.83 . . . . 0.0 111.602 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.4 mt -75.43 -30.8 60.14 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.336 1.055 . . . . 0.0 110.222 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.96 -26.11 61.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.321 1.048 . . . . 0.0 110.587 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp -64.91 -9.7 23.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.573 0.749 . . . . 0.0 112.865 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.74 -18.79 22.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.992 1.269 . . . . 0.0 112.159 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -125.92 31.23 5.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.117 1.367 . . . . 0.0 110.217 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.04 141.13 34.96 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 170.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.14 164.87 28.49 Favored 'Cis proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.712 0.933 . . . . 0.0 111.907 -14.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -148.94 165.53 31.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.171 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -110.61 158.9 18.07 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 162.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -151.92 -171.79 4.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.007 0.923 . . . . 0.0 108.863 164.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -97.73 138.04 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.774 1.629 . . . . 0.0 107.224 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.09 64.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.452 1.101 . . . . 0.0 110.127 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -68.66 143.59 54.73 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.476 -1.29 . . . . 0.0 107.524 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 p -111.03 155.33 22.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.971 0.805 . . . . 0.0 109.938 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -147.26 73.19 1.28 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 76.21 0.55 Allowed Glycine 0 C--O 1.218 -0.856 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.808 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.21 25.22 15.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.723 2.009 . . . . 0.0 112.011 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.546 ' CD ' ' HG ' ' A' ' 76' ' ' CYS . 0.3 OUTLIER -135.41 157.77 46.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.631 165.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.1 mt -125.15 117.66 50.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.052 1.741 . . . . 0.0 107.247 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -110.9 166.9 10.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.761 1.267 . . . . 0.0 109.718 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -151.04 149.21 29.27 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.2 t -79.0 102.85 8.56 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -79.35 150.57 74.01 Favored Pre-proline 0 N--CA 1.451 -0.417 0 O-C-N 121.765 -0.584 . . . . 0.0 110.969 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.74 -16.48 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.074 3.183 . . . . 0.0 114.601 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.11 107.13 14.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -90.14 51.03 1.96 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 123.413 1.578 . . . . 0.0 109.254 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 p -80.81 155.86 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.348 1.459 . . . . 0.0 107.716 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.05 4.55 2.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 166.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -62.46 102.36 0.31 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.236 1.38 . . . . 0.0 112.333 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.02 124.58 40.09 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.791 0.837 . . . . 0.0 110.308 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.84 -24.42 13.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.518 0.727 . . . . 0.0 112.529 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -114.9 55.73 0.88 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-O 117.49 -1.243 . . . . 0.0 110.044 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.45 126.9 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.217 1.944 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -136.0 127.86 29.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.78 0.45 57.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 118.45 -0.785 . . . . 0.0 111.164 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.1 t -138.88 141.64 36.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.91 174.32 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.175 1.39 . . . . 0.0 109.587 -171.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.62 -177.05 3.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 110.841 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mt -86.43 1.51 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.064 1.345 . . . . 0.0 112.454 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.79 44.55 0.78 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 125.012 1.291 . . . . 0.0 113.128 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' OD1' ' HE2' ' A' ' 100' ' ' LYS . 70.8 m-20 -125.82 174.66 8.2 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.22 147.52 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.25 147.85 19.35 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -93.69 141.6 28.31 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.803 1.301 . . . . 0.0 109.688 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -112.69 85.87 7.99 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.904 1.281 . . . . 0.0 109.946 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -64.32 -33.18 60.02 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.645 1.563 . . . . 0.0 115.264 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.47 -7.23 20.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.504 2.803 . . . . 0.0 112.335 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.52 9.15 8.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.215 1.864 . . . . 0.0 113.569 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.71 32.76 20.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.674 1.237 . . . . 0.0 111.868 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.33 13.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.906 0.775 . . . . 0.0 111.343 -167.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -173.96 4.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.159 0.584 . . . . 0.0 110.153 162.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.546 ' HG ' ' CD ' ' A' ' 42' ' ' GLU . 7.5 t -154.91 143.69 20.76 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.22 2.208 . . . . 0.0 106.823 165.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.4 mt -135.57 103.75 5.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.801 1.64 . . . . 0.0 107.742 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -87.71 135.7 33.26 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.028 1.286 . . . . 0.0 109.9 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -148.4 9.79 0.84 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.74 62.75 0.06 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.114 -1.993 . . . . 0.0 115.224 165.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 75.22 179.07 0.19 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.338 1.855 . . . . 0.0 107.803 -170.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.24 160.0 31.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.8 -27.74 37.27 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.123 2.549 . . . . 0.0 111.435 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.65 31.96 0.2 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.866 1.266 . . . . 0.0 111.219 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -148.75 166.15 29.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.739 -1.225 . . . . 0.0 112.001 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -136.91 -56.52 0.72 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.51 -61.81 1.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.574 1.15 . . . . 0.0 110.476 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -122.82 144.91 48.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.395 1.478 . . . . 0.0 107.103 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.5 mt -59.3 118.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -130.86 145.01 55.85 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.59 175.13 11.5 Favored 'Trans proline' 0 N--CA 1.455 -0.782 1 C-N-CA 126.219 4.613 . . . . 0.0 113.179 171.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.78 -7.04 50.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 t -171.87 -177.66 2.0 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.713 2.005 . . . . 0.0 106.718 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 73.89 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.22 165.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.7 m -68.84 -177.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 161.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -138.4 124.68 20.42 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.161 -0.962 . . . . 0.0 111.449 -169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.09 72.66 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 122.431 1.11 . . . . 0.0 108.999 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.9 pt -92.77 -14.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.175 1.39 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.66 173.48 23.5 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HE2' ' OD1' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -125.93 175.14 7.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.804 1.242 . . . . 0.0 110.415 177.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.47 77.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 122.861 1.315 . . . . 0.0 107.979 166.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -29.32 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.084 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -146.69 158.32 43.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.99 2.516 . . . . 0.0 109.241 168.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 81.02 61.17 2.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.598 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.16 -60.46 1.67 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -70.3 -27.73 64.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.111 0.957 . . . . 0.0 110.001 -166.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 1.69 5.36 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.786 2.035 . . . . 0.0 112.48 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -87.37 -35.79 18.16 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.842 1.201 . . . . 0.0 111.756 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -14.24 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.523 -1.361 . . . . 0.0 114.472 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.58 0.86 26.9 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.624 2.37 . . . . 0.0 111.7 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mm -83.66 157.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -109.73 172.7 6.7 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 109.118 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.61 11.9 0.23 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.755 2.422 . . . . 0.0 114.286 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.58 75.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.401 0 O-C-N 119.991 -1.693 . . . . 0.0 109.885 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -117.46 37.91 3.75 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.863 1.665 . . . . 0.0 111.242 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.4 mttm 44.04 74.24 0.13 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.869 2.068 . . . . 0.0 112.018 166.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.92 101.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.37 100.21 9.85 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.99 135.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 126.373 1.869 . . . . 0.0 108.713 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -140.57 178.59 7.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.773 1.629 . . . . 0.0 109.178 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.95 3.54 11.94 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.965 1.84 . . . . 0.0 115.351 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.065 0 C-N-CA 126.172 1.789 . . . . 0.0 110.728 -156.329 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 121.782 0.801 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 164.48 15.34 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.97 -1.081 . . . . 0.0 109.444 168.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.25 108.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -81.78 128.83 34.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.169 -1.582 . . . . 0.0 107.657 164.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.59 114.2 25.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.982 1.713 . . . . 0.0 107.257 169.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.11 133.21 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -123.06 178.49 5.06 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.388 1.075 . . . . 0.0 109.572 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -68.27 -27.37 66.27 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.655 -1.278 . . . . 0.0 112.7 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 m -115.42 -10.75 11.94 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.76 -163.79 28.52 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 119.069 0.849 . . . . 0.0 111.237 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -157.08 149.05 22.68 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.125 0.97 . . . . 0.0 110.356 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -126.1 172.37 10.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 103' ' ' GLU . 15.9 t -138.03 126.03 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 160.06 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 123.539 1.638 . . . . 0.0 106.744 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -124.18 115.77 21.64 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 129.449 3.1 . . . . 0.0 104.818 -170.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.4 mt -119.19 138.73 52.75 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -96.66 139.06 33.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.61 36.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.851 1.26 . . . . 0.0 112.383 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.87 -7.47 14.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 110.481 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CD2' ' HB ' ' A' ' 98' ' ' ILE . 24.2 m-85 -101.28 138.22 38.59 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 120.519 -1.363 . . . . 0.0 111.006 -172.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -49.22 -62.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.199 1.8 . . . . 0.0 108.09 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -50.98 -40.96 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -173.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.4 t -67.36 -34.48 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -65.06 -50.31 66.69 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 110.85 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -32.59 73.24 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.992 0.814 . . . . 0.0 109.5 -169.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.86 -37.8 83.39 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.476 2.311 . . . . 0.0 111.095 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -61.78 -24.73 67.03 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.001 1.273 . . . . 0.0 111.468 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.94 -17.06 57.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -127.26 36.82 4.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.124 1.77 . . . . 0.0 110.627 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.4 mt -128.76 145.94 58.3 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.35 160.11 62.18 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 119.224 0.758 . . . . 0.0 112.163 -9.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -149.17 162.21 40.44 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -118.88 165.86 13.53 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.402 0.681 . . . . 0.0 109.732 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.54 175.61 8.83 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.362 0.601 . . . . 0.0 111.382 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.53 131.3 39.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.3 t -79.81 71.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -64.2 154.3 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.798 1.181 . . . . 0.0 108.551 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.9 p -137.37 151.32 48.45 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.323 1.049 . . . . 0.0 111.838 -174.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -155.47 88.76 1.15 Allowed 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.2 80.91 0.05 OUTLIER Glycine 0 C--O 1.213 -1.193 0 CA-C-O 118.321 -1.266 . . . . 0.0 114.492 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 67.44 20.45 9.86 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.978 1.889 . . . . 0.0 112.22 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -135.1 146.95 49.36 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.953 0.901 . . . . 0.0 109.532 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.7 mt -130.35 127.76 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.353 1.861 . . . . 0.0 106.547 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -143.62 142.98 31.27 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.067 1.347 . . . . 0.0 109.376 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -131.26 144.78 51.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.77 -1.206 . . . . 0.0 109.059 -173.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 m -79.1 79.42 5.5 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.481 1.512 . . . . 0.0 110.728 -168.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.6 p -57.36 152.63 31.4 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.957 0.903 . . . . 0.0 112.896 -170.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.39 -12.74 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.627 2.885 . . . . 0.0 112.212 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.91 140.39 17.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -132.17 89.6 2.69 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -116.33 161.47 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.66 5.51 8.86 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.546 -0.721 . . . . 0.0 112.563 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -74.2 127.18 32.3 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.456 1.903 . . . . 0.0 110.187 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.34 101.85 7.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.177 1.391 . . . . 0.0 109.984 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.46 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.17 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -143.41 81.01 12.69 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 124.055 0.942 . . . . 0.0 111.772 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.64 143.22 26.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.465 3.443 . . . . 0.0 112.161 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -136.69 169.59 17.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.41 1.084 . . . . 0.0 108.63 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -121.98 4.36 9.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.806 1.243 . . . . 0.0 112.222 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.55 143.19 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 m -132.73 173.12 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 109.14 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -85.31 -176.64 6.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.806 0.812 . . . . 0.0 110.349 164.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.49 -7.58 10.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 124.611 1.165 . . . . 0.0 110.42 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.82 35.82 2.05 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-O 118.64 -1.089 . . . . 0.0 112.311 -168.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -112.87 173.77 6.22 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.463 1.505 . . . . 0.0 111.355 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.91 135.07 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 120.753 -1.217 . . . . 0.0 110.895 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.24 176.74 16.89 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.909 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -101.55 159.59 15.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.79 1.236 . . . . 0.0 110.334 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -132.82 83.06 53.94 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 119.347 0.976 . . . . 0.0 111.272 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.17 -24.37 65.93 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.448 2.765 . . . . 0.0 117.936 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -72.83 -45.06 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.057 2.504 . . . . 0.0 108.982 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.09 -4.36 58.66 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.439 -1.201 . . . . 0.0 114.273 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 55.24 73.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.671 1.988 . . . . 0.0 108.692 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.15 171.46 15.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.727 0.775 . . . . 0.0 112.9 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 0.9 OUTLIER -82.08 -178.42 7.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 109.519 157.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.438 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 31.5 m -142.95 160.52 40.19 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.875 1.27 . . . . 0.0 109.336 156.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -145.52 97.35 2.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 128.465 2.706 . . . . 0.0 105.273 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -83.52 146.75 28.18 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.14 26.69 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.46 -100.74 0.17 Allowed Glycine 0 C--N 1.333 0.392 0 O-C-N 119.514 -1.991 . . . . 0.0 111.744 165.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -128.14 -13.48 5.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 57.99 165.99 0.07 OUTLIER Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.155 1.782 . . . . 0.0 112.541 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.33 -18.31 9.8 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.563 2.175 . . . . 0.0 112.902 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.79 49.58 0.89 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 122.232 1.015 . . . . 0.0 109.255 -169.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.5 ' HG ' ' HB2' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -164.12 179.51 6.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.192 -0.943 . . . . 0.0 110.746 174.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -142.83 -42.97 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.734 1.214 . . . . 0.0 109.89 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.8 -56.27 2.37 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.25 -0.906 . . . . 0.0 111.538 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -127.93 178.67 6.02 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.553 1.941 . . . . 0.0 109.635 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -77.52 134.44 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 120.231 1.378 . . . . 0.0 108.069 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.5 ' HB2' ' HG ' ' A' ' 85' ' ' SER . 30.9 mt-30 -123.83 151.33 64.33 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 123.449 0.7 . . . . 0.0 109.311 165.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.89 177.92 7.91 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 124.005 3.137 . . . . 0.0 111.917 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.4 61.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.452 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.4 t -163.22 176.0 10.39 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 120.188 1.358 . . . . 0.0 108.885 -167.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 64.32 0.75 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.732 1.213 . . . . 0.0 110.694 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -66.98 165.46 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.688 1.195 . . . . 0.0 107.918 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -94.12 -178.9 4.78 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 120.05 -1.656 . . . . 0.0 109.902 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.42 45.19 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 122.878 1.323 . . . . 0.0 108.688 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.425 ' HB ' ' CD2' ' A' ' 20' ' ' TYR . 41.9 pt -69.99 -15.12 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.239 -1.538 . . . . 0.0 112.031 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.63 169.82 14.68 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -131.84 171.26 13.75 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.454 1.102 . . . . 0.0 108.505 168.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.6 mt -101.92 86.71 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 160.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -30.08 38.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.093 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.426 ' CB ' ' HB ' ' A' ' 13' ' ' VAL . 3.0 mt-10 -152.8 151.78 30.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 109.061 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.07 58.5 6.66 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.299 -0.876 . . . . 0.0 112.453 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.6 tp -84.43 -52.25 6.31 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.766 -0.844 . . . . 0.0 110.646 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.36 -24.68 57.32 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.339 -0.85 . . . . 0.0 111.089 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -26.61 68.88 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 110.688 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.18 -22.36 39.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.022 0.929 . . . . 0.0 112.288 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -72.6 -21.09 61.18 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.098 -1.626 . . . . 0.0 114.428 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 10.19 6.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 121.498 1.954 . . . . 0.0 112.457 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.0 mm -104.31 160.31 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.205 1.002 . . . . 0.0 108.805 -166.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.555 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 10.7 mmtp -131.74 175.03 9.54 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.354 2.262 . . . . 0.0 108.845 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.04 2.79 2.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.837 2.055 . . . . 0.0 115.666 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.49 48.82 0.33 Allowed Glycine 0 CA--C 1.52 0.403 0 O-C-N 120.63 -1.294 . . . . 0.0 110.961 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.555 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 8.6 mm-40 -101.69 30.43 4.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.542 -176.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 mttp 44.25 86.47 0.02 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.445 1.898 . . . . 0.0 113.266 166.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.4 p -78.52 133.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.71 111.18 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.13 127.25 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 127.117 2.167 . . . . 0.0 106.716 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -128.42 -166.59 1.65 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.479 1.112 . . . . 0.0 109.421 171.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -95.93 -5.37 41.57 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.08 0 C-N-CA 129.243 3.017 . . . . 0.0 110.547 -179.557 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 -67.6 154.08 42.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.305 -0.872 . . . . 0.0 108.912 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.95 147.51 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.398 1.479 . . . . 0.0 108.089 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -123.69 139.9 53.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.019 2.528 . . . . 0.0 106.809 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 mp -118.56 98.53 6.29 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 136.73 33.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -125.35 173.9 8.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.467 1.107 . . . . 0.0 109.142 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -30.36 70.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.948 0.899 . . . . 0.0 111.301 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -93.13 -13.27 28.69 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.11 -159.91 33.12 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 120.834 1.652 . . . . 0.0 109.894 -164.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -158.17 165.09 35.78 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 109.806 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -136.72 178.13 7.31 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.904 0.482 . . . . 0.0 110.276 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.45 128.08 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.3 pt -116.14 162.18 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 122.628 1.204 . . . . 0.0 109.075 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -120.82 130.36 53.94 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 107.699 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.3 mt -124.81 135.7 53.17 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.474 1.109 . . . . 0.0 109.254 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -76.48 136.47 39.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.081 0.952 . . . . 0.0 110.915 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.33 37.12 1.19 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.42 1.088 . . . . 0.0 113.278 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.08 22.87 11.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.187 -0.946 . . . . 0.0 111.194 170.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.09 133.13 45.36 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.94 0.896 . . . . 0.0 111.216 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -44.5 -55.36 5.15 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.791 2.036 . . . . 0.0 109.248 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.67 -40.24 78.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 116.894 -1.527 . . . . 0.0 113.276 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.06 -30.84 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 121.032 1.742 . . . . 0.0 109.858 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -64.87 -47.21 78.71 Favored 'General case' 0 C--N 1.342 0.263 0 O-C-N 121.608 -0.683 . . . . 0.0 110.383 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -36.7 73.33 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 120.822 -1.174 . . . . 0.0 109.25 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' CD2' HG12 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -55.91 -38.12 69.81 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.633 1.573 . . . . 0.0 109.721 174.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 tmpt? -59.23 -28.49 66.74 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.363 0.983 . . . . 0.0 111.164 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -69.01 -34.35 75.12 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.095 0.861 . . . . 0.0 110.236 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -107.57 33.54 3.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.346 2.258 . . . . 0.0 110.932 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -129.13 144.2 51.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 172.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -61.03 158.98 49.02 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 119.557 0.878 . . . . 0.0 112.536 -14.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -156.49 162.4 39.96 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.899 0.879 . . . . 0.0 110.817 170.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.91 155.57 33.92 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.435 0.694 . . . . 0.0 110.262 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -165.1 172.56 12.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.274 1.03 . . . . 0.0 110.145 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.77 140.59 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.699 1.6 . . . . 0.0 107.535 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 t -96.13 67.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -58.31 138.3 56.52 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -116.51 151.17 36.67 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 108.982 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -157.71 115.9 3.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 -102.7 0.34 Allowed Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -137.39 36.2 2.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.038 2.135 . . . . 0.0 108.413 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -122.72 165.7 16.12 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mt -122.51 147.43 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 171.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.62 175.36 9.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.101 0.953 . . . . 0.0 109.182 160.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -146.86 156.39 43.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -80.49 96.8 6.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -64.21 147.3 97.01 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.78 -39.13 15.67 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.284 1.99 . . . . 0.0 110.007 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG12 ' CD2' ' A' ' 26' ' ' LEU . 7.7 p -71.69 163.61 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.377 1.471 . . . . 0.0 110.36 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -141.54 38.34 1.68 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 t -60.83 153.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.713 0.805 . . . . 0.0 110.781 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.22 -8.46 4.78 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.959 1.304 . . . . 0.0 112.557 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -73.09 126.29 29.65 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.328 0.967 . . . . 0.0 109.404 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 125.63 35.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.781 1.233 . . . . 0.0 109.517 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.72 -33.45 15.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.009 0.924 . . . . 0.0 109.937 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -123.86 61.56 24.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.089 0.956 . . . . 0.0 111.009 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.5 124.19 12.11 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.059 1.839 . . . . 0.0 109.003 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -128.88 149.33 50.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.724 1.209 . . . . 0.0 109.324 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -111.16 -11.03 14.28 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.855 0.462 . . . . 0.0 111.595 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 t -128.38 135.16 63.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.47 -164.01 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.347 1.859 . . . . 0.0 107.513 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -143.63 176.8 8.94 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.55 1.14 . . . . 0.0 111.184 -165.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.4 mt -84.02 11.13 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 126.167 1.787 . . . . 0.0 110.586 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.56 9.81 2.91 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.672 1.606 . . . . 0.0 113.586 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.82 -177.06 4.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 124.33 2.015 . . . . 0.0 108.592 -165.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.03 146.66 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 128.454 2.701 . . . . 0.0 105.691 -149.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.34 174.06 22.42 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -131.36 116.49 17.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 127.029 2.131 . . . . 0.0 107.356 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -108.13 87.06 3.61 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 124.582 1.153 . . . . 0.0 109.381 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.86 -43.11 62.48 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.323 2.016 . . . . 0.0 114.969 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.24 -18.19 23.7 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.393 2.062 . . . . 0.0 111.128 -170.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.33 -0.13 70.81 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.443 -1.198 . . . . 0.0 113.29 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 46.68 39.8 7.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.198 1.999 . . . . 0.0 110.623 -166.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.4 146.1 44.68 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -167.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -179.04 1.99 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.572 158.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 55.9 m -145.75 158.87 43.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.302 1.441 . . . . 0.0 108.455 151.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mt -141.46 118.1 10.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 127.752 2.421 . . . . 0.0 106.457 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -114.81 121.29 42.82 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 109.563 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -149.14 7.97 0.72 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.13 0.972 . . . . 0.0 113.458 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.28 -114.06 0.42 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.346 -1.471 . . . . 0.0 112.0 -173.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.61 148.04 26.86 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.87 162.74 55.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.75 1.22 . . . . 0.0 112.077 -167.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.92 -3.07 8.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.164 2.576 . . . . 0.0 113.876 -167.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.87 16.9 14.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.69 1.132 . . . . 0.0 110.804 166.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 90' ' ' GLN . 3.7 t -129.86 178.98 6.12 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -142.07 -34.07 0.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.455 1.102 . . . . 0.0 109.848 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.3 -52.27 6.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.302 1.441 . . . . 0.0 112.029 172.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.07 -163.81 1.36 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.564 1.546 . . . . 0.0 109.68 -156.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.99 92.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 170.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.44 ' H ' ' HB2' ' A' ' 85' ' ' SER . 14.0 mt-30 -100.59 146.33 31.86 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 158.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.6 -179.43 5.33 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.229 3.286 . . . . 0.0 113.158 164.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.66 64.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.9 -171.87 3.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 84.12 7.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 123.647 1.689 . . . . 0.0 108.265 156.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . 0.332 46.9 t -44.33 161.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 C-N-CA 129.669 3.188 . . . . 0.0 110.668 143.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -98.21 124.62 42.89 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.694 1.597 . . . . 0.0 107.084 171.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.5 pt -120.11 -9.74 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.134 2.174 . . . . 0.0 111.351 -173.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.56 171.91 13.95 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 129.752 3.549 . . . . 0.0 112.694 -163.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -144.7 148.83 34.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.851 1.66 . . . . 0.0 108.693 143.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.01 98.99 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 159.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.0 m -73.74 -36.56 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.526 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.7 163.02 38.54 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 118.798 0.726 . . . . 0.0 110.829 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.41 42.44 73.91 Favored Glycine 0 C--O 1.222 -0.607 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.185 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -56.55 11.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.458 1.129 . . . . 0.0 110.003 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.18 -19.1 64.75 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.958 -0.464 . . . . 0.0 111.088 -168.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.04 -22.96 61.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.173 1.789 . . . . 0.0 110.654 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.33 -41.12 61.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.335 -1.478 . . . . 0.0 110.36 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -62.52 -5.29 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.051 1.341 . . . . 0.0 113.412 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.54 6.06 10.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.066 1.746 . . . . 0.0 112.147 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.293 19.2 mm -80.47 164.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.292 0.951 . . . . 0.0 108.875 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -121.62 167.85 12.43 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 127.278 2.231 . . . . 0.0 106.472 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.56 -1.63 1.91 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -169.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 116' ' ' LYS . . . -149.01 17.91 1.21 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.605 -1.109 . . . . 0.0 114.168 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.03 23.78 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.274 2.037 . . . . 0.0 113.975 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 114' ' ' GLY . 3.8 ttmt 44.75 89.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 128.848 2.859 . . . . 0.0 113.958 169.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.8 104.36 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.62 98.79 9.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 107.899 170.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -75.17 137.34 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.269 1.827 . . . . 0.0 108.589 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -139.75 -177.44 4.97 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.095 2.558 . . . . 0.0 110.096 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -86.62 -4.38 59.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 127.524 2.33 . . . . 0.0 112.07 -173.047 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.38 148.58 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -149.4 142.75 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -117.87 138.09 52.35 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.972 2.109 . . . . 0.0 106.068 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.26 98.94 6.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.972 2.109 . . . . 0.0 106.703 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.56 129.75 46.54 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.957 1.303 . . . . 0.0 109.139 -172.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.18 -176.1 3.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.015 1.326 . . . . 0.0 109.74 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.61 -53.79 36.83 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.928 -0.482 . . . . 0.0 110.467 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 t -76.18 -20.83 57.17 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.502 0.592 . . . . 0.0 111.039 -168.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.05 -152.29 12.73 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -164.73 152.92 12.14 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.477 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 64.7 m -141.26 173.59 11.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.059 0.943 . . . . 0.0 109.009 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 t -140.82 129.7 24.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.6 pt -114.15 166.35 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 122.427 1.108 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -123.42 149.43 45.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 163.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.4 mt -139.11 132.11 29.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.694 1.598 . . . . 0.0 110.799 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -84.93 126.43 33.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.633 0.254 . . . . 0.0 110.685 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.76 5.13 14.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.585 1.954 . . . . 0.0 113.961 -169.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -83.41 -11.8 57.17 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.093 -1.004 . . . . 0.0 109.95 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -99.34 141.14 32.51 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.862 2.065 . . . . 0.0 109.688 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -44.87 -59.5 2.52 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.844 1.658 . . . . 0.0 109.365 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.78 -35.53 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.87 -38.61 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.869 1.213 . . . . 0.0 109.819 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -55.72 -45.52 77.92 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.021 0.928 . . . . 0.0 111.066 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -40.06 89.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.03 -1.044 . . . . 0.0 109.511 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.22 -30.52 68.3 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.819 1.248 . . . . 0.0 111.901 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -69.17 -25.15 64.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.276 0.943 . . . . 0.0 109.918 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -78.06 -11.42 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.414 0.685 . . . . 0.0 112.296 171.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -126.1 26.1 6.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.552 1.541 . . . . 0.0 112.077 -166.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.43 143.96 47.85 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -62.04 158.7 56.95 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-N 119.531 0.868 . . . . 0.0 113.202 -10.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -152.79 163.77 39.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.529 0.732 . . . . 0.0 110.354 166.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -119.24 161.99 19.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.244 1.018 . . . . 0.0 110.241 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -168.75 171.36 8.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.673 0.789 . . . . 0.0 112.496 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.28 128.1 47.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.055 1.342 . . . . 0.0 108.852 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 t -91.12 80.88 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -164.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -68.15 151.21 47.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.6 p -126.22 131.61 51.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -134.57 94.71 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 175.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 44.2 82.62 0.03 OUTLIER Glycine 0 C--O 1.214 -1.134 0 C-N-CA 126.304 1.907 . . . . 0.0 115.424 167.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 71.42 21.61 4.5 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.718 1.607 . . . . 0.0 112.609 167.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -140.32 167.9 21.06 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 128.854 2.862 . . . . 0.0 106.395 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mt -132.62 146.09 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 128.003 2.521 . . . . 0.0 108.263 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -146.88 157.61 43.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.758 1.223 . . . . 0.0 111.256 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -150.55 163.05 39.42 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.245 0.618 . . . . 0.0 111.273 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -92.54 88.54 6.38 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.711 0.767 . . . . 0.0 109.825 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.2 p -60.82 148.46 82.84 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.038 0.535 . . . . 0.0 112.184 -170.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.06 -14.57 15.11 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.523 2.815 . . . . 0.0 111.997 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.23 153.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 108.786 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -137.63 119.93 15.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 p -156.92 152.45 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.951 1.3 . . . . 0.0 108.924 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.79 21.58 4.21 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.212 1.805 . . . . 0.0 112.591 -174.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -109.04 148.98 29.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.633 1.973 . . . . 0.0 108.862 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -139.64 157.67 45.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.536 1.134 . . . . 0.0 108.91 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -110.79 -50.09 2.98 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.663 0.785 . . . . 0.0 110.255 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -120.38 68.92 14.74 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.87 1.268 . . . . 0.0 108.042 -172.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 72.4 Cg_endo -71.53 156.53 57.87 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.571 2.181 . . . . 0.0 111.799 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.528 ' CZ ' ' CG2' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -144.11 158.29 43.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.623 1.569 . . . . 0.0 108.949 177.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -111.32 8.8 21.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 117.411 -1.28 . . . . 0.0 111.043 167.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 p -162.31 154.99 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 120.328 1.422 . . . . 0.0 111.749 173.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.43 HG13 ' CZ ' ' A' ' 58' ' ' ARG . 27.2 m -145.22 -179.85 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.599 1.559 . . . . 0.0 112.498 -174.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.12 171.17 12.23 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 110.31 163.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.29 -13.66 16.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 113.597 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.05 48.51 0.97 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 125.058 1.313 . . . . 0.0 110.446 -168.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -120.0 172.55 7.66 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.669 1.188 . . . . 0.0 108.869 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -137.94 136.78 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.99 172.1 18.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.494 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -123.5 137.47 54.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.478 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -116.83 88.23 24.86 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.211 1.804 . . . . 0.0 110.031 -162.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -64.57 -26.61 61.76 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.179 2.586 . . . . 0.0 116.429 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.05 -32.05 5.64 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 123.579 2.314 . . . . 0.0 110.077 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.28 14.17 21.01 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.687 1.613 . . . . 0.0 114.282 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 44.7 59.59 3.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.277 1.831 . . . . 0.0 111.058 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.4 168.83 18.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.618 1.199 . . . . 0.0 112.127 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.84 163.11 12.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.96 2.104 . . . . 0.0 109.508 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 p -134.79 137.81 43.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 119.63 1.105 . . . . 0.0 112.052 166.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -117.07 113.35 22.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.992 2.517 . . . . 0.0 105.149 170.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -88.22 149.73 23.69 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -158.9 9.99 0.13 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.947 0.794 . . . . 0.0 112.92 169.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.93 -174.84 38.48 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 120.451 -1.406 . . . . 0.0 111.14 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.21 101.17 5.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.29 165.11 42.62 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 125.316 1.446 . . . . 0.0 111.095 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.11 5.81 4.75 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.039 3.826 . . . . 0.0 114.121 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -134.31 72.46 1.47 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.71 -174.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.473 2.309 . . . . 0.0 106.537 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -156.11 -66.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -81.49 -44.72 17.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.175 1.39 . . . . 0.0 110.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -143.21 152.89 42.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.637 1.575 . . . . 0.0 108.541 -157.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.6 mt -81.9 81.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -169.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -75.09 143.48 77.4 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 108.231 170.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.9 174.65 12.23 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.646 2.897 . . . . 0.0 111.395 165.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.47 71.01 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -147.71 169.61 19.34 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.608 1.163 . . . . 0.0 107.905 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.67 80.81 0.43 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.952 1.251 . . . . 0.0 110.622 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.528 ' CG2' ' CZ ' ' A' ' 58' ' ' ARG . 2.7 m -77.55 170.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 1.1 p30 -84.47 152.21 24.12 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.307 -1.495 . . . . 0.0 112.031 169.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 58' ' ' ARG . 15.5 t -84.62 112.38 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 152.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.6 pt -123.06 -18.28 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.123 0.569 . . . . 0.0 112.184 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.53 172.05 23.2 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 65' ' ' ASP . 30.1 tptt -139.83 140.37 36.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.34 90.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -75.19 -34.2 30.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.075 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.55 157.74 43.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.69 1.196 . . . . 0.0 108.73 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 73.47 70.48 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 118.649 -1.739 . . . . 0.0 112.325 -176.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.35 -52.94 2.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 169.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -64.76 -28.6 69.69 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.906 -0.496 . . . . 0.0 111.599 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -71.38 -8.77 55.95 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.337 -0.852 . . . . 0.0 112.801 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -25.9 51.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.859 1.663 . . . . 0.0 113.003 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 5.98 6.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -174.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -129.76 9.97 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.941 2.496 . . . . 0.0 110.839 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.25 157.41 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 106.781 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -117.11 -165.02 1.03 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.765 1.226 . . . . 0.0 110.008 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.83 5.09 26.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.609 0.719 . . . . 0.0 112.644 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -172.16 80.81 0.08 OUTLIER Glycine 0 CA--C 1.523 0.56 0 O-C-N 120.83 -1.169 . . . . 0.0 110.926 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.56 22.45 10.63 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.005 1.722 . . . . 0.0 111.335 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 44.55 84.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.265 1.826 . . . . 0.0 112.918 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.41 129.02 37.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.73 107.87 19.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.08 126.5 36.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.613 2.365 . . . . 0.0 107.088 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -135.98 169.62 17.3 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.058 1.743 . . . . 0.0 109.744 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -77.32 -3.72 41.41 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.979 0 C-N-CA 126.242 1.817 . . . . 0.0 113.435 179.217 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 160.28 33.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 110.513 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.4 t -149.79 142.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 113.008 -1.905 . . . . 0.0 108.546 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -126.83 131.4 51.24 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 127.71 2.404 . . . . 0.0 107.018 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.59 120.29 41.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.533 1.933 . . . . 0.0 107.229 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.99 137.13 48.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -130.28 -176.65 4.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.513 1.125 . . . . 0.0 109.783 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.71 -39.71 43.7 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.875 0.87 . . . . 0.0 109.71 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 m -93.33 -16.16 24.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.426 1.091 . . . . 0.0 112.587 -174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.53 -163.38 27.03 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.508 0.575 . . . . 0.0 112.882 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -160.87 146.27 14.41 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.206 1.402 . . . . 0.0 108.378 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.484 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 34.5 m -146.86 174.94 11.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.173 1.789 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -147.98 131.46 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.269 -1.519 . . . . 0.0 108.397 -170.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.48 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.04 -1.037 . . . . 0.0 109.983 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.14 119.54 39.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 116.899 -1.524 . . . . 0.0 107.641 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.3 mt -119.29 132.19 55.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.212 0.915 . . . . 0.0 111.012 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -88.08 126.27 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.822 -168.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.35 34.64 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.822 1.649 . . . . 0.0 113.943 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -105.49 -9.48 17.46 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.527 -1.358 . . . . 0.0 110.815 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.34 144.2 34.54 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.603 1.561 . . . . 0.0 112.086 -170.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -56.67 -55.76 29.95 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.383 1.073 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 p -44.58 -40.29 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.504 1.522 . . . . 0.0 113.693 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.93 -44.18 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 120.911 1.687 . . . . 0.0 110.014 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -59.65 -38.36 81.22 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.181 0.992 . . . . 0.0 111.228 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.1 mt -72.09 -37.87 69.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.859 0.864 . . . . 0.0 109.689 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -32.52 73.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.853 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -32.96 64.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.158 0.89 . . . . 0.0 109.97 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.3 -13.77 61.99 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.743 0.817 . . . . 0.0 111.953 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -124.16 26.58 7.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.747 2.019 . . . . 0.0 110.833 -173.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -125.06 139.53 33.85 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.11 163.34 68.52 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 119.302 0.786 . . . . 0.0 112.375 -8.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -149.83 169.5 20.96 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.018 0.927 . . . . 0.0 109.473 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.98 155.69 37.76 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.9 170.1 18.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.513 0.673 . . . . 0.0 112.249 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.95 129.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.296 1.438 . . . . 0.0 108.11 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 115' ' ' GLU . 21.0 t -83.31 76.08 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -68.96 159.39 32.81 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.2 p -140.0 163.51 32.48 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.832 0.853 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -164.3 101.91 0.84 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 47.17 62.87 3.6 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.992 165.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 52.05 78.94 0.11 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.528 2.331 . . . . 0.0 110.655 -159.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -162.23 150.84 14.99 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 161.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.2 mt -127.45 121.19 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 167.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -133.09 151.37 52.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.512 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.69 150.59 52.14 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -70.86 91.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.51 1.524 . . . . 0.0 109.542 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -62.39 146.66 93.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.988 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.35 -3.76 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.424 2.749 . . . . 0.0 111.992 172.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -76.41 163.62 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.269 1.428 . . . . 0.0 109.606 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -148.9 101.68 3.2 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.578 0.751 . . . . 0.0 109.624 170.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.406 HG21 ' H ' ' A' ' 53' ' ' LYS . 9.0 p -152.44 154.86 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.176 2.19 . . . . 0.0 108.348 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.83 13.95 6.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.648 1.179 . . . . 0.0 113.139 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.406 ' H ' HG21 ' A' ' 51' ' ' VAL . 15.4 tttt -75.37 125.13 28.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.287 1.835 . . . . 0.0 111.452 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.35 143.3 50.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.603 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -132.73 -30.84 1.38 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.244 1.017 . . . . 0.0 112.601 -169.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -120.13 61.82 8.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.54 150.95 41.36 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.087 1.858 . . . . 0.0 113.201 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -146.51 153.58 40.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.463 1.505 . . . . 0.0 109.773 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -105.44 7.04 32.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.207 1.403 . . . . 0.0 113.221 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.35 152.63 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 129.788 3.235 . . . . 0.0 108.086 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.0 m -147.48 175.14 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.302 1.841 . . . . 0.0 108.414 -167.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 64' ' ' GLY . 17.7 mt-10 -91.15 169.35 10.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 122.32 1.057 . . . . 0.0 112.363 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.9 mt -73.16 23.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 0.0 110.779 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 62' ' ' GLU . . . -167.66 16.11 0.07 OUTLIER Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.305 0.955 . . . . 0.0 113.789 -177.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -93.67 -177.22 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -138.34 149.91 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.228 1.011 . . . . 0.0 108.95 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.08 21.59 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 165.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.95 159.85 27.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.006 0.922 . . . . 0.0 108.981 166.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -127.61 85.62 60.38 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -66.2 -28.06 48.34 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.069 1.846 . . . . 0.0 115.391 -174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.26 -23.61 32.9 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 123.087 2.138 . . . . 0.0 109.847 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.17 27.47 6.69 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 117.791 -1.561 . . . . 0.0 113.674 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.78 36.9 4.17 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.505 2.153 . . . . 0.0 113.141 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.31 174.16 6.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.274 -1.516 . . . . 0.0 111.398 -167.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.77 -178.88 5.37 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.839 161.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 54.0 m -147.33 163.29 36.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.948 2.499 . . . . 0.0 107.441 157.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.22 121.94 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.62 114.3 27.87 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.859 1.264 . . . . 0.0 109.648 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -145.06 27.63 1.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.253 1.821 . . . . 0.0 113.789 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.97 -112.43 0.28 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 120.51 1.504 . . . . 0.0 115.142 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 120.62 2.89 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 129.225 3.01 . . . . 0.0 104.782 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.411 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 33.8 p -86.45 165.74 31.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.661 1.119 . . . . 0.0 111.275 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 73.1 Cg_endo -69.2 0.36 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.591 2.861 . . . . 0.0 113.932 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -95.08 -33.01 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.545 1.521 . . . . 0.0 111.967 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 t -79.99 -169.31 1.96 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 161.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.13 -49.13 0.32 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.76 -51.08 9.63 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 126.049 1.74 . . . . 0.0 112.853 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -137.02 -164.18 1.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.302 1.441 . . . . 0.0 109.021 -154.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 mt -110.28 67.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -172.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -82.32 142.33 46.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.205 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.2 177.21 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 125.158 3.905 . . . . 0.0 112.672 171.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.33 -29.43 68.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.98 -174.26 4.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.476 1.489 . . . . 0.0 109.973 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.03 98.69 0.31 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 m -92.9 -164.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.35 1.46 . . . . 0.0 107.728 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -138.62 125.21 20.72 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.67 48.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.921 0.888 . . . . 0.0 109.956 -170.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 pt -72.1 -12.96 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 120.181 -1.574 . . . . 0.0 112.8 -172.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.4 159.29 21.91 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 118.681 0.673 . . . . 0.0 111.578 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -124.81 141.78 51.88 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.3 mt -76.4 112.79 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 161.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -29.67 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 -165.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -144.42 160.23 41.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.313 2.245 . . . . 0.0 107.84 170.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 75.62 60.85 3.09 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 118.55 -1.786 . . . . 0.0 112.037 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -107.82 -36.93 6.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.593 0.711 . . . . 0.0 111.157 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.11 -36.19 48.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.2 6.07 3.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.197 0.999 . . . . 0.0 112.96 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 74.0 mt -86.75 -37.17 18.13 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 111.451 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -4.62 16.78 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.719 -1.238 . . . . 0.0 113.123 -172.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -100.81 -0.95 36.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.25 1.42 . . . . 0.0 112.67 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.9 mm -80.31 162.37 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.537 0.735 . . . . 0.0 110.635 -167.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -118.31 169.4 9.76 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 127.291 2.236 . . . . 0.0 111.248 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.69 20.67 1.7 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.551 2.34 . . . . 0.0 113.702 -172.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.79 64.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.459 ' H ' ' HB ' ' A' ' 36' ' ' VAL . 6.7 pt-20 -114.37 30.5 7.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -174.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.84 85.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.685 1.594 . . . . 0.0 112.881 171.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 133.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.24 116.01 31.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 164.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -88.37 127.61 41.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 107.39 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -132.53 -179.2 5.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.993 1.717 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -79.25 -3.69 47.08 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.842 0 C-N-CA 125.318 1.447 . . . . 0.0 110.349 -163.668 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ttp . . . . . 0 CA--C 1.509 -0.602 0 CA-C-O 122.403 1.097 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -71.53 163.25 28.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.363 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.35 113.33 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 5.3 tt0 -86.91 137.85 32.04 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.075 -1.015 . . . . 0.0 108.41 -175.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.3 mt -115.8 97.9 6.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.705 0.684 . . . . 0.0 110.196 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 148.08 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.416 1.087 . . . . 0.0 109.246 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -135.64 178.83 6.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.232 1.413 . . . . 0.0 108.86 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.59 -16.61 57.2 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.932 0.893 . . . . 0.0 111.937 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -124.26 0.48 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.753 0.821 . . . . 0.0 111.292 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.08 -174.25 43.34 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 124.556 1.074 . . . . 0.0 111.429 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -163.04 149.68 12.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.726 1.21 . . . . 0.0 108.47 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -137.28 -177.2 4.67 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 125.877 2.751 . . . . 0.0 105.101 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 4' ' ' GLU 0.258 3.8 p -136.75 164.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 110.275 -3.148 . . . . 0.0 105.869 167.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 pt -135.91 121.29 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 125.47 1.508 . . . . 0.0 107.252 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.94 117.13 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 115.325 -2.274 . . . . 0.0 110.044 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt -121.03 143.3 49.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.652 2.024 . . . . 0.0 112.649 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -89.54 140.86 29.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 111.315 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.34 8.69 3.16 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -91.7 9.93 30.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.663 -1.898 . . . . 0.0 110.479 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.22 133.34 55.16 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.745 1.618 . . . . 0.0 109.279 -170.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -48.52 -49.84 34.43 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.791 1.636 . . . . 0.0 109.888 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.89 -37.3 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 117.673 -1.155 . . . . 0.0 111.5 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t -72.1 -43.75 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 120.315 1.416 . . . . 0.0 109.232 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -59.71 -33.1 71.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.659 0.784 . . . . 0.0 111.827 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.93 -37.19 20.84 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.914 0.886 . . . . 0.0 110.769 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mt -57.03 -35.63 69.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.151 0.98 . . . . 0.0 110.225 172.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -58.5 -30.82 67.31 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 119.291 0.95 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.292 1.037 . . . . 0.0 110.973 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.52 26.24 4.75 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.624 1.569 . . . . 0.0 110.347 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -126.46 146.59 57.09 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.55 157.76 41.91 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 CA-C-N 119.44 0.836 . . . . 0.0 111.646 -12.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -148.77 150.22 32.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -105.02 156.63 17.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.32 175.55 11.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 35' ' ' VAL . 2.4 p -55.07 165.95 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.4 1.88 . . . . 0.0 111.204 157.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.0 t -117.51 123.91 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 144.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -106.11 164.68 11.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 162.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.7 p -136.24 151.15 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.427 -0.796 . . . . 0.0 109.66 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -149.98 83.75 1.39 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.965 0.802 . . . . 0.0 108.99 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 57.91 69.48 1.26 Allowed Glycine 0 C--O 1.213 -1.195 0 O-C-N 121.215 -0.928 . . . . 0.0 113.569 170.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.265 6.1 mt-10 65.98 35.64 6.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 127.984 2.514 . . . . 0.0 112.531 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.83 152.45 46.51 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.443 1.897 . . . . 0.0 108.373 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 mt -113.84 139.66 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 159.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -136.06 160.22 39.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.34 157.83 42.99 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.32 -0.862 . . . . 0.0 110.317 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -87.91 94.7 9.85 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 p -63.15 151.36 86.77 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.0 -26.58 9.24 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.026 2.484 . . . . 0.0 111.374 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -83.15 146.23 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.163 1.385 . . . . 0.0 107.851 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -133.08 133.57 43.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 m -141.34 179.15 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.807 2.443 . . . . 0.0 107.66 170.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.82 13.81 3.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.839 0.856 . . . . 0.0 112.311 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -92.8 128.6 38.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 113.116 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.98 106.18 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.201 1.8 . . . . 0.0 112.805 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -79.9 -13.94 59.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.585 1.954 . . . . 0.0 114.085 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -139.32 68.43 39.71 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 119.595 1.089 . . . . 0.0 109.878 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.79 107.97 2.46 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.628 2.219 . . . . 0.0 109.772 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -112.97 140.69 47.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 109.582 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -89.99 9.27 28.54 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.697 0.799 . . . . 0.0 112.105 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.55 154.16 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 127.555 2.342 . . . . 0.0 109.821 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -143.38 -175.57 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 127.389 2.276 . . . . 0.0 107.861 -172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -106.05 173.39 6.33 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.0 111.469 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.3 mt -71.62 11.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.977 2.111 . . . . 0.0 112.238 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.06 34.18 0.44 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 124.93 1.252 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -109.86 -177.93 3.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.31 164.65 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -146.23 170.33 27.37 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 167.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 143.49 48.28 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 167.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.26 85.87 42.52 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 125.249 1.419 . . . . 0.0 107.414 -174.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -60.62 -35.33 90.2 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.286 1.324 . . . . 0.0 115.037 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.57 -32.91 9.15 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 CA-C-N 122.785 2.031 . . . . 0.0 109.939 -168.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.19 23.01 17.08 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.682 -1.621 . . . . 0.0 113.295 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt 44.64 63.97 1.51 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.107 1.763 . . . . 0.0 111.555 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.65 157.17 44.32 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.35 0.595 . . . . 0.0 111.995 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 177.39 8.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.536 158.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.3 m -150.14 155.85 40.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.378 1.471 . . . . 0.0 108.474 161.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.0 mt -145.97 108.56 4.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.924 2.09 . . . . 0.0 107.5 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -99.4 112.91 25.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.221 0.608 . . . . 0.0 110.176 -168.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -138.77 28.86 2.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.637 1.175 . . . . 0.0 113.915 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.64 52.07 0.02 OUTLIER Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.83 -1.169 . . . . 0.0 114.282 153.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttm 71.6 175.97 0.28 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.053 2.141 . . . . 0.0 109.534 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.6 OUTLIER -153.3 159.31 32.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -165.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.55 6.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.548 4.165 . . . . 0.0 114.394 -172.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.44 44.93 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.681 1.592 . . . . 0.0 107.871 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -162.61 -179.51 6.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.353 2.261 . . . . 0.0 107.083 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -144.17 -39.9 0.28 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 165.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -89.17 -38.65 14.12 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.323 1.059 . . . . 0.0 111.413 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.76 -164.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 128.027 2.531 . . . . 0.0 107.374 -161.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.06 74.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 120.187 1.358 . . . . 0.0 107.614 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.91 143.47 62.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -89.32 175.88 3.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.436 3.424 . . . . 0.0 110.715 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.8 -16.88 62.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -169.07 15.41 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -165.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 69.19 82.0 0.17 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.016 1.726 . . . . 0.0 109.102 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.5 -169.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 113.626 -1.624 . . . . 0.0 108.841 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -128.32 125.31 38.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.07 45.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.117 0.967 . . . . 0.0 110.112 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 pt -59.18 -14.95 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 117.885 -1.055 . . . . 0.0 113.262 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -129.16 162.04 22.6 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.744 0.688 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -129.42 135.27 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 108.154 167.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.26 85.14 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.442 HG21 ' CG1' ' A' ' 13' ' ' VAL . 35.7 m -68.48 -47.74 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.27 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.66 159.11 31.55 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.908 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.44 74.33 0.51 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 125.961 2.038 . . . . 0.0 112.471 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -107.39 -48.74 3.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.992 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -90.0 -10.78 43.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.565 0.746 . . . . 0.0 111.877 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.79 -12.62 59.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 112.051 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.37 -21.46 63.8 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 119.033 -2.292 . . . . 0.0 112.422 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -10.06 59.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 171.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -77.65 -26.36 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.796 -1.19 . . . . 0.0 111.093 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 mm -77.3 157.18 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -172.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -116.79 170.14 8.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.537 1.535 . . . . 0.0 109.526 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.91 32.23 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.647 2.379 . . . . 0.0 112.569 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.86 63.9 0.03 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.541 -1.144 . . . . 0.0 110.836 172.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -118.79 13.82 13.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp 47.43 155.14 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -160.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.97 159.44 31.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.865 1.266 . . . . 0.0 107.85 164.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.13 97.6 4.83 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.724 2.809 . . . . 0.0 105.954 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.0 t -82.01 134.72 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.289 1.436 . . . . 0.0 108.095 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -140.46 -170.1 2.92 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.583 1.953 . . . . 0.0 109.141 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -98.79 5.25 47.61 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.153 0 C-N-CA 127.224 2.21 . . . . 0.0 112.006 175.436 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttp . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -63.3 162.78 11.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.976 0.893 . . . . 0.0 109.316 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.67 135.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 127.563 2.345 . . . . 0.0 105.332 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -112.78 141.03 47.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.95 120.97 40.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.559 1.944 . . . . 0.0 107.327 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.43 110.91 15.11 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.287 1.435 . . . . 0.0 107.933 -173.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -108.33 167.83 9.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 110.431 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.49 -13.73 62.52 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -115.97 -9.44 11.76 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 -166.34 35.07 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 121.621 2.009 . . . . 0.0 111.326 -168.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.8 149.23 7.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.241 1.521 . . . . 0.0 110.545 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.648 ' HG ' ' CD1' ' A' ' 108' ' ' LEU . 65.5 m -149.59 176.15 10.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.629 1.972 . . . . 0.0 109.343 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -140.1 145.75 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 122.522 1.153 . . . . 0.0 108.246 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.68 150.03 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 125.303 1.441 . . . . 0.0 107.302 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.58 121.54 43.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.413 1.885 . . . . 0.0 108.395 -171.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -127.79 124.55 37.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 122.432 1.11 . . . . 0.0 111.312 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.56 122.03 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.401 1.481 . . . . 0.0 111.002 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.4 33.03 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.586 172.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -101.42 -9.13 21.39 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 120.512 -1.367 . . . . 0.0 111.247 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -107.91 138.7 43.7 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.535 0.734 . . . . 0.0 110.101 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.26 -51.12 57.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.845 1.658 . . . . 0.0 112.114 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.87 -26.53 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.497 1.119 . . . . 0.0 112.588 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.63 -47.37 20.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.531 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.97 -36.78 75.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.046 0.538 . . . . 0.0 109.946 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.37 -20.92 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.591 1.156 . . . . 0.0 112.16 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.71 -30.28 62.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.829 1.252 . . . . 0.0 111.093 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -59.79 -23.64 63.46 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.582 0.628 . . . . 0.0 110.558 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -70.5 -16.5 62.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.095 1.358 . . . . 0.0 113.544 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -131.73 39.1 3.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.421 1.488 . . . . 0.0 109.515 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.45 141.98 35.66 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.77 154.85 72.41 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 119.629 0.903 . . . . 0.0 110.521 -7.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -145.1 160.87 40.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.528 0.331 . . . . 0.0 110.275 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.95 149.0 49.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 165.55 32.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.3 t -86.58 133.0 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.85 72.68 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -68.38 150.98 47.51 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 p -129.3 157.86 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.731 0.812 . . . . 0.0 110.027 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -156.02 89.83 1.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.77 74.32 0.23 Allowed Glycine 0 C--O 1.213 -1.168 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.396 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 69.03 26.43 5.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.943 1.371 . . . . 0.0 113.189 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.36 152.01 51.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.338 1.855 . . . . 0.0 108.741 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.4 mt -133.57 135.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -147.69 155.37 41.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.24 146.21 38.34 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -85.7 78.68 9.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.528 1.131 . . . . 0.0 108.389 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -56.91 147.89 51.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 111.661 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 -15.66 21.7 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.993 2.462 . . . . 0.0 112.972 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.8 t -76.49 148.02 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.223 0.919 . . . . 0.0 109.372 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.46 99.75 5.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.561 0.744 . . . . 0.0 109.26 173.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.5 t -135.1 153.1 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -131.69 0.75 3.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.357 1.063 . . . . 0.0 113.486 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.93 120.57 23.72 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.557 1.143 . . . . 0.0 109.085 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.2 mtt -95.92 135.47 37.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -96.75 -28.39 14.31 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.766 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -146.53 71.26 12.85 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.448 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.93 135.04 39.46 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.716 1.611 . . . . 0.0 110.657 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -108.89 -176.48 3.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 164.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -127.72 7.11 6.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.779 0.831 . . . . 0.0 112.844 166.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.41 153.8 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 129.631 3.172 . . . . 0.0 108.267 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.15 170.96 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.173 1.389 . . . . 0.0 109.534 -170.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.43 161.15 20.43 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.377 -0.827 . . . . 0.0 110.361 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.66 74.26 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 166.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.59 8.46 0.06 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.684 -1.065 . . . . 0.0 113.912 -169.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -111.3 173.01 6.55 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.734 1.767 . . . . 0.0 110.361 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.53 131.04 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.731 1.212 . . . . 0.0 108.402 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.49 158.9 14.56 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.881 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.69 135.8 46.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -104.83 87.69 1.95 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 126.657 1.983 . . . . 0.0 109.552 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.18 -41.61 26.9 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.75 -27.15 12.84 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.55 2.167 . . . . 0.0 110.735 -162.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.13 25.92 7.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.098 1.809 . . . . 0.0 112.43 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt 43.35 65.54 0.96 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.865 1.666 . . . . 0.0 111.826 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.68 177.29 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.843 0.457 . . . . 0.0 111.792 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tp -98.44 -177.37 3.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 110.419 167.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 30.7 m -152.87 146.01 24.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.804 1.638 . . . . 0.0 112.371 154.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.265 6.9 mp -114.9 121.83 44.4 Favored 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.342 4.257 . . . . 0.0 106.634 169.815 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -110.64 113.69 26.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.23 0.923 . . . . 0.0 109.129 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CD1' HD21 ' A' ' 108' ' ' LEU . 42.6 p90 -136.51 35.55 2.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.16 -127.14 0.88 Allowed Glycine 0 C--O 1.225 -0.453 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 163.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -110.85 -15.1 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.074 0.937 . . . . 0.0 112.745 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.256 11.2 p 57.03 165.56 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 128.553 2.741 . . . . 0.0 112.464 175.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.91 -28.44 5.05 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.665 1.577 . . . . 0.0 114.215 -165.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.9 mmt -94.41 70.43 3.69 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -157.44 171.49 20.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.756 0.822 . . . . 0.0 109.421 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -143.72 -46.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 156.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -77.16 -56.88 4.18 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.042 0.937 . . . . 0.0 110.035 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 160.03 43.68 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.091 1.356 . . . . 0.0 108.991 -150.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.7 75.79 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 123.937 0.895 . . . . 0.0 109.077 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -75.35 144.09 77.54 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.455 160.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.71 -176.35 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.355 3.37 . . . . 0.0 111.891 171.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.82 74.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.023 169.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.3 t -164.71 170.04 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.847 1.659 . . . . 0.0 107.952 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.48 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.202 1.401 . . . . 0.0 110.742 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 m -102.44 152.64 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -74.21 168.85 18.79 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.637 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.1 t -120.15 44.24 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 123.194 1.473 . . . . 0.0 108.452 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.0 pt -72.24 -18.11 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.582 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.66 159.5 13.78 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.298 0.951 . . . . 0.0 111.404 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -130.27 143.13 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 0.0 107.551 172.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.82 105.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.17 -29.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -163.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.63 163.51 32.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 125.876 1.67 . . . . 0.0 106.574 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 71.36 64.62 2.69 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 117.778 -2.154 . . . . 0.0 111.457 172.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.2 tp -91.87 -45.99 8.09 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.052 0.926 . . . . 0.0 109.474 164.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -79.93 -20.97 44.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.184 -0.947 . . . . 0.0 112.183 -166.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.7 3.92 17.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.217 1.007 . . . . 0.0 111.381 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.648 ' CD1' ' HG ' ' A' ' 12' ' ' CYS . 6.1 mp -76.8 -43.5 36.41 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.786 1.175 . . . . 0.0 111.277 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -66.12 -24.3 66.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.309 -1.494 . . . . 0.0 113.662 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -78.25 -11.07 59.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.733 1.613 . . . . 0.0 114.208 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 mm -77.67 166.85 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.655 1.116 . . . . 0.0 109.045 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.463 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 8.0 mmtp -118.55 -179.48 3.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.16 1.784 . . . . 0.0 107.803 177.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.14 9.42 3.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.948 1.299 . . . . 0.0 114.467 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.17 72.9 0.14 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 120.636 -1.29 . . . . 0.0 110.548 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 21.7 mm-40 -132.24 33.48 3.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.984 0.914 . . . . 0.0 111.599 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 43.41 74.14 0.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.969 1.707 . . . . 0.0 111.57 160.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.08 120.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.66 128.73 34.75 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.9 t -111.16 124.73 68.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 127.058 2.143 . . . . 0.0 106.014 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.26 168.39 19.85 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.822 1.649 . . . . 0.0 110.66 -171.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.81 -7.15 58.51 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.959 0 C-N-CA 127.116 2.166 . . . . 0.0 111.711 -171.291 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 CA--C 1.503 -0.831 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.479 ' CB ' HH11 ' A' ' 2' ' ' ARG . 0.0 OUTLIER -66.62 148.87 51.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.6 t -151.63 147.25 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.914 2.085 . . . . 0.0 109.605 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -134.6 136.67 43.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.751 2.021 . . . . 0.0 107.636 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.58 100.32 7.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.953 2.501 . . . . 0.0 106.596 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.28 100.42 13.22 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.69 175.53 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.879 0.871 . . . . 0.0 108.869 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.28 -35.58 76.19 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 166.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -91.27 -14.88 30.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -172.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.38 -167.06 33.98 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -155.77 145.93 21.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 168.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.89 166.33 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.656 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.16 104.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -162.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.0 pt -120.55 160.38 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.92 1.288 . . . . 0.0 109.806 -166.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -140.56 139.43 34.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.93 124.49 35.27 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.73 137.36 51.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.18 -166.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -81.93 35.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.066 1.346 . . . . 0.0 111.983 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -119.66 3.78 11.13 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.245 2.218 . . . . 0.0 111.919 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -120.28 137.72 54.08 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.545 1.138 . . . . 0.0 109.94 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -44.0 -65.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.534 2.334 . . . . 0.0 107.739 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' A' ' 68' ' ' TYR . 7.3 p -48.54 -38.16 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.25 -43.35 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.052 1.296 . . . . 0.0 109.427 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -62.78 -38.25 89.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 120.913 -1.117 . . . . 0.0 111.602 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -44.0 69.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mt -51.17 -43.79 61.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -54.31 -23.41 15.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.995 0.816 . . . . 0.0 112.43 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.37 -30.98 17.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.58 0.627 . . . . 0.0 110.84 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.6 -40.23 64.01 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.866 1.266 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.2 140.73 98.0 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.859 1.263 . . . . 0.0 108.699 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.74 149.26 93.8 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.139 0.728 . . . . 0.0 112.594 -9.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.64 176.48 10.05 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.977 1.311 . . . . 0.0 110.103 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -133.17 166.86 21.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.514 1.126 . . . . 0.0 109.314 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -165.06 -177.96 4.89 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.4 129.07 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 C-N-CA 125.981 1.712 . . . . 0.0 107.387 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.5 117.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -102.79 156.89 17.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 160.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -144.93 137.34 26.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.211 0.604 . . . . 0.0 109.596 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -148.93 98.44 2.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -165.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 50.49 45.53 46.25 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 78.01 27.57 0.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 130.787 3.635 . . . . 0.0 114.543 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -108.93 160.71 15.79 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.67 1.588 . . . . 0.0 110.257 161.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.8 134.99 63.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.689 1.996 . . . . 0.0 105.846 165.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -142.11 168.22 20.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.201 0.6 . . . . 0.0 110.78 164.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.8 154.99 36.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.36 76.99 10.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.549 1.14 . . . . 0.0 111.433 -167.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.7 p -60.04 150.47 70.0 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.088 0.955 . . . . 0.0 112.053 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.1 -6.18 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.526 3.484 . . . . 0.0 113.303 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 p -112.34 113.11 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 125.196 1.398 . . . . 0.0 107.998 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.77 103.73 7.22 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.513 1.925 . . . . 0.0 109.438 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.24 154.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.424 2.29 . . . . 0.0 107.879 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -108.75 7.28 26.28 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.302 -0.874 . . . . 0.0 112.483 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -86.42 136.21 33.2 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.353 0.661 . . . . 0.0 109.495 171.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.47 175.46 5.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.932 2.093 . . . . 0.0 109.854 163.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.46 -35.53 1.73 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.795 1.238 . . . . 0.0 110.382 163.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -137.82 65.1 45.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 109.029 -171.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.76 138.53 23.79 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.522 2.148 . . . . 0.0 110.746 171.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -126.45 154.46 43.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.34 -0.85 . . . . 0.0 111.333 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -95.45 6.02 50.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.331 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.19 150.05 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.168 2.987 . . . . 0.0 109.894 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.08 178.35 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 127.784 2.434 . . . . 0.0 108.038 -170.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -102.26 173.47 6.35 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.106 0.962 . . . . 0.0 112.313 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.08 74.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 165.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.49 29.19 0.17 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.885 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -104.23 175.73 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.16 1.98 . . . . 0.0 109.057 167.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.1 117.94 45.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 108.417 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.76 171.64 26.4 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.891 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.419 ' CE1' HG22 ' A' ' 22' ' ' VAL . 61.7 t80 -129.28 123.36 31.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -114.18 85.92 11.03 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.469 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 36.8 Cg_endo -61.46 -33.75 87.47 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.392 2.728 . . . . 0.0 117.072 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.469 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 1.9 Cg_endo -63.46 -52.29 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.841 2.361 . . . . 0.0 109.439 -168.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.74 -6.54 87.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.578 -1.124 . . . . 0.0 114.321 174.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 47.04 90.8 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.158 2.583 . . . . 0.0 113.508 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -160.32 166.71 28.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.212 0.529 . . . . 0.0 112.407 169.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.459 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 2.5 tp -63.39 178.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.013 0.925 . . . . 0.0 110.314 160.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.459 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 32.9 m -150.58 143.7 24.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.699 2.0 . . . . 0.0 108.23 158.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 mt -125.38 135.99 52.98 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.522 2.329 . . . . 0.0 105.67 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.5 105.87 12.1 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.967 0.907 . . . . 0.0 109.299 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -136.13 23.11 3.27 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.82 -140.38 2.86 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 120.277 -1.514 . . . . 0.0 112.449 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.79 90.69 2.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -74.63 159.33 83.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 127.701 2.4 . . . . 0.0 110.8 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.22 72.36 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.344 3.363 . . . . 0.0 113.437 -166.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.64 20.85 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.997 -1.065 . . . . 0.0 112.396 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -152.42 -162.61 1.54 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.714 1.206 . . . . 0.0 108.628 -171.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -43.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.336 1.454 . . . . 0.0 109.053 160.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.47 -55.3 6.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.536 0.684 . . . . 0.0 110.698 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -138.1 -165.1 1.74 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.954 1.702 . . . . 0.0 109.595 -160.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 mt -100.62 77.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.683 1.128 . . . . 0.0 108.47 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -77.75 142.94 66.3 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.47 -0.769 . . . . 0.0 109.415 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.73 177.43 5.55 Favored 'Trans proline' 0 C--N 1.347 0.494 1 C-N-CA 125.539 4.159 . . . . 0.0 113.423 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.06 -19.69 64.63 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -172.32 176.52 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.465 2.306 . . . . 0.0 106.331 158.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.72 86.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.311 0.959 . . . . 0.0 112.812 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -69.11 136.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.995 0.918 . . . . 0.0 109.052 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -58.85 111.42 1.28 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 164.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.81 63.88 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 pt -72.84 -21.12 19.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 118.646 -0.693 . . . . 0.0 112.221 -170.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.19 -177.5 16.48 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.114 0.841 . . . . 0.0 114.325 -170.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -140.43 134.55 30.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.522 1.529 . . . . 0.0 109.442 -170.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 92.5 mt -81.07 87.58 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 165.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.5 -35.54 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 118.174 -0.917 . . . . 0.0 108.683 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.35 160.69 40.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.974 0.806 . . . . 0.0 111.7 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.95 74.61 0.35 Allowed Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.213 1.387 . . . . 0.0 110.897 -167.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.44 -63.24 1.28 Allowed 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.45 -22.11 60.28 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.997 -1.064 . . . . 0.0 111.689 -163.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -14.49 59.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 111.667 170.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.38 -31.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.224 -1.548 . . . . 0.0 110.726 169.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -77.55 34.5 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.834 1.254 . . . . 0.0 112.907 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 -16.71 0.84 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.381 -1.449 . . . . 0.0 111.415 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 mm -74.09 154.69 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -113.05 -178.39 3.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.676 0.79 . . . . 0.0 109.441 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -74.19 38.57 0.11 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.738 2.015 . . . . 0.0 111.898 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 151.8 79.9 0.03 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.832 1.206 . . . . 0.0 111.067 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -138.06 29.87 2.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.55 1.54 . . . . 0.0 110.834 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.54 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 128.595 2.758 . . . . 0.0 115.064 -170.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.53 137.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 161.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 104.73 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.942 1.697 . . . . 0.0 106.808 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.67 124.24 50.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 127.443 2.297 . . . . 0.0 106.931 -161.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -138.12 177.0 8.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.647 1.979 . . . . 0.0 110.775 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.96 -6.78 55.51 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.947 0 C-N-CA 125.262 1.425 . . . . 0.0 112.922 -177.629 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttm . . . . . 0 CA--C 1.509 -0.626 0 CA-C-O 121.953 0.882 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -99.89 163.85 12.27 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.539 0.735 . . . . 0.0 109.198 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.3 t -148.47 129.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 2.7 tt0 -111.7 129.26 56.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.121 -1.612 . . . . 0.0 110.509 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.44 96.09 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.121 0.962 . . . . 0.0 111.934 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.6 142.24 28.41 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 109.057 168.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.51 173.25 11.04 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.751 1.62 . . . . 0.0 110.09 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.45 -27.04 66.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.866 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 m -113.35 0.4 14.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.08 -165.93 37.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 119.793 1.179 . . . . 0.0 111.426 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -162.84 143.85 9.8 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.551 ' CB ' ' HA3' ' A' ' 104' ' ' GLY 0.258 11.8 m -152.54 154.22 35.0 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.441 ' CG1' HG22 ' A' ' 102' ' ' VAL . 3.9 p -122.06 164.97 18.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.59 158.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 166.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -123.71 133.09 53.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 117.648 -1.167 . . . . 0.0 110.537 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.0 mt -117.32 156.49 27.75 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.758 1.623 . . . . 0.0 111.484 -172.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -105.72 118.08 35.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.756 -1.116 . . . . 0.0 108.741 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.61 16.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.18 2.192 . . . . 0.0 115.486 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -102.53 8.2 39.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.443 1.897 . . . . 0.0 110.29 -169.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.565 1.146 . . . . 0.0 109.13 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.12 -45.95 53.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.759 1.624 . . . . 0.0 109.116 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.19 -22.57 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 112.557 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.01 -51.75 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 120.354 1.434 . . . . 0.0 108.009 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -57.7 -27.6 63.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.724 1.209 . . . . 0.0 110.496 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.8 mt -92.94 -34.85 13.61 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.835 1.654 . . . . 0.0 111.695 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.36 -35.71 78.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 120.141 1.337 . . . . 0.0 110.509 171.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -34.03 51.19 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.893 0.877 . . . . 0.0 110.735 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.98 -15.63 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -120.57 0.82 10.54 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.837 0.855 . . . . 0.0 113.071 -166.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.1 mt -99.28 145.31 29.82 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.235 1.38 . . . . 0.0 108.631 -173.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.26 159.53 81.05 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 CA-C-N 119.039 0.693 . . . . 0.0 113.34 -12.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -148.65 159.76 43.8 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.773 1.229 . . . . 0.0 109.244 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -114.61 159.53 20.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.448 1.099 . . . . 0.0 109.709 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -161.92 172.59 15.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.058 -170.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.32 132.89 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 115' ' ' GLU . 23.1 t -89.25 73.16 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -68.64 147.24 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -123.48 136.15 54.43 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.921 0.888 . . . . 0.0 109.449 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -144.82 96.81 2.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 45.02 71.84 0.43 Allowed Glycine 0 C--O 1.211 -1.325 0 O-C-N 124.258 0.974 . . . . 0.0 112.266 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 60.74 31.44 20.11 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.639 1.22 . . . . 0.0 111.792 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -123.73 155.22 38.26 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.82 2.448 . . . . 0.0 108.594 161.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.9 mm -115.47 147.91 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 158.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -144.95 169.34 18.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.111 0.957 . . . . 0.0 108.565 161.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.24 148.24 33.29 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -80.11 77.91 6.79 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 109.537 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -59.73 150.37 67.78 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 122.093 0.949 . . . . 0.0 111.855 -171.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -68.33 -12.24 34.36 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.804 2.336 . . . . 0.0 112.246 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 t -96.77 122.59 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.862 1.665 . . . . 0.0 109.835 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -128.06 30.76 5.19 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.074 1.349 . . . . 0.0 114.003 -167.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.6 m -72.65 164.46 3.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.124 1.37 . . . . 0.0 109.731 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -139.51 33.21 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.628 0.771 . . . . 0.0 111.217 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -85.87 148.69 25.68 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.646 0.778 . . . . 0.0 109.177 166.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.88 158.67 44.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 167.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.18 -20.85 1.88 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.773 171.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -117.45 57.11 2.1 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 120.696 1.589 . . . . 0.0 111.819 171.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.66 134.46 35.31 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.065 1.843 . . . . 0.0 112.717 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.52 169.72 17.29 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.881 0.848 . . . . 0.0 112.714 172.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -122.88 9.21 9.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.263 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -159.99 101.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 125.349 1.46 . . . . 0.0 114.817 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 78' ' ' PHE . 31.5 m -100.16 -177.92 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 127.358 2.263 . . . . 0.0 110.137 -168.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -90.09 171.95 9.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.724 -1.235 . . . . 0.0 111.294 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.21 -9.55 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.507 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.31 26.38 2.0 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 125.658 1.599 . . . . 0.0 111.748 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -83.01 -154.86 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 160.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.8 t -137.62 173.89 12.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 130.107 3.363 . . . . 0.0 104.701 162.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.02 154.37 25.87 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 146.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 150.25 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -119.98 87.87 39.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.92 -43.67 56.06 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 121.582 1.521 . . . . 0.0 114.972 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.62 -1.44 11.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.084 2.523 . . . . 0.0 114.902 -155.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.26 5.16 5.98 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 127.01 2.243 . . . . 0.0 112.78 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 55.08 78.16 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.746 2.018 . . . . 0.0 111.942 -167.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.27 176.9 11.12 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.243 0.617 . . . . 0.0 111.893 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.533 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 4.9 tp -90.09 -172.79 3.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.211 1.405 . . . . 0.0 109.919 158.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.533 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 66.8 m -146.85 151.13 36.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.66 3.184 . . . . 0.0 107.734 160.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.37 96.04 3.64 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.547 2.339 . . . . 0.0 105.093 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.462 ' CD2' HG22 ' A' ' 61' ' ' VAL . 1.8 m-85 -82.11 132.09 35.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 172.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -147.47 16.08 1.14 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.41 -82.49 0.04 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 165.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -151.39 -13.71 0.21 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 57.43 166.71 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 -1.06 8.01 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.681 2.254 . . . . 0.0 113.241 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.16 39.39 2.44 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.597 1.159 . . . . 0.0 109.299 -169.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -136.24 178.9 6.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.789 1.636 . . . . 0.0 108.617 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -138.47 -47.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 165.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.496 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 26.4 t0 -118.97 -13.39 9.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -163.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 87' ' ' ASP . 3.2 pttt -167.64 164.49 14.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.758 1.623 . . . . 0.0 109.221 -166.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.0 mp -81.65 77.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 122.798 1.285 . . . . 0.0 108.739 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -69.98 144.68 93.29 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.455 163.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.44 -174.46 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.847 3.698 . . . . 0.0 111.329 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.71 -11.54 53.42 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 t -166.37 170.21 13.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 167.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.51 98.5 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.793 0.837 . . . . 0.0 110.62 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.84 -178.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.736 1.214 . . . . 0.0 109.43 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -130.95 118.9 21.33 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.72 47.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 123.025 1.393 . . . . 0.0 112.63 -171.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.55 -28.71 37.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 126.874 2.069 . . . . 0.0 113.841 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.57 168.16 20.5 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.184 1.849 . . . . 0.0 112.341 -174.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -141.95 129.05 20.87 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.665 1.986 . . . . 0.0 108.252 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.9 mt -65.08 103.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 164.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.441 HG22 ' CG1' ' A' ' 13' ' ' VAL . 33.4 m -75.47 -61.9 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 165.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -113.03 158.31 20.47 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 88.62 61.61 1.44 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.403 176.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.53 -20.66 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.05 -33.09 7.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.269 1.027 . . . . 0.0 108.671 -173.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -10.01 59.08 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.244 -0.91 . . . . 0.0 111.516 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.6 mt -72.41 -20.67 61.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.652 -1.28 . . . . 0.0 112.458 172.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -64.7 -31.68 73.01 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.889 -1.132 . . . . 0.0 110.504 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.76 10.38 41.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.188 2.595 . . . . 0.0 114.213 -172.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.36 159.95 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 120.975 -1.078 . . . . 0.0 109.276 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.56 174.58 5.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.362 1.865 . . . . 0.0 109.746 173.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.06 16.48 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.703 2.001 . . . . 0.0 113.637 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -179.92 65.16 0.07 OUTLIER Glycine 0 CA--C 1.525 0.684 0 O-C-N 119.644 -1.91 . . . . 0.0 113.787 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.447 ' H ' ' HB ' ' A' ' 36' ' ' VAL . 8.0 mm-40 -94.57 24.97 4.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.642 1.177 . . . . 0.0 112.71 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.9 mttt 43.99 71.98 0.22 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 130.075 3.35 . . . . 0.0 112.629 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -69.29 119.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.54 103.6 16.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 168.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.42 125.75 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 168.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -136.49 -175.98 4.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.307 1.843 . . . . 0.0 109.203 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.63 8.85 34.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 117.93 2.567 . . . . 0.0 117.93 -168.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 129.983 3.313 . . . . 0.0 111.275 -165.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ttm . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -84.85 173.03 10.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 173.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.8 t -147.78 141.06 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.072 1.749 . . . . 0.0 106.5 169.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -125.26 131.13 53.16 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.786 2.034 . . . . 0.0 107.18 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.82 102.94 10.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.478 1.911 . . . . 0.0 106.773 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.26 136.67 32.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -125.91 170.23 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.994 1.318 . . . . 0.0 109.747 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.97 -27.47 66.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.415 -0.803 . . . . 0.0 113.093 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 m -111.26 -3.74 15.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.27 20.81 Favored Glycine 0 N--CA 1.464 0.527 0 CA-C-O 118.08 -1.4 . . . . 0.0 110.1 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.55 161.04 23.77 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.74 1.77 . . . . 0.0 111.869 -167.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.7 p -143.81 174.83 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.793 0.837 . . . . 0.0 110.32 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.1 128.2 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 pt -117.11 148.79 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -120.24 128.51 53.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.251 -0.906 . . . . 0.0 111.015 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 42.3 mt -119.89 169.56 10.05 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 123.523 1.63 . . . . 0.0 111.912 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -128.38 114.9 17.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.99 2.116 . . . . 0.0 109.505 -167.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -72.67 52.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.789 2.036 . . . . 0.0 112.326 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -130.63 -34.15 1.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.317 1.447 . . . . 0.0 110.905 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -74.69 151.02 39.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -57.91 -46.35 85.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.865 0.866 . . . . 0.0 109.076 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.6 t -61.09 -38.08 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.82 -46.14 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -52.46 -46.76 66.63 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.094 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.1 mt -74.5 -32.91 62.68 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.741 0.816 . . . . 0.0 111.1 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -39.0 91.63 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.748 1.219 . . . . 0.0 110.184 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -53.68 -41.53 66.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.468 0.707 . . . . 0.0 109.805 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -62.21 -20.64 64.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.185 0.994 . . . . 0.0 111.918 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -111.31 -1.64 15.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 116.893 -1.527 . . . . 0.0 113.003 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -99.3 143.3 26.16 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 121.405 1.911 . . . . 0.0 109.106 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -70.15 159.65 90.53 Favored 'Cis proline' 0 C--N 1.351 0.662 0 CA-C-N 119.109 0.718 . . . . 0.0 113.242 -11.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -146.97 172.23 14.03 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 126.138 1.775 . . . . 0.0 109.722 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -124.52 167.33 14.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 109.784 167.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.34 178.09 3.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.411 0.685 . . . . 0.0 112.046 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.8 t -82.53 138.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 125.385 1.474 . . . . 0.0 109.342 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.3 t -94.29 71.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.133 0.973 . . . . 0.0 108.379 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -70.13 152.11 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 p -123.01 152.18 41.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.266 0.626 . . . . 0.0 109.997 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -156.89 79.63 0.92 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.718 0.807 . . . . 0.0 109.757 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.19 55.02 2.44 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 119.856 -1.777 . . . . 0.0 113.118 175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 52.28 40.93 30.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.157 1.383 . . . . 0.0 109.569 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.24 166.03 24.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.81 2.044 . . . . 0.0 107.858 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -132.47 124.28 51.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 108.266 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -127.41 149.26 50.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.396 1.093 . . . . 0.0 109.636 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -136.63 148.45 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 108.446 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.93 74.77 3.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.007 1.723 . . . . 0.0 111.445 -165.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.4 p -63.03 145.52 96.59 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.191 -0.943 . . . . 0.0 112.7 -164.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.68 -1.97 11.21 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.056 3.171 . . . . 0.0 113.096 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.72 136.51 37.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -132.63 82.36 2.0 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.51 0.724 . . . . 0.0 111.768 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.92 173.04 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 O-C-N 121.509 -0.744 . . . . 0.0 110.568 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -132.54 13.93 4.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.292 1.437 . . . . 0.0 112.212 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -111.69 123.19 49.72 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.812 1.187 . . . . 0.0 111.641 -167.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.4 122.7 26.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.291 1.836 . . . . 0.0 110.245 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.44 -37.28 10.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.295 0.638 . . . . 0.0 110.208 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.14 60.07 1.28 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.82 1.648 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -65.31 145.05 82.66 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.224 1.949 . . . . 0.0 110.513 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -143.58 146.56 33.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.228 1.011 . . . . 0.0 108.996 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.16 -5.29 24.59 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.094 1.358 . . . . 0.0 111.391 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.05 149.77 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 127.845 2.458 . . . . 0.0 108.895 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.8 m -132.78 -178.72 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.958 1.703 . . . . 0.0 108.587 -173.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.87 176.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.251 1.024 . . . . 0.0 109.472 172.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.6 mt -78.73 -4.54 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.196 0.998 . . . . 0.0 111.128 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.43 37.81 1.94 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.863 1.221 . . . . 0.0 111.083 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -116.85 174.77 5.91 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.1 165.87 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -141.72 179.19 19.98 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 165.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.648 ' H ' ' CG1' ' A' ' 95' ' ' VAL . 0.2 OUTLIER -128.82 129.64 45.89 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 -170.28 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . 0.297 2.9 t90 -118.57 86.62 29.46 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-N 120.135 1.334 . . . . 0.0 109.876 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.78 -26.33 22.87 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 116.834 1.821 . . . . 0.0 116.834 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.55 -17.59 14.29 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.955 2.437 . . . . 0.0 112.395 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.45 -2.56 50.52 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.88 1.705 . . . . 0.0 112.79 167.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 52.25 65.49 1.49 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.228 1.811 . . . . 0.0 110.973 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.58 177.51 10.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.75 0.786 . . . . 0.0 111.153 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.92 -177.75 5.56 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 126.213 1.805 . . . . 0.0 112.074 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 65.7 m -152.94 127.93 9.66 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.638 1.575 . . . . 0.0 109.205 156.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.61 105.12 15.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.393 2.277 . . . . 0.0 105.965 168.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -86.8 132.53 33.82 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -150.25 27.31 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.48 0.582 . . . . 0.0 112.419 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.38 0.09 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-O 118.212 -1.327 . . . . 0.0 112.331 168.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 136.36 4.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.686 1.195 . . . . 0.0 111.3 165.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.56 165.44 30.38 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.277 2.231 . . . . 0.0 113.118 -172.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.59 -17.8 9.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.65 2.9 . . . . 0.0 114.404 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.21 57.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.432 0.693 . . . . 0.0 111.997 -173.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -172.11 1.85 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.138 2.175 . . . . 0.0 109.839 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.53 -49.97 0.32 Allowed 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 158.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.459 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 8.1 m-20 -72.12 -54.99 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.883 -0.511 . . . . 0.0 110.261 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -139.4 179.71 6.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.677 2.391 . . . . 0.0 109.489 -153.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.7 74.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 121.519 1.963 . . . . 0.0 110.291 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -84.52 142.58 40.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.561 -0.712 . . . . 0.0 109.911 166.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -74.96 -178.57 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.494 3.462 . . . . 0.0 113.72 160.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.08 -12.9 43.4 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t 180.0 -177.95 0.4 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.886 2.074 . . . . 0.0 106.848 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.16 96.06 1.74 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 124.533 2.111 . . . . 0.0 109.609 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.648 ' CG1' ' H ' ' A' ' 68' ' ' TYR 0.308 46.9 t -58.59 -172.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 CA-C-N 110.945 -2.843 . . . . 0.0 111.199 140.146 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.567 ' H ' ' CG1' ' A' ' 95' ' ' VAL . 63.8 t-20 -142.54 130.39 21.68 Favored 'General case' 0 N--CA 1.438 -1.044 1 C-N-CA 132.677 4.391 . . . . 0.0 105.207 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.07 82.71 2.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.2 pt -77.4 -65.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.968 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.59 173.92 31.48 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.848 1.213 . . . . 0.0 111.464 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -134.5 141.51 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.611 1.964 . . . . 0.0 108.203 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.84 100.18 2.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 102.339 -3.208 . . . . 0.0 102.339 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -83.72 -38.73 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.363 0.529 . . . . 0.0 110.236 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.74 159.66 41.57 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.557 1.143 . . . . 0.0 109.973 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.0 70.51 1.16 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 tp -87.85 -64.09 1.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.4 -29.14 68.57 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.584 -0.697 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -12.78 24.19 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.38 1.072 . . . . 0.0 111.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.65 -34.91 22.95 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.213 1.405 . . . . 0.0 111.875 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.36 -21.93 66.25 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.08 -1.012 . . . . 0.0 112.361 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.71 10.32 33.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.495 1.518 . . . . 0.0 112.494 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.5 mm -95.37 138.66 20.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.263 0.938 . . . . 0.0 108.983 176.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -85.14 175.08 9.21 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.809 1.244 . . . . 0.0 110.281 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.69 16.4 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 129.652 3.181 . . . . 0.0 114.914 174.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.93 80.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 O-C-N 120.334 -1.479 . . . . 0.0 109.463 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -133.53 31.41 3.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt 46.03 70.11 0.4 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 128.046 2.538 . . . . 0.0 112.347 162.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.44 129.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.58 107.75 20.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.049 1.74 . . . . 0.0 106.992 164.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.5 t -88.57 121.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 128.131 2.572 . . . . 0.0 107.695 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -138.66 174.13 10.86 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.128 1.371 . . . . 0.0 110.116 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -78.66 -9.44 59.39 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 122.228 2.285 . . . . 0.0 117.036 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.064 0 C-N-CA 126.335 1.854 . . . . 0.0 112.06 -164.734 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 C--O 1.236 0.378 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.74 157.39 24.4 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 t -155.23 140.43 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.701 1.6 . . . . 0.0 107.646 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -123.1 117.96 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.928 2.091 . . . . 0.0 106.476 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.87 110.28 19.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.987 1.715 . . . . 0.0 106.448 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.8 122.28 39.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.363 1.465 . . . . 0.0 107.268 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -114.14 170.51 8.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.622 1.169 . . . . 0.0 109.588 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.49 -17.79 62.97 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.406 -1.434 . . . . 0.0 112.358 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 m -113.68 -0.58 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 114.16 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.17 -157.19 28.42 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 119.999 1.272 . . . . 0.0 109.927 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -158.59 166.71 31.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.47 0.708 . . . . 0.0 109.371 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -144.38 179.42 7.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.433 0.693 . . . . 0.0 109.304 166.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.05 126.74 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.19 153.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 122.691 1.234 . . . . 0.0 107.831 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -116.51 126.44 53.36 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 125.842 1.657 . . . . 0.0 106.983 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.35 133.19 51.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.182 0.901 . . . . 0.0 109.546 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.86 137.42 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.15 -18.95 63.23 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.017 0.927 . . . . 0.0 112.591 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.84 -19.5 59.97 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.496 1.043 . . . . 0.0 113.518 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -92.33 126.96 37.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.163 1.385 . . . . 0.0 110.092 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -45.96 -54.76 7.78 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 126.193 1.797 . . . . 0.0 110.915 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -54.98 -32.95 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.143 -1.408 . . . . 0.0 113.998 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.0 t -69.41 -38.75 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.772 1.624 . . . . 0.0 109.379 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -63.41 -42.7 98.75 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.799 0.84 . . . . 0.0 110.759 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -43.99 84.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -54.27 -28.07 39.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.226 1.41 . . . . 0.0 112.8 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -65.29 -27.25 68.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.014 0.824 . . . . 0.0 110.496 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.79 -20.59 63.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.593 0.711 . . . . 0.0 110.817 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -118.29 18.33 13.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.95 2.1 . . . . 0.0 110.753 -165.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.5 mt -121.29 139.97 30.47 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.678 1.581 . . . . 0.0 107.456 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.89 156.99 83.01 Favored 'Cis proline' 0 N--CA 1.458 -0.6 0 C-N-CA 125.089 -0.796 . . . . 0.0 112.053 -9.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -143.72 165.17 28.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.578 1.174 . . . . 0.0 109.947 165.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.96 155.32 41.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -162.05 166.3 26.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.819 0.848 . . . . 0.0 111.471 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.57 127.97 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.9 t -80.38 98.54 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -90.75 156.06 18.34 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -144.45 149.45 36.03 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.161 0.585 . . . . 0.0 110.253 -168.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -146.62 82.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.18 -84.98 1.23 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -142.03 38.62 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.58 1.552 . . . . 0.0 109.181 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.68 165.32 26.66 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.21 172.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mt -131.95 123.19 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -121.18 176.35 5.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.071 0.939 . . . . 0.0 109.751 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.43 161.15 38.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.915 2.086 . . . . 0.0 106.679 173.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p -94.57 85.41 4.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 p -59.12 150.21 63.37 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -166.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.87 -25.16 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.287 1.992 . . . . 0.0 111.263 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.88 143.8 10.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.152 0.981 . . . . 0.0 109.938 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -138.87 101.13 4.23 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.395 1.478 . . . . 0.0 108.202 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.8 160.19 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.626 1.57 . . . . 0.0 108.022 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -123.37 2.65 9.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.69 1.196 . . . . 0.0 113.123 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -71.95 157.98 36.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.051 0.841 . . . . 0.0 109.107 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 46.4 mtm -147.59 158.38 43.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.565 1.546 . . . . 0.0 106.939 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -126.64 -51.69 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.533 1.533 . . . . 0.0 108.819 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -123.89 54.41 7.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.297 1.039 . . . . 0.0 111.641 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.77 134.37 27.81 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 120.264 1.13 . . . . 0.0 110.516 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -127.9 148.6 50.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.387 0.675 . . . . 0.0 109.33 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -92.89 5.75 50.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.843 0.857 . . . . 0.0 112.304 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -148.39 153.41 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.034 2.134 . . . . 0.0 106.59 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.2 -178.74 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.542 2.337 . . . . 0.0 107.207 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.48 172.15 7.67 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.489 -0.757 . . . . 0.0 111.335 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -72.14 71.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.954 . . . . 0.0 107.215 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.73 11.74 0.16 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.813 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -105.07 -177.74 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.399 2.1 . . . . 0.0 108.7 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -131.65 148.34 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.638 1.175 . . . . 0.0 108.463 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -134.09 149.9 19.86 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -120.24 120.51 36.31 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -105.06 87.97 2.18 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.536 1.934 . . . . 0.0 110.35 -167.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.06 -52.0 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.104 2.536 . . . . 0.0 114.844 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.67 -28.6 7.98 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.939 2.426 . . . . 0.0 111.212 -161.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.66 87.39 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.57 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 47.24 67.62 0.77 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 108.924 -162.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.0 157.2 45.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.629 0.728 . . . . 0.0 111.702 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.5 -175.62 5.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.663 159.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 t -164.09 154.54 15.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.62 1.168 . . . . 0.0 109.278 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -136.09 142.14 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 107.12 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -120.66 106.38 11.68 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 119.929 1.241 . . . . 0.0 110.829 -170.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.25 52.52 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.328 1.061 . . . . 0.0 112.42 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.36 -98.94 0.13 Allowed Glycine 0 CA--C 1.506 -0.47 0 O-C-N 120.368 -1.457 . . . . 0.0 111.095 159.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -135.08 -15.38 1.98 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 167.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 55.72 165.63 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.232 1.813 . . . . 0.0 112.136 -174.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.64 5.43 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.185 2.59 . . . . 0.0 113.16 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.19 88.26 2.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 p 174.18 172.94 0.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.369 2.668 . . . . 0.0 107.223 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -147.21 -47.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 158.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.83 -53.49 7.85 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.737 0.78 . . . . 0.0 109.429 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -149.82 152.05 34.53 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 128.682 2.793 . . . . 0.0 107.527 -161.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 89' ' ' ILE . 5.4 mp -54.47 122.19 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -138.9 143.4 37.19 Favored Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.501 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -82.71 171.45 11.98 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.625 2.883 . . . . 0.0 113.331 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.12 52.31 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.72 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.9 m -173.02 -175.36 1.2 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.105 2.562 . . . . 0.0 107.089 166.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.9 104.99 0.61 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.433 1.015 . . . . 0.0 108.678 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -106.83 138.83 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -66.21 106.74 1.74 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.292 1.437 . . . . 0.0 108.707 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.21 61.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 122.469 1.128 . . . . 0.0 109.154 -168.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.77 -13.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.194 0.998 . . . . 0.0 112.933 -167.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.11 164.41 17.41 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -129.13 137.72 51.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.72 90.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -73.5 -30.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.704 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -148.98 162.77 39.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.225 0.536 . . . . 0.0 110.801 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.57 70.74 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.261 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -54.66 44.45 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.378 1.089 . . . . 0.0 109.922 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.25 -18.35 61.24 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.045 -1.035 . . . . 0.0 110.624 -167.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.85 -13.26 61.4 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.161 -0.962 . . . . 0.0 111.781 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.62 -29.1 56.35 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.112 -1.617 . . . . 0.0 113.23 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.39 81.16 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 120.308 -1.495 . . . . 0.0 111.872 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.448 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -67.38 -11.14 56.99 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.765 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.0 164.33 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 126.866 2.067 . . . . 0.0 109.6 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HE3' ' O ' ' A' ' 110' ' ' LYS . 5.7 mmtp -120.86 175.31 6.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.977 1.711 . . . . 0.0 109.488 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.13 44.68 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.0 2.12 . . . . 0.0 112.899 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.77 83.15 0.04 OUTLIER Glycine 0 C--N 1.333 0.366 0 O-C-N 120.721 -1.237 . . . . 0.0 110.94 168.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.5 31.11 5.05 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.264 1.026 . . . . 0.0 111.798 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.1 mttt 47.35 89.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.32 2.248 . . . . 0.0 115.225 171.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.54 152.95 5.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.49 119.14 33.65 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.467 1.907 . . . . 0.0 106.878 159.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.9 t -98.48 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 127.496 2.318 . . . . 0.0 107.192 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -130.99 163.17 28.14 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.694 -1.253 . . . . 0.0 110.395 -171.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.92 -18.17 64.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.228 1 C-N-CA 131.974 4.11 . . . . 0.0 107.375 152.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -74.86 159.4 31.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.446 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.1 t -153.74 120.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.459 1.903 . . . . 0.0 106.031 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -100.23 136.56 39.94 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.71 -1.244 . . . . 0.0 109.007 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.78 103.11 10.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.679 1.592 . . . . 0.0 106.906 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 143.13 30.64 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.54 -178.72 4.34 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.641 1.976 . . . . 0.0 107.67 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.44 -52.51 38.62 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.808 1.243 . . . . 0.0 110.387 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 m -70.67 -33.35 70.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.004 -0.435 . . . . 0.0 111.858 -173.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.23 -150.45 8.15 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -161.21 164.53 30.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.715 1.257 . . . . 0.0 110.658 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.8 p -146.8 175.47 10.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.564 . . . . 0.0 108.965 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.02 141.98 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.5 pt -129.93 147.73 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -132.94 125.88 30.8 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.26 131.1 53.75 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 125.265 1.603 . . . . 0.0 109.47 -163.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -69.94 122.07 18.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.947 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.86 9.35 1.54 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.138 1.375 . . . . 0.0 114.067 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.02 -6.52 56.57 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.091 -1.005 . . . . 0.0 110.39 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.22 132.96 55.93 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.255 1.022 . . . . 0.0 109.702 -164.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.88 -44.09 70.16 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.274 1.429 . . . . 0.0 111.159 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -54.06 -43.09 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.591 1.156 . . . . 0.0 112.358 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.56 -44.79 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.51 1.504 . . . . 0.0 108.643 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -61.3 -40.23 93.42 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.365 0.666 . . . . 0.0 111.041 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -79.01 -29.41 43.67 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.972 0.909 . . . . 0.0 111.046 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mt -60.97 -24.58 66.21 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.228 1.411 . . . . 0.0 111.363 168.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -64.33 -20.13 65.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.345 0.975 . . . . 0.0 111.177 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -81.89 -14.97 55.46 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.068 0.947 . . . . 0.0 112.251 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -124.33 28.93 6.51 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.294 1.038 . . . . 0.0 111.414 -166.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -131.81 141.26 40.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.0 158.35 74.35 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.075 1.063 . . . . 0.0 112.332 -8.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -150.31 166.0 31.33 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.31 0.644 . . . . 0.0 110.003 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.48 166.93 12.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.3 163.19 17.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.702 0.763 . . . . 0.0 111.736 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.96 131.85 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 164.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.6 99.96 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -85.59 154.85 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.4 p -129.6 150.91 50.72 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.627 1.171 . . . . 0.0 108.681 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -149.31 98.22 2.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.43 -87.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.2 29.61 1.81 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.292 1.837 . . . . 0.0 110.327 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -133.11 161.83 33.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.436 1.094 . . . . 0.0 108.589 168.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -127.3 143.22 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -148.69 166.9 26.99 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -154.38 155.64 35.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.759 -1.213 . . . . 0.0 108.584 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -83.02 86.55 6.98 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.541 0.737 . . . . 0.0 109.511 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.0 p -58.15 150.88 49.58 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 122.663 0.385 . . . . 0.0 111.874 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.85 -13.31 13.06 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.277 2.651 . . . . 0.0 112.647 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.81 158.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-N 119.092 0.86 . . . . 0.0 108.904 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.32 103.83 4.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.229 1.412 . . . . 0.0 107.879 172.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.55 147.12 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -125.47 -7.45 6.92 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -65.17 146.7 54.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.723 1.209 . . . . 0.0 107.778 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 18.0 ptp -144.81 104.35 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.24 1.416 . . . . 0.0 110.304 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.66 -30.34 59.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.156 -1.018 . . . . 0.0 113.221 -172.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -133.29 72.9 74.87 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 119.432 1.015 . . . . 0.0 110.522 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 56.3 Cg_endo -69.48 150.67 70.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.75 2.967 . . . . 0.0 112.113 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -140.13 173.36 11.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.494 1.917 . . . . 0.0 108.384 170.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.27 10.67 8.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 112.657 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.72 154.11 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 131.001 3.72 . . . . 0.0 107.004 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.14 -174.48 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.23 1.412 . . . . 0.0 109.575 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -90.94 175.84 6.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.698 0.761 . . . . 0.0 110.935 166.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.58 5.23 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.923 1.289 . . . . 0.0 110.68 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.17 30.91 1.6 Allowed Glycine 0 C--N 1.337 0.615 0 O-C-N 120.692 -1.255 . . . . 0.0 112.949 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -115.79 169.92 8.85 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.049 0.924 . . . . 0.0 109.462 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -136.99 140.99 41.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.703 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -127.03 176.82 17.64 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.875 1.226 . . . . 0.0 110.987 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -111.4 143.01 42.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 165.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -104.77 86.06 1.36 Allowed Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 125.631 1.572 . . . . 0.0 107.667 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.05 -43.39 42.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.359 2.039 . . . . 0.0 115.054 -172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.74 -22.65 43.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.639 2.226 . . . . 0.0 111.482 -165.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -115.76 15.13 16.95 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.763 1.649 . . . . 0.0 113.751 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 47.56 37.96 7.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.755 2.278 . . . . 0.0 113.024 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.83 160.95 15.34 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.724 -1.235 . . . . 0.0 110.531 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.07 -179.14 6.87 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 161.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.6 m -139.15 163.93 31.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.796 0.838 . . . . 0.0 109.777 154.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.5 mt -151.05 101.49 2.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 129.36 3.064 . . . . 0.0 105.066 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -99.97 119.88 38.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.73 1.56 2.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.14 -178.74 34.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 166.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -83.25 106.88 15.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -59.71 165.43 4.38 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 125.465 1.506 . . . . 0.0 110.961 169.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.41 1.48 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.333 2.022 . . . . 0.0 114.165 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ttp -107.17 58.31 0.63 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 120.208 1.367 . . . . 0.0 110.182 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 p -159.83 -178.63 7.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 122.161 0.982 . . . . 0.0 110.501 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.93 -62.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 154.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.39 -43.54 40.18 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.046 0.538 . . . . 0.0 112.022 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -149.68 161.98 41.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.957 1.303 . . . . 0.0 108.6 -162.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.78 80.54 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -167.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -79.85 141.85 55.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -89.26 177.29 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 124.494 3.463 . . . . 0.0 112.935 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.78 16.16 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.4 t -164.86 173.86 11.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.029 1.286 . . . . 0.0 109.783 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.57 78.8 0.58 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.8 148.92 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 25.7 p30 -64.97 158.59 25.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.213 0.53 . . . . 0.0 112.177 164.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.56 99.32 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 166.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.2 pt -113.47 -16.38 9.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.511 1.124 . . . . 0.0 111.408 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.1 175.56 20.03 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-O 122.061 0.811 . . . . 0.0 112.413 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -135.86 134.0 38.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.7 mt -73.76 95.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 165.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -76.62 -24.2 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.365 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -148.66 158.68 44.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 110.421 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.78 42.34 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.371 1.462 . . . . 0.0 112.569 160.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tp -67.63 -11.81 59.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -162.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -107.18 -35.27 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 119.258 0.935 . . . . 0.0 110.331 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.56 -18.21 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.484 0.713 . . . . 0.0 111.316 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mp -66.76 -29.09 68.97 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.088 -1.007 . . . . 0.0 112.314 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -67.22 -22.79 65.69 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.818 1.644 . . . . 0.0 112.87 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -99.16 5.77 46.69 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.932 -171.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.86 165.37 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 119.744 1.157 . . . . 0.0 108.741 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -109.39 172.84 6.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.29 35.8 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 112.735 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.45 51.97 0.04 OUTLIER Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.804 -1.185 . . . . 0.0 112.93 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -103.4 24.92 10.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.016 1.408 . . . . 0.0 113.302 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.6 mttt 44.19 88.25 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.452 1.901 . . . . 0.0 113.258 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.75 142.38 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -125.06 94.49 4.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.443 1.897 . . . . 0.0 106.826 162.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.28 140.39 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 128.724 2.81 . . . . 0.0 109.1 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -140.97 177.06 8.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.999 2.12 . . . . 0.0 109.61 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -78.71 -2.32 38.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 55.61 -164.67 0.13 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.831 -160.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . 0.342 10.3 p 47.18 16.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 129.771 3.229 . . . . 0.0 116.868 -175.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.249 1.029 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 132.902 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.977 0.894 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -62.57 160.59 13.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.932 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 36.8 t -151.11 149.69 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.494 1.518 . . . . 0.0 109.075 166.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -116.54 139.86 50.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.423 2.289 . . . . 0.0 106.229 166.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.8 mt -112.08 119.49 38.61 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 117' ' ' VAL . 3.5 tt -121.49 141.01 51.45 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -164.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.45 ' CE1' HG11 ' A' ' 117' ' ' VAL . 18.8 m-85 -128.98 166.45 19.15 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.3 1.409 . . . . 0.0 108.616 -172.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.11 -19.16 62.71 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.244 -0.91 . . . . 0.0 111.543 171.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -25.76 12.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -172.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.5 -156.37 18.11 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 126.379 1.942 . . . . 0.0 108.274 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 13.0 pttp -168.02 157.54 9.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.174 1.487 . . . . 0.0 111.695 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.3 p -136.31 175.24 9.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.36 1.064 . . . . 0.0 111.043 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 127.22 56.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 pt -121.65 129.01 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -96.14 133.65 40.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.127 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.4 mt -124.62 130.53 52.6 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.588 1.085 . . . . 0.0 110.574 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -71.35 135.97 47.58 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.868 1.667 . . . . 0.0 111.375 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -90.96 45.35 1.25 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 112.854 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -129.05 30.15 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.094 -1.628 . . . . 0.0 108.964 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -132.53 139.47 47.9 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.012 -1.055 . . . . 0.0 109.034 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -45.0 -62.76 1.11 Allowed 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 126.373 1.869 . . . . 0.0 109.609 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.33 -39.64 28.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 121.071 -1.018 . . . . 0.0 113.17 -171.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.8 -44.77 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.513 1.125 . . . . 0.0 109.247 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -52.05 -53.57 40.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -43.94 97.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.863 0.865 . . . . 0.0 109.424 -170.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.21 -29.05 20.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.392 1.877 . . . . 0.0 112.866 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -59.98 -29.44 68.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.009 0.822 . . . . 0.0 110.895 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -74.07 -35.62 64.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.04 0.448 . . . . 0.0 109.935 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.35 21.05 3.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.648 2.779 . . . . 0.0 111.407 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -128.26 137.71 31.45 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 121.187 1.812 . . . . 0.0 107.733 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.93 153.14 97.39 Favored 'Cis proline' 0 C--N 1.348 0.518 0 CA-C-N 119.161 0.736 . . . . 0.0 112.428 -5.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -139.75 167.48 22.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 122.667 0.387 . . . . 0.0 111.377 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.15 155.06 46.84 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 t -166.74 161.62 15.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.5 128.2 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.4 HG23 HG11 ' A' ' 117' ' ' VAL . 2.8 t -75.66 73.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -65.29 153.48 40.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -139.46 161.03 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.95 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -160.54 92.62 0.97 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.37 84.34 0.03 OUTLIER Glycine 0 C--O 1.212 -1.248 0 CA-C-O 119.194 -0.781 . . . . 0.0 114.577 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.36 25.23 7.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.095 2.958 . . . . 0.0 113.252 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -128.8 149.38 50.76 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.468 1.107 . . . . 0.0 109.099 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.7 mt -125.04 141.35 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.59 172.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 168.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -156.71 151.36 25.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -74.11 98.33 3.1 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.9 p -66.95 149.8 98.26 Favored Pre-proline 0 N--CA 1.437 -1.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.06 -3.03 12.87 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.389 3.392 . . . . 0.0 112.102 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.2 149.79 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 108.141 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.02 15.79 6.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.84 117.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 123.978 0.911 . . . . 0.0 110.019 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -94.73 2.04 55.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -81.61 96.39 7.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.498 2.319 . . . . 0.0 110.29 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.8 ptp -86.57 123.42 31.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.508 1.123 . . . . 0.0 110.378 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.88 -23.88 16.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -137.9 70.69 50.06 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.2 146.75 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.282 2.655 . . . . 0.0 109.87 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -135.76 174.92 10.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 164.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -125.3 7.05 7.76 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.223 1.009 . . . . 0.0 111.503 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -144.74 137.06 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -142.9 -179.56 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.057 1.343 . . . . 0.0 109.722 -173.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.37 -167.56 1.52 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.977 2.111 . . . . 0.0 111.438 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.19 45.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.429 1.891 . . . . 0.0 107.545 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.03 38.2 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.24 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -110.28 176.04 5.2 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.41 134.33 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.89 148.16 18.88 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -86.75 139.14 31.02 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 168.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -104.89 85.21 1.15 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -64.39 -36.68 43.47 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.167 1.245 . . . . 0.0 114.837 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.05 -21.04 18.61 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.266 1.977 . . . . 0.0 110.599 -167.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 22.17 7.58 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 118.05 -1.416 . . . . 0.0 113.352 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 46.21 49.59 12.56 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.766 1.783 . . . . 0.0 111.995 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.97 175.46 9.35 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 111.286 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.18 -169.66 2.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.141 1.376 . . . . 0.0 111.06 166.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -166.13 140.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.554 1.542 . . . . 0.0 110.371 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -137.36 124.12 21.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.413 2.285 . . . . 0.0 107.538 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.62 119.63 40.09 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.248 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -140.94 14.7 2.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.54 48.32 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 CA-C-N 119.755 1.161 . . . . 0.0 114.327 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.8 tttt 62.24 177.44 0.13 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.64 1.976 . . . . 0.0 109.844 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.2 p -149.25 165.54 17.42 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 120.119 1.327 . . . . 0.0 109.925 -172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.62 64.73 8.12 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.377 3.384 . . . . 0.0 111.462 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.23 -44.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.719 1.608 . . . . 0.0 108.753 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.79 154.74 23.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.479 1.511 . . . . 0.0 108.227 -159.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.73 -58.03 1.6 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.4 -49.42 55.41 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.194 0.521 . . . . 0.0 110.926 -167.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -135.89 166.09 24.12 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 127.005 2.122 . . . . 0.0 108.109 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.73 115.91 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -125.6 144.78 49.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.115 0.966 . . . . 0.0 111.139 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.5 173.56 14.08 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.305 3.336 . . . . 0.0 112.975 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.268 1.427 . . . . 0.0 114.346 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -147.86 173.37 12.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.569 1.547 . . . . 0.0 107.679 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.11 85.59 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 m -90.93 150.02 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -75.32 175.22 8.58 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.9 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.42 44.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.7 pt -64.65 -39.96 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.312 -1.492 . . . . 0.0 110.927 -174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.82 169.08 16.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -138.47 132.71 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.9 mt -73.62 90.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 103.687 -2.708 . . . . 0.0 103.687 167.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.9 m -72.65 -25.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.511 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 155.1 36.76 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.586 0.755 . . . . 0.0 112.23 -165.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.6 20.17 62.38 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.888 1.232 . . . . 0.0 113.897 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.02 -38.03 87.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.745 1.273 . . . . 0.0 111.542 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -76.39 -1.17 25.62 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.25 1.96 26.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.871 0.868 . . . . 0.0 113.024 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.1 mt -84.31 -41.97 16.28 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.622 1.169 . . . . 0.0 113.68 -172.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.55 -23.41 64.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.61 1.671 . . . . 0.0 111.135 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -69.07 -10.55 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.543 -1.348 . . . . 0.0 111.212 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -92.44 157.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 120.334 1.425 . . . . 0.0 109.634 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.42 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 16.5 mmtp -102.08 172.4 6.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.767 1.627 . . . . 0.0 108.013 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.31 25.24 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 128.492 2.717 . . . . 0.0 113.649 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.85 65.16 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 120.337 -1.477 . . . . 0.0 111.992 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 1.5 mm-40 -125.12 38.16 4.25 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.964 1.306 . . . . 0.0 110.465 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 mttt 42.24 87.26 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.542 1.937 . . . . 0.0 110.597 164.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.45 HG11 ' CE1' ' A' ' 7' ' ' PHE . 19.5 m -64.0 178.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -150.47 90.36 1.64 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.42 125.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -137.55 170.9 15.28 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.509 1.05 . . . . 0.0 109.69 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.11 -11.52 60.33 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 62.03 115.72 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 128.652 2.781 . . . . 0.0 110.783 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.8 m -110.68 82.37 1.58 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.009 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.413 0.625 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -72.38 167.44 20.51 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 t -147.62 130.19 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.15 1.38 . . . . 0.0 108.599 167.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.74 128.61 45.04 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -100.61 105.1 16.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.5 31.54 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 169.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.93 175.09 8.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.93 1.292 . . . . 0.0 109.383 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.97 -29.64 67.9 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.503 -1.373 . . . . 0.0 112.057 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.8 m -103.53 -3.0 25.87 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.31 -166.76 39.6 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 119.712 1.142 . . . . 0.0 111.266 -173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 150.34 25.53 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.808 0.304 . . . . 0.0 110.397 168.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.8 p -132.85 172.87 12.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.598 0.713 . . . . 0.0 109.385 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -135.06 146.85 29.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.5 pt -128.13 156.97 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -111.02 135.15 51.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.29 134.69 55.21 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.076 1.351 . . . . 0.0 108.781 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -86.66 118.53 26.12 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.778 0.831 . . . . 0.0 109.478 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -66.21 20.05 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.028 2.131 . . . . 0.0 114.64 -171.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.86 24.17 5.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.39 1.876 . . . . 0.0 109.511 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -129.92 147.81 51.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.438 2.295 . . . . 0.0 108.311 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.77 -46.49 59.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.701 2.0 . . . . 0.0 110.157 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.07 -46.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.337 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -72.16 -43.91 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -165.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -60.89 -24.62 66.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.966 1.307 . . . . 0.0 111.715 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.5 mt -90.18 -25.8 20.46 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.48 1.112 . . . . 0.0 112.501 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mt -70.11 -28.82 65.71 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 121.065 -1.022 . . . . 0.0 110.804 172.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.66 -36.68 47.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.337 0.655 . . . . 0.0 111.044 175.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -71.36 -17.51 62.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 112.17 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -123.13 12.46 9.59 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.902 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -106.01 135.76 19.39 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 121.003 1.729 . . . . 0.0 108.109 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.86 164.32 79.83 Favored 'Cis proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.911 1.004 . . . . 0.0 112.824 -6.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -147.54 168.58 21.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.713 1.258 . . . . 0.0 109.403 165.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 47.3 mp0 -130.71 154.51 47.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.174 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -165.2 -175.46 3.66 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.905 0.882 . . . . 0.0 111.551 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 t -93.26 142.19 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 128.017 2.527 . . . . 0.0 107.891 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -97.11 91.33 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -86.79 159.64 19.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.6 p -132.4 149.32 52.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.03 0.932 . . . . 0.0 110.561 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.0 t90 -166.91 103.3 0.56 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -172.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.41 20.09 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 160.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.357 17.2 pt-20 47.71 50.91 14.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.966 1.707 . . . . 0.0 111.234 -159.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -140.01 159.56 41.89 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 126.962 2.105 . . . . 0.0 107.615 168.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.99 139.64 50.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 127.513 2.325 . . . . 0.0 106.478 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -155.34 150.02 26.36 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.962 1.363 . . . . 0.0 111.263 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -135.64 151.76 50.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.163 1.385 . . . . 0.0 108.204 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -88.82 83.34 6.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -166.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -53.98 152.29 10.8 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.256 0.622 . . . . 0.0 111.971 -168.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -79.2 4.93 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.505 1 C-N-CA 125.41 4.073 . . . . 0.0 112.505 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.0 t -107.98 131.53 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.071 1.348 . . . . 0.0 110.421 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.46 66.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.31 1.444 . . . . 0.0 107.19 -171.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -110.49 128.99 66.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 124.48 1.112 . . . . 0.0 108.297 -175.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.98 45.07 2.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.584 1.153 . . . . 0.0 111.264 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -127.69 146.35 50.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.457 1.503 . . . . 0.0 108.405 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.62 110.48 2.45 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.154 1.782 . . . . 0.0 108.329 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -87.36 -25.48 23.83 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.633 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -123.35 65.68 31.51 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 120.138 1.336 . . . . 0.0 110.147 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.26 114.63 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.048 2.499 . . . . 0.0 110.391 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 131.42 55.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.544 1.537 . . . . 0.0 108.087 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -93.12 5.27 52.1 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -160.86 149.28 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 128.095 2.558 . . . . 0.0 109.648 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.0 m -140.95 174.18 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.053 1.741 . . . . 0.0 109.39 -165.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -94.51 170.03 9.77 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.86 0.838 . . . . 0.0 110.708 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.74 -7.42 8.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 124.965 1.306 . . . . 0.0 112.237 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.11 27.22 4.59 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.681 1.61 . . . . 0.0 112.596 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -103.8 175.78 5.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.016 0.908 . . . . 0.0 109.331 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.4 t -135.42 133.86 52.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.709 0.804 . . . . 0.0 109.639 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.74 156.66 21.54 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -103.64 143.37 32.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 163.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -109.33 85.66 3.69 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 124.699 1.2 . . . . 0.0 108.552 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.65 -29.84 90.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.265 1.31 . . . . 0.0 114.671 172.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -77.75 -9.0 17.07 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.509 2.139 . . . . 0.0 111.917 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.59 8.95 4.0 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 118.411 -1.216 . . . . 0.0 115.583 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 44.65 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.741 1.27 . . . . 0.0 109.971 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.49 165.69 20.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.534 -0.729 . . . . 0.0 111.611 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -84.0 178.15 7.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.409 166.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -151.26 108.93 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.082 1.753 . . . . 0.0 108.39 165.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.21 105.29 17.11 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -80.35 133.59 35.94 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -152.84 22.18 0.59 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.946 0.898 . . . . 0.0 110.955 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.2 -139.66 2.76 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.41 103.01 4.78 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -58.52 156.11 24.96 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.487 1.915 . . . . 0.0 111.166 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -3.0 11.89 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.059 3.173 . . . . 0.0 113.459 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.0 tpt -73.09 -8.79 57.33 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.777 -1.202 . . . . 0.0 112.336 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t -132.54 -177.46 4.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.497 1.142 . . . . 0.0 109.914 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -144.35 -42.68 0.25 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.96 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -71.5 -56.81 5.19 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.57 1.176 . . . . 0.0 108.147 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -133.11 -164.84 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.177 2.191 . . . . 0.0 107.41 -153.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.95 77.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.538 1.517 . . . . 0.0 107.662 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -76.14 142.74 72.51 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.59 179.74 6.22 Favored 'Trans proline' 0 CA--C 1.533 0.449 1 C-N-CA 126.925 5.083 . . . . 0.0 113.665 170.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.37 -14.01 62.39 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.32 -172.07 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.89 97.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.4 m -90.0 172.67 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -126.55 124.5 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.47 55.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.586 1.184 . . . . 0.0 109.256 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.6 pt -80.05 -14.57 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.236 1.014 . . . . 0.0 111.381 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.12 155.89 16.82 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -135.88 140.83 44.42 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.879 0.872 . . . . 0.0 108.659 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 97.1 mt -79.63 93.95 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 123.814 1.768 . . . . 0.0 108.634 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.48 -23.68 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.002 -163.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.04 159.71 44.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.252 2.621 . . . . 0.0 108.716 171.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.53 69.2 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-O 117.927 -1.485 . . . . 0.0 115.277 167.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.69 -49.99 73.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.188 1.994 . . . . 0.0 111.212 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.3 -25.6 66.11 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.814 -0.554 . . . . 0.0 110.956 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.9 -5.97 34.75 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.754 1.222 . . . . 0.0 112.164 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.5 mt -80.7 -44.41 18.77 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 119.028 0.831 . . . . 0.0 111.46 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -57.53 -22.92 47.32 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.03 -1.044 . . . . 0.0 113.147 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -91.82 16.59 10.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.386 1.474 . . . . 0.0 112.978 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.3 mm -113.3 148.13 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 121.156 1.798 . . . . 0.0 109.922 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -89.16 171.98 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.667 1.587 . . . . 0.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.05 40.14 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 130.127 3.371 . . . . 0.0 112.724 167.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.87 12.67 0.03 OUTLIER Glycine 0 CA--C 1.522 0.522 0 O-C-N 120.452 -1.405 . . . . 0.0 116.156 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.53 22.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.607 1.704 . . . . 0.0 114.34 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 33' ' ' GLU . 0.1 OUTLIER 64.87 152.95 0.05 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.003 2.121 . . . . 0.0 112.373 167.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.51 148.26 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 O-C-N 120.435 -1.416 . . . . 0.0 109.048 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.06 108.47 15.27 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.492 2.317 . . . . 0.0 107.14 160.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.8 t -86.51 124.38 40.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.788 2.435 . . . . 0.0 107.792 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -140.67 179.76 6.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.571 1.532 . . . . 0.0 110.17 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -81.31 -10.33 59.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 62.0 108.55 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 127.545 2.338 . . . . 0.0 111.266 -169.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 92.6 p -89.53 -11.19 43.56 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.257 1.47 0 C-N-CA 128.49 2.716 . . . . 0.0 115.677 -169.327 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttp . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.62 152.14 39.72 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 50.8 t -153.82 147.85 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.546 1.939 . . . . 0.0 108.132 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -131.81 137.41 48.11 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.479 1.911 . . . . 0.0 107.528 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.1 mt -108.57 104.62 13.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.678 1.991 . . . . 0.0 105.857 -174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.67 103.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.56 173.45 9.57 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.931 0.892 . . . . 0.0 108.985 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.77 -42.22 95.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -80.82 -17.08 51.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.62 -161.79 34.09 Favored Glycine 0 N--CA 1.464 0.565 0 CA-C-N 121.11 1.777 . . . . 0.0 110.252 -165.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -159.33 159.92 34.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.203 1.501 . . . . 0.0 111.668 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.8 p -142.84 178.41 7.67 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.195 0.998 . . . . 0.0 109.877 170.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -132.92 129.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.62 144.71 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.401 1.08 . . . . 0.0 108.309 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -136.01 128.97 31.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.314 -0.866 . . . . 0.0 112.858 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.59 123.79 42.81 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 125.084 1.49 . . . . 0.0 108.824 -164.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.22 138.58 57.9 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.608 1.563 . . . . 0.0 111.462 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -97.2 50.26 1.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.518 0.727 . . . . 0.0 112.0 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.35 17.75 3.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.144 1.378 . . . . 0.0 111.85 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.68 144.76 50.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.376 1.47 . . . . 0.0 112.438 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -53.24 -50.58 64.47 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.326 1.451 . . . . 0.0 111.829 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.22 -44.74 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.0 -34.17 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -66.53 -48.94 68.13 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.17 0.988 . . . . 0.0 111.016 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.5 mt -70.96 -21.78 62.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.691 0.796 . . . . 0.0 110.515 -173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.2 -41.97 80.57 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.852 2.061 . . . . 0.0 111.608 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -56.0 -36.72 68.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.362 0.983 . . . . 0.0 110.0 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.86 -29.54 70.83 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -108.39 2.25 22.33 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.992 1.317 . . . . 0.0 112.04 -168.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.12 142.17 24.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.26 160.43 83.03 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 CA-C-N 119.421 0.829 . . . . 0.0 112.941 -7.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.86 175.45 12.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.933 1.693 . . . . 0.0 109.874 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 177.47 7.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.12 2.168 . . . . 0.0 110.728 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -162.63 -154.73 0.32 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.293 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 t -120.39 134.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.877 1.671 . . . . 0.0 107.661 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -88.09 77.03 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 118.995 0.816 . . . . 0.0 109.379 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.62 150.93 34.84 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.681 -1.262 . . . . 0.0 109.239 171.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.8 p -124.69 142.53 51.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.082 1.353 . . . . 0.0 108.886 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -153.36 107.26 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.87 22.13 70.01 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.939 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 75.52 28.38 0.96 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.846 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -115.47 153.26 31.43 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 155.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -124.48 123.97 67.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -138.24 132.4 31.69 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.088 1.755 . . . . 0.0 108.284 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -136.8 156.83 47.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.459 -1.401 . . . . 0.0 107.483 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.72 115.76 7.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.1 p -80.73 153.34 73.01 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 160.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.7 -0.77 10.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.12 3.213 . . . . 0.0 112.53 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.2 t -80.78 163.94 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 126.578 1.951 . . . . 0.0 108.722 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -143.07 21.93 1.92 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.83 155.71 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -135.13 -4.88 2.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.699 0.8 . . . . 0.0 112.445 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 55' ' ' GLU . 74.0 tttt -70.44 140.52 52.02 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.041 1.291 . . . . 0.0 109.914 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.24 131.01 46.97 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.345 1.458 . . . . 0.0 107.299 167.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 53' ' ' LYS . 71.8 mm-40 -87.45 -38.07 16.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.218 0.532 . . . . 0.0 109.679 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.65 62.02 12.83 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.344 1.857 . . . . 0.0 108.085 -161.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.87 125.75 15.35 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 108.022 -1.568 . . . . 0.0 108.022 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -117.22 145.77 43.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.221 1.009 . . . . 0.0 109.018 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.77 -1.64 27.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.883 1.273 . . . . 0.0 111.905 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.66 146.96 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 129.026 2.931 . . . . 0.0 108.438 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.98 -173.0 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 109.488 -166.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -105.43 159.09 16.19 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.16 1.384 . . . . 0.0 111.31 171.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 58.7 mt -73.37 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.36 0.82 0.5 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 119.033 -0.87 . . . . 0.0 113.975 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -100.48 175.57 5.64 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.764 1.782 . . . . 0.0 109.11 170.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -136.24 134.02 49.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.519 1.127 . . . . 0.0 108.157 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.78 -172.26 31.72 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.78 156.38 48.1 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 146.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -121.0 86.77 42.57 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.83 -46.39 31.87 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.253 1.968 . . . . 0.0 114.875 -167.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 -23.76 46.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.809 2.34 . . . . 0.0 111.636 -165.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.57 12.26 46.86 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.757 1.646 . . . . 0.0 113.983 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.458 ' N ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER 44.45 48.08 8.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.701 2.0 . . . . 0.0 110.776 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.41 157.03 27.96 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.09 0.948 . . . . 0.0 111.066 -172.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.53 172.56 12.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.641 161.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.53 105.27 3.29 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.872 1.669 . . . . 0.0 109.836 169.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -86.57 120.28 27.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 107.865 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -105.46 105.69 15.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.991 0.814 . . . . 0.0 109.325 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -136.25 9.24 3.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.46 -121.21 1.02 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 119.782 1.173 . . . . 0.0 110.65 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -156.56 121.77 4.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.375 1.087 . . . . 0.0 108.517 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -98.14 155.86 36.51 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.996 2.519 . . . . 0.0 112.079 -165.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.61 3.12 6.7 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.489 2.793 . . . . 0.0 115.39 -170.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.5 mmt -81.99 -32.16 30.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.596 1.544 . . . . 0.0 111.289 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -90.96 175.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.565 0.746 . . . . 0.0 110.087 -176.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 -62.77 0.44 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.16 -26.27 61.12 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.246 0.546 . . . . 0.0 112.395 -165.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -167.9 162.38 13.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 128.359 2.664 . . . . 0.0 107.119 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -75.76 84.19 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 119.534 1.061 . . . . 0.0 109.211 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.49 ' H ' ' HB3' ' A' ' 85' ' ' SER . 11.1 mt-30 -75.77 144.41 76.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.508 159.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.18 -177.36 3.82 Favored 'Trans proline' 0 C--N 1.346 0.44 1 C-N-CA 125.382 4.055 . . . . 0.0 112.003 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.701 167.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -166.36 179.85 5.38 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 126.099 1.76 . . . . 0.0 106.781 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.11 102.36 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.635 1.174 . . . . 0.0 112.17 -171.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.21 149.07 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.96 109.04 15.95 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 p -80.61 33.06 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 122.548 1.166 . . . . 0.0 112.347 -162.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.3 pt -63.88 -12.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.633 2.373 . . . . 0.0 115.431 -159.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.73 13.61 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 122.571 1.095 . . . . 0.0 111.825 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -117.42 140.81 49.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 163.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.4 mt -72.51 94.82 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 157.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -77.4 -32.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.725 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -153.77 163.45 40.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.821 0.819 . . . . 0.0 111.385 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.62 31.41 54.14 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.283 0.944 . . . . 0.0 112.361 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.77 -54.01 51.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.619 1.209 . . . . 0.0 111.268 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.72 -17.41 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.766 -0.584 . . . . 0.0 112.141 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.4 -11.75 25.39 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 124.008 0.923 . . . . 0.0 110.828 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.9 -25.76 32.17 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.704 1.138 . . . . 0.0 112.428 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.95 -20.79 62.42 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.711 -1.243 . . . . 0.0 111.485 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.57 28.85 5.23 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.634 2.773 . . . . 0.0 111.108 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.92 166.43 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 127.895 2.478 . . . . 0.0 107.276 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -127.27 -169.51 2.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.323 -1.486 . . . . 0.0 111.264 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -78.43 11.87 2.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.561 1.544 . . . . 0.0 113.854 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.89 79.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.576 0 O-C-N 120.423 -1.423 . . . . 0.0 111.496 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -130.52 40.14 3.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.95 2.1 . . . . 0.0 109.584 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 43.77 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.162 2.585 . . . . 0.0 114.047 163.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.5 p -81.8 111.14 17.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.7 13.4 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.1 t -86.17 126.16 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 127.717 2.407 . . . . 0.0 107.674 -168.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -135.92 172.12 13.47 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.533 1.97 . . . . 0.0 111.428 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -72.24 -11.1 60.57 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 55.71 58.82 4.21 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 125.517 1.527 . . . . 0.0 114.249 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.2 m -71.32 50.55 0.16 Allowed 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 126.861 2.065 . . . . 0.0 111.457 167.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.094 0 C-N-CA 126.48 1.912 . . . . 0.0 110.158 -169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpp . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 121.359 0.599 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -78.9 163.62 25.12 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 123.067 0.547 . . . . 0.0 109.582 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.3 t -148.02 146.29 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.518 168.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -120.77 131.62 54.59 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.488 1.915 . . . . 0.0 105.844 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.3 mt -108.71 121.28 44.72 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 tt -123.66 142.13 51.35 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -167.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 11' ' ' LYS . 5.9 m-85 -134.32 172.13 13.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 119.674 1.125 . . . . 0.0 110.438 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.207 -0.308 . . . . 0.0 110.71 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 m -101.4 -5.65 25.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.02 -163.58 33.82 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 120.931 1.696 . . . . 0.0 111.476 -169.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -160.42 165.1 31.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.7 1.25 . . . . 0.0 110.261 173.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.7 p -146.73 178.0 8.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.469 1.108 . . . . 0.0 111.529 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -133.85 130.18 55.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.141 0.976 . . . . 0.0 108.585 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.9 pt -128.01 147.08 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.435 0.694 . . . . 0.0 109.173 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -131.11 127.77 38.78 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 116.188 1.921 . . . . 0.0 116.188 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.91 126.24 45.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.433 1.708 . . . . 0.0 111.563 -161.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -69.6 122.54 19.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.185 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.95 6.6 1.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -85.89 -5.82 59.17 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 120.943 -1.098 . . . . 0.0 110.57 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -105.24 143.14 33.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.09 0.956 . . . . 0.0 109.932 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -45.36 -58.84 3.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.889 1.676 . . . . 0.0 109.427 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.92 -35.87 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.749 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -63.42 -42.99 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.489 1.041 . . . . 0.0 108.909 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -61.53 -44.32 97.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.685 0.794 . . . . 0.0 111.599 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -37.61 78.38 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.338 -1.476 . . . . 0.0 110.905 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.76 -39.83 65.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.842 1.657 . . . . 0.0 110.483 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -62.43 -31.79 72.55 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 123.037 0.535 . . . . 0.0 111.368 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -72.17 -8.92 57.4 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.37 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -131.05 30.25 4.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.93 1.692 . . . . 0.0 110.296 -173.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.43 144.27 52.17 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -63.84 158.96 67.78 Favored 'Cis proline' 0 N--CA 1.459 -0.503 0 CA-C-N 119.029 0.689 . . . . 0.0 113.604 -8.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -150.16 160.85 43.36 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 124.068 0.947 . . . . 0.0 110.682 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -114.45 160.21 19.44 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.187 0.995 . . . . 0.0 108.356 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.56 172.5 10.68 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.536 -0.727 . . . . 0.0 110.297 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.15 124.03 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -81.57 74.97 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 123.574 0.749 . . . . 0.0 110.356 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -68.07 163.94 21.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.858 0.754 . . . . 0.0 110.251 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.3 p -137.51 155.64 49.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.42 . . . . 0.0 110.197 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -155.6 99.19 2.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.41 -62.27 2.69 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 124.25 0.928 . . . . 0.0 115.18 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -168.75 40.56 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.958 1.703 . . . . 0.0 109.246 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.78 167.05 31.65 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.8 mt -135.39 133.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.027 1.331 . . . . 0.0 109.357 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.95 159.25 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.968 0.907 . . . . 0.0 109.648 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -145.27 157.72 43.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.795 -1.191 . . . . 0.0 108.882 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -76.3 98.01 4.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.048 0.939 . . . . 0.0 109.4 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.1 p -68.93 144.79 96.16 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.142 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.7 -28.95 7.62 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.001 2.467 . . . . 0.0 111.003 175.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -67.25 140.21 19.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -121.66 114.98 21.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.94 154.18 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -134.71 21.37 3.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.604 0.761 . . . . 0.0 112.861 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -94.48 119.61 33.45 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.13 1.372 . . . . 0.0 110.94 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.81 112.87 14.02 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.588 1.155 . . . . 0.0 111.84 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.04 -25.95 36.74 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.504 1.122 . . . . 0.0 113.138 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -133.94 60.55 46.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 119.037 0.835 . . . . 0.0 110.675 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.4 95.38 0.61 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.924 2.416 . . . . 0.0 108.876 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.7 mtt-85 -85.35 169.31 13.84 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -123.94 4.71 8.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.743 0.417 . . . . 0.0 111.679 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.7 t -139.92 151.37 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.91 1.684 . . . . 0.0 106.659 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.47 -175.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.323 1.849 . . . . 0.0 109.503 -172.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -114.98 -179.3 3.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.272 1.029 . . . . 0.0 110.303 167.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.13 10.15 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 126.649 1.98 . . . . 0.0 110.999 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.39 32.26 1.87 Allowed Glycine 0 CA--C 1.524 0.65 0 O-C-N 120.165 -1.584 . . . . 0.0 112.371 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -123.5 169.74 11.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.35 1.075 . . . . 0.0 109.66 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -139.91 114.76 7.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 -177.46 48.69 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.103 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -131.11 138.7 49.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -116.46 82.63 12.37 Favored Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.55 -47.25 22.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.669 2.246 . . . . 0.0 114.449 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.26 -22.45 40.17 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.167 2.578 . . . . 0.0 111.141 -165.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.53 26.43 6.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.522 1.058 . . . . 0.0 113.165 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mttt 46.25 50.92 11.77 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.417 1.487 . . . . 0.0 112.174 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.7 -177.86 4.75 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.061 0.544 . . . . 0.0 110.973 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 2.7 tp -104.8 -170.96 1.84 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.047 1.739 . . . . 0.0 109.296 172.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.422 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -156.32 153.13 28.54 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.191 1.796 . . . . 0.0 110.05 158.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.57 102.37 4.59 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.986 2.514 . . . . 0.0 105.15 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -91.06 116.11 28.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.216 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -141.88 15.23 2.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.06 -146.1 4.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 104.75 8.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -69.28 166.27 31.19 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.502 2.321 . . . . 0.0 113.284 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.98 6.52 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 125.248 3.965 . . . . 0.0 113.419 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.89 136.38 53.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.164 1.785 . . . . 0.0 107.061 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.73 163.52 0.25 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 128.834 2.854 . . . . 0.0 109.679 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.67 -42.51 2.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.97 -81.25 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.428 0.632 . . . . 0.0 111.223 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -98.94 153.84 18.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 127.334 2.254 . . . . 0.0 107.859 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.9 126.81 15.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 124.358 1.063 . . . . 0.0 109.05 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -126.96 150.42 71.8 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.16 0.984 . . . . 0.0 113.064 167.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.3 -174.43 2.2 Favored 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 126.315 4.677 . . . . 0.0 113.284 174.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.03 -10.1 59.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 t -173.84 -176.52 1.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.86 1.264 . . . . 0.0 108.806 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.28 73.81 0.5 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.414 1.486 . . . . 0.0 111.766 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.4 141.56 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.548 . . . . 0.0 110.31 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -74.76 125.47 28.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.91 49.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.78 -21.77 29.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.684 -172.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.45 164.03 13.44 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 119.631 1.105 . . . . 0.0 112.275 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -129.65 145.63 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.528 1.131 . . . . 0.0 108.352 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mt -76.09 101.67 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.83 -22.23 6.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.972 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -155.63 159.07 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.908 0.883 . . . . 0.0 111.652 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.96 11.02 70.93 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 118.746 -1.03 . . . . 0.0 115.145 169.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 tp -51.74 -48.25 63.74 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.005 1.403 . . . . 0.0 111.369 -172.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -70.2 -19.37 63.17 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 120.785 -1.197 . . . . 0.0 111.971 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.2 -0.67 32.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.247 1.019 . . . . 0.0 111.784 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.89 -39.01 61.73 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 119.954 -1.717 . . . . 0.0 111.567 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.422 ' H ' ' HD2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -63.68 -23.74 67.5 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.995 -1.066 . . . . 0.0 111.91 -172.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -94.45 23.0 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 0.0 112.679 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.46 165.63 2.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.397 1.479 . . . . 0.0 107.168 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -125.86 171.08 11.0 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.91 1.684 . . . . 0.0 108.095 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.01 1.91 2.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.218 2.207 . . . . 0.0 114.738 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.41 74.79 0.12 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.74 29.98 5.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.056 2.143 . . . . 0.0 110.029 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.4 mttt 43.07 101.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.611 2.764 . . . . 0.0 113.937 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.2 167.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 116.126 -2.23 . . . . 0.0 105.325 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -135.47 109.82 8.42 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 154.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.9 t -78.53 126.26 38.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 125.337 1.455 . . . . 0.0 107.087 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 mtm105 -128.92 176.04 8.18 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 0.0 110.231 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -72.53 -6.94 47.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 124' ' ' SER . . . 58.23 -166.38 0.16 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 126.81 2.044 . . . . 0.0 112.419 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . 0.288 12.0 p 62.97 -11.9 0.08 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.908 3.283 . . . . 0.0 116.961 170.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 122' ' ' ALA . 6.9 m . . . . . 0 C--O 1.257 1.492 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.189 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 ttm . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -68.4 160.88 28.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.048 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.1 t -152.94 143.48 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 126.613 1.965 . . . . 0.0 107.126 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -135.93 112.55 10.06 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 119.889 -1.757 . . . . 0.0 108.499 -171.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.57 92.26 9.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 131.412 3.885 . . . . 0.0 108.631 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.61 152.4 40.56 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 164.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -131.63 177.82 7.22 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.879 1.672 . . . . 0.0 107.62 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.18 -44.56 83.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m -86.16 -15.4 41.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -172.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.93 -165.49 34.0 Favored Glycine 0 N--CA 1.467 0.717 0 CA-C-N 120.734 1.606 . . . . 0.0 110.942 -166.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 138.01 8.94 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.915 1.358 . . . . 0.0 110.259 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.515 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 24.1 m -140.11 164.2 30.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.607 1.163 . . . . 0.0 111.772 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.29 112.67 21.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.428 1.091 . . . . 0.0 108.64 -167.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 pt -101.63 139.28 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.12 110.34 21.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -109.82 122.78 48.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.534 1.134 . . . . 0.0 109.708 -167.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 49.6 t30 -84.64 125.3 32.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.52 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.54 -1.82 12.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.597 1.559 . . . . 0.0 113.538 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.2 -21.14 64.88 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.139 0.881 . . . . 0.0 109.638 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 16.2 m-85 -92.79 124.63 36.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.321 1.448 . . . . 0.0 110.049 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -47.4 -53.91 12.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.241 1.817 . . . . 0.0 111.495 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -44.65 -40.43 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -71.76 -42.09 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.023 1.283 . . . . 0.0 109.958 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -59.26 -37.73 78.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.662 0.785 . . . . 0.0 110.085 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.49 -34.9 54.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.007 1.323 . . . . 0.0 109.983 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.97 -23.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.493 1.117 . . . . 0.0 112.052 172.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -14.4 50.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.742 1.156 . . . . 0.0 111.993 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -86.57 -14.37 43.07 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 120.723 -1.236 . . . . 0.0 112.25 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -124.93 4.58 8.02 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.433 1.093 . . . . 0.0 113.205 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.6 mt -104.6 141.33 22.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 120.1 1.318 . . . . 0.0 107.507 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.32 159.35 94.26 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.294 -0.711 . . . . 0.0 112.589 -6.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -140.21 164.62 29.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 122.125 -0.359 . . . . 0.0 110.055 165.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -124.26 150.4 45.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.3 161.91 37.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.006 -172.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.01 123.07 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.69 98.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -85.77 155.14 21.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 165.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -131.79 144.55 51.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 108.731 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -154.1 102.63 2.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.47 19.76 79.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 116.45 -2.306 . . . . 0.0 116.674 154.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 76.94 37.96 0.27 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.851 2.826 . . . . 0.0 112.566 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -131.71 163.74 27.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.612 1.965 . . . . 0.0 106.187 150.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.0 mt -127.79 146.24 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 127.009 2.124 . . . . 0.0 107.097 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -134.95 169.32 17.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 122.678 1.228 . . . . 0.0 109.715 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -149.99 150.55 31.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -88.75 82.79 6.74 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -167.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 p -65.26 147.92 98.28 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -165.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.19 -26.22 12.86 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.623 2.216 . . . . 0.0 112.072 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.3 136.46 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -122.66 100.02 6.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.733 1.613 . . . . 0.0 107.38 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.04 171.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 129.034 2.934 . . . . 0.0 104.669 165.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.94 3.14 2.0 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 166.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -44.81 118.84 1.74 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.918 1.287 . . . . 0.0 111.053 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtm -108.72 90.59 3.34 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.78 2.032 . . . . 0.0 106.042 -171.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -67.94 -26.88 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.455 -0.778 . . . . 0.0 111.466 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -153.7 54.83 1.2 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.141 1.776 . . . . 0.0 113.692 -167.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.58 162.97 19.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.762 1.642 . . . . 0.0 111.993 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -146.63 -175.71 4.9 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 128.331 2.652 . . . . 0.0 106.489 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -120.28 1.15 10.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.322 1.049 . . . . 0.0 112.916 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.62 159.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.269 2.227 . . . . 0.0 108.998 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG23 ' CD2' ' A' ' 78' ' ' PHE . 24.6 m -141.3 -179.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.809 2.044 . . . . 0.0 109.233 -172.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -88.76 178.56 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 120.722 -1.236 . . . . 0.0 110.844 163.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.7 mt -76.56 4.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.489 1.516 . . . . 0.0 110.261 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 43.07 0.67 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -111.78 -154.47 0.54 Allowed 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 129.368 3.067 . . . . 0.0 103.412 161.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.536 ' CG1' ' HA3' ' A' ' 99' ' ' GLY . 4.9 p -158.72 177.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -143.89 152.26 24.06 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 119.641 -1.912 . . . . 0.0 111.55 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -105.22 123.84 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.321 1.048 . . . . 0.0 109.189 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -104.76 88.29 2.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 127.403 2.281 . . . . 0.0 109.246 -172.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -61.64 -31.15 86.55 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.033 1.822 . . . . 0.0 115.366 -171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.17 -36.7 20.65 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 123.48 2.278 . . . . 0.0 109.463 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.93 64.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.138 -1.368 . . . . 0.0 113.501 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 45.78 55.63 6.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.388 2.094 . . . . 0.0 108.904 -166.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.83 157.83 44.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.55 176.16 6.79 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.32 124.54 7.5 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.871 1.268 . . . . 0.0 108.855 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.19 115.17 29.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.72 2.408 . . . . 0.0 107.553 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.402 ' CD2' HG23 ' A' ' 61' ' ' VAL . 1.9 m-85 -107.73 110.45 22.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.862 1.21 . . . . 0.0 108.204 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -125.77 11.24 7.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.695 0.798 . . . . 0.0 112.826 -170.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.64 -128.6 0.96 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 165.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -132.77 107.91 8.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.119 1.459 . . . . 0.0 110.584 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -64.85 165.51 15.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 126.655 1.982 . . . . 0.0 113.383 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.93 7.49 1.31 Allowed 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.889 4.393 . . . . 0.0 114.523 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.1 mmt -116.08 81.37 1.6 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.529 -1.357 . . . . 0.0 109.505 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 p 174.92 -177.03 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.041 2.137 . . . . 0.0 107.632 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -127.94 -59.51 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 143.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -81.4 -37.34 28.3 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.43 162.36 34.65 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.427 1.491 . . . . 0.0 107.733 -165.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.13 83.97 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 121.373 1.897 . . . . 0.0 108.334 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.68 146.29 52.69 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 126.768 2.027 . . . . 0.0 109.923 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.53 -175.34 1.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.932 3.755 . . . . 0.0 112.043 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -38.98 61.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.145 1.378 . . . . 0.0 113.751 168.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.24 174.25 3.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.661 1.584 . . . . 0.0 109.118 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.37 103.02 0.05 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.6 1.56 . . . . 0.0 111.31 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.21 142.7 23.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.446 1.099 . . . . 0.0 109.734 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -79.58 125.45 29.62 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -90.06 71.06 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.5 pt -87.4 -32.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.536 ' HA3' ' CG1' ' A' ' 66' ' ' VAL . . . -75.74 169.41 54.77 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 161.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.63 147.56 35.23 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 101.948 -3.352 . . . . 0.0 101.948 131.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.99 83.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 156.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.4 -41.0 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 120.558 -1.339 . . . . 0.0 111.016 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.49 150.09 46.07 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 125.739 1.615 . . . . 0.0 108.713 -169.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.515 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 78.35 78.08 0.83 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tp -108.77 -60.52 1.73 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.164 1.786 . . . . 0.0 110.108 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.49 -23.22 58.83 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.47 -0.769 . . . . 0.0 110.439 -172.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -24.11 54.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.415 1.086 . . . . 0.0 111.085 173.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.46 -29.57 56.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.399 0.999 . . . . 0.0 112.027 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -72.4 17.85 0.1 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.952 -1.092 . . . . 0.0 112.74 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -147.85 23.34 1.1 Allowed 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 126.124 1.77 . . . . 0.0 112.437 -178.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.2 mm -105.82 141.05 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 43.3 mmtt -85.18 174.73 9.44 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.4 1.48 . . . . 0.0 109.842 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.61 43.2 0.73 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.674 1.59 . . . . 0.0 112.643 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.43 64.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.385 0 O-C-N 120.12 -1.613 . . . . 0.0 111.91 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 6.2 mm-40 -122.22 24.64 9.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.025 1.73 . . . . 0.0 112.405 -172.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mttp 43.41 86.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.632 2.373 . . . . 0.0 113.494 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.69 104.81 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.804 -0.56 . . . . 0.0 109.522 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.71 96.8 7.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.824 1.65 . . . . 0.0 109.59 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.1 t -77.42 117.64 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.779 2.432 . . . . 0.0 108.177 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.7 173.74 10.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.92 1.288 . . . . 0.0 109.821 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -79.55 -10.6 59.83 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 121.547 1.976 . . . . 0.0 115.602 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 66.92 102.76 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.016 2.126 . . . . 0.0 111.067 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.69 35.02 2.9 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.086 -1.009 . . . . 0.0 110.368 168.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.977 1.711 . . . . 0.0 110.568 -177.251 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttm . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.674 1.225 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.9 mtm-85 -67.2 161.19 25.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.66 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 t -146.73 105.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.521 1.128 . . . . 0.0 107.978 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.78 142.15 34.05 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.636 -1.29 . . . . 0.0 109.403 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.98 97.69 5.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.044 0.938 . . . . 0.0 111.48 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 148.41 25.51 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.98 175.94 8.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.946 1.698 . . . . 0.0 110.36 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -78.2 -5.12 50.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -132.85 5.17 3.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -167.87 39.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -158.95 163.69 36.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.45 1.1 . . . . 0.0 108.25 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 p -161.73 179.87 7.78 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 130.198 3.399 . . . . 0.0 103.862 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.524 ' CG1' ' CG2' ' A' ' 102' ' ' VAL . 4.0 p -149.68 150.85 13.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 112.126 -2.306 . . . . 0.0 105.115 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -129.79 114.99 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 124.675 1.19 . . . . 0.0 109.246 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -89.45 107.52 19.12 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.7 -170.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.59 138.61 46.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.768 0.713 . . . . 0.0 110.586 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -87.98 149.51 23.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.742 -0.599 . . . . 0.0 109.69 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.38 -0.66 53.51 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.622 1.169 . . . . 0.0 114.135 -164.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -96.21 5.72 50.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.134 1.374 . . . . 0.0 109.024 -167.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -111.53 133.29 53.91 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.014 2.126 . . . . 0.0 109.178 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.71 -51.7 66.4 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.402 1.081 . . . . 0.0 110.218 -170.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -49.74 -36.06 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.452 1.501 . . . . 0.0 114.456 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.07 -39.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 119.786 1.175 . . . . 0.0 109.283 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.38 -37.5 80.97 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 0.0 110.427 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.0 -36.23 30.93 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.936 0.894 . . . . 0.0 110.735 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.08 -28.32 66.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.361 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -58.52 -26.91 64.0 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.677 0.671 . . . . 0.0 111.591 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -68.12 -26.13 65.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.989 0.813 . . . . 0.0 110.541 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -124.22 24.3 8.13 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 120.952 -1.093 . . . . 0.0 112.614 -160.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.7 mt -115.61 153.38 47.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.449 1.477 . . . . 0.0 108.335 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.26 160.83 23.75 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.067 -1.222 . . . . 0.0 111.341 -24.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -146.85 171.34 15.35 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.224 1.41 . . . . 0.0 109.756 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -122.25 162.58 21.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.252 1.021 . . . . 0.0 109.408 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 -179.92 6.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.063 0.545 . . . . 0.0 109.807 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.15 142.26 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG21 ' HB ' ' A' ' 117' ' ' VAL . 18.3 t -91.65 76.35 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.943 1.297 . . . . 0.0 107.803 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -69.82 156.48 38.98 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.899 -1.126 . . . . 0.0 108.912 175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.5 p -136.45 137.81 40.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.281 1.032 . . . . 0.0 109.956 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 67.9 t90 -142.58 75.6 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.454 1.502 . . . . 0.0 108.163 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.13 81.53 0.19 Allowed Glycine 0 C--O 1.218 -0.847 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.987 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 51.6 63.44 2.24 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 118.367 1.084 . . . . 0.0 109.253 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.9 154.87 15.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -131.66 144.09 38.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -148.74 170.62 17.79 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.332 1.453 . . . . 0.0 109.945 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.42 144.13 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.291 1.036 . . . . 0.0 109.256 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -74.85 84.95 2.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.796 2.038 . . . . 0.0 109.384 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 p -61.78 152.32 76.25 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-O 121.413 0.625 . . . . 0.0 111.869 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -81.18 0.23 10.11 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.13 3.22 . . . . 0.0 112.584 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.55 134.19 47.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 125.12 1.368 . . . . 0.0 108.541 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -114.97 18.03 16.59 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.92 0.888 . . . . 0.0 112.589 -168.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.33 150.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.739 0.781 . . . . 0.0 112.354 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -135.76 40.9 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.758 2.423 . . . . 0.0 108.586 -172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -121.61 105.84 10.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.105 2.162 . . . . 0.0 111.165 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -93.19 130.79 38.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.359 1.463 . . . . 0.0 109.716 171.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.32 -44.88 8.48 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.683 -0.636 . . . . 0.0 110.864 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -114.46 60.67 1.09 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.121 0.968 . . . . 0.0 109.581 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.12 144.67 42.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.36 2.04 . . . . 0.0 112.593 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -143.64 164.97 28.91 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.533 0.733 . . . . 0.0 109.751 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.07 12.98 18.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.414 1.886 . . . . 0.0 110.51 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -166.78 150.93 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 129.987 3.315 . . . . 0.0 110.016 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.09 -175.49 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.94 1.296 . . . . 0.0 111.74 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -94.58 175.48 6.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.821 1.248 . . . . 0.0 110.817 170.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.7 mt -81.44 33.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.692 1.597 . . . . 0.0 111.074 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.96 34.67 0.2 Allowed Glycine 0 CA--C 1.511 -0.207 0 O-C-N 120.369 -1.457 . . . . 0.0 111.888 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -121.6 -175.28 3.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.214 1.006 . . . . 0.0 108.35 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -139.12 164.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.182 1.793 . . . . 0.0 107.6 -168.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -165.34 129.12 1.89 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.49 144.5 49.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -114.34 86.79 12.57 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 68.8 Cg_endo -65.98 -22.23 55.68 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.243 2.629 . . . . 0.0 117.512 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 42.7 Cg_endo -80.48 -19.1 9.15 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 CA-C-N 123.007 2.11 . . . . 0.0 112.096 -171.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.35 -9.67 11.41 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.615 1.579 . . . . 0.0 114.137 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 58.83 84.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.094 2.157 . . . . 0.0 111.299 -164.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.28 175.92 13.23 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.457 HD11 ' H ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -87.14 -172.42 3.95 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.687 1.595 . . . . 0.0 110.928 162.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.457 ' H ' HD11 ' A' ' 75' ' ' LEU . 15.8 t -158.22 149.8 21.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.866 1.666 . . . . 0.0 109.09 161.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.46 128.86 47.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.99 2.516 . . . . 0.0 109.448 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.05 112.91 24.01 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 125.011 1.324 . . . . 0.0 109.363 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -134.33 5.55 3.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.767 2.427 . . . . 0.0 113.459 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.18 -168.32 40.43 Favored Glycine 0 CA--C 1.52 0.405 0 O-C-N 119.978 -1.701 . . . . 0.0 110.707 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.08 102.27 14.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -163.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.8 p -74.79 166.33 46.22 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 110.824 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.5 -19.88 48.31 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.362 2.708 . . . . 0.0 113.334 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.7 tpt -97.41 50.69 1.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.229 1.011 . . . . 0.0 110.317 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.0 p -158.93 177.84 10.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.147 0.579 . . . . 0.0 110.26 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.52 -62.46 0.87 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 148.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.05 -49.04 21.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.116 0.96 . . . . 0.0 111.912 -166.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -136.7 158.7 43.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.239 1.816 . . . . 0.0 108.205 -164.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mt -79.6 83.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.56 143.64 59.61 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.807 1.643 . . . . 0.0 111.398 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -81.97 174.99 9.67 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.436 3.424 . . . . 0.0 112.284 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.97 -20.5 65.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 m -156.93 170.35 22.7 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.81 2.444 . . . . 0.0 108.892 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.11 0.51 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.852 0.751 . . . . 0.0 109.848 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.89 -165.62 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 128.275 2.63 . . . . 0.0 107.396 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -139.8 127.37 21.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 112.511 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 32.75 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.432 -1.418 . . . . 0.0 111.1 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -61.25 -15.63 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 119.68 -1.887 . . . . 0.0 113.698 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.73 165.83 15.32 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -134.7 126.18 28.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 170.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.78 93.17 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 166.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.524 ' CG2' ' CG1' ' A' ' 13' ' ' VAL . 30.8 m -76.42 -63.32 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.405 ' H ' HG12 ' A' ' 13' ' ' VAL . 1.1 mm-40 -93.07 166.03 12.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -172.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.38 16.57 80.62 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-N 115.241 -0.89 . . . . 0.0 114.793 158.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.88 -62.61 1.55 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.162 0.985 . . . . 0.0 109.276 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.35 -21.2 62.92 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.176 -167.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.5 -19.83 64.55 Favored 'General case' 0 C--O 1.225 -0.23 0 O-C-N 121.67 -0.644 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.61 -18.52 65.38 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.618 -1.301 . . . . 0.0 113.44 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -59.11 -29.54 67.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.086 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 27.86 9.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.653 1.115 . . . . 0.0 112.879 -163.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.61 150.55 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.84 170.67 9.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.92 15.81 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.643 2.377 . . . . 0.0 112.932 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.71 54.67 0.09 OUTLIER Glycine 0 CA--C 1.533 1.173 0 O-C-N 119.206 -2.184 . . . . 0.0 114.758 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -100.3 32.35 3.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.938 1.295 . . . . 0.0 113.274 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.8 mttp 42.03 74.78 0.1 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.309 1.844 . . . . 0.0 112.619 171.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.407 ' HB ' HG21 ' A' ' 36' ' ' VAL . 7.5 p -68.14 105.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.25 88.91 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.39 1.476 . . . . 0.0 107.185 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.51 134.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 126.704 2.002 . . . . 0.0 108.648 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -141.93 -172.21 3.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.231 1.812 . . . . 0.0 110.332 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -99.9 0.1 40.62 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 60.72 82.56 0.16 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 126.989 2.116 . . . . 0.0 112.718 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.59 24.43 1.97 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.139 165.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.253 1.286 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 160.177 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.236 0.363 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 152.92 42.83 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.9 t -150.91 130.98 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.267 1.427 . . . . 0.0 107.613 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -115.56 120.53 39.77 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.516 2.326 . . . . 0.0 107.01 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.25 109.34 22.11 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 126.884 2.074 . . . . 0.0 106.903 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 126.94 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -110.11 173.03 6.51 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.069 0.948 . . . . 0.0 108.445 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.55 -17.66 62.3 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.046 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -115.48 4.59 14.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.594 1.557 . . . . 0.0 114.666 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.75 -164.98 38.38 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.642 -1.286 . . . . 0.0 110.724 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -157.83 158.63 35.53 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.067 0.947 . . . . 0.0 109.079 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -145.38 177.31 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.998 0.919 . . . . 0.0 108.971 174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 t -135.11 133.29 53.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.0 pt -122.66 166.32 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -144.7 135.99 25.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.32 114.93 19.55 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 126.686 1.994 . . . . 0.0 108.627 -168.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.92 132.25 52.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.381 0.673 . . . . 0.0 110.411 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.68 21.05 0.21 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.311 1.444 . . . . 0.0 113.842 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.0 10.24 22.16 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.329 1.052 . . . . 0.0 110.454 -173.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -122.72 137.33 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.589 1.156 . . . . 0.0 108.938 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.94 -53.67 30.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.963 0.905 . . . . 0.0 110.458 -173.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.37 -32.25 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.36 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.26 -50.45 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.855 1.262 . . . . 0.0 107.886 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -58.71 -43.83 90.19 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.155 0.582 . . . . 0.0 110.942 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -41.97 90.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.766 0.826 . . . . 0.0 109.351 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.34 -28.6 54.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.93 1.292 . . . . 0.0 111.112 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -60.74 -29.96 69.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.713 0.688 . . . . 0.0 110.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -72.35 -14.42 61.72 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.595 0.758 . . . . 0.0 111.863 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -125.29 24.47 7.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.769 1.628 . . . . 0.0 110.982 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mt -121.56 136.86 26.33 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.26 164.97 57.82 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 N-CA-C 114.772 1.028 . . . . 0.0 114.772 -7.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.26 165.49 35.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.686 0.794 . . . . 0.0 112.136 166.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -121.78 160.11 25.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.366 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -163.57 -159.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.432 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.12 134.49 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.075 1.35 . . . . 0.0 108.606 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.38 76.34 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 124.884 1.274 . . . . 0.0 108.111 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -69.31 144.96 53.39 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.256 -1.527 . . . . 0.0 107.615 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.5 p -129.07 147.31 50.92 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.624 0.647 . . . . 0.0 110.215 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -151.79 64.32 0.86 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.725 0.81 . . . . 0.0 109.685 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.91 77.72 0.48 Allowed Glycine 0 C--O 1.211 -1.298 0 O-C-N 120.98 -1.075 . . . . 0.0 111.581 170.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 62.06 23.0 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.106 1.453 . . . . 0.0 112.333 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -126.49 145.98 50.29 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.649 2.38 . . . . 0.0 107.317 171.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mt -122.73 144.48 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 163.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.08 158.17 43.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 166.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -141.89 153.85 44.7 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.2 t -79.91 104.54 10.55 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -68.43 149.64 97.96 Favored Pre-proline 0 N--CA 1.447 -0.588 0 O-C-N 121.813 -0.554 . . . . 0.0 110.008 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.72 -36.85 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.076 2.518 . . . . 0.0 110.793 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 149.36 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -132.2 121.87 24.35 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.539 1.936 . . . . 0.0 106.048 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.9 143.81 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -128.54 36.37 4.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.3 1.04 . . . . 0.0 111.31 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -128.91 114.87 17.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.093 2.557 . . . . 0.0 107.623 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 162.27 13.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.443 1.097 . . . . 0.0 109.933 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.2 -39.8 3.56 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.996 1.719 . . . . 0.0 110.517 166.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -122.0 60.85 12.65 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.174 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.61 131.49 29.74 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.007 1.138 . . . . 0.0 110.61 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -129.79 124.94 34.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -90.19 0.48 57.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.339 0.518 . . . . 0.0 111.919 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -137.29 135.58 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.65 173.27 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.959 -167.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -115.65 168.02 10.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.937 0.875 . . . . 0.0 112.866 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.2 mt -78.52 68.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.789 2.035 . . . . 0.0 106.85 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.77 -1.14 0.16 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.406 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.3 174.54 7.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.306 2.053 . . . . 0.0 109.564 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.29 146.55 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.181 1.392 . . . . 0.0 107.941 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.64 161.03 26.18 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.316 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -81.21 146.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 168.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -121.03 85.43 40.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.897 1.279 . . . . 0.0 108.382 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.05 -38.96 84.57 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.382 2.055 . . . . 0.0 115.854 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.5 -28.5 32.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.673 2.249 . . . . 0.0 109.814 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.82 4.52 75.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.028 -1.429 . . . . 0.0 114.535 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.96 25.84 4.29 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.47 2.135 . . . . 0.0 112.728 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.44 178.1 7.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.08 -158.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -172.97 4.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.166 166.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.7 m -148.25 158.37 44.04 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.888 2.475 . . . . 0.0 107.02 161.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mt -146.62 114.25 6.4 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.138 1.775 . . . . 0.0 109.488 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -102.73 106.22 16.81 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.103 0.961 . . . . 0.0 110.335 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -138.28 18.25 2.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.47 -134.25 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.148 0.885 . . . . 0.0 111.514 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -127.64 94.44 3.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.67 154.26 85.42 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.86 1.664 . . . . 0.0 111.222 -175.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.97 5.36 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 125.087 3.858 . . . . 0.0 113.685 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.98 24.75 12.3 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.379 1.472 . . . . 0.0 109.212 175.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.46 166.63 23.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.552 1.541 . . . . 0.0 107.985 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -153.17 -68.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -170.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -73.69 -50.83 18.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 122.206 1.003 . . . . 0.0 111.106 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.77 177.57 7.15 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 130.369 3.467 . . . . 0.0 107.187 -173.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -80.89 141.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.99 1.268 . . . . 0.0 108.62 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -141.46 144.87 35.43 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.02 0.928 . . . . 0.0 110.236 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.1 169.58 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.501 3.467 . . . . 0.0 113.911 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.16 64.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.7 p -164.52 -168.86 1.61 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.475 1.11 . . . . 0.0 108.195 165.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 76.9 0.12 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.697 0.761 . . . . 0.0 111.567 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.52 169.84 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.765 1.226 . . . . 0.0 109.242 165.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -114.71 129.16 56.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.866 1.266 . . . . 0.0 109.729 171.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.83 86.13 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.6 pt -103.73 -22.64 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 110.504 170.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.03 163.64 12.51 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -128.41 145.32 51.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.246 1.018 . . . . 0.0 108.596 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 91.9 mt -74.08 102.39 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 158.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -27.88 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 112.783 -2.008 . . . . 0.0 107.293 -167.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -155.86 161.45 40.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.022 2.529 . . . . 0.0 112.299 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.85 30.78 37.79 Favored Glycine 0 C--O 1.221 -0.674 0 CA-C-O 118.205 -1.331 . . . . 0.0 113.284 172.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.73 -41.36 97.53 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.142 1.971 . . . . 0.0 113.17 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.81 -19.87 47.46 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.121 -0.987 . . . . 0.0 111.246 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.3 -22.72 63.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.705 1.202 . . . . 0.0 110.371 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.04 -34.42 77.65 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.167 1.787 . . . . 0.0 110.285 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -67.56 -2.62 6.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -100.9 -16.03 17.35 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 123.929 0.892 . . . . 0.0 112.01 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.02 165.27 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.01 0.823 . . . . 0.0 109.65 -165.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -113.69 -179.76 3.73 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.202 1.401 . . . . 0.0 108.449 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.16 22.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.028 2.131 . . . . 0.0 114.876 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.99 26.81 0.03 OUTLIER Glycine 0 C--N 1.338 0.666 0 O-C-N 119.817 -1.802 . . . . 0.0 115.907 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.06 49.05 1.04 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.806 1.803 . . . . 0.0 112.052 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.2 mttt 42.98 82.53 0.03 OUTLIER 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.263 2.225 . . . . 0.0 114.161 157.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.73 104.09 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.415 1.486 . . . . 0.0 107.699 175.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.37 101.07 13.21 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.72 134.01 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 128.58 2.752 . . . . 0.0 107.632 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -138.98 175.36 9.62 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.194 2.598 . . . . 0.0 109.634 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -73.6 -10.2 59.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 121.025 1.739 . . . . 0.0 114.884 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 63.97 162.96 0.12 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 126.097 1.759 . . . . 0.0 111.105 -154.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.6 m -141.6 2.19 1.59 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.944 2.098 . . . . 0.0 110.212 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.252 1.196 0 C-N-CA 125.489 1.516 . . . . 0.0 108.763 173.806 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpp . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -112.82 179.68 3.9 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.51 1.924 . . . . 0.0 107.706 162.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.5 t -147.59 150.31 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.274 2.229 . . . . 0.0 106.838 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -125.23 145.71 49.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.705 2.002 . . . . 0.0 107.256 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.8 mt -121.98 111.96 17.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.99 122.17 44.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -106.8 172.08 7.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.4 -23.82 67.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.588 0.755 . . . . 0.0 111.562 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -125.26 8.74 7.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -167.79 40.84 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-O 119.527 -0.596 . . . . 0.0 111.816 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -159.2 153.66 24.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.831 0.815 . . . . 0.0 111.117 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.0 p -136.8 179.42 6.38 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.426 0.691 . . . . 0.0 110.595 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.61 135.22 49.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.51 124.45 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -96.31 117.89 31.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.986 1.314 . . . . 0.0 107.754 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -128.12 135.72 50.18 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 118.848 0.749 . . . . 0.0 109.715 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -101.04 106.78 18.1 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.01 1.71 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 1 C-N-CA 131.836 4.054 . . . . 0.0 117.151 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.76 -44.21 64.45 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.635 -1.29 . . . . 0.0 107.953 164.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -62.6 139.69 58.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 110.194 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.74 -56.35 16.19 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.283 1.833 . . . . 0.0 107.28 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -57.45 -38.64 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.042 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.36 -35.62 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.001 -170.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -61.25 -47.32 86.57 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.876 -0.515 . . . . 0.0 111.008 170.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -32.25 71.36 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.719 1.208 . . . . 0.0 110.417 -171.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' CD2' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -59.94 -40.99 90.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.389 1.876 . . . . 0.0 109.825 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -50.42 -36.19 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.897 0.879 . . . . 0.0 110.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -69.89 -23.83 63.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.615 0.766 . . . . 0.0 111.622 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -113.13 -10.35 13.43 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 111.336 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -83.21 143.57 45.47 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -70.17 149.72 90.02 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 125.47 -0.637 . . . . 0.0 112.229 -10.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -139.48 168.33 20.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.124 0.97 . . . . 0.0 109.802 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -114.13 166.0 12.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.32 161.24 39.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.603 -0.685 . . . . 0.0 109.928 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.76 128.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 t -77.62 107.45 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 167.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -96.61 151.23 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 163.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.4 p -122.46 149.97 43.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.214 1.006 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -149.43 92.88 1.99 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.2 -88.17 0.49 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 123.646 0.641 . . . . 0.0 111.758 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -141.43 36.74 1.68 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.972 1.709 . . . . 0.0 107.944 -173.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -133.17 163.84 28.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 109.681 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.0 mt -123.07 142.59 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -136.46 161.56 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.588 1.555 . . . . 0.0 107.303 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.39 142.83 27.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -75.2 93.33 2.81 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.566 1.146 . . . . 0.0 109.325 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.1 p -62.29 150.92 83.51 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -67.9 -39.04 11.91 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.107 2.538 . . . . 0.0 110.914 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.475 HG12 ' CD2' ' A' ' 26' ' ' LEU . 11.9 p -67.24 155.25 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.595 -0.69 . . . . 0.0 109.673 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -154.63 56.11 0.68 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.329 0.652 . . . . 0.0 112.464 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.12 173.3 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 0.0 110.103 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.0 14.03 2.26 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -69.94 127.76 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -136.03 93.99 2.99 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.827 1.251 . . . . 0.0 110.205 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -75.33 -43.54 50.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -117.19 66.35 4.25 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 111.635 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.31 155.39 69.46 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 120.759 0.972 . . . . 0.0 111.212 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -144.61 157.72 44.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.605 1.162 . . . . 0.0 108.911 168.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -119.63 5.48 11.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.85 1.26 . . . . 0.0 111.892 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.3 145.05 27.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.15 179.45 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.805 0.842 . . . . 0.0 110.115 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -87.88 -168.59 2.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 0.0 111.139 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.7 mt -90.79 -8.62 10.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 124.803 1.241 . . . . 0.0 110.917 161.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.68 83.22 0.25 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 105.663 -2.975 . . . . 0.0 105.663 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -141.15 -175.18 4.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.74 3.216 . . . . 0.0 105.884 152.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.96 163.3 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 131.312 3.845 . . . . 0.0 109.443 -166.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.91 144.25 9.3 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.87 163.52 27.19 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.169 0.984 . . . . 0.0 109.771 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -136.66 87.31 20.86 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 109.973 -172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.58 -27.53 69.6 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 121.465 1.443 . . . . 0.0 115.201 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.79 -28.39 16.88 Favored 'Trans proline' 0 C--N 1.354 0.822 0 CA-C-N 123.787 2.388 . . . . 0.0 111.362 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.28 9.93 26.63 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.736 -1.035 . . . . 0.0 113.737 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm 46.17 55.84 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.697 1.599 . . . . 0.0 110.814 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.93 176.94 7.47 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.699 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.0 174.49 6.53 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 125.784 1.633 . . . . 0.0 109.929 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.61 137.2 23.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.565 1.946 . . . . 0.0 109.861 162.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.64 109.7 14.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.745 3.618 . . . . 0.0 106.079 172.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.23 49.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.647 1.112 . . . . 0.0 108.632 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -147.01 34.57 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.93 -120.94 0.55 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.877 2.18 . . . . 0.0 108.135 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.81 5.8 7.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.667 1.733 . . . . 0.0 113.302 170.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.298 0.0 OUTLIER 62.93 167.72 0.1 Allowed Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.68 1.127 . . . . 0.0 113.858 167.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -91.41 6.15 3.7 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.973 3.115 . . . . 0.0 113.527 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -132.54 62.86 1.64 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.7 1.136 . . . . 0.0 108.277 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -156.62 175.0 14.62 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.343 1.457 . . . . 0.0 109.633 -174.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -148.38 -50.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 154.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.41 -58.98 2.97 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -132.2 168.46 18.0 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.228 2.611 . . . . 0.0 108.502 -167.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.73 122.06 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -129.77 144.32 52.51 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 123.413 0.445 . . . . 0.0 110.479 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.02 173.26 14.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.136 3.224 . . . . 0.0 112.717 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.12 -33.29 75.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.76 175.03 10.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.154 1.382 . . . . 0.0 107.511 172.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 100.33 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.18 -173.46 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -130.92 125.14 32.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.266 2.4 t -90.39 61.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.838 -163.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.3 pt -77.14 -10.48 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.715 2.006 . . . . 0.0 112.398 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.18 167.18 12.58 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 130.423 3.868 . . . . 0.0 112.268 -166.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -148.14 129.04 14.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.825 2.05 . . . . 0.0 106.751 150.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.8 mt -56.98 100.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 155.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 m -76.57 -36.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 118.903 0.774 . . . . 0.0 110.869 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -149.97 164.13 36.28 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.29 1.036 . . . . 0.0 111.142 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.5 33.05 71.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.994 1.283 . . . . 0.0 112.59 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.74 -52.33 66.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.332 1.053 . . . . 0.0 112.288 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.48 -21.26 56.06 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.001 -0.437 . . . . 0.0 111.316 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -9.89 6.63 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.021 1.328 . . . . 0.0 111.75 175.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.9 mt -79.78 -41.23 26.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.808 1.643 . . . . 0.0 111.611 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -65.23 -12.2 48.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.825 -1.172 . . . . 0.0 113.142 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -102.96 14.17 32.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.566 1.146 . . . . 0.0 112.125 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -107.3 127.47 63.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.253 1.421 . . . . 0.0 107.727 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -70.27 174.34 5.71 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.287 1.035 . . . . 0.0 110.471 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.34 49.57 0.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.929 1.692 . . . . 0.0 111.624 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.03 88.54 0.07 OUTLIER Glycine 0 C--O 1.231 -0.074 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -138.5 26.68 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 -173.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 mttm 43.41 75.33 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.013 2.125 . . . . 0.0 111.746 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.75 105.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.72 102.35 10.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.95 123.5 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 126.423 1.889 . . . . 0.0 107.669 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -132.97 172.43 12.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.14 1.336 . . . . 0.0 109.139 164.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -70.76 -12.49 61.58 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 55.66 99.43 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.122 1.369 . . . . 0.0 109.969 -162.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 87.5 p 59.09 -13.16 0.03 OUTLIER 'General case' 0 C--N 1.335 -0.061 0 N-CA-C 119.101 3.0 . . . . 0.0 119.101 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.247 0.931 0 CA-C-N 119.107 0.867 . . . . 0.0 109.133 -147.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttp . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -94.72 164.91 12.75 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.206 1.002 . . . . 0.0 109.821 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -149.27 132.5 7.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.06 140.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 mp -114.15 99.97 8.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.38 142.44 33.01 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -133.96 165.91 23.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.42 -17.16 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.912 -1.118 . . . . 0.0 112.332 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 m -115.61 -6.01 12.19 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.44 -169.01 39.93 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 120.633 1.56 . . . . 0.0 109.511 -172.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -169.95 113.29 0.48 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.002 0.906 . . . . 0.0 111.578 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.494 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 30.7 m -119.46 171.69 8.17 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.961 1.304 . . . . 0.0 108.713 -169.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 t -139.9 133.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -166.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.5 pt -123.36 160.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 123.386 1.565 . . . . 0.0 108.371 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -145.96 128.18 15.74 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.555 -164.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.85 149.19 51.69 Favored 'General case' 0 C--O 1.246 0.887 0 O-C-N 125.08 1.487 . . . . 0.0 110.291 -166.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -87.01 22.34 2.06 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 46.27 14.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.844 2.058 . . . . 0.0 116.215 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -116.18 10.53 14.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.013 -1.055 . . . . 0.0 110.084 -166.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -125.71 135.68 52.35 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -171.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -47.34 -51.31 19.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 110.152 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.279 7.5 p -48.86 -56.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.678 1.991 . . . . 0.0 112.376 172.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.74 -45.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 121.797 2.09 . . . . 0.0 110.74 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -65.51 -43.15 91.0 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.775 0.83 . . . . 0.0 111.602 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.4 mt -75.43 -30.8 60.14 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.336 1.055 . . . . 0.0 110.222 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.96 -26.11 61.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.321 1.048 . . . . 0.0 110.587 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp -64.91 -9.7 23.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.573 0.749 . . . . 0.0 112.865 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.74 -18.79 22.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.992 1.269 . . . . 0.0 112.159 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -125.92 31.23 5.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.117 1.367 . . . . 0.0 110.217 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.04 141.13 34.96 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 170.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.14 164.87 28.49 Favored 'Cis proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.712 0.933 . . . . 0.0 111.907 -14.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -148.94 165.53 31.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.171 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -110.61 158.9 18.07 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 162.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -151.92 -171.79 4.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.007 0.923 . . . . 0.0 108.863 164.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -97.73 138.04 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.774 1.629 . . . . 0.0 107.224 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.09 64.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.452 1.101 . . . . 0.0 110.127 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -68.66 143.59 54.73 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.476 -1.29 . . . . 0.0 107.524 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 p -111.03 155.33 22.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.971 0.805 . . . . 0.0 109.938 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -147.26 73.19 1.28 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 76.21 0.55 Allowed Glycine 0 C--O 1.218 -0.856 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.808 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.21 25.22 15.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.723 2.009 . . . . 0.0 112.011 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.546 ' CD ' ' HG ' ' A' ' 76' ' ' CYS . 0.3 OUTLIER -135.41 157.77 46.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.631 165.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.1 mt -125.15 117.66 50.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.052 1.741 . . . . 0.0 107.247 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -110.9 166.9 10.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.761 1.267 . . . . 0.0 109.718 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -151.04 149.21 29.27 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.2 t -79.0 102.85 8.56 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -79.35 150.57 74.01 Favored Pre-proline 0 N--CA 1.451 -0.417 0 O-C-N 121.765 -0.584 . . . . 0.0 110.969 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.74 -16.48 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.074 3.183 . . . . 0.0 114.601 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.11 107.13 14.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -90.14 51.03 1.96 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 123.413 1.578 . . . . 0.0 109.254 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 p -80.81 155.86 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.348 1.459 . . . . 0.0 107.716 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.05 4.55 2.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 166.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -62.46 102.36 0.31 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.236 1.38 . . . . 0.0 112.333 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.02 124.58 40.09 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.791 0.837 . . . . 0.0 110.308 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.84 -24.42 13.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.518 0.727 . . . . 0.0 112.529 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -114.9 55.73 0.88 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-O 117.49 -1.243 . . . . 0.0 110.044 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.45 126.9 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.217 1.944 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -136.0 127.86 29.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.78 0.45 57.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 118.45 -0.785 . . . . 0.0 111.164 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.1 t -138.88 141.64 36.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.91 174.32 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.175 1.39 . . . . 0.0 109.587 -171.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.62 -177.05 3.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 110.841 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mt -86.43 1.51 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.064 1.345 . . . . 0.0 112.454 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.79 44.55 0.78 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 125.012 1.291 . . . . 0.0 113.128 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' OD1' ' HE2' ' A' ' 100' ' ' LYS . 70.8 m-20 -125.82 174.66 8.2 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.22 147.52 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.25 147.85 19.35 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -93.69 141.6 28.31 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.803 1.301 . . . . 0.0 109.688 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -112.69 85.87 7.99 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.904 1.281 . . . . 0.0 109.946 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -64.32 -33.18 60.02 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.645 1.563 . . . . 0.0 115.264 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.47 -7.23 20.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.504 2.803 . . . . 0.0 112.335 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.52 9.15 8.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.215 1.864 . . . . 0.0 113.569 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.71 32.76 20.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.674 1.237 . . . . 0.0 111.868 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.33 13.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.906 0.775 . . . . 0.0 111.343 -167.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -173.96 4.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.159 0.584 . . . . 0.0 110.153 162.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.546 ' HG ' ' CD ' ' A' ' 42' ' ' GLU . 7.5 t -154.91 143.69 20.76 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.22 2.208 . . . . 0.0 106.823 165.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.4 mt -135.57 103.75 5.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.801 1.64 . . . . 0.0 107.742 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -87.71 135.7 33.26 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.028 1.286 . . . . 0.0 109.9 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -148.4 9.79 0.84 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.74 62.75 0.06 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.114 -1.993 . . . . 0.0 115.224 165.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 75.22 179.07 0.19 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.338 1.855 . . . . 0.0 107.803 -170.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.24 160.0 31.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.8 -27.74 37.27 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.123 2.549 . . . . 0.0 111.435 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.65 31.96 0.2 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.866 1.266 . . . . 0.0 111.219 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -148.75 166.15 29.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.739 -1.225 . . . . 0.0 112.001 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -136.91 -56.52 0.72 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.51 -61.81 1.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.574 1.15 . . . . 0.0 110.476 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -122.82 144.91 48.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.395 1.478 . . . . 0.0 107.103 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.5 mt -59.3 118.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -130.86 145.01 55.85 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.59 175.13 11.5 Favored 'Trans proline' 0 N--CA 1.455 -0.782 1 C-N-CA 126.219 4.613 . . . . 0.0 113.179 171.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.78 -7.04 50.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 t -171.87 -177.66 2.0 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.713 2.005 . . . . 0.0 106.718 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 73.89 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.22 165.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.7 m -68.84 -177.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 161.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -138.4 124.68 20.42 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.161 -0.962 . . . . 0.0 111.449 -169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.09 72.66 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 122.431 1.11 . . . . 0.0 108.999 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.9 pt -92.77 -14.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.175 1.39 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.66 173.48 23.5 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HE2' ' OD1' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -125.93 175.14 7.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.804 1.242 . . . . 0.0 110.415 177.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.47 77.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 122.861 1.315 . . . . 0.0 107.979 166.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -29.32 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.084 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -146.69 158.32 43.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.99 2.516 . . . . 0.0 109.241 168.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 81.02 61.17 2.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.598 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.16 -60.46 1.67 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -70.3 -27.73 64.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.111 0.957 . . . . 0.0 110.001 -166.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 1.69 5.36 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.786 2.035 . . . . 0.0 112.48 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -87.37 -35.79 18.16 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.842 1.201 . . . . 0.0 111.756 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -14.24 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.523 -1.361 . . . . 0.0 114.472 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.58 0.86 26.9 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.624 2.37 . . . . 0.0 111.7 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mm -83.66 157.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -109.73 172.7 6.7 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 109.118 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.61 11.9 0.23 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.755 2.422 . . . . 0.0 114.286 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.58 75.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.401 0 O-C-N 119.991 -1.693 . . . . 0.0 109.885 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -117.46 37.91 3.75 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.863 1.665 . . . . 0.0 111.242 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.4 mttm 44.04 74.24 0.13 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.869 2.068 . . . . 0.0 112.018 166.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.92 101.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.37 100.21 9.85 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.99 135.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 126.373 1.869 . . . . 0.0 108.713 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -140.57 178.59 7.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.773 1.629 . . . . 0.0 109.178 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.95 3.54 11.94 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.965 1.84 . . . . 0.0 115.351 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 56.21 -164.28 0.15 Allowed 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 126.172 1.789 . . . . 0.0 110.728 -156.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 98.8 p 56.24 46.78 20.6 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.567 1.947 . . . . 0.0 111.434 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.856 -1.545 . . . . 0.0 112.436 177.195 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 121.782 0.801 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 164.48 15.34 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.97 -1.081 . . . . 0.0 109.444 168.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.25 108.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -81.78 128.83 34.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.169 -1.582 . . . . 0.0 107.657 164.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.59 114.2 25.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.982 1.713 . . . . 0.0 107.257 169.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.11 133.21 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -123.06 178.49 5.06 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.388 1.075 . . . . 0.0 109.572 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -68.27 -27.37 66.27 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.655 -1.278 . . . . 0.0 112.7 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 m -115.42 -10.75 11.94 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.76 -163.79 28.52 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 119.069 0.849 . . . . 0.0 111.237 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -157.08 149.05 22.68 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.125 0.97 . . . . 0.0 110.356 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -126.1 172.37 10.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 103' ' ' GLU . 15.9 t -138.03 126.03 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 160.06 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 123.539 1.638 . . . . 0.0 106.744 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -124.18 115.77 21.64 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 129.449 3.1 . . . . 0.0 104.818 -170.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.4 mt -119.19 138.73 52.75 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -96.66 139.06 33.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.61 36.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.851 1.26 . . . . 0.0 112.383 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.87 -7.47 14.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 110.481 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CD2' ' HB ' ' A' ' 98' ' ' ILE . 24.2 m-85 -101.28 138.22 38.59 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 120.519 -1.363 . . . . 0.0 111.006 -172.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -49.22 -62.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.199 1.8 . . . . 0.0 108.09 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -50.98 -40.96 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -173.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.4 t -67.36 -34.48 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -65.06 -50.31 66.69 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 110.85 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -32.59 73.24 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.992 0.814 . . . . 0.0 109.5 -169.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.86 -37.8 83.39 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.476 2.311 . . . . 0.0 111.095 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -61.78 -24.73 67.03 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.001 1.273 . . . . 0.0 111.468 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.94 -17.06 57.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -127.26 36.82 4.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.124 1.77 . . . . 0.0 110.627 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.4 mt -128.76 145.94 58.3 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.35 160.11 62.18 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 119.224 0.758 . . . . 0.0 112.163 -9.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -149.17 162.21 40.44 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -118.88 165.86 13.53 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.402 0.681 . . . . 0.0 109.732 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.54 175.61 8.83 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.362 0.601 . . . . 0.0 111.382 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.53 131.3 39.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.3 t -79.81 71.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -64.2 154.3 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.798 1.181 . . . . 0.0 108.551 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.9 p -137.37 151.32 48.45 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.323 1.049 . . . . 0.0 111.838 -174.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -155.47 88.76 1.15 Allowed 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.2 80.91 0.05 OUTLIER Glycine 0 C--O 1.213 -1.193 0 CA-C-O 118.321 -1.266 . . . . 0.0 114.492 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 67.44 20.45 9.86 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.978 1.889 . . . . 0.0 112.22 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -135.1 146.95 49.36 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.953 0.901 . . . . 0.0 109.532 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.7 mt -130.35 127.76 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.353 1.861 . . . . 0.0 106.547 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -143.62 142.98 31.27 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.067 1.347 . . . . 0.0 109.376 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -131.26 144.78 51.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.77 -1.206 . . . . 0.0 109.059 -173.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 m -79.1 79.42 5.5 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.481 1.512 . . . . 0.0 110.728 -168.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.6 p -57.36 152.63 31.4 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.957 0.903 . . . . 0.0 112.896 -170.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.39 -12.74 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.627 2.885 . . . . 0.0 112.212 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.91 140.39 17.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -132.17 89.6 2.69 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -116.33 161.47 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.66 5.51 8.86 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.546 -0.721 . . . . 0.0 112.563 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -74.2 127.18 32.3 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.456 1.903 . . . . 0.0 110.187 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.34 101.85 7.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.177 1.391 . . . . 0.0 109.984 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.46 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.17 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -143.41 81.01 12.69 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 124.055 0.942 . . . . 0.0 111.772 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.64 143.22 26.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.465 3.443 . . . . 0.0 112.161 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -136.69 169.59 17.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.41 1.084 . . . . 0.0 108.63 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -121.98 4.36 9.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.806 1.243 . . . . 0.0 112.222 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.55 143.19 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 m -132.73 173.12 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 109.14 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -85.31 -176.64 6.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.806 0.812 . . . . 0.0 110.349 164.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.49 -7.58 10.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 124.611 1.165 . . . . 0.0 110.42 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.82 35.82 2.05 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-O 118.64 -1.089 . . . . 0.0 112.311 -168.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -112.87 173.77 6.22 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.463 1.505 . . . . 0.0 111.355 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.91 135.07 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 120.753 -1.217 . . . . 0.0 110.895 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.24 176.74 16.89 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.909 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -101.55 159.59 15.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.79 1.236 . . . . 0.0 110.334 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -132.82 83.06 53.94 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 119.347 0.976 . . . . 0.0 111.272 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.17 -24.37 65.93 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.448 2.765 . . . . 0.0 117.936 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -72.83 -45.06 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.057 2.504 . . . . 0.0 108.982 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.09 -4.36 58.66 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.439 -1.201 . . . . 0.0 114.273 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 55.24 73.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.671 1.988 . . . . 0.0 108.692 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.15 171.46 15.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.727 0.775 . . . . 0.0 112.9 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 0.9 OUTLIER -82.08 -178.42 7.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 109.519 157.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.438 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 31.5 m -142.95 160.52 40.19 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.875 1.27 . . . . 0.0 109.336 156.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -145.52 97.35 2.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 128.465 2.706 . . . . 0.0 105.273 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -83.52 146.75 28.18 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.14 26.69 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.46 -100.74 0.17 Allowed Glycine 0 C--N 1.333 0.392 0 O-C-N 119.514 -1.991 . . . . 0.0 111.744 165.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -128.14 -13.48 5.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 57.99 165.99 0.07 OUTLIER Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.155 1.782 . . . . 0.0 112.541 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.33 -18.31 9.8 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.563 2.175 . . . . 0.0 112.902 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.79 49.58 0.89 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 122.232 1.015 . . . . 0.0 109.255 -169.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.5 ' HG ' ' HB2' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -164.12 179.51 6.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.192 -0.943 . . . . 0.0 110.746 174.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -142.83 -42.97 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.734 1.214 . . . . 0.0 109.89 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.8 -56.27 2.37 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.25 -0.906 . . . . 0.0 111.538 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -127.93 178.67 6.02 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.553 1.941 . . . . 0.0 109.635 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -77.52 134.44 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 120.231 1.378 . . . . 0.0 108.069 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.5 ' HB2' ' HG ' ' A' ' 85' ' ' SER . 30.9 mt-30 -123.83 151.33 64.33 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 123.449 0.7 . . . . 0.0 109.311 165.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.89 177.92 7.91 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 124.005 3.137 . . . . 0.0 111.917 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.4 61.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.452 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.4 t -163.22 176.0 10.39 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 120.188 1.358 . . . . 0.0 108.885 -167.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 64.32 0.75 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.732 1.213 . . . . 0.0 110.694 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -66.98 165.46 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.688 1.195 . . . . 0.0 107.918 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -94.12 -178.9 4.78 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 120.05 -1.656 . . . . 0.0 109.902 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.42 45.19 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 122.878 1.323 . . . . 0.0 108.688 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.425 ' HB ' ' CD2' ' A' ' 20' ' ' TYR . 41.9 pt -69.99 -15.12 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.239 -1.538 . . . . 0.0 112.031 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.63 169.82 14.68 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -131.84 171.26 13.75 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.454 1.102 . . . . 0.0 108.505 168.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.6 mt -101.92 86.71 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 160.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -30.08 38.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.093 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.426 ' CB ' ' HB ' ' A' ' 13' ' ' VAL . 3.0 mt-10 -152.8 151.78 30.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 109.061 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.07 58.5 6.66 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.299 -0.876 . . . . 0.0 112.453 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.6 tp -84.43 -52.25 6.31 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.766 -0.844 . . . . 0.0 110.646 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.36 -24.68 57.32 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.339 -0.85 . . . . 0.0 111.089 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -26.61 68.88 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 110.688 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.18 -22.36 39.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.022 0.929 . . . . 0.0 112.288 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -72.6 -21.09 61.18 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.098 -1.626 . . . . 0.0 114.428 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 10.19 6.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 121.498 1.954 . . . . 0.0 112.457 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.0 mm -104.31 160.31 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.205 1.002 . . . . 0.0 108.805 -166.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.555 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 10.7 mmtp -131.74 175.03 9.54 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.354 2.262 . . . . 0.0 108.845 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.04 2.79 2.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.837 2.055 . . . . 0.0 115.666 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.49 48.82 0.33 Allowed Glycine 0 CA--C 1.52 0.403 0 O-C-N 120.63 -1.294 . . . . 0.0 110.961 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.555 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 8.6 mm-40 -101.69 30.43 4.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.542 -176.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 mttp 44.25 86.47 0.02 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.445 1.898 . . . . 0.0 113.266 166.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.4 p -78.52 133.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.71 111.18 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.13 127.25 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 127.117 2.167 . . . . 0.0 106.716 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -128.42 -166.59 1.65 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.479 1.112 . . . . 0.0 109.421 171.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -95.93 -5.37 41.57 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 75.49 127.23 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 129.243 3.017 . . . . 0.0 110.547 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.1 m -131.75 55.65 1.86 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.666 1.186 . . . . 0.0 109.07 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.249 1.061 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 158.289 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 -67.6 154.08 42.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.305 -0.872 . . . . 0.0 108.912 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.95 147.51 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.398 1.479 . . . . 0.0 108.089 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -123.69 139.9 53.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.019 2.528 . . . . 0.0 106.809 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 mp -118.56 98.53 6.29 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 136.73 33.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -125.35 173.9 8.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.467 1.107 . . . . 0.0 109.142 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -30.36 70.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.948 0.899 . . . . 0.0 111.301 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -93.13 -13.27 28.69 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.11 -159.91 33.12 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 120.834 1.652 . . . . 0.0 109.894 -164.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -158.17 165.09 35.78 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 109.806 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -136.72 178.13 7.31 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.904 0.482 . . . . 0.0 110.276 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.45 128.08 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.3 pt -116.14 162.18 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 122.628 1.204 . . . . 0.0 109.075 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -120.82 130.36 53.94 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 107.699 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.3 mt -124.81 135.7 53.17 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.474 1.109 . . . . 0.0 109.254 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -76.48 136.47 39.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.081 0.952 . . . . 0.0 110.915 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.33 37.12 1.19 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.42 1.088 . . . . 0.0 113.278 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.08 22.87 11.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.187 -0.946 . . . . 0.0 111.194 170.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.09 133.13 45.36 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.94 0.896 . . . . 0.0 111.216 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -44.5 -55.36 5.15 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.791 2.036 . . . . 0.0 109.248 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.67 -40.24 78.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 116.894 -1.527 . . . . 0.0 113.276 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.06 -30.84 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 121.032 1.742 . . . . 0.0 109.858 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -64.87 -47.21 78.71 Favored 'General case' 0 C--N 1.342 0.263 0 O-C-N 121.608 -0.683 . . . . 0.0 110.383 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -36.7 73.33 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 120.822 -1.174 . . . . 0.0 109.25 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' CD2' HG12 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -55.91 -38.12 69.81 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.633 1.573 . . . . 0.0 109.721 174.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 tmpt? -59.23 -28.49 66.74 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.363 0.983 . . . . 0.0 111.164 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -69.01 -34.35 75.12 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.095 0.861 . . . . 0.0 110.236 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -107.57 33.54 3.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.346 2.258 . . . . 0.0 110.932 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -129.13 144.2 51.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 172.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -61.03 158.98 49.02 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 119.557 0.878 . . . . 0.0 112.536 -14.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -156.49 162.4 39.96 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.899 0.879 . . . . 0.0 110.817 170.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.91 155.57 33.92 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.435 0.694 . . . . 0.0 110.262 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -165.1 172.56 12.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.274 1.03 . . . . 0.0 110.145 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.77 140.59 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.699 1.6 . . . . 0.0 107.535 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 t -96.13 67.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -58.31 138.3 56.52 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -116.51 151.17 36.67 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 108.982 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -157.71 115.9 3.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 -102.7 0.34 Allowed Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -137.39 36.2 2.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.038 2.135 . . . . 0.0 108.413 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -122.72 165.7 16.12 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mt -122.51 147.43 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 171.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.62 175.36 9.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.101 0.953 . . . . 0.0 109.182 160.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -146.86 156.39 43.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -80.49 96.8 6.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -64.21 147.3 97.01 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.78 -39.13 15.67 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.284 1.99 . . . . 0.0 110.007 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG12 ' CD2' ' A' ' 26' ' ' LEU . 7.7 p -71.69 163.61 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.377 1.471 . . . . 0.0 110.36 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -141.54 38.34 1.68 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 t -60.83 153.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.713 0.805 . . . . 0.0 110.781 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.22 -8.46 4.78 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.959 1.304 . . . . 0.0 112.557 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -73.09 126.29 29.65 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.328 0.967 . . . . 0.0 109.404 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 125.63 35.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.781 1.233 . . . . 0.0 109.517 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.72 -33.45 15.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.009 0.924 . . . . 0.0 109.937 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -123.86 61.56 24.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.089 0.956 . . . . 0.0 111.009 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.5 124.19 12.11 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.059 1.839 . . . . 0.0 109.003 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -128.88 149.33 50.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.724 1.209 . . . . 0.0 109.324 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -111.16 -11.03 14.28 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.855 0.462 . . . . 0.0 111.595 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 t -128.38 135.16 63.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.47 -164.01 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.347 1.859 . . . . 0.0 107.513 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -143.63 176.8 8.94 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.55 1.14 . . . . 0.0 111.184 -165.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.4 mt -84.02 11.13 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 126.167 1.787 . . . . 0.0 110.586 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.56 9.81 2.91 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.672 1.606 . . . . 0.0 113.586 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.82 -177.06 4.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 124.33 2.015 . . . . 0.0 108.592 -165.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.03 146.66 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 128.454 2.701 . . . . 0.0 105.691 -149.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.34 174.06 22.42 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -131.36 116.49 17.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 127.029 2.131 . . . . 0.0 107.356 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -108.13 87.06 3.61 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 124.582 1.153 . . . . 0.0 109.381 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.86 -43.11 62.48 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.323 2.016 . . . . 0.0 114.969 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.24 -18.19 23.7 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.393 2.062 . . . . 0.0 111.128 -170.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.33 -0.13 70.81 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.443 -1.198 . . . . 0.0 113.29 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 46.68 39.8 7.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.198 1.999 . . . . 0.0 110.623 -166.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.4 146.1 44.68 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -167.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -179.04 1.99 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.572 158.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 55.9 m -145.75 158.87 43.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.302 1.441 . . . . 0.0 108.455 151.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mt -141.46 118.1 10.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 127.752 2.421 . . . . 0.0 106.457 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -114.81 121.29 42.82 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 109.563 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -149.14 7.97 0.72 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.13 0.972 . . . . 0.0 113.458 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.28 -114.06 0.42 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.346 -1.471 . . . . 0.0 112.0 -173.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.61 148.04 26.86 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.87 162.74 55.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.75 1.22 . . . . 0.0 112.077 -167.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.92 -3.07 8.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.164 2.576 . . . . 0.0 113.876 -167.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.87 16.9 14.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.69 1.132 . . . . 0.0 110.804 166.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 90' ' ' GLN . 3.7 t -129.86 178.98 6.12 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -142.07 -34.07 0.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.455 1.102 . . . . 0.0 109.848 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.3 -52.27 6.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.302 1.441 . . . . 0.0 112.029 172.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.07 -163.81 1.36 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.564 1.546 . . . . 0.0 109.68 -156.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.99 92.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 170.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.44 ' H ' ' HB2' ' A' ' 85' ' ' SER . 14.0 mt-30 -100.59 146.33 31.86 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 158.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.6 -179.43 5.33 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.229 3.286 . . . . 0.0 113.158 164.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.66 64.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.9 -171.87 3.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 84.12 7.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 123.647 1.689 . . . . 0.0 108.265 156.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . 0.332 46.9 t -44.33 161.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 C-N-CA 129.669 3.188 . . . . 0.0 110.668 143.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -98.21 124.62 42.89 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.694 1.597 . . . . 0.0 107.084 171.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.5 pt -120.11 -9.74 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.134 2.174 . . . . 0.0 111.351 -173.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.56 171.91 13.95 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 129.752 3.549 . . . . 0.0 112.694 -163.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -144.7 148.83 34.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.851 1.66 . . . . 0.0 108.693 143.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.01 98.99 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 159.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.0 m -73.74 -36.56 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.526 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.7 163.02 38.54 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 118.798 0.726 . . . . 0.0 110.829 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.41 42.44 73.91 Favored Glycine 0 C--O 1.222 -0.607 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.185 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -56.55 11.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.458 1.129 . . . . 0.0 110.003 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.18 -19.1 64.75 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.958 -0.464 . . . . 0.0 111.088 -168.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.04 -22.96 61.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.173 1.789 . . . . 0.0 110.654 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.33 -41.12 61.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.335 -1.478 . . . . 0.0 110.36 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -62.52 -5.29 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.051 1.341 . . . . 0.0 113.412 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.54 6.06 10.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.066 1.746 . . . . 0.0 112.147 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.293 19.2 mm -80.47 164.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.292 0.951 . . . . 0.0 108.875 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -121.62 167.85 12.43 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 127.278 2.231 . . . . 0.0 106.472 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.56 -1.63 1.91 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -169.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 116' ' ' LYS . . . -149.01 17.91 1.21 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.605 -1.109 . . . . 0.0 114.168 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.03 23.78 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.274 2.037 . . . . 0.0 113.975 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 114' ' ' GLY . 3.8 ttmt 44.75 89.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 128.848 2.859 . . . . 0.0 113.958 169.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.8 104.36 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.62 98.79 9.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 107.899 170.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -75.17 137.34 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.269 1.827 . . . . 0.0 108.589 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -139.75 -177.44 4.97 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.095 2.558 . . . . 0.0 110.096 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -86.62 -4.38 59.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 56.73 76.18 0.32 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 127.524 2.33 . . . . 0.0 112.07 -173.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.6 m -81.45 25.96 0.49 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.869 1.667 . . . . 0.0 112.694 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.814 1.646 . . . . 0.0 107.626 -166.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.38 148.58 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -149.4 142.75 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -117.87 138.09 52.35 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.972 2.109 . . . . 0.0 106.068 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.26 98.94 6.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.972 2.109 . . . . 0.0 106.703 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.56 129.75 46.54 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.957 1.303 . . . . 0.0 109.139 -172.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.18 -176.1 3.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.015 1.326 . . . . 0.0 109.74 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.61 -53.79 36.83 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.928 -0.482 . . . . 0.0 110.467 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 t -76.18 -20.83 57.17 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.502 0.592 . . . . 0.0 111.039 -168.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.05 -152.29 12.73 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -164.73 152.92 12.14 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.477 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 64.7 m -141.26 173.59 11.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.059 0.943 . . . . 0.0 109.009 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 t -140.82 129.7 24.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.6 pt -114.15 166.35 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 122.427 1.108 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -123.42 149.43 45.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 163.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.4 mt -139.11 132.11 29.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.694 1.598 . . . . 0.0 110.799 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -84.93 126.43 33.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.633 0.254 . . . . 0.0 110.685 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.76 5.13 14.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.585 1.954 . . . . 0.0 113.961 -169.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -83.41 -11.8 57.17 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.093 -1.004 . . . . 0.0 109.95 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -99.34 141.14 32.51 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.862 2.065 . . . . 0.0 109.688 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -44.87 -59.5 2.52 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.844 1.658 . . . . 0.0 109.365 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.78 -35.53 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.87 -38.61 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.869 1.213 . . . . 0.0 109.819 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -55.72 -45.52 77.92 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.021 0.928 . . . . 0.0 111.066 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -40.06 89.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.03 -1.044 . . . . 0.0 109.511 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.22 -30.52 68.3 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.819 1.248 . . . . 0.0 111.901 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -69.17 -25.15 64.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.276 0.943 . . . . 0.0 109.918 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -78.06 -11.42 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.414 0.685 . . . . 0.0 112.296 171.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -126.1 26.1 6.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.552 1.541 . . . . 0.0 112.077 -166.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.43 143.96 47.85 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -62.04 158.7 56.95 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-N 119.531 0.868 . . . . 0.0 113.202 -10.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -152.79 163.77 39.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.529 0.732 . . . . 0.0 110.354 166.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -119.24 161.99 19.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.244 1.018 . . . . 0.0 110.241 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -168.75 171.36 8.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.673 0.789 . . . . 0.0 112.496 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.28 128.1 47.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.055 1.342 . . . . 0.0 108.852 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 t -91.12 80.88 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -164.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -68.15 151.21 47.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.6 p -126.22 131.61 51.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -134.57 94.71 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 175.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 44.2 82.62 0.03 OUTLIER Glycine 0 C--O 1.214 -1.134 0 C-N-CA 126.304 1.907 . . . . 0.0 115.424 167.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 71.42 21.61 4.5 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.718 1.607 . . . . 0.0 112.609 167.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -140.32 167.9 21.06 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 128.854 2.862 . . . . 0.0 106.395 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mt -132.62 146.09 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 128.003 2.521 . . . . 0.0 108.263 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -146.88 157.61 43.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.758 1.223 . . . . 0.0 111.256 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -150.55 163.05 39.42 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.245 0.618 . . . . 0.0 111.273 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -92.54 88.54 6.38 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.711 0.767 . . . . 0.0 109.825 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.2 p -60.82 148.46 82.84 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.038 0.535 . . . . 0.0 112.184 -170.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.06 -14.57 15.11 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.523 2.815 . . . . 0.0 111.997 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.23 153.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 108.786 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -137.63 119.93 15.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 p -156.92 152.45 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.951 1.3 . . . . 0.0 108.924 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.79 21.58 4.21 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.212 1.805 . . . . 0.0 112.591 -174.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -109.04 148.98 29.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.633 1.973 . . . . 0.0 108.862 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -139.64 157.67 45.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.536 1.134 . . . . 0.0 108.91 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -110.79 -50.09 2.98 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.663 0.785 . . . . 0.0 110.255 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -120.38 68.92 14.74 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.87 1.268 . . . . 0.0 108.042 -172.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 72.4 Cg_endo -71.53 156.53 57.87 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.571 2.181 . . . . 0.0 111.799 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.528 ' CZ ' ' CG2' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -144.11 158.29 43.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.623 1.569 . . . . 0.0 108.949 177.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -111.32 8.8 21.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 117.411 -1.28 . . . . 0.0 111.043 167.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 p -162.31 154.99 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 120.328 1.422 . . . . 0.0 111.749 173.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.43 HG13 ' CZ ' ' A' ' 58' ' ' ARG . 27.2 m -145.22 -179.85 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.599 1.559 . . . . 0.0 112.498 -174.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.12 171.17 12.23 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 110.31 163.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.29 -13.66 16.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 113.597 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.05 48.51 0.97 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 125.058 1.313 . . . . 0.0 110.446 -168.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -120.0 172.55 7.66 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.669 1.188 . . . . 0.0 108.869 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -137.94 136.78 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.99 172.1 18.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.494 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -123.5 137.47 54.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.478 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -116.83 88.23 24.86 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.211 1.804 . . . . 0.0 110.031 -162.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -64.57 -26.61 61.76 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.179 2.586 . . . . 0.0 116.429 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.05 -32.05 5.64 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 123.579 2.314 . . . . 0.0 110.077 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.28 14.17 21.01 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.687 1.613 . . . . 0.0 114.282 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 44.7 59.59 3.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.277 1.831 . . . . 0.0 111.058 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.4 168.83 18.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.618 1.199 . . . . 0.0 112.127 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.84 163.11 12.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.96 2.104 . . . . 0.0 109.508 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 p -134.79 137.81 43.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 119.63 1.105 . . . . 0.0 112.052 166.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -117.07 113.35 22.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.992 2.517 . . . . 0.0 105.149 170.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -88.22 149.73 23.69 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -158.9 9.99 0.13 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.947 0.794 . . . . 0.0 112.92 169.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.93 -174.84 38.48 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 120.451 -1.406 . . . . 0.0 111.14 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.21 101.17 5.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.29 165.11 42.62 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 125.316 1.446 . . . . 0.0 111.095 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.11 5.81 4.75 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.039 3.826 . . . . 0.0 114.121 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -134.31 72.46 1.47 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.71 -174.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.473 2.309 . . . . 0.0 106.537 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -156.11 -66.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -81.49 -44.72 17.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.175 1.39 . . . . 0.0 110.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -143.21 152.89 42.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.637 1.575 . . . . 0.0 108.541 -157.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.6 mt -81.9 81.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -169.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -75.09 143.48 77.4 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 108.231 170.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.9 174.65 12.23 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.646 2.897 . . . . 0.0 111.395 165.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.47 71.01 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -147.71 169.61 19.34 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.608 1.163 . . . . 0.0 107.905 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.67 80.81 0.43 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.952 1.251 . . . . 0.0 110.622 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.528 ' CG2' ' CZ ' ' A' ' 58' ' ' ARG . 2.7 m -77.55 170.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 1.1 p30 -84.47 152.21 24.12 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.307 -1.495 . . . . 0.0 112.031 169.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 58' ' ' ARG . 15.5 t -84.62 112.38 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 152.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.6 pt -123.06 -18.28 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.123 0.569 . . . . 0.0 112.184 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.53 172.05 23.2 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 65' ' ' ASP . 30.1 tptt -139.83 140.37 36.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.34 90.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -75.19 -34.2 30.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.075 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.55 157.74 43.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.69 1.196 . . . . 0.0 108.73 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 73.47 70.48 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 118.649 -1.739 . . . . 0.0 112.325 -176.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.35 -52.94 2.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 169.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -64.76 -28.6 69.69 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.906 -0.496 . . . . 0.0 111.599 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -71.38 -8.77 55.95 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.337 -0.852 . . . . 0.0 112.801 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -25.9 51.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.859 1.663 . . . . 0.0 113.003 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 5.98 6.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -174.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -129.76 9.97 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.941 2.496 . . . . 0.0 110.839 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.25 157.41 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 106.781 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -117.11 -165.02 1.03 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.765 1.226 . . . . 0.0 110.008 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.83 5.09 26.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.609 0.719 . . . . 0.0 112.644 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -172.16 80.81 0.08 OUTLIER Glycine 0 CA--C 1.523 0.56 0 O-C-N 120.83 -1.169 . . . . 0.0 110.926 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.56 22.45 10.63 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.005 1.722 . . . . 0.0 111.335 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 44.55 84.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.265 1.826 . . . . 0.0 112.918 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.41 129.02 37.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.73 107.87 19.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.08 126.5 36.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.613 2.365 . . . . 0.0 107.088 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -135.98 169.62 17.3 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.058 1.743 . . . . 0.0 109.744 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -77.32 -3.72 41.41 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 59.06 38.83 23.87 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 126.242 1.817 . . . . 0.0 113.435 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.74 52.54 0.22 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.349 1.859 . . . . 0.0 111.671 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.25 1.093 0 C-N-CA 127.573 2.349 . . . . 0.0 112.938 178.002 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 160.28 33.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 110.513 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.4 t -149.79 142.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 113.008 -1.905 . . . . 0.0 108.546 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -126.83 131.4 51.24 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 127.71 2.404 . . . . 0.0 107.018 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.59 120.29 41.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.533 1.933 . . . . 0.0 107.229 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.99 137.13 48.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -130.28 -176.65 4.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.513 1.125 . . . . 0.0 109.783 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.71 -39.71 43.7 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.875 0.87 . . . . 0.0 109.71 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 m -93.33 -16.16 24.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.426 1.091 . . . . 0.0 112.587 -174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.53 -163.38 27.03 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.508 0.575 . . . . 0.0 112.882 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -160.87 146.27 14.41 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.206 1.402 . . . . 0.0 108.378 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.484 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 34.5 m -146.86 174.94 11.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.173 1.789 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -147.98 131.46 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.269 -1.519 . . . . 0.0 108.397 -170.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.48 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.04 -1.037 . . . . 0.0 109.983 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.14 119.54 39.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 116.899 -1.524 . . . . 0.0 107.641 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.3 mt -119.29 132.19 55.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.212 0.915 . . . . 0.0 111.012 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -88.08 126.27 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.822 -168.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.35 34.64 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.822 1.649 . . . . 0.0 113.943 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -105.49 -9.48 17.46 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.527 -1.358 . . . . 0.0 110.815 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.34 144.2 34.54 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.603 1.561 . . . . 0.0 112.086 -170.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -56.67 -55.76 29.95 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.383 1.073 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 p -44.58 -40.29 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.504 1.522 . . . . 0.0 113.693 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.93 -44.18 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 120.911 1.687 . . . . 0.0 110.014 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -59.65 -38.36 81.22 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.181 0.992 . . . . 0.0 111.228 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.1 mt -72.09 -37.87 69.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.859 0.864 . . . . 0.0 109.689 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -32.52 73.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.853 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -32.96 64.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.158 0.89 . . . . 0.0 109.97 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.3 -13.77 61.99 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.743 0.817 . . . . 0.0 111.953 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -124.16 26.58 7.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.747 2.019 . . . . 0.0 110.833 -173.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -125.06 139.53 33.85 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.11 163.34 68.52 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 119.302 0.786 . . . . 0.0 112.375 -8.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -149.83 169.5 20.96 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.018 0.927 . . . . 0.0 109.473 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.98 155.69 37.76 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.9 170.1 18.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.513 0.673 . . . . 0.0 112.249 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.95 129.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.296 1.438 . . . . 0.0 108.11 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 115' ' ' GLU . 21.0 t -83.31 76.08 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -68.96 159.39 32.81 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.2 p -140.0 163.51 32.48 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.832 0.853 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -164.3 101.91 0.84 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 47.17 62.87 3.6 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.992 165.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 52.05 78.94 0.11 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.528 2.331 . . . . 0.0 110.655 -159.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -162.23 150.84 14.99 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 161.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.2 mt -127.45 121.19 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 167.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -133.09 151.37 52.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.512 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.69 150.59 52.14 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -70.86 91.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.51 1.524 . . . . 0.0 109.542 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -62.39 146.66 93.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.988 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.35 -3.76 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.424 2.749 . . . . 0.0 111.992 172.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -76.41 163.62 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.269 1.428 . . . . 0.0 109.606 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -148.9 101.68 3.2 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.578 0.751 . . . . 0.0 109.624 170.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.406 HG21 ' H ' ' A' ' 53' ' ' LYS . 9.0 p -152.44 154.86 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.176 2.19 . . . . 0.0 108.348 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.83 13.95 6.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.648 1.179 . . . . 0.0 113.139 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.406 ' H ' HG21 ' A' ' 51' ' ' VAL . 15.4 tttt -75.37 125.13 28.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.287 1.835 . . . . 0.0 111.452 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.35 143.3 50.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.603 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -132.73 -30.84 1.38 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.244 1.017 . . . . 0.0 112.601 -169.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -120.13 61.82 8.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.54 150.95 41.36 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.087 1.858 . . . . 0.0 113.201 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -146.51 153.58 40.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.463 1.505 . . . . 0.0 109.773 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -105.44 7.04 32.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.207 1.403 . . . . 0.0 113.221 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.35 152.63 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 129.788 3.235 . . . . 0.0 108.086 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.0 m -147.48 175.14 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.302 1.841 . . . . 0.0 108.414 -167.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 64' ' ' GLY . 17.7 mt-10 -91.15 169.35 10.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 122.32 1.057 . . . . 0.0 112.363 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.9 mt -73.16 23.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 0.0 110.779 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 62' ' ' GLU . . . -167.66 16.11 0.07 OUTLIER Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.305 0.955 . . . . 0.0 113.789 -177.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -93.67 -177.22 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -138.34 149.91 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.228 1.011 . . . . 0.0 108.95 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.08 21.59 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 165.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.95 159.85 27.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.006 0.922 . . . . 0.0 108.981 166.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -127.61 85.62 60.38 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -66.2 -28.06 48.34 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.069 1.846 . . . . 0.0 115.391 -174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.26 -23.61 32.9 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 123.087 2.138 . . . . 0.0 109.847 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.17 27.47 6.69 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 117.791 -1.561 . . . . 0.0 113.674 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.78 36.9 4.17 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.505 2.153 . . . . 0.0 113.141 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.31 174.16 6.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.274 -1.516 . . . . 0.0 111.398 -167.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.77 -178.88 5.37 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.839 161.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 54.0 m -147.33 163.29 36.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.948 2.499 . . . . 0.0 107.441 157.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.22 121.94 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.62 114.3 27.87 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.859 1.264 . . . . 0.0 109.648 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -145.06 27.63 1.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.253 1.821 . . . . 0.0 113.789 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.97 -112.43 0.28 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 120.51 1.504 . . . . 0.0 115.142 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 120.62 2.89 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 129.225 3.01 . . . . 0.0 104.782 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.411 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 33.8 p -86.45 165.74 31.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.661 1.119 . . . . 0.0 111.275 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 73.1 Cg_endo -69.2 0.36 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.591 2.861 . . . . 0.0 113.932 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -95.08 -33.01 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.545 1.521 . . . . 0.0 111.967 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 t -79.99 -169.31 1.96 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 161.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.13 -49.13 0.32 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.76 -51.08 9.63 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 126.049 1.74 . . . . 0.0 112.853 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -137.02 -164.18 1.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.302 1.441 . . . . 0.0 109.021 -154.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 mt -110.28 67.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -172.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -82.32 142.33 46.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.205 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.2 177.21 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 125.158 3.905 . . . . 0.0 112.672 171.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.33 -29.43 68.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.98 -174.26 4.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.476 1.489 . . . . 0.0 109.973 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.03 98.69 0.31 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 m -92.9 -164.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.35 1.46 . . . . 0.0 107.728 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -138.62 125.21 20.72 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.67 48.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.921 0.888 . . . . 0.0 109.956 -170.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 pt -72.1 -12.96 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 120.181 -1.574 . . . . 0.0 112.8 -172.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.4 159.29 21.91 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 118.681 0.673 . . . . 0.0 111.578 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -124.81 141.78 51.88 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.3 mt -76.4 112.79 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 161.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -29.67 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 -165.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -144.42 160.23 41.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.313 2.245 . . . . 0.0 107.84 170.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 75.62 60.85 3.09 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 118.55 -1.786 . . . . 0.0 112.037 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -107.82 -36.93 6.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.593 0.711 . . . . 0.0 111.157 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.11 -36.19 48.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.2 6.07 3.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.197 0.999 . . . . 0.0 112.96 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 74.0 mt -86.75 -37.17 18.13 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 111.451 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -4.62 16.78 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.719 -1.238 . . . . 0.0 113.123 -172.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -100.81 -0.95 36.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.25 1.42 . . . . 0.0 112.67 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.9 mm -80.31 162.37 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.537 0.735 . . . . 0.0 110.635 -167.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -118.31 169.4 9.76 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 127.291 2.236 . . . . 0.0 111.248 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.69 20.67 1.7 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.551 2.34 . . . . 0.0 113.702 -172.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.79 64.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.459 ' H ' ' HB ' ' A' ' 36' ' ' VAL . 6.7 pt-20 -114.37 30.5 7.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -174.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.84 85.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.685 1.594 . . . . 0.0 112.881 171.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 133.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.24 116.01 31.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 164.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -88.37 127.61 41.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 107.39 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -132.53 -179.2 5.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.993 1.717 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -79.25 -3.69 47.08 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 58.72 -169.74 0.13 Allowed 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 125.318 1.447 . . . . 0.0 110.349 -163.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.5 p -147.95 16.54 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.851 1.66 . . . . 0.0 110.788 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.258 1.509 0 C-N-CA 126.812 2.045 . . . . 0.0 106.581 -160.682 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ttp . . . . . 0 CA--C 1.509 -0.602 0 CA-C-O 122.403 1.097 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -71.53 163.25 28.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.363 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.35 113.33 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 5.3 tt0 -86.91 137.85 32.04 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.075 -1.015 . . . . 0.0 108.41 -175.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.3 mt -115.8 97.9 6.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.705 0.684 . . . . 0.0 110.196 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 148.08 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.416 1.087 . . . . 0.0 109.246 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -135.64 178.83 6.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.232 1.413 . . . . 0.0 108.86 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.59 -16.61 57.2 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.932 0.893 . . . . 0.0 111.937 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -124.26 0.48 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.753 0.821 . . . . 0.0 111.292 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.08 -174.25 43.34 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 124.556 1.074 . . . . 0.0 111.429 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -163.04 149.68 12.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.726 1.21 . . . . 0.0 108.47 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -137.28 -177.2 4.67 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 125.877 2.751 . . . . 0.0 105.101 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 4' ' ' GLU 0.258 3.8 p -136.75 164.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 110.275 -3.148 . . . . 0.0 105.869 167.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 pt -135.91 121.29 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 125.47 1.508 . . . . 0.0 107.252 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.94 117.13 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 115.325 -2.274 . . . . 0.0 110.044 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt -121.03 143.3 49.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.652 2.024 . . . . 0.0 112.649 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -89.54 140.86 29.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 111.315 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.34 8.69 3.16 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -91.7 9.93 30.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.663 -1.898 . . . . 0.0 110.479 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.22 133.34 55.16 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.745 1.618 . . . . 0.0 109.279 -170.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -48.52 -49.84 34.43 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.791 1.636 . . . . 0.0 109.888 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.89 -37.3 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 117.673 -1.155 . . . . 0.0 111.5 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t -72.1 -43.75 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 120.315 1.416 . . . . 0.0 109.232 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -59.71 -33.1 71.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.659 0.784 . . . . 0.0 111.827 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.93 -37.19 20.84 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.914 0.886 . . . . 0.0 110.769 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mt -57.03 -35.63 69.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.151 0.98 . . . . 0.0 110.225 172.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -58.5 -30.82 67.31 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 119.291 0.95 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.292 1.037 . . . . 0.0 110.973 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.52 26.24 4.75 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.624 1.569 . . . . 0.0 110.347 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -126.46 146.59 57.09 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.55 157.76 41.91 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 CA-C-N 119.44 0.836 . . . . 0.0 111.646 -12.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -148.77 150.22 32.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -105.02 156.63 17.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.32 175.55 11.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 35' ' ' VAL . 2.4 p -55.07 165.95 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.4 1.88 . . . . 0.0 111.204 157.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.0 t -117.51 123.91 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 144.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -106.11 164.68 11.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 162.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.7 p -136.24 151.15 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.427 -0.796 . . . . 0.0 109.66 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -149.98 83.75 1.39 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.965 0.802 . . . . 0.0 108.99 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 57.91 69.48 1.26 Allowed Glycine 0 C--O 1.213 -1.195 0 O-C-N 121.215 -0.928 . . . . 0.0 113.569 170.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.265 6.1 mt-10 65.98 35.64 6.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 127.984 2.514 . . . . 0.0 112.531 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.83 152.45 46.51 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.443 1.897 . . . . 0.0 108.373 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 mt -113.84 139.66 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 159.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -136.06 160.22 39.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.34 157.83 42.99 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.32 -0.862 . . . . 0.0 110.317 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -87.91 94.7 9.85 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 p -63.15 151.36 86.77 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.0 -26.58 9.24 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.026 2.484 . . . . 0.0 111.374 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -83.15 146.23 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.163 1.385 . . . . 0.0 107.851 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -133.08 133.57 43.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 m -141.34 179.15 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.807 2.443 . . . . 0.0 107.66 170.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.82 13.81 3.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.839 0.856 . . . . 0.0 112.311 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -92.8 128.6 38.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 113.116 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.98 106.18 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.201 1.8 . . . . 0.0 112.805 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -79.9 -13.94 59.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.585 1.954 . . . . 0.0 114.085 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -139.32 68.43 39.71 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 119.595 1.089 . . . . 0.0 109.878 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.79 107.97 2.46 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.628 2.219 . . . . 0.0 109.772 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -112.97 140.69 47.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 109.582 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -89.99 9.27 28.54 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.697 0.799 . . . . 0.0 112.105 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.55 154.16 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 127.555 2.342 . . . . 0.0 109.821 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -143.38 -175.57 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 127.389 2.276 . . . . 0.0 107.861 -172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -106.05 173.39 6.33 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.0 111.469 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.3 mt -71.62 11.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.977 2.111 . . . . 0.0 112.238 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.06 34.18 0.44 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 124.93 1.252 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -109.86 -177.93 3.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.31 164.65 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -146.23 170.33 27.37 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 167.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 143.49 48.28 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 167.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.26 85.87 42.52 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 125.249 1.419 . . . . 0.0 107.414 -174.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -60.62 -35.33 90.2 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.286 1.324 . . . . 0.0 115.037 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.57 -32.91 9.15 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 CA-C-N 122.785 2.031 . . . . 0.0 109.939 -168.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.19 23.01 17.08 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.682 -1.621 . . . . 0.0 113.295 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt 44.64 63.97 1.51 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.107 1.763 . . . . 0.0 111.555 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.65 157.17 44.32 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.35 0.595 . . . . 0.0 111.995 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 177.39 8.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.536 158.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.3 m -150.14 155.85 40.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.378 1.471 . . . . 0.0 108.474 161.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.0 mt -145.97 108.56 4.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.924 2.09 . . . . 0.0 107.5 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -99.4 112.91 25.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.221 0.608 . . . . 0.0 110.176 -168.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -138.77 28.86 2.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.637 1.175 . . . . 0.0 113.915 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.64 52.07 0.02 OUTLIER Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.83 -1.169 . . . . 0.0 114.282 153.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttm 71.6 175.97 0.28 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.053 2.141 . . . . 0.0 109.534 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.6 OUTLIER -153.3 159.31 32.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -165.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.55 6.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.548 4.165 . . . . 0.0 114.394 -172.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.44 44.93 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.681 1.592 . . . . 0.0 107.871 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -162.61 -179.51 6.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.353 2.261 . . . . 0.0 107.083 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -144.17 -39.9 0.28 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 165.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -89.17 -38.65 14.12 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.323 1.059 . . . . 0.0 111.413 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.76 -164.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 128.027 2.531 . . . . 0.0 107.374 -161.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.06 74.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 120.187 1.358 . . . . 0.0 107.614 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.91 143.47 62.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -89.32 175.88 3.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.436 3.424 . . . . 0.0 110.715 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.8 -16.88 62.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -169.07 15.41 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -165.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 69.19 82.0 0.17 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.016 1.726 . . . . 0.0 109.102 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.5 -169.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 113.626 -1.624 . . . . 0.0 108.841 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -128.32 125.31 38.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.07 45.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.117 0.967 . . . . 0.0 110.112 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 pt -59.18 -14.95 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 117.885 -1.055 . . . . 0.0 113.262 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -129.16 162.04 22.6 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.744 0.688 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -129.42 135.27 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 108.154 167.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.26 85.14 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.442 HG21 ' CG1' ' A' ' 13' ' ' VAL . 35.7 m -68.48 -47.74 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.27 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.66 159.11 31.55 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.908 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.44 74.33 0.51 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 125.961 2.038 . . . . 0.0 112.471 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -107.39 -48.74 3.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.992 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -90.0 -10.78 43.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.565 0.746 . . . . 0.0 111.877 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.79 -12.62 59.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 112.051 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.37 -21.46 63.8 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 119.033 -2.292 . . . . 0.0 112.422 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -10.06 59.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 171.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -77.65 -26.36 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.796 -1.19 . . . . 0.0 111.093 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 mm -77.3 157.18 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -172.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -116.79 170.14 8.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.537 1.535 . . . . 0.0 109.526 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.91 32.23 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.647 2.379 . . . . 0.0 112.569 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.86 63.9 0.03 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.541 -1.144 . . . . 0.0 110.836 172.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -118.79 13.82 13.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp 47.43 155.14 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -160.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.97 159.44 31.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.865 1.266 . . . . 0.0 107.85 164.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.13 97.6 4.83 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.724 2.809 . . . . 0.0 105.954 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.0 t -82.01 134.72 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.289 1.436 . . . . 0.0 108.095 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -140.46 -170.1 2.92 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.583 1.953 . . . . 0.0 109.141 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -98.79 5.25 47.61 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 64.6 71.7 0.46 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.224 2.21 . . . . 0.0 112.006 175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 t 70.31 3.24 4.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.12 1.768 . . . . 0.0 113.624 -169.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 C--O 1.245 0.83 0 C-N-CA 128.317 2.647 . . . . 0.0 110.404 -168.768 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttp . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -63.3 162.78 11.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.976 0.893 . . . . 0.0 109.316 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.67 135.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 127.563 2.345 . . . . 0.0 105.332 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -112.78 141.03 47.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.95 120.97 40.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.559 1.944 . . . . 0.0 107.327 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.43 110.91 15.11 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.287 1.435 . . . . 0.0 107.933 -173.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -108.33 167.83 9.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 110.431 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.49 -13.73 62.52 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -115.97 -9.44 11.76 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 -166.34 35.07 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 121.621 2.009 . . . . 0.0 111.326 -168.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.8 149.23 7.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.241 1.521 . . . . 0.0 110.545 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.648 ' HG ' ' CD1' ' A' ' 108' ' ' LEU . 65.5 m -149.59 176.15 10.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.629 1.972 . . . . 0.0 109.343 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -140.1 145.75 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 122.522 1.153 . . . . 0.0 108.246 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.68 150.03 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 125.303 1.441 . . . . 0.0 107.302 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.58 121.54 43.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.413 1.885 . . . . 0.0 108.395 -171.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -127.79 124.55 37.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 122.432 1.11 . . . . 0.0 111.312 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.56 122.03 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.401 1.481 . . . . 0.0 111.002 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.4 33.03 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.586 172.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -101.42 -9.13 21.39 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 120.512 -1.367 . . . . 0.0 111.247 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -107.91 138.7 43.7 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.535 0.734 . . . . 0.0 110.101 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.26 -51.12 57.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.845 1.658 . . . . 0.0 112.114 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.87 -26.53 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.497 1.119 . . . . 0.0 112.588 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.63 -47.37 20.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.531 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.97 -36.78 75.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.046 0.538 . . . . 0.0 109.946 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.37 -20.92 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.591 1.156 . . . . 0.0 112.16 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.71 -30.28 62.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.829 1.252 . . . . 0.0 111.093 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -59.79 -23.64 63.46 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.582 0.628 . . . . 0.0 110.558 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -70.5 -16.5 62.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.095 1.358 . . . . 0.0 113.544 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -131.73 39.1 3.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.421 1.488 . . . . 0.0 109.515 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.45 141.98 35.66 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.77 154.85 72.41 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 119.629 0.903 . . . . 0.0 110.521 -7.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -145.1 160.87 40.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.528 0.331 . . . . 0.0 110.275 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.95 149.0 49.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 165.55 32.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.3 t -86.58 133.0 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.85 72.68 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -68.38 150.98 47.51 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 p -129.3 157.86 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.731 0.812 . . . . 0.0 110.027 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -156.02 89.83 1.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.77 74.32 0.23 Allowed Glycine 0 C--O 1.213 -1.168 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.396 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 69.03 26.43 5.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.943 1.371 . . . . 0.0 113.189 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.36 152.01 51.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.338 1.855 . . . . 0.0 108.741 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.4 mt -133.57 135.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -147.69 155.37 41.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.24 146.21 38.34 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -85.7 78.68 9.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.528 1.131 . . . . 0.0 108.389 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -56.91 147.89 51.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 111.661 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 -15.66 21.7 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.993 2.462 . . . . 0.0 112.972 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.8 t -76.49 148.02 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.223 0.919 . . . . 0.0 109.372 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.46 99.75 5.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.561 0.744 . . . . 0.0 109.26 173.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.5 t -135.1 153.1 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -131.69 0.75 3.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.357 1.063 . . . . 0.0 113.486 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.93 120.57 23.72 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.557 1.143 . . . . 0.0 109.085 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.2 mtt -95.92 135.47 37.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -96.75 -28.39 14.31 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.766 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -146.53 71.26 12.85 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.448 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.93 135.04 39.46 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.716 1.611 . . . . 0.0 110.657 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -108.89 -176.48 3.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 164.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -127.72 7.11 6.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.779 0.831 . . . . 0.0 112.844 166.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.41 153.8 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 129.631 3.172 . . . . 0.0 108.267 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.15 170.96 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.173 1.389 . . . . 0.0 109.534 -170.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.43 161.15 20.43 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.377 -0.827 . . . . 0.0 110.361 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.66 74.26 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 166.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.59 8.46 0.06 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.684 -1.065 . . . . 0.0 113.912 -169.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -111.3 173.01 6.55 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.734 1.767 . . . . 0.0 110.361 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.53 131.04 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.731 1.212 . . . . 0.0 108.402 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.49 158.9 14.56 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.881 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.69 135.8 46.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -104.83 87.69 1.95 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 126.657 1.983 . . . . 0.0 109.552 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.18 -41.61 26.9 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.75 -27.15 12.84 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.55 2.167 . . . . 0.0 110.735 -162.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.13 25.92 7.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.098 1.809 . . . . 0.0 112.43 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt 43.35 65.54 0.96 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.865 1.666 . . . . 0.0 111.826 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.68 177.29 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.843 0.457 . . . . 0.0 111.792 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tp -98.44 -177.37 3.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 110.419 167.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 30.7 m -152.87 146.01 24.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.804 1.638 . . . . 0.0 112.371 154.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.265 6.9 mp -114.9 121.83 44.4 Favored 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.342 4.257 . . . . 0.0 106.634 169.815 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -110.64 113.69 26.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.23 0.923 . . . . 0.0 109.129 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CD1' HD21 ' A' ' 108' ' ' LEU . 42.6 p90 -136.51 35.55 2.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.16 -127.14 0.88 Allowed Glycine 0 C--O 1.225 -0.453 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 163.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -110.85 -15.1 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.074 0.937 . . . . 0.0 112.745 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.256 11.2 p 57.03 165.56 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 128.553 2.741 . . . . 0.0 112.464 175.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.91 -28.44 5.05 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.665 1.577 . . . . 0.0 114.215 -165.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.9 mmt -94.41 70.43 3.69 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -157.44 171.49 20.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.756 0.822 . . . . 0.0 109.421 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -143.72 -46.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 156.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -77.16 -56.88 4.18 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.042 0.937 . . . . 0.0 110.035 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 160.03 43.68 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.091 1.356 . . . . 0.0 108.991 -150.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.7 75.79 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 123.937 0.895 . . . . 0.0 109.077 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -75.35 144.09 77.54 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.455 160.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.71 -176.35 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.355 3.37 . . . . 0.0 111.891 171.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.82 74.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.023 169.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.3 t -164.71 170.04 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.847 1.659 . . . . 0.0 107.952 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.48 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.202 1.401 . . . . 0.0 110.742 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 m -102.44 152.64 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -74.21 168.85 18.79 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.637 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.1 t -120.15 44.24 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 123.194 1.473 . . . . 0.0 108.452 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.0 pt -72.24 -18.11 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.582 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.66 159.5 13.78 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.298 0.951 . . . . 0.0 111.404 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -130.27 143.13 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 0.0 107.551 172.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.82 105.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.17 -29.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -163.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.63 163.51 32.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 125.876 1.67 . . . . 0.0 106.574 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 71.36 64.62 2.69 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 117.778 -2.154 . . . . 0.0 111.457 172.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.2 tp -91.87 -45.99 8.09 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.052 0.926 . . . . 0.0 109.474 164.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -79.93 -20.97 44.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.184 -0.947 . . . . 0.0 112.183 -166.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.7 3.92 17.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.217 1.007 . . . . 0.0 111.381 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.648 ' CD1' ' HG ' ' A' ' 12' ' ' CYS . 6.1 mp -76.8 -43.5 36.41 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.786 1.175 . . . . 0.0 111.277 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -66.12 -24.3 66.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.309 -1.494 . . . . 0.0 113.662 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -78.25 -11.07 59.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.733 1.613 . . . . 0.0 114.208 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 mm -77.67 166.85 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.655 1.116 . . . . 0.0 109.045 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.463 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 8.0 mmtp -118.55 -179.48 3.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.16 1.784 . . . . 0.0 107.803 177.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.14 9.42 3.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.948 1.299 . . . . 0.0 114.467 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.17 72.9 0.14 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 120.636 -1.29 . . . . 0.0 110.548 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 21.7 mm-40 -132.24 33.48 3.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.984 0.914 . . . . 0.0 111.599 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 43.41 74.14 0.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.969 1.707 . . . . 0.0 111.57 160.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.08 120.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.66 128.73 34.75 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.9 t -111.16 124.73 68.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 127.058 2.143 . . . . 0.0 106.014 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.26 168.39 19.85 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.822 1.649 . . . . 0.0 110.66 -171.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.81 -7.15 58.51 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 57.61 89.67 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 127.116 2.166 . . . . 0.0 111.711 -171.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.0 m -71.83 0.95 7.8 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.233 -0.917 . . . . 0.0 112.811 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . 0.274 96.7 p . . . . . 0 C--O 1.243 0.73 0 C-N-CA 131.034 3.734 . . . . 0.0 112.161 -167.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 CA--C 1.503 -0.831 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.479 ' CB ' HH11 ' A' ' 2' ' ' ARG . 0.0 OUTLIER -66.62 148.87 51.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.6 t -151.63 147.25 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.914 2.085 . . . . 0.0 109.605 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -134.6 136.67 43.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.751 2.021 . . . . 0.0 107.636 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.58 100.32 7.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.953 2.501 . . . . 0.0 106.596 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.28 100.42 13.22 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.69 175.53 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.879 0.871 . . . . 0.0 108.869 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.28 -35.58 76.19 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 166.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -91.27 -14.88 30.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -172.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.38 -167.06 33.98 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -155.77 145.93 21.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 168.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.89 166.33 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.656 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.16 104.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -162.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.0 pt -120.55 160.38 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.92 1.288 . . . . 0.0 109.806 -166.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -140.56 139.43 34.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.93 124.49 35.27 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.73 137.36 51.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.18 -166.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -81.93 35.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.066 1.346 . . . . 0.0 111.983 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -119.66 3.78 11.13 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.245 2.218 . . . . 0.0 111.919 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -120.28 137.72 54.08 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.545 1.138 . . . . 0.0 109.94 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -44.0 -65.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.534 2.334 . . . . 0.0 107.739 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' A' ' 68' ' ' TYR . 7.3 p -48.54 -38.16 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.25 -43.35 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.052 1.296 . . . . 0.0 109.427 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -62.78 -38.25 89.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 120.913 -1.117 . . . . 0.0 111.602 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -44.0 69.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mt -51.17 -43.79 61.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -54.31 -23.41 15.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.995 0.816 . . . . 0.0 112.43 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.37 -30.98 17.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.58 0.627 . . . . 0.0 110.84 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.6 -40.23 64.01 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.866 1.266 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.2 140.73 98.0 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.859 1.263 . . . . 0.0 108.699 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.74 149.26 93.8 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.139 0.728 . . . . 0.0 112.594 -9.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.64 176.48 10.05 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.977 1.311 . . . . 0.0 110.103 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -133.17 166.86 21.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.514 1.126 . . . . 0.0 109.314 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -165.06 -177.96 4.89 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.4 129.07 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 C-N-CA 125.981 1.712 . . . . 0.0 107.387 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.5 117.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -102.79 156.89 17.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 160.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -144.93 137.34 26.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.211 0.604 . . . . 0.0 109.596 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -148.93 98.44 2.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -165.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 50.49 45.53 46.25 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 78.01 27.57 0.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 130.787 3.635 . . . . 0.0 114.543 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -108.93 160.71 15.79 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.67 1.588 . . . . 0.0 110.257 161.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.8 134.99 63.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.689 1.996 . . . . 0.0 105.846 165.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -142.11 168.22 20.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.201 0.6 . . . . 0.0 110.78 164.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.8 154.99 36.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.36 76.99 10.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.549 1.14 . . . . 0.0 111.433 -167.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.7 p -60.04 150.47 70.0 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.088 0.955 . . . . 0.0 112.053 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.1 -6.18 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.526 3.484 . . . . 0.0 113.303 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 p -112.34 113.11 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 125.196 1.398 . . . . 0.0 107.998 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.77 103.73 7.22 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.513 1.925 . . . . 0.0 109.438 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.24 154.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.424 2.29 . . . . 0.0 107.879 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -108.75 7.28 26.28 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.302 -0.874 . . . . 0.0 112.483 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -86.42 136.21 33.2 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.353 0.661 . . . . 0.0 109.495 171.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.47 175.46 5.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.932 2.093 . . . . 0.0 109.854 163.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.46 -35.53 1.73 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.795 1.238 . . . . 0.0 110.382 163.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -137.82 65.1 45.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 109.029 -171.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.76 138.53 23.79 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.522 2.148 . . . . 0.0 110.746 171.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -126.45 154.46 43.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.34 -0.85 . . . . 0.0 111.333 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -95.45 6.02 50.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.331 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.19 150.05 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.168 2.987 . . . . 0.0 109.894 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.08 178.35 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 127.784 2.434 . . . . 0.0 108.038 -170.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -102.26 173.47 6.35 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.106 0.962 . . . . 0.0 112.313 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.08 74.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 165.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.49 29.19 0.17 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.885 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -104.23 175.73 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.16 1.98 . . . . 0.0 109.057 167.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.1 117.94 45.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 108.417 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.76 171.64 26.4 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.891 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.419 ' CE1' HG22 ' A' ' 22' ' ' VAL . 61.7 t80 -129.28 123.36 31.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -114.18 85.92 11.03 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.469 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 36.8 Cg_endo -61.46 -33.75 87.47 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.392 2.728 . . . . 0.0 117.072 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.469 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 1.9 Cg_endo -63.46 -52.29 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.841 2.361 . . . . 0.0 109.439 -168.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.74 -6.54 87.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.578 -1.124 . . . . 0.0 114.321 174.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 47.04 90.8 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.158 2.583 . . . . 0.0 113.508 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -160.32 166.71 28.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.212 0.529 . . . . 0.0 112.407 169.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.459 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 2.5 tp -63.39 178.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.013 0.925 . . . . 0.0 110.314 160.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.459 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 32.9 m -150.58 143.7 24.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.699 2.0 . . . . 0.0 108.23 158.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 mt -125.38 135.99 52.98 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.522 2.329 . . . . 0.0 105.67 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.5 105.87 12.1 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.967 0.907 . . . . 0.0 109.299 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -136.13 23.11 3.27 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.82 -140.38 2.86 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 120.277 -1.514 . . . . 0.0 112.449 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.79 90.69 2.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -74.63 159.33 83.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 127.701 2.4 . . . . 0.0 110.8 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.22 72.36 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.344 3.363 . . . . 0.0 113.437 -166.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.64 20.85 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.997 -1.065 . . . . 0.0 112.396 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -152.42 -162.61 1.54 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.714 1.206 . . . . 0.0 108.628 -171.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -43.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.336 1.454 . . . . 0.0 109.053 160.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.47 -55.3 6.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.536 0.684 . . . . 0.0 110.698 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -138.1 -165.1 1.74 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.954 1.702 . . . . 0.0 109.595 -160.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 mt -100.62 77.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.683 1.128 . . . . 0.0 108.47 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -77.75 142.94 66.3 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.47 -0.769 . . . . 0.0 109.415 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.73 177.43 5.55 Favored 'Trans proline' 0 C--N 1.347 0.494 1 C-N-CA 125.539 4.159 . . . . 0.0 113.423 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.06 -19.69 64.63 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -172.32 176.52 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.465 2.306 . . . . 0.0 106.331 158.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.72 86.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.311 0.959 . . . . 0.0 112.812 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -69.11 136.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.995 0.918 . . . . 0.0 109.052 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -58.85 111.42 1.28 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 164.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.81 63.88 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 pt -72.84 -21.12 19.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 118.646 -0.693 . . . . 0.0 112.221 -170.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.19 -177.5 16.48 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.114 0.841 . . . . 0.0 114.325 -170.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -140.43 134.55 30.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.522 1.529 . . . . 0.0 109.442 -170.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 92.5 mt -81.07 87.58 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 165.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.5 -35.54 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 118.174 -0.917 . . . . 0.0 108.683 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.35 160.69 40.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.974 0.806 . . . . 0.0 111.7 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.95 74.61 0.35 Allowed Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.213 1.387 . . . . 0.0 110.897 -167.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.44 -63.24 1.28 Allowed 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.45 -22.11 60.28 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.997 -1.064 . . . . 0.0 111.689 -163.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -14.49 59.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 111.667 170.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.38 -31.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.224 -1.548 . . . . 0.0 110.726 169.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -77.55 34.5 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.834 1.254 . . . . 0.0 112.907 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 -16.71 0.84 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.381 -1.449 . . . . 0.0 111.415 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 mm -74.09 154.69 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -113.05 -178.39 3.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.676 0.79 . . . . 0.0 109.441 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -74.19 38.57 0.11 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.738 2.015 . . . . 0.0 111.898 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 151.8 79.9 0.03 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.832 1.206 . . . . 0.0 111.067 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -138.06 29.87 2.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.55 1.54 . . . . 0.0 110.834 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.54 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 128.595 2.758 . . . . 0.0 115.064 -170.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.53 137.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 161.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 104.73 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.942 1.697 . . . . 0.0 106.808 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.67 124.24 50.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 127.443 2.297 . . . . 0.0 106.931 -161.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -138.12 177.0 8.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.647 1.979 . . . . 0.0 110.775 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.96 -6.78 55.51 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 124' ' ' SER . . . 60.87 52.92 4.0 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 125.262 1.425 . . . . 0.0 112.922 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 65.2 m -64.87 34.36 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.417 2.287 . . . . 0.0 114.61 172.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 122' ' ' ALA . 6.5 m . . . . . 0 C--O 1.256 1.402 0 C-N-CA 129.038 2.935 . . . . 0.0 110.995 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttm . . . . . 0 CA--C 1.509 -0.626 0 CA-C-O 121.953 0.882 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -99.89 163.85 12.27 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.539 0.735 . . . . 0.0 109.198 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.3 t -148.47 129.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 2.7 tt0 -111.7 129.26 56.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.121 -1.612 . . . . 0.0 110.509 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.44 96.09 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.121 0.962 . . . . 0.0 111.934 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.6 142.24 28.41 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 109.057 168.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.51 173.25 11.04 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.751 1.62 . . . . 0.0 110.09 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.45 -27.04 66.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.866 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 m -113.35 0.4 14.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.08 -165.93 37.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 119.793 1.179 . . . . 0.0 111.426 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -162.84 143.85 9.8 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.551 ' CB ' ' HA3' ' A' ' 104' ' ' GLY 0.258 11.8 m -152.54 154.22 35.0 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.441 ' CG1' HG22 ' A' ' 102' ' ' VAL . 3.9 p -122.06 164.97 18.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.59 158.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 166.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -123.71 133.09 53.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 117.648 -1.167 . . . . 0.0 110.537 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.0 mt -117.32 156.49 27.75 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.758 1.623 . . . . 0.0 111.484 -172.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -105.72 118.08 35.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.756 -1.116 . . . . 0.0 108.741 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.61 16.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.18 2.192 . . . . 0.0 115.486 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -102.53 8.2 39.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.443 1.897 . . . . 0.0 110.29 -169.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.565 1.146 . . . . 0.0 109.13 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.12 -45.95 53.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.759 1.624 . . . . 0.0 109.116 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.19 -22.57 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 112.557 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.01 -51.75 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 120.354 1.434 . . . . 0.0 108.009 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -57.7 -27.6 63.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.724 1.209 . . . . 0.0 110.496 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.8 mt -92.94 -34.85 13.61 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.835 1.654 . . . . 0.0 111.695 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.36 -35.71 78.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 120.141 1.337 . . . . 0.0 110.509 171.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -34.03 51.19 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.893 0.877 . . . . 0.0 110.735 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.98 -15.63 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -120.57 0.82 10.54 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.837 0.855 . . . . 0.0 113.071 -166.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.1 mt -99.28 145.31 29.82 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.235 1.38 . . . . 0.0 108.631 -173.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.26 159.53 81.05 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 CA-C-N 119.039 0.693 . . . . 0.0 113.34 -12.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -148.65 159.76 43.8 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.773 1.229 . . . . 0.0 109.244 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -114.61 159.53 20.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.448 1.099 . . . . 0.0 109.709 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -161.92 172.59 15.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.058 -170.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.32 132.89 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 115' ' ' GLU . 23.1 t -89.25 73.16 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -68.64 147.24 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -123.48 136.15 54.43 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.921 0.888 . . . . 0.0 109.449 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -144.82 96.81 2.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 45.02 71.84 0.43 Allowed Glycine 0 C--O 1.211 -1.325 0 O-C-N 124.258 0.974 . . . . 0.0 112.266 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 60.74 31.44 20.11 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.639 1.22 . . . . 0.0 111.792 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -123.73 155.22 38.26 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.82 2.448 . . . . 0.0 108.594 161.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.9 mm -115.47 147.91 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 158.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -144.95 169.34 18.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.111 0.957 . . . . 0.0 108.565 161.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.24 148.24 33.29 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -80.11 77.91 6.79 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 109.537 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -59.73 150.37 67.78 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 122.093 0.949 . . . . 0.0 111.855 -171.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -68.33 -12.24 34.36 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.804 2.336 . . . . 0.0 112.246 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 t -96.77 122.59 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.862 1.665 . . . . 0.0 109.835 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -128.06 30.76 5.19 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.074 1.349 . . . . 0.0 114.003 -167.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.6 m -72.65 164.46 3.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.124 1.37 . . . . 0.0 109.731 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -139.51 33.21 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.628 0.771 . . . . 0.0 111.217 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -85.87 148.69 25.68 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.646 0.778 . . . . 0.0 109.177 166.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.88 158.67 44.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 167.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.18 -20.85 1.88 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.773 171.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -117.45 57.11 2.1 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 120.696 1.589 . . . . 0.0 111.819 171.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.66 134.46 35.31 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.065 1.843 . . . . 0.0 112.717 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.52 169.72 17.29 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.881 0.848 . . . . 0.0 112.714 172.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -122.88 9.21 9.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.263 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -159.99 101.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 125.349 1.46 . . . . 0.0 114.817 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 78' ' ' PHE . 31.5 m -100.16 -177.92 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 127.358 2.263 . . . . 0.0 110.137 -168.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -90.09 171.95 9.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.724 -1.235 . . . . 0.0 111.294 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.21 -9.55 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.507 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.31 26.38 2.0 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 125.658 1.599 . . . . 0.0 111.748 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -83.01 -154.86 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 160.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.8 t -137.62 173.89 12.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 130.107 3.363 . . . . 0.0 104.701 162.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.02 154.37 25.87 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 146.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 150.25 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -119.98 87.87 39.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.92 -43.67 56.06 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 121.582 1.521 . . . . 0.0 114.972 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.62 -1.44 11.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.084 2.523 . . . . 0.0 114.902 -155.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.26 5.16 5.98 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 127.01 2.243 . . . . 0.0 112.78 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 55.08 78.16 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.746 2.018 . . . . 0.0 111.942 -167.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.27 176.9 11.12 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.243 0.617 . . . . 0.0 111.893 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.533 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 4.9 tp -90.09 -172.79 3.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.211 1.405 . . . . 0.0 109.919 158.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.533 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 66.8 m -146.85 151.13 36.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.66 3.184 . . . . 0.0 107.734 160.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.37 96.04 3.64 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.547 2.339 . . . . 0.0 105.093 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.462 ' CD2' HG22 ' A' ' 61' ' ' VAL . 1.8 m-85 -82.11 132.09 35.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 172.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -147.47 16.08 1.14 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.41 -82.49 0.04 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 165.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -151.39 -13.71 0.21 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 57.43 166.71 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 -1.06 8.01 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.681 2.254 . . . . 0.0 113.241 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.16 39.39 2.44 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.597 1.159 . . . . 0.0 109.299 -169.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -136.24 178.9 6.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.789 1.636 . . . . 0.0 108.617 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -138.47 -47.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 165.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.496 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 26.4 t0 -118.97 -13.39 9.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -163.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 87' ' ' ASP . 3.2 pttt -167.64 164.49 14.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.758 1.623 . . . . 0.0 109.221 -166.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.0 mp -81.65 77.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 122.798 1.285 . . . . 0.0 108.739 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -69.98 144.68 93.29 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.455 163.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.44 -174.46 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.847 3.698 . . . . 0.0 111.329 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.71 -11.54 53.42 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 t -166.37 170.21 13.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 167.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.51 98.5 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.793 0.837 . . . . 0.0 110.62 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.84 -178.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.736 1.214 . . . . 0.0 109.43 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -130.95 118.9 21.33 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.72 47.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 123.025 1.393 . . . . 0.0 112.63 -171.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.55 -28.71 37.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 126.874 2.069 . . . . 0.0 113.841 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.57 168.16 20.5 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.184 1.849 . . . . 0.0 112.341 -174.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -141.95 129.05 20.87 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.665 1.986 . . . . 0.0 108.252 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.9 mt -65.08 103.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 164.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.441 HG22 ' CG1' ' A' ' 13' ' ' VAL . 33.4 m -75.47 -61.9 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 165.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -113.03 158.31 20.47 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 88.62 61.61 1.44 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.403 176.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.53 -20.66 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.05 -33.09 7.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.269 1.027 . . . . 0.0 108.671 -173.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -10.01 59.08 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.244 -0.91 . . . . 0.0 111.516 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.6 mt -72.41 -20.67 61.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.652 -1.28 . . . . 0.0 112.458 172.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -64.7 -31.68 73.01 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.889 -1.132 . . . . 0.0 110.504 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.76 10.38 41.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.188 2.595 . . . . 0.0 114.213 -172.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.36 159.95 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 120.975 -1.078 . . . . 0.0 109.276 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.56 174.58 5.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.362 1.865 . . . . 0.0 109.746 173.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.06 16.48 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.703 2.001 . . . . 0.0 113.637 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -179.92 65.16 0.07 OUTLIER Glycine 0 CA--C 1.525 0.684 0 O-C-N 119.644 -1.91 . . . . 0.0 113.787 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.447 ' H ' ' HB ' ' A' ' 36' ' ' VAL . 8.0 mm-40 -94.57 24.97 4.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.642 1.177 . . . . 0.0 112.71 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.9 mttt 43.99 71.98 0.22 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 130.075 3.35 . . . . 0.0 112.629 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -69.29 119.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.54 103.6 16.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 168.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.42 125.75 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 168.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -136.49 -175.98 4.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.307 1.843 . . . . 0.0 109.203 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.63 8.85 34.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 117.93 2.567 . . . . 0.0 117.93 -168.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . . . 55.48 111.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 129.983 3.313 . . . . 0.0 111.275 -165.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.2 t -68.07 -16.41 64.01 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.245 -0.909 . . . . 0.0 111.33 171.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.059 0 C-N-CA 130.677 3.591 . . . . 0.0 111.566 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ttm . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -84.85 173.03 10.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 173.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.8 t -147.78 141.06 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.072 1.749 . . . . 0.0 106.5 169.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -125.26 131.13 53.16 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.786 2.034 . . . . 0.0 107.18 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.82 102.94 10.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.478 1.911 . . . . 0.0 106.773 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.26 136.67 32.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -125.91 170.23 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.994 1.318 . . . . 0.0 109.747 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.97 -27.47 66.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.415 -0.803 . . . . 0.0 113.093 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 m -111.26 -3.74 15.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.27 20.81 Favored Glycine 0 N--CA 1.464 0.527 0 CA-C-O 118.08 -1.4 . . . . 0.0 110.1 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.55 161.04 23.77 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.74 1.77 . . . . 0.0 111.869 -167.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.7 p -143.81 174.83 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.793 0.837 . . . . 0.0 110.32 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.1 128.2 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 pt -117.11 148.79 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -120.24 128.51 53.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.251 -0.906 . . . . 0.0 111.015 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 42.3 mt -119.89 169.56 10.05 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 123.523 1.63 . . . . 0.0 111.912 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -128.38 114.9 17.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.99 2.116 . . . . 0.0 109.505 -167.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -72.67 52.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.789 2.036 . . . . 0.0 112.326 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -130.63 -34.15 1.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.317 1.447 . . . . 0.0 110.905 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -74.69 151.02 39.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -57.91 -46.35 85.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.865 0.866 . . . . 0.0 109.076 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.6 t -61.09 -38.08 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.82 -46.14 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -52.46 -46.76 66.63 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.094 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.1 mt -74.5 -32.91 62.68 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.741 0.816 . . . . 0.0 111.1 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -39.0 91.63 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.748 1.219 . . . . 0.0 110.184 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -53.68 -41.53 66.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.468 0.707 . . . . 0.0 109.805 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -62.21 -20.64 64.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.185 0.994 . . . . 0.0 111.918 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -111.31 -1.64 15.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 116.893 -1.527 . . . . 0.0 113.003 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -99.3 143.3 26.16 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 121.405 1.911 . . . . 0.0 109.106 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -70.15 159.65 90.53 Favored 'Cis proline' 0 C--N 1.351 0.662 0 CA-C-N 119.109 0.718 . . . . 0.0 113.242 -11.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -146.97 172.23 14.03 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 126.138 1.775 . . . . 0.0 109.722 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -124.52 167.33 14.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 109.784 167.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.34 178.09 3.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.411 0.685 . . . . 0.0 112.046 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.8 t -82.53 138.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 125.385 1.474 . . . . 0.0 109.342 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.3 t -94.29 71.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.133 0.973 . . . . 0.0 108.379 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -70.13 152.11 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 p -123.01 152.18 41.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.266 0.626 . . . . 0.0 109.997 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -156.89 79.63 0.92 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.718 0.807 . . . . 0.0 109.757 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.19 55.02 2.44 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 119.856 -1.777 . . . . 0.0 113.118 175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 52.28 40.93 30.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.157 1.383 . . . . 0.0 109.569 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.24 166.03 24.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.81 2.044 . . . . 0.0 107.858 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -132.47 124.28 51.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 108.266 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -127.41 149.26 50.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.396 1.093 . . . . 0.0 109.636 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -136.63 148.45 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 108.446 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.93 74.77 3.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.007 1.723 . . . . 0.0 111.445 -165.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.4 p -63.03 145.52 96.59 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.191 -0.943 . . . . 0.0 112.7 -164.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.68 -1.97 11.21 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.056 3.171 . . . . 0.0 113.096 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.72 136.51 37.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -132.63 82.36 2.0 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.51 0.724 . . . . 0.0 111.768 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.92 173.04 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 O-C-N 121.509 -0.744 . . . . 0.0 110.568 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -132.54 13.93 4.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.292 1.437 . . . . 0.0 112.212 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -111.69 123.19 49.72 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.812 1.187 . . . . 0.0 111.641 -167.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.4 122.7 26.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.291 1.836 . . . . 0.0 110.245 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.44 -37.28 10.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.295 0.638 . . . . 0.0 110.208 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.14 60.07 1.28 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.82 1.648 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -65.31 145.05 82.66 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.224 1.949 . . . . 0.0 110.513 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -143.58 146.56 33.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.228 1.011 . . . . 0.0 108.996 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.16 -5.29 24.59 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.094 1.358 . . . . 0.0 111.391 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.05 149.77 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 127.845 2.458 . . . . 0.0 108.895 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.8 m -132.78 -178.72 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.958 1.703 . . . . 0.0 108.587 -173.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.87 176.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.251 1.024 . . . . 0.0 109.472 172.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.6 mt -78.73 -4.54 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.196 0.998 . . . . 0.0 111.128 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.43 37.81 1.94 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.863 1.221 . . . . 0.0 111.083 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -116.85 174.77 5.91 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.1 165.87 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -141.72 179.19 19.98 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 165.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.648 ' H ' ' CG1' ' A' ' 95' ' ' VAL . 0.2 OUTLIER -128.82 129.64 45.89 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 -170.28 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . 0.297 2.9 t90 -118.57 86.62 29.46 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-N 120.135 1.334 . . . . 0.0 109.876 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.78 -26.33 22.87 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 116.834 1.821 . . . . 0.0 116.834 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.55 -17.59 14.29 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.955 2.437 . . . . 0.0 112.395 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.45 -2.56 50.52 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.88 1.705 . . . . 0.0 112.79 167.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 52.25 65.49 1.49 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.228 1.811 . . . . 0.0 110.973 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.58 177.51 10.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.75 0.786 . . . . 0.0 111.153 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.92 -177.75 5.56 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 126.213 1.805 . . . . 0.0 112.074 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 65.7 m -152.94 127.93 9.66 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.638 1.575 . . . . 0.0 109.205 156.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.61 105.12 15.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.393 2.277 . . . . 0.0 105.965 168.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -86.8 132.53 33.82 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -150.25 27.31 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.48 0.582 . . . . 0.0 112.419 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.38 0.09 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-O 118.212 -1.327 . . . . 0.0 112.331 168.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 136.36 4.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.686 1.195 . . . . 0.0 111.3 165.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.56 165.44 30.38 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.277 2.231 . . . . 0.0 113.118 -172.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.59 -17.8 9.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.65 2.9 . . . . 0.0 114.404 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.21 57.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.432 0.693 . . . . 0.0 111.997 -173.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -172.11 1.85 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.138 2.175 . . . . 0.0 109.839 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.53 -49.97 0.32 Allowed 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 158.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.459 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 8.1 m-20 -72.12 -54.99 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.883 -0.511 . . . . 0.0 110.261 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -139.4 179.71 6.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.677 2.391 . . . . 0.0 109.489 -153.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.7 74.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 121.519 1.963 . . . . 0.0 110.291 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -84.52 142.58 40.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.561 -0.712 . . . . 0.0 109.911 166.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -74.96 -178.57 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.494 3.462 . . . . 0.0 113.72 160.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.08 -12.9 43.4 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t 180.0 -177.95 0.4 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.886 2.074 . . . . 0.0 106.848 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.16 96.06 1.74 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 124.533 2.111 . . . . 0.0 109.609 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.648 ' CG1' ' H ' ' A' ' 68' ' ' TYR 0.308 46.9 t -58.59 -172.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 CA-C-N 110.945 -2.843 . . . . 0.0 111.199 140.146 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.567 ' H ' ' CG1' ' A' ' 95' ' ' VAL . 63.8 t-20 -142.54 130.39 21.68 Favored 'General case' 0 N--CA 1.438 -1.044 1 C-N-CA 132.677 4.391 . . . . 0.0 105.207 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.07 82.71 2.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.2 pt -77.4 -65.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.968 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.59 173.92 31.48 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.848 1.213 . . . . 0.0 111.464 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -134.5 141.51 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.611 1.964 . . . . 0.0 108.203 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.84 100.18 2.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 102.339 -3.208 . . . . 0.0 102.339 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -83.72 -38.73 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.363 0.529 . . . . 0.0 110.236 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.74 159.66 41.57 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.557 1.143 . . . . 0.0 109.973 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.0 70.51 1.16 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 tp -87.85 -64.09 1.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.4 -29.14 68.57 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.584 -0.697 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -12.78 24.19 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.38 1.072 . . . . 0.0 111.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.65 -34.91 22.95 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.213 1.405 . . . . 0.0 111.875 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.36 -21.93 66.25 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.08 -1.012 . . . . 0.0 112.361 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.71 10.32 33.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.495 1.518 . . . . 0.0 112.494 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.5 mm -95.37 138.66 20.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.263 0.938 . . . . 0.0 108.983 176.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -85.14 175.08 9.21 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.809 1.244 . . . . 0.0 110.281 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.69 16.4 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 129.652 3.181 . . . . 0.0 114.914 174.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.93 80.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 O-C-N 120.334 -1.479 . . . . 0.0 109.463 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -133.53 31.41 3.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt 46.03 70.11 0.4 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 128.046 2.538 . . . . 0.0 112.347 162.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.44 129.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.58 107.75 20.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.049 1.74 . . . . 0.0 106.992 164.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.5 t -88.57 121.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 128.131 2.572 . . . . 0.0 107.695 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -138.66 174.13 10.86 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.128 1.371 . . . . 0.0 110.116 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -78.66 -9.44 59.39 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 122.228 2.285 . . . . 0.0 117.036 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 62.59 178.21 0.14 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 126.335 1.854 . . . . 0.0 112.06 -164.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.7 m -158.91 36.59 0.22 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.99 2.116 . . . . 0.0 111.055 169.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 C--O 1.247 0.933 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 161.717 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 C--O 1.236 0.378 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.74 157.39 24.4 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 t -155.23 140.43 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.701 1.6 . . . . 0.0 107.646 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -123.1 117.96 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.928 2.091 . . . . 0.0 106.476 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.87 110.28 19.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.987 1.715 . . . . 0.0 106.448 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.8 122.28 39.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.363 1.465 . . . . 0.0 107.268 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -114.14 170.51 8.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.622 1.169 . . . . 0.0 109.588 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.49 -17.79 62.97 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.406 -1.434 . . . . 0.0 112.358 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 m -113.68 -0.58 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 114.16 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.17 -157.19 28.42 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 119.999 1.272 . . . . 0.0 109.927 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -158.59 166.71 31.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.47 0.708 . . . . 0.0 109.371 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -144.38 179.42 7.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.433 0.693 . . . . 0.0 109.304 166.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.05 126.74 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.19 153.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 122.691 1.234 . . . . 0.0 107.831 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -116.51 126.44 53.36 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 125.842 1.657 . . . . 0.0 106.983 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.35 133.19 51.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.182 0.901 . . . . 0.0 109.546 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.86 137.42 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.15 -18.95 63.23 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.017 0.927 . . . . 0.0 112.591 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.84 -19.5 59.97 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.496 1.043 . . . . 0.0 113.518 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -92.33 126.96 37.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.163 1.385 . . . . 0.0 110.092 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -45.96 -54.76 7.78 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 126.193 1.797 . . . . 0.0 110.915 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -54.98 -32.95 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.143 -1.408 . . . . 0.0 113.998 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.0 t -69.41 -38.75 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.772 1.624 . . . . 0.0 109.379 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -63.41 -42.7 98.75 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.799 0.84 . . . . 0.0 110.759 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -43.99 84.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -54.27 -28.07 39.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.226 1.41 . . . . 0.0 112.8 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -65.29 -27.25 68.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.014 0.824 . . . . 0.0 110.496 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.79 -20.59 63.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.593 0.711 . . . . 0.0 110.817 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -118.29 18.33 13.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.95 2.1 . . . . 0.0 110.753 -165.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.5 mt -121.29 139.97 30.47 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.678 1.581 . . . . 0.0 107.456 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.89 156.99 83.01 Favored 'Cis proline' 0 N--CA 1.458 -0.6 0 C-N-CA 125.089 -0.796 . . . . 0.0 112.053 -9.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -143.72 165.17 28.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.578 1.174 . . . . 0.0 109.947 165.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.96 155.32 41.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -162.05 166.3 26.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.819 0.848 . . . . 0.0 111.471 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.57 127.97 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.9 t -80.38 98.54 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -90.75 156.06 18.34 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -144.45 149.45 36.03 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.161 0.585 . . . . 0.0 110.253 -168.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -146.62 82.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.18 -84.98 1.23 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -142.03 38.62 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.58 1.552 . . . . 0.0 109.181 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.68 165.32 26.66 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.21 172.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mt -131.95 123.19 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -121.18 176.35 5.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.071 0.939 . . . . 0.0 109.751 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.43 161.15 38.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.915 2.086 . . . . 0.0 106.679 173.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p -94.57 85.41 4.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 p -59.12 150.21 63.37 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -166.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.87 -25.16 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.287 1.992 . . . . 0.0 111.263 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.88 143.8 10.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.152 0.981 . . . . 0.0 109.938 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -138.87 101.13 4.23 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.395 1.478 . . . . 0.0 108.202 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.8 160.19 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.626 1.57 . . . . 0.0 108.022 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -123.37 2.65 9.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.69 1.196 . . . . 0.0 113.123 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -71.95 157.98 36.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.051 0.841 . . . . 0.0 109.107 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 46.4 mtm -147.59 158.38 43.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.565 1.546 . . . . 0.0 106.939 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -126.64 -51.69 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.533 1.533 . . . . 0.0 108.819 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -123.89 54.41 7.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.297 1.039 . . . . 0.0 111.641 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.77 134.37 27.81 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 120.264 1.13 . . . . 0.0 110.516 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -127.9 148.6 50.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.387 0.675 . . . . 0.0 109.33 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -92.89 5.75 50.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.843 0.857 . . . . 0.0 112.304 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -148.39 153.41 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.034 2.134 . . . . 0.0 106.59 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.2 -178.74 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.542 2.337 . . . . 0.0 107.207 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.48 172.15 7.67 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.489 -0.757 . . . . 0.0 111.335 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -72.14 71.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.954 . . . . 0.0 107.215 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.73 11.74 0.16 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.813 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -105.07 -177.74 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.399 2.1 . . . . 0.0 108.7 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -131.65 148.34 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.638 1.175 . . . . 0.0 108.463 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -134.09 149.9 19.86 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -120.24 120.51 36.31 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -105.06 87.97 2.18 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.536 1.934 . . . . 0.0 110.35 -167.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.06 -52.0 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.104 2.536 . . . . 0.0 114.844 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.67 -28.6 7.98 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.939 2.426 . . . . 0.0 111.212 -161.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.66 87.39 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.57 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 47.24 67.62 0.77 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 108.924 -162.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.0 157.2 45.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.629 0.728 . . . . 0.0 111.702 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.5 -175.62 5.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.663 159.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 t -164.09 154.54 15.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.62 1.168 . . . . 0.0 109.278 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -136.09 142.14 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 107.12 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -120.66 106.38 11.68 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 119.929 1.241 . . . . 0.0 110.829 -170.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.25 52.52 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.328 1.061 . . . . 0.0 112.42 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.36 -98.94 0.13 Allowed Glycine 0 CA--C 1.506 -0.47 0 O-C-N 120.368 -1.457 . . . . 0.0 111.095 159.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -135.08 -15.38 1.98 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 167.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 55.72 165.63 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.232 1.813 . . . . 0.0 112.136 -174.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.64 5.43 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.185 2.59 . . . . 0.0 113.16 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.19 88.26 2.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 p 174.18 172.94 0.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.369 2.668 . . . . 0.0 107.223 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -147.21 -47.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 158.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.83 -53.49 7.85 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.737 0.78 . . . . 0.0 109.429 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -149.82 152.05 34.53 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 128.682 2.793 . . . . 0.0 107.527 -161.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 89' ' ' ILE . 5.4 mp -54.47 122.19 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -138.9 143.4 37.19 Favored Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.501 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -82.71 171.45 11.98 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.625 2.883 . . . . 0.0 113.331 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.12 52.31 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.72 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.9 m -173.02 -175.36 1.2 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.105 2.562 . . . . 0.0 107.089 166.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.9 104.99 0.61 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.433 1.015 . . . . 0.0 108.678 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -106.83 138.83 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -66.21 106.74 1.74 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.292 1.437 . . . . 0.0 108.707 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.21 61.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 122.469 1.128 . . . . 0.0 109.154 -168.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.77 -13.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.194 0.998 . . . . 0.0 112.933 -167.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.11 164.41 17.41 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -129.13 137.72 51.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.72 90.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -73.5 -30.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.704 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -148.98 162.77 39.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.225 0.536 . . . . 0.0 110.801 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.57 70.74 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.261 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -54.66 44.45 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.378 1.089 . . . . 0.0 109.922 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.25 -18.35 61.24 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.045 -1.035 . . . . 0.0 110.624 -167.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.85 -13.26 61.4 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.161 -0.962 . . . . 0.0 111.781 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.62 -29.1 56.35 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.112 -1.617 . . . . 0.0 113.23 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.39 81.16 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 120.308 -1.495 . . . . 0.0 111.872 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.448 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -67.38 -11.14 56.99 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.765 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.0 164.33 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 126.866 2.067 . . . . 0.0 109.6 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HE3' ' O ' ' A' ' 110' ' ' LYS . 5.7 mmtp -120.86 175.31 6.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.977 1.711 . . . . 0.0 109.488 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.13 44.68 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.0 2.12 . . . . 0.0 112.899 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.77 83.15 0.04 OUTLIER Glycine 0 C--N 1.333 0.366 0 O-C-N 120.721 -1.237 . . . . 0.0 110.94 168.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.5 31.11 5.05 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.264 1.026 . . . . 0.0 111.798 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.1 mttt 47.35 89.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.32 2.248 . . . . 0.0 115.225 171.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.54 152.95 5.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.49 119.14 33.65 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.467 1.907 . . . . 0.0 106.878 159.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.9 t -98.48 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 127.496 2.318 . . . . 0.0 107.192 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -130.99 163.17 28.14 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.694 -1.253 . . . . 0.0 110.395 -171.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.92 -18.17 64.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 173.31 -171.65 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.228 1 C-N-CA 131.974 4.11 . . . . 0.0 107.375 152.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.92 42.26 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.14 -0.975 . . . . 0.0 109.788 162.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 C--O 1.249 1.064 0 C-N-CA 126.617 1.967 . . . . 0.0 107.356 172.853 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 7.7 mtt180 -74.86 159.4 31.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.446 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.1 t -153.74 120.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.459 1.903 . . . . 0.0 106.031 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -100.23 136.56 39.94 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.71 -1.244 . . . . 0.0 109.007 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.78 103.11 10.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.679 1.592 . . . . 0.0 106.906 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 143.13 30.64 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.54 -178.72 4.34 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.641 1.976 . . . . 0.0 107.67 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.44 -52.51 38.62 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.808 1.243 . . . . 0.0 110.387 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 m -70.67 -33.35 70.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.004 -0.435 . . . . 0.0 111.858 -173.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.23 -150.45 8.15 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -161.21 164.53 30.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.715 1.257 . . . . 0.0 110.658 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.8 p -146.8 175.47 10.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.564 . . . . 0.0 108.965 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.02 141.98 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.5 pt -129.93 147.73 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -132.94 125.88 30.8 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.26 131.1 53.75 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 125.265 1.603 . . . . 0.0 109.47 -163.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -69.94 122.07 18.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.947 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.86 9.35 1.54 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.138 1.375 . . . . 0.0 114.067 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.02 -6.52 56.57 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.091 -1.005 . . . . 0.0 110.39 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.22 132.96 55.93 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.255 1.022 . . . . 0.0 109.702 -164.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.88 -44.09 70.16 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.274 1.429 . . . . 0.0 111.159 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -54.06 -43.09 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.591 1.156 . . . . 0.0 112.358 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.56 -44.79 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.51 1.504 . . . . 0.0 108.643 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -61.3 -40.23 93.42 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.365 0.666 . . . . 0.0 111.041 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -79.01 -29.41 43.67 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.972 0.909 . . . . 0.0 111.046 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mt -60.97 -24.58 66.21 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.228 1.411 . . . . 0.0 111.363 168.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -64.33 -20.13 65.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.345 0.975 . . . . 0.0 111.177 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -81.89 -14.97 55.46 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.068 0.947 . . . . 0.0 112.251 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -124.33 28.93 6.51 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.294 1.038 . . . . 0.0 111.414 -166.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -131.81 141.26 40.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.0 158.35 74.35 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.075 1.063 . . . . 0.0 112.332 -8.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -150.31 166.0 31.33 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.31 0.644 . . . . 0.0 110.003 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.48 166.93 12.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.3 163.19 17.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.702 0.763 . . . . 0.0 111.736 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.96 131.85 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 164.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.6 99.96 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -85.59 154.85 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.4 p -129.6 150.91 50.72 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.627 1.171 . . . . 0.0 108.681 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -149.31 98.22 2.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.43 -87.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.2 29.61 1.81 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.292 1.837 . . . . 0.0 110.327 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -133.11 161.83 33.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.436 1.094 . . . . 0.0 108.589 168.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -127.3 143.22 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -148.69 166.9 26.99 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 2.5 p90 -154.38 155.64 35.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.759 -1.213 . . . . 0.0 108.584 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -83.02 86.55 6.98 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.541 0.737 . . . . 0.0 109.511 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.0 p -58.15 150.88 49.58 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 122.663 0.385 . . . . 0.0 111.874 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.85 -13.31 13.06 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.277 2.651 . . . . 0.0 112.647 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.81 158.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-N 119.092 0.86 . . . . 0.0 108.904 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.32 103.83 4.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.229 1.412 . . . . 0.0 107.879 172.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.55 147.12 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -125.47 -7.45 6.92 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -65.17 146.7 54.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.723 1.209 . . . . 0.0 107.778 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 18.0 ptp -144.81 104.35 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.24 1.416 . . . . 0.0 110.304 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.66 -30.34 59.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.156 -1.018 . . . . 0.0 113.221 -172.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -133.29 72.9 74.87 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 119.432 1.015 . . . . 0.0 110.522 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 56.3 Cg_endo -69.48 150.67 70.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.75 2.967 . . . . 0.0 112.113 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -140.13 173.36 11.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.494 1.917 . . . . 0.0 108.384 170.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.27 10.67 8.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 112.657 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.72 154.11 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 131.001 3.72 . . . . 0.0 107.004 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.14 -174.48 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.23 1.412 . . . . 0.0 109.575 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -90.94 175.84 6.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.698 0.761 . . . . 0.0 110.935 166.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.456 ' O ' HD11 ' A' ' 105' ' ' LEU . 56.5 mt -75.58 5.23 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.923 1.289 . . . . 0.0 110.68 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.17 30.91 1.6 Allowed Glycine 0 C--N 1.337 0.615 0 O-C-N 120.692 -1.255 . . . . 0.0 112.949 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -115.79 169.92 8.85 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.049 0.924 . . . . 0.0 109.462 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -136.99 140.99 41.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.703 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -127.03 176.82 17.64 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.875 1.226 . . . . 0.0 110.987 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -111.4 143.01 42.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 165.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -104.77 86.06 1.36 Allowed Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 125.631 1.572 . . . . 0.0 107.667 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.05 -43.39 42.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.359 2.039 . . . . 0.0 115.054 -172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.74 -22.65 43.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.639 2.226 . . . . 0.0 111.482 -165.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -115.76 15.13 16.95 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.763 1.649 . . . . 0.0 113.751 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 47.56 37.96 7.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.755 2.278 . . . . 0.0 113.024 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.83 160.95 15.34 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.724 -1.235 . . . . 0.0 110.531 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -80.07 -179.14 6.87 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 161.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.6 m -139.15 163.93 31.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.796 0.838 . . . . 0.0 109.777 154.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.5 mt -151.05 101.49 2.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 129.36 3.064 . . . . 0.0 105.066 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -99.97 119.88 38.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.73 1.56 2.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.14 -178.74 34.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 166.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -83.25 106.88 15.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -59.71 165.43 4.38 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 125.465 1.506 . . . . 0.0 110.961 169.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.41 1.48 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.333 2.022 . . . . 0.0 114.165 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ttp -107.17 58.31 0.63 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 120.208 1.367 . . . . 0.0 110.182 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 p -159.83 -178.63 7.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 122.161 0.982 . . . . 0.0 110.501 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.93 -62.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 154.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.39 -43.54 40.18 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.046 0.538 . . . . 0.0 112.022 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -149.68 161.98 41.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.957 1.303 . . . . 0.0 108.6 -162.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.78 80.54 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -167.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -79.85 141.85 55.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -89.26 177.29 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 124.494 3.463 . . . . 0.0 112.935 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.78 16.16 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.4 t -164.86 173.86 11.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.029 1.286 . . . . 0.0 109.783 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.57 78.8 0.58 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.8 148.92 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 25.7 p30 -64.97 158.59 25.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.213 0.53 . . . . 0.0 112.177 164.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.56 99.32 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 166.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.2 pt -113.47 -16.38 9.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.511 1.124 . . . . 0.0 111.408 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.1 175.56 20.03 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-O 122.061 0.811 . . . . 0.0 112.413 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -135.86 134.0 38.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 105' ' ' LEU . 52.7 mt -73.76 95.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 165.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -76.62 -24.2 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.365 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -148.66 158.68 44.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 110.421 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.78 42.34 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.371 1.462 . . . . 0.0 112.569 160.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 63' ' ' ILE . 1.8 tp -67.63 -11.81 59.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -162.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -107.18 -35.27 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 119.258 0.935 . . . . 0.0 110.331 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.56 -18.21 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.484 0.713 . . . . 0.0 111.316 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mp -66.76 -29.09 68.97 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.088 -1.007 . . . . 0.0 112.314 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -67.22 -22.79 65.69 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.818 1.644 . . . . 0.0 112.87 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -99.16 5.77 46.69 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.932 -171.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.86 165.37 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 119.744 1.157 . . . . 0.0 108.741 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -109.39 172.84 6.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.29 35.8 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 112.735 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.45 51.97 0.04 OUTLIER Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.804 -1.185 . . . . 0.0 112.93 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -103.4 24.92 10.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.016 1.408 . . . . 0.0 113.302 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.6 mttt 44.19 88.25 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.452 1.901 . . . . 0.0 113.258 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.75 142.38 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -125.06 94.49 4.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.443 1.897 . . . . 0.0 106.826 162.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.28 140.39 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 128.724 2.81 . . . . 0.0 109.1 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -140.97 177.06 8.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.999 2.12 . . . . 0.0 109.61 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -78.71 -2.32 38.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--N 1.315 -0.924 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.831 -160.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.977 0.894 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.433 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 1.3 mmt-85 -62.57 160.59 13.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.932 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 2' ' ' ARG . 36.8 t -151.11 149.69 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.494 1.518 . . . . 0.0 109.075 166.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -116.54 139.86 50.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.423 2.289 . . . . 0.0 106.229 166.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.428 HD22 HG22 ' A' ' 119' ' ' VAL . 42.8 mt -112.08 119.49 38.61 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 170.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 3.5 tt -121.49 141.01 51.45 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -164.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.73 ' CE1' HG12 ' A' ' 117' ' ' VAL . 18.8 m-85 -128.98 166.45 19.15 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.3 1.409 . . . . 0.0 108.616 -172.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.11 -19.16 62.71 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.244 -0.91 . . . . 0.0 111.543 171.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -25.76 12.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -172.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.5 -156.37 18.11 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 126.379 1.942 . . . . 0.0 108.274 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 13.0 pttp -168.02 157.54 9.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.174 1.487 . . . . 0.0 111.695 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HB3' HD21 ' A' ' 108' ' ' LEU . 14.3 p -136.31 175.24 9.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.36 1.064 . . . . 0.0 111.043 170.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 127.22 56.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 pt -121.65 129.01 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -96.14 133.65 40.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.127 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.4 mt -124.62 130.53 52.6 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.588 1.085 . . . . 0.0 110.574 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -71.35 135.97 47.58 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.868 1.667 . . . . 0.0 111.375 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -90.96 45.35 1.25 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 112.854 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -129.05 30.15 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.094 -1.628 . . . . 0.0 108.964 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.434 ' CE2' HG22 ' A' ' 98' ' ' ILE . 23.0 m-85 -132.53 139.47 47.9 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.012 -1.055 . . . . 0.0 109.034 175.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -45.0 -62.76 1.11 Allowed 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 126.373 1.869 . . . . 0.0 109.609 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.33 -39.64 28.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 121.071 -1.018 . . . . 0.0 113.17 -171.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.8 -44.77 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.513 1.125 . . . . 0.0 109.247 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -52.05 -53.57 40.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -43.94 97.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.863 0.865 . . . . 0.0 109.424 -170.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.21 -29.05 20.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.392 1.877 . . . . 0.0 112.866 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -59.98 -29.44 68.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.009 0.822 . . . . 0.0 110.895 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -74.07 -35.62 64.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.04 0.448 . . . . 0.0 109.935 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.35 21.05 3.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.648 2.779 . . . . 0.0 111.407 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -128.26 137.71 31.45 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 121.187 1.812 . . . . 0.0 107.733 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.93 153.14 97.39 Favored 'Cis proline' 0 C--N 1.348 0.518 0 CA-C-N 119.161 0.736 . . . . 0.0 112.428 -5.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CE1' HG11 ' A' ' 119' ' ' VAL . 23.2 p90 -139.75 167.48 22.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 122.667 0.387 . . . . 0.0 111.377 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.15 155.06 46.84 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 t -166.74 161.62 15.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.5 128.2 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.804 HG22 HG13 ' A' ' 117' ' ' VAL . 2.8 t -75.66 73.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -65.29 153.48 40.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -139.46 161.03 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.95 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -160.54 92.62 0.97 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.37 84.34 0.03 OUTLIER Glycine 0 C--O 1.212 -1.248 0 CA-C-O 119.194 -0.781 . . . . 0.0 114.577 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.36 25.23 7.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.095 2.958 . . . . 0.0 113.252 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -128.8 149.38 50.76 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.468 1.107 . . . . 0.0 109.099 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.7 mt -125.04 141.35 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.59 172.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 168.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -156.71 151.36 25.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.103 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -74.11 98.33 3.1 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.9 p -66.95 149.8 98.26 Favored Pre-proline 0 N--CA 1.437 -1.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.06 -3.03 12.87 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.389 3.392 . . . . 0.0 112.102 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.2 149.79 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 108.141 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.02 15.79 6.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.84 117.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 123.978 0.911 . . . . 0.0 110.019 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 70' ' ' PRO . 48.6 mt-30 -94.73 2.04 55.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -81.61 96.39 7.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.498 2.319 . . . . 0.0 110.29 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.8 ptp -86.57 123.42 31.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.508 1.123 . . . . 0.0 110.378 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.88 -23.88 16.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -137.9 70.69 50.06 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.2 146.75 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.282 2.655 . . . . 0.0 109.87 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -135.76 174.92 10.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 164.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -125.3 7.05 7.76 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.223 1.009 . . . . 0.0 111.503 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -144.74 137.06 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -142.9 -179.56 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.057 1.343 . . . . 0.0 109.722 -173.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.37 -167.56 1.52 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.977 2.111 . . . . 0.0 111.438 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.19 45.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.429 1.891 . . . . 0.0 107.545 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.03 38.2 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.24 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -110.28 176.04 5.2 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.41 134.33 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.89 148.16 18.88 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -86.75 139.14 31.02 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 168.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -104.89 85.21 1.15 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.484 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 63.9 Cg_endo -64.39 -36.68 43.47 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.167 1.245 . . . . 0.0 114.837 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.484 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 60.5 Cg_endo -74.05 -21.04 18.61 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.266 1.977 . . . . 0.0 110.599 -167.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 22.17 7.58 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 118.05 -1.416 . . . . 0.0 113.352 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 46.21 49.59 12.56 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.766 1.783 . . . . 0.0 111.995 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.97 175.46 9.35 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 111.286 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.438 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 1.3 tp -93.18 -169.66 2.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.141 1.376 . . . . 0.0 111.06 166.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -166.13 140.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.554 1.542 . . . . 0.0 110.371 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -137.36 124.12 21.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.413 2.285 . . . . 0.0 107.538 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.62 119.63 40.09 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.248 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -140.94 14.7 2.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.54 48.32 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 CA-C-N 119.755 1.161 . . . . 0.0 114.327 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.8 tttt 62.24 177.44 0.13 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.64 1.976 . . . . 0.0 109.844 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 43.2 p -149.25 165.54 17.42 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 120.119 1.327 . . . . 0.0 109.925 -172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 96.5 Cg_endo -77.62 64.73 8.12 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.377 3.384 . . . . 0.0 111.462 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.23 -44.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.719 1.608 . . . . 0.0 108.753 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.79 154.74 23.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.479 1.511 . . . . 0.0 108.227 -159.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.73 -58.03 1.6 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.4 -49.42 55.41 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.194 0.521 . . . . 0.0 110.926 -167.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -135.89 166.09 24.12 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 127.005 2.122 . . . . 0.0 108.109 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.73 115.91 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -125.6 144.78 49.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.115 0.966 . . . . 0.0 111.139 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.479 ' HG3' HG22 ' A' ' 95' ' ' VAL . 57.9 Cg_endo -74.5 173.56 14.08 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.305 3.336 . . . . 0.0 112.975 170.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.268 1.427 . . . . 0.0 114.346 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -147.86 173.37 12.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.569 1.547 . . . . 0.0 107.679 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.11 85.59 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.479 HG22 ' HG3' ' A' ' 91' ' ' PRO . 15.5 m -90.93 150.02 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -75.32 175.22 8.58 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.9 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.42 44.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.434 HG22 ' CE2' ' A' ' 20' ' ' TYR . 35.7 pt -64.65 -39.96 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.312 -1.492 . . . . 0.0 110.927 -174.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.82 169.08 16.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -138.47 132.71 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.9 mt -73.62 90.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 103.687 -2.708 . . . . 0.0 103.687 167.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.9 m -72.65 -25.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.511 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 155.1 36.76 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.586 0.755 . . . . 0.0 112.23 -165.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.6 20.17 62.38 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.888 1.232 . . . . 0.0 113.897 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.02 -38.03 87.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.745 1.273 . . . . 0.0 111.542 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -76.39 -1.17 25.62 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.25 1.96 26.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.871 0.868 . . . . 0.0 113.024 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' A' ' 12' ' ' CYS . 23.1 mt -84.31 -41.97 16.28 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.622 1.169 . . . . 0.0 113.68 -172.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.55 -23.41 64.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.61 1.671 . . . . 0.0 111.135 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -69.07 -10.55 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.543 -1.348 . . . . 0.0 111.212 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -92.44 157.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 120.334 1.425 . . . . 0.0 109.634 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.51 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 16.5 mmtp -102.08 172.4 6.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.767 1.627 . . . . 0.0 108.013 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.31 25.24 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 128.492 2.717 . . . . 0.0 113.649 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.85 65.16 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 120.337 -1.477 . . . . 0.0 111.992 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 1.5 mm-40 -125.12 38.16 4.25 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.964 1.306 . . . . 0.0 110.465 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 mttt 42.24 87.26 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.542 1.937 . . . . 0.0 110.597 164.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.804 HG13 HG22 ' A' ' 36' ' ' VAL . 19.5 m -64.0 178.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -150.47 90.36 1.64 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 171.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 32' ' ' PHE . 91.8 t -70.42 125.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -137.55 170.9 15.28 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.509 1.05 . . . . 0.0 109.69 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.11 -11.52 60.33 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--N 1.321 -0.657 0 C-N-CA 128.652 2.781 . . . . 0.0 110.783 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.413 0.625 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -72.38 167.44 20.51 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 25.4 t -147.62 130.19 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.15 1.38 . . . . 0.0 108.599 167.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.74 128.61 45.04 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 119' ' ' VAL . 1.2 mm? -100.61 105.1 16.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.5 31.54 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 169.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.93 175.09 8.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.93 1.292 . . . . 0.0 109.383 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.97 -29.64 67.9 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.503 -1.373 . . . . 0.0 112.057 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.8 m -103.53 -3.0 25.87 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.31 -166.76 39.6 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 119.712 1.142 . . . . 0.0 111.266 -173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 150.34 25.53 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.808 0.304 . . . . 0.0 110.397 168.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.8 p -132.85 172.87 12.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.598 0.713 . . . . 0.0 109.385 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -135.06 146.85 29.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.5 pt -128.13 156.97 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -111.02 135.15 51.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.29 134.69 55.21 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.076 1.351 . . . . 0.0 108.781 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -86.66 118.53 26.12 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.778 0.831 . . . . 0.0 109.478 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -66.21 20.05 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.028 2.131 . . . . 0.0 114.64 -171.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.86 24.17 5.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.39 1.876 . . . . 0.0 109.511 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -129.92 147.81 51.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.438 2.295 . . . . 0.0 108.311 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.77 -46.49 59.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.701 2.0 . . . . 0.0 110.157 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.07 -46.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.337 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -72.16 -43.91 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -165.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -60.89 -24.62 66.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.966 1.307 . . . . 0.0 111.715 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 25' ' ' LEU . 20.5 mt -90.18 -25.8 20.46 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.48 1.112 . . . . 0.0 112.501 176.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.469 ' HG ' HG21 ' A' ' 49' ' ' VAL . 1.4 mt -70.11 -28.82 65.71 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 121.065 -1.022 . . . . 0.0 110.804 172.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.66 -36.68 47.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.337 0.655 . . . . 0.0 111.044 175.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -71.36 -17.51 62.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 112.17 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -123.13 12.46 9.59 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.902 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -106.01 135.76 19.39 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 121.003 1.729 . . . . 0.0 108.109 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.86 164.32 79.83 Favored 'Cis proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.911 1.004 . . . . 0.0 112.824 -6.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CE1' HG11 ' A' ' 119' ' ' VAL . 47.4 p90 -147.54 168.58 21.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.713 1.258 . . . . 0.0 109.403 165.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 47.3 mp0 -130.71 154.51 47.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.174 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -165.2 -175.46 3.66 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.905 0.882 . . . . 0.0 111.551 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 t -93.26 142.19 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 128.017 2.527 . . . . 0.0 107.891 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -97.11 91.33 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -86.79 159.64 19.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.6 p -132.4 149.32 52.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.03 0.932 . . . . 0.0 110.561 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.0 t90 -166.91 103.3 0.56 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -172.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.41 20.09 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 160.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.357 17.2 pt-20 47.71 50.91 14.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.966 1.707 . . . . 0.0 111.234 -159.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -140.01 159.56 41.89 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 126.962 2.105 . . . . 0.0 107.615 168.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.99 139.64 50.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 127.513 2.325 . . . . 0.0 106.478 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -155.34 150.02 26.36 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.962 1.363 . . . . 0.0 111.263 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 2.7 p90 -135.64 151.76 50.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.163 1.385 . . . . 0.0 108.204 -174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -88.82 83.34 6.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -166.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 48' ' ' PRO . 16.5 p -53.98 152.29 10.8 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.256 0.622 . . . . 0.0 111.971 -168.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 47' ' ' THR . 42.4 Cg_endo -79.2 4.93 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.505 1 C-N-CA 125.41 4.073 . . . . 0.0 112.505 175.016 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.469 HG21 ' HG ' ' A' ' 26' ' ' LEU . 94.0 t -107.98 131.53 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.071 1.348 . . . . 0.0 110.421 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.46 66.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.31 1.444 . . . . 0.0 107.19 -171.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -110.49 128.99 66.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 124.48 1.112 . . . . 0.0 108.297 -175.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.98 45.07 2.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.584 1.153 . . . . 0.0 111.264 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -127.69 146.35 50.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.457 1.503 . . . . 0.0 108.405 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.62 110.48 2.45 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.154 1.782 . . . . 0.0 108.329 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -87.36 -25.48 23.83 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.633 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -123.35 65.68 31.51 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 120.138 1.336 . . . . 0.0 110.147 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.26 114.63 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.048 2.499 . . . . 0.0 110.391 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 131.42 55.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.544 1.537 . . . . 0.0 108.087 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -93.12 5.27 52.1 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -160.86 149.28 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 128.095 2.558 . . . . 0.0 109.648 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 78' ' ' PHE . 17.0 m -140.95 174.18 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.053 1.741 . . . . 0.0 109.39 -165.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -94.51 170.03 9.77 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.86 0.838 . . . . 0.0 110.708 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.74 -7.42 8.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 124.965 1.306 . . . . 0.0 112.237 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.11 27.22 4.59 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.681 1.61 . . . . 0.0 112.596 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -103.8 175.78 5.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.016 0.908 . . . . 0.0 109.331 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.507 HG23 HG13 ' A' ' 101' ' ' ILE . 42.4 t -135.42 133.86 52.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.709 0.804 . . . . 0.0 109.639 166.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.74 156.66 21.54 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -103.64 143.37 32.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 163.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -109.33 85.66 3.69 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 124.699 1.2 . . . . 0.0 108.552 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.65 -29.84 90.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.265 1.31 . . . . 0.0 114.671 172.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -77.75 -9.0 17.07 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.509 2.139 . . . . 0.0 111.917 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.59 8.95 4.0 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 118.411 -1.216 . . . . 0.0 115.583 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 44.65 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.741 1.27 . . . . 0.0 109.971 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.49 165.69 20.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.534 -0.729 . . . . 0.0 111.611 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 5.3 tp -84.0 178.15 7.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.409 166.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -151.26 108.93 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.082 1.753 . . . . 0.0 108.39 165.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.21 105.29 17.11 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.436 ' CD2' HG21 ' A' ' 61' ' ' VAL . 91.1 m-85 -80.35 133.59 35.94 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -152.84 22.18 0.59 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.946 0.898 . . . . 0.0 110.955 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.2 -139.66 2.76 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.41 103.01 4.78 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -58.52 156.11 24.96 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.487 1.915 . . . . 0.0 111.166 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -3.0 11.89 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.059 3.173 . . . . 0.0 113.459 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.426 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 3.0 tpt -73.09 -8.79 57.33 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.777 -1.202 . . . . 0.0 112.336 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t -132.54 -177.46 4.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.497 1.142 . . . . 0.0 109.914 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -144.35 -42.68 0.25 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.96 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -71.5 -56.81 5.19 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.57 1.176 . . . . 0.0 108.147 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -133.11 -164.84 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.177 2.191 . . . . 0.0 107.41 -153.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.95 77.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.538 1.517 . . . . 0.0 107.662 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 42.5 mt-30 -76.14 142.74 72.51 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.525 ' HG3' HG22 ' A' ' 95' ' ' VAL . 51.0 Cg_endo -77.59 179.74 6.22 Favored 'Trans proline' 0 CA--C 1.533 0.449 1 C-N-CA 126.925 5.083 . . . . 0.0 113.665 170.388 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HA ' ' HG2' ' A' ' 84' ' ' MET . . . -70.37 -14.01 62.39 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.32 -172.07 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.89 97.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG22 ' HG3' ' A' ' 91' ' ' PRO . 24.4 m -90.0 172.67 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -126.55 124.5 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.47 55.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.586 1.184 . . . . 0.0 109.256 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.6 pt -80.05 -14.57 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.236 1.014 . . . . 0.0 111.381 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.12 155.89 16.82 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -135.88 140.83 44.42 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.879 0.872 . . . . 0.0 108.659 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.507 HG13 HG23 ' A' ' 66' ' ' VAL . 97.1 mt -79.63 93.95 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 123.814 1.768 . . . . 0.0 108.634 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.48 -23.68 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.002 -163.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.04 159.71 44.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.252 2.621 . . . . 0.0 108.716 171.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.53 69.2 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-O 117.927 -1.485 . . . . 0.0 115.277 167.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.69 -49.99 73.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.188 1.994 . . . . 0.0 111.212 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.3 -25.6 66.11 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.814 -0.554 . . . . 0.0 110.956 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.9 -5.97 34.75 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.754 1.222 . . . . 0.0 112.164 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.5 mt -80.7 -44.41 18.77 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 119.028 0.831 . . . . 0.0 111.46 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -57.53 -22.92 47.32 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.03 -1.044 . . . . 0.0 113.147 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -91.82 16.59 10.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.386 1.474 . . . . 0.0 112.978 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.3 mm -113.3 148.13 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 121.156 1.798 . . . . 0.0 109.922 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -89.16 171.98 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.667 1.587 . . . . 0.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.05 40.14 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 130.127 3.371 . . . . 0.0 112.724 167.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.87 12.67 0.03 OUTLIER Glycine 0 CA--C 1.522 0.522 0 O-C-N 120.452 -1.405 . . . . 0.0 116.156 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.53 22.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.607 1.704 . . . . 0.0 114.34 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.538 ' HE2' ' HB3' ' A' ' 33' ' ' GLU . 0.1 OUTLIER 64.87 152.95 0.05 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.003 2.121 . . . . 0.0 112.373 167.15 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.51 148.26 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 O-C-N 120.435 -1.416 . . . . 0.0 109.048 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.06 108.47 15.27 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.492 2.317 . . . . 0.0 107.14 160.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 32' ' ' PHE . 48.8 t -86.51 124.38 40.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.788 2.435 . . . . 0.0 107.792 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 48.7 mtt180 -140.67 179.76 6.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.571 1.532 . . . . 0.0 110.17 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -81.31 -10.33 59.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.937 0 C-N-CA 127.545 2.338 . . . . 0.0 111.266 -169.271 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttp . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.62 152.14 39.72 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 50.8 t -153.82 147.85 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.546 1.939 . . . . 0.0 108.132 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.619 ' CB ' ' HB2' ' A' ' 122' ' ' ALA . 42.1 tt0 -131.81 137.41 48.11 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.479 1.911 . . . . 0.0 107.528 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.1 mt -108.57 104.62 13.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.678 1.991 . . . . 0.0 105.857 -174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.67 103.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.56 173.45 9.57 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.931 0.892 . . . . 0.0 108.985 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.77 -42.22 95.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -80.82 -17.08 51.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.62 -161.79 34.09 Favored Glycine 0 N--CA 1.464 0.565 0 CA-C-N 121.11 1.777 . . . . 0.0 110.252 -165.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -159.33 159.92 34.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.203 1.501 . . . . 0.0 111.668 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.8 p -142.84 178.41 7.67 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.195 0.998 . . . . 0.0 109.877 170.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -132.92 129.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.62 144.71 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.401 1.08 . . . . 0.0 108.309 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -136.01 128.97 31.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.314 -0.866 . . . . 0.0 112.858 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.59 123.79 42.81 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 125.084 1.49 . . . . 0.0 108.824 -164.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.22 138.58 57.9 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.608 1.563 . . . . 0.0 111.462 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -97.2 50.26 1.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.518 0.727 . . . . 0.0 112.0 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.35 17.75 3.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.144 1.378 . . . . 0.0 111.85 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.68 144.76 50.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.376 1.47 . . . . 0.0 112.438 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -53.24 -50.58 64.47 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.326 1.451 . . . . 0.0 111.829 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HA ' HG11 ' A' ' 51' ' ' VAL . 3.6 t -57.22 -44.74 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -175.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.0 -34.17 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -66.53 -48.94 68.13 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.17 0.988 . . . . 0.0 111.016 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 51' ' ' VAL . 67.5 mt -70.96 -21.78 62.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.691 0.796 . . . . 0.0 110.515 -173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.2 -41.97 80.57 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.852 2.061 . . . . 0.0 111.608 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -56.0 -36.72 68.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.362 0.983 . . . . 0.0 110.0 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.86 -29.54 70.83 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -108.39 2.25 22.33 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.992 1.317 . . . . 0.0 112.04 -168.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG22 ' CE2' ' A' ' 121' ' ' PHE . 60.6 mt -98.12 142.17 24.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.26 160.43 83.03 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 CA-C-N 119.421 0.829 . . . . 0.0 112.941 -7.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.86 175.45 12.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.933 1.693 . . . . 0.0 109.874 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 177.47 7.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.12 2.168 . . . . 0.0 110.728 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -162.63 -154.73 0.32 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.293 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 t -120.39 134.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.877 1.671 . . . . 0.0 107.661 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -88.09 77.03 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 118.995 0.816 . . . . 0.0 109.379 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.62 150.93 34.84 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.681 -1.262 . . . . 0.0 109.239 171.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.8 p -124.69 142.53 51.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.082 1.353 . . . . 0.0 108.886 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -153.36 107.26 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.87 22.13 70.01 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.939 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 75.52 28.38 0.96 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.846 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -115.47 153.26 31.43 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 155.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -124.48 123.97 67.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -138.24 132.4 31.69 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.088 1.755 . . . . 0.0 108.284 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -136.8 156.83 47.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.459 -1.401 . . . . 0.0 107.483 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.72 115.76 7.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.1 p -80.73 153.34 73.01 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 160.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.7 -0.77 10.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.12 3.213 . . . . 0.0 112.53 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 51' ' ' VAL . 26.2 t -80.78 163.94 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 126.578 1.951 . . . . 0.0 108.722 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -143.07 21.93 1.92 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.579 HG11 ' HA ' ' A' ' 22' ' ' VAL . 7.4 p -60.83 155.71 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -135.13 -4.88 2.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.699 0.8 . . . . 0.0 112.445 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HE2' ' OE2' ' A' ' 55' ' ' GLU . 74.0 tttt -70.44 140.52 52.02 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.041 1.291 . . . . 0.0 109.914 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.24 131.01 46.97 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.345 1.458 . . . . 0.0 107.299 167.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' OE2' ' HE2' ' A' ' 53' ' ' LYS . 71.8 mm-40 -87.45 -38.07 16.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.218 0.532 . . . . 0.0 109.679 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.42 ' ND2' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.65 62.02 12.83 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.344 1.857 . . . . 0.0 108.085 -161.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.87 125.75 15.35 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 108.022 -1.568 . . . . 0.0 108.022 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -117.22 145.77 43.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.221 1.009 . . . . 0.0 109.018 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.77 -1.64 27.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.883 1.273 . . . . 0.0 111.905 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.66 146.96 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 129.026 2.931 . . . . 0.0 108.438 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.98 -173.0 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 109.488 -166.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -105.43 159.09 16.19 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.16 1.384 . . . . 0.0 111.31 171.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.401 HG23 ' HA ' ' A' ' 79' ' ' PHE . 58.7 mt -73.37 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.36 0.82 0.5 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 119.033 -0.87 . . . . 0.0 113.975 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -100.48 175.57 5.64 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.764 1.782 . . . . 0.0 109.11 170.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -136.24 134.02 49.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.519 1.127 . . . . 0.0 108.157 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.78 -172.26 31.72 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -133.78 156.38 48.1 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 146.089 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -121.0 86.77 42.57 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.83 -46.39 31.87 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.253 1.968 . . . . 0.0 114.875 -167.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 -23.76 46.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.809 2.34 . . . . 0.0 111.636 -165.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.57 12.26 46.86 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.757 1.646 . . . . 0.0 113.983 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.489 ' HE3' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER 44.45 48.08 8.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.701 2.0 . . . . 0.0 110.776 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.41 157.03 27.96 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.09 0.948 . . . . 0.0 111.066 -172.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.53 172.56 12.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.641 161.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.53 105.27 3.29 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.872 1.669 . . . . 0.0 109.836 169.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -86.57 120.28 27.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 107.865 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -105.46 105.69 15.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.991 0.814 . . . . 0.0 109.325 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.401 ' HA ' HG23 ' A' ' 63' ' ' ILE . 45.2 p90 -136.25 9.24 3.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -175.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.46 -121.21 1.02 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 119.782 1.173 . . . . 0.0 110.65 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -156.56 121.77 4.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.375 1.087 . . . . 0.0 108.517 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -98.14 155.86 36.51 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.996 2.519 . . . . 0.0 112.079 -165.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.61 3.12 6.7 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.489 2.793 . . . . 0.0 115.39 -170.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.5 mmt -81.99 -32.16 30.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.596 1.544 . . . . 0.0 111.289 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.491 ' HB3' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -90.96 175.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.565 0.746 . . . . 0.0 110.087 -176.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 -62.77 0.44 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.16 -26.27 61.12 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.246 0.546 . . . . 0.0 112.395 -165.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -167.9 162.38 13.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 128.359 2.664 . . . . 0.0 107.119 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -75.76 84.19 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 119.534 1.061 . . . . 0.0 109.211 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 85' ' ' SER . 11.1 mt-30 -75.77 144.41 76.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.508 159.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.18 -177.36 3.82 Favored 'Trans proline' 0 C--N 1.346 0.44 1 C-N-CA 125.382 4.055 . . . . 0.0 112.003 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.701 167.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -166.36 179.85 5.38 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 126.099 1.76 . . . . 0.0 106.781 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.11 102.36 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.635 1.174 . . . . 0.0 112.17 -171.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.21 149.07 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.96 109.04 15.95 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.42 HG12 ' ND2' ' A' ' 56' ' ' ASN . 1.3 p -80.61 33.06 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 122.548 1.166 . . . . 0.0 112.347 -162.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.3 pt -63.88 -12.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.633 2.373 . . . . 0.0 115.431 -159.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.73 13.61 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 122.571 1.095 . . . . 0.0 111.825 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -117.42 140.81 49.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 163.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.4 mt -72.51 94.82 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 157.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -77.4 -32.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.725 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -153.77 163.45 40.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.821 0.819 . . . . 0.0 111.385 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.62 31.41 54.14 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.283 0.944 . . . . 0.0 112.361 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.77 -54.01 51.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.619 1.209 . . . . 0.0 111.268 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.72 -17.41 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.766 -0.584 . . . . 0.0 112.141 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.4 -11.75 25.39 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 124.008 0.923 . . . . 0.0 110.828 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.9 -25.76 32.17 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.704 1.138 . . . . 0.0 112.428 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.95 -20.79 62.42 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.711 -1.243 . . . . 0.0 111.485 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.57 28.85 5.23 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.634 2.773 . . . . 0.0 111.108 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.92 166.43 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 127.895 2.478 . . . . 0.0 107.276 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -127.27 -169.51 2.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.323 -1.486 . . . . 0.0 111.264 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -78.43 11.87 2.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.561 1.544 . . . . 0.0 113.854 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.89 79.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.576 0 O-C-N 120.423 -1.423 . . . . 0.0 111.496 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -130.52 40.14 3.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.95 2.1 . . . . 0.0 109.584 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 43.77 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.162 2.585 . . . . 0.0 114.047 163.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.5 p -81.8 111.14 17.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.7 13.4 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.1 t -86.17 126.16 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 127.717 2.407 . . . . 0.0 107.674 -168.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -135.92 172.12 13.47 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.533 1.97 . . . . 0.0 111.428 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.457 ' CE2' HG22 ' A' ' 30' ' ' ILE . 42.0 m-85 -72.24 -11.1 60.57 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.619 ' HB2' ' CB ' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.04 0 C-N-CA 125.517 1.527 . . . . 0.0 114.249 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpp . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 121.359 0.599 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 2.4 mmt-85 -78.9 163.62 25.12 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 123.067 0.547 . . . . 0.0 109.582 173.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.3 t -148.02 146.29 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.518 168.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 14.6 tt0 -120.77 131.62 54.59 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.488 1.915 . . . . 0.0 105.844 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.551 HD11 HD13 ' A' ' 14' ' ' ILE . 54.3 mt -108.71 121.28 44.72 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 7' ' ' PHE . 1.6 tt -123.66 142.13 51.35 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -167.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.834 ' HE1' HG12 ' A' ' 117' ' ' VAL . 5.9 m-85 -134.32 172.13 13.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 119.674 1.125 . . . . 0.0 110.438 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.207 -0.308 . . . . 0.0 110.71 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 m -101.4 -5.65 25.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.02 -163.58 33.82 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 120.931 1.696 . . . . 0.0 111.476 -169.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -160.42 165.1 31.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.7 1.25 . . . . 0.0 110.261 173.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.7 p -146.73 178.0 8.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.469 1.108 . . . . 0.0 111.529 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -133.85 130.18 55.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.141 0.976 . . . . 0.0 108.585 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.551 HD13 HD11 ' A' ' 5' ' ' LEU . 35.9 pt -128.01 147.08 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.435 0.694 . . . . 0.0 109.173 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -131.11 127.77 38.78 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 116.188 1.921 . . . . 0.0 116.188 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -124.91 126.24 45.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.433 1.708 . . . . 0.0 111.563 -161.184 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -69.6 122.54 19.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.185 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.95 6.6 1.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -85.89 -5.82 59.17 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 120.943 -1.098 . . . . 0.0 110.57 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -105.24 143.14 33.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.09 0.956 . . . . 0.0 109.932 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -45.36 -58.84 3.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.889 1.676 . . . . 0.0 109.427 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.92 -35.87 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.749 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -63.42 -42.99 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.489 1.041 . . . . 0.0 108.909 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -61.53 -44.32 97.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.685 0.794 . . . . 0.0 111.599 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -37.61 78.38 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.338 -1.476 . . . . 0.0 110.905 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.76 -39.83 65.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.842 1.657 . . . . 0.0 110.483 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -62.43 -31.79 72.55 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 123.037 0.535 . . . . 0.0 111.368 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -72.17 -8.92 57.4 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.37 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -131.05 30.25 4.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.93 1.692 . . . . 0.0 110.296 -173.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.43 144.27 52.17 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -63.84 158.96 67.78 Favored 'Cis proline' 0 N--CA 1.459 -0.503 0 CA-C-N 119.029 0.689 . . . . 0.0 113.604 -8.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -150.16 160.85 43.36 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 124.068 0.947 . . . . 0.0 110.682 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -114.45 160.21 19.44 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.187 0.995 . . . . 0.0 108.356 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.56 172.5 10.68 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.536 -0.727 . . . . 0.0 110.297 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.15 124.03 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.965 HG22 HG13 ' A' ' 117' ' ' VAL . 3.0 t -81.57 74.97 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 123.574 0.749 . . . . 0.0 110.356 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -68.07 163.94 21.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.858 0.754 . . . . 0.0 110.251 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.489 HG22 HG12 ' A' ' 43' ' ' ILE . 72.3 p -137.51 155.64 49.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.42 . . . . 0.0 110.197 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -155.6 99.19 2.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.41 -62.27 2.69 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 124.25 0.928 . . . . 0.0 115.18 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -168.75 40.56 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.958 1.703 . . . . 0.0 109.246 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.78 167.05 31.65 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 38' ' ' THR . 57.8 mt -135.39 133.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.027 1.331 . . . . 0.0 109.357 -176.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.95 159.25 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.968 0.907 . . . . 0.0 109.648 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 3.4 p90 -145.27 157.72 43.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.795 -1.191 . . . . 0.0 108.882 172.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -76.3 98.01 4.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.048 0.939 . . . . 0.0 109.4 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.1 p -68.93 144.79 96.16 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.142 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.7 -28.95 7.62 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.001 2.467 . . . . 0.0 111.003 175.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -67.25 140.21 19.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -121.66 114.98 21.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.94 154.18 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -134.71 21.37 3.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.604 0.761 . . . . 0.0 112.861 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -94.48 119.61 33.45 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.13 1.372 . . . . 0.0 110.94 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.81 112.87 14.02 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.588 1.155 . . . . 0.0 111.84 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.04 -25.95 36.74 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.504 1.122 . . . . 0.0 113.138 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -133.94 60.55 46.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 119.037 0.835 . . . . 0.0 110.675 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.4 95.38 0.61 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.924 2.416 . . . . 0.0 108.876 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.7 mtt-85 -85.35 169.31 13.84 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -123.94 4.71 8.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.743 0.417 . . . . 0.0 111.679 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.7 t -139.92 151.37 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.91 1.684 . . . . 0.0 106.659 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.47 -175.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.323 1.849 . . . . 0.0 109.503 -172.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -114.98 -179.3 3.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.272 1.029 . . . . 0.0 110.303 167.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 63' ' ' ILE . 70.6 mt -77.13 10.15 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 126.649 1.98 . . . . 0.0 110.999 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.39 32.26 1.87 Allowed Glycine 0 CA--C 1.524 0.65 0 O-C-N 120.165 -1.584 . . . . 0.0 112.371 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -123.5 169.74 11.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.35 1.075 . . . . 0.0 109.66 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -139.91 114.76 7.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 -177.46 48.69 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.103 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -131.11 138.7 49.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -116.46 82.63 12.37 Favored Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.406 ' HD2' ' CD ' ' A' ' 71' ' ' PRO . 4.0 Cg_exo -57.55 -47.25 22.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.669 2.246 . . . . 0.0 114.449 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' CD ' ' HD2' ' A' ' 70' ' ' PRO . 56.3 Cg_endo -68.26 -22.45 40.17 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.167 2.578 . . . . 0.0 111.141 -165.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.53 26.43 6.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.522 1.058 . . . . 0.0 113.165 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mttt 46.25 50.92 11.77 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.417 1.487 . . . . 0.0 112.174 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.7 -177.86 4.75 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.061 0.544 . . . . 0.0 110.973 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.405 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 2.7 tp -104.8 -170.96 1.84 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.047 1.739 . . . . 0.0 109.296 172.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.32 153.13 28.54 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.191 1.796 . . . . 0.0 110.05 158.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.57 102.37 4.59 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.986 2.514 . . . . 0.0 105.15 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -91.06 116.11 28.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.216 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.469 ' CD1' HD23 ' A' ' 108' ' ' LEU . 48.9 p90 -141.88 15.23 2.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.06 -146.1 4.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 104.75 8.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -69.28 166.27 31.19 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.502 2.321 . . . . 0.0 113.284 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.98 6.52 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 125.248 3.965 . . . . 0.0 113.419 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.89 136.38 53.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.164 1.785 . . . . 0.0 107.061 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 75.73 163.52 0.25 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 128.834 2.854 . . . . 0.0 109.679 -171.288 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.67 -42.51 2.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.97 -81.25 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.428 0.632 . . . . 0.0 111.223 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -98.94 153.84 18.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 127.334 2.254 . . . . 0.0 107.859 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.9 126.81 15.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 124.358 1.063 . . . . 0.0 109.05 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 18.2 mt-30 -126.96 150.42 71.8 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.16 0.984 . . . . 0.0 113.064 167.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.3 -174.43 2.2 Favored 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 126.315 4.677 . . . . 0.0 113.284 174.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.03 -10.1 59.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 t -173.84 -176.52 1.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.86 1.264 . . . . 0.0 108.806 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.28 73.81 0.5 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.414 1.486 . . . . 0.0 111.766 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.4 141.56 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.548 . . . . 0.0 110.31 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -74.76 125.47 28.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.91 49.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.78 -21.77 29.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.684 -172.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.45 164.03 13.44 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 119.631 1.105 . . . . 0.0 112.275 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -129.65 145.63 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.528 1.131 . . . . 0.0 108.352 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mt -76.09 101.67 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.83 -22.23 6.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.972 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -155.63 159.07 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.908 0.883 . . . . 0.0 111.652 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.96 11.02 70.93 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 118.746 -1.03 . . . . 0.0 115.145 169.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 tp -51.74 -48.25 63.74 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.005 1.403 . . . . 0.0 111.369 -172.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -70.2 -19.37 63.17 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 120.785 -1.197 . . . . 0.0 111.971 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.2 -0.67 32.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.247 1.019 . . . . 0.0 111.784 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 79' ' ' PHE . 4.9 mp -74.89 -39.01 61.73 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 119.954 -1.717 . . . . 0.0 111.567 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -63.68 -23.74 67.5 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.995 -1.066 . . . . 0.0 111.91 -172.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -94.45 23.0 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 0.0 112.679 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.46 165.63 2.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.397 1.479 . . . . 0.0 107.168 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -125.86 171.08 11.0 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.91 1.684 . . . . 0.0 108.095 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.01 1.91 2.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.218 2.207 . . . . 0.0 114.738 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.41 74.79 0.12 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.74 29.98 5.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.056 2.143 . . . . 0.0 110.029 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.4 mttt 43.07 101.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.611 2.764 . . . . 0.0 113.937 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.965 HG13 HG22 ' A' ' 36' ' ' VAL . 28.0 m -68.2 167.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 116.126 -2.23 . . . . 0.0 105.325 174.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -135.47 109.82 8.42 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 154.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.9 t -78.53 126.26 38.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 125.337 1.455 . . . . 0.0 107.087 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 mtm105 -128.92 176.04 8.18 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 0.0 110.231 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -72.53 -6.94 47.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.781 0 C-N-CA 126.81 2.044 . . . . 0.0 112.419 -170.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 ttm . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -68.4 160.88 28.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.048 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 16' ' ' LEU . 26.1 t -152.94 143.48 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 126.613 1.965 . . . . 0.0 107.126 170.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 41.0 tt0 -135.93 112.55 10.06 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 119.889 -1.757 . . . . 0.0 108.499 -171.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.57 92.26 9.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 131.412 3.885 . . . . 0.0 108.631 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.61 152.4 40.56 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 164.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -131.63 177.82 7.22 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.879 1.672 . . . . 0.0 107.62 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.18 -44.56 83.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.418 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m -86.16 -15.4 41.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -172.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.93 -165.49 34.0 Favored Glycine 0 N--CA 1.467 0.717 0 CA-C-N 120.734 1.606 . . . . 0.0 110.942 -166.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 138.01 8.94 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.915 1.358 . . . . 0.0 110.259 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.575 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 24.1 m -140.11 164.2 30.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.607 1.163 . . . . 0.0 111.772 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.29 112.67 21.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.428 1.091 . . . . 0.0 108.64 -167.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 pt -101.63 139.28 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.12 110.34 21.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 3' ' ' VAL . 25.0 mt -109.82 122.78 48.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.534 1.134 . . . . 0.0 109.708 -167.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.465 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 49.6 t30 -84.64 125.3 32.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.52 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.54 -1.82 12.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.597 1.559 . . . . 0.0 113.538 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.2 -21.14 64.88 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.139 0.881 . . . . 0.0 109.638 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 16.2 m-85 -92.79 124.63 36.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.321 1.448 . . . . 0.0 110.049 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -47.4 -53.91 12.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.241 1.817 . . . . 0.0 111.495 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -44.65 -40.43 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -71.76 -42.09 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.023 1.283 . . . . 0.0 109.958 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -59.26 -37.73 78.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.662 0.785 . . . . 0.0 110.085 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.49 -34.9 54.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.007 1.323 . . . . 0.0 109.983 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.97 -23.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.493 1.117 . . . . 0.0 112.052 172.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -14.4 50.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.742 1.156 . . . . 0.0 111.993 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -86.57 -14.37 43.07 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 120.723 -1.236 . . . . 0.0 112.25 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -124.93 4.58 8.02 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.433 1.093 . . . . 0.0 113.205 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.6 mt -104.6 141.33 22.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 120.1 1.318 . . . . 0.0 107.507 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.32 159.35 94.26 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.294 -0.711 . . . . 0.0 112.589 -6.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 119' ' ' VAL . 34.6 p90 -140.21 164.62 29.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 122.125 -0.359 . . . . 0.0 110.055 165.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -124.26 150.4 45.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.3 161.91 37.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.006 -172.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.01 123.07 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.69 98.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -85.77 155.14 21.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 165.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -131.79 144.55 51.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 108.731 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -154.1 102.63 2.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.47 19.76 79.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 116.45 -2.306 . . . . 0.0 116.674 154.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 76.94 37.96 0.27 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.851 2.826 . . . . 0.0 112.566 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 6.2 tt0 -131.71 163.74 27.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.612 1.965 . . . . 0.0 106.187 150.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.0 mt -127.79 146.24 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 127.009 2.124 . . . . 0.0 107.097 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -134.95 169.32 17.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 122.678 1.228 . . . . 0.0 109.715 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -149.99 150.55 31.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -88.75 82.79 6.74 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -167.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.782 HG21 HD23 ' A' ' 75' ' ' LEU . 11.0 p -65.26 147.92 98.28 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -165.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.19 -26.22 12.86 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.623 2.216 . . . . 0.0 112.072 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.3 136.46 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -122.66 100.02 6.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.733 1.613 . . . . 0.0 107.38 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.04 171.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 129.034 2.934 . . . . 0.0 104.669 165.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.94 3.14 2.0 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 166.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -44.81 118.84 1.74 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.918 1.287 . . . . 0.0 111.053 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtm -108.72 90.59 3.34 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.78 2.032 . . . . 0.0 106.042 -171.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -67.94 -26.88 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.455 -0.778 . . . . 0.0 111.466 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -153.7 54.83 1.2 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.141 1.776 . . . . 0.0 113.692 -167.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.58 162.97 19.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.762 1.642 . . . . 0.0 111.993 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -146.63 -175.71 4.9 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 128.331 2.652 . . . . 0.0 106.489 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -120.28 1.15 10.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.322 1.049 . . . . 0.0 112.916 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.62 159.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.269 2.227 . . . . 0.0 108.998 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.6 m -141.3 -179.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.809 2.044 . . . . 0.0 109.233 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -88.76 178.56 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 120.722 -1.236 . . . . 0.0 110.844 163.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.674 ' O ' HD11 ' A' ' 105' ' ' LEU . 38.7 mt -76.56 4.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.489 1.516 . . . . 0.0 110.261 173.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 43.07 0.67 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -111.78 -154.47 0.54 Allowed 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 129.368 3.067 . . . . 0.0 103.412 161.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.917 HG11 ' HA3' ' A' ' 99' ' ' GLY . 4.9 p -158.72 177.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -143.89 152.26 24.06 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 119.641 -1.912 . . . . 0.0 111.55 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -105.22 123.84 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.321 1.048 . . . . 0.0 109.189 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.401 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 8.1 t90 -104.76 88.29 2.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 127.403 2.281 . . . . 0.0 109.246 -172.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD2' ' CD ' ' A' ' 71' ' ' PRO . 73.5 Cg_endo -61.64 -31.15 86.55 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.033 1.822 . . . . 0.0 115.366 -171.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD2' ' C ' ' A' ' 69' ' ' TRP . 50.7 Cg_endo -67.17 -36.7 20.65 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 123.48 2.278 . . . . 0.0 109.463 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.93 64.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.138 -1.368 . . . . 0.0 113.501 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 45.78 55.63 6.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.388 2.094 . . . . 0.0 108.904 -166.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.83 157.83 44.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.782 HD23 HG21 ' A' ' 47' ' ' THR . 3.5 mm? -90.55 176.16 6.79 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.32 124.54 7.5 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.871 1.268 . . . . 0.0 108.855 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' GLU . 8.0 mp -106.19 115.17 29.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.72 2.408 . . . . 0.0 107.553 174.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -107.73 110.45 22.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.862 1.21 . . . . 0.0 108.204 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -125.77 11.24 7.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.695 0.798 . . . . 0.0 112.826 -170.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.64 -128.6 0.96 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 165.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -132.77 107.91 8.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.119 1.459 . . . . 0.0 110.584 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -64.85 165.51 15.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 126.655 1.982 . . . . 0.0 113.383 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.93 7.49 1.31 Allowed 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.889 4.393 . . . . 0.0 114.523 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.1 mmt -116.08 81.37 1.6 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.529 -1.357 . . . . 0.0 109.505 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 p 174.92 -177.03 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.041 2.137 . . . . 0.0 107.632 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -127.94 -59.51 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 143.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -81.4 -37.34 28.3 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.43 162.36 34.65 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.427 1.491 . . . . 0.0 107.733 -165.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.13 83.97 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 121.373 1.897 . . . . 0.0 108.334 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.68 146.29 52.69 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 126.768 2.027 . . . . 0.0 109.923 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.53 -175.34 1.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.932 3.755 . . . . 0.0 112.043 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -38.98 61.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.145 1.378 . . . . 0.0 113.751 168.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -173.24 174.25 3.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.661 1.584 . . . . 0.0 109.118 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.37 103.02 0.05 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.6 1.56 . . . . 0.0 111.31 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 93' ' ' SER . 17.2 m -112.21 142.7 23.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.446 1.099 . . . . 0.0 109.734 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -79.58 125.45 29.62 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -90.06 71.06 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.5 pt -87.4 -32.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.917 ' HA3' HG11 ' A' ' 66' ' ' VAL . . . -75.74 169.41 54.77 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 161.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.63 147.56 35.23 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 101.948 -3.352 . . . . 0.0 101.948 131.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.99 83.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 156.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.4 -41.0 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 120.558 -1.339 . . . . 0.0 111.016 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.49 150.09 46.07 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 125.739 1.615 . . . . 0.0 108.713 -169.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 78.35 78.08 0.83 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.674 HD11 ' O ' ' A' ' 63' ' ' ILE . 2.0 tp -108.77 -60.52 1.73 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.164 1.786 . . . . 0.0 110.108 172.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.49 -23.22 58.83 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.47 -0.769 . . . . 0.0 110.439 -172.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -24.11 54.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.415 1.086 . . . . 0.0 111.085 173.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.46 -29.57 56.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.399 0.999 . . . . 0.0 112.027 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -72.4 17.85 0.1 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.952 -1.092 . . . . 0.0 112.74 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -147.85 23.34 1.1 Allowed 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 126.124 1.77 . . . . 0.0 112.437 -178.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.2 mm -105.82 141.05 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 43.3 mmtt -85.18 174.73 9.44 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.4 1.48 . . . . 0.0 109.842 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.61 43.2 0.73 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.674 1.59 . . . . 0.0 112.643 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.43 64.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.385 0 O-C-N 120.12 -1.613 . . . . 0.0 111.91 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 6.2 mm-40 -122.22 24.64 9.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.025 1.73 . . . . 0.0 112.405 -172.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mttp 43.41 86.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.632 2.373 . . . . 0.0 113.494 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.69 104.81 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.804 -0.56 . . . . 0.0 109.522 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.71 96.8 7.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.824 1.65 . . . . 0.0 109.59 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.411 HG11 ' CE1' ' A' ' 32' ' ' PHE . 79.1 t -77.42 117.64 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.779 2.432 . . . . 0.0 108.177 174.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.494 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -130.7 173.74 10.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.92 1.288 . . . . 0.0 109.821 177.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -79.55 -10.6 59.83 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 121.547 1.976 . . . . 0.0 115.602 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 127.016 2.126 . . . . 0.0 111.067 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttm . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.674 1.225 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.502 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 46.9 mtm-85 -67.2 161.19 25.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.66 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 t -146.73 105.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.521 1.128 . . . . 0.0 107.978 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.635 ' HA ' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -80.78 142.15 34.05 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.636 -1.29 . . . . 0.0 109.403 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.98 97.69 5.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.044 0.938 . . . . 0.0 111.48 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 148.41 25.51 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.98 175.94 8.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.946 1.698 . . . . 0.0 110.36 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -78.2 -5.12 50.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -132.85 5.17 3.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -167.87 39.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -158.95 163.69 36.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.45 1.1 . . . . 0.0 108.25 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 p -161.73 179.87 7.78 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 130.198 3.399 . . . . 0.0 103.862 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -149.68 150.85 13.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 112.126 -2.306 . . . . 0.0 105.115 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 25.1 pt -129.79 114.99 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 124.675 1.19 . . . . 0.0 109.246 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -89.45 107.52 19.12 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.7 -170.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.59 138.61 46.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.768 0.713 . . . . 0.0 110.586 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -87.98 149.51 23.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.742 -0.599 . . . . 0.0 109.69 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.38 -0.66 53.51 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.622 1.169 . . . . 0.0 114.135 -164.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -96.21 5.72 50.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.134 1.374 . . . . 0.0 109.024 -167.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -111.53 133.29 53.91 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.014 2.126 . . . . 0.0 109.178 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.71 -51.7 66.4 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.402 1.081 . . . . 0.0 110.218 -170.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -49.74 -36.06 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.452 1.501 . . . . 0.0 114.456 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.07 -39.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 119.786 1.175 . . . . 0.0 109.283 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.38 -37.5 80.97 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 0.0 110.427 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.0 -36.23 30.93 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.936 0.894 . . . . 0.0 110.735 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.08 -28.32 66.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.361 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -58.52 -26.91 64.0 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.677 0.671 . . . . 0.0 111.591 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -68.12 -26.13 65.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.989 0.813 . . . . 0.0 110.541 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -124.22 24.3 8.13 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 120.952 -1.093 . . . . 0.0 112.614 -160.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.7 mt -115.61 153.38 47.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.449 1.477 . . . . 0.0 108.335 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.26 160.83 23.75 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.067 -1.222 . . . . 0.0 111.341 -24.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.511 ' CE1' HG11 ' A' ' 119' ' ' VAL . 33.0 p90 -146.85 171.34 15.35 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.224 1.41 . . . . 0.0 109.756 169.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -122.25 162.58 21.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.252 1.021 . . . . 0.0 109.408 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 -179.92 6.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.063 0.545 . . . . 0.0 109.807 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.15 142.26 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 117' ' ' VAL . 18.3 t -91.65 76.35 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.943 1.297 . . . . 0.0 107.803 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -69.82 156.48 38.98 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.899 -1.126 . . . . 0.0 108.912 175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.5 p -136.45 137.81 40.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.281 1.032 . . . . 0.0 109.956 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 92' ' ' ALA . 67.9 t90 -142.58 75.6 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.454 1.502 . . . . 0.0 108.163 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.13 81.53 0.19 Allowed Glycine 0 C--O 1.218 -0.847 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.987 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 51.6 63.44 2.24 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 118.367 1.084 . . . . 0.0 109.253 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.9 154.87 15.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -131.66 144.09 38.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -148.74 170.62 17.79 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.332 1.453 . . . . 0.0 109.945 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.42 144.13 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.291 1.036 . . . . 0.0 109.256 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -74.85 84.95 2.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.796 2.038 . . . . 0.0 109.384 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 p -61.78 152.32 76.25 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-O 121.413 0.625 . . . . 0.0 111.869 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -81.18 0.23 10.11 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.13 3.22 . . . . 0.0 112.584 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 51' ' ' VAL . 16.9 t -105.55 134.19 47.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 125.12 1.368 . . . . 0.0 108.541 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -114.97 18.03 16.59 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.92 0.888 . . . . 0.0 112.589 -168.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 49' ' ' VAL . 8.3 p -69.33 150.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.739 0.781 . . . . 0.0 112.354 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -135.76 40.9 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.758 2.423 . . . . 0.0 108.586 -172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.411 ' H ' HG22 ' A' ' 51' ' ' VAL . 58.5 tttp -121.61 105.84 10.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.105 2.162 . . . . 0.0 111.165 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -93.19 130.79 38.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.359 1.463 . . . . 0.0 109.716 171.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.32 -44.88 8.48 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.683 -0.636 . . . . 0.0 110.864 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -114.46 60.67 1.09 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.121 0.968 . . . . 0.0 109.581 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.12 144.67 42.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.36 2.04 . . . . 0.0 112.593 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -143.64 164.97 28.91 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.533 0.733 . . . . 0.0 109.751 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.07 12.98 18.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.414 1.886 . . . . 0.0 110.51 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -166.78 150.93 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 129.987 3.315 . . . . 0.0 110.016 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.09 -175.49 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.94 1.296 . . . . 0.0 111.74 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -94.58 175.48 6.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.821 1.248 . . . . 0.0 110.817 170.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 63' ' ' ILE . 51.7 mt -81.44 33.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.692 1.597 . . . . 0.0 111.074 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.508 ' HA2' HD21 ' A' ' 105' ' ' LEU . . . -167.96 34.67 0.2 Allowed Glycine 0 CA--C 1.511 -0.207 0 O-C-N 120.369 -1.457 . . . . 0.0 111.888 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -121.6 -175.28 3.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.214 1.006 . . . . 0.0 108.35 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -139.12 164.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.182 1.793 . . . . 0.0 107.6 -168.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -165.34 129.12 1.89 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.49 144.5 49.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -114.34 86.79 12.57 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.486 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 68.8 Cg_endo -65.98 -22.23 55.68 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.243 2.629 . . . . 0.0 117.512 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.486 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 42.7 Cg_endo -80.48 -19.1 9.15 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 CA-C-N 123.007 2.11 . . . . 0.0 112.096 -171.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.35 -9.67 11.41 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.615 1.579 . . . . 0.0 114.137 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 58.83 84.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.094 2.157 . . . . 0.0 111.299 -164.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.28 175.92 13.23 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.14 -172.42 3.95 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.687 1.595 . . . . 0.0 110.928 162.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 15.8 t -158.22 149.8 21.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.866 1.666 . . . . 0.0 109.09 161.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.46 128.86 47.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.99 2.516 . . . . 0.0 109.448 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.05 112.91 24.01 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 125.011 1.324 . . . . 0.0 109.363 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -134.33 5.55 3.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.767 2.427 . . . . 0.0 113.459 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.18 -168.32 40.43 Favored Glycine 0 CA--C 1.52 0.405 0 O-C-N 119.978 -1.701 . . . . 0.0 110.707 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.08 102.27 14.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -163.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.8 p -74.79 166.33 46.22 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 110.824 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.5 -19.88 48.31 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.362 2.708 . . . . 0.0 113.334 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.7 tpt -97.41 50.69 1.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.229 1.011 . . . . 0.0 110.317 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.0 p -158.93 177.84 10.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.147 0.579 . . . . 0.0 110.26 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.52 -62.46 0.87 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 148.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.05 -49.04 21.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.116 0.96 . . . . 0.0 111.912 -166.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -136.7 158.7 43.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.239 1.816 . . . . 0.0 108.205 -164.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mt -79.6 83.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.56 143.64 59.61 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.807 1.643 . . . . 0.0 111.398 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -81.97 174.99 9.67 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.436 3.424 . . . . 0.0 112.284 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.528 ' HB2' ' CH2' ' A' ' 39' ' ' TRP . . . -66.97 -20.5 65.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 m -156.93 170.35 22.7 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.81 2.444 . . . . 0.0 108.892 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.11 0.51 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.852 0.751 . . . . 0.0 109.848 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.89 -165.62 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 128.275 2.63 . . . . 0.0 107.396 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -139.8 127.37 21.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 112.511 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 32.75 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.432 -1.418 . . . . 0.0 111.1 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -61.25 -15.63 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 119.68 -1.887 . . . . 0.0 113.698 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.73 165.83 15.32 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 33.3 tptt -134.7 126.18 28.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 170.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.78 93.17 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 166.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.564 ' CG2' HG13 ' A' ' 13' ' ' VAL . 30.8 m -76.42 -63.32 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.612 ' HB2' HG12 ' A' ' 13' ' ' VAL . 1.1 mm-40 -93.07 166.03 12.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -172.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.38 16.57 80.62 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-N 115.241 -0.89 . . . . 0.0 114.793 158.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -54.88 -62.61 1.55 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.162 0.985 . . . . 0.0 109.276 -173.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.35 -21.2 62.92 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.176 -167.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.5 -19.83 64.55 Favored 'General case' 0 C--O 1.225 -0.23 0 O-C-N 121.67 -0.644 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.61 -18.52 65.38 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.618 -1.301 . . . . 0.0 113.44 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -59.11 -29.54 67.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.086 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 27.86 9.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.653 1.115 . . . . 0.0 112.879 -163.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.61 150.55 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -92.84 170.67 9.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.92 15.81 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.643 2.377 . . . . 0.0 112.932 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.71 54.67 0.09 OUTLIER Glycine 0 CA--C 1.533 1.173 0 O-C-N 119.206 -2.184 . . . . 0.0 114.758 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.424 ' CG ' ' H ' ' A' ' 112' ' ' LYS . 13.6 mm-40 -100.3 32.35 3.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.938 1.295 . . . . 0.0 113.274 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.8 mttp 42.03 74.78 0.1 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.309 1.844 . . . . 0.0 112.619 171.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.574 ' HB ' HG22 ' A' ' 36' ' ' VAL . 7.5 p -68.14 105.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.25 88.91 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.39 1.476 . . . . 0.0 107.185 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.511 HG11 ' CE1' ' A' ' 32' ' ' PHE . 90.6 t -71.51 134.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 126.704 2.002 . . . . 0.0 108.648 -173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -141.93 -172.21 3.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.231 1.812 . . . . 0.0 110.332 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -99.9 0.1 40.62 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--N 1.307 -1.262 0 C-N-CA 126.989 2.116 . . . . 0.0 112.718 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.236 0.363 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 152.92 42.83 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.9 t -150.91 130.98 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.267 1.427 . . . . 0.0 107.613 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 22.2 tt0 -115.56 120.53 39.77 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.516 2.326 . . . . 0.0 107.01 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 117' ' ' VAL . 11.2 mp -98.25 109.34 22.11 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 126.884 2.074 . . . . 0.0 106.903 172.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 126.94 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -110.11 173.03 6.51 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.069 0.948 . . . . 0.0 108.445 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.55 -17.66 62.3 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.046 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -115.48 4.59 14.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.594 1.557 . . . . 0.0 114.666 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.75 -164.98 38.38 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.642 -1.286 . . . . 0.0 110.724 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -157.83 158.63 35.53 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.067 0.947 . . . . 0.0 109.079 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -145.38 177.31 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.998 0.919 . . . . 0.0 108.971 174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 t -135.11 133.29 53.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.0 pt -122.66 166.32 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -144.7 135.99 25.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -125.32 114.93 19.55 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 126.686 1.994 . . . . 0.0 108.627 -168.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.92 132.25 52.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.381 0.673 . . . . 0.0 110.411 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.68 21.05 0.21 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.311 1.444 . . . . 0.0 113.842 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.0 10.24 22.16 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.329 1.052 . . . . 0.0 110.454 -173.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -122.72 137.33 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.589 1.156 . . . . 0.0 108.938 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.94 -53.67 30.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.963 0.905 . . . . 0.0 110.458 -173.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.37 -32.25 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.36 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.26 -50.45 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.855 1.262 . . . . 0.0 107.886 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -58.71 -43.83 90.19 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.155 0.582 . . . . 0.0 110.942 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -41.97 90.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.766 0.826 . . . . 0.0 109.351 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.34 -28.6 54.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.93 1.292 . . . . 0.0 111.112 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -60.74 -29.96 69.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.713 0.688 . . . . 0.0 110.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -72.35 -14.42 61.72 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.595 0.758 . . . . 0.0 111.863 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -125.29 24.47 7.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.769 1.628 . . . . 0.0 110.982 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mt -121.56 136.86 26.33 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.26 164.97 57.82 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 N-CA-C 114.772 1.028 . . . . 0.0 114.772 -7.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.26 165.49 35.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.686 0.794 . . . . 0.0 112.136 166.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -121.78 160.11 25.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.366 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -163.57 -159.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.432 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.12 134.49 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.075 1.35 . . . . 0.0 108.606 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.38 76.34 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 124.884 1.274 . . . . 0.0 108.111 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -69.31 144.96 53.39 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.256 -1.527 . . . . 0.0 107.615 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.5 p -129.07 147.31 50.92 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.624 0.647 . . . . 0.0 110.215 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -151.79 64.32 0.86 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.725 0.81 . . . . 0.0 109.685 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 82' ' ' THR . . . 70.91 77.72 0.48 Allowed Glycine 0 C--O 1.211 -1.298 0 O-C-N 120.98 -1.075 . . . . 0.0 111.581 170.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 62.06 23.0 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.106 1.453 . . . . 0.0 112.333 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -126.49 145.98 50.29 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.649 2.38 . . . . 0.0 107.317 171.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mt -122.73 144.48 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 163.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.08 158.17 43.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 166.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -141.89 153.85 44.7 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.2 t -79.91 104.54 10.55 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -68.43 149.64 97.96 Favored Pre-proline 0 N--CA 1.447 -0.588 0 O-C-N 121.813 -0.554 . . . . 0.0 110.008 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.72 -36.85 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.076 2.518 . . . . 0.0 110.793 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 149.36 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -132.2 121.87 24.35 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.539 1.936 . . . . 0.0 106.048 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.9 143.81 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -128.54 36.37 4.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.3 1.04 . . . . 0.0 111.31 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -128.91 114.87 17.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.093 2.557 . . . . 0.0 107.623 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 162.27 13.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.443 1.097 . . . . 0.0 109.933 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.2 -39.8 3.56 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.996 1.719 . . . . 0.0 110.517 166.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -122.0 60.85 12.65 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.174 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.61 131.49 29.74 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.007 1.138 . . . . 0.0 110.61 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -129.79 124.94 34.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -90.19 0.48 57.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.339 0.518 . . . . 0.0 111.919 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -137.29 135.58 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.65 173.27 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.959 -167.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -115.65 168.02 10.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.937 0.875 . . . . 0.0 112.866 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.2 mt -78.52 68.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.789 2.035 . . . . 0.0 106.85 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.77 -1.14 0.16 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.406 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.3 174.54 7.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.306 2.053 . . . . 0.0 109.564 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.29 146.55 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.181 1.392 . . . . 0.0 107.941 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.64 161.03 26.18 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.316 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -81.21 146.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 168.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.422 ' HE1' ' HG ' ' A' ' 93' ' ' SER . 6.5 t90 -121.03 85.43 40.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.897 1.279 . . . . 0.0 108.382 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.05 -38.96 84.57 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.382 2.055 . . . . 0.0 115.854 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.5 -28.5 32.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.673 2.249 . . . . 0.0 109.814 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.82 4.52 75.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.028 -1.429 . . . . 0.0 114.535 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.96 25.84 4.29 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.47 2.135 . . . . 0.0 112.728 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.44 178.1 7.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.08 -158.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -172.97 4.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.166 166.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.7 m -148.25 158.37 44.04 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.888 2.475 . . . . 0.0 107.02 161.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mt -146.62 114.25 6.4 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.138 1.775 . . . . 0.0 109.488 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -102.73 106.22 16.81 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.103 0.961 . . . . 0.0 110.335 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -138.28 18.25 2.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.47 -134.25 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.148 0.885 . . . . 0.0 111.514 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -127.64 94.44 3.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 40' ' ' GLY . 0.7 OUTLIER -64.67 154.26 85.42 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.86 1.664 . . . . 0.0 111.222 -175.076 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.97 5.36 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 125.087 3.858 . . . . 0.0 113.685 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.98 24.75 12.3 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.379 1.472 . . . . 0.0 109.212 175.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.46 166.63 23.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.552 1.541 . . . . 0.0 107.985 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -153.17 -68.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -170.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.407 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 19.3 t70 -73.69 -50.83 18.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 122.206 1.003 . . . . 0.0 111.106 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -129.77 177.57 7.15 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 130.369 3.467 . . . . 0.0 107.187 -173.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -80.89 141.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.99 1.268 . . . . 0.0 108.62 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -141.46 144.87 35.43 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.02 0.928 . . . . 0.0 110.236 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.1 169.58 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.501 3.467 . . . . 0.0 113.911 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.16 64.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.422 ' HG ' ' HE1' ' A' ' 69' ' ' TRP . 81.7 p -164.52 -168.86 1.61 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.475 1.11 . . . . 0.0 108.195 165.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 76.9 0.12 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.697 0.761 . . . . 0.0 111.567 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.52 169.84 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.765 1.226 . . . . 0.0 109.242 165.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -114.71 129.16 56.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.866 1.266 . . . . 0.0 109.729 171.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.83 86.13 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.6 pt -103.73 -22.64 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 110.504 170.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.03 163.64 12.51 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -128.41 145.32 51.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.246 1.018 . . . . 0.0 108.596 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 91.9 mt -74.08 102.39 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 158.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -27.88 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 112.783 -2.008 . . . . 0.0 107.293 -167.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -155.86 161.45 40.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.022 2.529 . . . . 0.0 112.299 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.85 30.78 37.79 Favored Glycine 0 C--O 1.221 -0.674 0 CA-C-O 118.205 -1.331 . . . . 0.0 113.284 172.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.73 -41.36 97.53 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.142 1.971 . . . . 0.0 113.17 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.81 -19.87 47.46 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.121 -0.987 . . . . 0.0 111.246 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.3 -22.72 63.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.705 1.202 . . . . 0.0 110.371 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.04 -34.42 77.65 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.167 1.787 . . . . 0.0 110.285 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -67.56 -2.62 6.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -100.9 -16.03 17.35 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 123.929 0.892 . . . . 0.0 112.01 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.02 165.27 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.01 0.823 . . . . 0.0 109.65 -165.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -113.69 -179.76 3.73 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.202 1.401 . . . . 0.0 108.449 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.16 22.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.028 2.131 . . . . 0.0 114.876 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.99 26.81 0.03 OUTLIER Glycine 0 C--N 1.338 0.666 0 O-C-N 119.817 -1.802 . . . . 0.0 115.907 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.06 49.05 1.04 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.806 1.803 . . . . 0.0 112.052 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.2 mttt 42.98 82.53 0.03 OUTLIER 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.263 2.225 . . . . 0.0 114.161 157.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.515 HG21 HD23 ' A' ' 5' ' ' LEU . 4.8 p -76.73 104.09 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.415 1.486 . . . . 0.0 107.699 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.37 101.07 13.21 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.72 134.01 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 128.58 2.752 . . . . 0.0 107.632 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -138.98 175.36 9.62 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.194 2.598 . . . . 0.0 109.634 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -73.6 -10.2 59.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 121.025 1.739 . . . . 0.0 114.884 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.821 0 C-N-CA 126.097 1.759 . . . . 0.0 111.105 -154.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpp . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -112.82 179.68 3.9 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.51 1.924 . . . . 0.0 107.706 162.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.5 t -147.59 150.31 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.274 2.229 . . . . 0.0 106.838 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 27.5 tt0 -125.23 145.71 49.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.705 2.002 . . . . 0.0 107.256 173.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.8 mt -121.98 111.96 17.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.99 122.17 44.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -106.8 172.08 7.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.4 -23.82 67.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.588 0.755 . . . . 0.0 111.562 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -125.26 8.74 7.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -167.79 40.84 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-O 119.527 -0.596 . . . . 0.0 111.816 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -159.2 153.66 24.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.831 0.815 . . . . 0.0 111.117 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.0 p -136.8 179.42 6.38 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.426 0.691 . . . . 0.0 110.595 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.61 135.22 49.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.51 124.45 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -96.31 117.89 31.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.986 1.314 . . . . 0.0 107.754 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -128.12 135.72 50.18 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 118.848 0.749 . . . . 0.0 109.715 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -101.04 106.78 18.1 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.01 1.71 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 1 C-N-CA 131.836 4.054 . . . . 0.0 117.151 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.76 -44.21 64.45 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.635 -1.29 . . . . 0.0 107.953 164.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -62.6 139.69 58.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 110.194 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.74 -56.35 16.19 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.283 1.833 . . . . 0.0 107.28 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.441 HG12 HD23 ' A' ' 26' ' ' LEU . 1.5 t -57.45 -38.64 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.042 -173.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.36 -35.62 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.001 -170.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -61.25 -47.32 86.57 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.876 -0.515 . . . . 0.0 111.008 170.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -32.25 71.36 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.719 1.208 . . . . 0.0 110.417 -171.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.773 ' CD2' HG11 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -59.94 -40.99 90.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.389 1.876 . . . . 0.0 109.825 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -50.42 -36.19 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.897 0.879 . . . . 0.0 110.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -69.89 -23.83 63.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.615 0.766 . . . . 0.0 111.622 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -113.13 -10.35 13.43 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 111.336 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -83.21 143.57 45.47 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -70.17 149.72 90.02 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 125.47 -0.637 . . . . 0.0 112.229 -10.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -139.48 168.33 20.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.124 0.97 . . . . 0.0 109.802 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -114.13 166.0 12.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.32 161.24 39.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.603 -0.685 . . . . 0.0 109.928 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.76 128.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 43' ' ' ILE . 35.5 t -77.62 107.45 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 167.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -96.61 151.23 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 163.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.4 p -122.46 149.97 43.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.214 1.006 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -149.43 92.88 1.99 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.2 -88.17 0.49 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 123.646 0.641 . . . . 0.0 111.758 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HB2' ' H ' ' A' ' 82' ' ' THR . 98.0 mt-10 -141.43 36.74 1.68 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.972 1.709 . . . . 0.0 107.944 -173.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -133.17 163.84 28.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 109.681 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.507 HG23 HG13 ' A' ' 36' ' ' VAL . 20.0 mt -123.07 142.59 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -136.46 161.56 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.588 1.555 . . . . 0.0 107.303 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.39 142.83 27.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -75.2 93.33 2.81 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.566 1.146 . . . . 0.0 109.325 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.1 p -62.29 150.92 83.51 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -67.9 -39.04 11.91 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.107 2.538 . . . . 0.0 110.914 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.773 HG11 ' CD2' ' A' ' 26' ' ' LEU . 11.9 p -67.24 155.25 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.595 -0.69 . . . . 0.0 109.673 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -154.63 56.11 0.68 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.329 0.652 . . . . 0.0 112.464 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.12 173.3 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 0.0 110.103 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.0 14.03 2.26 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -69.94 127.76 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -136.03 93.99 2.99 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.827 1.251 . . . . 0.0 110.205 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -75.33 -43.54 50.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -117.19 66.35 4.25 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 111.635 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.31 155.39 69.46 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 120.759 0.972 . . . . 0.0 111.212 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -144.61 157.72 44.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.605 1.162 . . . . 0.0 108.911 168.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -119.63 5.48 11.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.85 1.26 . . . . 0.0 111.892 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.3 145.05 27.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.15 179.45 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.805 0.842 . . . . 0.0 110.115 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -87.88 -168.59 2.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 0.0 111.139 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.408 ' O ' HD11 ' A' ' 105' ' ' LEU . 13.7 mt -90.79 -8.62 10.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 124.803 1.241 . . . . 0.0 110.917 161.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.68 83.22 0.25 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 105.663 -2.975 . . . . 0.0 105.663 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -141.15 -175.18 4.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.74 3.216 . . . . 0.0 105.884 152.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.96 163.3 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 131.312 3.845 . . . . 0.0 109.443 -166.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.91 144.25 9.3 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.87 163.52 27.19 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.169 0.984 . . . . 0.0 109.771 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -136.66 87.31 20.86 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 109.973 -172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.58 -27.53 69.6 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 121.465 1.443 . . . . 0.0 115.201 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.79 -28.39 16.88 Favored 'Trans proline' 0 C--N 1.354 0.822 0 CA-C-N 123.787 2.388 . . . . 0.0 111.362 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.28 9.93 26.63 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.736 -1.035 . . . . 0.0 113.737 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm 46.17 55.84 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.697 1.599 . . . . 0.0 110.814 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.93 176.94 7.47 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.699 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.0 174.49 6.53 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 125.784 1.633 . . . . 0.0 109.929 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.61 137.2 23.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.565 1.946 . . . . 0.0 109.861 162.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.64 109.7 14.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.745 3.618 . . . . 0.0 106.079 172.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.23 49.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.647 1.112 . . . . 0.0 108.632 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -147.01 34.57 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.93 -120.94 0.55 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.877 2.18 . . . . 0.0 108.135 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.81 5.8 7.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.667 1.733 . . . . 0.0 113.302 170.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 41' ' ' GLU 0.298 0.0 OUTLIER 62.93 167.72 0.1 Allowed Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.68 1.127 . . . . 0.0 113.858 167.948 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -91.41 6.15 3.7 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.973 3.115 . . . . 0.0 113.527 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -132.54 62.86 1.64 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.7 1.136 . . . . 0.0 108.277 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -156.62 175.0 14.62 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.343 1.457 . . . . 0.0 109.633 -174.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -148.38 -50.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 154.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.41 -58.98 2.97 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -132.2 168.46 18.0 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.228 2.611 . . . . 0.0 108.502 -167.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.73 122.06 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -129.77 144.32 52.51 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 123.413 0.445 . . . . 0.0 110.479 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.02 173.26 14.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.136 3.224 . . . . 0.0 112.717 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.12 -33.29 75.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.76 175.03 10.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.154 1.382 . . . . 0.0 107.511 172.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 100.33 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.18 -173.46 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -130.92 125.14 32.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.266 2.4 t -90.39 61.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.838 -163.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.3 pt -77.14 -10.48 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.715 2.006 . . . . 0.0 112.398 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.18 167.18 12.58 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 130.423 3.868 . . . . 0.0 112.268 -166.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -148.14 129.04 14.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.825 2.05 . . . . 0.0 106.751 150.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.8 mt -56.98 100.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 155.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 m -76.57 -36.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 118.903 0.774 . . . . 0.0 110.869 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -149.97 164.13 36.28 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.29 1.036 . . . . 0.0 111.142 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.5 33.05 71.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.994 1.283 . . . . 0.0 112.59 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 63' ' ' ILE . 55.0 tp -58.74 -52.33 66.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.332 1.053 . . . . 0.0 112.288 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.48 -21.26 56.06 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.001 -0.437 . . . . 0.0 111.316 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -9.89 6.63 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.021 1.328 . . . . 0.0 111.75 175.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.9 mt -79.78 -41.23 26.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.808 1.643 . . . . 0.0 111.611 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -65.23 -12.2 48.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.825 -1.172 . . . . 0.0 113.142 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -102.96 14.17 32.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.566 1.146 . . . . 0.0 112.125 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -107.3 127.47 63.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.253 1.421 . . . . 0.0 107.727 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -70.27 174.34 5.71 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.287 1.035 . . . . 0.0 110.471 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.34 49.57 0.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.929 1.692 . . . . 0.0 111.624 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.03 88.54 0.07 OUTLIER Glycine 0 C--O 1.231 -0.074 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -138.5 26.68 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 -173.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 mttm 43.41 75.33 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.013 2.125 . . . . 0.0 111.746 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.75 105.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.72 102.35 10.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.95 123.5 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 126.423 1.889 . . . . 0.0 107.669 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -132.97 172.43 12.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.14 1.336 . . . . 0.0 109.139 164.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -70.76 -12.49 61.58 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.774 0 C-N-CA 125.122 1.369 . . . . 0.0 109.969 -162.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttp . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -94.72 164.91 12.75 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.206 1.002 . . . . 0.0 109.821 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -149.27 132.5 7.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 35.0 tt0 -113.06 140.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 mp -114.15 99.97 8.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.38 142.44 33.01 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -133.96 165.91 23.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.42 -17.16 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.912 -1.118 . . . . 0.0 112.332 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 m -115.61 -6.01 12.19 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.44 -169.01 39.93 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 120.633 1.56 . . . . 0.0 109.511 -172.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -169.95 113.29 0.48 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.002 0.906 . . . . 0.0 111.578 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.542 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 30.7 m -119.46 171.69 8.17 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.961 1.304 . . . . 0.0 108.713 -169.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 t -139.9 133.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -166.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.5 pt -123.36 160.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 123.386 1.565 . . . . 0.0 108.371 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.433 ' CA ' HD22 ' A' ' 16' ' ' LEU . 11.9 p-10 -145.96 128.18 15.74 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.555 -164.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -129.85 149.19 51.69 Favored 'General case' 0 C--O 1.246 0.887 0 O-C-N 125.08 1.487 . . . . 0.0 110.291 -166.179 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -87.01 22.34 2.06 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 24.1 mt-10 46.27 14.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.844 2.058 . . . . 0.0 116.215 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -116.18 10.53 14.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.013 -1.055 . . . . 0.0 110.084 -166.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -125.71 135.68 52.35 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -171.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -47.34 -51.31 19.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 110.152 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.279 7.5 p -48.86 -56.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.678 1.991 . . . . 0.0 112.376 172.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.74 -45.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 121.797 2.09 . . . . 0.0 110.74 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 18' ' ' GLU . 79.9 mttt -65.51 -43.15 91.0 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.775 0.83 . . . . 0.0 111.602 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.4 mt -75.43 -30.8 60.14 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.336 1.055 . . . . 0.0 110.222 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.96 -26.11 61.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.321 1.048 . . . . 0.0 110.587 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp -64.91 -9.7 23.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.573 0.749 . . . . 0.0 112.865 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.74 -18.79 22.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.992 1.269 . . . . 0.0 112.159 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -125.92 31.23 5.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.117 1.367 . . . . 0.0 110.217 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.04 141.13 34.96 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 170.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.14 164.87 28.49 Favored 'Cis proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.712 0.933 . . . . 0.0 111.907 -14.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CE1' HG11 ' A' ' 119' ' ' VAL . 22.6 p90 -148.94 165.53 31.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.171 165.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -110.61 158.9 18.07 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 162.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -151.92 -171.79 4.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.007 0.923 . . . . 0.0 108.863 164.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -97.73 138.04 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.774 1.629 . . . . 0.0 107.224 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 117' ' ' VAL . 6.2 t -90.09 64.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.452 1.101 . . . . 0.0 110.127 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -68.66 143.59 54.73 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.476 -1.29 . . . . 0.0 107.524 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 43' ' ' ILE . 18.8 p -111.03 155.33 22.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.971 0.805 . . . . 0.0 109.938 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -147.26 73.19 1.28 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 76.21 0.55 Allowed Glycine 0 C--O 1.218 -0.856 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.808 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.21 25.22 15.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.723 2.009 . . . . 0.0 112.011 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -135.41 157.77 46.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.631 165.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 38' ' ' THR . 34.1 mt -125.15 117.66 50.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.052 1.741 . . . . 0.0 107.247 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -110.9 166.9 10.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.761 1.267 . . . . 0.0 109.718 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.618 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 3.4 p90 -151.04 149.21 29.27 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.2 t -79.0 102.85 8.56 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -79.35 150.57 74.01 Favored Pre-proline 0 N--CA 1.451 -0.417 0 O-C-N 121.765 -0.584 . . . . 0.0 110.969 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.74 -16.48 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.074 3.183 . . . . 0.0 114.601 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.427 HG12 HG12 ' A' ' 51' ' ' VAL . 21.6 t -83.11 107.13 14.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -90.14 51.03 1.96 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 123.413 1.578 . . . . 0.0 109.254 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG12 HG12 ' A' ' 49' ' ' VAL . 4.6 p -80.81 155.86 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.348 1.459 . . . . 0.0 107.716 166.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -138.05 4.55 2.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 166.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -62.46 102.36 0.31 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.236 1.38 . . . . 0.0 112.333 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.02 124.58 40.09 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.791 0.837 . . . . 0.0 110.308 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.84 -24.42 13.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.518 0.727 . . . . 0.0 112.529 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -114.9 55.73 0.88 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-O 117.49 -1.243 . . . . 0.0 110.044 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.45 126.9 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.217 1.944 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -136.0 127.86 29.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.78 0.45 57.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 118.45 -0.785 . . . . 0.0 111.164 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.1 t -138.88 141.64 36.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.91 174.32 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.175 1.39 . . . . 0.0 109.587 -171.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.62 -177.05 3.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 110.841 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mt -86.43 1.51 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.064 1.345 . . . . 0.0 112.454 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.79 44.55 0.78 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 125.012 1.291 . . . . 0.0 113.128 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' OD1' ' HE2' ' A' ' 100' ' ' LYS . 70.8 m-20 -125.82 174.66 8.2 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.22 147.52 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.25 147.85 19.35 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -93.69 141.6 28.31 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.803 1.301 . . . . 0.0 109.688 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -112.69 85.87 7.99 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.904 1.281 . . . . 0.0 109.946 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -64.32 -33.18 60.02 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.645 1.563 . . . . 0.0 115.264 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.47 -7.23 20.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.504 2.803 . . . . 0.0 112.335 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.52 9.15 8.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.215 1.864 . . . . 0.0 113.569 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.71 32.76 20.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.674 1.237 . . . . 0.0 111.868 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.33 13.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.906 0.775 . . . . 0.0 111.343 -167.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.618 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -80.48 -173.96 4.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.159 0.584 . . . . 0.0 110.153 162.351 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.415 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 7.5 t -154.91 143.69 20.76 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.22 2.208 . . . . 0.0 106.823 165.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 42' ' ' GLU . 28.4 mt -135.57 103.75 5.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.801 1.64 . . . . 0.0 107.742 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -87.71 135.7 33.26 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.028 1.286 . . . . 0.0 109.9 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -148.4 9.79 0.84 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.74 62.75 0.06 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.114 -1.993 . . . . 0.0 115.224 165.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 75.22 179.07 0.19 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.338 1.855 . . . . 0.0 107.803 -170.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.24 160.0 31.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.8 -27.74 37.27 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.123 2.549 . . . . 0.0 111.435 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.65 31.96 0.2 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.866 1.266 . . . . 0.0 111.219 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -148.75 166.15 29.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.739 -1.225 . . . . 0.0 112.001 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -136.91 -56.52 0.72 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.51 -61.81 1.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.574 1.15 . . . . 0.0 110.476 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -122.82 144.91 48.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.395 1.478 . . . . 0.0 107.103 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.5 mt -59.3 118.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -130.86 145.01 55.85 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 95' ' ' VAL . 38.1 Cg_endo -74.59 175.13 11.5 Favored 'Trans proline' 0 N--CA 1.455 -0.782 1 C-N-CA 126.219 4.613 . . . . 0.0 113.179 171.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.78 -7.04 50.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 t -171.87 -177.66 2.0 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.713 2.005 . . . . 0.0 106.718 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 73.89 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.22 165.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 91' ' ' PRO . 14.7 m -68.84 -177.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 161.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -138.4 124.68 20.42 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.161 -0.962 . . . . 0.0 111.449 -169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.09 72.66 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 122.431 1.11 . . . . 0.0 108.999 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.9 pt -92.77 -14.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.175 1.39 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.66 173.48 23.5 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.428 ' HE2' ' OD1' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -125.93 175.14 7.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.804 1.242 . . . . 0.0 110.415 177.09 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.47 77.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 122.861 1.315 . . . . 0.0 107.979 166.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -29.32 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.084 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -146.69 158.32 43.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.99 2.516 . . . . 0.0 109.241 168.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.542 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 81.02 61.17 2.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.598 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.16 -60.46 1.67 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -70.3 -27.73 64.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.111 0.957 . . . . 0.0 110.001 -166.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 1.69 5.36 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.786 2.035 . . . . 0.0 112.48 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -87.37 -35.79 18.16 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.842 1.201 . . . . 0.0 111.756 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -14.24 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.523 -1.361 . . . . 0.0 114.472 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.58 0.86 26.9 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.624 2.37 . . . . 0.0 111.7 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mm -83.66 157.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -109.73 172.7 6.7 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 109.118 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.408 ' HA ' HG23 ' A' ' 38' ' ' THR . 0.4 OUTLIER -69.61 11.9 0.23 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.755 2.422 . . . . 0.0 114.286 -175.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.58 75.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.401 0 O-C-N 119.991 -1.693 . . . . 0.0 109.885 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -117.46 37.91 3.75 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.863 1.665 . . . . 0.0 111.242 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.4 mttm 44.04 74.24 0.13 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.869 2.068 . . . . 0.0 112.018 166.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.473 ' HB ' HG22 ' A' ' 36' ' ' VAL . 1.7 p -73.92 101.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.37 100.21 9.85 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.443 HG11 ' CE1' ' A' ' 32' ' ' PHE . 62.0 t -75.99 135.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 126.373 1.869 . . . . 0.0 108.713 173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -140.57 178.59 7.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.773 1.629 . . . . 0.0 109.178 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.95 3.54 11.94 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.965 1.84 . . . . 0.0 115.351 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.457 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.311 -1.065 0 C-N-CA 126.172 1.789 . . . . 0.0 110.728 -156.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 121.782 0.801 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.484 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -66.08 164.48 15.34 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.97 -1.081 . . . . 0.0 109.444 168.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.25 108.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -81.78 128.83 34.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.169 -1.582 . . . . 0.0 107.657 164.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 119' ' ' VAL . 2.6 mm? -96.59 114.2 25.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.982 1.713 . . . . 0.0 107.257 169.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.11 133.21 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -123.06 178.49 5.06 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.388 1.075 . . . . 0.0 109.572 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -68.27 -27.37 66.27 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.655 -1.278 . . . . 0.0 112.7 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 m -115.42 -10.75 11.94 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.76 -163.79 28.52 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 119.069 0.849 . . . . 0.0 111.237 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -157.08 149.05 22.68 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.125 0.97 . . . . 0.0 110.356 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -126.1 172.37 10.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 103' ' ' GLU . 15.9 t -138.03 126.03 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 160.06 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 123.539 1.638 . . . . 0.0 106.744 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 100' ' ' LYS . 7.4 p-10 -124.18 115.77 21.64 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 129.449 3.1 . . . . 0.0 104.818 -170.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.406 HD23 ' CA ' ' A' ' 99' ' ' GLY . 84.4 mt -119.19 138.73 52.75 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -96.66 139.06 33.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.61 36.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.851 1.26 . . . . 0.0 112.383 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.87 -7.47 14.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 110.481 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -101.28 138.22 38.59 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 120.519 -1.363 . . . . 0.0 111.006 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -49.22 -62.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.199 1.8 . . . . 0.0 108.09 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.605 HG12 HD23 ' A' ' 26' ' ' LEU . 1.5 t -50.98 -40.96 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -173.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.4 t -67.36 -34.48 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -65.06 -50.31 66.69 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 110.85 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -32.59 73.24 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.992 0.814 . . . . 0.0 109.5 -169.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.678 HD22 HG21 ' A' ' 49' ' ' VAL . 3.2 mm? -60.86 -37.8 83.39 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.476 2.311 . . . . 0.0 111.095 172.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -61.78 -24.73 67.03 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.001 1.273 . . . . 0.0 111.468 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.94 -17.06 57.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -127.26 36.82 4.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.124 1.77 . . . . 0.0 110.627 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' A' ' 31' ' ' PRO . 61.4 mt -128.76 145.94 58.3 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 173.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 30' ' ' ILE . 20.1 Cg_endo -63.35 160.11 62.18 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 119.224 0.758 . . . . 0.0 112.163 -9.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.506 ' CE1' HG11 ' A' ' 119' ' ' VAL . 35.2 p90 -149.17 162.21 40.44 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -118.88 165.86 13.53 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.402 0.681 . . . . 0.0 109.732 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.54 175.61 8.83 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.362 0.601 . . . . 0.0 111.382 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.53 131.3 39.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.403 HG11 ' CG2' ' A' ' 111' ' ' ILE . 40.3 t -79.81 71.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -64.2 154.3 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.798 1.181 . . . . 0.0 108.551 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.428 HG22 HG12 ' A' ' 43' ' ' ILE . 34.9 p -137.37 151.32 48.45 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.323 1.049 . . . . 0.0 111.838 -174.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -155.47 88.76 1.15 Allowed 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.2 80.91 0.05 OUTLIER Glycine 0 C--O 1.213 -1.193 0 CA-C-O 118.321 -1.266 . . . . 0.0 114.492 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 67.44 20.45 9.86 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.978 1.889 . . . . 0.0 112.22 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -135.1 146.95 49.36 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.953 0.901 . . . . 0.0 109.532 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 38' ' ' THR . 62.7 mt -130.35 127.76 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.353 1.861 . . . . 0.0 106.547 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -143.62 142.98 31.27 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.067 1.347 . . . . 0.0 109.376 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -131.26 144.78 51.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.77 -1.206 . . . . 0.0 109.059 -173.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 m -79.1 79.42 5.5 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.481 1.512 . . . . 0.0 110.728 -168.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.6 p -57.36 152.63 31.4 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.957 0.903 . . . . 0.0 112.896 -170.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.39 -12.74 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.627 2.885 . . . . 0.0 112.212 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.678 HG21 HD22 ' A' ' 26' ' ' LEU . 47.2 t -96.91 140.39 17.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -132.17 89.6 2.69 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -116.33 161.47 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.66 5.51 8.86 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.546 -0.721 . . . . 0.0 112.563 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -74.2 127.18 32.3 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.456 1.903 . . . . 0.0 110.187 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.34 101.85 7.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.177 1.391 . . . . 0.0 109.984 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.46 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.17 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -143.41 81.01 12.69 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 124.055 0.942 . . . . 0.0 111.772 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 65.5 Cg_endo -75.64 143.22 26.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.465 3.443 . . . . 0.0 112.161 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -136.69 169.59 17.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.41 1.084 . . . . 0.0 108.63 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -121.98 4.36 9.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.806 1.243 . . . . 0.0 112.222 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.55 143.19 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 m -132.73 173.12 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 109.14 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -85.31 -176.64 6.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.806 0.812 . . . . 0.0 110.349 164.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.49 -7.58 10.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 124.611 1.165 . . . . 0.0 110.42 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.82 35.82 2.05 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-O 118.64 -1.089 . . . . 0.0 112.311 -168.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.402 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . 74.1 m-20 -112.87 173.77 6.22 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.463 1.505 . . . . 0.0 111.355 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.91 135.07 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 120.753 -1.217 . . . . 0.0 110.895 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.24 176.74 16.89 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.909 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -101.55 159.59 15.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.79 1.236 . . . . 0.0 110.334 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.408 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 t90 -132.82 83.06 53.94 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 119.347 0.976 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.17 -24.37 65.93 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.448 2.765 . . . . 0.0 117.936 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HD2' ' C ' ' A' ' 69' ' ' TRP . 22.1 Cg_endo -72.83 -45.06 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.057 2.504 . . . . 0.0 108.982 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.09 -4.36 58.66 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.439 -1.201 . . . . 0.0 114.273 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 55.24 73.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.671 1.988 . . . . 0.0 108.692 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.15 171.46 15.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.727 0.775 . . . . 0.0 112.9 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.08 -178.42 7.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 109.519 157.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 31.5 m -142.95 160.52 40.19 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.875 1.27 . . . . 0.0 109.336 156.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -145.52 97.35 2.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 128.465 2.706 . . . . 0.0 105.273 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -83.52 146.75 28.18 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.14 26.69 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.46 -100.74 0.17 Allowed Glycine 0 C--N 1.333 0.392 0 O-C-N 119.514 -1.991 . . . . 0.0 111.744 165.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -128.14 -13.48 5.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 57.99 165.99 0.07 OUTLIER Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.155 1.782 . . . . 0.0 112.541 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.33 -18.31 9.8 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.563 2.175 . . . . 0.0 112.902 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.79 49.58 0.89 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 122.232 1.015 . . . . 0.0 109.255 -169.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.12 179.51 6.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.192 -0.943 . . . . 0.0 110.746 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -142.83 -42.97 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.734 1.214 . . . . 0.0 109.89 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.8 -56.27 2.37 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.25 -0.906 . . . . 0.0 111.538 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -127.93 178.67 6.02 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.553 1.941 . . . . 0.0 109.635 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -77.52 134.44 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 120.231 1.378 . . . . 0.0 108.069 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -123.83 151.33 64.33 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 123.449 0.7 . . . . 0.0 109.311 165.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.89 177.92 7.91 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 124.005 3.137 . . . . 0.0 111.917 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.4 61.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.452 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.4 t -163.22 176.0 10.39 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 120.188 1.358 . . . . 0.0 108.885 -167.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 64.32 0.75 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.732 1.213 . . . . 0.0 110.694 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -66.98 165.46 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.688 1.195 . . . . 0.0 107.918 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 36.1 p30 -94.12 -178.9 4.78 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 120.05 -1.656 . . . . 0.0 109.902 169.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.42 45.19 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 122.878 1.323 . . . . 0.0 108.688 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.9 pt -69.99 -15.12 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.239 -1.538 . . . . 0.0 112.031 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.406 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -121.63 169.82 14.68 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 17.0 tttt -131.84 171.26 13.75 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.454 1.102 . . . . 0.0 108.505 168.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.6 mt -101.92 86.71 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 160.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -30.08 38.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.093 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 3.0 mt-10 -152.8 151.78 30.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 109.061 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.07 58.5 6.66 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.299 -0.876 . . . . 0.0 112.453 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.6 tp -84.43 -52.25 6.31 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.766 -0.844 . . . . 0.0 110.646 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.36 -24.68 57.32 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.339 -0.85 . . . . 0.0 111.089 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -26.61 68.88 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 110.688 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.18 -22.36 39.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.022 0.929 . . . . 0.0 112.288 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -72.6 -21.09 61.18 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.098 -1.626 . . . . 0.0 114.428 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 10.19 6.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 121.498 1.954 . . . . 0.0 112.457 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.403 ' CG2' HG11 ' A' ' 36' ' ' VAL . 28.0 mm -104.31 160.31 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.205 1.002 . . . . 0.0 108.805 -166.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.629 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 10.7 mmtp -131.74 175.03 9.54 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.354 2.262 . . . . 0.0 108.845 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.04 2.79 2.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.837 2.055 . . . . 0.0 115.666 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.49 48.82 0.33 Allowed Glycine 0 CA--C 1.52 0.403 0 O-C-N 120.63 -1.294 . . . . 0.0 110.961 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.629 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 8.6 mm-40 -101.69 30.43 4.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.542 -176.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 mttp 44.25 86.47 0.02 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.445 1.898 . . . . 0.0 113.266 166.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 36' ' ' VAL . 6.4 p -78.52 133.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 176.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.71 111.18 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.574 HG22 HD12 ' A' ' 5' ' ' LEU . 93.5 t -79.13 127.25 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 127.117 2.167 . . . . 0.0 106.716 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -128.42 -166.59 1.65 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.479 1.112 . . . . 0.0 109.421 171.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -95.93 -5.37 41.57 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--N 1.311 -1.08 0 C-N-CA 129.243 3.017 . . . . 0.0 110.547 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 -67.6 154.08 42.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.305 -0.872 . . . . 0.0 108.912 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.95 147.51 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.398 1.479 . . . . 0.0 108.089 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 40.0 tt0 -123.69 139.9 53.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.019 2.528 . . . . 0.0 106.809 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 4' ' ' GLU . 8.8 mp -118.56 98.53 6.29 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 136.73 33.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -125.35 173.9 8.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.467 1.107 . . . . 0.0 109.142 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -30.36 70.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.948 0.899 . . . . 0.0 111.301 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -93.13 -13.27 28.69 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.11 -159.91 33.12 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 120.834 1.652 . . . . 0.0 109.894 -164.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -158.17 165.09 35.78 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 109.806 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -136.72 178.13 7.31 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.904 0.482 . . . . 0.0 110.276 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.45 128.08 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 16' ' ' LEU . 21.3 pt -116.14 162.18 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 122.628 1.204 . . . . 0.0 109.075 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -120.82 130.36 53.94 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 107.699 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.4 HD21 HD12 ' A' ' 14' ' ' ILE . 55.3 mt -124.81 135.7 53.17 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.474 1.109 . . . . 0.0 109.254 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -76.48 136.47 39.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.081 0.952 . . . . 0.0 110.915 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.33 37.12 1.19 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.42 1.088 . . . . 0.0 113.278 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.08 22.87 11.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.187 -0.946 . . . . 0.0 111.194 170.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.09 133.13 45.36 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.94 0.896 . . . . 0.0 111.216 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -44.5 -55.36 5.15 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.791 2.036 . . . . 0.0 109.248 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.67 -40.24 78.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 116.894 -1.527 . . . . 0.0 113.276 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.06 -30.84 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 121.032 1.742 . . . . 0.0 109.858 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -64.87 -47.21 78.71 Favored 'General case' 0 C--N 1.342 0.263 0 O-C-N 121.608 -0.683 . . . . 0.0 110.383 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB3' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -70.72 -36.7 73.33 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 120.822 -1.174 . . . . 0.0 109.25 -174.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.56 ' CD2' HG11 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -55.91 -38.12 69.81 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.633 1.573 . . . . 0.0 109.721 174.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 tmpt? -59.23 -28.49 66.74 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.363 0.983 . . . . 0.0 111.164 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -69.01 -34.35 75.12 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.095 0.861 . . . . 0.0 110.236 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -107.57 33.54 3.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.346 2.258 . . . . 0.0 110.932 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -129.13 144.2 51.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 172.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -61.03 158.98 49.02 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 119.557 0.878 . . . . 0.0 112.536 -14.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -156.49 162.4 39.96 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.899 0.879 . . . . 0.0 110.817 170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.91 155.57 33.92 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.435 0.694 . . . . 0.0 110.262 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -165.1 172.56 12.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.274 1.03 . . . . 0.0 110.145 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.77 140.59 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.699 1.6 . . . . 0.0 107.535 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 t -96.13 67.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -58.31 138.3 56.52 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -116.51 151.17 36.67 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 108.982 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -157.71 115.9 3.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 -102.7 0.34 Allowed Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -137.39 36.2 2.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.038 2.135 . . . . 0.0 108.413 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -122.72 165.7 16.12 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mt -122.51 147.43 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 171.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.62 175.36 9.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.101 0.953 . . . . 0.0 109.182 160.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -146.86 156.39 43.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -80.49 96.8 6.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -64.21 147.3 97.01 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.78 -39.13 15.67 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.284 1.99 . . . . 0.0 110.007 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.56 HG11 ' CD2' ' A' ' 26' ' ' LEU . 7.7 p -71.69 163.61 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.377 1.471 . . . . 0.0 110.36 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -141.54 38.34 1.68 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 HG22 ' A' ' 49' ' ' VAL . 27.1 t -60.83 153.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.713 0.805 . . . . 0.0 110.781 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.22 -8.46 4.78 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.959 1.304 . . . . 0.0 112.557 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -73.09 126.29 29.65 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.328 0.967 . . . . 0.0 109.404 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 125.63 35.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.781 1.233 . . . . 0.0 109.517 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.72 -33.45 15.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.009 0.924 . . . . 0.0 109.937 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -123.86 61.56 24.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.089 0.956 . . . . 0.0 111.009 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.5 124.19 12.11 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.059 1.839 . . . . 0.0 109.003 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -128.88 149.33 50.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.724 1.209 . . . . 0.0 109.324 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -111.16 -11.03 14.28 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.855 0.462 . . . . 0.0 111.595 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 t -128.38 135.16 63.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.47 -164.01 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.347 1.859 . . . . 0.0 107.513 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -143.63 176.8 8.94 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.55 1.14 . . . . 0.0 111.184 -165.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.4 mt -84.02 11.13 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 126.167 1.787 . . . . 0.0 110.586 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.56 9.81 2.91 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.672 1.606 . . . . 0.0 113.586 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.82 -177.06 4.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 124.33 2.015 . . . . 0.0 108.592 -165.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.453 HG13 HG13 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -153.03 146.66 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 128.454 2.701 . . . . 0.0 105.691 -149.091 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.34 174.06 22.42 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -131.36 116.49 17.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 127.029 2.131 . . . . 0.0 107.356 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.424 ' HE1' ' HB2' ' A' ' 93' ' ' SER . 8.2 t90 -108.13 87.06 3.61 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 124.582 1.153 . . . . 0.0 109.381 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.86 -43.11 62.48 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.323 2.016 . . . . 0.0 114.969 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.24 -18.19 23.7 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.393 2.062 . . . . 0.0 111.128 -170.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.33 -0.13 70.81 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.443 -1.198 . . . . 0.0 113.29 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 46.68 39.8 7.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.198 1.999 . . . . 0.0 110.623 -166.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.4 146.1 44.68 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -167.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -179.04 1.99 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.572 158.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 55.9 m -145.75 158.87 43.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.302 1.441 . . . . 0.0 108.455 151.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mt -141.46 118.1 10.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 127.752 2.421 . . . . 0.0 106.457 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -114.81 121.29 42.82 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 109.563 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -149.14 7.97 0.72 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.13 0.972 . . . . 0.0 113.458 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.28 -114.06 0.42 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.346 -1.471 . . . . 0.0 112.0 -173.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.61 148.04 26.86 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.87 162.74 55.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.75 1.22 . . . . 0.0 112.077 -167.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.92 -3.07 8.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.164 2.576 . . . . 0.0 113.876 -167.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.87 16.9 14.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.69 1.132 . . . . 0.0 110.804 166.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 90' ' ' GLN . 3.7 t -129.86 178.98 6.12 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -142.07 -34.07 0.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.455 1.102 . . . . 0.0 109.848 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.3 -52.27 6.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.302 1.441 . . . . 0.0 112.029 172.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.07 -163.81 1.36 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.564 1.546 . . . . 0.0 109.68 -156.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.99 92.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 170.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.5 ' H ' ' HB2' ' A' ' 85' ' ' SER . 14.0 mt-30 -100.59 146.33 31.86 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 158.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.6 -179.43 5.33 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.229 3.286 . . . . 0.0 113.158 164.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.66 64.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.424 ' HB2' ' HE1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -157.9 -171.87 3.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 84.12 7.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 123.647 1.689 . . . . 0.0 108.265 156.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 95' ' ' VAL 0.332 46.9 t -44.33 161.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 C-N-CA 129.669 3.188 . . . . 0.0 110.668 143.198 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -98.21 124.62 42.89 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.694 1.597 . . . . 0.0 107.084 171.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.5 pt -120.11 -9.74 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.134 2.174 . . . . 0.0 111.351 -173.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.56 171.91 13.95 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 129.752 3.549 . . . . 0.0 112.694 -163.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -144.7 148.83 34.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.851 1.66 . . . . 0.0 108.693 143.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.453 HG13 HG13 ' A' ' 66' ' ' VAL . 16.4 mt -75.01 98.99 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 159.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.0 m -73.74 -36.56 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.526 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.7 163.02 38.54 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 118.798 0.726 . . . . 0.0 110.829 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.41 42.44 73.91 Favored Glycine 0 C--O 1.222 -0.607 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.185 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -56.55 11.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.458 1.129 . . . . 0.0 110.003 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.18 -19.1 64.75 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.958 -0.464 . . . . 0.0 111.088 -168.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.04 -22.96 61.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.173 1.789 . . . . 0.0 110.654 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.33 -41.12 61.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.335 -1.478 . . . . 0.0 110.36 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -62.52 -5.29 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.051 1.341 . . . . 0.0 113.412 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.54 6.06 10.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.066 1.746 . . . . 0.0 112.147 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.293 19.2 mm -80.47 164.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.292 0.951 . . . . 0.0 108.875 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.406 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 4.5 mmpt? -121.62 167.85 12.43 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 127.278 2.231 . . . . 0.0 106.472 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.56 -1.63 1.91 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -169.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.01 17.91 1.21 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.605 -1.109 . . . . 0.0 114.168 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 14.7 mm-40 -72.03 23.78 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.274 2.037 . . . . 0.0 113.975 -176.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt 44.75 89.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 128.848 2.859 . . . . 0.0 113.958 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.8 104.36 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.62 98.79 9.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 107.899 170.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -75.17 137.34 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.269 1.827 . . . . 0.0 108.589 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -139.75 -177.44 4.97 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.095 2.558 . . . . 0.0 110.096 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -86.62 -4.38 59.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 127.524 2.33 . . . . 0.0 112.07 -173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.38 148.58 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -149.4 142.75 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 27.0 tt0 -117.87 138.09 52.35 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.972 2.109 . . . . 0.0 106.068 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.26 98.94 6.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.972 2.109 . . . . 0.0 106.703 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.56 129.75 46.54 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.957 1.303 . . . . 0.0 109.139 -172.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.18 -176.1 3.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.015 1.326 . . . . 0.0 109.74 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.61 -53.79 36.83 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.928 -0.482 . . . . 0.0 110.467 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 t -76.18 -20.83 57.17 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.502 0.592 . . . . 0.0 111.039 -168.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.05 -152.29 12.73 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -164.73 152.92 12.14 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.525 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 64.7 m -141.26 173.59 11.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.059 0.943 . . . . 0.0 109.009 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 t -140.82 129.7 24.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.6 pt -114.15 166.35 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 122.427 1.108 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -123.42 149.43 45.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 163.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.407 HD23 ' HA3' ' A' ' 99' ' ' GLY . 59.4 mt -139.11 132.11 29.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.694 1.598 . . . . 0.0 110.799 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -84.93 126.43 33.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.633 0.254 . . . . 0.0 110.685 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.76 5.13 14.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.585 1.954 . . . . 0.0 113.961 -169.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -83.41 -11.8 57.17 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.093 -1.004 . . . . 0.0 109.95 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.418 ' CD2' HG22 ' A' ' 98' ' ' ILE . 32.7 m-85 -99.34 141.14 32.51 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.862 2.065 . . . . 0.0 109.688 -174.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -44.87 -59.5 2.52 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.844 1.658 . . . . 0.0 109.365 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.78 -35.53 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.87 -38.61 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.869 1.213 . . . . 0.0 109.819 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -55.72 -45.52 77.92 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.021 0.928 . . . . 0.0 111.066 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -40.06 89.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.03 -1.044 . . . . 0.0 109.511 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.22 -30.52 68.3 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.819 1.248 . . . . 0.0 111.901 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -69.17 -25.15 64.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.276 0.943 . . . . 0.0 109.918 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -78.06 -11.42 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.414 0.685 . . . . 0.0 112.296 171.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -126.1 26.1 6.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.552 1.541 . . . . 0.0 112.077 -166.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.43 143.96 47.85 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -62.04 158.7 56.95 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-N 119.531 0.868 . . . . 0.0 113.202 -10.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -152.79 163.77 39.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.529 0.732 . . . . 0.0 110.354 166.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -119.24 161.99 19.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.244 1.018 . . . . 0.0 110.241 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -168.75 171.36 8.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.673 0.789 . . . . 0.0 112.496 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.28 128.1 47.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.055 1.342 . . . . 0.0 108.852 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 t -91.12 80.88 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -164.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -68.15 151.21 47.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.6 p -126.22 131.61 51.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -134.57 94.71 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 175.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 82' ' ' THR . . . 44.2 82.62 0.03 OUTLIER Glycine 0 C--O 1.214 -1.134 0 C-N-CA 126.304 1.907 . . . . 0.0 115.424 167.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 71.42 21.61 4.5 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.718 1.607 . . . . 0.0 112.609 167.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -140.32 167.9 21.06 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 128.854 2.862 . . . . 0.0 106.395 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mt -132.62 146.09 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 128.003 2.521 . . . . 0.0 108.263 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -146.88 157.61 43.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.758 1.223 . . . . 0.0 111.256 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -150.55 163.05 39.42 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.245 0.618 . . . . 0.0 111.273 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -92.54 88.54 6.38 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.711 0.767 . . . . 0.0 109.825 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.2 p -60.82 148.46 82.84 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.038 0.535 . . . . 0.0 112.184 -170.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.06 -14.57 15.11 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.523 2.815 . . . . 0.0 111.997 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.23 153.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 108.786 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -137.63 119.93 15.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 p -156.92 152.45 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.951 1.3 . . . . 0.0 108.924 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -132.79 21.58 4.21 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.212 1.805 . . . . 0.0 112.591 -174.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -109.04 148.98 29.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.633 1.973 . . . . 0.0 108.862 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -139.64 157.67 45.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.536 1.134 . . . . 0.0 108.91 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -110.79 -50.09 2.98 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.663 0.785 . . . . 0.0 110.255 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -120.38 68.92 14.74 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.87 1.268 . . . . 0.0 108.042 -172.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 72.4 Cg_endo -71.53 156.53 57.87 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.571 2.181 . . . . 0.0 111.799 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.685 ' HG2' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -144.11 158.29 43.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.623 1.569 . . . . 0.0 108.949 177.519 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -111.32 8.8 21.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 117.411 -1.28 . . . . 0.0 111.043 167.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 p -162.31 154.99 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 120.328 1.422 . . . . 0.0 111.749 173.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.58 HG11 ' CZ ' ' A' ' 58' ' ' ARG . 27.2 m -145.22 -179.85 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.599 1.559 . . . . 0.0 112.498 -174.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.12 171.17 12.23 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 110.31 163.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.29 -13.66 16.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 113.597 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.05 48.51 0.97 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 125.058 1.313 . . . . 0.0 110.446 -168.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.44 ' CG ' ' HZ2' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -120.0 172.55 7.66 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.669 1.188 . . . . 0.0 108.869 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -137.94 136.78 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.99 172.1 18.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.494 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -123.5 137.47 54.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.478 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -116.83 88.23 24.86 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.211 1.804 . . . . 0.0 110.031 -162.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.454 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 91.2 Cg_endo -64.57 -26.61 61.76 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.179 2.586 . . . . 0.0 116.429 -171.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 66.7 Cg_endo -75.05 -32.05 5.64 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 123.579 2.314 . . . . 0.0 110.077 -173.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.28 14.17 21.01 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.687 1.613 . . . . 0.0 114.282 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 44.7 59.59 3.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.277 1.831 . . . . 0.0 111.058 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.4 168.83 18.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.618 1.199 . . . . 0.0 112.127 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.84 163.11 12.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.96 2.104 . . . . 0.0 109.508 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 p -134.79 137.81 43.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 119.63 1.105 . . . . 0.0 112.052 166.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -117.07 113.35 22.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.992 2.517 . . . . 0.0 105.149 170.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -88.22 149.73 23.69 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -158.9 9.99 0.13 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.947 0.794 . . . . 0.0 112.92 169.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.93 -174.84 38.48 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 120.451 -1.406 . . . . 0.0 111.14 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.21 101.17 5.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -69.29 165.11 42.62 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 125.316 1.446 . . . . 0.0 111.095 -178.611 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.11 5.81 4.75 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.039 3.826 . . . . 0.0 114.121 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -134.31 72.46 1.47 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.71 -174.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.473 2.309 . . . . 0.0 106.537 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -156.11 -66.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -81.49 -44.72 17.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.175 1.39 . . . . 0.0 110.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -143.21 152.89 42.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.637 1.575 . . . . 0.0 108.541 -157.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.6 mt -81.9 81.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -169.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -75.09 143.48 77.4 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 108.231 170.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.9 174.65 12.23 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.646 2.897 . . . . 0.0 111.395 165.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.47 71.01 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -147.71 169.61 19.34 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.608 1.163 . . . . 0.0 107.905 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.67 80.81 0.43 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.952 1.251 . . . . 0.0 110.622 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.528 ' CG2' ' CZ ' ' A' ' 58' ' ' ARG . 2.7 m -77.55 170.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 1.1 p30 -84.47 152.21 24.12 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.307 -1.495 . . . . 0.0 112.031 169.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.685 HG23 ' HG2' ' A' ' 58' ' ' ARG . 15.5 t -84.62 112.38 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 152.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.418 HG22 ' CD2' ' A' ' 20' ' ' TYR . 26.6 pt -123.06 -18.28 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.123 0.569 . . . . 0.0 112.184 169.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' A' ' 16' ' ' LEU . . . -138.53 172.05 23.2 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 30.1 tptt -139.83 140.37 36.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.34 90.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -75.19 -34.2 30.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.075 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.55 157.74 43.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.69 1.196 . . . . 0.0 108.73 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 73.47 70.48 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 118.649 -1.739 . . . . 0.0 112.325 -176.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.35 -52.94 2.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 169.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -64.76 -28.6 69.69 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.906 -0.496 . . . . 0.0 111.599 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -71.38 -8.77 55.95 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.337 -0.852 . . . . 0.0 112.801 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -25.9 51.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.859 1.663 . . . . 0.0 113.003 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 5.98 6.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -174.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -129.76 9.97 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.941 2.496 . . . . 0.0 110.839 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.25 157.41 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 106.781 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -117.11 -165.02 1.03 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.765 1.226 . . . . 0.0 110.008 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.83 5.09 26.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.609 0.719 . . . . 0.0 112.644 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -172.16 80.81 0.08 OUTLIER Glycine 0 CA--C 1.523 0.56 0 O-C-N 120.83 -1.169 . . . . 0.0 110.926 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.56 22.45 10.63 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.005 1.722 . . . . 0.0 111.335 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 44.55 84.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.265 1.826 . . . . 0.0 112.918 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.41 129.02 37.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.73 107.87 19.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.08 126.5 36.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.613 2.365 . . . . 0.0 107.088 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -135.98 169.62 17.3 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.058 1.743 . . . . 0.0 109.744 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -77.32 -3.72 41.41 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.313 -0.979 0 C-N-CA 126.242 1.817 . . . . 0.0 113.435 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 160.28 33.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 110.513 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.4 t -149.79 142.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 113.008 -1.905 . . . . 0.0 108.546 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 32.0 tt0 -126.83 131.4 51.24 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 127.71 2.404 . . . . 0.0 107.018 -173.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.59 120.29 41.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.533 1.933 . . . . 0.0 107.229 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.99 137.13 48.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -130.28 -176.65 4.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.513 1.125 . . . . 0.0 109.783 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.71 -39.71 43.7 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.875 0.87 . . . . 0.0 109.71 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB2' HD13 ' A' ' 111' ' ' ILE . 9.5 m -93.33 -16.16 24.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.426 1.091 . . . . 0.0 112.587 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.53 -163.38 27.03 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.508 0.575 . . . . 0.0 112.882 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -160.87 146.27 14.41 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.206 1.402 . . . . 0.0 108.378 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.53 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 34.5 m -146.86 174.94 11.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.173 1.789 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -147.98 131.46 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.269 -1.519 . . . . 0.0 108.397 -170.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.48 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.04 -1.037 . . . . 0.0 109.983 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.14 119.54 39.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 116.899 -1.524 . . . . 0.0 107.641 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.494 HD23 ' CA ' ' A' ' 99' ' ' GLY . 83.3 mt -119.29 132.19 55.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.212 0.915 . . . . 0.0 111.012 -174.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -88.08 126.27 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.822 -168.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.35 34.64 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.822 1.649 . . . . 0.0 113.943 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -105.49 -9.48 17.46 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.527 -1.358 . . . . 0.0 110.815 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.34 144.2 34.54 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.603 1.561 . . . . 0.0 112.086 -170.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -56.67 -55.76 29.95 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.383 1.073 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 p -44.58 -40.29 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.504 1.522 . . . . 0.0 113.693 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.93 -44.18 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 120.911 1.687 . . . . 0.0 110.014 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -59.65 -38.36 81.22 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.181 0.992 . . . . 0.0 111.228 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.1 mt -72.09 -37.87 69.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.859 0.864 . . . . 0.0 109.689 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -32.52 73.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.853 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -32.96 64.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.158 0.89 . . . . 0.0 109.97 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.3 -13.77 61.99 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.743 0.817 . . . . 0.0 111.953 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -124.16 26.58 7.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.747 2.019 . . . . 0.0 110.833 -173.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -125.06 139.53 33.85 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.11 163.34 68.52 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 119.302 0.786 . . . . 0.0 112.375 -8.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -149.83 169.5 20.96 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.018 0.927 . . . . 0.0 109.473 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.98 155.69 37.76 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.9 170.1 18.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.513 0.673 . . . . 0.0 112.249 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.95 129.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.296 1.438 . . . . 0.0 108.11 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.513 HG13 HG23 ' A' ' 43' ' ' ILE . 21.0 t -83.31 76.08 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -68.96 159.39 32.81 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.2 p -140.0 163.51 32.48 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.832 0.853 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -164.3 101.91 0.84 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 47.17 62.87 3.6 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.992 165.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 52.05 78.94 0.11 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.528 2.331 . . . . 0.0 110.655 -159.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -162.23 150.84 14.99 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 161.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.513 HG23 HG13 ' A' ' 36' ' ' VAL . 55.2 mt -127.45 121.19 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 167.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -133.09 151.37 52.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.512 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.69 150.59 52.14 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -70.86 91.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.51 1.524 . . . . 0.0 109.542 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -62.39 146.66 93.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.988 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.35 -3.76 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.424 2.749 . . . . 0.0 111.992 172.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -76.41 163.62 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.269 1.428 . . . . 0.0 109.606 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -148.9 101.68 3.2 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.578 0.751 . . . . 0.0 109.624 170.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG22 ' H ' ' A' ' 53' ' ' LYS . 9.0 p -152.44 154.86 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.176 2.19 . . . . 0.0 108.348 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -128.83 13.95 6.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.648 1.179 . . . . 0.0 113.139 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 51' ' ' VAL . 15.4 tttt -75.37 125.13 28.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.287 1.835 . . . . 0.0 111.452 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.35 143.3 50.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.603 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -132.73 -30.84 1.38 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.244 1.017 . . . . 0.0 112.601 -169.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -120.13 61.82 8.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.54 150.95 41.36 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.087 1.858 . . . . 0.0 113.201 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -146.51 153.58 40.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.463 1.505 . . . . 0.0 109.773 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -105.44 7.04 32.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.207 1.403 . . . . 0.0 113.221 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.35 152.63 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 129.788 3.235 . . . . 0.0 108.086 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.0 m -147.48 175.14 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.302 1.841 . . . . 0.0 108.414 -167.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.15 169.35 10.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 122.32 1.057 . . . . 0.0 112.363 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 63' ' ' ILE . 44.9 mt -73.16 23.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 0.0 110.779 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.66 16.11 0.07 OUTLIER Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.305 0.955 . . . . 0.0 113.789 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -93.67 -177.22 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -138.34 149.91 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.228 1.011 . . . . 0.0 108.95 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.08 21.59 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 165.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.95 159.85 27.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.006 0.922 . . . . 0.0 108.981 166.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -127.61 85.62 60.38 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.406 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 89.3 Cg_endo -66.2 -28.06 48.34 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.069 1.846 . . . . 0.0 115.391 -174.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 55.4 Cg_endo -69.26 -23.61 32.9 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 123.087 2.138 . . . . 0.0 109.847 -172.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.17 27.47 6.69 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 117.791 -1.561 . . . . 0.0 113.674 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.78 36.9 4.17 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.505 2.153 . . . . 0.0 113.141 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.31 174.16 6.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.274 -1.516 . . . . 0.0 111.398 -167.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -90.77 -178.88 5.37 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.839 161.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 54.0 m -147.33 163.29 36.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.948 2.499 . . . . 0.0 107.441 157.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.22 121.94 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.62 114.3 27.87 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.859 1.264 . . . . 0.0 109.648 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -145.06 27.63 1.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.253 1.821 . . . . 0.0 113.789 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.97 -112.43 0.28 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 120.51 1.504 . . . . 0.0 115.142 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 120.62 2.89 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 129.225 3.01 . . . . 0.0 104.782 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 33.8 p -86.45 165.74 31.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.661 1.119 . . . . 0.0 111.275 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 73.1 Cg_endo -69.2 0.36 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.591 2.861 . . . . 0.0 113.932 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -95.08 -33.01 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.545 1.521 . . . . 0.0 111.967 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 t -79.99 -169.31 1.96 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 161.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.13 -49.13 0.32 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.76 -51.08 9.63 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 126.049 1.74 . . . . 0.0 112.853 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -137.02 -164.18 1.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.302 1.441 . . . . 0.0 109.021 -154.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.414 HD13 ' CG1' ' A' ' 63' ' ' ILE . 13.5 mt -110.28 67.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -172.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -82.32 142.33 46.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.205 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.2 177.21 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 125.158 3.905 . . . . 0.0 112.672 171.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.33 -29.43 68.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.98 -174.26 4.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.476 1.489 . . . . 0.0 109.973 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.03 98.69 0.31 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 m -92.9 -164.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.35 1.46 . . . . 0.0 107.728 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -138.62 125.21 20.72 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.67 48.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.921 0.888 . . . . 0.0 109.956 -170.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 pt -72.1 -12.96 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 120.181 -1.574 . . . . 0.0 112.8 -172.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.494 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -128.4 159.29 21.91 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 118.681 0.673 . . . . 0.0 111.578 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -124.81 141.78 51.88 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.3 mt -76.4 112.79 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 161.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -29.67 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 -165.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -144.42 160.23 41.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.313 2.245 . . . . 0.0 107.84 170.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 75.62 60.85 3.09 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 118.55 -1.786 . . . . 0.0 112.037 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -107.82 -36.93 6.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.593 0.711 . . . . 0.0 111.157 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.11 -36.19 48.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.2 6.07 3.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.197 0.999 . . . . 0.0 112.96 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 74.0 mt -86.75 -37.17 18.13 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 111.451 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -4.62 16.78 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.719 -1.238 . . . . 0.0 113.123 -172.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -100.81 -0.95 36.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.25 1.42 . . . . 0.0 112.67 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.48 HD13 ' HB2' ' A' ' 9' ' ' SER . 22.9 mm -80.31 162.37 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.537 0.735 . . . . 0.0 110.635 -167.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -118.31 169.4 9.76 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 127.291 2.236 . . . . 0.0 111.248 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.69 20.67 1.7 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.551 2.34 . . . . 0.0 113.702 -172.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.79 64.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.467 ' H ' ' HB ' ' A' ' 36' ' ' VAL . 6.7 pt-20 -114.37 30.5 7.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -174.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.84 85.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.685 1.594 . . . . 0.0 112.881 171.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 133.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.24 116.01 31.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 164.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -88.37 127.61 41.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 107.39 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -132.53 -179.2 5.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.993 1.717 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -79.25 -3.69 47.08 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.842 0 C-N-CA 125.318 1.447 . . . . 0.0 110.349 -163.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ttp . . . . . 0 CA--C 1.509 -0.602 0 CA-C-O 122.403 1.097 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -71.53 163.25 28.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.363 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.35 113.33 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 5.3 tt0 -86.91 137.85 32.04 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.075 -1.015 . . . . 0.0 108.41 -175.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.3 mt -115.8 97.9 6.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.705 0.684 . . . . 0.0 110.196 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 148.08 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.416 1.087 . . . . 0.0 109.246 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -135.64 178.83 6.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.232 1.413 . . . . 0.0 108.86 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.59 -16.61 57.2 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.932 0.893 . . . . 0.0 111.937 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -124.26 0.48 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.753 0.821 . . . . 0.0 111.292 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.08 -174.25 43.34 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 124.556 1.074 . . . . 0.0 111.429 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -163.04 149.68 12.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.726 1.21 . . . . 0.0 108.47 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.447 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 1.4 p -137.28 -177.2 4.67 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 125.877 2.751 . . . . 0.0 105.101 171.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 4' ' ' GLU 0.258 3.8 p -136.75 164.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 110.275 -3.148 . . . . 0.0 105.869 167.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 pt -135.91 121.29 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 125.47 1.508 . . . . 0.0 107.252 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.94 117.13 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 115.325 -2.274 . . . . 0.0 110.044 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt -121.03 143.3 49.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.652 2.024 . . . . 0.0 112.649 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -89.54 140.86 29.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 111.315 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.34 8.69 3.16 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -91.7 9.93 30.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.663 -1.898 . . . . 0.0 110.479 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.22 133.34 55.16 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.745 1.618 . . . . 0.0 109.279 -170.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -48.52 -49.84 34.43 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.791 1.636 . . . . 0.0 109.888 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.658 ' HB ' HG21 ' A' ' 51' ' ' VAL . 7.2 p -56.89 -37.3 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 117.673 -1.155 . . . . 0.0 111.5 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t -72.1 -43.75 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 120.315 1.416 . . . . 0.0 109.232 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -59.71 -33.1 71.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.659 0.784 . . . . 0.0 111.827 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.405 HD12 ' CG1' ' A' ' 51' ' ' VAL . 18.7 mt -84.93 -37.19 20.84 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.914 0.886 . . . . 0.0 110.769 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mt -57.03 -35.63 69.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.151 0.98 . . . . 0.0 110.225 172.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -58.5 -30.82 67.31 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 119.291 0.95 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.292 1.037 . . . . 0.0 110.973 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.52 26.24 4.75 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.624 1.569 . . . . 0.0 110.347 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.41 HG23 ' HA ' ' A' ' 31' ' ' PRO . 76.2 mt -126.46 146.59 57.09 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HA ' HG23 ' A' ' 30' ' ' ILE . 10.2 Cg_endo -59.55 157.76 41.91 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 CA-C-N 119.44 0.836 . . . . 0.0 111.646 -12.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -148.77 150.22 32.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -105.02 156.63 17.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.32 175.55 11.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG22 ' C ' ' A' ' 36' ' ' VAL . 2.4 p -55.07 165.95 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.4 1.88 . . . . 0.0 111.204 157.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.598 HG13 HG23 ' A' ' 43' ' ' ILE . 38.0 t -117.51 123.91 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 144.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -106.11 164.68 11.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 162.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.7 p -136.24 151.15 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.427 -0.796 . . . . 0.0 109.66 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -149.98 83.75 1.39 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.965 0.802 . . . . 0.0 108.99 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 57.91 69.48 1.26 Allowed Glycine 0 C--O 1.213 -1.195 0 O-C-N 121.215 -0.928 . . . . 0.0 113.569 170.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.265 6.1 mt-10 65.98 35.64 6.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 127.984 2.514 . . . . 0.0 112.531 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.83 152.45 46.51 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.443 1.897 . . . . 0.0 108.373 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.598 HG23 HG13 ' A' ' 36' ' ' VAL . 9.6 mt -113.84 139.66 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 159.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -136.06 160.22 39.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.34 157.83 42.99 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.32 -0.862 . . . . 0.0 110.317 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -87.91 94.7 9.85 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 p -63.15 151.36 86.77 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.0 -26.58 9.24 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.026 2.484 . . . . 0.0 111.374 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -83.15 146.23 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.163 1.385 . . . . 0.0 107.851 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -133.08 133.57 43.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.658 HG21 ' HB ' ' A' ' 22' ' ' VAL . 5.6 m -141.34 179.15 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.807 2.443 . . . . 0.0 107.66 170.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.82 13.81 3.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.839 0.856 . . . . 0.0 112.311 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -92.8 128.6 38.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 113.116 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.575 ' HA ' HD22 ' A' ' 96' ' ' ASN . 0.0 OUTLIER -133.98 106.18 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.201 1.8 . . . . 0.0 112.805 175.445 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -79.9 -13.94 59.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.585 1.954 . . . . 0.0 114.085 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -139.32 68.43 39.71 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 119.595 1.089 . . . . 0.0 109.878 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.79 107.97 2.46 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.628 2.219 . . . . 0.0 109.772 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -112.97 140.69 47.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 109.582 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 26.2 mt-10 -89.99 9.27 28.54 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.697 0.799 . . . . 0.0 112.105 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.55 154.16 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 127.555 2.342 . . . . 0.0 109.821 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -143.38 -175.57 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 127.389 2.276 . . . . 0.0 107.861 -172.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -106.05 173.39 6.33 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.0 111.469 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 63' ' ' ILE . 22.3 mt -71.62 11.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.977 2.111 . . . . 0.0 112.238 177.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.06 34.18 0.44 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 124.93 1.252 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -109.86 -177.93 3.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.31 164.65 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -146.23 170.33 27.37 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 167.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 143.49 48.28 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 167.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.26 85.87 42.52 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 125.249 1.419 . . . . 0.0 107.414 -174.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.42 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 54.7 Cg_endo -60.62 -35.33 90.2 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.286 1.324 . . . . 0.0 115.037 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 59.5 Cg_endo -72.57 -32.91 9.15 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 CA-C-N 122.785 2.031 . . . . 0.0 109.939 -168.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.19 23.01 17.08 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.682 -1.621 . . . . 0.0 113.295 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt 44.64 63.97 1.51 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.107 1.763 . . . . 0.0 111.555 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.65 157.17 44.32 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.35 0.595 . . . . 0.0 111.995 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 177.39 8.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.536 158.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.3 m -150.14 155.85 40.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.378 1.471 . . . . 0.0 108.474 161.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.0 mt -145.97 108.56 4.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.924 2.09 . . . . 0.0 107.5 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -99.4 112.91 25.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.221 0.608 . . . . 0.0 110.176 -168.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -138.77 28.86 2.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.637 1.175 . . . . 0.0 113.915 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.64 52.07 0.02 OUTLIER Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.83 -1.169 . . . . 0.0 114.282 153.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttm 71.6 175.97 0.28 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.053 2.141 . . . . 0.0 109.534 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.6 OUTLIER -153.3 159.31 32.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -165.186 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.55 6.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.548 4.165 . . . . 0.0 114.394 -172.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.44 44.93 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.681 1.592 . . . . 0.0 107.871 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -162.61 -179.51 6.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.353 2.261 . . . . 0.0 107.083 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -144.17 -39.9 0.28 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 165.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -89.17 -38.65 14.12 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.323 1.059 . . . . 0.0 111.413 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.76 -164.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 128.027 2.531 . . . . 0.0 107.374 -161.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.06 74.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 120.187 1.358 . . . . 0.0 107.614 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.91 143.47 62.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HG2' ' H ' ' A' ' 94' ' ' ALA . 89.1 Cg_endo -89.32 175.88 3.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.436 3.424 . . . . 0.0 110.715 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.8 -16.88 62.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -169.07 15.41 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -165.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.512 ' H ' ' HG2' ' A' ' 91' ' ' PRO . . . 69.19 82.0 0.17 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.016 1.726 . . . . 0.0 109.102 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.5 -169.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 113.626 -1.624 . . . . 0.0 108.841 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.575 HD22 ' HA ' ' A' ' 54' ' ' MET . 52.6 t-20 -128.32 125.31 38.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.07 45.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.117 0.967 . . . . 0.0 110.112 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 pt -59.18 -14.95 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 117.885 -1.055 . . . . 0.0 113.262 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -129.16 162.04 22.6 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.744 0.688 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -129.42 135.27 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 108.154 167.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.26 85.14 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 13' ' ' VAL . 35.7 m -68.48 -47.74 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.27 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.416 ' H ' HG12 ' A' ' 13' ' ' VAL . 37.7 mt-10 -124.66 159.11 31.55 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.908 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 12' ' ' CYS . . . 65.44 74.33 0.51 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 125.961 2.038 . . . . 0.0 112.471 -176.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -107.39 -48.74 3.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.992 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -90.0 -10.78 43.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.565 0.746 . . . . 0.0 111.877 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.79 -12.62 59.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 112.051 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.37 -21.46 63.8 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 119.033 -2.292 . . . . 0.0 112.422 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -10.06 59.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 171.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -77.65 -26.36 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.796 -1.19 . . . . 0.0 111.093 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 mm -77.3 157.18 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -172.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -116.79 170.14 8.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.537 1.535 . . . . 0.0 109.526 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.91 32.23 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.647 2.379 . . . . 0.0 112.569 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.86 63.9 0.03 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.541 -1.144 . . . . 0.0 110.836 172.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -118.79 13.82 13.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp 47.43 155.14 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -160.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.97 159.44 31.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.865 1.266 . . . . 0.0 107.85 164.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.13 97.6 4.83 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.724 2.809 . . . . 0.0 105.954 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.0 t -82.01 134.72 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.289 1.436 . . . . 0.0 108.095 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -140.46 -170.1 2.92 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.583 1.953 . . . . 0.0 109.141 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 30' ' ' ILE . 41.6 m-85 -98.79 5.25 47.61 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.153 0 C-N-CA 127.224 2.21 . . . . 0.0 112.006 175.436 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttp . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -63.3 162.78 11.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.976 0.893 . . . . 0.0 109.316 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.67 135.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 127.563 2.345 . . . . 0.0 105.332 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 35.4 tt0 -112.78 141.03 47.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.95 120.97 40.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.559 1.944 . . . . 0.0 107.327 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.43 110.91 15.11 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.287 1.435 . . . . 0.0 107.933 -173.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -108.33 167.83 9.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 110.431 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.49 -13.73 62.52 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -115.97 -9.44 11.76 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 -166.34 35.07 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 121.621 2.009 . . . . 0.0 111.326 -168.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.8 149.23 7.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.241 1.521 . . . . 0.0 110.545 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.524 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 65.5 m -149.59 176.15 10.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.629 1.972 . . . . 0.0 109.343 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -140.1 145.75 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 122.522 1.153 . . . . 0.0 108.246 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.68 150.03 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 125.303 1.441 . . . . 0.0 107.302 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.58 121.54 43.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.413 1.885 . . . . 0.0 108.395 -171.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -127.79 124.55 37.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 122.432 1.11 . . . . 0.0 111.312 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.56 122.03 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.401 1.481 . . . . 0.0 111.002 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.4 33.03 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.586 172.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -101.42 -9.13 21.39 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 120.512 -1.367 . . . . 0.0 111.247 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -107.91 138.7 43.7 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.535 0.734 . . . . 0.0 110.101 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.26 -51.12 57.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.845 1.658 . . . . 0.0 112.114 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.87 -26.53 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.497 1.119 . . . . 0.0 112.588 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.63 -47.37 20.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.531 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.97 -36.78 75.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.046 0.538 . . . . 0.0 109.946 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.37 -20.92 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.591 1.156 . . . . 0.0 112.16 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.71 -30.28 62.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.829 1.252 . . . . 0.0 111.093 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -59.79 -23.64 63.46 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.582 0.628 . . . . 0.0 110.558 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -70.5 -16.5 62.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.095 1.358 . . . . 0.0 113.544 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -131.73 39.1 3.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.421 1.488 . . . . 0.0 109.515 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.45 141.98 35.66 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.77 154.85 72.41 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 119.629 0.903 . . . . 0.0 110.521 -7.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CE1' HG11 ' A' ' 119' ' ' VAL . 24.7 p90 -145.1 160.87 40.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.528 0.331 . . . . 0.0 110.275 171.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.95 149.0 49.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 165.55 32.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.3 t -86.58 133.0 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.41 HG13 HG23 ' A' ' 43' ' ' ILE . 13.5 t -81.85 72.68 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -68.38 150.98 47.51 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 p -129.3 157.86 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.731 0.812 . . . . 0.0 110.027 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -156.02 89.83 1.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.77 74.32 0.23 Allowed Glycine 0 C--O 1.213 -1.168 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.396 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 69.03 26.43 5.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.943 1.371 . . . . 0.0 113.189 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.36 152.01 51.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.338 1.855 . . . . 0.0 108.741 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 36' ' ' VAL . 17.4 mt -133.57 135.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -147.69 155.37 41.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -140.24 146.21 38.34 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.413 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -85.7 78.68 9.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.528 1.131 . . . . 0.0 108.389 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -56.91 147.89 51.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 111.661 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 -15.66 21.7 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.993 2.462 . . . . 0.0 112.972 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.8 t -76.49 148.02 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.223 0.919 . . . . 0.0 109.372 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -127.46 99.75 5.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.561 0.744 . . . . 0.0 109.26 173.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.5 t -135.1 153.1 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 70' ' ' PRO . 14.2 mt-30 -131.69 0.75 3.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.357 1.063 . . . . 0.0 113.486 175.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.93 120.57 23.72 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.557 1.143 . . . . 0.0 109.085 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.2 mtt -95.92 135.47 37.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -96.75 -28.39 14.31 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.766 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -146.53 71.26 12.85 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.448 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.93 135.04 39.46 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.716 1.611 . . . . 0.0 110.657 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -108.89 -176.48 3.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 164.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -127.72 7.11 6.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.779 0.831 . . . . 0.0 112.844 166.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.41 153.8 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 129.631 3.172 . . . . 0.0 108.267 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.15 170.96 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.173 1.389 . . . . 0.0 109.534 -170.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.43 161.15 20.43 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.377 -0.827 . . . . 0.0 110.361 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.66 74.26 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 166.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.59 8.46 0.06 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.684 -1.065 . . . . 0.0 113.912 -169.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -111.3 173.01 6.55 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.734 1.767 . . . . 0.0 110.361 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.53 131.04 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.731 1.212 . . . . 0.0 108.402 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.49 158.9 14.56 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.881 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.69 135.8 46.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -104.83 87.69 1.95 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 126.657 1.983 . . . . 0.0 109.552 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 59.4 Cg_endo -63.18 -41.61 26.9 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.498 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 73.3 Cg_endo -73.75 -27.15 12.84 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.55 2.167 . . . . 0.0 110.735 -162.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.13 25.92 7.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.098 1.809 . . . . 0.0 112.43 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt 43.35 65.54 0.96 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.865 1.666 . . . . 0.0 111.826 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.68 177.29 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.843 0.457 . . . . 0.0 111.792 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.557 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 2.2 tp -98.44 -177.37 3.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 110.419 167.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 30.7 m -152.87 146.01 24.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.804 1.638 . . . . 0.0 112.371 154.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.265 6.9 mp -114.9 121.83 44.4 Favored 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.342 4.257 . . . . 0.0 106.634 169.815 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -110.64 113.69 26.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.23 0.923 . . . . 0.0 109.129 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 108' ' ' LEU . 42.6 p90 -136.51 35.55 2.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.16 -127.14 0.88 Allowed Glycine 0 C--O 1.225 -0.453 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 163.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -110.85 -15.1 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.074 0.937 . . . . 0.0 112.745 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 83' ' ' PRO 0.256 11.2 p 57.03 165.56 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 128.553 2.741 . . . . 0.0 112.464 175.305 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 60.2 Cg_endo -77.91 -28.44 5.05 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.665 1.577 . . . . 0.0 114.215 -165.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.9 mmt -94.41 70.43 3.69 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -157.44 171.49 20.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.756 0.822 . . . . 0.0 109.421 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -143.72 -46.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 156.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -77.16 -56.88 4.18 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.042 0.937 . . . . 0.0 110.035 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 160.03 43.68 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.091 1.356 . . . . 0.0 108.991 -150.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.7 75.79 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 123.937 0.895 . . . . 0.0 109.077 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -75.35 144.09 77.54 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.455 160.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.71 -176.35 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.355 3.37 . . . . 0.0 111.891 171.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.82 74.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.023 169.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.3 t -164.71 170.04 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.847 1.659 . . . . 0.0 107.952 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.48 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.202 1.401 . . . . 0.0 110.742 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 m -102.44 152.64 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -74.21 168.85 18.79 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.637 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.1 t -120.15 44.24 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 123.194 1.473 . . . . 0.0 108.452 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.0 pt -72.24 -18.11 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.582 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.66 159.5 13.78 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.298 0.951 . . . . 0.0 111.404 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -130.27 143.13 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 0.0 107.551 172.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.82 105.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.17 -29.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -163.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.63 163.51 32.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 125.876 1.67 . . . . 0.0 106.574 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.524 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 71.36 64.62 2.69 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 117.778 -2.154 . . . . 0.0 111.457 172.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.2 tp -91.87 -45.99 8.09 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.052 0.926 . . . . 0.0 109.474 164.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -79.93 -20.97 44.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.184 -0.947 . . . . 0.0 112.183 -166.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.7 3.92 17.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.217 1.007 . . . . 0.0 111.381 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 79' ' ' PHE . 6.1 mp -76.8 -43.5 36.41 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.786 1.175 . . . . 0.0 111.277 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -66.12 -24.3 66.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.309 -1.494 . . . . 0.0 113.662 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -78.25 -11.07 59.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.733 1.613 . . . . 0.0 114.208 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 mm -77.67 166.85 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.655 1.116 . . . . 0.0 109.045 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.591 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 8.0 mmtp -118.55 -179.48 3.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.16 1.784 . . . . 0.0 107.803 177.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.14 9.42 3.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.948 1.299 . . . . 0.0 114.467 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.17 72.9 0.14 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 120.636 -1.29 . . . . 0.0 110.548 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.591 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 21.7 mm-40 -132.24 33.48 3.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.984 0.914 . . . . 0.0 111.599 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 43.41 74.14 0.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.969 1.707 . . . . 0.0 111.57 160.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.08 120.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.66 128.73 34.75 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.549 HG11 ' CE1' ' A' ' 32' ' ' PHE . 63.9 t -111.16 124.73 68.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 127.058 2.143 . . . . 0.0 106.014 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.26 168.39 19.85 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.822 1.649 . . . . 0.0 110.66 -171.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.81 -7.15 58.51 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.314 -0.959 0 C-N-CA 127.116 2.166 . . . . 0.0 111.711 -171.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 CA--C 1.503 -0.831 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.51 ' CB ' HH11 ' A' ' 2' ' ' ARG . 0.0 OUTLIER -66.62 148.87 51.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.6 t -151.63 147.25 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.914 2.085 . . . . 0.0 109.605 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 11.4 tt0 -134.6 136.67 43.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.751 2.021 . . . . 0.0 107.636 -175.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.58 100.32 7.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.953 2.501 . . . . 0.0 106.596 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.28 100.42 13.22 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.69 175.53 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.879 0.871 . . . . 0.0 108.869 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.28 -35.58 76.19 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 166.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -91.27 -14.88 30.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -172.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.38 -167.06 33.98 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -155.77 145.93 21.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 168.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.89 166.33 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.656 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.16 104.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -162.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.0 pt -120.55 160.38 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.92 1.288 . . . . 0.0 109.806 -166.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -140.56 139.43 34.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -128.93 124.49 35.27 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.201 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.73 137.36 51.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.18 -166.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -81.93 35.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.066 1.346 . . . . 0.0 111.983 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -119.66 3.78 11.13 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.245 2.218 . . . . 0.0 111.919 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -120.28 137.72 54.08 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.545 1.138 . . . . 0.0 109.94 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -44.0 -65.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.534 2.334 . . . . 0.0 107.739 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 68' ' ' TYR . 7.3 p -48.54 -38.16 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.25 -43.35 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.052 1.296 . . . . 0.0 109.427 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -62.78 -38.25 89.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 120.913 -1.117 . . . . 0.0 111.602 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -44.0 69.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mt -51.17 -43.79 61.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -54.31 -23.41 15.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.995 0.816 . . . . 0.0 112.43 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.37 -30.98 17.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.58 0.627 . . . . 0.0 110.84 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.6 -40.23 64.01 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.866 1.266 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.2 140.73 98.0 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.859 1.263 . . . . 0.0 108.699 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.74 149.26 93.8 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.139 0.728 . . . . 0.0 112.594 -9.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.64 176.48 10.05 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.977 1.311 . . . . 0.0 110.103 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -133.17 166.86 21.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.514 1.126 . . . . 0.0 109.314 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -165.06 -177.96 4.89 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.4 129.07 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 C-N-CA 125.981 1.712 . . . . 0.0 107.387 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.466 HG13 HG23 ' A' ' 43' ' ' ILE . 2.5 t -69.5 117.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -102.79 156.89 17.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 160.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -144.93 137.34 26.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.211 0.604 . . . . 0.0 109.596 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -148.93 98.44 2.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -165.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 50.49 45.53 46.25 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 78.01 27.57 0.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 130.787 3.635 . . . . 0.0 114.543 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -108.93 160.71 15.79 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.67 1.588 . . . . 0.0 110.257 161.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.466 HG23 HG13 ' A' ' 36' ' ' VAL . 14.6 mt -128.8 134.99 63.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.689 1.996 . . . . 0.0 105.846 165.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.43 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 49.4 p90 -142.11 168.22 20.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.201 0.6 . . . . 0.0 110.78 164.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.8 154.99 36.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.36 76.99 10.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.549 1.14 . . . . 0.0 111.433 -167.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.7 p -60.04 150.47 70.0 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.088 0.955 . . . . 0.0 112.053 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.1 -6.18 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.526 3.484 . . . . 0.0 113.303 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 p -112.34 113.11 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 125.196 1.398 . . . . 0.0 107.998 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.77 103.73 7.22 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.513 1.925 . . . . 0.0 109.438 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.24 154.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.424 2.29 . . . . 0.0 107.879 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -108.75 7.28 26.28 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.302 -0.874 . . . . 0.0 112.483 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -86.42 136.21 33.2 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.353 0.661 . . . . 0.0 109.495 171.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.47 175.46 5.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.932 2.093 . . . . 0.0 109.854 163.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.46 -35.53 1.73 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.795 1.238 . . . . 0.0 110.382 163.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -137.82 65.1 45.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 109.029 -171.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.76 138.53 23.79 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.522 2.148 . . . . 0.0 110.746 171.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -126.45 154.46 43.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.34 -0.85 . . . . 0.0 111.333 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -95.45 6.02 50.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.331 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.19 150.05 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.168 2.987 . . . . 0.0 109.894 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.08 178.35 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 127.784 2.434 . . . . 0.0 108.038 -170.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -102.26 173.47 6.35 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.106 0.962 . . . . 0.0 112.313 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.08 74.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 165.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.49 29.19 0.17 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.885 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -104.23 175.73 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.16 1.98 . . . . 0.0 109.057 167.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.1 117.94 45.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 108.417 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.76 171.64 26.4 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.891 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 22' ' ' VAL . 61.7 t80 -129.28 123.36 31.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -114.18 85.92 11.03 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.561 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 36.8 Cg_endo -61.46 -33.75 87.47 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.392 2.728 . . . . 0.0 117.072 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.561 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 1.9 Cg_endo -63.46 -52.29 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.841 2.361 . . . . 0.0 109.439 -168.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.74 -6.54 87.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.578 -1.124 . . . . 0.0 114.321 174.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 47.04 90.8 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.158 2.583 . . . . 0.0 113.508 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 44' ' ' TYR . . . -160.32 166.71 28.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.212 0.529 . . . . 0.0 112.407 169.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tp -63.39 178.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.013 0.925 . . . . 0.0 110.314 160.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 32.9 m -150.58 143.7 24.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.699 2.0 . . . . 0.0 108.23 158.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 mt -125.38 135.99 52.98 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.522 2.329 . . . . 0.0 105.67 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.5 105.87 12.1 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.967 0.907 . . . . 0.0 109.299 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -136.13 23.11 3.27 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.82 -140.38 2.86 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 120.277 -1.514 . . . . 0.0 112.449 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.79 90.69 2.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -74.63 159.33 83.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 127.701 2.4 . . . . 0.0 110.8 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.22 72.36 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.344 3.363 . . . . 0.0 113.437 -166.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.64 20.85 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.997 -1.065 . . . . 0.0 112.396 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -152.42 -162.61 1.54 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.714 1.206 . . . . 0.0 108.628 -171.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -43.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.336 1.454 . . . . 0.0 109.053 160.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.47 -55.3 6.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.536 0.684 . . . . 0.0 110.698 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -138.1 -165.1 1.74 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.954 1.702 . . . . 0.0 109.595 -160.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 mt -100.62 77.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.683 1.128 . . . . 0.0 108.47 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -77.75 142.94 66.3 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.47 -0.769 . . . . 0.0 109.415 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.73 177.43 5.55 Favored 'Trans proline' 0 C--N 1.347 0.494 1 C-N-CA 125.539 4.159 . . . . 0.0 113.423 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.06 -19.69 64.63 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -172.32 176.52 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.465 2.306 . . . . 0.0 106.331 158.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.72 86.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.311 0.959 . . . . 0.0 112.812 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -69.11 136.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.995 0.918 . . . . 0.0 109.052 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -58.85 111.42 1.28 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 164.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.81 63.88 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 pt -72.84 -21.12 19.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 118.646 -0.693 . . . . 0.0 112.221 -170.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.19 -177.5 16.48 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.114 0.841 . . . . 0.0 114.325 -170.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -140.43 134.55 30.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.522 1.529 . . . . 0.0 109.442 -170.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 92.5 mt -81.07 87.58 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 165.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.5 -35.54 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 118.174 -0.917 . . . . 0.0 108.683 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.35 160.69 40.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.974 0.806 . . . . 0.0 111.7 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.95 74.61 0.35 Allowed Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.213 1.387 . . . . 0.0 110.897 -167.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.44 -63.24 1.28 Allowed 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.45 -22.11 60.28 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.997 -1.064 . . . . 0.0 111.689 -163.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -14.49 59.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 111.667 170.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.38 -31.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.224 -1.548 . . . . 0.0 110.726 169.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -77.55 34.5 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.834 1.254 . . . . 0.0 112.907 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 -16.71 0.84 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.381 -1.449 . . . . 0.0 111.415 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 mm -74.09 154.69 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -113.05 -178.39 3.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.676 0.79 . . . . 0.0 109.441 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -74.19 38.57 0.11 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.738 2.015 . . . . 0.0 111.898 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 151.8 79.9 0.03 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.832 1.206 . . . . 0.0 111.067 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -138.06 29.87 2.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.55 1.54 . . . . 0.0 110.834 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.54 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 128.595 2.758 . . . . 0.0 115.064 -170.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.53 137.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 161.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 104.73 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.942 1.697 . . . . 0.0 106.808 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.67 124.24 50.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 127.443 2.297 . . . . 0.0 106.931 -161.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -138.12 177.0 8.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.647 1.979 . . . . 0.0 110.775 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.96 -6.78 55.51 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.314 -0.947 0 C-N-CA 125.262 1.425 . . . . 0.0 112.922 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttm . . . . . 0 CA--C 1.509 -0.626 0 CA-C-O 121.953 0.882 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -99.89 163.85 12.27 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.539 0.735 . . . . 0.0 109.198 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.3 t -148.47 129.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 2.7 tt0 -111.7 129.26 56.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.121 -1.612 . . . . 0.0 110.509 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -103.44 96.09 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.121 0.962 . . . . 0.0 111.934 174.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.6 142.24 28.41 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 109.057 168.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.51 173.25 11.04 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.751 1.62 . . . . 0.0 110.09 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.45 -27.04 66.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.866 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 m -113.35 0.4 14.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.08 -165.93 37.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 119.793 1.179 . . . . 0.0 111.426 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -162.84 143.85 9.8 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.581 ' CB ' ' HA3' ' A' ' 104' ' ' GLY 0.258 11.8 m -152.54 154.22 35.0 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 3.9 p -122.06 164.97 18.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.485 ' CD1' HD21 ' A' ' 16' ' ' LEU . 1.6 pp -135.59 158.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 166.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -123.71 133.09 53.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 117.648 -1.167 . . . . 0.0 110.537 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 14' ' ' ILE . 81.0 mt -117.32 156.49 27.75 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.758 1.623 . . . . 0.0 111.484 -172.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.631 ' O ' HG21 ' A' ' 23' ' ' VAL . 6.9 t-20 -105.72 118.08 35.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.756 -1.116 . . . . 0.0 108.741 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.61 16.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.18 2.192 . . . . 0.0 115.486 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -102.53 8.2 39.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.443 1.897 . . . . 0.0 110.29 -169.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.624 ' HB2' HG23 ' A' ' 23' ' ' VAL . 54.8 m-85 -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.565 1.146 . . . . 0.0 109.13 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.12 -45.95 53.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.759 1.624 . . . . 0.0 109.116 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.19 -22.57 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 112.557 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 17' ' ' ASN . 3.1 t -81.01 -51.75 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 120.354 1.434 . . . . 0.0 108.009 175.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -57.7 -27.6 63.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.724 1.209 . . . . 0.0 110.496 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.547 HD12 HG11 ' A' ' 51' ' ' VAL . 32.8 mt -92.94 -34.85 13.61 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.835 1.654 . . . . 0.0 111.695 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 49' ' ' VAL . 2.6 mt -61.36 -35.71 78.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 120.141 1.337 . . . . 0.0 110.509 171.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -34.03 51.19 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.893 0.877 . . . . 0.0 110.735 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.98 -15.63 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -120.57 0.82 10.54 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.837 0.855 . . . . 0.0 113.071 -166.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.1 mt -99.28 145.31 29.82 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.235 1.38 . . . . 0.0 108.631 -173.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.26 159.53 81.05 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 CA-C-N 119.039 0.693 . . . . 0.0 113.34 -12.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -148.65 159.76 43.8 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.773 1.229 . . . . 0.0 109.244 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -114.61 159.53 20.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.448 1.099 . . . . 0.0 109.709 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -161.92 172.59 15.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.058 -170.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.32 132.89 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.25 73.16 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -68.64 147.24 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -123.48 136.15 54.43 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.921 0.888 . . . . 0.0 109.449 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' A' ' 92' ' ' ALA . 37.1 t90 -144.82 96.81 2.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 45.02 71.84 0.43 Allowed Glycine 0 C--O 1.211 -1.325 0 O-C-N 124.258 0.974 . . . . 0.0 112.266 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 60.74 31.44 20.11 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.639 1.22 . . . . 0.0 111.792 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -123.73 155.22 38.26 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.82 2.448 . . . . 0.0 108.594 161.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.9 mm -115.47 147.91 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 158.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -144.95 169.34 18.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.111 0.957 . . . . 0.0 108.565 161.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.24 148.24 33.29 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -80.11 77.91 6.79 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 109.537 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -59.73 150.37 67.78 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 122.093 0.949 . . . . 0.0 111.855 -171.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -68.33 -12.24 34.36 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.804 2.336 . . . . 0.0 112.246 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG21 ' HG ' ' A' ' 26' ' ' LEU . 5.7 t -96.77 122.59 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.862 1.665 . . . . 0.0 109.835 -172.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -128.06 30.76 5.19 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.074 1.349 . . . . 0.0 114.003 -167.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG11 HD12 ' A' ' 25' ' ' LEU . 10.6 m -72.65 164.46 3.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.124 1.37 . . . . 0.0 109.731 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -139.51 33.21 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.628 0.771 . . . . 0.0 111.217 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -85.87 148.69 25.68 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.646 0.778 . . . . 0.0 109.177 166.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.88 158.67 44.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 167.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.18 -20.85 1.88 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.773 171.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -117.45 57.11 2.1 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 120.696 1.589 . . . . 0.0 111.819 171.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.66 134.46 35.31 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.065 1.843 . . . . 0.0 112.717 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.474 ' HD2' ' C ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -138.52 169.72 17.29 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.881 0.848 . . . . 0.0 112.714 172.108 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -122.88 9.21 9.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.263 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' C ' ' HD2' ' A' ' 58' ' ' ARG . 1.6 p -159.99 101.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 125.349 1.46 . . . . 0.0 114.817 174.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 78' ' ' PHE . 31.5 m -100.16 -177.92 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 127.358 2.263 . . . . 0.0 110.137 -168.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -90.09 171.95 9.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.724 -1.235 . . . . 0.0 111.294 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.21 -9.55 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.507 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.31 26.38 2.0 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 125.658 1.599 . . . . 0.0 111.748 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -83.01 -154.86 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 160.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.8 t -137.62 173.89 12.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 130.107 3.363 . . . . 0.0 104.701 162.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.02 154.37 25.87 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 146.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 150.25 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -119.98 87.87 39.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.92 -43.67 56.06 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 121.582 1.521 . . . . 0.0 114.972 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.62 -1.44 11.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.084 2.523 . . . . 0.0 114.902 -155.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.26 5.16 5.98 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 127.01 2.243 . . . . 0.0 112.78 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 55.08 78.16 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.746 2.018 . . . . 0.0 111.942 -167.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.27 176.9 11.12 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.243 0.617 . . . . 0.0 111.893 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.533 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 4.9 tp -90.09 -172.79 3.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.211 1.405 . . . . 0.0 109.919 158.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.533 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 66.8 m -146.85 151.13 36.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.66 3.184 . . . . 0.0 107.734 160.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.37 96.04 3.64 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.547 2.339 . . . . 0.0 105.093 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 61' ' ' VAL . 1.8 m-85 -82.11 132.09 35.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 172.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -147.47 16.08 1.14 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.41 -82.49 0.04 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 165.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -151.39 -13.71 0.21 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 57.43 166.71 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.193 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 -1.06 8.01 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.681 2.254 . . . . 0.0 113.241 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.16 39.39 2.44 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.597 1.159 . . . . 0.0 109.299 -169.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -136.24 178.9 6.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.789 1.636 . . . . 0.0 108.617 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -138.47 -47.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 165.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.512 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 26.4 t0 -118.97 -13.39 9.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -163.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 87' ' ' ASP . 3.2 pttt -167.64 164.49 14.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.758 1.623 . . . . 0.0 109.221 -166.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.0 mp -81.65 77.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 122.798 1.285 . . . . 0.0 108.739 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -69.98 144.68 93.29 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.455 163.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.44 -174.46 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.847 3.698 . . . . 0.0 111.329 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HB2' ' CH2' ' A' ' 39' ' ' TRP . . . -85.71 -11.54 53.42 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 t -166.37 170.21 13.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 167.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.51 98.5 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.793 0.837 . . . . 0.0 110.62 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.84 -178.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.736 1.214 . . . . 0.0 109.43 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -130.95 118.9 21.33 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG21 ' NE ' ' A' ' 58' ' ' ARG . 21.4 t -76.72 47.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 123.025 1.393 . . . . 0.0 112.63 -171.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.55 -28.71 37.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 126.874 2.069 . . . . 0.0 113.841 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.421 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -128.57 168.16 20.5 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.184 1.849 . . . . 0.0 112.341 -174.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -141.95 129.05 20.87 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.665 1.986 . . . . 0.0 108.252 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.9 mt -65.08 103.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 164.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 13' ' ' VAL . 33.4 m -75.47 -61.9 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 165.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.451 ' HB2' HG12 ' A' ' 13' ' ' VAL . 6.6 mt-10 -113.03 158.31 20.47 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 88.62 61.61 1.44 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.403 176.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.53 -20.66 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.05 -33.09 7.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.269 1.027 . . . . 0.0 108.671 -173.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -10.01 59.08 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.244 -0.91 . . . . 0.0 111.516 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.414 HD21 ' SG ' ' A' ' 12' ' ' CYS . 53.6 mt -72.41 -20.67 61.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.652 -1.28 . . . . 0.0 112.458 172.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -64.7 -31.68 73.01 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.889 -1.132 . . . . 0.0 110.504 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.76 10.38 41.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.188 2.595 . . . . 0.0 114.213 -172.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.36 159.95 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 120.975 -1.078 . . . . 0.0 109.276 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.56 174.58 5.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.362 1.865 . . . . 0.0 109.746 173.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.06 16.48 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.703 2.001 . . . . 0.0 113.637 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -179.92 65.16 0.07 OUTLIER Glycine 0 CA--C 1.525 0.684 0 O-C-N 119.644 -1.91 . . . . 0.0 113.787 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -94.57 24.97 4.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.642 1.177 . . . . 0.0 112.71 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.9 mttt 43.99 71.98 0.22 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 130.075 3.35 . . . . 0.0 112.629 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -69.29 119.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.54 103.6 16.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 168.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 5' ' ' LEU . 75.6 t -72.42 125.75 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 168.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -136.49 -175.98 4.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.307 1.843 . . . . 0.0 109.203 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.63 8.85 34.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 117.93 2.567 . . . . 0.0 117.93 -168.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 129.983 3.313 . . . . 0.0 111.275 -165.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ttm . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 54.0 mtt180 -84.85 173.03 10.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 173.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 72.8 t -147.78 141.06 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.072 1.749 . . . . 0.0 106.5 169.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 36.1 tt0 -125.26 131.13 53.16 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.786 2.034 . . . . 0.0 107.18 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.82 102.94 10.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.478 1.911 . . . . 0.0 106.773 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.26 136.67 32.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -125.91 170.23 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.994 1.318 . . . . 0.0 109.747 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.97 -27.47 66.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.415 -0.803 . . . . 0.0 113.093 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 m -111.26 -3.74 15.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.27 20.81 Favored Glycine 0 N--CA 1.464 0.527 0 CA-C-O 118.08 -1.4 . . . . 0.0 110.1 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.55 161.04 23.77 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.74 1.77 . . . . 0.0 111.869 -167.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.7 p -143.81 174.83 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.793 0.837 . . . . 0.0 110.32 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.1 128.2 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 pt -117.11 148.79 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -120.24 128.51 53.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.251 -0.906 . . . . 0.0 111.015 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD23 ' CA ' ' A' ' 99' ' ' GLY . 42.3 mt -119.89 169.56 10.05 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 123.523 1.63 . . . . 0.0 111.912 -175.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -128.38 114.9 17.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.99 2.116 . . . . 0.0 109.505 -167.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -72.67 52.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.789 2.036 . . . . 0.0 112.326 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -130.63 -34.15 1.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.317 1.447 . . . . 0.0 110.905 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -74.69 151.02 39.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -57.91 -46.35 85.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.865 0.866 . . . . 0.0 109.076 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 51' ' ' VAL . 1.6 t -61.09 -38.08 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -170.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.82 -46.14 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -52.46 -46.76 66.63 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.094 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.619 HD12 HG12 ' A' ' 51' ' ' VAL . 29.1 mt -74.5 -32.91 62.68 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.741 0.816 . . . . 0.0 111.1 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -39.0 91.63 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.748 1.219 . . . . 0.0 110.184 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -53.68 -41.53 66.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.468 0.707 . . . . 0.0 109.805 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -62.21 -20.64 64.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.185 0.994 . . . . 0.0 111.918 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -111.31 -1.64 15.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 116.893 -1.527 . . . . 0.0 113.003 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -99.3 143.3 26.16 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 121.405 1.911 . . . . 0.0 109.106 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -70.15 159.65 90.53 Favored 'Cis proline' 0 C--N 1.351 0.662 0 CA-C-N 119.109 0.718 . . . . 0.0 113.242 -11.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -146.97 172.23 14.03 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 126.138 1.775 . . . . 0.0 109.722 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -124.52 167.33 14.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 109.784 167.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.34 178.09 3.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.411 0.685 . . . . 0.0 112.046 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.8 t -82.53 138.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 125.385 1.474 . . . . 0.0 109.342 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 111' ' ' ILE . 10.3 t -94.29 71.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.133 0.973 . . . . 0.0 108.379 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -70.13 152.11 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 p -123.01 152.18 41.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.266 0.626 . . . . 0.0 109.997 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -156.89 79.63 0.92 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.718 0.807 . . . . 0.0 109.757 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 83' ' ' PRO . . . 87.19 55.02 2.44 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 119.856 -1.777 . . . . 0.0 113.118 175.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 52.28 40.93 30.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.157 1.383 . . . . 0.0 109.569 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.24 166.03 24.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.81 2.044 . . . . 0.0 107.858 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -132.47 124.28 51.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 108.266 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -127.41 149.26 50.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.396 1.093 . . . . 0.0 109.636 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -136.63 148.45 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 108.446 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.93 74.77 3.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.007 1.723 . . . . 0.0 111.445 -165.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.4 p -63.03 145.52 96.59 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.191 -0.943 . . . . 0.0 112.7 -164.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.68 -1.97 11.21 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.056 3.171 . . . . 0.0 113.096 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.72 136.51 37.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -132.63 82.36 2.0 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.51 0.724 . . . . 0.0 111.768 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.619 HG12 HD12 ' A' ' 25' ' ' LEU . 3.0 m -91.92 173.04 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 O-C-N 121.509 -0.744 . . . . 0.0 110.568 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -132.54 13.93 4.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.292 1.437 . . . . 0.0 112.212 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -111.69 123.19 49.72 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.812 1.187 . . . . 0.0 111.641 -167.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.4 122.7 26.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.291 1.836 . . . . 0.0 110.245 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.44 -37.28 10.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.295 0.638 . . . . 0.0 110.208 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.14 60.07 1.28 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.82 1.648 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -65.31 145.05 82.66 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.224 1.949 . . . . 0.0 110.513 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -143.58 146.56 33.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.228 1.011 . . . . 0.0 108.996 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.16 -5.29 24.59 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.094 1.358 . . . . 0.0 111.391 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.05 149.77 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 127.845 2.458 . . . . 0.0 108.895 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.674 HG21 ' CD1' ' A' ' 78' ' ' PHE . 20.8 m -132.78 -178.72 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.958 1.703 . . . . 0.0 108.587 -173.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.87 176.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.251 1.024 . . . . 0.0 109.472 172.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.6 mt -78.73 -4.54 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.196 0.998 . . . . 0.0 111.128 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.43 37.81 1.94 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.863 1.221 . . . . 0.0 111.083 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -116.85 174.77 5.91 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.1 165.87 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 95' ' ' VAL . . . -141.72 179.19 19.98 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 165.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.986 ' H ' HG13 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -128.82 129.64 45.89 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 -170.28 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . 0.297 2.9 t90 -118.57 86.62 29.46 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-N 120.135 1.334 . . . . 0.0 109.876 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 69.6 Cg_endo -70.78 -26.33 22.87 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 116.834 1.821 . . . . 0.0 116.834 -171.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.455 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 95.4 Cg_endo -77.55 -17.59 14.29 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.955 2.437 . . . . 0.0 112.395 -172.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.45 -2.56 50.52 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.88 1.705 . . . . 0.0 112.79 167.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 52.25 65.49 1.49 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.228 1.811 . . . . 0.0 110.973 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.58 177.51 10.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.75 0.786 . . . . 0.0 111.153 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -88.92 -177.75 5.56 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 126.213 1.805 . . . . 0.0 112.074 175.258 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 65.7 m -152.94 127.93 9.66 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.638 1.575 . . . . 0.0 109.205 156.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.61 105.12 15.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.393 2.277 . . . . 0.0 105.965 168.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.674 ' CD1' HG21 ' A' ' 61' ' ' VAL . 39.4 m-85 -86.8 132.53 33.82 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -150.25 27.31 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.48 0.582 . . . . 0.0 112.419 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.38 0.09 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-O 118.212 -1.327 . . . . 0.0 112.331 168.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 136.36 4.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.686 1.195 . . . . 0.0 111.3 165.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.56 165.44 30.38 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.277 2.231 . . . . 0.0 113.118 -172.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 85.7 Cg_endo -80.59 -17.8 9.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.65 2.9 . . . . 0.0 114.404 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.21 57.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.432 0.693 . . . . 0.0 111.997 -173.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -172.11 1.85 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.138 2.175 . . . . 0.0 109.839 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.53 -49.97 0.32 Allowed 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 158.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.457 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 8.1 m-20 -72.12 -54.99 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.883 -0.511 . . . . 0.0 110.261 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -139.4 179.71 6.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.677 2.391 . . . . 0.0 109.489 -153.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.7 74.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 121.519 1.963 . . . . 0.0 110.291 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -84.52 142.58 40.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.561 -0.712 . . . . 0.0 109.911 166.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -74.96 -178.57 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.494 3.462 . . . . 0.0 113.72 160.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.08 -12.9 43.4 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t 180.0 -177.95 0.4 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.886 2.074 . . . . 0.0 106.848 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.16 96.06 1.74 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 124.533 2.111 . . . . 0.0 109.609 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.986 HG13 ' H ' ' A' ' 68' ' ' TYR 0.308 46.9 t -58.59 -172.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 CA-C-N 110.945 -2.843 . . . . 0.0 111.199 140.146 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.679 ' H ' HG12 ' A' ' 95' ' ' VAL . 63.8 t-20 -142.54 130.39 21.68 Favored 'General case' 0 N--CA 1.438 -1.044 1 C-N-CA 132.677 4.391 . . . . 0.0 105.207 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.07 82.71 2.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 22' ' ' VAL . 8.2 pt -77.4 -65.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.968 172.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.469 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -95.59 173.92 31.48 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.848 1.213 . . . . 0.0 111.464 -178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -134.5 141.51 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.611 1.964 . . . . 0.0 108.203 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.84 100.18 2.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 102.339 -3.208 . . . . 0.0 102.339 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -83.72 -38.73 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.363 0.529 . . . . 0.0 110.236 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.74 159.66 41.57 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.557 1.143 . . . . 0.0 109.973 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.0 70.51 1.16 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 tp -87.85 -64.09 1.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.4 -29.14 68.57 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.584 -0.697 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -12.78 24.19 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.38 1.072 . . . . 0.0 111.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.65 -34.91 22.95 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.213 1.405 . . . . 0.0 111.875 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.36 -21.93 66.25 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.08 -1.012 . . . . 0.0 112.361 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.71 10.32 33.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.495 1.518 . . . . 0.0 112.494 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.426 HG21 HG11 ' A' ' 36' ' ' VAL . 23.5 mm -95.37 138.66 20.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.263 0.938 . . . . 0.0 108.983 176.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -85.14 175.08 9.21 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.809 1.244 . . . . 0.0 110.281 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.69 16.4 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 129.652 3.181 . . . . 0.0 114.914 174.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.93 80.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 O-C-N 120.334 -1.479 . . . . 0.0 109.463 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -133.53 31.41 3.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt 46.03 70.11 0.4 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 128.046 2.538 . . . . 0.0 112.347 162.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.44 129.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.58 107.75 20.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.049 1.74 . . . . 0.0 106.992 164.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.5 t -88.57 121.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 128.131 2.572 . . . . 0.0 107.695 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 25.6 mtm180 -138.66 174.13 10.86 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.128 1.371 . . . . 0.0 110.116 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -78.66 -9.44 59.39 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 122.228 2.285 . . . . 0.0 117.036 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.064 0 C-N-CA 126.335 1.854 . . . . 0.0 112.06 -164.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 C--O 1.236 0.378 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.74 157.39 24.4 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 t -155.23 140.43 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.701 1.6 . . . . 0.0 107.646 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 122' ' ' ALA . 43.7 tt0 -123.1 117.96 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.928 2.091 . . . . 0.0 106.476 177.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.87 110.28 19.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.987 1.715 . . . . 0.0 106.448 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.8 122.28 39.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.363 1.465 . . . . 0.0 107.268 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -114.14 170.51 8.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.622 1.169 . . . . 0.0 109.588 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.49 -17.79 62.97 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.406 -1.434 . . . . 0.0 112.358 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 m -113.68 -0.58 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 114.16 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.17 -157.19 28.42 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 119.999 1.272 . . . . 0.0 109.927 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -158.59 166.71 31.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.47 0.708 . . . . 0.0 109.371 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -144.38 179.42 7.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.433 0.693 . . . . 0.0 109.304 166.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.05 126.74 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.19 153.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 122.691 1.234 . . . . 0.0 107.831 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -116.51 126.44 53.36 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 125.842 1.657 . . . . 0.0 106.983 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.35 133.19 51.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.182 0.901 . . . . 0.0 109.546 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.86 137.42 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.15 -18.95 63.23 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.017 0.927 . . . . 0.0 112.591 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.84 -19.5 59.97 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.496 1.043 . . . . 0.0 113.518 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -92.33 126.96 37.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.163 1.385 . . . . 0.0 110.092 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -45.96 -54.76 7.78 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 126.193 1.797 . . . . 0.0 110.915 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -54.98 -32.95 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.143 -1.408 . . . . 0.0 113.998 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.0 t -69.41 -38.75 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.772 1.624 . . . . 0.0 109.379 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -63.41 -42.7 98.75 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.799 0.84 . . . . 0.0 110.759 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -43.99 84.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -54.27 -28.07 39.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.226 1.41 . . . . 0.0 112.8 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -65.29 -27.25 68.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.014 0.824 . . . . 0.0 110.496 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.79 -20.59 63.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.593 0.711 . . . . 0.0 110.817 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -118.29 18.33 13.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.95 2.1 . . . . 0.0 110.753 -165.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.5 mt -121.29 139.97 30.47 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.678 1.581 . . . . 0.0 107.456 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.89 156.99 83.01 Favored 'Cis proline' 0 N--CA 1.458 -0.6 0 C-N-CA 125.089 -0.796 . . . . 0.0 112.053 -9.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.491 ' CE1' HG11 ' A' ' 119' ' ' VAL . 20.5 p90 -143.72 165.17 28.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.578 1.174 . . . . 0.0 109.947 165.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.96 155.32 41.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -162.05 166.3 26.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.819 0.848 . . . . 0.0 111.471 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.57 127.97 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.845 HG13 HG23 ' A' ' 43' ' ' ILE . 98.9 t -80.38 98.54 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 171.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -90.75 156.06 18.34 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -144.45 149.45 36.03 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.161 0.585 . . . . 0.0 110.253 -168.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -146.62 82.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 83' ' ' PRO . . . 79.18 -84.98 1.23 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -142.03 38.62 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.58 1.552 . . . . 0.0 109.181 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.68 165.32 26.66 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.21 172.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.845 HG23 HG13 ' A' ' 36' ' ' VAL . 30.3 mt -131.95 123.19 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -121.18 176.35 5.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.071 0.939 . . . . 0.0 109.751 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.43 161.15 38.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.915 2.086 . . . . 0.0 106.679 173.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p -94.57 85.41 4.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.666 HG21 HD23 ' A' ' 75' ' ' LEU . 40.2 p -59.12 150.21 63.37 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -166.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.87 -25.16 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.287 1.992 . . . . 0.0 111.263 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.88 143.8 10.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.152 0.981 . . . . 0.0 109.938 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -138.87 101.13 4.23 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.395 1.478 . . . . 0.0 108.202 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.8 160.19 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.626 1.57 . . . . 0.0 108.022 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -123.37 2.65 9.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.69 1.196 . . . . 0.0 113.123 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -71.95 157.98 36.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.051 0.841 . . . . 0.0 109.107 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 46.4 mtm -147.59 158.38 43.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.565 1.546 . . . . 0.0 106.939 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -126.64 -51.69 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.533 1.533 . . . . 0.0 108.819 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -123.89 54.41 7.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.297 1.039 . . . . 0.0 111.641 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.77 134.37 27.81 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 120.264 1.13 . . . . 0.0 110.516 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -127.9 148.6 50.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.387 0.675 . . . . 0.0 109.33 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -92.89 5.75 50.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.843 0.857 . . . . 0.0 112.304 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -148.39 153.41 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.034 2.134 . . . . 0.0 106.59 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 78' ' ' PHE . 27.3 m -146.2 -178.74 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.542 2.337 . . . . 0.0 107.207 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.48 172.15 7.67 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.489 -0.757 . . . . 0.0 111.335 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -72.14 71.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.954 . . . . 0.0 107.215 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.73 11.74 0.16 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.813 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -105.07 -177.74 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.399 2.1 . . . . 0.0 108.7 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -131.65 148.34 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.638 1.175 . . . . 0.0 108.463 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -134.09 149.9 19.86 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.462 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 6.7 m-85 -120.24 120.51 36.31 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -105.06 87.97 2.18 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.536 1.934 . . . . 0.0 110.35 -167.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.06 -52.0 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.104 2.536 . . . . 0.0 114.844 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.67 -28.6 7.98 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.939 2.426 . . . . 0.0 111.212 -161.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.66 87.39 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.57 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 47.24 67.62 0.77 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 108.924 -162.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.0 157.2 45.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.629 0.728 . . . . 0.0 111.702 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.666 HD23 HG21 ' A' ' 47' ' ' THR . 0.2 OUTLIER -80.5 -175.62 5.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.663 159.416 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 t -164.09 154.54 15.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.62 1.168 . . . . 0.0 109.278 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -136.09 142.14 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 107.12 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD2' HG21 ' A' ' 61' ' ' VAL . 56.7 m-85 -120.66 106.38 11.68 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 119.929 1.241 . . . . 0.0 110.829 -170.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.25 52.52 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.328 1.061 . . . . 0.0 112.42 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.36 -98.94 0.13 Allowed Glycine 0 CA--C 1.506 -0.47 0 O-C-N 120.368 -1.457 . . . . 0.0 111.095 159.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.411 ' HA ' HG13 ' A' ' 89' ' ' ILE . 11.6 tttt -135.08 -15.38 1.98 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 167.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 55.72 165.63 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.232 1.813 . . . . 0.0 112.136 -174.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 71.9 Cg_endo -72.64 5.43 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.185 2.59 . . . . 0.0 113.16 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.19 88.26 2.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 p 174.18 172.94 0.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.369 2.668 . . . . 0.0 107.223 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -147.21 -47.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 158.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.83 -53.49 7.85 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.737 0.78 . . . . 0.0 109.429 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -149.82 152.05 34.53 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 128.682 2.793 . . . . 0.0 107.527 -161.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 89' ' ' ILE . 5.4 mp -54.47 122.19 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -138.9 143.4 37.19 Favored Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.501 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -82.71 171.45 11.98 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.625 2.883 . . . . 0.0 113.331 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.12 52.31 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.72 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.9 m -173.02 -175.36 1.2 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.105 2.562 . . . . 0.0 107.089 166.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.9 104.99 0.61 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.433 1.015 . . . . 0.0 108.678 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -106.83 138.83 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -66.21 106.74 1.74 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.292 1.437 . . . . 0.0 108.707 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.21 61.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 122.469 1.128 . . . . 0.0 109.154 -168.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.77 -13.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.194 0.998 . . . . 0.0 112.933 -167.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.11 164.41 17.41 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -129.13 137.72 51.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.72 90.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -73.5 -30.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.704 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -148.98 162.77 39.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.225 0.536 . . . . 0.0 110.801 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.57 70.74 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.261 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -54.66 44.45 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.378 1.089 . . . . 0.0 109.922 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.25 -18.35 61.24 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.045 -1.035 . . . . 0.0 110.624 -167.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.85 -13.26 61.4 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.161 -0.962 . . . . 0.0 111.781 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.62 -29.1 56.35 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.112 -1.617 . . . . 0.0 113.23 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.39 81.16 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 120.308 -1.495 . . . . 0.0 111.872 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -67.38 -11.14 56.99 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.765 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.0 164.33 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 126.866 2.067 . . . . 0.0 109.6 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 110' ' ' LYS . 5.7 mmtp -120.86 175.31 6.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.977 1.711 . . . . 0.0 109.488 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.13 44.68 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.0 2.12 . . . . 0.0 112.899 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.77 83.15 0.04 OUTLIER Glycine 0 C--N 1.333 0.366 0 O-C-N 120.721 -1.237 . . . . 0.0 110.94 168.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.5 31.11 5.05 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.264 1.026 . . . . 0.0 111.798 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.1 mttt 47.35 89.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.32 2.248 . . . . 0.0 115.225 171.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.54 152.95 5.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.49 119.14 33.65 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.467 1.907 . . . . 0.0 106.878 159.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.491 HG11 ' CE1' ' A' ' 32' ' ' PHE . 75.9 t -98.48 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 127.496 2.318 . . . . 0.0 107.192 -174.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -130.99 163.17 28.14 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.694 -1.253 . . . . 0.0 110.395 -171.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.92 -18.17 64.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.308 -1.228 1 C-N-CA 131.974 4.11 . . . . 0.0 107.375 152.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 7.7 mtt180 -74.86 159.4 31.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.446 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.1 t -153.74 120.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.459 1.903 . . . . 0.0 106.031 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -100.23 136.56 39.94 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.71 -1.244 . . . . 0.0 109.007 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.78 103.11 10.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.679 1.592 . . . . 0.0 106.906 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 143.13 30.64 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.54 -178.72 4.34 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.641 1.976 . . . . 0.0 107.67 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.44 -52.51 38.62 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.808 1.243 . . . . 0.0 110.387 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 m -70.67 -33.35 70.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.004 -0.435 . . . . 0.0 111.858 -173.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.23 -150.45 8.15 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -161.21 164.53 30.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.715 1.257 . . . . 0.0 110.658 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.8 p -146.8 175.47 10.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.564 . . . . 0.0 108.965 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.02 141.98 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.5 pt -129.93 147.73 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -132.94 125.88 30.8 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.26 131.1 53.75 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 125.265 1.603 . . . . 0.0 109.47 -163.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -69.94 122.07 18.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.947 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.86 9.35 1.54 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.138 1.375 . . . . 0.0 114.067 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.02 -6.52 56.57 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.091 -1.005 . . . . 0.0 110.39 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.22 132.96 55.93 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.255 1.022 . . . . 0.0 109.702 -164.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.88 -44.09 70.16 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.274 1.429 . . . . 0.0 111.159 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -54.06 -43.09 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.591 1.156 . . . . 0.0 112.358 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.56 -44.79 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.51 1.504 . . . . 0.0 108.643 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -61.3 -40.23 93.42 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.365 0.666 . . . . 0.0 111.041 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -79.01 -29.41 43.67 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.972 0.909 . . . . 0.0 111.046 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mt -60.97 -24.58 66.21 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.228 1.411 . . . . 0.0 111.363 168.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -64.33 -20.13 65.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.345 0.975 . . . . 0.0 111.177 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -81.89 -14.97 55.46 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.068 0.947 . . . . 0.0 112.251 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -124.33 28.93 6.51 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.294 1.038 . . . . 0.0 111.414 -166.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -131.81 141.26 40.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.0 158.35 74.35 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.075 1.063 . . . . 0.0 112.332 -8.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -150.31 166.0 31.33 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.31 0.644 . . . . 0.0 110.003 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.48 166.93 12.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.3 163.19 17.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.702 0.763 . . . . 0.0 111.736 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.96 131.85 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 164.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.6 99.96 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -85.59 154.85 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.4 p -129.6 150.91 50.72 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.627 1.171 . . . . 0.0 108.681 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -149.31 98.22 2.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.43 -87.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.2 29.61 1.81 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.292 1.837 . . . . 0.0 110.327 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -133.11 161.83 33.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.436 1.094 . . . . 0.0 108.589 168.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -127.3 143.22 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -148.69 166.9 26.99 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 2.5 p90 -154.38 155.64 35.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.759 -1.213 . . . . 0.0 108.584 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -83.02 86.55 6.98 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.541 0.737 . . . . 0.0 109.511 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.0 p -58.15 150.88 49.58 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 122.663 0.385 . . . . 0.0 111.874 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.85 -13.31 13.06 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.277 2.651 . . . . 0.0 112.647 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.81 158.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-N 119.092 0.86 . . . . 0.0 108.904 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.32 103.83 4.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.229 1.412 . . . . 0.0 107.879 172.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.55 147.12 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -125.47 -7.45 6.92 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -65.17 146.7 54.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.723 1.209 . . . . 0.0 107.778 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 18.0 ptp -144.81 104.35 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.24 1.416 . . . . 0.0 110.304 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.66 -30.34 59.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.156 -1.018 . . . . 0.0 113.221 -172.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -133.29 72.9 74.87 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 119.432 1.015 . . . . 0.0 110.522 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 56.3 Cg_endo -69.48 150.67 70.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.75 2.967 . . . . 0.0 112.113 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -140.13 173.36 11.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.494 1.917 . . . . 0.0 108.384 170.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.27 10.67 8.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 112.657 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.72 154.11 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 131.001 3.72 . . . . 0.0 107.004 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.14 -174.48 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.23 1.412 . . . . 0.0 109.575 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -90.94 175.84 6.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.698 0.761 . . . . 0.0 110.935 166.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.456 ' O ' HD11 ' A' ' 105' ' ' LEU . 56.5 mt -75.58 5.23 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.923 1.289 . . . . 0.0 110.68 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.17 30.91 1.6 Allowed Glycine 0 C--N 1.337 0.615 0 O-C-N 120.692 -1.255 . . . . 0.0 112.949 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -115.79 169.92 8.85 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.049 0.924 . . . . 0.0 109.462 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -136.99 140.99 41.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.703 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -127.03 176.82 17.64 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.875 1.226 . . . . 0.0 110.987 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -111.4 143.01 42.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 165.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -104.77 86.06 1.36 Allowed Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 125.631 1.572 . . . . 0.0 107.667 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.05 -43.39 42.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.359 2.039 . . . . 0.0 115.054 -172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.74 -22.65 43.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.639 2.226 . . . . 0.0 111.482 -165.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -115.76 15.13 16.95 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.763 1.649 . . . . 0.0 113.751 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 47.56 37.96 7.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.755 2.278 . . . . 0.0 113.024 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.83 160.95 15.34 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.724 -1.235 . . . . 0.0 110.531 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -80.07 -179.14 6.87 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 161.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.6 m -139.15 163.93 31.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.796 0.838 . . . . 0.0 109.777 154.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.5 mt -151.05 101.49 2.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 129.36 3.064 . . . . 0.0 105.066 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -99.97 119.88 38.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.73 1.56 2.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.14 -178.74 34.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 166.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -83.25 106.88 15.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -59.71 165.43 4.38 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 125.465 1.506 . . . . 0.0 110.961 169.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.41 1.48 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.333 2.022 . . . . 0.0 114.165 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ttp -107.17 58.31 0.63 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 120.208 1.367 . . . . 0.0 110.182 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 p -159.83 -178.63 7.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 122.161 0.982 . . . . 0.0 110.501 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.93 -62.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 154.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.39 -43.54 40.18 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.046 0.538 . . . . 0.0 112.022 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -149.68 161.98 41.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.957 1.303 . . . . 0.0 108.6 -162.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.78 80.54 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -167.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -79.85 141.85 55.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -89.26 177.29 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 124.494 3.463 . . . . 0.0 112.935 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.78 16.16 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.4 t -164.86 173.86 11.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.029 1.286 . . . . 0.0 109.783 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.57 78.8 0.58 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.8 148.92 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 25.7 p30 -64.97 158.59 25.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.213 0.53 . . . . 0.0 112.177 164.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.56 99.32 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 166.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.2 pt -113.47 -16.38 9.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.511 1.124 . . . . 0.0 111.408 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.1 175.56 20.03 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-O 122.061 0.811 . . . . 0.0 112.413 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -135.86 134.0 38.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 105' ' ' LEU . 52.7 mt -73.76 95.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 165.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -76.62 -24.2 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.365 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -148.66 158.68 44.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 110.421 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.78 42.34 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.371 1.462 . . . . 0.0 112.569 160.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 63' ' ' ILE . 1.8 tp -67.63 -11.81 59.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -162.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -107.18 -35.27 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 119.258 0.935 . . . . 0.0 110.331 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.56 -18.21 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.484 0.713 . . . . 0.0 111.316 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mp -66.76 -29.09 68.97 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.088 -1.007 . . . . 0.0 112.314 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -67.22 -22.79 65.69 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.818 1.644 . . . . 0.0 112.87 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -99.16 5.77 46.69 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.932 -171.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.86 165.37 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 119.744 1.157 . . . . 0.0 108.741 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -109.39 172.84 6.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.29 35.8 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 112.735 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.45 51.97 0.04 OUTLIER Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.804 -1.185 . . . . 0.0 112.93 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -103.4 24.92 10.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.016 1.408 . . . . 0.0 113.302 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.6 mttt 44.19 88.25 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.452 1.901 . . . . 0.0 113.258 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.75 142.38 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -125.06 94.49 4.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.443 1.897 . . . . 0.0 106.826 162.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.28 140.39 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 128.724 2.81 . . . . 0.0 109.1 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -140.97 177.06 8.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.999 2.12 . . . . 0.0 109.61 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -78.71 -2.32 38.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . 55.61 -164.67 0.13 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.831 -160.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . 0.342 10.3 p 47.18 16.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 129.771 3.229 . . . . 0.0 116.868 -175.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.249 1.029 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 132.902 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.977 0.894 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.433 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 1.3 mmt-85 -62.57 160.59 13.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.932 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 2' ' ' ARG . 36.8 t -151.11 149.69 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.494 1.518 . . . . 0.0 109.075 166.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -116.54 139.86 50.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.423 2.289 . . . . 0.0 106.229 166.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.428 HD22 HG22 ' A' ' 119' ' ' VAL . 42.8 mt -112.08 119.49 38.61 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 170.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 3.5 tt -121.49 141.01 51.45 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -164.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.73 ' CE1' HG12 ' A' ' 117' ' ' VAL . 18.8 m-85 -128.98 166.45 19.15 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.3 1.409 . . . . 0.0 108.616 -172.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.11 -19.16 62.71 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.244 -0.91 . . . . 0.0 111.543 171.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -25.76 12.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -172.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.5 -156.37 18.11 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 126.379 1.942 . . . . 0.0 108.274 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 13.0 pttp -168.02 157.54 9.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.174 1.487 . . . . 0.0 111.695 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HB3' HD21 ' A' ' 108' ' ' LEU . 14.3 p -136.31 175.24 9.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.36 1.064 . . . . 0.0 111.043 170.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 127.22 56.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 pt -121.65 129.01 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -96.14 133.65 40.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.127 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.4 mt -124.62 130.53 52.6 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.588 1.085 . . . . 0.0 110.574 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -71.35 135.97 47.58 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.868 1.667 . . . . 0.0 111.375 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -90.96 45.35 1.25 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 112.854 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -129.05 30.15 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.094 -1.628 . . . . 0.0 108.964 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.434 ' CE2' HG22 ' A' ' 98' ' ' ILE . 23.0 m-85 -132.53 139.47 47.9 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.012 -1.055 . . . . 0.0 109.034 175.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -45.0 -62.76 1.11 Allowed 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 126.373 1.869 . . . . 0.0 109.609 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.33 -39.64 28.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 121.071 -1.018 . . . . 0.0 113.17 -171.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.8 -44.77 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.513 1.125 . . . . 0.0 109.247 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -52.05 -53.57 40.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -43.94 97.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.863 0.865 . . . . 0.0 109.424 -170.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.21 -29.05 20.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.392 1.877 . . . . 0.0 112.866 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -59.98 -29.44 68.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.009 0.822 . . . . 0.0 110.895 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -74.07 -35.62 64.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.04 0.448 . . . . 0.0 109.935 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.35 21.05 3.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.648 2.779 . . . . 0.0 111.407 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -128.26 137.71 31.45 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 121.187 1.812 . . . . 0.0 107.733 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.93 153.14 97.39 Favored 'Cis proline' 0 C--N 1.348 0.518 0 CA-C-N 119.161 0.736 . . . . 0.0 112.428 -5.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CE1' HG11 ' A' ' 119' ' ' VAL . 23.2 p90 -139.75 167.48 22.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 122.667 0.387 . . . . 0.0 111.377 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.15 155.06 46.84 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 t -166.74 161.62 15.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.5 128.2 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.804 HG22 HG13 ' A' ' 117' ' ' VAL . 2.8 t -75.66 73.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -65.29 153.48 40.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -139.46 161.03 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.95 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -160.54 92.62 0.97 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.37 84.34 0.03 OUTLIER Glycine 0 C--O 1.212 -1.248 0 CA-C-O 119.194 -0.781 . . . . 0.0 114.577 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.36 25.23 7.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.095 2.958 . . . . 0.0 113.252 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -128.8 149.38 50.76 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.468 1.107 . . . . 0.0 109.099 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.7 mt -125.04 141.35 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.59 172.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 168.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -156.71 151.36 25.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.103 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -74.11 98.33 3.1 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.9 p -66.95 149.8 98.26 Favored Pre-proline 0 N--CA 1.437 -1.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.06 -3.03 12.87 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.389 3.392 . . . . 0.0 112.102 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.2 149.79 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 108.141 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.02 15.79 6.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.84 117.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 123.978 0.911 . . . . 0.0 110.019 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 70' ' ' PRO . 48.6 mt-30 -94.73 2.04 55.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -81.61 96.39 7.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.498 2.319 . . . . 0.0 110.29 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.8 ptp -86.57 123.42 31.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.508 1.123 . . . . 0.0 110.378 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.88 -23.88 16.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -137.9 70.69 50.06 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.2 146.75 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.282 2.655 . . . . 0.0 109.87 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -135.76 174.92 10.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 164.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -125.3 7.05 7.76 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.223 1.009 . . . . 0.0 111.503 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -144.74 137.06 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -142.9 -179.56 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.057 1.343 . . . . 0.0 109.722 -173.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.37 -167.56 1.52 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.977 2.111 . . . . 0.0 111.438 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.19 45.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.429 1.891 . . . . 0.0 107.545 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.03 38.2 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.24 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -110.28 176.04 5.2 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.41 134.33 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.89 148.16 18.88 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -86.75 139.14 31.02 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 168.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -104.89 85.21 1.15 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.484 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 63.9 Cg_endo -64.39 -36.68 43.47 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.167 1.245 . . . . 0.0 114.837 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.484 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 60.5 Cg_endo -74.05 -21.04 18.61 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.266 1.977 . . . . 0.0 110.599 -167.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 22.17 7.58 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 118.05 -1.416 . . . . 0.0 113.352 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 46.21 49.59 12.56 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.766 1.783 . . . . 0.0 111.995 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.97 175.46 9.35 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 111.286 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.438 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 1.3 tp -93.18 -169.66 2.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.141 1.376 . . . . 0.0 111.06 166.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -166.13 140.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.554 1.542 . . . . 0.0 110.371 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -137.36 124.12 21.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.413 2.285 . . . . 0.0 107.538 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.62 119.63 40.09 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.248 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -140.94 14.7 2.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.54 48.32 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 CA-C-N 119.755 1.161 . . . . 0.0 114.327 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.8 tttt 62.24 177.44 0.13 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.64 1.976 . . . . 0.0 109.844 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 43.2 p -149.25 165.54 17.42 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 120.119 1.327 . . . . 0.0 109.925 -172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 96.5 Cg_endo -77.62 64.73 8.12 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.377 3.384 . . . . 0.0 111.462 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.23 -44.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.719 1.608 . . . . 0.0 108.753 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.79 154.74 23.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.479 1.511 . . . . 0.0 108.227 -159.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.73 -58.03 1.6 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.4 -49.42 55.41 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.194 0.521 . . . . 0.0 110.926 -167.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -135.89 166.09 24.12 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 127.005 2.122 . . . . 0.0 108.109 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.73 115.91 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -125.6 144.78 49.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.115 0.966 . . . . 0.0 111.139 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.479 ' HG3' HG22 ' A' ' 95' ' ' VAL . 57.9 Cg_endo -74.5 173.56 14.08 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.305 3.336 . . . . 0.0 112.975 170.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.268 1.427 . . . . 0.0 114.346 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -147.86 173.37 12.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.569 1.547 . . . . 0.0 107.679 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.11 85.59 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.479 HG22 ' HG3' ' A' ' 91' ' ' PRO . 15.5 m -90.93 150.02 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -75.32 175.22 8.58 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.9 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.42 44.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.434 HG22 ' CE2' ' A' ' 20' ' ' TYR . 35.7 pt -64.65 -39.96 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.312 -1.492 . . . . 0.0 110.927 -174.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.82 169.08 16.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -138.47 132.71 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.9 mt -73.62 90.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 103.687 -2.708 . . . . 0.0 103.687 167.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.9 m -72.65 -25.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.511 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 155.1 36.76 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.586 0.755 . . . . 0.0 112.23 -165.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.6 20.17 62.38 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.888 1.232 . . . . 0.0 113.897 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.02 -38.03 87.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.745 1.273 . . . . 0.0 111.542 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -76.39 -1.17 25.62 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.25 1.96 26.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.871 0.868 . . . . 0.0 113.024 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' A' ' 12' ' ' CYS . 23.1 mt -84.31 -41.97 16.28 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.622 1.169 . . . . 0.0 113.68 -172.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.55 -23.41 64.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.61 1.671 . . . . 0.0 111.135 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -69.07 -10.55 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.543 -1.348 . . . . 0.0 111.212 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -92.44 157.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 120.334 1.425 . . . . 0.0 109.634 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.51 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 16.5 mmtp -102.08 172.4 6.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.767 1.627 . . . . 0.0 108.013 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.31 25.24 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 128.492 2.717 . . . . 0.0 113.649 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.85 65.16 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 120.337 -1.477 . . . . 0.0 111.992 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 1.5 mm-40 -125.12 38.16 4.25 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.964 1.306 . . . . 0.0 110.465 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 mttt 42.24 87.26 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.542 1.937 . . . . 0.0 110.597 164.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.804 HG13 HG22 ' A' ' 36' ' ' VAL . 19.5 m -64.0 178.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -150.47 90.36 1.64 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 171.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 32' ' ' PHE . 91.8 t -70.42 125.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -137.55 170.9 15.28 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.509 1.05 . . . . 0.0 109.69 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.11 -11.52 60.33 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . 62.03 115.72 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 128.652 2.781 . . . . 0.0 110.783 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.8 m -110.68 82.37 1.58 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.009 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.413 0.625 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -72.38 167.44 20.51 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 25.4 t -147.62 130.19 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.15 1.38 . . . . 0.0 108.599 167.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.74 128.61 45.04 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 119' ' ' VAL . 1.2 mm? -100.61 105.1 16.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.5 31.54 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 169.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.93 175.09 8.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.93 1.292 . . . . 0.0 109.383 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.97 -29.64 67.9 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.503 -1.373 . . . . 0.0 112.057 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.8 m -103.53 -3.0 25.87 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.31 -166.76 39.6 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 119.712 1.142 . . . . 0.0 111.266 -173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 150.34 25.53 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.808 0.304 . . . . 0.0 110.397 168.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.8 p -132.85 172.87 12.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.598 0.713 . . . . 0.0 109.385 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -135.06 146.85 29.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.5 pt -128.13 156.97 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -111.02 135.15 51.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.29 134.69 55.21 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.076 1.351 . . . . 0.0 108.781 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -86.66 118.53 26.12 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.778 0.831 . . . . 0.0 109.478 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -66.21 20.05 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.028 2.131 . . . . 0.0 114.64 -171.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.86 24.17 5.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.39 1.876 . . . . 0.0 109.511 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -129.92 147.81 51.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.438 2.295 . . . . 0.0 108.311 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.77 -46.49 59.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.701 2.0 . . . . 0.0 110.157 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.07 -46.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.337 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -72.16 -43.91 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -165.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -60.89 -24.62 66.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.966 1.307 . . . . 0.0 111.715 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 25' ' ' LEU . 20.5 mt -90.18 -25.8 20.46 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.48 1.112 . . . . 0.0 112.501 176.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.469 ' HG ' HG21 ' A' ' 49' ' ' VAL . 1.4 mt -70.11 -28.82 65.71 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 121.065 -1.022 . . . . 0.0 110.804 172.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.66 -36.68 47.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.337 0.655 . . . . 0.0 111.044 175.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -71.36 -17.51 62.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 112.17 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -123.13 12.46 9.59 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.902 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -106.01 135.76 19.39 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 121.003 1.729 . . . . 0.0 108.109 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.86 164.32 79.83 Favored 'Cis proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.911 1.004 . . . . 0.0 112.824 -6.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CE1' HG11 ' A' ' 119' ' ' VAL . 47.4 p90 -147.54 168.58 21.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.713 1.258 . . . . 0.0 109.403 165.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 47.3 mp0 -130.71 154.51 47.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.174 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -165.2 -175.46 3.66 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.905 0.882 . . . . 0.0 111.551 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 t -93.26 142.19 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 128.017 2.527 . . . . 0.0 107.891 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -97.11 91.33 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -86.79 159.64 19.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.6 p -132.4 149.32 52.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.03 0.932 . . . . 0.0 110.561 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.0 t90 -166.91 103.3 0.56 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -172.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.41 20.09 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 160.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.357 17.2 pt-20 47.71 50.91 14.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.966 1.707 . . . . 0.0 111.234 -159.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -140.01 159.56 41.89 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 126.962 2.105 . . . . 0.0 107.615 168.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.99 139.64 50.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 127.513 2.325 . . . . 0.0 106.478 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -155.34 150.02 26.36 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.962 1.363 . . . . 0.0 111.263 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 2.7 p90 -135.64 151.76 50.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.163 1.385 . . . . 0.0 108.204 -174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -88.82 83.34 6.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -166.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 48' ' ' PRO . 16.5 p -53.98 152.29 10.8 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.256 0.622 . . . . 0.0 111.971 -168.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 47' ' ' THR . 42.4 Cg_endo -79.2 4.93 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.505 1 C-N-CA 125.41 4.073 . . . . 0.0 112.505 175.016 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.469 HG21 ' HG ' ' A' ' 26' ' ' LEU . 94.0 t -107.98 131.53 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.071 1.348 . . . . 0.0 110.421 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.46 66.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.31 1.444 . . . . 0.0 107.19 -171.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -110.49 128.99 66.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 124.48 1.112 . . . . 0.0 108.297 -175.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.98 45.07 2.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.584 1.153 . . . . 0.0 111.264 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -127.69 146.35 50.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.457 1.503 . . . . 0.0 108.405 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.62 110.48 2.45 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.154 1.782 . . . . 0.0 108.329 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -87.36 -25.48 23.83 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.633 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -123.35 65.68 31.51 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 120.138 1.336 . . . . 0.0 110.147 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.26 114.63 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.048 2.499 . . . . 0.0 110.391 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 131.42 55.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.544 1.537 . . . . 0.0 108.087 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -93.12 5.27 52.1 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -160.86 149.28 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 128.095 2.558 . . . . 0.0 109.648 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 78' ' ' PHE . 17.0 m -140.95 174.18 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.053 1.741 . . . . 0.0 109.39 -165.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -94.51 170.03 9.77 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.86 0.838 . . . . 0.0 110.708 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.74 -7.42 8.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 124.965 1.306 . . . . 0.0 112.237 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.11 27.22 4.59 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.681 1.61 . . . . 0.0 112.596 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -103.8 175.78 5.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.016 0.908 . . . . 0.0 109.331 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.507 HG23 HG13 ' A' ' 101' ' ' ILE . 42.4 t -135.42 133.86 52.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.709 0.804 . . . . 0.0 109.639 166.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.74 156.66 21.54 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -103.64 143.37 32.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 163.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -109.33 85.66 3.69 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 124.699 1.2 . . . . 0.0 108.552 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.65 -29.84 90.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.265 1.31 . . . . 0.0 114.671 172.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -77.75 -9.0 17.07 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.509 2.139 . . . . 0.0 111.917 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.59 8.95 4.0 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 118.411 -1.216 . . . . 0.0 115.583 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 44.65 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.741 1.27 . . . . 0.0 109.971 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.49 165.69 20.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.534 -0.729 . . . . 0.0 111.611 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 5.3 tp -84.0 178.15 7.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.409 166.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -151.26 108.93 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.082 1.753 . . . . 0.0 108.39 165.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.21 105.29 17.11 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.436 ' CD2' HG21 ' A' ' 61' ' ' VAL . 91.1 m-85 -80.35 133.59 35.94 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -152.84 22.18 0.59 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.946 0.898 . . . . 0.0 110.955 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.2 -139.66 2.76 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.41 103.01 4.78 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -58.52 156.11 24.96 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.487 1.915 . . . . 0.0 111.166 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -3.0 11.89 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.059 3.173 . . . . 0.0 113.459 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.426 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 3.0 tpt -73.09 -8.79 57.33 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.777 -1.202 . . . . 0.0 112.336 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t -132.54 -177.46 4.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.497 1.142 . . . . 0.0 109.914 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -144.35 -42.68 0.25 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.96 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -71.5 -56.81 5.19 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.57 1.176 . . . . 0.0 108.147 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -133.11 -164.84 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.177 2.191 . . . . 0.0 107.41 -153.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.95 77.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.538 1.517 . . . . 0.0 107.662 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 42.5 mt-30 -76.14 142.74 72.51 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' HG3' HG22 ' A' ' 95' ' ' VAL . 51.0 Cg_endo -77.59 179.74 6.22 Favored 'Trans proline' 0 CA--C 1.533 0.449 1 C-N-CA 126.925 5.083 . . . . 0.0 113.665 170.388 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HA ' ' HG2' ' A' ' 84' ' ' MET . . . -70.37 -14.01 62.39 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.32 -172.07 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.89 97.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG22 ' HG3' ' A' ' 91' ' ' PRO . 24.4 m -90.0 172.67 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -126.55 124.5 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.47 55.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.586 1.184 . . . . 0.0 109.256 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.6 pt -80.05 -14.57 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.236 1.014 . . . . 0.0 111.381 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.12 155.89 16.82 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -135.88 140.83 44.42 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.879 0.872 . . . . 0.0 108.659 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.507 HG13 HG23 ' A' ' 66' ' ' VAL . 97.1 mt -79.63 93.95 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 123.814 1.768 . . . . 0.0 108.634 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.48 -23.68 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.002 -163.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.04 159.71 44.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.252 2.621 . . . . 0.0 108.716 171.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.53 69.2 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-O 117.927 -1.485 . . . . 0.0 115.277 167.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.69 -49.99 73.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.188 1.994 . . . . 0.0 111.212 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.3 -25.6 66.11 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.814 -0.554 . . . . 0.0 110.956 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.9 -5.97 34.75 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.754 1.222 . . . . 0.0 112.164 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.5 mt -80.7 -44.41 18.77 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 119.028 0.831 . . . . 0.0 111.46 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -57.53 -22.92 47.32 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.03 -1.044 . . . . 0.0 113.147 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -91.82 16.59 10.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.386 1.474 . . . . 0.0 112.978 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.3 mm -113.3 148.13 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 121.156 1.798 . . . . 0.0 109.922 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -89.16 171.98 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.667 1.587 . . . . 0.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.05 40.14 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 130.127 3.371 . . . . 0.0 112.724 167.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.87 12.67 0.03 OUTLIER Glycine 0 CA--C 1.522 0.522 0 O-C-N 120.452 -1.405 . . . . 0.0 116.156 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.53 22.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.607 1.704 . . . . 0.0 114.34 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.538 ' HE2' ' HB3' ' A' ' 33' ' ' GLU . 0.1 OUTLIER 64.87 152.95 0.05 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.003 2.121 . . . . 0.0 112.373 167.15 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.51 148.26 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 O-C-N 120.435 -1.416 . . . . 0.0 109.048 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.06 108.47 15.27 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.492 2.317 . . . . 0.0 107.14 160.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 32' ' ' PHE . 48.8 t -86.51 124.38 40.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.788 2.435 . . . . 0.0 107.792 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 48.7 mtt180 -140.67 179.76 6.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.571 1.532 . . . . 0.0 110.17 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -81.31 -10.33 59.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 62.0 108.55 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 127.545 2.338 . . . . 0.0 111.266 -169.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 92.6 p -89.53 -11.19 43.56 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.257 1.47 0 C-N-CA 128.49 2.716 . . . . 0.0 115.677 -169.327 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttp . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.62 152.14 39.72 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 50.8 t -153.82 147.85 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.546 1.939 . . . . 0.0 108.132 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.619 ' CB ' ' HB2' ' A' ' 122' ' ' ALA . 42.1 tt0 -131.81 137.41 48.11 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.479 1.911 . . . . 0.0 107.528 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.1 mt -108.57 104.62 13.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.678 1.991 . . . . 0.0 105.857 -174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.67 103.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.56 173.45 9.57 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.931 0.892 . . . . 0.0 108.985 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.77 -42.22 95.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -80.82 -17.08 51.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.62 -161.79 34.09 Favored Glycine 0 N--CA 1.464 0.565 0 CA-C-N 121.11 1.777 . . . . 0.0 110.252 -165.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -159.33 159.92 34.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.203 1.501 . . . . 0.0 111.668 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.8 p -142.84 178.41 7.67 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.195 0.998 . . . . 0.0 109.877 170.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -132.92 129.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.62 144.71 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.401 1.08 . . . . 0.0 108.309 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -136.01 128.97 31.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.314 -0.866 . . . . 0.0 112.858 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.59 123.79 42.81 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 125.084 1.49 . . . . 0.0 108.824 -164.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.22 138.58 57.9 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.608 1.563 . . . . 0.0 111.462 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -97.2 50.26 1.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.518 0.727 . . . . 0.0 112.0 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.35 17.75 3.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.144 1.378 . . . . 0.0 111.85 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.68 144.76 50.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.376 1.47 . . . . 0.0 112.438 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -53.24 -50.58 64.47 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.326 1.451 . . . . 0.0 111.829 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HA ' HG11 ' A' ' 51' ' ' VAL . 3.6 t -57.22 -44.74 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -175.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.0 -34.17 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -66.53 -48.94 68.13 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.17 0.988 . . . . 0.0 111.016 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 51' ' ' VAL . 67.5 mt -70.96 -21.78 62.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.691 0.796 . . . . 0.0 110.515 -173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.2 -41.97 80.57 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.852 2.061 . . . . 0.0 111.608 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -56.0 -36.72 68.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.362 0.983 . . . . 0.0 110.0 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.86 -29.54 70.83 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -108.39 2.25 22.33 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.992 1.317 . . . . 0.0 112.04 -168.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG22 ' CE2' ' A' ' 121' ' ' PHE . 60.6 mt -98.12 142.17 24.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.26 160.43 83.03 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 CA-C-N 119.421 0.829 . . . . 0.0 112.941 -7.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.86 175.45 12.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.933 1.693 . . . . 0.0 109.874 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 177.47 7.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.12 2.168 . . . . 0.0 110.728 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -162.63 -154.73 0.32 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.293 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 t -120.39 134.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.877 1.671 . . . . 0.0 107.661 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -88.09 77.03 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 118.995 0.816 . . . . 0.0 109.379 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.62 150.93 34.84 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.681 -1.262 . . . . 0.0 109.239 171.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.8 p -124.69 142.53 51.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.082 1.353 . . . . 0.0 108.886 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -153.36 107.26 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.87 22.13 70.01 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.939 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 75.52 28.38 0.96 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.846 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -115.47 153.26 31.43 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 155.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -124.48 123.97 67.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -138.24 132.4 31.69 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.088 1.755 . . . . 0.0 108.284 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -136.8 156.83 47.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.459 -1.401 . . . . 0.0 107.483 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.72 115.76 7.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.1 p -80.73 153.34 73.01 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 160.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.7 -0.77 10.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.12 3.213 . . . . 0.0 112.53 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 51' ' ' VAL . 26.2 t -80.78 163.94 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 126.578 1.951 . . . . 0.0 108.722 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -143.07 21.93 1.92 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.579 HG11 ' HA ' ' A' ' 22' ' ' VAL . 7.4 p -60.83 155.71 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -135.13 -4.88 2.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.699 0.8 . . . . 0.0 112.445 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HE2' ' OE2' ' A' ' 55' ' ' GLU . 74.0 tttt -70.44 140.52 52.02 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.041 1.291 . . . . 0.0 109.914 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.24 131.01 46.97 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.345 1.458 . . . . 0.0 107.299 167.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' OE2' ' HE2' ' A' ' 53' ' ' LYS . 71.8 mm-40 -87.45 -38.07 16.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.218 0.532 . . . . 0.0 109.679 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.42 ' ND2' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.65 62.02 12.83 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.344 1.857 . . . . 0.0 108.085 -161.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.87 125.75 15.35 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 108.022 -1.568 . . . . 0.0 108.022 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -117.22 145.77 43.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.221 1.009 . . . . 0.0 109.018 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.77 -1.64 27.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.883 1.273 . . . . 0.0 111.905 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.66 146.96 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 129.026 2.931 . . . . 0.0 108.438 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.98 -173.0 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 109.488 -166.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -105.43 159.09 16.19 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.16 1.384 . . . . 0.0 111.31 171.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.401 HG23 ' HA ' ' A' ' 79' ' ' PHE . 58.7 mt -73.37 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.36 0.82 0.5 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 119.033 -0.87 . . . . 0.0 113.975 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -100.48 175.57 5.64 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.764 1.782 . . . . 0.0 109.11 170.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -136.24 134.02 49.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.519 1.127 . . . . 0.0 108.157 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.78 -172.26 31.72 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -133.78 156.38 48.1 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 146.089 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -121.0 86.77 42.57 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.83 -46.39 31.87 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.253 1.968 . . . . 0.0 114.875 -167.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 -23.76 46.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.809 2.34 . . . . 0.0 111.636 -165.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.57 12.26 46.86 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.757 1.646 . . . . 0.0 113.983 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.489 ' HE3' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER 44.45 48.08 8.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.701 2.0 . . . . 0.0 110.776 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.41 157.03 27.96 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.09 0.948 . . . . 0.0 111.066 -172.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.53 172.56 12.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.641 161.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.53 105.27 3.29 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.872 1.669 . . . . 0.0 109.836 169.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -86.57 120.28 27.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 107.865 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -105.46 105.69 15.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.991 0.814 . . . . 0.0 109.325 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' HA ' HG23 ' A' ' 63' ' ' ILE . 45.2 p90 -136.25 9.24 3.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -175.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.46 -121.21 1.02 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 119.782 1.173 . . . . 0.0 110.65 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -156.56 121.77 4.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.375 1.087 . . . . 0.0 108.517 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -98.14 155.86 36.51 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.996 2.519 . . . . 0.0 112.079 -165.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.61 3.12 6.7 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.489 2.793 . . . . 0.0 115.39 -170.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.5 mmt -81.99 -32.16 30.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.596 1.544 . . . . 0.0 111.289 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.491 ' HB3' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -90.96 175.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.565 0.746 . . . . 0.0 110.087 -176.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 -62.77 0.44 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.16 -26.27 61.12 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.246 0.546 . . . . 0.0 112.395 -165.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -167.9 162.38 13.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 128.359 2.664 . . . . 0.0 107.119 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -75.76 84.19 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 119.534 1.061 . . . . 0.0 109.211 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 85' ' ' SER . 11.1 mt-30 -75.77 144.41 76.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.508 159.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.18 -177.36 3.82 Favored 'Trans proline' 0 C--N 1.346 0.44 1 C-N-CA 125.382 4.055 . . . . 0.0 112.003 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.701 167.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -166.36 179.85 5.38 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 126.099 1.76 . . . . 0.0 106.781 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.11 102.36 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.635 1.174 . . . . 0.0 112.17 -171.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.21 149.07 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.96 109.04 15.95 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.42 HG12 ' ND2' ' A' ' 56' ' ' ASN . 1.3 p -80.61 33.06 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 122.548 1.166 . . . . 0.0 112.347 -162.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.3 pt -63.88 -12.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.633 2.373 . . . . 0.0 115.431 -159.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.73 13.61 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 122.571 1.095 . . . . 0.0 111.825 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -117.42 140.81 49.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 163.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.4 mt -72.51 94.82 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 157.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -77.4 -32.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.725 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -153.77 163.45 40.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.821 0.819 . . . . 0.0 111.385 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.62 31.41 54.14 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.283 0.944 . . . . 0.0 112.361 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.77 -54.01 51.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.619 1.209 . . . . 0.0 111.268 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.72 -17.41 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.766 -0.584 . . . . 0.0 112.141 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.4 -11.75 25.39 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 124.008 0.923 . . . . 0.0 110.828 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.9 -25.76 32.17 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.704 1.138 . . . . 0.0 112.428 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.95 -20.79 62.42 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.711 -1.243 . . . . 0.0 111.485 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.57 28.85 5.23 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.634 2.773 . . . . 0.0 111.108 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.92 166.43 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 127.895 2.478 . . . . 0.0 107.276 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -127.27 -169.51 2.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.323 -1.486 . . . . 0.0 111.264 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -78.43 11.87 2.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.561 1.544 . . . . 0.0 113.854 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.89 79.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.576 0 O-C-N 120.423 -1.423 . . . . 0.0 111.496 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -130.52 40.14 3.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.95 2.1 . . . . 0.0 109.584 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 43.77 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.162 2.585 . . . . 0.0 114.047 163.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.5 p -81.8 111.14 17.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.7 13.4 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.1 t -86.17 126.16 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 127.717 2.407 . . . . 0.0 107.674 -168.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -135.92 172.12 13.47 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.533 1.97 . . . . 0.0 111.428 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.457 ' CE2' HG22 ' A' ' 30' ' ' ILE . 42.0 m-85 -72.24 -11.1 60.57 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.619 ' HB2' ' CB ' ' A' ' 4' ' ' GLU . . . 55.71 58.82 4.21 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 125.517 1.527 . . . . 0.0 114.249 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.2 m -71.32 50.55 0.16 Allowed 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 126.861 2.065 . . . . 0.0 111.457 167.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.094 0 C-N-CA 126.48 1.912 . . . . 0.0 110.158 -169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpp . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 121.359 0.599 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 2.4 mmt-85 -78.9 163.62 25.12 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 123.067 0.547 . . . . 0.0 109.582 173.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.3 t -148.02 146.29 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.518 168.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 14.6 tt0 -120.77 131.62 54.59 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.488 1.915 . . . . 0.0 105.844 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.551 HD11 HD13 ' A' ' 14' ' ' ILE . 54.3 mt -108.71 121.28 44.72 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 7' ' ' PHE . 1.6 tt -123.66 142.13 51.35 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -167.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.834 ' HE1' HG12 ' A' ' 117' ' ' VAL . 5.9 m-85 -134.32 172.13 13.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 119.674 1.125 . . . . 0.0 110.438 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.207 -0.308 . . . . 0.0 110.71 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 m -101.4 -5.65 25.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.02 -163.58 33.82 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 120.931 1.696 . . . . 0.0 111.476 -169.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -160.42 165.1 31.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.7 1.25 . . . . 0.0 110.261 173.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.7 p -146.73 178.0 8.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.469 1.108 . . . . 0.0 111.529 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -133.85 130.18 55.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.141 0.976 . . . . 0.0 108.585 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.551 HD13 HD11 ' A' ' 5' ' ' LEU . 35.9 pt -128.01 147.08 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.435 0.694 . . . . 0.0 109.173 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -131.11 127.77 38.78 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 116.188 1.921 . . . . 0.0 116.188 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -124.91 126.24 45.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.433 1.708 . . . . 0.0 111.563 -161.184 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -69.6 122.54 19.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.185 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.95 6.6 1.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -85.89 -5.82 59.17 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 120.943 -1.098 . . . . 0.0 110.57 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -105.24 143.14 33.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.09 0.956 . . . . 0.0 109.932 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -45.36 -58.84 3.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.889 1.676 . . . . 0.0 109.427 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.92 -35.87 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.749 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -63.42 -42.99 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.489 1.041 . . . . 0.0 108.909 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -61.53 -44.32 97.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.685 0.794 . . . . 0.0 111.599 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -37.61 78.38 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.338 -1.476 . . . . 0.0 110.905 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.76 -39.83 65.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.842 1.657 . . . . 0.0 110.483 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -62.43 -31.79 72.55 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 123.037 0.535 . . . . 0.0 111.368 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -72.17 -8.92 57.4 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.37 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -131.05 30.25 4.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.93 1.692 . . . . 0.0 110.296 -173.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.43 144.27 52.17 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -63.84 158.96 67.78 Favored 'Cis proline' 0 N--CA 1.459 -0.503 0 CA-C-N 119.029 0.689 . . . . 0.0 113.604 -8.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -150.16 160.85 43.36 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 124.068 0.947 . . . . 0.0 110.682 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -114.45 160.21 19.44 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.187 0.995 . . . . 0.0 108.356 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.56 172.5 10.68 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.536 -0.727 . . . . 0.0 110.297 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.15 124.03 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.965 HG22 HG13 ' A' ' 117' ' ' VAL . 3.0 t -81.57 74.97 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 123.574 0.749 . . . . 0.0 110.356 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -68.07 163.94 21.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.858 0.754 . . . . 0.0 110.251 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.489 HG22 HG12 ' A' ' 43' ' ' ILE . 72.3 p -137.51 155.64 49.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.42 . . . . 0.0 110.197 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -155.6 99.19 2.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.41 -62.27 2.69 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 124.25 0.928 . . . . 0.0 115.18 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -168.75 40.56 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.958 1.703 . . . . 0.0 109.246 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.78 167.05 31.65 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 38' ' ' THR . 57.8 mt -135.39 133.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.027 1.331 . . . . 0.0 109.357 -176.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.95 159.25 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.968 0.907 . . . . 0.0 109.648 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 3.4 p90 -145.27 157.72 43.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.795 -1.191 . . . . 0.0 108.882 172.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -76.3 98.01 4.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.048 0.939 . . . . 0.0 109.4 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.1 p -68.93 144.79 96.16 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.142 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.7 -28.95 7.62 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.001 2.467 . . . . 0.0 111.003 175.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -67.25 140.21 19.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -121.66 114.98 21.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.94 154.18 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -134.71 21.37 3.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.604 0.761 . . . . 0.0 112.861 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -94.48 119.61 33.45 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.13 1.372 . . . . 0.0 110.94 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.81 112.87 14.02 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.588 1.155 . . . . 0.0 111.84 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.04 -25.95 36.74 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.504 1.122 . . . . 0.0 113.138 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -133.94 60.55 46.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 119.037 0.835 . . . . 0.0 110.675 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.4 95.38 0.61 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.924 2.416 . . . . 0.0 108.876 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.7 mtt-85 -85.35 169.31 13.84 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -123.94 4.71 8.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.743 0.417 . . . . 0.0 111.679 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.7 t -139.92 151.37 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.91 1.684 . . . . 0.0 106.659 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.47 -175.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.323 1.849 . . . . 0.0 109.503 -172.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -114.98 -179.3 3.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.272 1.029 . . . . 0.0 110.303 167.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 63' ' ' ILE . 70.6 mt -77.13 10.15 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 126.649 1.98 . . . . 0.0 110.999 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.39 32.26 1.87 Allowed Glycine 0 CA--C 1.524 0.65 0 O-C-N 120.165 -1.584 . . . . 0.0 112.371 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -123.5 169.74 11.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.35 1.075 . . . . 0.0 109.66 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -139.91 114.76 7.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 -177.46 48.69 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.103 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -131.11 138.7 49.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -116.46 82.63 12.37 Favored Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.406 ' HD2' ' CD ' ' A' ' 71' ' ' PRO . 4.0 Cg_exo -57.55 -47.25 22.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.669 2.246 . . . . 0.0 114.449 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' CD ' ' HD2' ' A' ' 70' ' ' PRO . 56.3 Cg_endo -68.26 -22.45 40.17 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.167 2.578 . . . . 0.0 111.141 -165.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.53 26.43 6.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.522 1.058 . . . . 0.0 113.165 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mttt 46.25 50.92 11.77 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.417 1.487 . . . . 0.0 112.174 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.7 -177.86 4.75 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.061 0.544 . . . . 0.0 110.973 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.405 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 2.7 tp -104.8 -170.96 1.84 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.047 1.739 . . . . 0.0 109.296 172.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.32 153.13 28.54 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.191 1.796 . . . . 0.0 110.05 158.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.57 102.37 4.59 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.986 2.514 . . . . 0.0 105.15 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -91.06 116.11 28.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.216 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.469 ' CD1' HD23 ' A' ' 108' ' ' LEU . 48.9 p90 -141.88 15.23 2.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.06 -146.1 4.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 104.75 8.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -69.28 166.27 31.19 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.502 2.321 . . . . 0.0 113.284 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.98 6.52 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 125.248 3.965 . . . . 0.0 113.419 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.89 136.38 53.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.164 1.785 . . . . 0.0 107.061 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 75.73 163.52 0.25 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 128.834 2.854 . . . . 0.0 109.679 -171.288 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.67 -42.51 2.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.97 -81.25 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.428 0.632 . . . . 0.0 111.223 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -98.94 153.84 18.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 127.334 2.254 . . . . 0.0 107.859 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.9 126.81 15.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 124.358 1.063 . . . . 0.0 109.05 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 18.2 mt-30 -126.96 150.42 71.8 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.16 0.984 . . . . 0.0 113.064 167.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.3 -174.43 2.2 Favored 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 126.315 4.677 . . . . 0.0 113.284 174.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.03 -10.1 59.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 t -173.84 -176.52 1.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.86 1.264 . . . . 0.0 108.806 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.28 73.81 0.5 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.414 1.486 . . . . 0.0 111.766 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.4 141.56 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.548 . . . . 0.0 110.31 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -74.76 125.47 28.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.91 49.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.78 -21.77 29.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.684 -172.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.45 164.03 13.44 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 119.631 1.105 . . . . 0.0 112.275 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -129.65 145.63 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.528 1.131 . . . . 0.0 108.352 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mt -76.09 101.67 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.83 -22.23 6.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.972 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -155.63 159.07 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.908 0.883 . . . . 0.0 111.652 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.96 11.02 70.93 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 118.746 -1.03 . . . . 0.0 115.145 169.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 tp -51.74 -48.25 63.74 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.005 1.403 . . . . 0.0 111.369 -172.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -70.2 -19.37 63.17 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 120.785 -1.197 . . . . 0.0 111.971 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.2 -0.67 32.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.247 1.019 . . . . 0.0 111.784 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 79' ' ' PHE . 4.9 mp -74.89 -39.01 61.73 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 119.954 -1.717 . . . . 0.0 111.567 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -63.68 -23.74 67.5 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.995 -1.066 . . . . 0.0 111.91 -172.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -94.45 23.0 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 0.0 112.679 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.46 165.63 2.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.397 1.479 . . . . 0.0 107.168 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -125.86 171.08 11.0 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.91 1.684 . . . . 0.0 108.095 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.01 1.91 2.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.218 2.207 . . . . 0.0 114.738 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.41 74.79 0.12 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.74 29.98 5.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.056 2.143 . . . . 0.0 110.029 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.4 mttt 43.07 101.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.611 2.764 . . . . 0.0 113.937 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.965 HG13 HG22 ' A' ' 36' ' ' VAL . 28.0 m -68.2 167.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 116.126 -2.23 . . . . 0.0 105.325 174.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -135.47 109.82 8.42 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 154.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.9 t -78.53 126.26 38.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 125.337 1.455 . . . . 0.0 107.087 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 mtm105 -128.92 176.04 8.18 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 0.0 110.231 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -72.53 -6.94 47.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 58.23 -166.38 0.16 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 126.81 2.044 . . . . 0.0 112.419 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . 0.288 12.0 p 62.97 -11.9 0.08 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.908 3.283 . . . . 0.0 116.961 170.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.257 1.492 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.189 174.151 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 ttm . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -68.4 160.88 28.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.048 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 16' ' ' LEU . 26.1 t -152.94 143.48 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 126.613 1.965 . . . . 0.0 107.126 170.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 41.0 tt0 -135.93 112.55 10.06 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 119.889 -1.757 . . . . 0.0 108.499 -171.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.57 92.26 9.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 131.412 3.885 . . . . 0.0 108.631 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.61 152.4 40.56 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 164.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -131.63 177.82 7.22 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.879 1.672 . . . . 0.0 107.62 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.18 -44.56 83.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.418 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m -86.16 -15.4 41.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -172.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.93 -165.49 34.0 Favored Glycine 0 N--CA 1.467 0.717 0 CA-C-N 120.734 1.606 . . . . 0.0 110.942 -166.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 138.01 8.94 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.915 1.358 . . . . 0.0 110.259 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.575 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 24.1 m -140.11 164.2 30.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.607 1.163 . . . . 0.0 111.772 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.29 112.67 21.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.428 1.091 . . . . 0.0 108.64 -167.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 pt -101.63 139.28 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.12 110.34 21.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 3' ' ' VAL . 25.0 mt -109.82 122.78 48.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.534 1.134 . . . . 0.0 109.708 -167.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.465 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 49.6 t30 -84.64 125.3 32.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.52 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.54 -1.82 12.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.597 1.559 . . . . 0.0 113.538 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.2 -21.14 64.88 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.139 0.881 . . . . 0.0 109.638 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 16.2 m-85 -92.79 124.63 36.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.321 1.448 . . . . 0.0 110.049 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -47.4 -53.91 12.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.241 1.817 . . . . 0.0 111.495 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -44.65 -40.43 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -71.76 -42.09 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.023 1.283 . . . . 0.0 109.958 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -59.26 -37.73 78.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.662 0.785 . . . . 0.0 110.085 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.49 -34.9 54.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.007 1.323 . . . . 0.0 109.983 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.97 -23.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.493 1.117 . . . . 0.0 112.052 172.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -14.4 50.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.742 1.156 . . . . 0.0 111.993 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -86.57 -14.37 43.07 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 120.723 -1.236 . . . . 0.0 112.25 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -124.93 4.58 8.02 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.433 1.093 . . . . 0.0 113.205 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.6 mt -104.6 141.33 22.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 120.1 1.318 . . . . 0.0 107.507 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.32 159.35 94.26 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.294 -0.711 . . . . 0.0 112.589 -6.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 119' ' ' VAL . 34.6 p90 -140.21 164.62 29.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 122.125 -0.359 . . . . 0.0 110.055 165.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -124.26 150.4 45.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.3 161.91 37.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.006 -172.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.01 123.07 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.69 98.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -85.77 155.14 21.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 165.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -131.79 144.55 51.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 108.731 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -154.1 102.63 2.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.47 19.76 79.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 116.45 -2.306 . . . . 0.0 116.674 154.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 76.94 37.96 0.27 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.851 2.826 . . . . 0.0 112.566 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 6.2 tt0 -131.71 163.74 27.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.612 1.965 . . . . 0.0 106.187 150.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.0 mt -127.79 146.24 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 127.009 2.124 . . . . 0.0 107.097 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -134.95 169.32 17.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 122.678 1.228 . . . . 0.0 109.715 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -149.99 150.55 31.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -88.75 82.79 6.74 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -167.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.782 HG21 HD23 ' A' ' 75' ' ' LEU . 11.0 p -65.26 147.92 98.28 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -165.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.19 -26.22 12.86 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.623 2.216 . . . . 0.0 112.072 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.3 136.46 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -122.66 100.02 6.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.733 1.613 . . . . 0.0 107.38 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.04 171.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 129.034 2.934 . . . . 0.0 104.669 165.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.94 3.14 2.0 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 166.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -44.81 118.84 1.74 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.918 1.287 . . . . 0.0 111.053 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtm -108.72 90.59 3.34 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.78 2.032 . . . . 0.0 106.042 -171.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -67.94 -26.88 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.455 -0.778 . . . . 0.0 111.466 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -153.7 54.83 1.2 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.141 1.776 . . . . 0.0 113.692 -167.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.58 162.97 19.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.762 1.642 . . . . 0.0 111.993 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -146.63 -175.71 4.9 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 128.331 2.652 . . . . 0.0 106.489 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -120.28 1.15 10.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.322 1.049 . . . . 0.0 112.916 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.62 159.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.269 2.227 . . . . 0.0 108.998 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.6 m -141.3 -179.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.809 2.044 . . . . 0.0 109.233 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -88.76 178.56 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 120.722 -1.236 . . . . 0.0 110.844 163.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.674 ' O ' HD11 ' A' ' 105' ' ' LEU . 38.7 mt -76.56 4.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.489 1.516 . . . . 0.0 110.261 173.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 43.07 0.67 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -111.78 -154.47 0.54 Allowed 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 129.368 3.067 . . . . 0.0 103.412 161.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.917 HG11 ' HA3' ' A' ' 99' ' ' GLY . 4.9 p -158.72 177.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -143.89 152.26 24.06 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 119.641 -1.912 . . . . 0.0 111.55 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -105.22 123.84 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.321 1.048 . . . . 0.0 109.189 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.401 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 8.1 t90 -104.76 88.29 2.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 127.403 2.281 . . . . 0.0 109.246 -172.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD2' ' CD ' ' A' ' 71' ' ' PRO . 73.5 Cg_endo -61.64 -31.15 86.55 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.033 1.822 . . . . 0.0 115.366 -171.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD2' ' C ' ' A' ' 69' ' ' TRP . 50.7 Cg_endo -67.17 -36.7 20.65 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 123.48 2.278 . . . . 0.0 109.463 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.93 64.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.138 -1.368 . . . . 0.0 113.501 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 45.78 55.63 6.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.388 2.094 . . . . 0.0 108.904 -166.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.83 157.83 44.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.782 HD23 HG21 ' A' ' 47' ' ' THR . 3.5 mm? -90.55 176.16 6.79 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.32 124.54 7.5 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.871 1.268 . . . . 0.0 108.855 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' GLU . 8.0 mp -106.19 115.17 29.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.72 2.408 . . . . 0.0 107.553 174.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -107.73 110.45 22.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.862 1.21 . . . . 0.0 108.204 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -125.77 11.24 7.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.695 0.798 . . . . 0.0 112.826 -170.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.64 -128.6 0.96 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 165.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -132.77 107.91 8.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.119 1.459 . . . . 0.0 110.584 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -64.85 165.51 15.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 126.655 1.982 . . . . 0.0 113.383 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.93 7.49 1.31 Allowed 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.889 4.393 . . . . 0.0 114.523 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.1 mmt -116.08 81.37 1.6 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.529 -1.357 . . . . 0.0 109.505 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 p 174.92 -177.03 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.041 2.137 . . . . 0.0 107.632 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -127.94 -59.51 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 143.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -81.4 -37.34 28.3 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.43 162.36 34.65 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.427 1.491 . . . . 0.0 107.733 -165.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.13 83.97 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 121.373 1.897 . . . . 0.0 108.334 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.68 146.29 52.69 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 126.768 2.027 . . . . 0.0 109.923 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.53 -175.34 1.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.932 3.755 . . . . 0.0 112.043 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -38.98 61.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.145 1.378 . . . . 0.0 113.751 168.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -173.24 174.25 3.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.661 1.584 . . . . 0.0 109.118 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.37 103.02 0.05 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.6 1.56 . . . . 0.0 111.31 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 93' ' ' SER . 17.2 m -112.21 142.7 23.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.446 1.099 . . . . 0.0 109.734 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -79.58 125.45 29.62 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -90.06 71.06 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.5 pt -87.4 -32.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.917 ' HA3' HG11 ' A' ' 66' ' ' VAL . . . -75.74 169.41 54.77 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 161.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.63 147.56 35.23 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 101.948 -3.352 . . . . 0.0 101.948 131.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.99 83.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 156.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.4 -41.0 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 120.558 -1.339 . . . . 0.0 111.016 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.49 150.09 46.07 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 125.739 1.615 . . . . 0.0 108.713 -169.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 78.35 78.08 0.83 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.674 HD11 ' O ' ' A' ' 63' ' ' ILE . 2.0 tp -108.77 -60.52 1.73 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.164 1.786 . . . . 0.0 110.108 172.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.49 -23.22 58.83 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.47 -0.769 . . . . 0.0 110.439 -172.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -24.11 54.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.415 1.086 . . . . 0.0 111.085 173.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.46 -29.57 56.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.399 0.999 . . . . 0.0 112.027 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -72.4 17.85 0.1 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.952 -1.092 . . . . 0.0 112.74 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -147.85 23.34 1.1 Allowed 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 126.124 1.77 . . . . 0.0 112.437 -178.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.2 mm -105.82 141.05 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 43.3 mmtt -85.18 174.73 9.44 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.4 1.48 . . . . 0.0 109.842 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.61 43.2 0.73 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.674 1.59 . . . . 0.0 112.643 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.43 64.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.385 0 O-C-N 120.12 -1.613 . . . . 0.0 111.91 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 6.2 mm-40 -122.22 24.64 9.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.025 1.73 . . . . 0.0 112.405 -172.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mttp 43.41 86.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.632 2.373 . . . . 0.0 113.494 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.69 104.81 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.804 -0.56 . . . . 0.0 109.522 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.71 96.8 7.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.824 1.65 . . . . 0.0 109.59 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.411 HG11 ' CE1' ' A' ' 32' ' ' PHE . 79.1 t -77.42 117.64 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.779 2.432 . . . . 0.0 108.177 174.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.494 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -130.7 173.74 10.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.92 1.288 . . . . 0.0 109.821 177.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -79.55 -10.6 59.83 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 121.547 1.976 . . . . 0.0 115.602 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 66.92 102.76 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.016 2.126 . . . . 0.0 111.067 -175.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.69 35.02 2.9 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.086 -1.009 . . . . 0.0 110.368 168.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.977 1.711 . . . . 0.0 110.568 -177.251 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttm . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.674 1.225 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.502 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 46.9 mtm-85 -67.2 161.19 25.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.66 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 t -146.73 105.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.521 1.128 . . . . 0.0 107.978 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.635 ' HA ' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -80.78 142.15 34.05 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.636 -1.29 . . . . 0.0 109.403 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.98 97.69 5.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.044 0.938 . . . . 0.0 111.48 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 148.41 25.51 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.98 175.94 8.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.946 1.698 . . . . 0.0 110.36 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -78.2 -5.12 50.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -132.85 5.17 3.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -167.87 39.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -158.95 163.69 36.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.45 1.1 . . . . 0.0 108.25 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 p -161.73 179.87 7.78 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 130.198 3.399 . . . . 0.0 103.862 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -149.68 150.85 13.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 112.126 -2.306 . . . . 0.0 105.115 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 25.1 pt -129.79 114.99 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 124.675 1.19 . . . . 0.0 109.246 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -89.45 107.52 19.12 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.7 -170.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.59 138.61 46.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.768 0.713 . . . . 0.0 110.586 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -87.98 149.51 23.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.742 -0.599 . . . . 0.0 109.69 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.38 -0.66 53.51 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.622 1.169 . . . . 0.0 114.135 -164.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -96.21 5.72 50.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.134 1.374 . . . . 0.0 109.024 -167.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -111.53 133.29 53.91 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.014 2.126 . . . . 0.0 109.178 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.71 -51.7 66.4 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.402 1.081 . . . . 0.0 110.218 -170.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -49.74 -36.06 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.452 1.501 . . . . 0.0 114.456 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.07 -39.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 119.786 1.175 . . . . 0.0 109.283 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.38 -37.5 80.97 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 0.0 110.427 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.0 -36.23 30.93 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.936 0.894 . . . . 0.0 110.735 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.08 -28.32 66.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.361 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -58.52 -26.91 64.0 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.677 0.671 . . . . 0.0 111.591 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -68.12 -26.13 65.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.989 0.813 . . . . 0.0 110.541 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -124.22 24.3 8.13 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 120.952 -1.093 . . . . 0.0 112.614 -160.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.7 mt -115.61 153.38 47.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.449 1.477 . . . . 0.0 108.335 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.26 160.83 23.75 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.067 -1.222 . . . . 0.0 111.341 -24.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' CE1' HG11 ' A' ' 119' ' ' VAL . 33.0 p90 -146.85 171.34 15.35 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.224 1.41 . . . . 0.0 109.756 169.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -122.25 162.58 21.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.252 1.021 . . . . 0.0 109.408 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 -179.92 6.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.063 0.545 . . . . 0.0 109.807 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.15 142.26 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 117' ' ' VAL . 18.3 t -91.65 76.35 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.943 1.297 . . . . 0.0 107.803 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -69.82 156.48 38.98 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.899 -1.126 . . . . 0.0 108.912 175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.5 p -136.45 137.81 40.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.281 1.032 . . . . 0.0 109.956 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 92' ' ' ALA . 67.9 t90 -142.58 75.6 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.454 1.502 . . . . 0.0 108.163 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.13 81.53 0.19 Allowed Glycine 0 C--O 1.218 -0.847 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.987 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 51.6 63.44 2.24 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 118.367 1.084 . . . . 0.0 109.253 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.9 154.87 15.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -131.66 144.09 38.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -148.74 170.62 17.79 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.332 1.453 . . . . 0.0 109.945 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.42 144.13 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.291 1.036 . . . . 0.0 109.256 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -74.85 84.95 2.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.796 2.038 . . . . 0.0 109.384 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 p -61.78 152.32 76.25 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-O 121.413 0.625 . . . . 0.0 111.869 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -81.18 0.23 10.11 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.13 3.22 . . . . 0.0 112.584 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 51' ' ' VAL . 16.9 t -105.55 134.19 47.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 125.12 1.368 . . . . 0.0 108.541 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -114.97 18.03 16.59 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.92 0.888 . . . . 0.0 112.589 -168.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 49' ' ' VAL . 8.3 p -69.33 150.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.739 0.781 . . . . 0.0 112.354 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -135.76 40.9 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.758 2.423 . . . . 0.0 108.586 -172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.411 ' H ' HG22 ' A' ' 51' ' ' VAL . 58.5 tttp -121.61 105.84 10.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.105 2.162 . . . . 0.0 111.165 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -93.19 130.79 38.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.359 1.463 . . . . 0.0 109.716 171.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.32 -44.88 8.48 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.683 -0.636 . . . . 0.0 110.864 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -114.46 60.67 1.09 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.121 0.968 . . . . 0.0 109.581 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.12 144.67 42.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.36 2.04 . . . . 0.0 112.593 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -143.64 164.97 28.91 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.533 0.733 . . . . 0.0 109.751 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.07 12.98 18.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.414 1.886 . . . . 0.0 110.51 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -166.78 150.93 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 129.987 3.315 . . . . 0.0 110.016 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.09 -175.49 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.94 1.296 . . . . 0.0 111.74 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -94.58 175.48 6.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.821 1.248 . . . . 0.0 110.817 170.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 63' ' ' ILE . 51.7 mt -81.44 33.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.692 1.597 . . . . 0.0 111.074 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.508 ' HA2' HD21 ' A' ' 105' ' ' LEU . . . -167.96 34.67 0.2 Allowed Glycine 0 CA--C 1.511 -0.207 0 O-C-N 120.369 -1.457 . . . . 0.0 111.888 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -121.6 -175.28 3.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.214 1.006 . . . . 0.0 108.35 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -139.12 164.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.182 1.793 . . . . 0.0 107.6 -168.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -165.34 129.12 1.89 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.49 144.5 49.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -114.34 86.79 12.57 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.486 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 68.8 Cg_endo -65.98 -22.23 55.68 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.243 2.629 . . . . 0.0 117.512 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.486 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 42.7 Cg_endo -80.48 -19.1 9.15 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 CA-C-N 123.007 2.11 . . . . 0.0 112.096 -171.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.35 -9.67 11.41 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.615 1.579 . . . . 0.0 114.137 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 58.83 84.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.094 2.157 . . . . 0.0 111.299 -164.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.28 175.92 13.23 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.14 -172.42 3.95 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.687 1.595 . . . . 0.0 110.928 162.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 15.8 t -158.22 149.8 21.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.866 1.666 . . . . 0.0 109.09 161.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.46 128.86 47.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.99 2.516 . . . . 0.0 109.448 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.05 112.91 24.01 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 125.011 1.324 . . . . 0.0 109.363 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -134.33 5.55 3.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.767 2.427 . . . . 0.0 113.459 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.18 -168.32 40.43 Favored Glycine 0 CA--C 1.52 0.405 0 O-C-N 119.978 -1.701 . . . . 0.0 110.707 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.08 102.27 14.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -163.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.8 p -74.79 166.33 46.22 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 110.824 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.5 -19.88 48.31 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.362 2.708 . . . . 0.0 113.334 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.7 tpt -97.41 50.69 1.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.229 1.011 . . . . 0.0 110.317 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.0 p -158.93 177.84 10.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.147 0.579 . . . . 0.0 110.26 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.52 -62.46 0.87 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 148.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.05 -49.04 21.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.116 0.96 . . . . 0.0 111.912 -166.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -136.7 158.7 43.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.239 1.816 . . . . 0.0 108.205 -164.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mt -79.6 83.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.56 143.64 59.61 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.807 1.643 . . . . 0.0 111.398 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -81.97 174.99 9.67 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.436 3.424 . . . . 0.0 112.284 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.528 ' HB2' ' CH2' ' A' ' 39' ' ' TRP . . . -66.97 -20.5 65.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 m -156.93 170.35 22.7 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.81 2.444 . . . . 0.0 108.892 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.11 0.51 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.852 0.751 . . . . 0.0 109.848 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.89 -165.62 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 128.275 2.63 . . . . 0.0 107.396 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -139.8 127.37 21.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 112.511 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 32.75 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.432 -1.418 . . . . 0.0 111.1 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -61.25 -15.63 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 119.68 -1.887 . . . . 0.0 113.698 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.73 165.83 15.32 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 33.3 tptt -134.7 126.18 28.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 170.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.78 93.17 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 166.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.564 ' CG2' HG13 ' A' ' 13' ' ' VAL . 30.8 m -76.42 -63.32 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.612 ' HB2' HG12 ' A' ' 13' ' ' VAL . 1.1 mm-40 -93.07 166.03 12.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -172.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.38 16.57 80.62 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-N 115.241 -0.89 . . . . 0.0 114.793 158.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -54.88 -62.61 1.55 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.162 0.985 . . . . 0.0 109.276 -173.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.35 -21.2 62.92 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.176 -167.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.5 -19.83 64.55 Favored 'General case' 0 C--O 1.225 -0.23 0 O-C-N 121.67 -0.644 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.61 -18.52 65.38 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.618 -1.301 . . . . 0.0 113.44 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -59.11 -29.54 67.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.086 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 27.86 9.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.653 1.115 . . . . 0.0 112.879 -163.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.61 150.55 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -92.84 170.67 9.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.92 15.81 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.643 2.377 . . . . 0.0 112.932 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.71 54.67 0.09 OUTLIER Glycine 0 CA--C 1.533 1.173 0 O-C-N 119.206 -2.184 . . . . 0.0 114.758 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.424 ' CG ' ' H ' ' A' ' 112' ' ' LYS . 13.6 mm-40 -100.3 32.35 3.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.938 1.295 . . . . 0.0 113.274 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.8 mttp 42.03 74.78 0.1 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.309 1.844 . . . . 0.0 112.619 171.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.574 ' HB ' HG22 ' A' ' 36' ' ' VAL . 7.5 p -68.14 105.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.25 88.91 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.39 1.476 . . . . 0.0 107.185 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.511 HG11 ' CE1' ' A' ' 32' ' ' PHE . 90.6 t -71.51 134.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 126.704 2.002 . . . . 0.0 108.648 -173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -141.93 -172.21 3.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.231 1.812 . . . . 0.0 110.332 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -99.9 0.1 40.62 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . 60.72 82.56 0.16 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 126.989 2.116 . . . . 0.0 112.718 -169.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.59 24.43 1.97 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.139 165.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.253 1.286 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 160.177 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.236 0.363 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 152.92 42.83 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.9 t -150.91 130.98 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.267 1.427 . . . . 0.0 107.613 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 22.2 tt0 -115.56 120.53 39.77 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.516 2.326 . . . . 0.0 107.01 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 117' ' ' VAL . 11.2 mp -98.25 109.34 22.11 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 126.884 2.074 . . . . 0.0 106.903 172.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 126.94 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -110.11 173.03 6.51 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.069 0.948 . . . . 0.0 108.445 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.55 -17.66 62.3 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.046 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -115.48 4.59 14.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.594 1.557 . . . . 0.0 114.666 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.75 -164.98 38.38 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.642 -1.286 . . . . 0.0 110.724 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -157.83 158.63 35.53 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.067 0.947 . . . . 0.0 109.079 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -145.38 177.31 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.998 0.919 . . . . 0.0 108.971 174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 t -135.11 133.29 53.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.0 pt -122.66 166.32 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -144.7 135.99 25.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -125.32 114.93 19.55 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 126.686 1.994 . . . . 0.0 108.627 -168.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.92 132.25 52.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.381 0.673 . . . . 0.0 110.411 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.68 21.05 0.21 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.311 1.444 . . . . 0.0 113.842 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.0 10.24 22.16 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.329 1.052 . . . . 0.0 110.454 -173.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -122.72 137.33 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.589 1.156 . . . . 0.0 108.938 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.94 -53.67 30.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.963 0.905 . . . . 0.0 110.458 -173.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.37 -32.25 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.36 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.26 -50.45 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.855 1.262 . . . . 0.0 107.886 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -58.71 -43.83 90.19 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.155 0.582 . . . . 0.0 110.942 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -41.97 90.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.766 0.826 . . . . 0.0 109.351 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.34 -28.6 54.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.93 1.292 . . . . 0.0 111.112 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -60.74 -29.96 69.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.713 0.688 . . . . 0.0 110.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -72.35 -14.42 61.72 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.595 0.758 . . . . 0.0 111.863 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -125.29 24.47 7.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.769 1.628 . . . . 0.0 110.982 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mt -121.56 136.86 26.33 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.26 164.97 57.82 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 N-CA-C 114.772 1.028 . . . . 0.0 114.772 -7.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.26 165.49 35.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.686 0.794 . . . . 0.0 112.136 166.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -121.78 160.11 25.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.366 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -163.57 -159.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.432 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.12 134.49 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.075 1.35 . . . . 0.0 108.606 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.38 76.34 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 124.884 1.274 . . . . 0.0 108.111 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -69.31 144.96 53.39 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.256 -1.527 . . . . 0.0 107.615 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.5 p -129.07 147.31 50.92 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.624 0.647 . . . . 0.0 110.215 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -151.79 64.32 0.86 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.725 0.81 . . . . 0.0 109.685 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 82' ' ' THR . . . 70.91 77.72 0.48 Allowed Glycine 0 C--O 1.211 -1.298 0 O-C-N 120.98 -1.075 . . . . 0.0 111.581 170.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 62.06 23.0 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.106 1.453 . . . . 0.0 112.333 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -126.49 145.98 50.29 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.649 2.38 . . . . 0.0 107.317 171.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mt -122.73 144.48 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 163.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.08 158.17 43.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 166.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -141.89 153.85 44.7 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.2 t -79.91 104.54 10.55 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -68.43 149.64 97.96 Favored Pre-proline 0 N--CA 1.447 -0.588 0 O-C-N 121.813 -0.554 . . . . 0.0 110.008 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.72 -36.85 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.076 2.518 . . . . 0.0 110.793 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 149.36 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -132.2 121.87 24.35 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.539 1.936 . . . . 0.0 106.048 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.9 143.81 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -128.54 36.37 4.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.3 1.04 . . . . 0.0 111.31 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -128.91 114.87 17.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.093 2.557 . . . . 0.0 107.623 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 162.27 13.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.443 1.097 . . . . 0.0 109.933 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.2 -39.8 3.56 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.996 1.719 . . . . 0.0 110.517 166.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -122.0 60.85 12.65 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.174 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.61 131.49 29.74 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.007 1.138 . . . . 0.0 110.61 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -129.79 124.94 34.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -90.19 0.48 57.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.339 0.518 . . . . 0.0 111.919 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -137.29 135.58 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.65 173.27 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.959 -167.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -115.65 168.02 10.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.937 0.875 . . . . 0.0 112.866 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.2 mt -78.52 68.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.789 2.035 . . . . 0.0 106.85 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.77 -1.14 0.16 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.406 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.3 174.54 7.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.306 2.053 . . . . 0.0 109.564 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.29 146.55 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.181 1.392 . . . . 0.0 107.941 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.64 161.03 26.18 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.316 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -81.21 146.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 168.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.422 ' HE1' ' HG ' ' A' ' 93' ' ' SER . 6.5 t90 -121.03 85.43 40.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.897 1.279 . . . . 0.0 108.382 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.05 -38.96 84.57 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.382 2.055 . . . . 0.0 115.854 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.5 -28.5 32.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.673 2.249 . . . . 0.0 109.814 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.82 4.52 75.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.028 -1.429 . . . . 0.0 114.535 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.96 25.84 4.29 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.47 2.135 . . . . 0.0 112.728 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.44 178.1 7.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.08 -158.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -172.97 4.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.166 166.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.7 m -148.25 158.37 44.04 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.888 2.475 . . . . 0.0 107.02 161.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mt -146.62 114.25 6.4 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.138 1.775 . . . . 0.0 109.488 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -102.73 106.22 16.81 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.103 0.961 . . . . 0.0 110.335 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -138.28 18.25 2.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.47 -134.25 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.148 0.885 . . . . 0.0 111.514 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -127.64 94.44 3.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 40' ' ' GLY . 0.7 OUTLIER -64.67 154.26 85.42 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.86 1.664 . . . . 0.0 111.222 -175.076 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.97 5.36 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 125.087 3.858 . . . . 0.0 113.685 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.98 24.75 12.3 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.379 1.472 . . . . 0.0 109.212 175.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.46 166.63 23.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.552 1.541 . . . . 0.0 107.985 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -153.17 -68.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -170.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.407 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 19.3 t70 -73.69 -50.83 18.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 122.206 1.003 . . . . 0.0 111.106 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -129.77 177.57 7.15 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 130.369 3.467 . . . . 0.0 107.187 -173.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -80.89 141.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.99 1.268 . . . . 0.0 108.62 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -141.46 144.87 35.43 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.02 0.928 . . . . 0.0 110.236 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.1 169.58 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.501 3.467 . . . . 0.0 113.911 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.16 64.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.422 ' HG ' ' HE1' ' A' ' 69' ' ' TRP . 81.7 p -164.52 -168.86 1.61 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.475 1.11 . . . . 0.0 108.195 165.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 76.9 0.12 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.697 0.761 . . . . 0.0 111.567 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.52 169.84 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.765 1.226 . . . . 0.0 109.242 165.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -114.71 129.16 56.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.866 1.266 . . . . 0.0 109.729 171.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.83 86.13 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.6 pt -103.73 -22.64 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 110.504 170.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.03 163.64 12.51 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -128.41 145.32 51.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.246 1.018 . . . . 0.0 108.596 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 91.9 mt -74.08 102.39 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 158.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -27.88 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 112.783 -2.008 . . . . 0.0 107.293 -167.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -155.86 161.45 40.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.022 2.529 . . . . 0.0 112.299 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.85 30.78 37.79 Favored Glycine 0 C--O 1.221 -0.674 0 CA-C-O 118.205 -1.331 . . . . 0.0 113.284 172.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.73 -41.36 97.53 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.142 1.971 . . . . 0.0 113.17 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.81 -19.87 47.46 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.121 -0.987 . . . . 0.0 111.246 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.3 -22.72 63.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.705 1.202 . . . . 0.0 110.371 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.04 -34.42 77.65 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.167 1.787 . . . . 0.0 110.285 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -67.56 -2.62 6.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -100.9 -16.03 17.35 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 123.929 0.892 . . . . 0.0 112.01 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.02 165.27 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.01 0.823 . . . . 0.0 109.65 -165.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -113.69 -179.76 3.73 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.202 1.401 . . . . 0.0 108.449 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.16 22.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.028 2.131 . . . . 0.0 114.876 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.99 26.81 0.03 OUTLIER Glycine 0 C--N 1.338 0.666 0 O-C-N 119.817 -1.802 . . . . 0.0 115.907 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.06 49.05 1.04 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.806 1.803 . . . . 0.0 112.052 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.2 mttt 42.98 82.53 0.03 OUTLIER 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.263 2.225 . . . . 0.0 114.161 157.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.515 HG21 HD23 ' A' ' 5' ' ' LEU . 4.8 p -76.73 104.09 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.415 1.486 . . . . 0.0 107.699 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.37 101.07 13.21 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.72 134.01 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 128.58 2.752 . . . . 0.0 107.632 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -138.98 175.36 9.62 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.194 2.598 . . . . 0.0 109.634 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -73.6 -10.2 59.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 121.025 1.739 . . . . 0.0 114.884 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 63.97 162.96 0.12 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 126.097 1.759 . . . . 0.0 111.105 -154.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.6 m -141.6 2.19 1.59 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.944 2.098 . . . . 0.0 110.212 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.252 1.196 0 C-N-CA 125.489 1.516 . . . . 0.0 108.763 173.806 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpp . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -112.82 179.68 3.9 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.51 1.924 . . . . 0.0 107.706 162.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.5 t -147.59 150.31 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.274 2.229 . . . . 0.0 106.838 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 27.5 tt0 -125.23 145.71 49.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.705 2.002 . . . . 0.0 107.256 173.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.8 mt -121.98 111.96 17.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.99 122.17 44.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -106.8 172.08 7.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.4 -23.82 67.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.588 0.755 . . . . 0.0 111.562 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -125.26 8.74 7.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -167.79 40.84 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-O 119.527 -0.596 . . . . 0.0 111.816 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -159.2 153.66 24.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.831 0.815 . . . . 0.0 111.117 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.0 p -136.8 179.42 6.38 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.426 0.691 . . . . 0.0 110.595 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.61 135.22 49.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.51 124.45 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -96.31 117.89 31.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.986 1.314 . . . . 0.0 107.754 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -128.12 135.72 50.18 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 118.848 0.749 . . . . 0.0 109.715 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -101.04 106.78 18.1 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.01 1.71 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 1 C-N-CA 131.836 4.054 . . . . 0.0 117.151 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.76 -44.21 64.45 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.635 -1.29 . . . . 0.0 107.953 164.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -62.6 139.69 58.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 110.194 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.74 -56.35 16.19 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.283 1.833 . . . . 0.0 107.28 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.441 HG12 HD23 ' A' ' 26' ' ' LEU . 1.5 t -57.45 -38.64 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.042 -173.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.36 -35.62 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.001 -170.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -61.25 -47.32 86.57 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.876 -0.515 . . . . 0.0 111.008 170.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -32.25 71.36 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.719 1.208 . . . . 0.0 110.417 -171.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.773 ' CD2' HG11 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -59.94 -40.99 90.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.389 1.876 . . . . 0.0 109.825 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -50.42 -36.19 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.897 0.879 . . . . 0.0 110.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -69.89 -23.83 63.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.615 0.766 . . . . 0.0 111.622 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -113.13 -10.35 13.43 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 111.336 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -83.21 143.57 45.47 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -70.17 149.72 90.02 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 125.47 -0.637 . . . . 0.0 112.229 -10.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -139.48 168.33 20.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.124 0.97 . . . . 0.0 109.802 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -114.13 166.0 12.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.32 161.24 39.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.603 -0.685 . . . . 0.0 109.928 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.76 128.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 43' ' ' ILE . 35.5 t -77.62 107.45 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 167.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -96.61 151.23 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 163.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.4 p -122.46 149.97 43.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.214 1.006 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -149.43 92.88 1.99 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.2 -88.17 0.49 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 123.646 0.641 . . . . 0.0 111.758 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HB2' ' H ' ' A' ' 82' ' ' THR . 98.0 mt-10 -141.43 36.74 1.68 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.972 1.709 . . . . 0.0 107.944 -173.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -133.17 163.84 28.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 109.681 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.507 HG23 HG13 ' A' ' 36' ' ' VAL . 20.0 mt -123.07 142.59 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -136.46 161.56 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.588 1.555 . . . . 0.0 107.303 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.39 142.83 27.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -75.2 93.33 2.81 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.566 1.146 . . . . 0.0 109.325 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.1 p -62.29 150.92 83.51 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -67.9 -39.04 11.91 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.107 2.538 . . . . 0.0 110.914 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.773 HG11 ' CD2' ' A' ' 26' ' ' LEU . 11.9 p -67.24 155.25 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.595 -0.69 . . . . 0.0 109.673 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -154.63 56.11 0.68 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.329 0.652 . . . . 0.0 112.464 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.12 173.3 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 0.0 110.103 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.0 14.03 2.26 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -69.94 127.76 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -136.03 93.99 2.99 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.827 1.251 . . . . 0.0 110.205 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -75.33 -43.54 50.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -117.19 66.35 4.25 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 111.635 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.31 155.39 69.46 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 120.759 0.972 . . . . 0.0 111.212 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -144.61 157.72 44.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.605 1.162 . . . . 0.0 108.911 168.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -119.63 5.48 11.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.85 1.26 . . . . 0.0 111.892 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.3 145.05 27.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.15 179.45 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.805 0.842 . . . . 0.0 110.115 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -87.88 -168.59 2.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 0.0 111.139 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.408 ' O ' HD11 ' A' ' 105' ' ' LEU . 13.7 mt -90.79 -8.62 10.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 124.803 1.241 . . . . 0.0 110.917 161.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.68 83.22 0.25 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 105.663 -2.975 . . . . 0.0 105.663 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -141.15 -175.18 4.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.74 3.216 . . . . 0.0 105.884 152.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.96 163.3 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 131.312 3.845 . . . . 0.0 109.443 -166.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.91 144.25 9.3 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.87 163.52 27.19 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.169 0.984 . . . . 0.0 109.771 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -136.66 87.31 20.86 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 109.973 -172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.58 -27.53 69.6 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 121.465 1.443 . . . . 0.0 115.201 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.79 -28.39 16.88 Favored 'Trans proline' 0 C--N 1.354 0.822 0 CA-C-N 123.787 2.388 . . . . 0.0 111.362 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.28 9.93 26.63 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.736 -1.035 . . . . 0.0 113.737 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm 46.17 55.84 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.697 1.599 . . . . 0.0 110.814 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.93 176.94 7.47 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.699 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.0 174.49 6.53 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 125.784 1.633 . . . . 0.0 109.929 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.61 137.2 23.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.565 1.946 . . . . 0.0 109.861 162.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.64 109.7 14.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.745 3.618 . . . . 0.0 106.079 172.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.23 49.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.647 1.112 . . . . 0.0 108.632 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -147.01 34.57 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.93 -120.94 0.55 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.877 2.18 . . . . 0.0 108.135 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.81 5.8 7.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.667 1.733 . . . . 0.0 113.302 170.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 41' ' ' GLU 0.298 0.0 OUTLIER 62.93 167.72 0.1 Allowed Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.68 1.127 . . . . 0.0 113.858 167.948 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -91.41 6.15 3.7 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.973 3.115 . . . . 0.0 113.527 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -132.54 62.86 1.64 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.7 1.136 . . . . 0.0 108.277 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -156.62 175.0 14.62 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.343 1.457 . . . . 0.0 109.633 -174.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -148.38 -50.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 154.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.41 -58.98 2.97 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -132.2 168.46 18.0 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.228 2.611 . . . . 0.0 108.502 -167.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.73 122.06 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -129.77 144.32 52.51 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 123.413 0.445 . . . . 0.0 110.479 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.02 173.26 14.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.136 3.224 . . . . 0.0 112.717 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.12 -33.29 75.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.76 175.03 10.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.154 1.382 . . . . 0.0 107.511 172.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 100.33 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.18 -173.46 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -130.92 125.14 32.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.266 2.4 t -90.39 61.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.838 -163.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.3 pt -77.14 -10.48 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.715 2.006 . . . . 0.0 112.398 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.18 167.18 12.58 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 130.423 3.868 . . . . 0.0 112.268 -166.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -148.14 129.04 14.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.825 2.05 . . . . 0.0 106.751 150.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.8 mt -56.98 100.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 155.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 m -76.57 -36.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 118.903 0.774 . . . . 0.0 110.869 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -149.97 164.13 36.28 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.29 1.036 . . . . 0.0 111.142 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.5 33.05 71.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.994 1.283 . . . . 0.0 112.59 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 63' ' ' ILE . 55.0 tp -58.74 -52.33 66.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.332 1.053 . . . . 0.0 112.288 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.48 -21.26 56.06 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.001 -0.437 . . . . 0.0 111.316 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -9.89 6.63 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.021 1.328 . . . . 0.0 111.75 175.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.9 mt -79.78 -41.23 26.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.808 1.643 . . . . 0.0 111.611 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -65.23 -12.2 48.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.825 -1.172 . . . . 0.0 113.142 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -102.96 14.17 32.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.566 1.146 . . . . 0.0 112.125 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -107.3 127.47 63.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.253 1.421 . . . . 0.0 107.727 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -70.27 174.34 5.71 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.287 1.035 . . . . 0.0 110.471 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.34 49.57 0.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.929 1.692 . . . . 0.0 111.624 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.03 88.54 0.07 OUTLIER Glycine 0 C--O 1.231 -0.074 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -138.5 26.68 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 -173.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 mttm 43.41 75.33 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.013 2.125 . . . . 0.0 111.746 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.75 105.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.72 102.35 10.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.95 123.5 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 126.423 1.889 . . . . 0.0 107.669 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -132.97 172.43 12.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.14 1.336 . . . . 0.0 109.139 164.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -70.76 -12.49 61.58 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 55.66 99.43 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.122 1.369 . . . . 0.0 109.969 -162.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 87.5 p 59.09 -13.16 0.03 OUTLIER 'General case' 0 C--N 1.335 -0.061 0 N-CA-C 119.101 3.0 . . . . 0.0 119.101 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.247 0.931 0 CA-C-N 119.107 0.867 . . . . 0.0 109.133 -147.989 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttp . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -94.72 164.91 12.75 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.206 1.002 . . . . 0.0 109.821 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -149.27 132.5 7.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 35.0 tt0 -113.06 140.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 mp -114.15 99.97 8.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.38 142.44 33.01 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -133.96 165.91 23.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.42 -17.16 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.912 -1.118 . . . . 0.0 112.332 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 m -115.61 -6.01 12.19 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.44 -169.01 39.93 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 120.633 1.56 . . . . 0.0 109.511 -172.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -169.95 113.29 0.48 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.002 0.906 . . . . 0.0 111.578 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.542 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 30.7 m -119.46 171.69 8.17 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.961 1.304 . . . . 0.0 108.713 -169.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 t -139.9 133.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -166.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.5 pt -123.36 160.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 123.386 1.565 . . . . 0.0 108.371 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.433 ' CA ' HD22 ' A' ' 16' ' ' LEU . 11.9 p-10 -145.96 128.18 15.74 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.555 -164.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -129.85 149.19 51.69 Favored 'General case' 0 C--O 1.246 0.887 0 O-C-N 125.08 1.487 . . . . 0.0 110.291 -166.179 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -87.01 22.34 2.06 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 24.1 mt-10 46.27 14.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.844 2.058 . . . . 0.0 116.215 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -116.18 10.53 14.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.013 -1.055 . . . . 0.0 110.084 -166.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -125.71 135.68 52.35 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -171.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -47.34 -51.31 19.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 110.152 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.279 7.5 p -48.86 -56.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.678 1.991 . . . . 0.0 112.376 172.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.74 -45.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 121.797 2.09 . . . . 0.0 110.74 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 18' ' ' GLU . 79.9 mttt -65.51 -43.15 91.0 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.775 0.83 . . . . 0.0 111.602 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.4 mt -75.43 -30.8 60.14 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.336 1.055 . . . . 0.0 110.222 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.96 -26.11 61.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.321 1.048 . . . . 0.0 110.587 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp -64.91 -9.7 23.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.573 0.749 . . . . 0.0 112.865 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.74 -18.79 22.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.992 1.269 . . . . 0.0 112.159 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -125.92 31.23 5.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.117 1.367 . . . . 0.0 110.217 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.04 141.13 34.96 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 170.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.14 164.87 28.49 Favored 'Cis proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.712 0.933 . . . . 0.0 111.907 -14.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CE1' HG11 ' A' ' 119' ' ' VAL . 22.6 p90 -148.94 165.53 31.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.171 165.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -110.61 158.9 18.07 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 162.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -151.92 -171.79 4.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.007 0.923 . . . . 0.0 108.863 164.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -97.73 138.04 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.774 1.629 . . . . 0.0 107.224 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 117' ' ' VAL . 6.2 t -90.09 64.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.452 1.101 . . . . 0.0 110.127 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -68.66 143.59 54.73 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.476 -1.29 . . . . 0.0 107.524 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 43' ' ' ILE . 18.8 p -111.03 155.33 22.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.971 0.805 . . . . 0.0 109.938 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -147.26 73.19 1.28 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 76.21 0.55 Allowed Glycine 0 C--O 1.218 -0.856 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.808 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.21 25.22 15.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.723 2.009 . . . . 0.0 112.011 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -135.41 157.77 46.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.631 165.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 38' ' ' THR . 34.1 mt -125.15 117.66 50.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.052 1.741 . . . . 0.0 107.247 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -110.9 166.9 10.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.761 1.267 . . . . 0.0 109.718 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.618 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 3.4 p90 -151.04 149.21 29.27 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.2 t -79.0 102.85 8.56 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -79.35 150.57 74.01 Favored Pre-proline 0 N--CA 1.451 -0.417 0 O-C-N 121.765 -0.584 . . . . 0.0 110.969 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.74 -16.48 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.074 3.183 . . . . 0.0 114.601 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.427 HG12 HG12 ' A' ' 51' ' ' VAL . 21.6 t -83.11 107.13 14.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -90.14 51.03 1.96 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 123.413 1.578 . . . . 0.0 109.254 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG12 HG12 ' A' ' 49' ' ' VAL . 4.6 p -80.81 155.86 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.348 1.459 . . . . 0.0 107.716 166.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -138.05 4.55 2.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 166.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -62.46 102.36 0.31 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.236 1.38 . . . . 0.0 112.333 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.02 124.58 40.09 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.791 0.837 . . . . 0.0 110.308 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.84 -24.42 13.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.518 0.727 . . . . 0.0 112.529 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -114.9 55.73 0.88 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-O 117.49 -1.243 . . . . 0.0 110.044 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.45 126.9 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.217 1.944 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -136.0 127.86 29.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.78 0.45 57.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 118.45 -0.785 . . . . 0.0 111.164 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.1 t -138.88 141.64 36.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.91 174.32 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.175 1.39 . . . . 0.0 109.587 -171.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.62 -177.05 3.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 110.841 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mt -86.43 1.51 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.064 1.345 . . . . 0.0 112.454 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.79 44.55 0.78 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 125.012 1.291 . . . . 0.0 113.128 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' OD1' ' HE2' ' A' ' 100' ' ' LYS . 70.8 m-20 -125.82 174.66 8.2 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.22 147.52 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.25 147.85 19.35 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -93.69 141.6 28.31 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.803 1.301 . . . . 0.0 109.688 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -112.69 85.87 7.99 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.904 1.281 . . . . 0.0 109.946 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -64.32 -33.18 60.02 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.645 1.563 . . . . 0.0 115.264 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.47 -7.23 20.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.504 2.803 . . . . 0.0 112.335 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.52 9.15 8.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.215 1.864 . . . . 0.0 113.569 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.71 32.76 20.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.674 1.237 . . . . 0.0 111.868 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.33 13.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.906 0.775 . . . . 0.0 111.343 -167.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.618 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -80.48 -173.96 4.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.159 0.584 . . . . 0.0 110.153 162.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.415 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 7.5 t -154.91 143.69 20.76 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.22 2.208 . . . . 0.0 106.823 165.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 42' ' ' GLU . 28.4 mt -135.57 103.75 5.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.801 1.64 . . . . 0.0 107.742 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -87.71 135.7 33.26 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.028 1.286 . . . . 0.0 109.9 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -148.4 9.79 0.84 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.74 62.75 0.06 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.114 -1.993 . . . . 0.0 115.224 165.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 75.22 179.07 0.19 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.338 1.855 . . . . 0.0 107.803 -170.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.24 160.0 31.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.8 -27.74 37.27 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.123 2.549 . . . . 0.0 111.435 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.65 31.96 0.2 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.866 1.266 . . . . 0.0 111.219 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -148.75 166.15 29.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.739 -1.225 . . . . 0.0 112.001 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -136.91 -56.52 0.72 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.51 -61.81 1.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.574 1.15 . . . . 0.0 110.476 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -122.82 144.91 48.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.395 1.478 . . . . 0.0 107.103 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.5 mt -59.3 118.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -130.86 145.01 55.85 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 95' ' ' VAL . 38.1 Cg_endo -74.59 175.13 11.5 Favored 'Trans proline' 0 N--CA 1.455 -0.782 1 C-N-CA 126.219 4.613 . . . . 0.0 113.179 171.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.78 -7.04 50.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 t -171.87 -177.66 2.0 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.713 2.005 . . . . 0.0 106.718 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 73.89 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.22 165.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 91' ' ' PRO . 14.7 m -68.84 -177.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 161.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -138.4 124.68 20.42 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.161 -0.962 . . . . 0.0 111.449 -169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.09 72.66 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 122.431 1.11 . . . . 0.0 108.999 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.9 pt -92.77 -14.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.175 1.39 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.66 173.48 23.5 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.428 ' HE2' ' OD1' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -125.93 175.14 7.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.804 1.242 . . . . 0.0 110.415 177.09 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.47 77.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 122.861 1.315 . . . . 0.0 107.979 166.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -29.32 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.084 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -146.69 158.32 43.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.99 2.516 . . . . 0.0 109.241 168.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.542 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 81.02 61.17 2.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.598 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.16 -60.46 1.67 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -70.3 -27.73 64.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.111 0.957 . . . . 0.0 110.001 -166.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 1.69 5.36 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.786 2.035 . . . . 0.0 112.48 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -87.37 -35.79 18.16 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.842 1.201 . . . . 0.0 111.756 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -14.24 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.523 -1.361 . . . . 0.0 114.472 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.58 0.86 26.9 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.624 2.37 . . . . 0.0 111.7 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mm -83.66 157.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -109.73 172.7 6.7 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 109.118 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.408 ' HA ' HG23 ' A' ' 38' ' ' THR . 0.4 OUTLIER -69.61 11.9 0.23 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.755 2.422 . . . . 0.0 114.286 -175.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.58 75.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.401 0 O-C-N 119.991 -1.693 . . . . 0.0 109.885 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -117.46 37.91 3.75 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.863 1.665 . . . . 0.0 111.242 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.4 mttm 44.04 74.24 0.13 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.869 2.068 . . . . 0.0 112.018 166.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.473 ' HB ' HG22 ' A' ' 36' ' ' VAL . 1.7 p -73.92 101.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.37 100.21 9.85 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.443 HG11 ' CE1' ' A' ' 32' ' ' PHE . 62.0 t -75.99 135.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 126.373 1.869 . . . . 0.0 108.713 173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -140.57 178.59 7.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.773 1.629 . . . . 0.0 109.178 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.95 3.54 11.94 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.965 1.84 . . . . 0.0 115.351 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.457 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 56.21 -164.28 0.15 Allowed 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 126.172 1.789 . . . . 0.0 110.728 -156.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 98.8 p 56.24 46.78 20.6 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.567 1.947 . . . . 0.0 111.434 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.856 -1.545 . . . . 0.0 112.436 177.195 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 121.782 0.801 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.484 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -66.08 164.48 15.34 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.97 -1.081 . . . . 0.0 109.444 168.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.25 108.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -81.78 128.83 34.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.169 -1.582 . . . . 0.0 107.657 164.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 119' ' ' VAL . 2.6 mm? -96.59 114.2 25.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.982 1.713 . . . . 0.0 107.257 169.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.11 133.21 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -123.06 178.49 5.06 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.388 1.075 . . . . 0.0 109.572 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -68.27 -27.37 66.27 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.655 -1.278 . . . . 0.0 112.7 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 m -115.42 -10.75 11.94 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.76 -163.79 28.52 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 119.069 0.849 . . . . 0.0 111.237 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -157.08 149.05 22.68 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.125 0.97 . . . . 0.0 110.356 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -126.1 172.37 10.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 103' ' ' GLU . 15.9 t -138.03 126.03 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 160.06 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 123.539 1.638 . . . . 0.0 106.744 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 100' ' ' LYS . 7.4 p-10 -124.18 115.77 21.64 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 129.449 3.1 . . . . 0.0 104.818 -170.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.406 HD23 ' CA ' ' A' ' 99' ' ' GLY . 84.4 mt -119.19 138.73 52.75 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -96.66 139.06 33.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.61 36.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.851 1.26 . . . . 0.0 112.383 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.87 -7.47 14.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 110.481 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -101.28 138.22 38.59 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 120.519 -1.363 . . . . 0.0 111.006 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -49.22 -62.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.199 1.8 . . . . 0.0 108.09 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.605 HG12 HD23 ' A' ' 26' ' ' LEU . 1.5 t -50.98 -40.96 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -173.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.4 t -67.36 -34.48 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -65.06 -50.31 66.69 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 110.85 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -32.59 73.24 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.992 0.814 . . . . 0.0 109.5 -169.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.678 HD22 HG21 ' A' ' 49' ' ' VAL . 3.2 mm? -60.86 -37.8 83.39 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.476 2.311 . . . . 0.0 111.095 172.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -61.78 -24.73 67.03 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.001 1.273 . . . . 0.0 111.468 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.94 -17.06 57.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -127.26 36.82 4.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.124 1.77 . . . . 0.0 110.627 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' A' ' 31' ' ' PRO . 61.4 mt -128.76 145.94 58.3 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 173.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 30' ' ' ILE . 20.1 Cg_endo -63.35 160.11 62.18 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 119.224 0.758 . . . . 0.0 112.163 -9.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.506 ' CE1' HG11 ' A' ' 119' ' ' VAL . 35.2 p90 -149.17 162.21 40.44 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -118.88 165.86 13.53 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.402 0.681 . . . . 0.0 109.732 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.54 175.61 8.83 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.362 0.601 . . . . 0.0 111.382 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.53 131.3 39.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.403 HG11 ' CG2' ' A' ' 111' ' ' ILE . 40.3 t -79.81 71.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -64.2 154.3 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.798 1.181 . . . . 0.0 108.551 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.428 HG22 HG12 ' A' ' 43' ' ' ILE . 34.9 p -137.37 151.32 48.45 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.323 1.049 . . . . 0.0 111.838 -174.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -155.47 88.76 1.15 Allowed 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.2 80.91 0.05 OUTLIER Glycine 0 C--O 1.213 -1.193 0 CA-C-O 118.321 -1.266 . . . . 0.0 114.492 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 67.44 20.45 9.86 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.978 1.889 . . . . 0.0 112.22 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -135.1 146.95 49.36 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.953 0.901 . . . . 0.0 109.532 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 38' ' ' THR . 62.7 mt -130.35 127.76 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.353 1.861 . . . . 0.0 106.547 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -143.62 142.98 31.27 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.067 1.347 . . . . 0.0 109.376 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -131.26 144.78 51.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.77 -1.206 . . . . 0.0 109.059 -173.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 m -79.1 79.42 5.5 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.481 1.512 . . . . 0.0 110.728 -168.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.6 p -57.36 152.63 31.4 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.957 0.903 . . . . 0.0 112.896 -170.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.39 -12.74 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.627 2.885 . . . . 0.0 112.212 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.678 HG21 HD22 ' A' ' 26' ' ' LEU . 47.2 t -96.91 140.39 17.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -132.17 89.6 2.69 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -116.33 161.47 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.66 5.51 8.86 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.546 -0.721 . . . . 0.0 112.563 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -74.2 127.18 32.3 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.456 1.903 . . . . 0.0 110.187 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.34 101.85 7.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.177 1.391 . . . . 0.0 109.984 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.46 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.17 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -143.41 81.01 12.69 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 124.055 0.942 . . . . 0.0 111.772 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 65.5 Cg_endo -75.64 143.22 26.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.465 3.443 . . . . 0.0 112.161 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -136.69 169.59 17.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.41 1.084 . . . . 0.0 108.63 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -121.98 4.36 9.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.806 1.243 . . . . 0.0 112.222 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.55 143.19 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 m -132.73 173.12 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 109.14 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -85.31 -176.64 6.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.806 0.812 . . . . 0.0 110.349 164.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.49 -7.58 10.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 124.611 1.165 . . . . 0.0 110.42 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.82 35.82 2.05 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-O 118.64 -1.089 . . . . 0.0 112.311 -168.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . 74.1 m-20 -112.87 173.77 6.22 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.463 1.505 . . . . 0.0 111.355 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.91 135.07 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 120.753 -1.217 . . . . 0.0 110.895 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.24 176.74 16.89 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.909 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -101.55 159.59 15.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.79 1.236 . . . . 0.0 110.334 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.408 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 t90 -132.82 83.06 53.94 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 119.347 0.976 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.17 -24.37 65.93 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.448 2.765 . . . . 0.0 117.936 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HD2' ' C ' ' A' ' 69' ' ' TRP . 22.1 Cg_endo -72.83 -45.06 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.057 2.504 . . . . 0.0 108.982 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.09 -4.36 58.66 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.439 -1.201 . . . . 0.0 114.273 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 55.24 73.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.671 1.988 . . . . 0.0 108.692 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.15 171.46 15.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.727 0.775 . . . . 0.0 112.9 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.08 -178.42 7.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 109.519 157.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 31.5 m -142.95 160.52 40.19 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.875 1.27 . . . . 0.0 109.336 156.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -145.52 97.35 2.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 128.465 2.706 . . . . 0.0 105.273 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -83.52 146.75 28.18 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.14 26.69 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.46 -100.74 0.17 Allowed Glycine 0 C--N 1.333 0.392 0 O-C-N 119.514 -1.991 . . . . 0.0 111.744 165.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -128.14 -13.48 5.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 57.99 165.99 0.07 OUTLIER Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.155 1.782 . . . . 0.0 112.541 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.33 -18.31 9.8 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.563 2.175 . . . . 0.0 112.902 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.79 49.58 0.89 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 122.232 1.015 . . . . 0.0 109.255 -169.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.12 179.51 6.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.192 -0.943 . . . . 0.0 110.746 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -142.83 -42.97 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.734 1.214 . . . . 0.0 109.89 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.8 -56.27 2.37 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.25 -0.906 . . . . 0.0 111.538 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -127.93 178.67 6.02 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.553 1.941 . . . . 0.0 109.635 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -77.52 134.44 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 120.231 1.378 . . . . 0.0 108.069 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -123.83 151.33 64.33 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 123.449 0.7 . . . . 0.0 109.311 165.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.89 177.92 7.91 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 124.005 3.137 . . . . 0.0 111.917 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.4 61.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.452 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.4 t -163.22 176.0 10.39 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 120.188 1.358 . . . . 0.0 108.885 -167.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 64.32 0.75 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.732 1.213 . . . . 0.0 110.694 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -66.98 165.46 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.688 1.195 . . . . 0.0 107.918 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 36.1 p30 -94.12 -178.9 4.78 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 120.05 -1.656 . . . . 0.0 109.902 169.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.42 45.19 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 122.878 1.323 . . . . 0.0 108.688 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.9 pt -69.99 -15.12 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.239 -1.538 . . . . 0.0 112.031 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.406 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -121.63 169.82 14.68 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 17.0 tttt -131.84 171.26 13.75 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.454 1.102 . . . . 0.0 108.505 168.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.6 mt -101.92 86.71 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 160.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -30.08 38.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.093 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 3.0 mt-10 -152.8 151.78 30.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 109.061 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.07 58.5 6.66 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.299 -0.876 . . . . 0.0 112.453 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.6 tp -84.43 -52.25 6.31 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.766 -0.844 . . . . 0.0 110.646 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.36 -24.68 57.32 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.339 -0.85 . . . . 0.0 111.089 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -26.61 68.88 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 110.688 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.18 -22.36 39.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.022 0.929 . . . . 0.0 112.288 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -72.6 -21.09 61.18 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.098 -1.626 . . . . 0.0 114.428 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 10.19 6.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 121.498 1.954 . . . . 0.0 112.457 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.403 ' CG2' HG11 ' A' ' 36' ' ' VAL . 28.0 mm -104.31 160.31 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.205 1.002 . . . . 0.0 108.805 -166.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.629 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 10.7 mmtp -131.74 175.03 9.54 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.354 2.262 . . . . 0.0 108.845 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.04 2.79 2.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.837 2.055 . . . . 0.0 115.666 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.49 48.82 0.33 Allowed Glycine 0 CA--C 1.52 0.403 0 O-C-N 120.63 -1.294 . . . . 0.0 110.961 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.629 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 8.6 mm-40 -101.69 30.43 4.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.542 -176.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 mttp 44.25 86.47 0.02 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.445 1.898 . . . . 0.0 113.266 166.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 36' ' ' VAL . 6.4 p -78.52 133.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 176.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.71 111.18 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.574 HG22 HD12 ' A' ' 5' ' ' LEU . 93.5 t -79.13 127.25 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 127.117 2.167 . . . . 0.0 106.716 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -128.42 -166.59 1.65 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.479 1.112 . . . . 0.0 109.421 171.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -95.93 -5.37 41.57 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . 75.49 127.23 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 129.243 3.017 . . . . 0.0 110.547 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.1 m -131.75 55.65 1.86 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.666 1.186 . . . . 0.0 109.07 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.249 1.061 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 158.289 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 -67.6 154.08 42.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.305 -0.872 . . . . 0.0 108.912 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.95 147.51 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.398 1.479 . . . . 0.0 108.089 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 40.0 tt0 -123.69 139.9 53.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.019 2.528 . . . . 0.0 106.809 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 4' ' ' GLU . 8.8 mp -118.56 98.53 6.29 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 136.73 33.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -125.35 173.9 8.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.467 1.107 . . . . 0.0 109.142 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -30.36 70.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.948 0.899 . . . . 0.0 111.301 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -93.13 -13.27 28.69 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.11 -159.91 33.12 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 120.834 1.652 . . . . 0.0 109.894 -164.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -158.17 165.09 35.78 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 109.806 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -136.72 178.13 7.31 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.904 0.482 . . . . 0.0 110.276 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.45 128.08 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 16' ' ' LEU . 21.3 pt -116.14 162.18 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 122.628 1.204 . . . . 0.0 109.075 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -120.82 130.36 53.94 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 107.699 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.4 HD21 HD12 ' A' ' 14' ' ' ILE . 55.3 mt -124.81 135.7 53.17 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.474 1.109 . . . . 0.0 109.254 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -76.48 136.47 39.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.081 0.952 . . . . 0.0 110.915 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.33 37.12 1.19 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.42 1.088 . . . . 0.0 113.278 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.08 22.87 11.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.187 -0.946 . . . . 0.0 111.194 170.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.09 133.13 45.36 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.94 0.896 . . . . 0.0 111.216 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -44.5 -55.36 5.15 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.791 2.036 . . . . 0.0 109.248 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.67 -40.24 78.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 116.894 -1.527 . . . . 0.0 113.276 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.06 -30.84 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 121.032 1.742 . . . . 0.0 109.858 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -64.87 -47.21 78.71 Favored 'General case' 0 C--N 1.342 0.263 0 O-C-N 121.608 -0.683 . . . . 0.0 110.383 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB3' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -70.72 -36.7 73.33 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 120.822 -1.174 . . . . 0.0 109.25 -174.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.56 ' CD2' HG11 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -55.91 -38.12 69.81 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.633 1.573 . . . . 0.0 109.721 174.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 tmpt? -59.23 -28.49 66.74 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.363 0.983 . . . . 0.0 111.164 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -69.01 -34.35 75.12 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.095 0.861 . . . . 0.0 110.236 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -107.57 33.54 3.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.346 2.258 . . . . 0.0 110.932 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -129.13 144.2 51.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 172.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -61.03 158.98 49.02 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 119.557 0.878 . . . . 0.0 112.536 -14.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -156.49 162.4 39.96 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.899 0.879 . . . . 0.0 110.817 170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.91 155.57 33.92 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.435 0.694 . . . . 0.0 110.262 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -165.1 172.56 12.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.274 1.03 . . . . 0.0 110.145 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.77 140.59 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.699 1.6 . . . . 0.0 107.535 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 t -96.13 67.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -58.31 138.3 56.52 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -116.51 151.17 36.67 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 108.982 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -157.71 115.9 3.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 -102.7 0.34 Allowed Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -137.39 36.2 2.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.038 2.135 . . . . 0.0 108.413 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -122.72 165.7 16.12 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mt -122.51 147.43 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 171.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.62 175.36 9.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.101 0.953 . . . . 0.0 109.182 160.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -146.86 156.39 43.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -80.49 96.8 6.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -64.21 147.3 97.01 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.78 -39.13 15.67 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.284 1.99 . . . . 0.0 110.007 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.56 HG11 ' CD2' ' A' ' 26' ' ' LEU . 7.7 p -71.69 163.61 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.377 1.471 . . . . 0.0 110.36 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -141.54 38.34 1.68 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 HG22 ' A' ' 49' ' ' VAL . 27.1 t -60.83 153.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.713 0.805 . . . . 0.0 110.781 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.22 -8.46 4.78 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.959 1.304 . . . . 0.0 112.557 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -73.09 126.29 29.65 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.328 0.967 . . . . 0.0 109.404 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 125.63 35.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.781 1.233 . . . . 0.0 109.517 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.72 -33.45 15.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.009 0.924 . . . . 0.0 109.937 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -123.86 61.56 24.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.089 0.956 . . . . 0.0 111.009 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.5 124.19 12.11 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.059 1.839 . . . . 0.0 109.003 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -128.88 149.33 50.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.724 1.209 . . . . 0.0 109.324 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -111.16 -11.03 14.28 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.855 0.462 . . . . 0.0 111.595 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 t -128.38 135.16 63.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.47 -164.01 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.347 1.859 . . . . 0.0 107.513 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -143.63 176.8 8.94 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.55 1.14 . . . . 0.0 111.184 -165.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.4 mt -84.02 11.13 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 126.167 1.787 . . . . 0.0 110.586 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.56 9.81 2.91 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.672 1.606 . . . . 0.0 113.586 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.82 -177.06 4.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 124.33 2.015 . . . . 0.0 108.592 -165.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.453 HG13 HG13 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -153.03 146.66 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 128.454 2.701 . . . . 0.0 105.691 -149.091 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.34 174.06 22.42 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -131.36 116.49 17.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 127.029 2.131 . . . . 0.0 107.356 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.424 ' HE1' ' HB2' ' A' ' 93' ' ' SER . 8.2 t90 -108.13 87.06 3.61 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 124.582 1.153 . . . . 0.0 109.381 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.86 -43.11 62.48 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.323 2.016 . . . . 0.0 114.969 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.24 -18.19 23.7 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.393 2.062 . . . . 0.0 111.128 -170.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.33 -0.13 70.81 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.443 -1.198 . . . . 0.0 113.29 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 46.68 39.8 7.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.198 1.999 . . . . 0.0 110.623 -166.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.4 146.1 44.68 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -167.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -179.04 1.99 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.572 158.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 55.9 m -145.75 158.87 43.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.302 1.441 . . . . 0.0 108.455 151.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mt -141.46 118.1 10.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 127.752 2.421 . . . . 0.0 106.457 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -114.81 121.29 42.82 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 109.563 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -149.14 7.97 0.72 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.13 0.972 . . . . 0.0 113.458 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.28 -114.06 0.42 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.346 -1.471 . . . . 0.0 112.0 -173.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.61 148.04 26.86 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.87 162.74 55.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.75 1.22 . . . . 0.0 112.077 -167.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.92 -3.07 8.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.164 2.576 . . . . 0.0 113.876 -167.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.87 16.9 14.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.69 1.132 . . . . 0.0 110.804 166.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 90' ' ' GLN . 3.7 t -129.86 178.98 6.12 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -142.07 -34.07 0.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.455 1.102 . . . . 0.0 109.848 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.3 -52.27 6.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.302 1.441 . . . . 0.0 112.029 172.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.07 -163.81 1.36 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.564 1.546 . . . . 0.0 109.68 -156.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.99 92.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 170.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.5 ' H ' ' HB2' ' A' ' 85' ' ' SER . 14.0 mt-30 -100.59 146.33 31.86 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 158.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.6 -179.43 5.33 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.229 3.286 . . . . 0.0 113.158 164.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.66 64.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.424 ' HB2' ' HE1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -157.9 -171.87 3.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 84.12 7.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 123.647 1.689 . . . . 0.0 108.265 156.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 95' ' ' VAL 0.332 46.9 t -44.33 161.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 C-N-CA 129.669 3.188 . . . . 0.0 110.668 143.198 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -98.21 124.62 42.89 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.694 1.597 . . . . 0.0 107.084 171.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.5 pt -120.11 -9.74 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.134 2.174 . . . . 0.0 111.351 -173.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.56 171.91 13.95 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 129.752 3.549 . . . . 0.0 112.694 -163.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -144.7 148.83 34.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.851 1.66 . . . . 0.0 108.693 143.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.453 HG13 HG13 ' A' ' 66' ' ' VAL . 16.4 mt -75.01 98.99 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 159.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.0 m -73.74 -36.56 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.526 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.7 163.02 38.54 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 118.798 0.726 . . . . 0.0 110.829 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.41 42.44 73.91 Favored Glycine 0 C--O 1.222 -0.607 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.185 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -56.55 11.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.458 1.129 . . . . 0.0 110.003 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.18 -19.1 64.75 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.958 -0.464 . . . . 0.0 111.088 -168.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.04 -22.96 61.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.173 1.789 . . . . 0.0 110.654 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.33 -41.12 61.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.335 -1.478 . . . . 0.0 110.36 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -62.52 -5.29 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.051 1.341 . . . . 0.0 113.412 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.54 6.06 10.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.066 1.746 . . . . 0.0 112.147 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.293 19.2 mm -80.47 164.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.292 0.951 . . . . 0.0 108.875 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.406 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 4.5 mmpt? -121.62 167.85 12.43 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 127.278 2.231 . . . . 0.0 106.472 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.56 -1.63 1.91 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -169.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.01 17.91 1.21 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.605 -1.109 . . . . 0.0 114.168 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 14.7 mm-40 -72.03 23.78 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.274 2.037 . . . . 0.0 113.975 -176.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt 44.75 89.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 128.848 2.859 . . . . 0.0 113.958 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.8 104.36 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.62 98.79 9.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 107.899 170.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -75.17 137.34 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.269 1.827 . . . . 0.0 108.589 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -139.75 -177.44 4.97 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.095 2.558 . . . . 0.0 110.096 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -86.62 -4.38 59.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 56.73 76.18 0.32 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 127.524 2.33 . . . . 0.0 112.07 -173.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.6 m -81.45 25.96 0.49 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.869 1.667 . . . . 0.0 112.694 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.814 1.646 . . . . 0.0 107.626 -166.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.38 148.58 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -149.4 142.75 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 27.0 tt0 -117.87 138.09 52.35 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.972 2.109 . . . . 0.0 106.068 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.26 98.94 6.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.972 2.109 . . . . 0.0 106.703 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.56 129.75 46.54 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.957 1.303 . . . . 0.0 109.139 -172.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.18 -176.1 3.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.015 1.326 . . . . 0.0 109.74 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.61 -53.79 36.83 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.928 -0.482 . . . . 0.0 110.467 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 t -76.18 -20.83 57.17 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.502 0.592 . . . . 0.0 111.039 -168.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.05 -152.29 12.73 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -164.73 152.92 12.14 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.525 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 64.7 m -141.26 173.59 11.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.059 0.943 . . . . 0.0 109.009 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 t -140.82 129.7 24.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.6 pt -114.15 166.35 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 122.427 1.108 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -123.42 149.43 45.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 163.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.407 HD23 ' HA3' ' A' ' 99' ' ' GLY . 59.4 mt -139.11 132.11 29.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.694 1.598 . . . . 0.0 110.799 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -84.93 126.43 33.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.633 0.254 . . . . 0.0 110.685 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.76 5.13 14.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.585 1.954 . . . . 0.0 113.961 -169.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -83.41 -11.8 57.17 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.093 -1.004 . . . . 0.0 109.95 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.418 ' CD2' HG22 ' A' ' 98' ' ' ILE . 32.7 m-85 -99.34 141.14 32.51 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.862 2.065 . . . . 0.0 109.688 -174.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -44.87 -59.5 2.52 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.844 1.658 . . . . 0.0 109.365 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.78 -35.53 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.87 -38.61 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.869 1.213 . . . . 0.0 109.819 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -55.72 -45.52 77.92 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.021 0.928 . . . . 0.0 111.066 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -40.06 89.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.03 -1.044 . . . . 0.0 109.511 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.22 -30.52 68.3 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.819 1.248 . . . . 0.0 111.901 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -69.17 -25.15 64.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.276 0.943 . . . . 0.0 109.918 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -78.06 -11.42 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.414 0.685 . . . . 0.0 112.296 171.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -126.1 26.1 6.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.552 1.541 . . . . 0.0 112.077 -166.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.43 143.96 47.85 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -62.04 158.7 56.95 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-N 119.531 0.868 . . . . 0.0 113.202 -10.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -152.79 163.77 39.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.529 0.732 . . . . 0.0 110.354 166.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -119.24 161.99 19.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.244 1.018 . . . . 0.0 110.241 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -168.75 171.36 8.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.673 0.789 . . . . 0.0 112.496 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.28 128.1 47.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.055 1.342 . . . . 0.0 108.852 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 t -91.12 80.88 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -164.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -68.15 151.21 47.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.6 p -126.22 131.61 51.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -134.57 94.71 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 175.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 82' ' ' THR . . . 44.2 82.62 0.03 OUTLIER Glycine 0 C--O 1.214 -1.134 0 C-N-CA 126.304 1.907 . . . . 0.0 115.424 167.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 71.42 21.61 4.5 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.718 1.607 . . . . 0.0 112.609 167.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -140.32 167.9 21.06 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 128.854 2.862 . . . . 0.0 106.395 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mt -132.62 146.09 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 128.003 2.521 . . . . 0.0 108.263 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -146.88 157.61 43.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.758 1.223 . . . . 0.0 111.256 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -150.55 163.05 39.42 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.245 0.618 . . . . 0.0 111.273 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -92.54 88.54 6.38 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.711 0.767 . . . . 0.0 109.825 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.2 p -60.82 148.46 82.84 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.038 0.535 . . . . 0.0 112.184 -170.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.06 -14.57 15.11 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.523 2.815 . . . . 0.0 111.997 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.23 153.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 108.786 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -137.63 119.93 15.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 p -156.92 152.45 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.951 1.3 . . . . 0.0 108.924 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -132.79 21.58 4.21 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.212 1.805 . . . . 0.0 112.591 -174.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -109.04 148.98 29.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.633 1.973 . . . . 0.0 108.862 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -139.64 157.67 45.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.536 1.134 . . . . 0.0 108.91 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -110.79 -50.09 2.98 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.663 0.785 . . . . 0.0 110.255 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -120.38 68.92 14.74 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.87 1.268 . . . . 0.0 108.042 -172.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 72.4 Cg_endo -71.53 156.53 57.87 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.571 2.181 . . . . 0.0 111.799 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.685 ' HG2' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -144.11 158.29 43.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.623 1.569 . . . . 0.0 108.949 177.519 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -111.32 8.8 21.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 117.411 -1.28 . . . . 0.0 111.043 167.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 p -162.31 154.99 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 120.328 1.422 . . . . 0.0 111.749 173.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.58 HG11 ' CZ ' ' A' ' 58' ' ' ARG . 27.2 m -145.22 -179.85 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.599 1.559 . . . . 0.0 112.498 -174.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.12 171.17 12.23 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 110.31 163.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.29 -13.66 16.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 113.597 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.05 48.51 0.97 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 125.058 1.313 . . . . 0.0 110.446 -168.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.44 ' CG ' ' HZ2' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -120.0 172.55 7.66 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.669 1.188 . . . . 0.0 108.869 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -137.94 136.78 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.99 172.1 18.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.494 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -123.5 137.47 54.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.478 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -116.83 88.23 24.86 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.211 1.804 . . . . 0.0 110.031 -162.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.454 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 91.2 Cg_endo -64.57 -26.61 61.76 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.179 2.586 . . . . 0.0 116.429 -171.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 66.7 Cg_endo -75.05 -32.05 5.64 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 123.579 2.314 . . . . 0.0 110.077 -173.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.28 14.17 21.01 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.687 1.613 . . . . 0.0 114.282 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 44.7 59.59 3.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.277 1.831 . . . . 0.0 111.058 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.4 168.83 18.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.618 1.199 . . . . 0.0 112.127 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.84 163.11 12.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.96 2.104 . . . . 0.0 109.508 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 p -134.79 137.81 43.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 119.63 1.105 . . . . 0.0 112.052 166.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -117.07 113.35 22.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.992 2.517 . . . . 0.0 105.149 170.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -88.22 149.73 23.69 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -158.9 9.99 0.13 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.947 0.794 . . . . 0.0 112.92 169.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.93 -174.84 38.48 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 120.451 -1.406 . . . . 0.0 111.14 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.21 101.17 5.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -69.29 165.11 42.62 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 125.316 1.446 . . . . 0.0 111.095 -178.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.11 5.81 4.75 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.039 3.826 . . . . 0.0 114.121 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -134.31 72.46 1.47 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.71 -174.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.473 2.309 . . . . 0.0 106.537 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -156.11 -66.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -81.49 -44.72 17.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.175 1.39 . . . . 0.0 110.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -143.21 152.89 42.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.637 1.575 . . . . 0.0 108.541 -157.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.6 mt -81.9 81.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -169.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -75.09 143.48 77.4 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 108.231 170.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.9 174.65 12.23 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.646 2.897 . . . . 0.0 111.395 165.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.47 71.01 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -147.71 169.61 19.34 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.608 1.163 . . . . 0.0 107.905 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.67 80.81 0.43 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.952 1.251 . . . . 0.0 110.622 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.528 ' CG2' ' CZ ' ' A' ' 58' ' ' ARG . 2.7 m -77.55 170.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 1.1 p30 -84.47 152.21 24.12 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.307 -1.495 . . . . 0.0 112.031 169.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.685 HG23 ' HG2' ' A' ' 58' ' ' ARG . 15.5 t -84.62 112.38 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 152.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.418 HG22 ' CD2' ' A' ' 20' ' ' TYR . 26.6 pt -123.06 -18.28 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.123 0.569 . . . . 0.0 112.184 169.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' A' ' 16' ' ' LEU . . . -138.53 172.05 23.2 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 30.1 tptt -139.83 140.37 36.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.34 90.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -75.19 -34.2 30.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.075 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.55 157.74 43.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.69 1.196 . . . . 0.0 108.73 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 73.47 70.48 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 118.649 -1.739 . . . . 0.0 112.325 -176.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.35 -52.94 2.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 169.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -64.76 -28.6 69.69 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.906 -0.496 . . . . 0.0 111.599 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -71.38 -8.77 55.95 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.337 -0.852 . . . . 0.0 112.801 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -25.9 51.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.859 1.663 . . . . 0.0 113.003 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 5.98 6.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -174.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -129.76 9.97 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.941 2.496 . . . . 0.0 110.839 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.25 157.41 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 106.781 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -117.11 -165.02 1.03 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.765 1.226 . . . . 0.0 110.008 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.83 5.09 26.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.609 0.719 . . . . 0.0 112.644 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -172.16 80.81 0.08 OUTLIER Glycine 0 CA--C 1.523 0.56 0 O-C-N 120.83 -1.169 . . . . 0.0 110.926 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.56 22.45 10.63 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.005 1.722 . . . . 0.0 111.335 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 44.55 84.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.265 1.826 . . . . 0.0 112.918 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.41 129.02 37.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.73 107.87 19.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.08 126.5 36.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.613 2.365 . . . . 0.0 107.088 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -135.98 169.62 17.3 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.058 1.743 . . . . 0.0 109.744 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -77.32 -3.72 41.41 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 59.06 38.83 23.87 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 126.242 1.817 . . . . 0.0 113.435 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.74 52.54 0.22 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.349 1.859 . . . . 0.0 111.671 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.25 1.093 0 C-N-CA 127.573 2.349 . . . . 0.0 112.938 178.002 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 160.28 33.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 110.513 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.4 t -149.79 142.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 113.008 -1.905 . . . . 0.0 108.546 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 32.0 tt0 -126.83 131.4 51.24 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 127.71 2.404 . . . . 0.0 107.018 -173.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.59 120.29 41.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.533 1.933 . . . . 0.0 107.229 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.99 137.13 48.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -130.28 -176.65 4.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.513 1.125 . . . . 0.0 109.783 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.71 -39.71 43.7 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.875 0.87 . . . . 0.0 109.71 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB2' HD13 ' A' ' 111' ' ' ILE . 9.5 m -93.33 -16.16 24.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.426 1.091 . . . . 0.0 112.587 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.53 -163.38 27.03 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.508 0.575 . . . . 0.0 112.882 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -160.87 146.27 14.41 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.206 1.402 . . . . 0.0 108.378 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.53 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 34.5 m -146.86 174.94 11.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.173 1.789 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -147.98 131.46 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.269 -1.519 . . . . 0.0 108.397 -170.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.48 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.04 -1.037 . . . . 0.0 109.983 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.14 119.54 39.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 116.899 -1.524 . . . . 0.0 107.641 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.494 HD23 ' CA ' ' A' ' 99' ' ' GLY . 83.3 mt -119.29 132.19 55.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.212 0.915 . . . . 0.0 111.012 -174.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -88.08 126.27 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.822 -168.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.35 34.64 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.822 1.649 . . . . 0.0 113.943 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -105.49 -9.48 17.46 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.527 -1.358 . . . . 0.0 110.815 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.34 144.2 34.54 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.603 1.561 . . . . 0.0 112.086 -170.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -56.67 -55.76 29.95 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.383 1.073 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 p -44.58 -40.29 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.504 1.522 . . . . 0.0 113.693 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.93 -44.18 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 120.911 1.687 . . . . 0.0 110.014 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -59.65 -38.36 81.22 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.181 0.992 . . . . 0.0 111.228 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.1 mt -72.09 -37.87 69.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.859 0.864 . . . . 0.0 109.689 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -32.52 73.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.853 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -32.96 64.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.158 0.89 . . . . 0.0 109.97 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.3 -13.77 61.99 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.743 0.817 . . . . 0.0 111.953 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -124.16 26.58 7.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.747 2.019 . . . . 0.0 110.833 -173.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -125.06 139.53 33.85 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.11 163.34 68.52 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 119.302 0.786 . . . . 0.0 112.375 -8.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -149.83 169.5 20.96 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.018 0.927 . . . . 0.0 109.473 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.98 155.69 37.76 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.9 170.1 18.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.513 0.673 . . . . 0.0 112.249 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.95 129.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.296 1.438 . . . . 0.0 108.11 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG13 HG23 ' A' ' 43' ' ' ILE . 21.0 t -83.31 76.08 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -68.96 159.39 32.81 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.2 p -140.0 163.51 32.48 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.832 0.853 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -164.3 101.91 0.84 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 47.17 62.87 3.6 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.992 165.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 52.05 78.94 0.11 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.528 2.331 . . . . 0.0 110.655 -159.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -162.23 150.84 14.99 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 161.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.513 HG23 HG13 ' A' ' 36' ' ' VAL . 55.2 mt -127.45 121.19 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 167.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -133.09 151.37 52.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.512 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.69 150.59 52.14 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -70.86 91.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.51 1.524 . . . . 0.0 109.542 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -62.39 146.66 93.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.988 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.35 -3.76 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.424 2.749 . . . . 0.0 111.992 172.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -76.41 163.62 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.269 1.428 . . . . 0.0 109.606 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -148.9 101.68 3.2 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.578 0.751 . . . . 0.0 109.624 170.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG22 ' H ' ' A' ' 53' ' ' LYS . 9.0 p -152.44 154.86 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.176 2.19 . . . . 0.0 108.348 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -128.83 13.95 6.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.648 1.179 . . . . 0.0 113.139 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 51' ' ' VAL . 15.4 tttt -75.37 125.13 28.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.287 1.835 . . . . 0.0 111.452 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.35 143.3 50.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.603 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -132.73 -30.84 1.38 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.244 1.017 . . . . 0.0 112.601 -169.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -120.13 61.82 8.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.54 150.95 41.36 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.087 1.858 . . . . 0.0 113.201 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -146.51 153.58 40.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.463 1.505 . . . . 0.0 109.773 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -105.44 7.04 32.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.207 1.403 . . . . 0.0 113.221 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.35 152.63 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 129.788 3.235 . . . . 0.0 108.086 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.0 m -147.48 175.14 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.302 1.841 . . . . 0.0 108.414 -167.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.15 169.35 10.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 122.32 1.057 . . . . 0.0 112.363 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 63' ' ' ILE . 44.9 mt -73.16 23.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 0.0 110.779 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.66 16.11 0.07 OUTLIER Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.305 0.955 . . . . 0.0 113.789 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -93.67 -177.22 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -138.34 149.91 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.228 1.011 . . . . 0.0 108.95 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.08 21.59 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 165.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.95 159.85 27.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.006 0.922 . . . . 0.0 108.981 166.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -127.61 85.62 60.38 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.406 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 89.3 Cg_endo -66.2 -28.06 48.34 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.069 1.846 . . . . 0.0 115.391 -174.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 55.4 Cg_endo -69.26 -23.61 32.9 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 123.087 2.138 . . . . 0.0 109.847 -172.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.17 27.47 6.69 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 117.791 -1.561 . . . . 0.0 113.674 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.78 36.9 4.17 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.505 2.153 . . . . 0.0 113.141 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.31 174.16 6.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.274 -1.516 . . . . 0.0 111.398 -167.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -90.77 -178.88 5.37 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.839 161.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 54.0 m -147.33 163.29 36.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.948 2.499 . . . . 0.0 107.441 157.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.22 121.94 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.62 114.3 27.87 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.859 1.264 . . . . 0.0 109.648 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -145.06 27.63 1.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.253 1.821 . . . . 0.0 113.789 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.97 -112.43 0.28 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 120.51 1.504 . . . . 0.0 115.142 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 120.62 2.89 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 129.225 3.01 . . . . 0.0 104.782 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 33.8 p -86.45 165.74 31.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.661 1.119 . . . . 0.0 111.275 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 73.1 Cg_endo -69.2 0.36 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.591 2.861 . . . . 0.0 113.932 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -95.08 -33.01 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.545 1.521 . . . . 0.0 111.967 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 t -79.99 -169.31 1.96 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 161.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.13 -49.13 0.32 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.76 -51.08 9.63 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 126.049 1.74 . . . . 0.0 112.853 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -137.02 -164.18 1.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.302 1.441 . . . . 0.0 109.021 -154.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.414 HD13 ' CG1' ' A' ' 63' ' ' ILE . 13.5 mt -110.28 67.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -172.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -82.32 142.33 46.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.205 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.2 177.21 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 125.158 3.905 . . . . 0.0 112.672 171.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.33 -29.43 68.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.98 -174.26 4.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.476 1.489 . . . . 0.0 109.973 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.03 98.69 0.31 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 m -92.9 -164.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.35 1.46 . . . . 0.0 107.728 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -138.62 125.21 20.72 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.67 48.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.921 0.888 . . . . 0.0 109.956 -170.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 pt -72.1 -12.96 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 120.181 -1.574 . . . . 0.0 112.8 -172.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.494 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -128.4 159.29 21.91 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 118.681 0.673 . . . . 0.0 111.578 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -124.81 141.78 51.88 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.3 mt -76.4 112.79 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 161.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -29.67 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 -165.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -144.42 160.23 41.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.313 2.245 . . . . 0.0 107.84 170.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 75.62 60.85 3.09 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 118.55 -1.786 . . . . 0.0 112.037 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -107.82 -36.93 6.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.593 0.711 . . . . 0.0 111.157 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.11 -36.19 48.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.2 6.07 3.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.197 0.999 . . . . 0.0 112.96 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 74.0 mt -86.75 -37.17 18.13 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 111.451 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -4.62 16.78 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.719 -1.238 . . . . 0.0 113.123 -172.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -100.81 -0.95 36.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.25 1.42 . . . . 0.0 112.67 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.48 HD13 ' HB2' ' A' ' 9' ' ' SER . 22.9 mm -80.31 162.37 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.537 0.735 . . . . 0.0 110.635 -167.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -118.31 169.4 9.76 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 127.291 2.236 . . . . 0.0 111.248 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.69 20.67 1.7 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.551 2.34 . . . . 0.0 113.702 -172.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.79 64.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.467 ' H ' ' HB ' ' A' ' 36' ' ' VAL . 6.7 pt-20 -114.37 30.5 7.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -174.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.84 85.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.685 1.594 . . . . 0.0 112.881 171.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 133.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.24 116.01 31.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 164.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -88.37 127.61 41.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 107.39 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -132.53 -179.2 5.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.993 1.717 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -79.25 -3.69 47.08 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 58.72 -169.74 0.13 Allowed 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 125.318 1.447 . . . . 0.0 110.349 -163.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.5 p -147.95 16.54 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.851 1.66 . . . . 0.0 110.788 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.258 1.509 0 C-N-CA 126.812 2.045 . . . . 0.0 106.581 -160.682 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ttp . . . . . 0 CA--C 1.509 -0.602 0 CA-C-O 122.403 1.097 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -71.53 163.25 28.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.363 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.35 113.33 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 5.3 tt0 -86.91 137.85 32.04 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.075 -1.015 . . . . 0.0 108.41 -175.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.3 mt -115.8 97.9 6.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.705 0.684 . . . . 0.0 110.196 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 148.08 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.416 1.087 . . . . 0.0 109.246 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -135.64 178.83 6.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.232 1.413 . . . . 0.0 108.86 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.59 -16.61 57.2 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.932 0.893 . . . . 0.0 111.937 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -124.26 0.48 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.753 0.821 . . . . 0.0 111.292 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.08 -174.25 43.34 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 124.556 1.074 . . . . 0.0 111.429 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -163.04 149.68 12.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.726 1.21 . . . . 0.0 108.47 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.447 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 1.4 p -137.28 -177.2 4.67 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 125.877 2.751 . . . . 0.0 105.101 171.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 4' ' ' GLU 0.258 3.8 p -136.75 164.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 110.275 -3.148 . . . . 0.0 105.869 167.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 pt -135.91 121.29 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 125.47 1.508 . . . . 0.0 107.252 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.94 117.13 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 115.325 -2.274 . . . . 0.0 110.044 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt -121.03 143.3 49.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.652 2.024 . . . . 0.0 112.649 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -89.54 140.86 29.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 111.315 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.34 8.69 3.16 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -91.7 9.93 30.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.663 -1.898 . . . . 0.0 110.479 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.22 133.34 55.16 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.745 1.618 . . . . 0.0 109.279 -170.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -48.52 -49.84 34.43 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.791 1.636 . . . . 0.0 109.888 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.658 ' HB ' HG21 ' A' ' 51' ' ' VAL . 7.2 p -56.89 -37.3 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 117.673 -1.155 . . . . 0.0 111.5 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t -72.1 -43.75 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 120.315 1.416 . . . . 0.0 109.232 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -59.71 -33.1 71.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.659 0.784 . . . . 0.0 111.827 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.405 HD12 ' CG1' ' A' ' 51' ' ' VAL . 18.7 mt -84.93 -37.19 20.84 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.914 0.886 . . . . 0.0 110.769 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mt -57.03 -35.63 69.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.151 0.98 . . . . 0.0 110.225 172.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -58.5 -30.82 67.31 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 119.291 0.95 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.292 1.037 . . . . 0.0 110.973 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.52 26.24 4.75 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.624 1.569 . . . . 0.0 110.347 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.41 HG23 ' HA ' ' A' ' 31' ' ' PRO . 76.2 mt -126.46 146.59 57.09 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HA ' HG23 ' A' ' 30' ' ' ILE . 10.2 Cg_endo -59.55 157.76 41.91 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 CA-C-N 119.44 0.836 . . . . 0.0 111.646 -12.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -148.77 150.22 32.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -105.02 156.63 17.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.32 175.55 11.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG22 ' C ' ' A' ' 36' ' ' VAL . 2.4 p -55.07 165.95 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.4 1.88 . . . . 0.0 111.204 157.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.598 HG13 HG23 ' A' ' 43' ' ' ILE . 38.0 t -117.51 123.91 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 144.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -106.11 164.68 11.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 162.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.7 p -136.24 151.15 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.427 -0.796 . . . . 0.0 109.66 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -149.98 83.75 1.39 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.965 0.802 . . . . 0.0 108.99 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 57.91 69.48 1.26 Allowed Glycine 0 C--O 1.213 -1.195 0 O-C-N 121.215 -0.928 . . . . 0.0 113.569 170.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.265 6.1 mt-10 65.98 35.64 6.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 127.984 2.514 . . . . 0.0 112.531 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.83 152.45 46.51 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.443 1.897 . . . . 0.0 108.373 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.598 HG23 HG13 ' A' ' 36' ' ' VAL . 9.6 mt -113.84 139.66 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 159.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -136.06 160.22 39.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.34 157.83 42.99 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.32 -0.862 . . . . 0.0 110.317 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -87.91 94.7 9.85 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 p -63.15 151.36 86.77 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.0 -26.58 9.24 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.026 2.484 . . . . 0.0 111.374 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -83.15 146.23 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.163 1.385 . . . . 0.0 107.851 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -133.08 133.57 43.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.658 HG21 ' HB ' ' A' ' 22' ' ' VAL . 5.6 m -141.34 179.15 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.807 2.443 . . . . 0.0 107.66 170.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.82 13.81 3.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.839 0.856 . . . . 0.0 112.311 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -92.8 128.6 38.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 113.116 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.575 ' HA ' HD22 ' A' ' 96' ' ' ASN . 0.0 OUTLIER -133.98 106.18 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.201 1.8 . . . . 0.0 112.805 175.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -79.9 -13.94 59.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.585 1.954 . . . . 0.0 114.085 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -139.32 68.43 39.71 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 119.595 1.089 . . . . 0.0 109.878 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.79 107.97 2.46 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.628 2.219 . . . . 0.0 109.772 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -112.97 140.69 47.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 109.582 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 26.2 mt-10 -89.99 9.27 28.54 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.697 0.799 . . . . 0.0 112.105 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.55 154.16 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 127.555 2.342 . . . . 0.0 109.821 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -143.38 -175.57 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 127.389 2.276 . . . . 0.0 107.861 -172.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -106.05 173.39 6.33 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.0 111.469 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 63' ' ' ILE . 22.3 mt -71.62 11.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.977 2.111 . . . . 0.0 112.238 177.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.06 34.18 0.44 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 124.93 1.252 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -109.86 -177.93 3.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.31 164.65 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -146.23 170.33 27.37 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 167.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 143.49 48.28 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 167.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.26 85.87 42.52 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 125.249 1.419 . . . . 0.0 107.414 -174.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.42 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 54.7 Cg_endo -60.62 -35.33 90.2 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.286 1.324 . . . . 0.0 115.037 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 59.5 Cg_endo -72.57 -32.91 9.15 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 CA-C-N 122.785 2.031 . . . . 0.0 109.939 -168.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.19 23.01 17.08 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.682 -1.621 . . . . 0.0 113.295 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt 44.64 63.97 1.51 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.107 1.763 . . . . 0.0 111.555 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.65 157.17 44.32 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.35 0.595 . . . . 0.0 111.995 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 177.39 8.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.536 158.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.3 m -150.14 155.85 40.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.378 1.471 . . . . 0.0 108.474 161.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.0 mt -145.97 108.56 4.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.924 2.09 . . . . 0.0 107.5 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -99.4 112.91 25.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.221 0.608 . . . . 0.0 110.176 -168.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -138.77 28.86 2.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.637 1.175 . . . . 0.0 113.915 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.64 52.07 0.02 OUTLIER Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.83 -1.169 . . . . 0.0 114.282 153.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttm 71.6 175.97 0.28 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.053 2.141 . . . . 0.0 109.534 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.6 OUTLIER -153.3 159.31 32.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -165.186 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.55 6.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.548 4.165 . . . . 0.0 114.394 -172.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.44 44.93 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.681 1.592 . . . . 0.0 107.871 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -162.61 -179.51 6.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.353 2.261 . . . . 0.0 107.083 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -144.17 -39.9 0.28 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 165.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -89.17 -38.65 14.12 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.323 1.059 . . . . 0.0 111.413 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.76 -164.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 128.027 2.531 . . . . 0.0 107.374 -161.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.06 74.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 120.187 1.358 . . . . 0.0 107.614 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.91 143.47 62.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HG2' ' H ' ' A' ' 94' ' ' ALA . 89.1 Cg_endo -89.32 175.88 3.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.436 3.424 . . . . 0.0 110.715 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.8 -16.88 62.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -169.07 15.41 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -165.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.512 ' H ' ' HG2' ' A' ' 91' ' ' PRO . . . 69.19 82.0 0.17 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.016 1.726 . . . . 0.0 109.102 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.5 -169.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 113.626 -1.624 . . . . 0.0 108.841 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.575 HD22 ' HA ' ' A' ' 54' ' ' MET . 52.6 t-20 -128.32 125.31 38.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.07 45.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.117 0.967 . . . . 0.0 110.112 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 pt -59.18 -14.95 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 117.885 -1.055 . . . . 0.0 113.262 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -129.16 162.04 22.6 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.744 0.688 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -129.42 135.27 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 108.154 167.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.26 85.14 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 13' ' ' VAL . 35.7 m -68.48 -47.74 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.27 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.416 ' H ' HG12 ' A' ' 13' ' ' VAL . 37.7 mt-10 -124.66 159.11 31.55 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.908 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 12' ' ' CYS . . . 65.44 74.33 0.51 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 125.961 2.038 . . . . 0.0 112.471 -176.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -107.39 -48.74 3.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.992 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -90.0 -10.78 43.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.565 0.746 . . . . 0.0 111.877 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.79 -12.62 59.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 112.051 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.37 -21.46 63.8 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 119.033 -2.292 . . . . 0.0 112.422 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -10.06 59.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 171.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -77.65 -26.36 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.796 -1.19 . . . . 0.0 111.093 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 mm -77.3 157.18 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -172.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -116.79 170.14 8.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.537 1.535 . . . . 0.0 109.526 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.91 32.23 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.647 2.379 . . . . 0.0 112.569 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.86 63.9 0.03 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.541 -1.144 . . . . 0.0 110.836 172.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -118.79 13.82 13.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp 47.43 155.14 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -160.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.97 159.44 31.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.865 1.266 . . . . 0.0 107.85 164.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.13 97.6 4.83 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.724 2.809 . . . . 0.0 105.954 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.0 t -82.01 134.72 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.289 1.436 . . . . 0.0 108.095 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -140.46 -170.1 2.92 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.583 1.953 . . . . 0.0 109.141 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 124' ' ' SER . 41.6 m-85 -98.79 5.25 47.61 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 64.6 71.7 0.46 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.224 2.21 . . . . 0.0 112.006 175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 t 70.31 3.24 4.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.12 1.768 . . . . 0.0 113.624 -169.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 121' ' ' PHE . 40.4 m . . . . . 0 C--O 1.245 0.83 0 C-N-CA 128.317 2.647 . . . . 0.0 110.404 -168.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttp . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -63.3 162.78 11.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.976 0.893 . . . . 0.0 109.316 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.67 135.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 127.563 2.345 . . . . 0.0 105.332 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 35.4 tt0 -112.78 141.03 47.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.95 120.97 40.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.559 1.944 . . . . 0.0 107.327 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.43 110.91 15.11 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.287 1.435 . . . . 0.0 107.933 -173.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -108.33 167.83 9.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 110.431 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.49 -13.73 62.52 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -115.97 -9.44 11.76 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 -166.34 35.07 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 121.621 2.009 . . . . 0.0 111.326 -168.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.8 149.23 7.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.241 1.521 . . . . 0.0 110.545 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.524 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 65.5 m -149.59 176.15 10.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.629 1.972 . . . . 0.0 109.343 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -140.1 145.75 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 122.522 1.153 . . . . 0.0 108.246 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.68 150.03 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 125.303 1.441 . . . . 0.0 107.302 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.58 121.54 43.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.413 1.885 . . . . 0.0 108.395 -171.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -127.79 124.55 37.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 122.432 1.11 . . . . 0.0 111.312 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.56 122.03 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.401 1.481 . . . . 0.0 111.002 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.4 33.03 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.586 172.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -101.42 -9.13 21.39 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 120.512 -1.367 . . . . 0.0 111.247 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -107.91 138.7 43.7 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.535 0.734 . . . . 0.0 110.101 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.26 -51.12 57.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.845 1.658 . . . . 0.0 112.114 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.87 -26.53 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.497 1.119 . . . . 0.0 112.588 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.63 -47.37 20.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.531 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.97 -36.78 75.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.046 0.538 . . . . 0.0 109.946 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.37 -20.92 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.591 1.156 . . . . 0.0 112.16 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.71 -30.28 62.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.829 1.252 . . . . 0.0 111.093 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -59.79 -23.64 63.46 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.582 0.628 . . . . 0.0 110.558 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -70.5 -16.5 62.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.095 1.358 . . . . 0.0 113.544 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -131.73 39.1 3.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.421 1.488 . . . . 0.0 109.515 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.45 141.98 35.66 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.77 154.85 72.41 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 119.629 0.903 . . . . 0.0 110.521 -7.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CE1' HG11 ' A' ' 119' ' ' VAL . 24.7 p90 -145.1 160.87 40.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.528 0.331 . . . . 0.0 110.275 171.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.95 149.0 49.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 165.55 32.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.3 t -86.58 133.0 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.41 HG13 HG23 ' A' ' 43' ' ' ILE . 13.5 t -81.85 72.68 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -68.38 150.98 47.51 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 p -129.3 157.86 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.731 0.812 . . . . 0.0 110.027 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -156.02 89.83 1.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.77 74.32 0.23 Allowed Glycine 0 C--O 1.213 -1.168 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.396 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 69.03 26.43 5.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.943 1.371 . . . . 0.0 113.189 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.36 152.01 51.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.338 1.855 . . . . 0.0 108.741 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 36' ' ' VAL . 17.4 mt -133.57 135.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -147.69 155.37 41.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -140.24 146.21 38.34 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.413 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -85.7 78.68 9.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.528 1.131 . . . . 0.0 108.389 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -56.91 147.89 51.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 111.661 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 -15.66 21.7 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.993 2.462 . . . . 0.0 112.972 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.8 t -76.49 148.02 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.223 0.919 . . . . 0.0 109.372 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -127.46 99.75 5.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.561 0.744 . . . . 0.0 109.26 173.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.5 t -135.1 153.1 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 70' ' ' PRO . 14.2 mt-30 -131.69 0.75 3.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.357 1.063 . . . . 0.0 113.486 175.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.93 120.57 23.72 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.557 1.143 . . . . 0.0 109.085 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.2 mtt -95.92 135.47 37.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -96.75 -28.39 14.31 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.766 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -146.53 71.26 12.85 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.448 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.93 135.04 39.46 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.716 1.611 . . . . 0.0 110.657 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -108.89 -176.48 3.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 164.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -127.72 7.11 6.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.779 0.831 . . . . 0.0 112.844 166.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.41 153.8 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 129.631 3.172 . . . . 0.0 108.267 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.15 170.96 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.173 1.389 . . . . 0.0 109.534 -170.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.43 161.15 20.43 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.377 -0.827 . . . . 0.0 110.361 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.66 74.26 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 166.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.59 8.46 0.06 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.684 -1.065 . . . . 0.0 113.912 -169.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -111.3 173.01 6.55 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.734 1.767 . . . . 0.0 110.361 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.53 131.04 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.731 1.212 . . . . 0.0 108.402 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.49 158.9 14.56 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.881 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.69 135.8 46.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -104.83 87.69 1.95 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 126.657 1.983 . . . . 0.0 109.552 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 59.4 Cg_endo -63.18 -41.61 26.9 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.498 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 73.3 Cg_endo -73.75 -27.15 12.84 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.55 2.167 . . . . 0.0 110.735 -162.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.13 25.92 7.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.098 1.809 . . . . 0.0 112.43 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt 43.35 65.54 0.96 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.865 1.666 . . . . 0.0 111.826 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.68 177.29 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.843 0.457 . . . . 0.0 111.792 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.557 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 2.2 tp -98.44 -177.37 3.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 110.419 167.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 30.7 m -152.87 146.01 24.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.804 1.638 . . . . 0.0 112.371 154.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.265 6.9 mp -114.9 121.83 44.4 Favored 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.342 4.257 . . . . 0.0 106.634 169.815 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -110.64 113.69 26.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.23 0.923 . . . . 0.0 109.129 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 108' ' ' LEU . 42.6 p90 -136.51 35.55 2.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.16 -127.14 0.88 Allowed Glycine 0 C--O 1.225 -0.453 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 163.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -110.85 -15.1 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.074 0.937 . . . . 0.0 112.745 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 83' ' ' PRO 0.256 11.2 p 57.03 165.56 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 128.553 2.741 . . . . 0.0 112.464 175.305 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 60.2 Cg_endo -77.91 -28.44 5.05 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.665 1.577 . . . . 0.0 114.215 -165.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.9 mmt -94.41 70.43 3.69 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -157.44 171.49 20.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.756 0.822 . . . . 0.0 109.421 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -143.72 -46.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 156.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -77.16 -56.88 4.18 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.042 0.937 . . . . 0.0 110.035 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 160.03 43.68 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.091 1.356 . . . . 0.0 108.991 -150.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.7 75.79 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 123.937 0.895 . . . . 0.0 109.077 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -75.35 144.09 77.54 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.455 160.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.71 -176.35 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.355 3.37 . . . . 0.0 111.891 171.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.82 74.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.023 169.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.3 t -164.71 170.04 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.847 1.659 . . . . 0.0 107.952 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.48 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.202 1.401 . . . . 0.0 110.742 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 m -102.44 152.64 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -74.21 168.85 18.79 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.637 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.1 t -120.15 44.24 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 123.194 1.473 . . . . 0.0 108.452 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.0 pt -72.24 -18.11 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.582 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.66 159.5 13.78 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.298 0.951 . . . . 0.0 111.404 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -130.27 143.13 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 0.0 107.551 172.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.82 105.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.17 -29.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -163.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.63 163.51 32.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 125.876 1.67 . . . . 0.0 106.574 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.524 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 71.36 64.62 2.69 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 117.778 -2.154 . . . . 0.0 111.457 172.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.2 tp -91.87 -45.99 8.09 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.052 0.926 . . . . 0.0 109.474 164.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -79.93 -20.97 44.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.184 -0.947 . . . . 0.0 112.183 -166.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.7 3.92 17.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.217 1.007 . . . . 0.0 111.381 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 79' ' ' PHE . 6.1 mp -76.8 -43.5 36.41 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.786 1.175 . . . . 0.0 111.277 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -66.12 -24.3 66.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.309 -1.494 . . . . 0.0 113.662 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -78.25 -11.07 59.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.733 1.613 . . . . 0.0 114.208 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 mm -77.67 166.85 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.655 1.116 . . . . 0.0 109.045 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.591 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 8.0 mmtp -118.55 -179.48 3.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.16 1.784 . . . . 0.0 107.803 177.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.14 9.42 3.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.948 1.299 . . . . 0.0 114.467 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.17 72.9 0.14 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 120.636 -1.29 . . . . 0.0 110.548 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.591 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 21.7 mm-40 -132.24 33.48 3.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.984 0.914 . . . . 0.0 111.599 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 43.41 74.14 0.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.969 1.707 . . . . 0.0 111.57 160.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.08 120.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.66 128.73 34.75 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.549 HG11 ' CE1' ' A' ' 32' ' ' PHE . 63.9 t -111.16 124.73 68.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 127.058 2.143 . . . . 0.0 106.014 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.26 168.39 19.85 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.822 1.649 . . . . 0.0 110.66 -171.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.81 -7.15 58.51 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 57.61 89.67 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 127.116 2.166 . . . . 0.0 111.711 -171.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.0 m -71.83 0.95 7.8 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.233 -0.917 . . . . 0.0 112.811 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . 0.274 96.7 p . . . . . 0 C--O 1.243 0.73 0 C-N-CA 131.034 3.734 . . . . 0.0 112.161 -167.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 CA--C 1.503 -0.831 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.51 ' CB ' HH11 ' A' ' 2' ' ' ARG . 0.0 OUTLIER -66.62 148.87 51.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.6 t -151.63 147.25 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.914 2.085 . . . . 0.0 109.605 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 11.4 tt0 -134.6 136.67 43.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.751 2.021 . . . . 0.0 107.636 -175.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.58 100.32 7.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.953 2.501 . . . . 0.0 106.596 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.28 100.42 13.22 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.69 175.53 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.879 0.871 . . . . 0.0 108.869 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.28 -35.58 76.19 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 166.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -91.27 -14.88 30.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -172.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.38 -167.06 33.98 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -155.77 145.93 21.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 168.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.89 166.33 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.656 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.16 104.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -162.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.0 pt -120.55 160.38 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.92 1.288 . . . . 0.0 109.806 -166.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -140.56 139.43 34.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -128.93 124.49 35.27 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.201 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.73 137.36 51.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.18 -166.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -81.93 35.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.066 1.346 . . . . 0.0 111.983 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -119.66 3.78 11.13 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.245 2.218 . . . . 0.0 111.919 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -120.28 137.72 54.08 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.545 1.138 . . . . 0.0 109.94 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -44.0 -65.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.534 2.334 . . . . 0.0 107.739 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 68' ' ' TYR . 7.3 p -48.54 -38.16 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.25 -43.35 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.052 1.296 . . . . 0.0 109.427 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -62.78 -38.25 89.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 120.913 -1.117 . . . . 0.0 111.602 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -44.0 69.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mt -51.17 -43.79 61.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -54.31 -23.41 15.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.995 0.816 . . . . 0.0 112.43 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.37 -30.98 17.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.58 0.627 . . . . 0.0 110.84 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.6 -40.23 64.01 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.866 1.266 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.2 140.73 98.0 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.859 1.263 . . . . 0.0 108.699 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.74 149.26 93.8 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.139 0.728 . . . . 0.0 112.594 -9.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.64 176.48 10.05 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.977 1.311 . . . . 0.0 110.103 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -133.17 166.86 21.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.514 1.126 . . . . 0.0 109.314 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -165.06 -177.96 4.89 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.4 129.07 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 C-N-CA 125.981 1.712 . . . . 0.0 107.387 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.466 HG13 HG23 ' A' ' 43' ' ' ILE . 2.5 t -69.5 117.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -102.79 156.89 17.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 160.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -144.93 137.34 26.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.211 0.604 . . . . 0.0 109.596 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -148.93 98.44 2.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -165.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 50.49 45.53 46.25 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 78.01 27.57 0.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 130.787 3.635 . . . . 0.0 114.543 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -108.93 160.71 15.79 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.67 1.588 . . . . 0.0 110.257 161.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.466 HG23 HG13 ' A' ' 36' ' ' VAL . 14.6 mt -128.8 134.99 63.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.689 1.996 . . . . 0.0 105.846 165.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.43 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 49.4 p90 -142.11 168.22 20.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.201 0.6 . . . . 0.0 110.78 164.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.8 154.99 36.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.36 76.99 10.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.549 1.14 . . . . 0.0 111.433 -167.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.7 p -60.04 150.47 70.0 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.088 0.955 . . . . 0.0 112.053 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.1 -6.18 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.526 3.484 . . . . 0.0 113.303 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 p -112.34 113.11 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 125.196 1.398 . . . . 0.0 107.998 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.77 103.73 7.22 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.513 1.925 . . . . 0.0 109.438 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.24 154.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.424 2.29 . . . . 0.0 107.879 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -108.75 7.28 26.28 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.302 -0.874 . . . . 0.0 112.483 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -86.42 136.21 33.2 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.353 0.661 . . . . 0.0 109.495 171.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.47 175.46 5.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.932 2.093 . . . . 0.0 109.854 163.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.46 -35.53 1.73 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.795 1.238 . . . . 0.0 110.382 163.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -137.82 65.1 45.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 109.029 -171.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.76 138.53 23.79 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.522 2.148 . . . . 0.0 110.746 171.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -126.45 154.46 43.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.34 -0.85 . . . . 0.0 111.333 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -95.45 6.02 50.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.331 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.19 150.05 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.168 2.987 . . . . 0.0 109.894 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.08 178.35 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 127.784 2.434 . . . . 0.0 108.038 -170.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -102.26 173.47 6.35 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.106 0.962 . . . . 0.0 112.313 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.08 74.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 165.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.49 29.19 0.17 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.885 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -104.23 175.73 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.16 1.98 . . . . 0.0 109.057 167.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.1 117.94 45.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 108.417 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.76 171.64 26.4 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.891 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 22' ' ' VAL . 61.7 t80 -129.28 123.36 31.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -114.18 85.92 11.03 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.561 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 36.8 Cg_endo -61.46 -33.75 87.47 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.392 2.728 . . . . 0.0 117.072 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.561 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 1.9 Cg_endo -63.46 -52.29 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.841 2.361 . . . . 0.0 109.439 -168.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.74 -6.54 87.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.578 -1.124 . . . . 0.0 114.321 174.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 47.04 90.8 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.158 2.583 . . . . 0.0 113.508 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 44' ' ' TYR . . . -160.32 166.71 28.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.212 0.529 . . . . 0.0 112.407 169.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tp -63.39 178.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.013 0.925 . . . . 0.0 110.314 160.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 32.9 m -150.58 143.7 24.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.699 2.0 . . . . 0.0 108.23 158.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 mt -125.38 135.99 52.98 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.522 2.329 . . . . 0.0 105.67 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.5 105.87 12.1 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.967 0.907 . . . . 0.0 109.299 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -136.13 23.11 3.27 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.82 -140.38 2.86 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 120.277 -1.514 . . . . 0.0 112.449 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.79 90.69 2.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -74.63 159.33 83.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 127.701 2.4 . . . . 0.0 110.8 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.22 72.36 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.344 3.363 . . . . 0.0 113.437 -166.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.64 20.85 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.997 -1.065 . . . . 0.0 112.396 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -152.42 -162.61 1.54 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.714 1.206 . . . . 0.0 108.628 -171.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -43.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.336 1.454 . . . . 0.0 109.053 160.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.47 -55.3 6.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.536 0.684 . . . . 0.0 110.698 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -138.1 -165.1 1.74 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.954 1.702 . . . . 0.0 109.595 -160.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 mt -100.62 77.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.683 1.128 . . . . 0.0 108.47 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -77.75 142.94 66.3 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.47 -0.769 . . . . 0.0 109.415 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.73 177.43 5.55 Favored 'Trans proline' 0 C--N 1.347 0.494 1 C-N-CA 125.539 4.159 . . . . 0.0 113.423 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.06 -19.69 64.63 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -172.32 176.52 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.465 2.306 . . . . 0.0 106.331 158.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.72 86.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.311 0.959 . . . . 0.0 112.812 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -69.11 136.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.995 0.918 . . . . 0.0 109.052 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -58.85 111.42 1.28 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 164.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.81 63.88 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 pt -72.84 -21.12 19.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 118.646 -0.693 . . . . 0.0 112.221 -170.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.19 -177.5 16.48 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.114 0.841 . . . . 0.0 114.325 -170.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -140.43 134.55 30.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.522 1.529 . . . . 0.0 109.442 -170.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 92.5 mt -81.07 87.58 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 165.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.5 -35.54 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 118.174 -0.917 . . . . 0.0 108.683 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.35 160.69 40.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.974 0.806 . . . . 0.0 111.7 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.95 74.61 0.35 Allowed Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.213 1.387 . . . . 0.0 110.897 -167.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.44 -63.24 1.28 Allowed 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.45 -22.11 60.28 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.997 -1.064 . . . . 0.0 111.689 -163.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -14.49 59.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 111.667 170.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.38 -31.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.224 -1.548 . . . . 0.0 110.726 169.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -77.55 34.5 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.834 1.254 . . . . 0.0 112.907 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 -16.71 0.84 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.381 -1.449 . . . . 0.0 111.415 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 mm -74.09 154.69 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -113.05 -178.39 3.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.676 0.79 . . . . 0.0 109.441 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -74.19 38.57 0.11 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.738 2.015 . . . . 0.0 111.898 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 151.8 79.9 0.03 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.832 1.206 . . . . 0.0 111.067 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -138.06 29.87 2.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.55 1.54 . . . . 0.0 110.834 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.54 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 128.595 2.758 . . . . 0.0 115.064 -170.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.53 137.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 161.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 104.73 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.942 1.697 . . . . 0.0 106.808 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.67 124.24 50.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 127.443 2.297 . . . . 0.0 106.931 -161.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -138.12 177.0 8.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.647 1.979 . . . . 0.0 110.775 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.96 -6.78 55.51 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 60.87 52.92 4.0 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 125.262 1.425 . . . . 0.0 112.922 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 65.2 m -64.87 34.36 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.417 2.287 . . . . 0.0 114.61 172.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.256 1.402 0 C-N-CA 129.038 2.935 . . . . 0.0 110.995 175.855 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttm . . . . . 0 CA--C 1.509 -0.626 0 CA-C-O 121.953 0.882 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -99.89 163.85 12.27 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.539 0.735 . . . . 0.0 109.198 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.3 t -148.47 129.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 2.7 tt0 -111.7 129.26 56.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.121 -1.612 . . . . 0.0 110.509 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -103.44 96.09 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.121 0.962 . . . . 0.0 111.934 174.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.6 142.24 28.41 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 109.057 168.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.51 173.25 11.04 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.751 1.62 . . . . 0.0 110.09 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.45 -27.04 66.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.866 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 m -113.35 0.4 14.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.08 -165.93 37.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 119.793 1.179 . . . . 0.0 111.426 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -162.84 143.85 9.8 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.581 ' CB ' ' HA3' ' A' ' 104' ' ' GLY 0.258 11.8 m -152.54 154.22 35.0 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 3.9 p -122.06 164.97 18.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.485 ' CD1' HD21 ' A' ' 16' ' ' LEU . 1.6 pp -135.59 158.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 166.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -123.71 133.09 53.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 117.648 -1.167 . . . . 0.0 110.537 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 14' ' ' ILE . 81.0 mt -117.32 156.49 27.75 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.758 1.623 . . . . 0.0 111.484 -172.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.631 ' O ' HG21 ' A' ' 23' ' ' VAL . 6.9 t-20 -105.72 118.08 35.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.756 -1.116 . . . . 0.0 108.741 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.61 16.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.18 2.192 . . . . 0.0 115.486 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -102.53 8.2 39.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.443 1.897 . . . . 0.0 110.29 -169.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.624 ' HB2' HG23 ' A' ' 23' ' ' VAL . 54.8 m-85 -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.565 1.146 . . . . 0.0 109.13 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.12 -45.95 53.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.759 1.624 . . . . 0.0 109.116 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.19 -22.57 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 112.557 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 17' ' ' ASN . 3.1 t -81.01 -51.75 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 120.354 1.434 . . . . 0.0 108.009 175.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -57.7 -27.6 63.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.724 1.209 . . . . 0.0 110.496 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.547 HD12 HG11 ' A' ' 51' ' ' VAL . 32.8 mt -92.94 -34.85 13.61 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.835 1.654 . . . . 0.0 111.695 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 49' ' ' VAL . 2.6 mt -61.36 -35.71 78.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 120.141 1.337 . . . . 0.0 110.509 171.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -34.03 51.19 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.893 0.877 . . . . 0.0 110.735 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.98 -15.63 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -120.57 0.82 10.54 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.837 0.855 . . . . 0.0 113.071 -166.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.1 mt -99.28 145.31 29.82 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.235 1.38 . . . . 0.0 108.631 -173.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.26 159.53 81.05 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 CA-C-N 119.039 0.693 . . . . 0.0 113.34 -12.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -148.65 159.76 43.8 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.773 1.229 . . . . 0.0 109.244 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -114.61 159.53 20.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.448 1.099 . . . . 0.0 109.709 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -161.92 172.59 15.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.058 -170.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.32 132.89 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.25 73.16 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -68.64 147.24 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -123.48 136.15 54.43 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.921 0.888 . . . . 0.0 109.449 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' A' ' 92' ' ' ALA . 37.1 t90 -144.82 96.81 2.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 45.02 71.84 0.43 Allowed Glycine 0 C--O 1.211 -1.325 0 O-C-N 124.258 0.974 . . . . 0.0 112.266 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 60.74 31.44 20.11 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.639 1.22 . . . . 0.0 111.792 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -123.73 155.22 38.26 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.82 2.448 . . . . 0.0 108.594 161.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.9 mm -115.47 147.91 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 158.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -144.95 169.34 18.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.111 0.957 . . . . 0.0 108.565 161.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.24 148.24 33.29 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -80.11 77.91 6.79 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 109.537 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -59.73 150.37 67.78 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 122.093 0.949 . . . . 0.0 111.855 -171.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -68.33 -12.24 34.36 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.804 2.336 . . . . 0.0 112.246 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG21 ' HG ' ' A' ' 26' ' ' LEU . 5.7 t -96.77 122.59 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.862 1.665 . . . . 0.0 109.835 -172.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -128.06 30.76 5.19 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.074 1.349 . . . . 0.0 114.003 -167.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG11 HD12 ' A' ' 25' ' ' LEU . 10.6 m -72.65 164.46 3.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.124 1.37 . . . . 0.0 109.731 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -139.51 33.21 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.628 0.771 . . . . 0.0 111.217 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -85.87 148.69 25.68 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.646 0.778 . . . . 0.0 109.177 166.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.88 158.67 44.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 167.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.18 -20.85 1.88 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.773 171.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -117.45 57.11 2.1 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 120.696 1.589 . . . . 0.0 111.819 171.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.66 134.46 35.31 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.065 1.843 . . . . 0.0 112.717 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.474 ' HD2' ' C ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -138.52 169.72 17.29 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.881 0.848 . . . . 0.0 112.714 172.108 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -122.88 9.21 9.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.263 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' C ' ' HD2' ' A' ' 58' ' ' ARG . 1.6 p -159.99 101.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 125.349 1.46 . . . . 0.0 114.817 174.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 78' ' ' PHE . 31.5 m -100.16 -177.92 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 127.358 2.263 . . . . 0.0 110.137 -168.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -90.09 171.95 9.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.724 -1.235 . . . . 0.0 111.294 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.21 -9.55 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.507 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.31 26.38 2.0 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 125.658 1.599 . . . . 0.0 111.748 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -83.01 -154.86 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 160.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.8 t -137.62 173.89 12.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 130.107 3.363 . . . . 0.0 104.701 162.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.02 154.37 25.87 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 146.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 150.25 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -119.98 87.87 39.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.92 -43.67 56.06 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 121.582 1.521 . . . . 0.0 114.972 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.62 -1.44 11.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.084 2.523 . . . . 0.0 114.902 -155.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.26 5.16 5.98 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 127.01 2.243 . . . . 0.0 112.78 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 55.08 78.16 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.746 2.018 . . . . 0.0 111.942 -167.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.27 176.9 11.12 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.243 0.617 . . . . 0.0 111.893 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.533 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 4.9 tp -90.09 -172.79 3.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.211 1.405 . . . . 0.0 109.919 158.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.533 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 66.8 m -146.85 151.13 36.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.66 3.184 . . . . 0.0 107.734 160.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.37 96.04 3.64 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.547 2.339 . . . . 0.0 105.093 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 61' ' ' VAL . 1.8 m-85 -82.11 132.09 35.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 172.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -147.47 16.08 1.14 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.41 -82.49 0.04 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 165.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -151.39 -13.71 0.21 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 57.43 166.71 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.193 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 -1.06 8.01 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.681 2.254 . . . . 0.0 113.241 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.16 39.39 2.44 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.597 1.159 . . . . 0.0 109.299 -169.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -136.24 178.9 6.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.789 1.636 . . . . 0.0 108.617 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -138.47 -47.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 165.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.512 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 26.4 t0 -118.97 -13.39 9.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -163.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 87' ' ' ASP . 3.2 pttt -167.64 164.49 14.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.758 1.623 . . . . 0.0 109.221 -166.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.0 mp -81.65 77.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 122.798 1.285 . . . . 0.0 108.739 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -69.98 144.68 93.29 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.455 163.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.44 -174.46 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.847 3.698 . . . . 0.0 111.329 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HB2' ' CH2' ' A' ' 39' ' ' TRP . . . -85.71 -11.54 53.42 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 t -166.37 170.21 13.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 167.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.51 98.5 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.793 0.837 . . . . 0.0 110.62 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.84 -178.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.736 1.214 . . . . 0.0 109.43 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -130.95 118.9 21.33 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG21 ' NE ' ' A' ' 58' ' ' ARG . 21.4 t -76.72 47.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 123.025 1.393 . . . . 0.0 112.63 -171.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.55 -28.71 37.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 126.874 2.069 . . . . 0.0 113.841 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.421 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -128.57 168.16 20.5 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.184 1.849 . . . . 0.0 112.341 -174.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -141.95 129.05 20.87 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.665 1.986 . . . . 0.0 108.252 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.9 mt -65.08 103.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 164.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 13' ' ' VAL . 33.4 m -75.47 -61.9 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 165.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.451 ' HB2' HG12 ' A' ' 13' ' ' VAL . 6.6 mt-10 -113.03 158.31 20.47 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 88.62 61.61 1.44 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.403 176.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.53 -20.66 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.05 -33.09 7.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.269 1.027 . . . . 0.0 108.671 -173.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -10.01 59.08 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.244 -0.91 . . . . 0.0 111.516 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.414 HD21 ' SG ' ' A' ' 12' ' ' CYS . 53.6 mt -72.41 -20.67 61.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.652 -1.28 . . . . 0.0 112.458 172.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -64.7 -31.68 73.01 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.889 -1.132 . . . . 0.0 110.504 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.76 10.38 41.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.188 2.595 . . . . 0.0 114.213 -172.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.36 159.95 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 120.975 -1.078 . . . . 0.0 109.276 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.56 174.58 5.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.362 1.865 . . . . 0.0 109.746 173.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.06 16.48 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.703 2.001 . . . . 0.0 113.637 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -179.92 65.16 0.07 OUTLIER Glycine 0 CA--C 1.525 0.684 0 O-C-N 119.644 -1.91 . . . . 0.0 113.787 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -94.57 24.97 4.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.642 1.177 . . . . 0.0 112.71 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.9 mttt 43.99 71.98 0.22 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 130.075 3.35 . . . . 0.0 112.629 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -69.29 119.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.54 103.6 16.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 168.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 5' ' ' LEU . 75.6 t -72.42 125.75 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 168.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -136.49 -175.98 4.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.307 1.843 . . . . 0.0 109.203 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.63 8.85 34.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 117.93 2.567 . . . . 0.0 117.93 -168.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . . . 55.48 111.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 129.983 3.313 . . . . 0.0 111.275 -165.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.2 t -68.07 -16.41 64.01 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.245 -0.909 . . . . 0.0 111.33 171.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.059 0 C-N-CA 130.677 3.591 . . . . 0.0 111.566 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ttm . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 54.0 mtt180 -84.85 173.03 10.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 173.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 72.8 t -147.78 141.06 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.072 1.749 . . . . 0.0 106.5 169.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 36.1 tt0 -125.26 131.13 53.16 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.786 2.034 . . . . 0.0 107.18 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.82 102.94 10.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.478 1.911 . . . . 0.0 106.773 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.26 136.67 32.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -125.91 170.23 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.994 1.318 . . . . 0.0 109.747 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.97 -27.47 66.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.415 -0.803 . . . . 0.0 113.093 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 m -111.26 -3.74 15.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.27 20.81 Favored Glycine 0 N--CA 1.464 0.527 0 CA-C-O 118.08 -1.4 . . . . 0.0 110.1 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.55 161.04 23.77 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.74 1.77 . . . . 0.0 111.869 -167.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.7 p -143.81 174.83 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.793 0.837 . . . . 0.0 110.32 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.1 128.2 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 pt -117.11 148.79 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -120.24 128.51 53.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.251 -0.906 . . . . 0.0 111.015 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD23 ' CA ' ' A' ' 99' ' ' GLY . 42.3 mt -119.89 169.56 10.05 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 123.523 1.63 . . . . 0.0 111.912 -175.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -128.38 114.9 17.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.99 2.116 . . . . 0.0 109.505 -167.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -72.67 52.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.789 2.036 . . . . 0.0 112.326 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -130.63 -34.15 1.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.317 1.447 . . . . 0.0 110.905 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -74.69 151.02 39.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -57.91 -46.35 85.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.865 0.866 . . . . 0.0 109.076 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 51' ' ' VAL . 1.6 t -61.09 -38.08 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -170.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.82 -46.14 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -52.46 -46.76 66.63 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.094 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.619 HD12 HG12 ' A' ' 51' ' ' VAL . 29.1 mt -74.5 -32.91 62.68 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.741 0.816 . . . . 0.0 111.1 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -39.0 91.63 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.748 1.219 . . . . 0.0 110.184 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -53.68 -41.53 66.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.468 0.707 . . . . 0.0 109.805 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -62.21 -20.64 64.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.185 0.994 . . . . 0.0 111.918 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -111.31 -1.64 15.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 116.893 -1.527 . . . . 0.0 113.003 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -99.3 143.3 26.16 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 121.405 1.911 . . . . 0.0 109.106 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -70.15 159.65 90.53 Favored 'Cis proline' 0 C--N 1.351 0.662 0 CA-C-N 119.109 0.718 . . . . 0.0 113.242 -11.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -146.97 172.23 14.03 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 126.138 1.775 . . . . 0.0 109.722 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -124.52 167.33 14.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 109.784 167.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.34 178.09 3.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.411 0.685 . . . . 0.0 112.046 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.8 t -82.53 138.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 125.385 1.474 . . . . 0.0 109.342 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 111' ' ' ILE . 10.3 t -94.29 71.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.133 0.973 . . . . 0.0 108.379 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -70.13 152.11 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 p -123.01 152.18 41.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.266 0.626 . . . . 0.0 109.997 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -156.89 79.63 0.92 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.718 0.807 . . . . 0.0 109.757 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 83' ' ' PRO . . . 87.19 55.02 2.44 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 119.856 -1.777 . . . . 0.0 113.118 175.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 52.28 40.93 30.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.157 1.383 . . . . 0.0 109.569 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.24 166.03 24.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.81 2.044 . . . . 0.0 107.858 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -132.47 124.28 51.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 108.266 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -127.41 149.26 50.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.396 1.093 . . . . 0.0 109.636 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -136.63 148.45 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 108.446 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.93 74.77 3.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.007 1.723 . . . . 0.0 111.445 -165.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.4 p -63.03 145.52 96.59 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.191 -0.943 . . . . 0.0 112.7 -164.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.68 -1.97 11.21 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.056 3.171 . . . . 0.0 113.096 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.72 136.51 37.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -132.63 82.36 2.0 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.51 0.724 . . . . 0.0 111.768 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.619 HG12 HD12 ' A' ' 25' ' ' LEU . 3.0 m -91.92 173.04 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 O-C-N 121.509 -0.744 . . . . 0.0 110.568 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -132.54 13.93 4.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.292 1.437 . . . . 0.0 112.212 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -111.69 123.19 49.72 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.812 1.187 . . . . 0.0 111.641 -167.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.4 122.7 26.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.291 1.836 . . . . 0.0 110.245 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.44 -37.28 10.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.295 0.638 . . . . 0.0 110.208 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.14 60.07 1.28 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.82 1.648 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -65.31 145.05 82.66 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.224 1.949 . . . . 0.0 110.513 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -143.58 146.56 33.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.228 1.011 . . . . 0.0 108.996 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.16 -5.29 24.59 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.094 1.358 . . . . 0.0 111.391 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.05 149.77 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 127.845 2.458 . . . . 0.0 108.895 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.674 HG21 ' CD1' ' A' ' 78' ' ' PHE . 20.8 m -132.78 -178.72 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.958 1.703 . . . . 0.0 108.587 -173.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.87 176.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.251 1.024 . . . . 0.0 109.472 172.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.6 mt -78.73 -4.54 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.196 0.998 . . . . 0.0 111.128 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.43 37.81 1.94 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.863 1.221 . . . . 0.0 111.083 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -116.85 174.77 5.91 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.1 165.87 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 95' ' ' VAL . . . -141.72 179.19 19.98 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 165.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.986 ' H ' HG13 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -128.82 129.64 45.89 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 -170.28 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . 0.297 2.9 t90 -118.57 86.62 29.46 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-N 120.135 1.334 . . . . 0.0 109.876 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 69.6 Cg_endo -70.78 -26.33 22.87 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 116.834 1.821 . . . . 0.0 116.834 -171.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.455 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 95.4 Cg_endo -77.55 -17.59 14.29 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.955 2.437 . . . . 0.0 112.395 -172.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.45 -2.56 50.52 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.88 1.705 . . . . 0.0 112.79 167.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 52.25 65.49 1.49 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.228 1.811 . . . . 0.0 110.973 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.58 177.51 10.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.75 0.786 . . . . 0.0 111.153 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -88.92 -177.75 5.56 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 126.213 1.805 . . . . 0.0 112.074 175.258 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 65.7 m -152.94 127.93 9.66 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.638 1.575 . . . . 0.0 109.205 156.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.61 105.12 15.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.393 2.277 . . . . 0.0 105.965 168.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.674 ' CD1' HG21 ' A' ' 61' ' ' VAL . 39.4 m-85 -86.8 132.53 33.82 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -150.25 27.31 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.48 0.582 . . . . 0.0 112.419 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.38 0.09 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-O 118.212 -1.327 . . . . 0.0 112.331 168.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 136.36 4.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.686 1.195 . . . . 0.0 111.3 165.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.56 165.44 30.38 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.277 2.231 . . . . 0.0 113.118 -172.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 85.7 Cg_endo -80.59 -17.8 9.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.65 2.9 . . . . 0.0 114.404 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.21 57.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.432 0.693 . . . . 0.0 111.997 -173.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -172.11 1.85 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.138 2.175 . . . . 0.0 109.839 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.53 -49.97 0.32 Allowed 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 158.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.457 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 8.1 m-20 -72.12 -54.99 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.883 -0.511 . . . . 0.0 110.261 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -139.4 179.71 6.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.677 2.391 . . . . 0.0 109.489 -153.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.7 74.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 121.519 1.963 . . . . 0.0 110.291 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -84.52 142.58 40.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.561 -0.712 . . . . 0.0 109.911 166.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -74.96 -178.57 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.494 3.462 . . . . 0.0 113.72 160.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.08 -12.9 43.4 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t 180.0 -177.95 0.4 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.886 2.074 . . . . 0.0 106.848 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.16 96.06 1.74 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 124.533 2.111 . . . . 0.0 109.609 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.986 HG13 ' H ' ' A' ' 68' ' ' TYR 0.308 46.9 t -58.59 -172.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 CA-C-N 110.945 -2.843 . . . . 0.0 111.199 140.146 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.679 ' H ' HG12 ' A' ' 95' ' ' VAL . 63.8 t-20 -142.54 130.39 21.68 Favored 'General case' 0 N--CA 1.438 -1.044 1 C-N-CA 132.677 4.391 . . . . 0.0 105.207 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.07 82.71 2.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 22' ' ' VAL . 8.2 pt -77.4 -65.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.968 172.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.469 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -95.59 173.92 31.48 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.848 1.213 . . . . 0.0 111.464 -178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -134.5 141.51 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.611 1.964 . . . . 0.0 108.203 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.84 100.18 2.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 102.339 -3.208 . . . . 0.0 102.339 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -83.72 -38.73 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.363 0.529 . . . . 0.0 110.236 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.74 159.66 41.57 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.557 1.143 . . . . 0.0 109.973 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.0 70.51 1.16 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 tp -87.85 -64.09 1.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.4 -29.14 68.57 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.584 -0.697 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -12.78 24.19 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.38 1.072 . . . . 0.0 111.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.65 -34.91 22.95 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.213 1.405 . . . . 0.0 111.875 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.36 -21.93 66.25 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.08 -1.012 . . . . 0.0 112.361 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.71 10.32 33.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.495 1.518 . . . . 0.0 112.494 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.426 HG21 HG11 ' A' ' 36' ' ' VAL . 23.5 mm -95.37 138.66 20.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.263 0.938 . . . . 0.0 108.983 176.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -85.14 175.08 9.21 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.809 1.244 . . . . 0.0 110.281 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.69 16.4 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 129.652 3.181 . . . . 0.0 114.914 174.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.93 80.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 O-C-N 120.334 -1.479 . . . . 0.0 109.463 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -133.53 31.41 3.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt 46.03 70.11 0.4 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 128.046 2.538 . . . . 0.0 112.347 162.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.44 129.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.58 107.75 20.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.049 1.74 . . . . 0.0 106.992 164.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.5 t -88.57 121.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 128.131 2.572 . . . . 0.0 107.695 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 25.6 mtm180 -138.66 174.13 10.86 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.128 1.371 . . . . 0.0 110.116 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -78.66 -9.44 59.39 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 122.228 2.285 . . . . 0.0 117.036 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 62.59 178.21 0.14 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 126.335 1.854 . . . . 0.0 112.06 -164.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.7 m -158.91 36.59 0.22 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.99 2.116 . . . . 0.0 111.055 169.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 C--O 1.247 0.933 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 161.717 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 C--O 1.236 0.378 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.74 157.39 24.4 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 t -155.23 140.43 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.701 1.6 . . . . 0.0 107.646 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 122' ' ' ALA . 43.7 tt0 -123.1 117.96 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.928 2.091 . . . . 0.0 106.476 177.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.87 110.28 19.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.987 1.715 . . . . 0.0 106.448 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.8 122.28 39.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.363 1.465 . . . . 0.0 107.268 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -114.14 170.51 8.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.622 1.169 . . . . 0.0 109.588 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.49 -17.79 62.97 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.406 -1.434 . . . . 0.0 112.358 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 m -113.68 -0.58 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 114.16 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.17 -157.19 28.42 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 119.999 1.272 . . . . 0.0 109.927 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -158.59 166.71 31.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.47 0.708 . . . . 0.0 109.371 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -144.38 179.42 7.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.433 0.693 . . . . 0.0 109.304 166.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.05 126.74 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.19 153.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 122.691 1.234 . . . . 0.0 107.831 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -116.51 126.44 53.36 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 125.842 1.657 . . . . 0.0 106.983 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.35 133.19 51.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.182 0.901 . . . . 0.0 109.546 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.86 137.42 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.15 -18.95 63.23 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.017 0.927 . . . . 0.0 112.591 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.84 -19.5 59.97 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.496 1.043 . . . . 0.0 113.518 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -92.33 126.96 37.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.163 1.385 . . . . 0.0 110.092 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -45.96 -54.76 7.78 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 126.193 1.797 . . . . 0.0 110.915 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -54.98 -32.95 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.143 -1.408 . . . . 0.0 113.998 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.0 t -69.41 -38.75 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.772 1.624 . . . . 0.0 109.379 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -63.41 -42.7 98.75 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.799 0.84 . . . . 0.0 110.759 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -43.99 84.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -54.27 -28.07 39.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.226 1.41 . . . . 0.0 112.8 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -65.29 -27.25 68.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.014 0.824 . . . . 0.0 110.496 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.79 -20.59 63.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.593 0.711 . . . . 0.0 110.817 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -118.29 18.33 13.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.95 2.1 . . . . 0.0 110.753 -165.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.5 mt -121.29 139.97 30.47 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.678 1.581 . . . . 0.0 107.456 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.89 156.99 83.01 Favored 'Cis proline' 0 N--CA 1.458 -0.6 0 C-N-CA 125.089 -0.796 . . . . 0.0 112.053 -9.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.491 ' CE1' HG11 ' A' ' 119' ' ' VAL . 20.5 p90 -143.72 165.17 28.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.578 1.174 . . . . 0.0 109.947 165.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.96 155.32 41.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -162.05 166.3 26.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.819 0.848 . . . . 0.0 111.471 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.57 127.97 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.845 HG13 HG23 ' A' ' 43' ' ' ILE . 98.9 t -80.38 98.54 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 171.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -90.75 156.06 18.34 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -144.45 149.45 36.03 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.161 0.585 . . . . 0.0 110.253 -168.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -146.62 82.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 83' ' ' PRO . . . 79.18 -84.98 1.23 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -142.03 38.62 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.58 1.552 . . . . 0.0 109.181 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.68 165.32 26.66 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.21 172.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.845 HG23 HG13 ' A' ' 36' ' ' VAL . 30.3 mt -131.95 123.19 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -121.18 176.35 5.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.071 0.939 . . . . 0.0 109.751 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.43 161.15 38.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.915 2.086 . . . . 0.0 106.679 173.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p -94.57 85.41 4.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.666 HG21 HD23 ' A' ' 75' ' ' LEU . 40.2 p -59.12 150.21 63.37 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -166.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.87 -25.16 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.287 1.992 . . . . 0.0 111.263 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.88 143.8 10.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.152 0.981 . . . . 0.0 109.938 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -138.87 101.13 4.23 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.395 1.478 . . . . 0.0 108.202 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.8 160.19 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.626 1.57 . . . . 0.0 108.022 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -123.37 2.65 9.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.69 1.196 . . . . 0.0 113.123 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -71.95 157.98 36.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.051 0.841 . . . . 0.0 109.107 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 46.4 mtm -147.59 158.38 43.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.565 1.546 . . . . 0.0 106.939 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -126.64 -51.69 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.533 1.533 . . . . 0.0 108.819 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -123.89 54.41 7.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.297 1.039 . . . . 0.0 111.641 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.77 134.37 27.81 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 120.264 1.13 . . . . 0.0 110.516 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -127.9 148.6 50.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.387 0.675 . . . . 0.0 109.33 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -92.89 5.75 50.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.843 0.857 . . . . 0.0 112.304 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -148.39 153.41 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.034 2.134 . . . . 0.0 106.59 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 78' ' ' PHE . 27.3 m -146.2 -178.74 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.542 2.337 . . . . 0.0 107.207 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.48 172.15 7.67 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.489 -0.757 . . . . 0.0 111.335 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -72.14 71.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.954 . . . . 0.0 107.215 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.73 11.74 0.16 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.813 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -105.07 -177.74 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.399 2.1 . . . . 0.0 108.7 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -131.65 148.34 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.638 1.175 . . . . 0.0 108.463 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -134.09 149.9 19.86 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.462 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 6.7 m-85 -120.24 120.51 36.31 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -105.06 87.97 2.18 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.536 1.934 . . . . 0.0 110.35 -167.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.06 -52.0 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.104 2.536 . . . . 0.0 114.844 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.67 -28.6 7.98 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.939 2.426 . . . . 0.0 111.212 -161.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.66 87.39 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.57 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 47.24 67.62 0.77 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 108.924 -162.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.0 157.2 45.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.629 0.728 . . . . 0.0 111.702 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.666 HD23 HG21 ' A' ' 47' ' ' THR . 0.2 OUTLIER -80.5 -175.62 5.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.663 159.416 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 t -164.09 154.54 15.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.62 1.168 . . . . 0.0 109.278 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -136.09 142.14 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 107.12 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD2' HG21 ' A' ' 61' ' ' VAL . 56.7 m-85 -120.66 106.38 11.68 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 119.929 1.241 . . . . 0.0 110.829 -170.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.25 52.52 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.328 1.061 . . . . 0.0 112.42 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.36 -98.94 0.13 Allowed Glycine 0 CA--C 1.506 -0.47 0 O-C-N 120.368 -1.457 . . . . 0.0 111.095 159.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.411 ' HA ' HG13 ' A' ' 89' ' ' ILE . 11.6 tttt -135.08 -15.38 1.98 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 167.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 55.72 165.63 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.232 1.813 . . . . 0.0 112.136 -174.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 71.9 Cg_endo -72.64 5.43 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.185 2.59 . . . . 0.0 113.16 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.19 88.26 2.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 p 174.18 172.94 0.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.369 2.668 . . . . 0.0 107.223 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -147.21 -47.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 158.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.83 -53.49 7.85 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.737 0.78 . . . . 0.0 109.429 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -149.82 152.05 34.53 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 128.682 2.793 . . . . 0.0 107.527 -161.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 89' ' ' ILE . 5.4 mp -54.47 122.19 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -138.9 143.4 37.19 Favored Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.501 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -82.71 171.45 11.98 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.625 2.883 . . . . 0.0 113.331 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.12 52.31 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.72 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.9 m -173.02 -175.36 1.2 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.105 2.562 . . . . 0.0 107.089 166.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.9 104.99 0.61 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.433 1.015 . . . . 0.0 108.678 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -106.83 138.83 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -66.21 106.74 1.74 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.292 1.437 . . . . 0.0 108.707 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.21 61.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 122.469 1.128 . . . . 0.0 109.154 -168.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.77 -13.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.194 0.998 . . . . 0.0 112.933 -167.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.11 164.41 17.41 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -129.13 137.72 51.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.72 90.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -73.5 -30.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.704 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -148.98 162.77 39.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.225 0.536 . . . . 0.0 110.801 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.57 70.74 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.261 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -54.66 44.45 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.378 1.089 . . . . 0.0 109.922 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.25 -18.35 61.24 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.045 -1.035 . . . . 0.0 110.624 -167.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.85 -13.26 61.4 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.161 -0.962 . . . . 0.0 111.781 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.62 -29.1 56.35 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.112 -1.617 . . . . 0.0 113.23 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.39 81.16 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 120.308 -1.495 . . . . 0.0 111.872 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -67.38 -11.14 56.99 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.765 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.0 164.33 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 126.866 2.067 . . . . 0.0 109.6 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 110' ' ' LYS . 5.7 mmtp -120.86 175.31 6.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.977 1.711 . . . . 0.0 109.488 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.13 44.68 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.0 2.12 . . . . 0.0 112.899 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.77 83.15 0.04 OUTLIER Glycine 0 C--N 1.333 0.366 0 O-C-N 120.721 -1.237 . . . . 0.0 110.94 168.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.5 31.11 5.05 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.264 1.026 . . . . 0.0 111.798 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.1 mttt 47.35 89.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.32 2.248 . . . . 0.0 115.225 171.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.54 152.95 5.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.49 119.14 33.65 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.467 1.907 . . . . 0.0 106.878 159.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.491 HG11 ' CE1' ' A' ' 32' ' ' PHE . 75.9 t -98.48 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 127.496 2.318 . . . . 0.0 107.192 -174.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -130.99 163.17 28.14 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.694 -1.253 . . . . 0.0 110.395 -171.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.92 -18.17 64.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 4' ' ' GLU . . . 173.31 -171.65 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.228 1 C-N-CA 131.974 4.11 . . . . 0.0 107.375 152.135 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.92 42.26 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.14 -0.975 . . . . 0.0 109.788 162.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 C--O 1.249 1.064 0 C-N-CA 126.617 1.967 . . . . 0.0 107.356 172.853 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 7.7 mtt180 -74.86 159.4 31.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.446 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.1 t -153.74 120.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.459 1.903 . . . . 0.0 106.031 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -100.23 136.56 39.94 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.71 -1.244 . . . . 0.0 109.007 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.78 103.11 10.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.679 1.592 . . . . 0.0 106.906 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 143.13 30.64 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.54 -178.72 4.34 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.641 1.976 . . . . 0.0 107.67 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.44 -52.51 38.62 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.808 1.243 . . . . 0.0 110.387 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 m -70.67 -33.35 70.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.004 -0.435 . . . . 0.0 111.858 -173.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.23 -150.45 8.15 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -161.21 164.53 30.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.715 1.257 . . . . 0.0 110.658 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.8 p -146.8 175.47 10.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.564 . . . . 0.0 108.965 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.02 141.98 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.5 pt -129.93 147.73 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -132.94 125.88 30.8 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.26 131.1 53.75 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 125.265 1.603 . . . . 0.0 109.47 -163.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -69.94 122.07 18.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.947 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.86 9.35 1.54 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.138 1.375 . . . . 0.0 114.067 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.02 -6.52 56.57 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.091 -1.005 . . . . 0.0 110.39 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.22 132.96 55.93 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.255 1.022 . . . . 0.0 109.702 -164.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.88 -44.09 70.16 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.274 1.429 . . . . 0.0 111.159 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -54.06 -43.09 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.591 1.156 . . . . 0.0 112.358 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.56 -44.79 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.51 1.504 . . . . 0.0 108.643 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -61.3 -40.23 93.42 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.365 0.666 . . . . 0.0 111.041 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -79.01 -29.41 43.67 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.972 0.909 . . . . 0.0 111.046 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mt -60.97 -24.58 66.21 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.228 1.411 . . . . 0.0 111.363 168.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -64.33 -20.13 65.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.345 0.975 . . . . 0.0 111.177 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -81.89 -14.97 55.46 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.068 0.947 . . . . 0.0 112.251 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -124.33 28.93 6.51 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.294 1.038 . . . . 0.0 111.414 -166.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -131.81 141.26 40.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.0 158.35 74.35 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.075 1.063 . . . . 0.0 112.332 -8.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -150.31 166.0 31.33 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.31 0.644 . . . . 0.0 110.003 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.48 166.93 12.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.3 163.19 17.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.702 0.763 . . . . 0.0 111.736 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.96 131.85 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 164.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.6 99.96 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -85.59 154.85 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.4 p -129.6 150.91 50.72 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.627 1.171 . . . . 0.0 108.681 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -149.31 98.22 2.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.43 -87.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.2 29.61 1.81 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.292 1.837 . . . . 0.0 110.327 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -133.11 161.83 33.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.436 1.094 . . . . 0.0 108.589 168.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -127.3 143.22 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -148.69 166.9 26.99 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 2.5 p90 -154.38 155.64 35.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.759 -1.213 . . . . 0.0 108.584 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -83.02 86.55 6.98 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.541 0.737 . . . . 0.0 109.511 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.0 p -58.15 150.88 49.58 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 122.663 0.385 . . . . 0.0 111.874 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.85 -13.31 13.06 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.277 2.651 . . . . 0.0 112.647 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.81 158.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-N 119.092 0.86 . . . . 0.0 108.904 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.32 103.83 4.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.229 1.412 . . . . 0.0 107.879 172.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.55 147.12 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -125.47 -7.45 6.92 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -65.17 146.7 54.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.723 1.209 . . . . 0.0 107.778 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 18.0 ptp -144.81 104.35 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.24 1.416 . . . . 0.0 110.304 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.66 -30.34 59.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.156 -1.018 . . . . 0.0 113.221 -172.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -133.29 72.9 74.87 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 119.432 1.015 . . . . 0.0 110.522 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 56.3 Cg_endo -69.48 150.67 70.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.75 2.967 . . . . 0.0 112.113 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -140.13 173.36 11.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.494 1.917 . . . . 0.0 108.384 170.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.27 10.67 8.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 112.657 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.72 154.11 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 131.001 3.72 . . . . 0.0 107.004 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.14 -174.48 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.23 1.412 . . . . 0.0 109.575 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -90.94 175.84 6.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.698 0.761 . . . . 0.0 110.935 166.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.456 ' O ' HD11 ' A' ' 105' ' ' LEU . 56.5 mt -75.58 5.23 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.923 1.289 . . . . 0.0 110.68 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.17 30.91 1.6 Allowed Glycine 0 C--N 1.337 0.615 0 O-C-N 120.692 -1.255 . . . . 0.0 112.949 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -115.79 169.92 8.85 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.049 0.924 . . . . 0.0 109.462 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -136.99 140.99 41.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.703 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -127.03 176.82 17.64 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.875 1.226 . . . . 0.0 110.987 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -111.4 143.01 42.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 165.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -104.77 86.06 1.36 Allowed Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 125.631 1.572 . . . . 0.0 107.667 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.05 -43.39 42.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.359 2.039 . . . . 0.0 115.054 -172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.74 -22.65 43.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.639 2.226 . . . . 0.0 111.482 -165.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -115.76 15.13 16.95 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.763 1.649 . . . . 0.0 113.751 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 47.56 37.96 7.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.755 2.278 . . . . 0.0 113.024 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.83 160.95 15.34 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.724 -1.235 . . . . 0.0 110.531 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -80.07 -179.14 6.87 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 161.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.6 m -139.15 163.93 31.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.796 0.838 . . . . 0.0 109.777 154.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.5 mt -151.05 101.49 2.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 129.36 3.064 . . . . 0.0 105.066 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -99.97 119.88 38.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.73 1.56 2.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.14 -178.74 34.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 166.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -83.25 106.88 15.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -59.71 165.43 4.38 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 125.465 1.506 . . . . 0.0 110.961 169.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.41 1.48 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.333 2.022 . . . . 0.0 114.165 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ttp -107.17 58.31 0.63 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 120.208 1.367 . . . . 0.0 110.182 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 p -159.83 -178.63 7.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 122.161 0.982 . . . . 0.0 110.501 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.93 -62.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 154.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.39 -43.54 40.18 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.046 0.538 . . . . 0.0 112.022 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -149.68 161.98 41.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.957 1.303 . . . . 0.0 108.6 -162.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.78 80.54 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -167.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -79.85 141.85 55.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -89.26 177.29 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 124.494 3.463 . . . . 0.0 112.935 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.78 16.16 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.4 t -164.86 173.86 11.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.029 1.286 . . . . 0.0 109.783 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.57 78.8 0.58 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.8 148.92 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 25.7 p30 -64.97 158.59 25.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.213 0.53 . . . . 0.0 112.177 164.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.56 99.32 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 166.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.2 pt -113.47 -16.38 9.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.511 1.124 . . . . 0.0 111.408 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.1 175.56 20.03 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-O 122.061 0.811 . . . . 0.0 112.413 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -135.86 134.0 38.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 105' ' ' LEU . 52.7 mt -73.76 95.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 165.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -76.62 -24.2 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.365 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -148.66 158.68 44.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 110.421 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.78 42.34 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.371 1.462 . . . . 0.0 112.569 160.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 63' ' ' ILE . 1.8 tp -67.63 -11.81 59.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -162.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -107.18 -35.27 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 119.258 0.935 . . . . 0.0 110.331 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.56 -18.21 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.484 0.713 . . . . 0.0 111.316 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mp -66.76 -29.09 68.97 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.088 -1.007 . . . . 0.0 112.314 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -67.22 -22.79 65.69 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.818 1.644 . . . . 0.0 112.87 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -99.16 5.77 46.69 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.932 -171.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.86 165.37 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 119.744 1.157 . . . . 0.0 108.741 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -109.39 172.84 6.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.29 35.8 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 112.735 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.45 51.97 0.04 OUTLIER Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.804 -1.185 . . . . 0.0 112.93 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -103.4 24.92 10.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.016 1.408 . . . . 0.0 113.302 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.6 mttt 44.19 88.25 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.452 1.901 . . . . 0.0 113.258 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.75 142.38 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -125.06 94.49 4.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.443 1.897 . . . . 0.0 106.826 162.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.28 140.39 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 128.724 2.81 . . . . 0.0 109.1 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -140.97 177.06 8.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.999 2.12 . . . . 0.0 109.61 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -78.71 -2.32 38.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--N 1.315 -0.924 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.831 -160.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.977 0.894 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.433 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 1.3 mmt-85 -62.57 160.59 13.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.932 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 2' ' ' ARG . 36.8 t -151.11 149.69 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.494 1.518 . . . . 0.0 109.075 166.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -116.54 139.86 50.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.423 2.289 . . . . 0.0 106.229 166.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.428 HD22 HG22 ' A' ' 119' ' ' VAL . 42.8 mt -112.08 119.49 38.61 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 170.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 3.5 tt -121.49 141.01 51.45 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -164.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.73 ' CE1' HG12 ' A' ' 117' ' ' VAL . 18.8 m-85 -128.98 166.45 19.15 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.3 1.409 . . . . 0.0 108.616 -172.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.11 -19.16 62.71 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.244 -0.91 . . . . 0.0 111.543 171.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -25.76 12.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -172.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.5 -156.37 18.11 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 126.379 1.942 . . . . 0.0 108.274 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 13.0 pttp -168.02 157.54 9.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.174 1.487 . . . . 0.0 111.695 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HB3' HD21 ' A' ' 108' ' ' LEU . 14.3 p -136.31 175.24 9.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.36 1.064 . . . . 0.0 111.043 170.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 127.22 56.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 pt -121.65 129.01 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -96.14 133.65 40.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.127 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.4 mt -124.62 130.53 52.6 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.588 1.085 . . . . 0.0 110.574 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -71.35 135.97 47.58 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.868 1.667 . . . . 0.0 111.375 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -90.96 45.35 1.25 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 112.854 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -129.05 30.15 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.094 -1.628 . . . . 0.0 108.964 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.434 ' CE2' HG22 ' A' ' 98' ' ' ILE . 23.0 m-85 -132.53 139.47 47.9 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.012 -1.055 . . . . 0.0 109.034 175.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -45.0 -62.76 1.11 Allowed 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 126.373 1.869 . . . . 0.0 109.609 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.33 -39.64 28.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 121.071 -1.018 . . . . 0.0 113.17 -171.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.8 -44.77 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.513 1.125 . . . . 0.0 109.247 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -52.05 -53.57 40.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -43.94 97.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.863 0.865 . . . . 0.0 109.424 -170.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.21 -29.05 20.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.392 1.877 . . . . 0.0 112.866 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -59.98 -29.44 68.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.009 0.822 . . . . 0.0 110.895 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -74.07 -35.62 64.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.04 0.448 . . . . 0.0 109.935 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.35 21.05 3.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.648 2.779 . . . . 0.0 111.407 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -128.26 137.71 31.45 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 121.187 1.812 . . . . 0.0 107.733 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.93 153.14 97.39 Favored 'Cis proline' 0 C--N 1.348 0.518 0 CA-C-N 119.161 0.736 . . . . 0.0 112.428 -5.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CE1' HG11 ' A' ' 119' ' ' VAL . 23.2 p90 -139.75 167.48 22.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 122.667 0.387 . . . . 0.0 111.377 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.15 155.06 46.84 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 t -166.74 161.62 15.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.5 128.2 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.804 HG22 HG13 ' A' ' 117' ' ' VAL . 2.8 t -75.66 73.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -65.29 153.48 40.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -139.46 161.03 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.95 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -160.54 92.62 0.97 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.37 84.34 0.03 OUTLIER Glycine 0 C--O 1.212 -1.248 0 CA-C-O 119.194 -0.781 . . . . 0.0 114.577 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.36 25.23 7.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.095 2.958 . . . . 0.0 113.252 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -128.8 149.38 50.76 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.468 1.107 . . . . 0.0 109.099 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.7 mt -125.04 141.35 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.59 172.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 168.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -156.71 151.36 25.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -74.11 98.33 3.1 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.9 p -66.95 149.8 98.26 Favored Pre-proline 0 N--CA 1.437 -1.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.06 -3.03 12.87 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.389 3.392 . . . . 0.0 112.102 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.2 149.79 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 108.141 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.02 15.79 6.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.84 117.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 123.978 0.911 . . . . 0.0 110.019 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 70' ' ' PRO . 48.6 mt-30 -94.73 2.04 55.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -81.61 96.39 7.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.498 2.319 . . . . 0.0 110.29 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.8 ptp -86.57 123.42 31.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.508 1.123 . . . . 0.0 110.378 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.88 -23.88 16.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -137.9 70.69 50.06 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.2 146.75 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.282 2.655 . . . . 0.0 109.87 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -135.76 174.92 10.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 164.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -125.3 7.05 7.76 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.223 1.009 . . . . 0.0 111.503 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -144.74 137.06 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -142.9 -179.56 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.057 1.343 . . . . 0.0 109.722 -173.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.37 -167.56 1.52 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.977 2.111 . . . . 0.0 111.438 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.19 45.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.429 1.891 . . . . 0.0 107.545 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.03 38.2 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.24 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -110.28 176.04 5.2 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.41 134.33 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.89 148.16 18.88 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -86.75 139.14 31.02 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 168.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -104.89 85.21 1.15 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.484 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 63.9 Cg_endo -64.39 -36.68 43.47 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.167 1.245 . . . . 0.0 114.837 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.484 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 60.5 Cg_endo -74.05 -21.04 18.61 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.266 1.977 . . . . 0.0 110.599 -167.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 22.17 7.58 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 118.05 -1.416 . . . . 0.0 113.352 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 46.21 49.59 12.56 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.766 1.783 . . . . 0.0 111.995 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.97 175.46 9.35 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 111.286 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.438 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 1.3 tp -93.18 -169.66 2.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.141 1.376 . . . . 0.0 111.06 166.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -166.13 140.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.554 1.542 . . . . 0.0 110.371 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -137.36 124.12 21.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.413 2.285 . . . . 0.0 107.538 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.62 119.63 40.09 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.248 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -140.94 14.7 2.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.54 48.32 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 CA-C-N 119.755 1.161 . . . . 0.0 114.327 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.8 tttt 62.24 177.44 0.13 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.64 1.976 . . . . 0.0 109.844 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 43.2 p -149.25 165.54 17.42 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 120.119 1.327 . . . . 0.0 109.925 -172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 96.5 Cg_endo -77.62 64.73 8.12 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.377 3.384 . . . . 0.0 111.462 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.23 -44.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.719 1.608 . . . . 0.0 108.753 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.79 154.74 23.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.479 1.511 . . . . 0.0 108.227 -159.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.73 -58.03 1.6 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.4 -49.42 55.41 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.194 0.521 . . . . 0.0 110.926 -167.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -135.89 166.09 24.12 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 127.005 2.122 . . . . 0.0 108.109 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.73 115.91 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -125.6 144.78 49.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.115 0.966 . . . . 0.0 111.139 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.479 ' HG3' HG22 ' A' ' 95' ' ' VAL . 57.9 Cg_endo -74.5 173.56 14.08 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.305 3.336 . . . . 0.0 112.975 170.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.268 1.427 . . . . 0.0 114.346 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -147.86 173.37 12.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.569 1.547 . . . . 0.0 107.679 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.11 85.59 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.479 HG22 ' HG3' ' A' ' 91' ' ' PRO . 15.5 m -90.93 150.02 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -75.32 175.22 8.58 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.9 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.42 44.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.434 HG22 ' CE2' ' A' ' 20' ' ' TYR . 35.7 pt -64.65 -39.96 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.312 -1.492 . . . . 0.0 110.927 -174.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.82 169.08 16.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -138.47 132.71 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.9 mt -73.62 90.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 103.687 -2.708 . . . . 0.0 103.687 167.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.9 m -72.65 -25.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.511 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 155.1 36.76 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.586 0.755 . . . . 0.0 112.23 -165.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.6 20.17 62.38 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.888 1.232 . . . . 0.0 113.897 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.02 -38.03 87.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.745 1.273 . . . . 0.0 111.542 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -76.39 -1.17 25.62 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.25 1.96 26.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.871 0.868 . . . . 0.0 113.024 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' A' ' 12' ' ' CYS . 23.1 mt -84.31 -41.97 16.28 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.622 1.169 . . . . 0.0 113.68 -172.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.55 -23.41 64.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.61 1.671 . . . . 0.0 111.135 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -69.07 -10.55 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.543 -1.348 . . . . 0.0 111.212 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -92.44 157.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 120.334 1.425 . . . . 0.0 109.634 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.51 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 16.5 mmtp -102.08 172.4 6.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.767 1.627 . . . . 0.0 108.013 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.31 25.24 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 128.492 2.717 . . . . 0.0 113.649 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.85 65.16 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 120.337 -1.477 . . . . 0.0 111.992 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 1.5 mm-40 -125.12 38.16 4.25 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.964 1.306 . . . . 0.0 110.465 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 mttt 42.24 87.26 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.542 1.937 . . . . 0.0 110.597 164.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.804 HG13 HG22 ' A' ' 36' ' ' VAL . 19.5 m -64.0 178.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -150.47 90.36 1.64 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 171.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 32' ' ' PHE . 91.8 t -70.42 125.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -137.55 170.9 15.28 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.509 1.05 . . . . 0.0 109.69 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.11 -11.52 60.33 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--N 1.321 -0.657 0 C-N-CA 128.652 2.781 . . . . 0.0 110.783 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.413 0.625 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -72.38 167.44 20.51 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 25.4 t -147.62 130.19 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.15 1.38 . . . . 0.0 108.599 167.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.74 128.61 45.04 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 119' ' ' VAL . 1.2 mm? -100.61 105.1 16.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.5 31.54 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 169.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.93 175.09 8.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.93 1.292 . . . . 0.0 109.383 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.97 -29.64 67.9 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.503 -1.373 . . . . 0.0 112.057 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.8 m -103.53 -3.0 25.87 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.31 -166.76 39.6 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 119.712 1.142 . . . . 0.0 111.266 -173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 150.34 25.53 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.808 0.304 . . . . 0.0 110.397 168.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.8 p -132.85 172.87 12.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.598 0.713 . . . . 0.0 109.385 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -135.06 146.85 29.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.5 pt -128.13 156.97 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -111.02 135.15 51.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.29 134.69 55.21 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.076 1.351 . . . . 0.0 108.781 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -86.66 118.53 26.12 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.778 0.831 . . . . 0.0 109.478 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -66.21 20.05 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.028 2.131 . . . . 0.0 114.64 -171.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.86 24.17 5.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.39 1.876 . . . . 0.0 109.511 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -129.92 147.81 51.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.438 2.295 . . . . 0.0 108.311 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.77 -46.49 59.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.701 2.0 . . . . 0.0 110.157 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.07 -46.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.337 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -72.16 -43.91 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -165.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -60.89 -24.62 66.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.966 1.307 . . . . 0.0 111.715 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 25' ' ' LEU . 20.5 mt -90.18 -25.8 20.46 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.48 1.112 . . . . 0.0 112.501 176.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.469 ' HG ' HG21 ' A' ' 49' ' ' VAL . 1.4 mt -70.11 -28.82 65.71 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 121.065 -1.022 . . . . 0.0 110.804 172.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.66 -36.68 47.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.337 0.655 . . . . 0.0 111.044 175.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -71.36 -17.51 62.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 112.17 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -123.13 12.46 9.59 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.902 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -106.01 135.76 19.39 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 121.003 1.729 . . . . 0.0 108.109 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.86 164.32 79.83 Favored 'Cis proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.911 1.004 . . . . 0.0 112.824 -6.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CE1' HG11 ' A' ' 119' ' ' VAL . 47.4 p90 -147.54 168.58 21.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.713 1.258 . . . . 0.0 109.403 165.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 47.3 mp0 -130.71 154.51 47.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.174 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -165.2 -175.46 3.66 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.905 0.882 . . . . 0.0 111.551 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 t -93.26 142.19 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 128.017 2.527 . . . . 0.0 107.891 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -97.11 91.33 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -86.79 159.64 19.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.6 p -132.4 149.32 52.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.03 0.932 . . . . 0.0 110.561 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.0 t90 -166.91 103.3 0.56 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -172.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.41 20.09 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 160.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.357 17.2 pt-20 47.71 50.91 14.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.966 1.707 . . . . 0.0 111.234 -159.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -140.01 159.56 41.89 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 126.962 2.105 . . . . 0.0 107.615 168.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.99 139.64 50.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 127.513 2.325 . . . . 0.0 106.478 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -155.34 150.02 26.36 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.962 1.363 . . . . 0.0 111.263 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 2.7 p90 -135.64 151.76 50.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.163 1.385 . . . . 0.0 108.204 -174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -88.82 83.34 6.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -166.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 48' ' ' PRO . 16.5 p -53.98 152.29 10.8 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.256 0.622 . . . . 0.0 111.971 -168.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 47' ' ' THR . 42.4 Cg_endo -79.2 4.93 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.505 1 C-N-CA 125.41 4.073 . . . . 0.0 112.505 175.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.469 HG21 ' HG ' ' A' ' 26' ' ' LEU . 94.0 t -107.98 131.53 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.071 1.348 . . . . 0.0 110.421 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.46 66.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.31 1.444 . . . . 0.0 107.19 -171.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -110.49 128.99 66.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 124.48 1.112 . . . . 0.0 108.297 -175.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.98 45.07 2.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.584 1.153 . . . . 0.0 111.264 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -127.69 146.35 50.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.457 1.503 . . . . 0.0 108.405 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.62 110.48 2.45 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.154 1.782 . . . . 0.0 108.329 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -87.36 -25.48 23.83 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.633 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -123.35 65.68 31.51 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 120.138 1.336 . . . . 0.0 110.147 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.26 114.63 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.048 2.499 . . . . 0.0 110.391 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 131.42 55.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.544 1.537 . . . . 0.0 108.087 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -93.12 5.27 52.1 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -160.86 149.28 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 128.095 2.558 . . . . 0.0 109.648 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 78' ' ' PHE . 17.0 m -140.95 174.18 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.053 1.741 . . . . 0.0 109.39 -165.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -94.51 170.03 9.77 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.86 0.838 . . . . 0.0 110.708 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.74 -7.42 8.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 124.965 1.306 . . . . 0.0 112.237 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.11 27.22 4.59 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.681 1.61 . . . . 0.0 112.596 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -103.8 175.78 5.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.016 0.908 . . . . 0.0 109.331 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.507 HG23 HG13 ' A' ' 101' ' ' ILE . 42.4 t -135.42 133.86 52.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.709 0.804 . . . . 0.0 109.639 166.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.74 156.66 21.54 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -103.64 143.37 32.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 163.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -109.33 85.66 3.69 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 124.699 1.2 . . . . 0.0 108.552 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.65 -29.84 90.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.265 1.31 . . . . 0.0 114.671 172.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -77.75 -9.0 17.07 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.509 2.139 . . . . 0.0 111.917 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.59 8.95 4.0 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 118.411 -1.216 . . . . 0.0 115.583 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 44.65 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.741 1.27 . . . . 0.0 109.971 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.49 165.69 20.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.534 -0.729 . . . . 0.0 111.611 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 5.3 tp -84.0 178.15 7.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.409 166.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -151.26 108.93 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.082 1.753 . . . . 0.0 108.39 165.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.21 105.29 17.11 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.436 ' CD2' HG21 ' A' ' 61' ' ' VAL . 91.1 m-85 -80.35 133.59 35.94 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -152.84 22.18 0.59 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.946 0.898 . . . . 0.0 110.955 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.2 -139.66 2.76 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.41 103.01 4.78 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -58.52 156.11 24.96 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.487 1.915 . . . . 0.0 111.166 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -3.0 11.89 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.059 3.173 . . . . 0.0 113.459 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.426 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 3.0 tpt -73.09 -8.79 57.33 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.777 -1.202 . . . . 0.0 112.336 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t -132.54 -177.46 4.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.497 1.142 . . . . 0.0 109.914 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -144.35 -42.68 0.25 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.96 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -71.5 -56.81 5.19 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.57 1.176 . . . . 0.0 108.147 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -133.11 -164.84 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.177 2.191 . . . . 0.0 107.41 -153.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.95 77.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.538 1.517 . . . . 0.0 107.662 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 42.5 mt-30 -76.14 142.74 72.51 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.525 ' HG3' HG22 ' A' ' 95' ' ' VAL . 51.0 Cg_endo -77.59 179.74 6.22 Favored 'Trans proline' 0 CA--C 1.533 0.449 1 C-N-CA 126.925 5.083 . . . . 0.0 113.665 170.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HA ' ' HG2' ' A' ' 84' ' ' MET . . . -70.37 -14.01 62.39 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.32 -172.07 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.89 97.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG22 ' HG3' ' A' ' 91' ' ' PRO . 24.4 m -90.0 172.67 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -126.55 124.5 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.47 55.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.586 1.184 . . . . 0.0 109.256 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.6 pt -80.05 -14.57 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.236 1.014 . . . . 0.0 111.381 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.12 155.89 16.82 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -135.88 140.83 44.42 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.879 0.872 . . . . 0.0 108.659 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.507 HG13 HG23 ' A' ' 66' ' ' VAL . 97.1 mt -79.63 93.95 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 123.814 1.768 . . . . 0.0 108.634 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.48 -23.68 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.002 -163.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.04 159.71 44.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.252 2.621 . . . . 0.0 108.716 171.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.53 69.2 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-O 117.927 -1.485 . . . . 0.0 115.277 167.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.69 -49.99 73.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.188 1.994 . . . . 0.0 111.212 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.3 -25.6 66.11 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.814 -0.554 . . . . 0.0 110.956 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.9 -5.97 34.75 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.754 1.222 . . . . 0.0 112.164 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.5 mt -80.7 -44.41 18.77 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 119.028 0.831 . . . . 0.0 111.46 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -57.53 -22.92 47.32 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.03 -1.044 . . . . 0.0 113.147 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -91.82 16.59 10.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.386 1.474 . . . . 0.0 112.978 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.3 mm -113.3 148.13 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 121.156 1.798 . . . . 0.0 109.922 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -89.16 171.98 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.667 1.587 . . . . 0.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.05 40.14 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 130.127 3.371 . . . . 0.0 112.724 167.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.87 12.67 0.03 OUTLIER Glycine 0 CA--C 1.522 0.522 0 O-C-N 120.452 -1.405 . . . . 0.0 116.156 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.53 22.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.607 1.704 . . . . 0.0 114.34 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.538 ' HE2' ' HB3' ' A' ' 33' ' ' GLU . 0.1 OUTLIER 64.87 152.95 0.05 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.003 2.121 . . . . 0.0 112.373 167.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.51 148.26 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 O-C-N 120.435 -1.416 . . . . 0.0 109.048 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.06 108.47 15.27 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.492 2.317 . . . . 0.0 107.14 160.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 32' ' ' PHE . 48.8 t -86.51 124.38 40.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.788 2.435 . . . . 0.0 107.792 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 48.7 mtt180 -140.67 179.76 6.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.571 1.532 . . . . 0.0 110.17 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -81.31 -10.33 59.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.937 0 C-N-CA 127.545 2.338 . . . . 0.0 111.266 -169.271 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttp . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.62 152.14 39.72 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 50.8 t -153.82 147.85 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.546 1.939 . . . . 0.0 108.132 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.619 ' CB ' ' HB2' ' A' ' 122' ' ' ALA . 42.1 tt0 -131.81 137.41 48.11 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.479 1.911 . . . . 0.0 107.528 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.1 mt -108.57 104.62 13.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.678 1.991 . . . . 0.0 105.857 -174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.67 103.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.56 173.45 9.57 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.931 0.892 . . . . 0.0 108.985 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.77 -42.22 95.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -80.82 -17.08 51.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.62 -161.79 34.09 Favored Glycine 0 N--CA 1.464 0.565 0 CA-C-N 121.11 1.777 . . . . 0.0 110.252 -165.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -159.33 159.92 34.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.203 1.501 . . . . 0.0 111.668 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.8 p -142.84 178.41 7.67 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.195 0.998 . . . . 0.0 109.877 170.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -132.92 129.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.62 144.71 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.401 1.08 . . . . 0.0 108.309 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -136.01 128.97 31.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.314 -0.866 . . . . 0.0 112.858 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.59 123.79 42.81 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 125.084 1.49 . . . . 0.0 108.824 -164.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.22 138.58 57.9 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.608 1.563 . . . . 0.0 111.462 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -97.2 50.26 1.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.518 0.727 . . . . 0.0 112.0 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.35 17.75 3.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.144 1.378 . . . . 0.0 111.85 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.68 144.76 50.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.376 1.47 . . . . 0.0 112.438 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -53.24 -50.58 64.47 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.326 1.451 . . . . 0.0 111.829 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HA ' HG11 ' A' ' 51' ' ' VAL . 3.6 t -57.22 -44.74 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -175.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.0 -34.17 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -66.53 -48.94 68.13 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.17 0.988 . . . . 0.0 111.016 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 51' ' ' VAL . 67.5 mt -70.96 -21.78 62.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.691 0.796 . . . . 0.0 110.515 -173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.2 -41.97 80.57 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.852 2.061 . . . . 0.0 111.608 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -56.0 -36.72 68.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.362 0.983 . . . . 0.0 110.0 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.86 -29.54 70.83 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -108.39 2.25 22.33 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.992 1.317 . . . . 0.0 112.04 -168.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG22 ' CE2' ' A' ' 121' ' ' PHE . 60.6 mt -98.12 142.17 24.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.26 160.43 83.03 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 CA-C-N 119.421 0.829 . . . . 0.0 112.941 -7.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.86 175.45 12.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.933 1.693 . . . . 0.0 109.874 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 177.47 7.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.12 2.168 . . . . 0.0 110.728 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -162.63 -154.73 0.32 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.293 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 t -120.39 134.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.877 1.671 . . . . 0.0 107.661 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -88.09 77.03 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 118.995 0.816 . . . . 0.0 109.379 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.62 150.93 34.84 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.681 -1.262 . . . . 0.0 109.239 171.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.8 p -124.69 142.53 51.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.082 1.353 . . . . 0.0 108.886 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -153.36 107.26 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.87 22.13 70.01 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.939 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 75.52 28.38 0.96 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.846 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -115.47 153.26 31.43 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 155.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -124.48 123.97 67.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -138.24 132.4 31.69 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.088 1.755 . . . . 0.0 108.284 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -136.8 156.83 47.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.459 -1.401 . . . . 0.0 107.483 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.72 115.76 7.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.1 p -80.73 153.34 73.01 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 160.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.7 -0.77 10.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.12 3.213 . . . . 0.0 112.53 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 51' ' ' VAL . 26.2 t -80.78 163.94 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 126.578 1.951 . . . . 0.0 108.722 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -143.07 21.93 1.92 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.579 HG11 ' HA ' ' A' ' 22' ' ' VAL . 7.4 p -60.83 155.71 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -135.13 -4.88 2.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.699 0.8 . . . . 0.0 112.445 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HE2' ' OE2' ' A' ' 55' ' ' GLU . 74.0 tttt -70.44 140.52 52.02 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.041 1.291 . . . . 0.0 109.914 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.24 131.01 46.97 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.345 1.458 . . . . 0.0 107.299 167.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' OE2' ' HE2' ' A' ' 53' ' ' LYS . 71.8 mm-40 -87.45 -38.07 16.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.218 0.532 . . . . 0.0 109.679 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.42 ' ND2' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.65 62.02 12.83 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.344 1.857 . . . . 0.0 108.085 -161.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.87 125.75 15.35 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 108.022 -1.568 . . . . 0.0 108.022 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -117.22 145.77 43.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.221 1.009 . . . . 0.0 109.018 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.77 -1.64 27.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.883 1.273 . . . . 0.0 111.905 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.66 146.96 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 129.026 2.931 . . . . 0.0 108.438 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.98 -173.0 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 109.488 -166.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -105.43 159.09 16.19 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.16 1.384 . . . . 0.0 111.31 171.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.401 HG23 ' HA ' ' A' ' 79' ' ' PHE . 58.7 mt -73.37 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.36 0.82 0.5 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 119.033 -0.87 . . . . 0.0 113.975 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -100.48 175.57 5.64 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.764 1.782 . . . . 0.0 109.11 170.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -136.24 134.02 49.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.519 1.127 . . . . 0.0 108.157 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.78 -172.26 31.72 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -133.78 156.38 48.1 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 146.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -121.0 86.77 42.57 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.83 -46.39 31.87 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.253 1.968 . . . . 0.0 114.875 -167.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 -23.76 46.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.809 2.34 . . . . 0.0 111.636 -165.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.57 12.26 46.86 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.757 1.646 . . . . 0.0 113.983 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.489 ' HE3' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER 44.45 48.08 8.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.701 2.0 . . . . 0.0 110.776 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.41 157.03 27.96 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.09 0.948 . . . . 0.0 111.066 -172.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.53 172.56 12.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.641 161.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.53 105.27 3.29 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.872 1.669 . . . . 0.0 109.836 169.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -86.57 120.28 27.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 107.865 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -105.46 105.69 15.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.991 0.814 . . . . 0.0 109.325 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.401 ' HA ' HG23 ' A' ' 63' ' ' ILE . 45.2 p90 -136.25 9.24 3.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -175.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.46 -121.21 1.02 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 119.782 1.173 . . . . 0.0 110.65 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -156.56 121.77 4.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.375 1.087 . . . . 0.0 108.517 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -98.14 155.86 36.51 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.996 2.519 . . . . 0.0 112.079 -165.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.61 3.12 6.7 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.489 2.793 . . . . 0.0 115.39 -170.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.5 mmt -81.99 -32.16 30.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.596 1.544 . . . . 0.0 111.289 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.491 ' HB3' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -90.96 175.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.565 0.746 . . . . 0.0 110.087 -176.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 -62.77 0.44 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.16 -26.27 61.12 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.246 0.546 . . . . 0.0 112.395 -165.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -167.9 162.38 13.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 128.359 2.664 . . . . 0.0 107.119 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -75.76 84.19 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 119.534 1.061 . . . . 0.0 109.211 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 85' ' ' SER . 11.1 mt-30 -75.77 144.41 76.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.508 159.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.18 -177.36 3.82 Favored 'Trans proline' 0 C--N 1.346 0.44 1 C-N-CA 125.382 4.055 . . . . 0.0 112.003 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.701 167.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -166.36 179.85 5.38 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 126.099 1.76 . . . . 0.0 106.781 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.11 102.36 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.635 1.174 . . . . 0.0 112.17 -171.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.21 149.07 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.96 109.04 15.95 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.42 HG12 ' ND2' ' A' ' 56' ' ' ASN . 1.3 p -80.61 33.06 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 122.548 1.166 . . . . 0.0 112.347 -162.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.3 pt -63.88 -12.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.633 2.373 . . . . 0.0 115.431 -159.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.73 13.61 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 122.571 1.095 . . . . 0.0 111.825 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -117.42 140.81 49.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 163.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.4 mt -72.51 94.82 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 157.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -77.4 -32.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.725 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -153.77 163.45 40.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.821 0.819 . . . . 0.0 111.385 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.62 31.41 54.14 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.283 0.944 . . . . 0.0 112.361 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.77 -54.01 51.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.619 1.209 . . . . 0.0 111.268 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.72 -17.41 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.766 -0.584 . . . . 0.0 112.141 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.4 -11.75 25.39 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 124.008 0.923 . . . . 0.0 110.828 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.9 -25.76 32.17 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.704 1.138 . . . . 0.0 112.428 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.95 -20.79 62.42 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.711 -1.243 . . . . 0.0 111.485 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.57 28.85 5.23 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.634 2.773 . . . . 0.0 111.108 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.92 166.43 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 127.895 2.478 . . . . 0.0 107.276 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -127.27 -169.51 2.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.323 -1.486 . . . . 0.0 111.264 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -78.43 11.87 2.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.561 1.544 . . . . 0.0 113.854 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.89 79.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.576 0 O-C-N 120.423 -1.423 . . . . 0.0 111.496 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -130.52 40.14 3.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.95 2.1 . . . . 0.0 109.584 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 43.77 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.162 2.585 . . . . 0.0 114.047 163.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.5 p -81.8 111.14 17.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.7 13.4 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.1 t -86.17 126.16 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 127.717 2.407 . . . . 0.0 107.674 -168.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -135.92 172.12 13.47 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.533 1.97 . . . . 0.0 111.428 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.457 ' CE2' HG22 ' A' ' 30' ' ' ILE . 42.0 m-85 -72.24 -11.1 60.57 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.619 ' HB2' ' CB ' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.04 0 C-N-CA 125.517 1.527 . . . . 0.0 114.249 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpp . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 121.359 0.599 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 2.4 mmt-85 -78.9 163.62 25.12 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 123.067 0.547 . . . . 0.0 109.582 173.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.3 t -148.02 146.29 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.518 168.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 14.6 tt0 -120.77 131.62 54.59 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.488 1.915 . . . . 0.0 105.844 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.551 HD11 HD13 ' A' ' 14' ' ' ILE . 54.3 mt -108.71 121.28 44.72 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 7' ' ' PHE . 1.6 tt -123.66 142.13 51.35 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -167.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.834 ' HE1' HG12 ' A' ' 117' ' ' VAL . 5.9 m-85 -134.32 172.13 13.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 119.674 1.125 . . . . 0.0 110.438 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.207 -0.308 . . . . 0.0 110.71 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 m -101.4 -5.65 25.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.02 -163.58 33.82 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 120.931 1.696 . . . . 0.0 111.476 -169.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -160.42 165.1 31.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.7 1.25 . . . . 0.0 110.261 173.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.7 p -146.73 178.0 8.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.469 1.108 . . . . 0.0 111.529 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -133.85 130.18 55.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.141 0.976 . . . . 0.0 108.585 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.551 HD13 HD11 ' A' ' 5' ' ' LEU . 35.9 pt -128.01 147.08 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.435 0.694 . . . . 0.0 109.173 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -131.11 127.77 38.78 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 116.188 1.921 . . . . 0.0 116.188 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -124.91 126.24 45.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.433 1.708 . . . . 0.0 111.563 -161.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -69.6 122.54 19.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.185 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.95 6.6 1.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -85.89 -5.82 59.17 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 120.943 -1.098 . . . . 0.0 110.57 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -105.24 143.14 33.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.09 0.956 . . . . 0.0 109.932 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -45.36 -58.84 3.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.889 1.676 . . . . 0.0 109.427 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.92 -35.87 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.749 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -63.42 -42.99 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.489 1.041 . . . . 0.0 108.909 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -61.53 -44.32 97.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.685 0.794 . . . . 0.0 111.599 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -37.61 78.38 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.338 -1.476 . . . . 0.0 110.905 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.76 -39.83 65.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.842 1.657 . . . . 0.0 110.483 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -62.43 -31.79 72.55 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 123.037 0.535 . . . . 0.0 111.368 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -72.17 -8.92 57.4 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.37 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -131.05 30.25 4.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.93 1.692 . . . . 0.0 110.296 -173.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.43 144.27 52.17 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -63.84 158.96 67.78 Favored 'Cis proline' 0 N--CA 1.459 -0.503 0 CA-C-N 119.029 0.689 . . . . 0.0 113.604 -8.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -150.16 160.85 43.36 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 124.068 0.947 . . . . 0.0 110.682 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -114.45 160.21 19.44 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.187 0.995 . . . . 0.0 108.356 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.56 172.5 10.68 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.536 -0.727 . . . . 0.0 110.297 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.15 124.03 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.965 HG22 HG13 ' A' ' 117' ' ' VAL . 3.0 t -81.57 74.97 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 123.574 0.749 . . . . 0.0 110.356 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -68.07 163.94 21.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.858 0.754 . . . . 0.0 110.251 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.489 HG22 HG12 ' A' ' 43' ' ' ILE . 72.3 p -137.51 155.64 49.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.42 . . . . 0.0 110.197 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -155.6 99.19 2.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.41 -62.27 2.69 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 124.25 0.928 . . . . 0.0 115.18 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -168.75 40.56 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.958 1.703 . . . . 0.0 109.246 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.78 167.05 31.65 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 38' ' ' THR . 57.8 mt -135.39 133.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.027 1.331 . . . . 0.0 109.357 -176.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.95 159.25 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.968 0.907 . . . . 0.0 109.648 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 3.4 p90 -145.27 157.72 43.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.795 -1.191 . . . . 0.0 108.882 172.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -76.3 98.01 4.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.048 0.939 . . . . 0.0 109.4 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.1 p -68.93 144.79 96.16 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.142 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.7 -28.95 7.62 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.001 2.467 . . . . 0.0 111.003 175.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -67.25 140.21 19.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -121.66 114.98 21.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.94 154.18 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -134.71 21.37 3.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.604 0.761 . . . . 0.0 112.861 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -94.48 119.61 33.45 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.13 1.372 . . . . 0.0 110.94 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.81 112.87 14.02 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.588 1.155 . . . . 0.0 111.84 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.04 -25.95 36.74 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.504 1.122 . . . . 0.0 113.138 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -133.94 60.55 46.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 119.037 0.835 . . . . 0.0 110.675 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.4 95.38 0.61 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.924 2.416 . . . . 0.0 108.876 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.7 mtt-85 -85.35 169.31 13.84 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -123.94 4.71 8.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.743 0.417 . . . . 0.0 111.679 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.7 t -139.92 151.37 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.91 1.684 . . . . 0.0 106.659 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.47 -175.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.323 1.849 . . . . 0.0 109.503 -172.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -114.98 -179.3 3.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.272 1.029 . . . . 0.0 110.303 167.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 63' ' ' ILE . 70.6 mt -77.13 10.15 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 126.649 1.98 . . . . 0.0 110.999 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.39 32.26 1.87 Allowed Glycine 0 CA--C 1.524 0.65 0 O-C-N 120.165 -1.584 . . . . 0.0 112.371 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -123.5 169.74 11.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.35 1.075 . . . . 0.0 109.66 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -139.91 114.76 7.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 -177.46 48.69 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.103 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -131.11 138.7 49.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -116.46 82.63 12.37 Favored Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.406 ' HD2' ' CD ' ' A' ' 71' ' ' PRO . 4.0 Cg_exo -57.55 -47.25 22.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.669 2.246 . . . . 0.0 114.449 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' CD ' ' HD2' ' A' ' 70' ' ' PRO . 56.3 Cg_endo -68.26 -22.45 40.17 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.167 2.578 . . . . 0.0 111.141 -165.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.53 26.43 6.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.522 1.058 . . . . 0.0 113.165 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mttt 46.25 50.92 11.77 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.417 1.487 . . . . 0.0 112.174 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.7 -177.86 4.75 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.061 0.544 . . . . 0.0 110.973 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.405 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 2.7 tp -104.8 -170.96 1.84 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.047 1.739 . . . . 0.0 109.296 172.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.32 153.13 28.54 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.191 1.796 . . . . 0.0 110.05 158.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.57 102.37 4.59 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.986 2.514 . . . . 0.0 105.15 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -91.06 116.11 28.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.216 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.469 ' CD1' HD23 ' A' ' 108' ' ' LEU . 48.9 p90 -141.88 15.23 2.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.06 -146.1 4.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 104.75 8.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -69.28 166.27 31.19 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.502 2.321 . . . . 0.0 113.284 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.98 6.52 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 125.248 3.965 . . . . 0.0 113.419 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.89 136.38 53.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.164 1.785 . . . . 0.0 107.061 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 75.73 163.52 0.25 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 128.834 2.854 . . . . 0.0 109.679 -171.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.67 -42.51 2.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.97 -81.25 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.428 0.632 . . . . 0.0 111.223 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -98.94 153.84 18.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 127.334 2.254 . . . . 0.0 107.859 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.9 126.81 15.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 124.358 1.063 . . . . 0.0 109.05 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 18.2 mt-30 -126.96 150.42 71.8 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.16 0.984 . . . . 0.0 113.064 167.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.3 -174.43 2.2 Favored 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 126.315 4.677 . . . . 0.0 113.284 174.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.03 -10.1 59.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 t -173.84 -176.52 1.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.86 1.264 . . . . 0.0 108.806 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.28 73.81 0.5 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.414 1.486 . . . . 0.0 111.766 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.4 141.56 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.548 . . . . 0.0 110.31 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -74.76 125.47 28.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.91 49.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.78 -21.77 29.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.684 -172.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.45 164.03 13.44 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 119.631 1.105 . . . . 0.0 112.275 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -129.65 145.63 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.528 1.131 . . . . 0.0 108.352 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mt -76.09 101.67 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.83 -22.23 6.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.972 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -155.63 159.07 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.908 0.883 . . . . 0.0 111.652 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.96 11.02 70.93 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 118.746 -1.03 . . . . 0.0 115.145 169.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 tp -51.74 -48.25 63.74 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.005 1.403 . . . . 0.0 111.369 -172.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -70.2 -19.37 63.17 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 120.785 -1.197 . . . . 0.0 111.971 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.2 -0.67 32.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.247 1.019 . . . . 0.0 111.784 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 79' ' ' PHE . 4.9 mp -74.89 -39.01 61.73 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 119.954 -1.717 . . . . 0.0 111.567 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -63.68 -23.74 67.5 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.995 -1.066 . . . . 0.0 111.91 -172.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -94.45 23.0 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 0.0 112.679 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.46 165.63 2.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.397 1.479 . . . . 0.0 107.168 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -125.86 171.08 11.0 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.91 1.684 . . . . 0.0 108.095 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.01 1.91 2.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.218 2.207 . . . . 0.0 114.738 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.41 74.79 0.12 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.74 29.98 5.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.056 2.143 . . . . 0.0 110.029 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.4 mttt 43.07 101.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.611 2.764 . . . . 0.0 113.937 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.965 HG13 HG22 ' A' ' 36' ' ' VAL . 28.0 m -68.2 167.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 116.126 -2.23 . . . . 0.0 105.325 174.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -135.47 109.82 8.42 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 154.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.9 t -78.53 126.26 38.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 125.337 1.455 . . . . 0.0 107.087 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 mtm105 -128.92 176.04 8.18 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 0.0 110.231 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -72.53 -6.94 47.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.781 0 C-N-CA 126.81 2.044 . . . . 0.0 112.419 -170.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 ttm . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -68.4 160.88 28.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.048 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 16' ' ' LEU . 26.1 t -152.94 143.48 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 126.613 1.965 . . . . 0.0 107.126 170.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 41.0 tt0 -135.93 112.55 10.06 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 119.889 -1.757 . . . . 0.0 108.499 -171.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.57 92.26 9.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 131.412 3.885 . . . . 0.0 108.631 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.61 152.4 40.56 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 164.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -131.63 177.82 7.22 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.879 1.672 . . . . 0.0 107.62 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.18 -44.56 83.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.418 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m -86.16 -15.4 41.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -172.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.93 -165.49 34.0 Favored Glycine 0 N--CA 1.467 0.717 0 CA-C-N 120.734 1.606 . . . . 0.0 110.942 -166.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 138.01 8.94 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.915 1.358 . . . . 0.0 110.259 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.575 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 24.1 m -140.11 164.2 30.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.607 1.163 . . . . 0.0 111.772 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.29 112.67 21.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.428 1.091 . . . . 0.0 108.64 -167.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 pt -101.63 139.28 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.12 110.34 21.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 3' ' ' VAL . 25.0 mt -109.82 122.78 48.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.534 1.134 . . . . 0.0 109.708 -167.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.465 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 49.6 t30 -84.64 125.3 32.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.52 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.54 -1.82 12.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.597 1.559 . . . . 0.0 113.538 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.2 -21.14 64.88 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.139 0.881 . . . . 0.0 109.638 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 16.2 m-85 -92.79 124.63 36.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.321 1.448 . . . . 0.0 110.049 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -47.4 -53.91 12.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.241 1.817 . . . . 0.0 111.495 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -44.65 -40.43 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -71.76 -42.09 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.023 1.283 . . . . 0.0 109.958 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -59.26 -37.73 78.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.662 0.785 . . . . 0.0 110.085 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.49 -34.9 54.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.007 1.323 . . . . 0.0 109.983 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.97 -23.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.493 1.117 . . . . 0.0 112.052 172.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -14.4 50.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.742 1.156 . . . . 0.0 111.993 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -86.57 -14.37 43.07 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 120.723 -1.236 . . . . 0.0 112.25 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -124.93 4.58 8.02 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.433 1.093 . . . . 0.0 113.205 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.6 mt -104.6 141.33 22.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 120.1 1.318 . . . . 0.0 107.507 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.32 159.35 94.26 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.294 -0.711 . . . . 0.0 112.589 -6.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 119' ' ' VAL . 34.6 p90 -140.21 164.62 29.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 122.125 -0.359 . . . . 0.0 110.055 165.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -124.26 150.4 45.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.3 161.91 37.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.006 -172.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.01 123.07 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.69 98.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -85.77 155.14 21.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 165.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -131.79 144.55 51.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 108.731 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -154.1 102.63 2.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.47 19.76 79.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 116.45 -2.306 . . . . 0.0 116.674 154.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 76.94 37.96 0.27 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.851 2.826 . . . . 0.0 112.566 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 6.2 tt0 -131.71 163.74 27.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.612 1.965 . . . . 0.0 106.187 150.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.0 mt -127.79 146.24 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 127.009 2.124 . . . . 0.0 107.097 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -134.95 169.32 17.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 122.678 1.228 . . . . 0.0 109.715 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -149.99 150.55 31.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -88.75 82.79 6.74 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -167.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.782 HG21 HD23 ' A' ' 75' ' ' LEU . 11.0 p -65.26 147.92 98.28 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -165.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.19 -26.22 12.86 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.623 2.216 . . . . 0.0 112.072 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.3 136.46 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -122.66 100.02 6.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.733 1.613 . . . . 0.0 107.38 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.04 171.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 129.034 2.934 . . . . 0.0 104.669 165.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.94 3.14 2.0 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 166.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -44.81 118.84 1.74 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.918 1.287 . . . . 0.0 111.053 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtm -108.72 90.59 3.34 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.78 2.032 . . . . 0.0 106.042 -171.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -67.94 -26.88 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.455 -0.778 . . . . 0.0 111.466 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -153.7 54.83 1.2 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.141 1.776 . . . . 0.0 113.692 -167.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.58 162.97 19.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.762 1.642 . . . . 0.0 111.993 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -146.63 -175.71 4.9 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 128.331 2.652 . . . . 0.0 106.489 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -120.28 1.15 10.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.322 1.049 . . . . 0.0 112.916 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.62 159.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.269 2.227 . . . . 0.0 108.998 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.6 m -141.3 -179.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.809 2.044 . . . . 0.0 109.233 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -88.76 178.56 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 120.722 -1.236 . . . . 0.0 110.844 163.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.674 ' O ' HD11 ' A' ' 105' ' ' LEU . 38.7 mt -76.56 4.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.489 1.516 . . . . 0.0 110.261 173.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 43.07 0.67 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -111.78 -154.47 0.54 Allowed 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 129.368 3.067 . . . . 0.0 103.412 161.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.917 HG11 ' HA3' ' A' ' 99' ' ' GLY . 4.9 p -158.72 177.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -143.89 152.26 24.06 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 119.641 -1.912 . . . . 0.0 111.55 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -105.22 123.84 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.321 1.048 . . . . 0.0 109.189 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.401 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 8.1 t90 -104.76 88.29 2.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 127.403 2.281 . . . . 0.0 109.246 -172.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD2' ' CD ' ' A' ' 71' ' ' PRO . 73.5 Cg_endo -61.64 -31.15 86.55 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.033 1.822 . . . . 0.0 115.366 -171.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD2' ' C ' ' A' ' 69' ' ' TRP . 50.7 Cg_endo -67.17 -36.7 20.65 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 123.48 2.278 . . . . 0.0 109.463 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.93 64.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.138 -1.368 . . . . 0.0 113.501 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 45.78 55.63 6.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.388 2.094 . . . . 0.0 108.904 -166.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.83 157.83 44.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.782 HD23 HG21 ' A' ' 47' ' ' THR . 3.5 mm? -90.55 176.16 6.79 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.32 124.54 7.5 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.871 1.268 . . . . 0.0 108.855 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' GLU . 8.0 mp -106.19 115.17 29.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.72 2.408 . . . . 0.0 107.553 174.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -107.73 110.45 22.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.862 1.21 . . . . 0.0 108.204 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -125.77 11.24 7.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.695 0.798 . . . . 0.0 112.826 -170.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.64 -128.6 0.96 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 165.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -132.77 107.91 8.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.119 1.459 . . . . 0.0 110.584 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -64.85 165.51 15.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 126.655 1.982 . . . . 0.0 113.383 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.93 7.49 1.31 Allowed 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.889 4.393 . . . . 0.0 114.523 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.1 mmt -116.08 81.37 1.6 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.529 -1.357 . . . . 0.0 109.505 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 p 174.92 -177.03 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.041 2.137 . . . . 0.0 107.632 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -127.94 -59.51 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 143.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -81.4 -37.34 28.3 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.43 162.36 34.65 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.427 1.491 . . . . 0.0 107.733 -165.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.13 83.97 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 121.373 1.897 . . . . 0.0 108.334 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.68 146.29 52.69 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 126.768 2.027 . . . . 0.0 109.923 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.53 -175.34 1.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.932 3.755 . . . . 0.0 112.043 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -38.98 61.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.145 1.378 . . . . 0.0 113.751 168.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -173.24 174.25 3.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.661 1.584 . . . . 0.0 109.118 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.37 103.02 0.05 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.6 1.56 . . . . 0.0 111.31 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 93' ' ' SER . 17.2 m -112.21 142.7 23.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.446 1.099 . . . . 0.0 109.734 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -79.58 125.45 29.62 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -90.06 71.06 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.5 pt -87.4 -32.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.917 ' HA3' HG11 ' A' ' 66' ' ' VAL . . . -75.74 169.41 54.77 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 161.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.63 147.56 35.23 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 101.948 -3.352 . . . . 0.0 101.948 131.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.99 83.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 156.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.4 -41.0 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 120.558 -1.339 . . . . 0.0 111.016 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.49 150.09 46.07 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 125.739 1.615 . . . . 0.0 108.713 -169.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 78.35 78.08 0.83 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.674 HD11 ' O ' ' A' ' 63' ' ' ILE . 2.0 tp -108.77 -60.52 1.73 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.164 1.786 . . . . 0.0 110.108 172.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.49 -23.22 58.83 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.47 -0.769 . . . . 0.0 110.439 -172.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -24.11 54.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.415 1.086 . . . . 0.0 111.085 173.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.46 -29.57 56.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.399 0.999 . . . . 0.0 112.027 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -72.4 17.85 0.1 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.952 -1.092 . . . . 0.0 112.74 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -147.85 23.34 1.1 Allowed 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 126.124 1.77 . . . . 0.0 112.437 -178.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.2 mm -105.82 141.05 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 43.3 mmtt -85.18 174.73 9.44 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.4 1.48 . . . . 0.0 109.842 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.61 43.2 0.73 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.674 1.59 . . . . 0.0 112.643 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.43 64.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.385 0 O-C-N 120.12 -1.613 . . . . 0.0 111.91 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 6.2 mm-40 -122.22 24.64 9.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.025 1.73 . . . . 0.0 112.405 -172.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mttp 43.41 86.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.632 2.373 . . . . 0.0 113.494 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.69 104.81 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.804 -0.56 . . . . 0.0 109.522 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.71 96.8 7.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.824 1.65 . . . . 0.0 109.59 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.411 HG11 ' CE1' ' A' ' 32' ' ' PHE . 79.1 t -77.42 117.64 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.779 2.432 . . . . 0.0 108.177 174.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.494 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -130.7 173.74 10.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.92 1.288 . . . . 0.0 109.821 177.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -79.55 -10.6 59.83 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 121.547 1.976 . . . . 0.0 115.602 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 127.016 2.126 . . . . 0.0 111.067 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttm . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.674 1.225 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.502 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 46.9 mtm-85 -67.2 161.19 25.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.66 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 t -146.73 105.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.521 1.128 . . . . 0.0 107.978 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.635 ' HA ' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -80.78 142.15 34.05 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.636 -1.29 . . . . 0.0 109.403 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.98 97.69 5.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.044 0.938 . . . . 0.0 111.48 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 148.41 25.51 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.98 175.94 8.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.946 1.698 . . . . 0.0 110.36 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -78.2 -5.12 50.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -132.85 5.17 3.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -167.87 39.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -158.95 163.69 36.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.45 1.1 . . . . 0.0 108.25 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 p -161.73 179.87 7.78 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 130.198 3.399 . . . . 0.0 103.862 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -149.68 150.85 13.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 112.126 -2.306 . . . . 0.0 105.115 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 25.1 pt -129.79 114.99 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 124.675 1.19 . . . . 0.0 109.246 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -89.45 107.52 19.12 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.7 -170.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.59 138.61 46.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.768 0.713 . . . . 0.0 110.586 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -87.98 149.51 23.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.742 -0.599 . . . . 0.0 109.69 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.38 -0.66 53.51 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.622 1.169 . . . . 0.0 114.135 -164.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -96.21 5.72 50.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.134 1.374 . . . . 0.0 109.024 -167.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -111.53 133.29 53.91 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.014 2.126 . . . . 0.0 109.178 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.71 -51.7 66.4 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.402 1.081 . . . . 0.0 110.218 -170.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -49.74 -36.06 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.452 1.501 . . . . 0.0 114.456 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.07 -39.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 119.786 1.175 . . . . 0.0 109.283 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.38 -37.5 80.97 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 0.0 110.427 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.0 -36.23 30.93 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.936 0.894 . . . . 0.0 110.735 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.08 -28.32 66.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.361 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -58.52 -26.91 64.0 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.677 0.671 . . . . 0.0 111.591 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -68.12 -26.13 65.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.989 0.813 . . . . 0.0 110.541 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -124.22 24.3 8.13 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 120.952 -1.093 . . . . 0.0 112.614 -160.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.7 mt -115.61 153.38 47.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.449 1.477 . . . . 0.0 108.335 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.26 160.83 23.75 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.067 -1.222 . . . . 0.0 111.341 -24.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.511 ' CE1' HG11 ' A' ' 119' ' ' VAL . 33.0 p90 -146.85 171.34 15.35 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.224 1.41 . . . . 0.0 109.756 169.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -122.25 162.58 21.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.252 1.021 . . . . 0.0 109.408 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 -179.92 6.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.063 0.545 . . . . 0.0 109.807 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.15 142.26 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 117' ' ' VAL . 18.3 t -91.65 76.35 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.943 1.297 . . . . 0.0 107.803 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -69.82 156.48 38.98 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.899 -1.126 . . . . 0.0 108.912 175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.5 p -136.45 137.81 40.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.281 1.032 . . . . 0.0 109.956 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 92' ' ' ALA . 67.9 t90 -142.58 75.6 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.454 1.502 . . . . 0.0 108.163 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.13 81.53 0.19 Allowed Glycine 0 C--O 1.218 -0.847 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.987 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 51.6 63.44 2.24 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 118.367 1.084 . . . . 0.0 109.253 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.9 154.87 15.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -131.66 144.09 38.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -148.74 170.62 17.79 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.332 1.453 . . . . 0.0 109.945 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.42 144.13 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.291 1.036 . . . . 0.0 109.256 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -74.85 84.95 2.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.796 2.038 . . . . 0.0 109.384 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 p -61.78 152.32 76.25 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-O 121.413 0.625 . . . . 0.0 111.869 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -81.18 0.23 10.11 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.13 3.22 . . . . 0.0 112.584 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 51' ' ' VAL . 16.9 t -105.55 134.19 47.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 125.12 1.368 . . . . 0.0 108.541 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -114.97 18.03 16.59 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.92 0.888 . . . . 0.0 112.589 -168.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 49' ' ' VAL . 8.3 p -69.33 150.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.739 0.781 . . . . 0.0 112.354 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -135.76 40.9 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.758 2.423 . . . . 0.0 108.586 -172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.411 ' H ' HG22 ' A' ' 51' ' ' VAL . 58.5 tttp -121.61 105.84 10.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.105 2.162 . . . . 0.0 111.165 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -93.19 130.79 38.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.359 1.463 . . . . 0.0 109.716 171.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.32 -44.88 8.48 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.683 -0.636 . . . . 0.0 110.864 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -114.46 60.67 1.09 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.121 0.968 . . . . 0.0 109.581 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.12 144.67 42.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.36 2.04 . . . . 0.0 112.593 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -143.64 164.97 28.91 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.533 0.733 . . . . 0.0 109.751 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.07 12.98 18.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.414 1.886 . . . . 0.0 110.51 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -166.78 150.93 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 129.987 3.315 . . . . 0.0 110.016 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.09 -175.49 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.94 1.296 . . . . 0.0 111.74 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -94.58 175.48 6.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.821 1.248 . . . . 0.0 110.817 170.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 63' ' ' ILE . 51.7 mt -81.44 33.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.692 1.597 . . . . 0.0 111.074 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.508 ' HA2' HD21 ' A' ' 105' ' ' LEU . . . -167.96 34.67 0.2 Allowed Glycine 0 CA--C 1.511 -0.207 0 O-C-N 120.369 -1.457 . . . . 0.0 111.888 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -121.6 -175.28 3.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.214 1.006 . . . . 0.0 108.35 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -139.12 164.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.182 1.793 . . . . 0.0 107.6 -168.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -165.34 129.12 1.89 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.49 144.5 49.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -114.34 86.79 12.57 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.486 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 68.8 Cg_endo -65.98 -22.23 55.68 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.243 2.629 . . . . 0.0 117.512 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.486 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 42.7 Cg_endo -80.48 -19.1 9.15 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 CA-C-N 123.007 2.11 . . . . 0.0 112.096 -171.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.35 -9.67 11.41 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.615 1.579 . . . . 0.0 114.137 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 58.83 84.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.094 2.157 . . . . 0.0 111.299 -164.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.28 175.92 13.23 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.14 -172.42 3.95 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.687 1.595 . . . . 0.0 110.928 162.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 15.8 t -158.22 149.8 21.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.866 1.666 . . . . 0.0 109.09 161.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.46 128.86 47.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.99 2.516 . . . . 0.0 109.448 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.05 112.91 24.01 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 125.011 1.324 . . . . 0.0 109.363 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -134.33 5.55 3.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.767 2.427 . . . . 0.0 113.459 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.18 -168.32 40.43 Favored Glycine 0 CA--C 1.52 0.405 0 O-C-N 119.978 -1.701 . . . . 0.0 110.707 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.08 102.27 14.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -163.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.8 p -74.79 166.33 46.22 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 110.824 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.5 -19.88 48.31 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.362 2.708 . . . . 0.0 113.334 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.7 tpt -97.41 50.69 1.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.229 1.011 . . . . 0.0 110.317 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.0 p -158.93 177.84 10.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.147 0.579 . . . . 0.0 110.26 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.52 -62.46 0.87 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 148.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.05 -49.04 21.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.116 0.96 . . . . 0.0 111.912 -166.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -136.7 158.7 43.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.239 1.816 . . . . 0.0 108.205 -164.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mt -79.6 83.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.56 143.64 59.61 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.807 1.643 . . . . 0.0 111.398 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -81.97 174.99 9.67 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.436 3.424 . . . . 0.0 112.284 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.528 ' HB2' ' CH2' ' A' ' 39' ' ' TRP . . . -66.97 -20.5 65.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 m -156.93 170.35 22.7 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.81 2.444 . . . . 0.0 108.892 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.11 0.51 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.852 0.751 . . . . 0.0 109.848 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.89 -165.62 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 128.275 2.63 . . . . 0.0 107.396 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -139.8 127.37 21.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 112.511 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 32.75 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.432 -1.418 . . . . 0.0 111.1 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -61.25 -15.63 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 119.68 -1.887 . . . . 0.0 113.698 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.73 165.83 15.32 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 33.3 tptt -134.7 126.18 28.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 170.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.78 93.17 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 166.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.564 ' CG2' HG13 ' A' ' 13' ' ' VAL . 30.8 m -76.42 -63.32 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.612 ' HB2' HG12 ' A' ' 13' ' ' VAL . 1.1 mm-40 -93.07 166.03 12.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -172.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.38 16.57 80.62 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-N 115.241 -0.89 . . . . 0.0 114.793 158.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -54.88 -62.61 1.55 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.162 0.985 . . . . 0.0 109.276 -173.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.35 -21.2 62.92 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.176 -167.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.5 -19.83 64.55 Favored 'General case' 0 C--O 1.225 -0.23 0 O-C-N 121.67 -0.644 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.61 -18.52 65.38 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.618 -1.301 . . . . 0.0 113.44 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -59.11 -29.54 67.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.086 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 27.86 9.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.653 1.115 . . . . 0.0 112.879 -163.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.61 150.55 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -92.84 170.67 9.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.92 15.81 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.643 2.377 . . . . 0.0 112.932 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.71 54.67 0.09 OUTLIER Glycine 0 CA--C 1.533 1.173 0 O-C-N 119.206 -2.184 . . . . 0.0 114.758 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.424 ' CG ' ' H ' ' A' ' 112' ' ' LYS . 13.6 mm-40 -100.3 32.35 3.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.938 1.295 . . . . 0.0 113.274 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.8 mttp 42.03 74.78 0.1 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.309 1.844 . . . . 0.0 112.619 171.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.574 ' HB ' HG22 ' A' ' 36' ' ' VAL . 7.5 p -68.14 105.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.25 88.91 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.39 1.476 . . . . 0.0 107.185 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.511 HG11 ' CE1' ' A' ' 32' ' ' PHE . 90.6 t -71.51 134.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 126.704 2.002 . . . . 0.0 108.648 -173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -141.93 -172.21 3.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.231 1.812 . . . . 0.0 110.332 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -99.9 0.1 40.62 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--N 1.307 -1.262 0 C-N-CA 126.989 2.116 . . . . 0.0 112.718 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.236 0.363 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 152.92 42.83 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.9 t -150.91 130.98 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.267 1.427 . . . . 0.0 107.613 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 22.2 tt0 -115.56 120.53 39.77 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.516 2.326 . . . . 0.0 107.01 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 117' ' ' VAL . 11.2 mp -98.25 109.34 22.11 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 126.884 2.074 . . . . 0.0 106.903 172.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 126.94 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -110.11 173.03 6.51 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.069 0.948 . . . . 0.0 108.445 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.55 -17.66 62.3 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.046 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -115.48 4.59 14.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.594 1.557 . . . . 0.0 114.666 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.75 -164.98 38.38 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.642 -1.286 . . . . 0.0 110.724 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -157.83 158.63 35.53 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.067 0.947 . . . . 0.0 109.079 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -145.38 177.31 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.998 0.919 . . . . 0.0 108.971 174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 t -135.11 133.29 53.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.0 pt -122.66 166.32 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -144.7 135.99 25.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -125.32 114.93 19.55 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 126.686 1.994 . . . . 0.0 108.627 -168.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.92 132.25 52.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.381 0.673 . . . . 0.0 110.411 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.68 21.05 0.21 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.311 1.444 . . . . 0.0 113.842 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.0 10.24 22.16 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.329 1.052 . . . . 0.0 110.454 -173.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -122.72 137.33 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.589 1.156 . . . . 0.0 108.938 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.94 -53.67 30.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.963 0.905 . . . . 0.0 110.458 -173.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.37 -32.25 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.36 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.26 -50.45 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.855 1.262 . . . . 0.0 107.886 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -58.71 -43.83 90.19 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.155 0.582 . . . . 0.0 110.942 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -41.97 90.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.766 0.826 . . . . 0.0 109.351 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.34 -28.6 54.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.93 1.292 . . . . 0.0 111.112 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -60.74 -29.96 69.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.713 0.688 . . . . 0.0 110.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -72.35 -14.42 61.72 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.595 0.758 . . . . 0.0 111.863 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -125.29 24.47 7.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.769 1.628 . . . . 0.0 110.982 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mt -121.56 136.86 26.33 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.26 164.97 57.82 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 N-CA-C 114.772 1.028 . . . . 0.0 114.772 -7.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.26 165.49 35.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.686 0.794 . . . . 0.0 112.136 166.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -121.78 160.11 25.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.366 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -163.57 -159.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.432 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.12 134.49 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.075 1.35 . . . . 0.0 108.606 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.38 76.34 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 124.884 1.274 . . . . 0.0 108.111 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -69.31 144.96 53.39 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.256 -1.527 . . . . 0.0 107.615 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.5 p -129.07 147.31 50.92 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.624 0.647 . . . . 0.0 110.215 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -151.79 64.32 0.86 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.725 0.81 . . . . 0.0 109.685 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 82' ' ' THR . . . 70.91 77.72 0.48 Allowed Glycine 0 C--O 1.211 -1.298 0 O-C-N 120.98 -1.075 . . . . 0.0 111.581 170.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 62.06 23.0 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.106 1.453 . . . . 0.0 112.333 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -126.49 145.98 50.29 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.649 2.38 . . . . 0.0 107.317 171.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mt -122.73 144.48 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 163.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.08 158.17 43.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 166.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -141.89 153.85 44.7 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.2 t -79.91 104.54 10.55 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -68.43 149.64 97.96 Favored Pre-proline 0 N--CA 1.447 -0.588 0 O-C-N 121.813 -0.554 . . . . 0.0 110.008 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.72 -36.85 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.076 2.518 . . . . 0.0 110.793 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 149.36 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -132.2 121.87 24.35 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.539 1.936 . . . . 0.0 106.048 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.9 143.81 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -128.54 36.37 4.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.3 1.04 . . . . 0.0 111.31 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -128.91 114.87 17.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.093 2.557 . . . . 0.0 107.623 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 162.27 13.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.443 1.097 . . . . 0.0 109.933 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.2 -39.8 3.56 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.996 1.719 . . . . 0.0 110.517 166.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -122.0 60.85 12.65 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.174 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.61 131.49 29.74 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.007 1.138 . . . . 0.0 110.61 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -129.79 124.94 34.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -90.19 0.48 57.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.339 0.518 . . . . 0.0 111.919 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -137.29 135.58 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.65 173.27 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.959 -167.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -115.65 168.02 10.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.937 0.875 . . . . 0.0 112.866 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.2 mt -78.52 68.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.789 2.035 . . . . 0.0 106.85 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.77 -1.14 0.16 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.406 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.3 174.54 7.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.306 2.053 . . . . 0.0 109.564 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.29 146.55 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.181 1.392 . . . . 0.0 107.941 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.64 161.03 26.18 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.316 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -81.21 146.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 168.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.422 ' HE1' ' HG ' ' A' ' 93' ' ' SER . 6.5 t90 -121.03 85.43 40.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.897 1.279 . . . . 0.0 108.382 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.05 -38.96 84.57 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.382 2.055 . . . . 0.0 115.854 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.5 -28.5 32.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.673 2.249 . . . . 0.0 109.814 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.82 4.52 75.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.028 -1.429 . . . . 0.0 114.535 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.96 25.84 4.29 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.47 2.135 . . . . 0.0 112.728 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.44 178.1 7.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.08 -158.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -172.97 4.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.166 166.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.7 m -148.25 158.37 44.04 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.888 2.475 . . . . 0.0 107.02 161.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mt -146.62 114.25 6.4 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.138 1.775 . . . . 0.0 109.488 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -102.73 106.22 16.81 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.103 0.961 . . . . 0.0 110.335 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -138.28 18.25 2.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.47 -134.25 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.148 0.885 . . . . 0.0 111.514 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -127.64 94.44 3.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 40' ' ' GLY . 0.7 OUTLIER -64.67 154.26 85.42 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.86 1.664 . . . . 0.0 111.222 -175.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.97 5.36 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 125.087 3.858 . . . . 0.0 113.685 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.98 24.75 12.3 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.379 1.472 . . . . 0.0 109.212 175.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.46 166.63 23.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.552 1.541 . . . . 0.0 107.985 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -153.17 -68.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -170.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.407 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 19.3 t70 -73.69 -50.83 18.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 122.206 1.003 . . . . 0.0 111.106 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -129.77 177.57 7.15 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 130.369 3.467 . . . . 0.0 107.187 -173.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -80.89 141.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.99 1.268 . . . . 0.0 108.62 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -141.46 144.87 35.43 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.02 0.928 . . . . 0.0 110.236 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.1 169.58 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.501 3.467 . . . . 0.0 113.911 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.16 64.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.422 ' HG ' ' HE1' ' A' ' 69' ' ' TRP . 81.7 p -164.52 -168.86 1.61 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.475 1.11 . . . . 0.0 108.195 165.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 76.9 0.12 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.697 0.761 . . . . 0.0 111.567 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.52 169.84 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.765 1.226 . . . . 0.0 109.242 165.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -114.71 129.16 56.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.866 1.266 . . . . 0.0 109.729 171.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.83 86.13 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.6 pt -103.73 -22.64 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 110.504 170.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.03 163.64 12.51 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -128.41 145.32 51.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.246 1.018 . . . . 0.0 108.596 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 91.9 mt -74.08 102.39 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 158.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -27.88 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 112.783 -2.008 . . . . 0.0 107.293 -167.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -155.86 161.45 40.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.022 2.529 . . . . 0.0 112.299 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.85 30.78 37.79 Favored Glycine 0 C--O 1.221 -0.674 0 CA-C-O 118.205 -1.331 . . . . 0.0 113.284 172.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.73 -41.36 97.53 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.142 1.971 . . . . 0.0 113.17 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.81 -19.87 47.46 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.121 -0.987 . . . . 0.0 111.246 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.3 -22.72 63.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.705 1.202 . . . . 0.0 110.371 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.04 -34.42 77.65 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.167 1.787 . . . . 0.0 110.285 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -67.56 -2.62 6.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -100.9 -16.03 17.35 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 123.929 0.892 . . . . 0.0 112.01 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.02 165.27 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.01 0.823 . . . . 0.0 109.65 -165.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -113.69 -179.76 3.73 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.202 1.401 . . . . 0.0 108.449 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.16 22.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.028 2.131 . . . . 0.0 114.876 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.99 26.81 0.03 OUTLIER Glycine 0 C--N 1.338 0.666 0 O-C-N 119.817 -1.802 . . . . 0.0 115.907 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.06 49.05 1.04 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.806 1.803 . . . . 0.0 112.052 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.2 mttt 42.98 82.53 0.03 OUTLIER 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.263 2.225 . . . . 0.0 114.161 157.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.515 HG21 HD23 ' A' ' 5' ' ' LEU . 4.8 p -76.73 104.09 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.415 1.486 . . . . 0.0 107.699 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.37 101.07 13.21 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.72 134.01 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 128.58 2.752 . . . . 0.0 107.632 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -138.98 175.36 9.62 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.194 2.598 . . . . 0.0 109.634 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -73.6 -10.2 59.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 121.025 1.739 . . . . 0.0 114.884 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.821 0 C-N-CA 126.097 1.759 . . . . 0.0 111.105 -154.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpp . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -112.82 179.68 3.9 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.51 1.924 . . . . 0.0 107.706 162.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.5 t -147.59 150.31 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.274 2.229 . . . . 0.0 106.838 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 27.5 tt0 -125.23 145.71 49.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.705 2.002 . . . . 0.0 107.256 173.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.8 mt -121.98 111.96 17.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.99 122.17 44.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -106.8 172.08 7.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.4 -23.82 67.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.588 0.755 . . . . 0.0 111.562 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -125.26 8.74 7.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -167.79 40.84 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-O 119.527 -0.596 . . . . 0.0 111.816 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -159.2 153.66 24.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.831 0.815 . . . . 0.0 111.117 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.0 p -136.8 179.42 6.38 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.426 0.691 . . . . 0.0 110.595 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.61 135.22 49.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.51 124.45 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -96.31 117.89 31.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.986 1.314 . . . . 0.0 107.754 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -128.12 135.72 50.18 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 118.848 0.749 . . . . 0.0 109.715 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -101.04 106.78 18.1 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.01 1.71 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 1 C-N-CA 131.836 4.054 . . . . 0.0 117.151 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.76 -44.21 64.45 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.635 -1.29 . . . . 0.0 107.953 164.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -62.6 139.69 58.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 110.194 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.74 -56.35 16.19 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.283 1.833 . . . . 0.0 107.28 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.441 HG12 HD23 ' A' ' 26' ' ' LEU . 1.5 t -57.45 -38.64 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.042 -173.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.36 -35.62 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.001 -170.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -61.25 -47.32 86.57 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.876 -0.515 . . . . 0.0 111.008 170.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -32.25 71.36 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.719 1.208 . . . . 0.0 110.417 -171.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.773 ' CD2' HG11 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -59.94 -40.99 90.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.389 1.876 . . . . 0.0 109.825 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -50.42 -36.19 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.897 0.879 . . . . 0.0 110.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -69.89 -23.83 63.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.615 0.766 . . . . 0.0 111.622 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -113.13 -10.35 13.43 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 111.336 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -83.21 143.57 45.47 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -70.17 149.72 90.02 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 125.47 -0.637 . . . . 0.0 112.229 -10.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -139.48 168.33 20.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.124 0.97 . . . . 0.0 109.802 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -114.13 166.0 12.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.32 161.24 39.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.603 -0.685 . . . . 0.0 109.928 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.76 128.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 43' ' ' ILE . 35.5 t -77.62 107.45 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 167.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -96.61 151.23 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 163.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.4 p -122.46 149.97 43.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.214 1.006 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -149.43 92.88 1.99 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.2 -88.17 0.49 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 123.646 0.641 . . . . 0.0 111.758 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HB2' ' H ' ' A' ' 82' ' ' THR . 98.0 mt-10 -141.43 36.74 1.68 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.972 1.709 . . . . 0.0 107.944 -173.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -133.17 163.84 28.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 109.681 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.507 HG23 HG13 ' A' ' 36' ' ' VAL . 20.0 mt -123.07 142.59 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -136.46 161.56 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.588 1.555 . . . . 0.0 107.303 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.39 142.83 27.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -75.2 93.33 2.81 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.566 1.146 . . . . 0.0 109.325 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.1 p -62.29 150.92 83.51 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -67.9 -39.04 11.91 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.107 2.538 . . . . 0.0 110.914 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.773 HG11 ' CD2' ' A' ' 26' ' ' LEU . 11.9 p -67.24 155.25 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.595 -0.69 . . . . 0.0 109.673 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -154.63 56.11 0.68 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.329 0.652 . . . . 0.0 112.464 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.12 173.3 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 0.0 110.103 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.0 14.03 2.26 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -69.94 127.76 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -136.03 93.99 2.99 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.827 1.251 . . . . 0.0 110.205 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -75.33 -43.54 50.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -117.19 66.35 4.25 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 111.635 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.31 155.39 69.46 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 120.759 0.972 . . . . 0.0 111.212 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -144.61 157.72 44.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.605 1.162 . . . . 0.0 108.911 168.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -119.63 5.48 11.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.85 1.26 . . . . 0.0 111.892 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.3 145.05 27.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.15 179.45 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.805 0.842 . . . . 0.0 110.115 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -87.88 -168.59 2.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 0.0 111.139 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.408 ' O ' HD11 ' A' ' 105' ' ' LEU . 13.7 mt -90.79 -8.62 10.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 124.803 1.241 . . . . 0.0 110.917 161.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.68 83.22 0.25 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 105.663 -2.975 . . . . 0.0 105.663 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -141.15 -175.18 4.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.74 3.216 . . . . 0.0 105.884 152.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.96 163.3 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 131.312 3.845 . . . . 0.0 109.443 -166.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.91 144.25 9.3 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.87 163.52 27.19 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.169 0.984 . . . . 0.0 109.771 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -136.66 87.31 20.86 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 109.973 -172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.58 -27.53 69.6 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 121.465 1.443 . . . . 0.0 115.201 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.79 -28.39 16.88 Favored 'Trans proline' 0 C--N 1.354 0.822 0 CA-C-N 123.787 2.388 . . . . 0.0 111.362 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.28 9.93 26.63 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.736 -1.035 . . . . 0.0 113.737 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm 46.17 55.84 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.697 1.599 . . . . 0.0 110.814 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.93 176.94 7.47 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.699 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.0 174.49 6.53 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 125.784 1.633 . . . . 0.0 109.929 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.61 137.2 23.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.565 1.946 . . . . 0.0 109.861 162.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.64 109.7 14.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.745 3.618 . . . . 0.0 106.079 172.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.23 49.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.647 1.112 . . . . 0.0 108.632 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -147.01 34.57 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.93 -120.94 0.55 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.877 2.18 . . . . 0.0 108.135 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.81 5.8 7.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.667 1.733 . . . . 0.0 113.302 170.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 41' ' ' GLU 0.298 0.0 OUTLIER 62.93 167.72 0.1 Allowed Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.68 1.127 . . . . 0.0 113.858 167.948 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -91.41 6.15 3.7 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.973 3.115 . . . . 0.0 113.527 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -132.54 62.86 1.64 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.7 1.136 . . . . 0.0 108.277 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -156.62 175.0 14.62 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.343 1.457 . . . . 0.0 109.633 -174.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -148.38 -50.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 154.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.41 -58.98 2.97 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -132.2 168.46 18.0 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.228 2.611 . . . . 0.0 108.502 -167.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.73 122.06 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -129.77 144.32 52.51 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 123.413 0.445 . . . . 0.0 110.479 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.02 173.26 14.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.136 3.224 . . . . 0.0 112.717 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.12 -33.29 75.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.76 175.03 10.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.154 1.382 . . . . 0.0 107.511 172.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 100.33 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.18 -173.46 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -130.92 125.14 32.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.266 2.4 t -90.39 61.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.838 -163.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.3 pt -77.14 -10.48 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.715 2.006 . . . . 0.0 112.398 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.18 167.18 12.58 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 130.423 3.868 . . . . 0.0 112.268 -166.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -148.14 129.04 14.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.825 2.05 . . . . 0.0 106.751 150.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.8 mt -56.98 100.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 155.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 m -76.57 -36.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 118.903 0.774 . . . . 0.0 110.869 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -149.97 164.13 36.28 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.29 1.036 . . . . 0.0 111.142 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.5 33.05 71.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.994 1.283 . . . . 0.0 112.59 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 63' ' ' ILE . 55.0 tp -58.74 -52.33 66.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.332 1.053 . . . . 0.0 112.288 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.48 -21.26 56.06 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.001 -0.437 . . . . 0.0 111.316 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -9.89 6.63 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.021 1.328 . . . . 0.0 111.75 175.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.9 mt -79.78 -41.23 26.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.808 1.643 . . . . 0.0 111.611 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -65.23 -12.2 48.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.825 -1.172 . . . . 0.0 113.142 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -102.96 14.17 32.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.566 1.146 . . . . 0.0 112.125 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -107.3 127.47 63.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.253 1.421 . . . . 0.0 107.727 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -70.27 174.34 5.71 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.287 1.035 . . . . 0.0 110.471 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.34 49.57 0.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.929 1.692 . . . . 0.0 111.624 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.03 88.54 0.07 OUTLIER Glycine 0 C--O 1.231 -0.074 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -138.5 26.68 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 -173.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 mttm 43.41 75.33 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.013 2.125 . . . . 0.0 111.746 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.75 105.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.72 102.35 10.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.95 123.5 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 126.423 1.889 . . . . 0.0 107.669 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -132.97 172.43 12.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.14 1.336 . . . . 0.0 109.139 164.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -70.76 -12.49 61.58 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.774 0 C-N-CA 125.122 1.369 . . . . 0.0 109.969 -162.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttp . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -94.72 164.91 12.75 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.206 1.002 . . . . 0.0 109.821 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -149.27 132.5 7.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 35.0 tt0 -113.06 140.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 mp -114.15 99.97 8.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.38 142.44 33.01 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -133.96 165.91 23.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.42 -17.16 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.912 -1.118 . . . . 0.0 112.332 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 m -115.61 -6.01 12.19 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.44 -169.01 39.93 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 120.633 1.56 . . . . 0.0 109.511 -172.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -169.95 113.29 0.48 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.002 0.906 . . . . 0.0 111.578 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.542 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 30.7 m -119.46 171.69 8.17 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.961 1.304 . . . . 0.0 108.713 -169.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 t -139.9 133.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -166.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.5 pt -123.36 160.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 123.386 1.565 . . . . 0.0 108.371 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.433 ' CA ' HD22 ' A' ' 16' ' ' LEU . 11.9 p-10 -145.96 128.18 15.74 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.555 -164.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -129.85 149.19 51.69 Favored 'General case' 0 C--O 1.246 0.887 0 O-C-N 125.08 1.487 . . . . 0.0 110.291 -166.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -87.01 22.34 2.06 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 24.1 mt-10 46.27 14.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.844 2.058 . . . . 0.0 116.215 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -116.18 10.53 14.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.013 -1.055 . . . . 0.0 110.084 -166.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -125.71 135.68 52.35 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -171.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -47.34 -51.31 19.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 110.152 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.279 7.5 p -48.86 -56.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.678 1.991 . . . . 0.0 112.376 172.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.74 -45.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 121.797 2.09 . . . . 0.0 110.74 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 18' ' ' GLU . 79.9 mttt -65.51 -43.15 91.0 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.775 0.83 . . . . 0.0 111.602 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.4 mt -75.43 -30.8 60.14 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.336 1.055 . . . . 0.0 110.222 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.96 -26.11 61.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.321 1.048 . . . . 0.0 110.587 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp -64.91 -9.7 23.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.573 0.749 . . . . 0.0 112.865 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.74 -18.79 22.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.992 1.269 . . . . 0.0 112.159 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -125.92 31.23 5.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.117 1.367 . . . . 0.0 110.217 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.04 141.13 34.96 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 170.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.14 164.87 28.49 Favored 'Cis proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.712 0.933 . . . . 0.0 111.907 -14.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CE1' HG11 ' A' ' 119' ' ' VAL . 22.6 p90 -148.94 165.53 31.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.171 165.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -110.61 158.9 18.07 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 162.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -151.92 -171.79 4.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.007 0.923 . . . . 0.0 108.863 164.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -97.73 138.04 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.774 1.629 . . . . 0.0 107.224 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 117' ' ' VAL . 6.2 t -90.09 64.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.452 1.101 . . . . 0.0 110.127 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -68.66 143.59 54.73 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.476 -1.29 . . . . 0.0 107.524 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 43' ' ' ILE . 18.8 p -111.03 155.33 22.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.971 0.805 . . . . 0.0 109.938 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -147.26 73.19 1.28 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 76.21 0.55 Allowed Glycine 0 C--O 1.218 -0.856 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.808 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.21 25.22 15.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.723 2.009 . . . . 0.0 112.011 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -135.41 157.77 46.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.631 165.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 38' ' ' THR . 34.1 mt -125.15 117.66 50.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.052 1.741 . . . . 0.0 107.247 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -110.9 166.9 10.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.761 1.267 . . . . 0.0 109.718 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.618 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 3.4 p90 -151.04 149.21 29.27 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.2 t -79.0 102.85 8.56 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -79.35 150.57 74.01 Favored Pre-proline 0 N--CA 1.451 -0.417 0 O-C-N 121.765 -0.584 . . . . 0.0 110.969 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.74 -16.48 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.074 3.183 . . . . 0.0 114.601 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.427 HG12 HG12 ' A' ' 51' ' ' VAL . 21.6 t -83.11 107.13 14.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -90.14 51.03 1.96 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 123.413 1.578 . . . . 0.0 109.254 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG12 HG12 ' A' ' 49' ' ' VAL . 4.6 p -80.81 155.86 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.348 1.459 . . . . 0.0 107.716 166.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.05 4.55 2.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 166.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -62.46 102.36 0.31 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.236 1.38 . . . . 0.0 112.333 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.02 124.58 40.09 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.791 0.837 . . . . 0.0 110.308 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.84 -24.42 13.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.518 0.727 . . . . 0.0 112.529 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -114.9 55.73 0.88 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-O 117.49 -1.243 . . . . 0.0 110.044 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.45 126.9 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.217 1.944 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -136.0 127.86 29.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.78 0.45 57.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 118.45 -0.785 . . . . 0.0 111.164 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.1 t -138.88 141.64 36.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.91 174.32 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.175 1.39 . . . . 0.0 109.587 -171.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.62 -177.05 3.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 110.841 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mt -86.43 1.51 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.064 1.345 . . . . 0.0 112.454 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.79 44.55 0.78 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 125.012 1.291 . . . . 0.0 113.128 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' OD1' ' HE2' ' A' ' 100' ' ' LYS . 70.8 m-20 -125.82 174.66 8.2 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.22 147.52 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.25 147.85 19.35 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -93.69 141.6 28.31 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.803 1.301 . . . . 0.0 109.688 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -112.69 85.87 7.99 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.904 1.281 . . . . 0.0 109.946 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -64.32 -33.18 60.02 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.645 1.563 . . . . 0.0 115.264 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.47 -7.23 20.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.504 2.803 . . . . 0.0 112.335 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.52 9.15 8.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.215 1.864 . . . . 0.0 113.569 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.71 32.76 20.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.674 1.237 . . . . 0.0 111.868 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.33 13.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.906 0.775 . . . . 0.0 111.343 -167.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.618 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -80.48 -173.96 4.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.159 0.584 . . . . 0.0 110.153 162.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.415 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 7.5 t -154.91 143.69 20.76 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.22 2.208 . . . . 0.0 106.823 165.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 42' ' ' GLU . 28.4 mt -135.57 103.75 5.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.801 1.64 . . . . 0.0 107.742 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -87.71 135.7 33.26 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.028 1.286 . . . . 0.0 109.9 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -148.4 9.79 0.84 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.74 62.75 0.06 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.114 -1.993 . . . . 0.0 115.224 165.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 75.22 179.07 0.19 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.338 1.855 . . . . 0.0 107.803 -170.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.24 160.0 31.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.8 -27.74 37.27 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.123 2.549 . . . . 0.0 111.435 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.65 31.96 0.2 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.866 1.266 . . . . 0.0 111.219 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -148.75 166.15 29.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.739 -1.225 . . . . 0.0 112.001 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -136.91 -56.52 0.72 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.51 -61.81 1.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.574 1.15 . . . . 0.0 110.476 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -122.82 144.91 48.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.395 1.478 . . . . 0.0 107.103 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.5 mt -59.3 118.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -130.86 145.01 55.85 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 95' ' ' VAL . 38.1 Cg_endo -74.59 175.13 11.5 Favored 'Trans proline' 0 N--CA 1.455 -0.782 1 C-N-CA 126.219 4.613 . . . . 0.0 113.179 171.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.78 -7.04 50.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 t -171.87 -177.66 2.0 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.713 2.005 . . . . 0.0 106.718 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 73.89 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.22 165.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 91' ' ' PRO . 14.7 m -68.84 -177.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 161.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -138.4 124.68 20.42 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.161 -0.962 . . . . 0.0 111.449 -169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.09 72.66 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 122.431 1.11 . . . . 0.0 108.999 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.9 pt -92.77 -14.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.175 1.39 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.66 173.48 23.5 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.428 ' HE2' ' OD1' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -125.93 175.14 7.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.804 1.242 . . . . 0.0 110.415 177.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.47 77.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 122.861 1.315 . . . . 0.0 107.979 166.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -29.32 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.084 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -146.69 158.32 43.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.99 2.516 . . . . 0.0 109.241 168.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.542 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 81.02 61.17 2.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.598 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.16 -60.46 1.67 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -70.3 -27.73 64.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.111 0.957 . . . . 0.0 110.001 -166.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 1.69 5.36 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.786 2.035 . . . . 0.0 112.48 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -87.37 -35.79 18.16 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.842 1.201 . . . . 0.0 111.756 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -14.24 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.523 -1.361 . . . . 0.0 114.472 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.58 0.86 26.9 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.624 2.37 . . . . 0.0 111.7 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mm -83.66 157.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -109.73 172.7 6.7 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 109.118 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.408 ' HA ' HG23 ' A' ' 38' ' ' THR . 0.4 OUTLIER -69.61 11.9 0.23 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.755 2.422 . . . . 0.0 114.286 -175.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.58 75.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.401 0 O-C-N 119.991 -1.693 . . . . 0.0 109.885 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -117.46 37.91 3.75 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.863 1.665 . . . . 0.0 111.242 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.4 mttm 44.04 74.24 0.13 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.869 2.068 . . . . 0.0 112.018 166.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.473 ' HB ' HG22 ' A' ' 36' ' ' VAL . 1.7 p -73.92 101.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.37 100.21 9.85 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.443 HG11 ' CE1' ' A' ' 32' ' ' PHE . 62.0 t -75.99 135.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 126.373 1.869 . . . . 0.0 108.713 173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -140.57 178.59 7.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.773 1.629 . . . . 0.0 109.178 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.95 3.54 11.94 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.965 1.84 . . . . 0.0 115.351 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.457 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.311 -1.065 0 C-N-CA 126.172 1.789 . . . . 0.0 110.728 -156.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 121.782 0.801 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.484 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -66.08 164.48 15.34 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.97 -1.081 . . . . 0.0 109.444 168.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.25 108.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -81.78 128.83 34.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.169 -1.582 . . . . 0.0 107.657 164.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 119' ' ' VAL . 2.6 mm? -96.59 114.2 25.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.982 1.713 . . . . 0.0 107.257 169.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.11 133.21 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -123.06 178.49 5.06 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.388 1.075 . . . . 0.0 109.572 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -68.27 -27.37 66.27 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.655 -1.278 . . . . 0.0 112.7 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 m -115.42 -10.75 11.94 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.76 -163.79 28.52 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 119.069 0.849 . . . . 0.0 111.237 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -157.08 149.05 22.68 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.125 0.97 . . . . 0.0 110.356 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -126.1 172.37 10.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 103' ' ' GLU . 15.9 t -138.03 126.03 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 160.06 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 123.539 1.638 . . . . 0.0 106.744 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 100' ' ' LYS . 7.4 p-10 -124.18 115.77 21.64 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 129.449 3.1 . . . . 0.0 104.818 -170.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.406 HD23 ' CA ' ' A' ' 99' ' ' GLY . 84.4 mt -119.19 138.73 52.75 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -96.66 139.06 33.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.61 36.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.851 1.26 . . . . 0.0 112.383 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.87 -7.47 14.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 110.481 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -101.28 138.22 38.59 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 120.519 -1.363 . . . . 0.0 111.006 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -49.22 -62.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.199 1.8 . . . . 0.0 108.09 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.605 HG12 HD23 ' A' ' 26' ' ' LEU . 1.5 t -50.98 -40.96 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -173.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.4 t -67.36 -34.48 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -65.06 -50.31 66.69 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 110.85 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -32.59 73.24 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.992 0.814 . . . . 0.0 109.5 -169.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.678 HD22 HG21 ' A' ' 49' ' ' VAL . 3.2 mm? -60.86 -37.8 83.39 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.476 2.311 . . . . 0.0 111.095 172.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -61.78 -24.73 67.03 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.001 1.273 . . . . 0.0 111.468 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.94 -17.06 57.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -127.26 36.82 4.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.124 1.77 . . . . 0.0 110.627 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' A' ' 31' ' ' PRO . 61.4 mt -128.76 145.94 58.3 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 173.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 30' ' ' ILE . 20.1 Cg_endo -63.35 160.11 62.18 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 119.224 0.758 . . . . 0.0 112.163 -9.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.506 ' CE1' HG11 ' A' ' 119' ' ' VAL . 35.2 p90 -149.17 162.21 40.44 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -118.88 165.86 13.53 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.402 0.681 . . . . 0.0 109.732 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.54 175.61 8.83 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.362 0.601 . . . . 0.0 111.382 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.53 131.3 39.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.403 HG11 ' CG2' ' A' ' 111' ' ' ILE . 40.3 t -79.81 71.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -64.2 154.3 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.798 1.181 . . . . 0.0 108.551 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.428 HG22 HG12 ' A' ' 43' ' ' ILE . 34.9 p -137.37 151.32 48.45 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.323 1.049 . . . . 0.0 111.838 -174.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -155.47 88.76 1.15 Allowed 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.2 80.91 0.05 OUTLIER Glycine 0 C--O 1.213 -1.193 0 CA-C-O 118.321 -1.266 . . . . 0.0 114.492 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 67.44 20.45 9.86 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.978 1.889 . . . . 0.0 112.22 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -135.1 146.95 49.36 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.953 0.901 . . . . 0.0 109.532 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 38' ' ' THR . 62.7 mt -130.35 127.76 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.353 1.861 . . . . 0.0 106.547 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -143.62 142.98 31.27 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.067 1.347 . . . . 0.0 109.376 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -131.26 144.78 51.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.77 -1.206 . . . . 0.0 109.059 -173.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 m -79.1 79.42 5.5 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.481 1.512 . . . . 0.0 110.728 -168.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.6 p -57.36 152.63 31.4 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.957 0.903 . . . . 0.0 112.896 -170.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.39 -12.74 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.627 2.885 . . . . 0.0 112.212 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.678 HG21 HD22 ' A' ' 26' ' ' LEU . 47.2 t -96.91 140.39 17.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -132.17 89.6 2.69 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -116.33 161.47 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.66 5.51 8.86 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.546 -0.721 . . . . 0.0 112.563 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -74.2 127.18 32.3 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.456 1.903 . . . . 0.0 110.187 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.34 101.85 7.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.177 1.391 . . . . 0.0 109.984 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.46 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.17 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -143.41 81.01 12.69 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 124.055 0.942 . . . . 0.0 111.772 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 65.5 Cg_endo -75.64 143.22 26.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.465 3.443 . . . . 0.0 112.161 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -136.69 169.59 17.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.41 1.084 . . . . 0.0 108.63 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -121.98 4.36 9.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.806 1.243 . . . . 0.0 112.222 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.55 143.19 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 m -132.73 173.12 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 109.14 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -85.31 -176.64 6.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.806 0.812 . . . . 0.0 110.349 164.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.49 -7.58 10.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 124.611 1.165 . . . . 0.0 110.42 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.82 35.82 2.05 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-O 118.64 -1.089 . . . . 0.0 112.311 -168.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.402 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . 74.1 m-20 -112.87 173.77 6.22 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.463 1.505 . . . . 0.0 111.355 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.91 135.07 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 120.753 -1.217 . . . . 0.0 110.895 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.24 176.74 16.89 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.909 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -101.55 159.59 15.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.79 1.236 . . . . 0.0 110.334 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.408 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 t90 -132.82 83.06 53.94 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 119.347 0.976 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.17 -24.37 65.93 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.448 2.765 . . . . 0.0 117.936 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HD2' ' C ' ' A' ' 69' ' ' TRP . 22.1 Cg_endo -72.83 -45.06 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.057 2.504 . . . . 0.0 108.982 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.09 -4.36 58.66 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.439 -1.201 . . . . 0.0 114.273 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 55.24 73.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.671 1.988 . . . . 0.0 108.692 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.15 171.46 15.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.727 0.775 . . . . 0.0 112.9 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.08 -178.42 7.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 109.519 157.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 31.5 m -142.95 160.52 40.19 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.875 1.27 . . . . 0.0 109.336 156.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -145.52 97.35 2.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 128.465 2.706 . . . . 0.0 105.273 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -83.52 146.75 28.18 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.14 26.69 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.46 -100.74 0.17 Allowed Glycine 0 C--N 1.333 0.392 0 O-C-N 119.514 -1.991 . . . . 0.0 111.744 165.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -128.14 -13.48 5.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 57.99 165.99 0.07 OUTLIER Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.155 1.782 . . . . 0.0 112.541 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.33 -18.31 9.8 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.563 2.175 . . . . 0.0 112.902 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.79 49.58 0.89 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 122.232 1.015 . . . . 0.0 109.255 -169.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.12 179.51 6.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.192 -0.943 . . . . 0.0 110.746 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -142.83 -42.97 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.734 1.214 . . . . 0.0 109.89 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.8 -56.27 2.37 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.25 -0.906 . . . . 0.0 111.538 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -127.93 178.67 6.02 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.553 1.941 . . . . 0.0 109.635 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -77.52 134.44 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 120.231 1.378 . . . . 0.0 108.069 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -123.83 151.33 64.33 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 123.449 0.7 . . . . 0.0 109.311 165.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.89 177.92 7.91 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 124.005 3.137 . . . . 0.0 111.917 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.4 61.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.452 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.4 t -163.22 176.0 10.39 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 120.188 1.358 . . . . 0.0 108.885 -167.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 64.32 0.75 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.732 1.213 . . . . 0.0 110.694 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -66.98 165.46 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.688 1.195 . . . . 0.0 107.918 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 36.1 p30 -94.12 -178.9 4.78 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 120.05 -1.656 . . . . 0.0 109.902 169.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.42 45.19 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 122.878 1.323 . . . . 0.0 108.688 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.9 pt -69.99 -15.12 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.239 -1.538 . . . . 0.0 112.031 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.406 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -121.63 169.82 14.68 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 17.0 tttt -131.84 171.26 13.75 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.454 1.102 . . . . 0.0 108.505 168.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.6 mt -101.92 86.71 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 160.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -30.08 38.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.093 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 3.0 mt-10 -152.8 151.78 30.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 109.061 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.07 58.5 6.66 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.299 -0.876 . . . . 0.0 112.453 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.6 tp -84.43 -52.25 6.31 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.766 -0.844 . . . . 0.0 110.646 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.36 -24.68 57.32 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.339 -0.85 . . . . 0.0 111.089 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -26.61 68.88 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 110.688 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.18 -22.36 39.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.022 0.929 . . . . 0.0 112.288 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -72.6 -21.09 61.18 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.098 -1.626 . . . . 0.0 114.428 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 10.19 6.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 121.498 1.954 . . . . 0.0 112.457 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.403 ' CG2' HG11 ' A' ' 36' ' ' VAL . 28.0 mm -104.31 160.31 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.205 1.002 . . . . 0.0 108.805 -166.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.629 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 10.7 mmtp -131.74 175.03 9.54 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.354 2.262 . . . . 0.0 108.845 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.04 2.79 2.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.837 2.055 . . . . 0.0 115.666 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.49 48.82 0.33 Allowed Glycine 0 CA--C 1.52 0.403 0 O-C-N 120.63 -1.294 . . . . 0.0 110.961 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.629 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 8.6 mm-40 -101.69 30.43 4.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.542 -176.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 mttp 44.25 86.47 0.02 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.445 1.898 . . . . 0.0 113.266 166.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 36' ' ' VAL . 6.4 p -78.52 133.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 176.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.71 111.18 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.574 HG22 HD12 ' A' ' 5' ' ' LEU . 93.5 t -79.13 127.25 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 127.117 2.167 . . . . 0.0 106.716 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -128.42 -166.59 1.65 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.479 1.112 . . . . 0.0 109.421 171.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -95.93 -5.37 41.57 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--N 1.311 -1.08 0 C-N-CA 129.243 3.017 . . . . 0.0 110.547 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 -67.6 154.08 42.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.305 -0.872 . . . . 0.0 108.912 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.95 147.51 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.398 1.479 . . . . 0.0 108.089 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 40.0 tt0 -123.69 139.9 53.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.019 2.528 . . . . 0.0 106.809 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 4' ' ' GLU . 8.8 mp -118.56 98.53 6.29 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 136.73 33.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -125.35 173.9 8.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.467 1.107 . . . . 0.0 109.142 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -30.36 70.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.948 0.899 . . . . 0.0 111.301 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -93.13 -13.27 28.69 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.11 -159.91 33.12 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 120.834 1.652 . . . . 0.0 109.894 -164.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -158.17 165.09 35.78 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 109.806 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -136.72 178.13 7.31 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.904 0.482 . . . . 0.0 110.276 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.45 128.08 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 16' ' ' LEU . 21.3 pt -116.14 162.18 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 122.628 1.204 . . . . 0.0 109.075 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -120.82 130.36 53.94 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 107.699 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.4 HD21 HD12 ' A' ' 14' ' ' ILE . 55.3 mt -124.81 135.7 53.17 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.474 1.109 . . . . 0.0 109.254 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -76.48 136.47 39.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.081 0.952 . . . . 0.0 110.915 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.33 37.12 1.19 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.42 1.088 . . . . 0.0 113.278 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.08 22.87 11.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.187 -0.946 . . . . 0.0 111.194 170.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.09 133.13 45.36 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.94 0.896 . . . . 0.0 111.216 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -44.5 -55.36 5.15 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.791 2.036 . . . . 0.0 109.248 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.67 -40.24 78.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 116.894 -1.527 . . . . 0.0 113.276 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.06 -30.84 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 121.032 1.742 . . . . 0.0 109.858 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -64.87 -47.21 78.71 Favored 'General case' 0 C--N 1.342 0.263 0 O-C-N 121.608 -0.683 . . . . 0.0 110.383 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB3' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -70.72 -36.7 73.33 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 120.822 -1.174 . . . . 0.0 109.25 -174.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.56 ' CD2' HG11 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -55.91 -38.12 69.81 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.633 1.573 . . . . 0.0 109.721 174.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 tmpt? -59.23 -28.49 66.74 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.363 0.983 . . . . 0.0 111.164 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -69.01 -34.35 75.12 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.095 0.861 . . . . 0.0 110.236 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -107.57 33.54 3.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.346 2.258 . . . . 0.0 110.932 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -129.13 144.2 51.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 172.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -61.03 158.98 49.02 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 119.557 0.878 . . . . 0.0 112.536 -14.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -156.49 162.4 39.96 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.899 0.879 . . . . 0.0 110.817 170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.91 155.57 33.92 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.435 0.694 . . . . 0.0 110.262 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -165.1 172.56 12.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.274 1.03 . . . . 0.0 110.145 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.77 140.59 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.699 1.6 . . . . 0.0 107.535 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 t -96.13 67.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -58.31 138.3 56.52 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -116.51 151.17 36.67 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 108.982 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -157.71 115.9 3.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 -102.7 0.34 Allowed Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -137.39 36.2 2.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.038 2.135 . . . . 0.0 108.413 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -122.72 165.7 16.12 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mt -122.51 147.43 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 171.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.62 175.36 9.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.101 0.953 . . . . 0.0 109.182 160.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -146.86 156.39 43.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -80.49 96.8 6.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -64.21 147.3 97.01 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.78 -39.13 15.67 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.284 1.99 . . . . 0.0 110.007 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.56 HG11 ' CD2' ' A' ' 26' ' ' LEU . 7.7 p -71.69 163.61 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.377 1.471 . . . . 0.0 110.36 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -141.54 38.34 1.68 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 HG22 ' A' ' 49' ' ' VAL . 27.1 t -60.83 153.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.713 0.805 . . . . 0.0 110.781 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.22 -8.46 4.78 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.959 1.304 . . . . 0.0 112.557 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -73.09 126.29 29.65 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.328 0.967 . . . . 0.0 109.404 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 125.63 35.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.781 1.233 . . . . 0.0 109.517 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.72 -33.45 15.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.009 0.924 . . . . 0.0 109.937 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -123.86 61.56 24.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.089 0.956 . . . . 0.0 111.009 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.5 124.19 12.11 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.059 1.839 . . . . 0.0 109.003 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -128.88 149.33 50.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.724 1.209 . . . . 0.0 109.324 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -111.16 -11.03 14.28 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.855 0.462 . . . . 0.0 111.595 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 t -128.38 135.16 63.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.47 -164.01 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.347 1.859 . . . . 0.0 107.513 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -143.63 176.8 8.94 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.55 1.14 . . . . 0.0 111.184 -165.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.4 mt -84.02 11.13 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 126.167 1.787 . . . . 0.0 110.586 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.56 9.81 2.91 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.672 1.606 . . . . 0.0 113.586 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.82 -177.06 4.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 124.33 2.015 . . . . 0.0 108.592 -165.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.453 HG13 HG13 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -153.03 146.66 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 128.454 2.701 . . . . 0.0 105.691 -149.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.34 174.06 22.42 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -131.36 116.49 17.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 127.029 2.131 . . . . 0.0 107.356 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.424 ' HE1' ' HB2' ' A' ' 93' ' ' SER . 8.2 t90 -108.13 87.06 3.61 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 124.582 1.153 . . . . 0.0 109.381 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.86 -43.11 62.48 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.323 2.016 . . . . 0.0 114.969 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.24 -18.19 23.7 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.393 2.062 . . . . 0.0 111.128 -170.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.33 -0.13 70.81 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.443 -1.198 . . . . 0.0 113.29 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 46.68 39.8 7.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.198 1.999 . . . . 0.0 110.623 -166.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.4 146.1 44.68 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -167.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -179.04 1.99 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.572 158.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 55.9 m -145.75 158.87 43.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.302 1.441 . . . . 0.0 108.455 151.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mt -141.46 118.1 10.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 127.752 2.421 . . . . 0.0 106.457 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -114.81 121.29 42.82 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 109.563 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -149.14 7.97 0.72 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.13 0.972 . . . . 0.0 113.458 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.28 -114.06 0.42 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.346 -1.471 . . . . 0.0 112.0 -173.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.61 148.04 26.86 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.87 162.74 55.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.75 1.22 . . . . 0.0 112.077 -167.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.92 -3.07 8.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.164 2.576 . . . . 0.0 113.876 -167.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.87 16.9 14.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.69 1.132 . . . . 0.0 110.804 166.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 90' ' ' GLN . 3.7 t -129.86 178.98 6.12 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -142.07 -34.07 0.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.455 1.102 . . . . 0.0 109.848 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.3 -52.27 6.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.302 1.441 . . . . 0.0 112.029 172.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.07 -163.81 1.36 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.564 1.546 . . . . 0.0 109.68 -156.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.99 92.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 170.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.5 ' H ' ' HB2' ' A' ' 85' ' ' SER . 14.0 mt-30 -100.59 146.33 31.86 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 158.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.6 -179.43 5.33 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.229 3.286 . . . . 0.0 113.158 164.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.66 64.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.424 ' HB2' ' HE1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -157.9 -171.87 3.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 84.12 7.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 123.647 1.689 . . . . 0.0 108.265 156.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 95' ' ' VAL 0.332 46.9 t -44.33 161.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 C-N-CA 129.669 3.188 . . . . 0.0 110.668 143.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -98.21 124.62 42.89 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.694 1.597 . . . . 0.0 107.084 171.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.5 pt -120.11 -9.74 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.134 2.174 . . . . 0.0 111.351 -173.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.56 171.91 13.95 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 129.752 3.549 . . . . 0.0 112.694 -163.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -144.7 148.83 34.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.851 1.66 . . . . 0.0 108.693 143.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.453 HG13 HG13 ' A' ' 66' ' ' VAL . 16.4 mt -75.01 98.99 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 159.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.0 m -73.74 -36.56 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.526 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.7 163.02 38.54 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 118.798 0.726 . . . . 0.0 110.829 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.41 42.44 73.91 Favored Glycine 0 C--O 1.222 -0.607 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.185 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -56.55 11.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.458 1.129 . . . . 0.0 110.003 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.18 -19.1 64.75 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.958 -0.464 . . . . 0.0 111.088 -168.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.04 -22.96 61.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.173 1.789 . . . . 0.0 110.654 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.33 -41.12 61.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.335 -1.478 . . . . 0.0 110.36 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -62.52 -5.29 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.051 1.341 . . . . 0.0 113.412 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.54 6.06 10.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.066 1.746 . . . . 0.0 112.147 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.293 19.2 mm -80.47 164.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.292 0.951 . . . . 0.0 108.875 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.406 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 4.5 mmpt? -121.62 167.85 12.43 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 127.278 2.231 . . . . 0.0 106.472 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.56 -1.63 1.91 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -169.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.01 17.91 1.21 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.605 -1.109 . . . . 0.0 114.168 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 14.7 mm-40 -72.03 23.78 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.274 2.037 . . . . 0.0 113.975 -176.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt 44.75 89.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 128.848 2.859 . . . . 0.0 113.958 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.8 104.36 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.62 98.79 9.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 107.899 170.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -75.17 137.34 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.269 1.827 . . . . 0.0 108.589 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -139.75 -177.44 4.97 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.095 2.558 . . . . 0.0 110.096 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -86.62 -4.38 59.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 127.524 2.33 . . . . 0.0 112.07 -173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.38 148.58 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -149.4 142.75 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 27.0 tt0 -117.87 138.09 52.35 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.972 2.109 . . . . 0.0 106.068 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.26 98.94 6.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.972 2.109 . . . . 0.0 106.703 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.56 129.75 46.54 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.957 1.303 . . . . 0.0 109.139 -172.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.18 -176.1 3.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.015 1.326 . . . . 0.0 109.74 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.61 -53.79 36.83 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.928 -0.482 . . . . 0.0 110.467 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 t -76.18 -20.83 57.17 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.502 0.592 . . . . 0.0 111.039 -168.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.05 -152.29 12.73 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -164.73 152.92 12.14 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.525 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 64.7 m -141.26 173.59 11.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.059 0.943 . . . . 0.0 109.009 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 t -140.82 129.7 24.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.6 pt -114.15 166.35 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 122.427 1.108 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -123.42 149.43 45.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 163.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.407 HD23 ' HA3' ' A' ' 99' ' ' GLY . 59.4 mt -139.11 132.11 29.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.694 1.598 . . . . 0.0 110.799 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -84.93 126.43 33.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.633 0.254 . . . . 0.0 110.685 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.76 5.13 14.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.585 1.954 . . . . 0.0 113.961 -169.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -83.41 -11.8 57.17 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.093 -1.004 . . . . 0.0 109.95 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.418 ' CD2' HG22 ' A' ' 98' ' ' ILE . 32.7 m-85 -99.34 141.14 32.51 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.862 2.065 . . . . 0.0 109.688 -174.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -44.87 -59.5 2.52 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.844 1.658 . . . . 0.0 109.365 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.78 -35.53 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.87 -38.61 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.869 1.213 . . . . 0.0 109.819 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -55.72 -45.52 77.92 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.021 0.928 . . . . 0.0 111.066 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -40.06 89.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.03 -1.044 . . . . 0.0 109.511 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.22 -30.52 68.3 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.819 1.248 . . . . 0.0 111.901 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -69.17 -25.15 64.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.276 0.943 . . . . 0.0 109.918 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -78.06 -11.42 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.414 0.685 . . . . 0.0 112.296 171.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -126.1 26.1 6.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.552 1.541 . . . . 0.0 112.077 -166.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.43 143.96 47.85 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -62.04 158.7 56.95 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-N 119.531 0.868 . . . . 0.0 113.202 -10.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -152.79 163.77 39.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.529 0.732 . . . . 0.0 110.354 166.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -119.24 161.99 19.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.244 1.018 . . . . 0.0 110.241 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -168.75 171.36 8.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.673 0.789 . . . . 0.0 112.496 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.28 128.1 47.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.055 1.342 . . . . 0.0 108.852 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 t -91.12 80.88 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -164.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -68.15 151.21 47.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.6 p -126.22 131.61 51.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -134.57 94.71 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 175.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 82' ' ' THR . . . 44.2 82.62 0.03 OUTLIER Glycine 0 C--O 1.214 -1.134 0 C-N-CA 126.304 1.907 . . . . 0.0 115.424 167.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 71.42 21.61 4.5 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.718 1.607 . . . . 0.0 112.609 167.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -140.32 167.9 21.06 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 128.854 2.862 . . . . 0.0 106.395 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mt -132.62 146.09 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 128.003 2.521 . . . . 0.0 108.263 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -146.88 157.61 43.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.758 1.223 . . . . 0.0 111.256 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -150.55 163.05 39.42 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.245 0.618 . . . . 0.0 111.273 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -92.54 88.54 6.38 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.711 0.767 . . . . 0.0 109.825 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.2 p -60.82 148.46 82.84 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.038 0.535 . . . . 0.0 112.184 -170.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.06 -14.57 15.11 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.523 2.815 . . . . 0.0 111.997 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.23 153.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 108.786 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -137.63 119.93 15.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 p -156.92 152.45 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.951 1.3 . . . . 0.0 108.924 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.79 21.58 4.21 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.212 1.805 . . . . 0.0 112.591 -174.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -109.04 148.98 29.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.633 1.973 . . . . 0.0 108.862 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -139.64 157.67 45.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.536 1.134 . . . . 0.0 108.91 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -110.79 -50.09 2.98 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.663 0.785 . . . . 0.0 110.255 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -120.38 68.92 14.74 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.87 1.268 . . . . 0.0 108.042 -172.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 72.4 Cg_endo -71.53 156.53 57.87 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.571 2.181 . . . . 0.0 111.799 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.685 ' HG2' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -144.11 158.29 43.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.623 1.569 . . . . 0.0 108.949 177.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -111.32 8.8 21.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 117.411 -1.28 . . . . 0.0 111.043 167.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 p -162.31 154.99 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 120.328 1.422 . . . . 0.0 111.749 173.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.58 HG11 ' CZ ' ' A' ' 58' ' ' ARG . 27.2 m -145.22 -179.85 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.599 1.559 . . . . 0.0 112.498 -174.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.12 171.17 12.23 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 110.31 163.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.29 -13.66 16.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 113.597 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.05 48.51 0.97 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 125.058 1.313 . . . . 0.0 110.446 -168.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.44 ' CG ' ' HZ2' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -120.0 172.55 7.66 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.669 1.188 . . . . 0.0 108.869 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -137.94 136.78 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.99 172.1 18.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.494 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -123.5 137.47 54.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.478 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -116.83 88.23 24.86 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.211 1.804 . . . . 0.0 110.031 -162.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.454 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 91.2 Cg_endo -64.57 -26.61 61.76 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.179 2.586 . . . . 0.0 116.429 -171.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 66.7 Cg_endo -75.05 -32.05 5.64 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 123.579 2.314 . . . . 0.0 110.077 -173.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.28 14.17 21.01 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.687 1.613 . . . . 0.0 114.282 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 44.7 59.59 3.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.277 1.831 . . . . 0.0 111.058 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.4 168.83 18.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.618 1.199 . . . . 0.0 112.127 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.84 163.11 12.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.96 2.104 . . . . 0.0 109.508 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 p -134.79 137.81 43.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 119.63 1.105 . . . . 0.0 112.052 166.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -117.07 113.35 22.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.992 2.517 . . . . 0.0 105.149 170.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -88.22 149.73 23.69 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -158.9 9.99 0.13 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.947 0.794 . . . . 0.0 112.92 169.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.93 -174.84 38.48 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 120.451 -1.406 . . . . 0.0 111.14 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.21 101.17 5.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -69.29 165.11 42.62 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 125.316 1.446 . . . . 0.0 111.095 -178.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.11 5.81 4.75 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.039 3.826 . . . . 0.0 114.121 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -134.31 72.46 1.47 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.71 -174.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.473 2.309 . . . . 0.0 106.537 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -156.11 -66.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -81.49 -44.72 17.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.175 1.39 . . . . 0.0 110.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -143.21 152.89 42.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.637 1.575 . . . . 0.0 108.541 -157.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.6 mt -81.9 81.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -169.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -75.09 143.48 77.4 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 108.231 170.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.9 174.65 12.23 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.646 2.897 . . . . 0.0 111.395 165.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.47 71.01 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -147.71 169.61 19.34 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.608 1.163 . . . . 0.0 107.905 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.67 80.81 0.43 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.952 1.251 . . . . 0.0 110.622 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.528 ' CG2' ' CZ ' ' A' ' 58' ' ' ARG . 2.7 m -77.55 170.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 1.1 p30 -84.47 152.21 24.12 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.307 -1.495 . . . . 0.0 112.031 169.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.685 HG23 ' HG2' ' A' ' 58' ' ' ARG . 15.5 t -84.62 112.38 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 152.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.418 HG22 ' CD2' ' A' ' 20' ' ' TYR . 26.6 pt -123.06 -18.28 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.123 0.569 . . . . 0.0 112.184 169.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' A' ' 16' ' ' LEU . . . -138.53 172.05 23.2 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 30.1 tptt -139.83 140.37 36.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.34 90.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -75.19 -34.2 30.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.075 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.55 157.74 43.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.69 1.196 . . . . 0.0 108.73 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 73.47 70.48 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 118.649 -1.739 . . . . 0.0 112.325 -176.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.35 -52.94 2.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 169.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -64.76 -28.6 69.69 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.906 -0.496 . . . . 0.0 111.599 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -71.38 -8.77 55.95 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.337 -0.852 . . . . 0.0 112.801 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -25.9 51.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.859 1.663 . . . . 0.0 113.003 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 5.98 6.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -174.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -129.76 9.97 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.941 2.496 . . . . 0.0 110.839 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.25 157.41 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 106.781 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -117.11 -165.02 1.03 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.765 1.226 . . . . 0.0 110.008 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.83 5.09 26.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.609 0.719 . . . . 0.0 112.644 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -172.16 80.81 0.08 OUTLIER Glycine 0 CA--C 1.523 0.56 0 O-C-N 120.83 -1.169 . . . . 0.0 110.926 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.56 22.45 10.63 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.005 1.722 . . . . 0.0 111.335 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 44.55 84.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.265 1.826 . . . . 0.0 112.918 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.41 129.02 37.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.73 107.87 19.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.08 126.5 36.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.613 2.365 . . . . 0.0 107.088 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -135.98 169.62 17.3 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.058 1.743 . . . . 0.0 109.744 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -77.32 -3.72 41.41 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.313 -0.979 0 C-N-CA 126.242 1.817 . . . . 0.0 113.435 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 160.28 33.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 110.513 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.4 t -149.79 142.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 113.008 -1.905 . . . . 0.0 108.546 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 32.0 tt0 -126.83 131.4 51.24 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 127.71 2.404 . . . . 0.0 107.018 -173.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.59 120.29 41.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.533 1.933 . . . . 0.0 107.229 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.99 137.13 48.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -130.28 -176.65 4.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.513 1.125 . . . . 0.0 109.783 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.71 -39.71 43.7 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.875 0.87 . . . . 0.0 109.71 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB2' HD13 ' A' ' 111' ' ' ILE . 9.5 m -93.33 -16.16 24.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.426 1.091 . . . . 0.0 112.587 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.53 -163.38 27.03 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.508 0.575 . . . . 0.0 112.882 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -160.87 146.27 14.41 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.206 1.402 . . . . 0.0 108.378 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.53 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 34.5 m -146.86 174.94 11.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.173 1.789 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -147.98 131.46 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.269 -1.519 . . . . 0.0 108.397 -170.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.48 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.04 -1.037 . . . . 0.0 109.983 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.14 119.54 39.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 116.899 -1.524 . . . . 0.0 107.641 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.494 HD23 ' CA ' ' A' ' 99' ' ' GLY . 83.3 mt -119.29 132.19 55.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.212 0.915 . . . . 0.0 111.012 -174.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -88.08 126.27 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.822 -168.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.35 34.64 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.822 1.649 . . . . 0.0 113.943 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -105.49 -9.48 17.46 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.527 -1.358 . . . . 0.0 110.815 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.34 144.2 34.54 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.603 1.561 . . . . 0.0 112.086 -170.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -56.67 -55.76 29.95 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.383 1.073 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 p -44.58 -40.29 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.504 1.522 . . . . 0.0 113.693 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.93 -44.18 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 120.911 1.687 . . . . 0.0 110.014 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -59.65 -38.36 81.22 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.181 0.992 . . . . 0.0 111.228 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.1 mt -72.09 -37.87 69.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.859 0.864 . . . . 0.0 109.689 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -32.52 73.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.853 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -32.96 64.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.158 0.89 . . . . 0.0 109.97 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.3 -13.77 61.99 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.743 0.817 . . . . 0.0 111.953 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -124.16 26.58 7.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.747 2.019 . . . . 0.0 110.833 -173.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -125.06 139.53 33.85 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.11 163.34 68.52 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 119.302 0.786 . . . . 0.0 112.375 -8.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -149.83 169.5 20.96 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.018 0.927 . . . . 0.0 109.473 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.98 155.69 37.76 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.9 170.1 18.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.513 0.673 . . . . 0.0 112.249 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.95 129.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.296 1.438 . . . . 0.0 108.11 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.513 HG13 HG23 ' A' ' 43' ' ' ILE . 21.0 t -83.31 76.08 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -68.96 159.39 32.81 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.2 p -140.0 163.51 32.48 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.832 0.853 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -164.3 101.91 0.84 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 47.17 62.87 3.6 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.992 165.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 52.05 78.94 0.11 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.528 2.331 . . . . 0.0 110.655 -159.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -162.23 150.84 14.99 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 161.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.513 HG23 HG13 ' A' ' 36' ' ' VAL . 55.2 mt -127.45 121.19 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 167.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -133.09 151.37 52.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.512 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.69 150.59 52.14 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -70.86 91.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.51 1.524 . . . . 0.0 109.542 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -62.39 146.66 93.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.988 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.35 -3.76 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.424 2.749 . . . . 0.0 111.992 172.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -76.41 163.62 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.269 1.428 . . . . 0.0 109.606 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -148.9 101.68 3.2 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.578 0.751 . . . . 0.0 109.624 170.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG22 ' H ' ' A' ' 53' ' ' LYS . 9.0 p -152.44 154.86 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.176 2.19 . . . . 0.0 108.348 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.83 13.95 6.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.648 1.179 . . . . 0.0 113.139 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 51' ' ' VAL . 15.4 tttt -75.37 125.13 28.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.287 1.835 . . . . 0.0 111.452 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.35 143.3 50.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.603 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -132.73 -30.84 1.38 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.244 1.017 . . . . 0.0 112.601 -169.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -120.13 61.82 8.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.54 150.95 41.36 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.087 1.858 . . . . 0.0 113.201 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -146.51 153.58 40.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.463 1.505 . . . . 0.0 109.773 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -105.44 7.04 32.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.207 1.403 . . . . 0.0 113.221 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.35 152.63 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 129.788 3.235 . . . . 0.0 108.086 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.0 m -147.48 175.14 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.302 1.841 . . . . 0.0 108.414 -167.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.15 169.35 10.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 122.32 1.057 . . . . 0.0 112.363 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 63' ' ' ILE . 44.9 mt -73.16 23.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 0.0 110.779 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.66 16.11 0.07 OUTLIER Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.305 0.955 . . . . 0.0 113.789 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -93.67 -177.22 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -138.34 149.91 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.228 1.011 . . . . 0.0 108.95 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.08 21.59 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 165.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.95 159.85 27.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.006 0.922 . . . . 0.0 108.981 166.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -127.61 85.62 60.38 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.406 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 89.3 Cg_endo -66.2 -28.06 48.34 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.069 1.846 . . . . 0.0 115.391 -174.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 55.4 Cg_endo -69.26 -23.61 32.9 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 123.087 2.138 . . . . 0.0 109.847 -172.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.17 27.47 6.69 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 117.791 -1.561 . . . . 0.0 113.674 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.78 36.9 4.17 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.505 2.153 . . . . 0.0 113.141 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.31 174.16 6.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.274 -1.516 . . . . 0.0 111.398 -167.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -90.77 -178.88 5.37 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.839 161.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 54.0 m -147.33 163.29 36.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.948 2.499 . . . . 0.0 107.441 157.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.22 121.94 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.62 114.3 27.87 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.859 1.264 . . . . 0.0 109.648 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -145.06 27.63 1.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.253 1.821 . . . . 0.0 113.789 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.97 -112.43 0.28 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 120.51 1.504 . . . . 0.0 115.142 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 120.62 2.89 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 129.225 3.01 . . . . 0.0 104.782 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 33.8 p -86.45 165.74 31.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.661 1.119 . . . . 0.0 111.275 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 73.1 Cg_endo -69.2 0.36 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.591 2.861 . . . . 0.0 113.932 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -95.08 -33.01 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.545 1.521 . . . . 0.0 111.967 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 t -79.99 -169.31 1.96 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 161.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.13 -49.13 0.32 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.76 -51.08 9.63 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 126.049 1.74 . . . . 0.0 112.853 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -137.02 -164.18 1.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.302 1.441 . . . . 0.0 109.021 -154.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.414 HD13 ' CG1' ' A' ' 63' ' ' ILE . 13.5 mt -110.28 67.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -172.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -82.32 142.33 46.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.205 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.2 177.21 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 125.158 3.905 . . . . 0.0 112.672 171.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.33 -29.43 68.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.98 -174.26 4.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.476 1.489 . . . . 0.0 109.973 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.03 98.69 0.31 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 m -92.9 -164.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.35 1.46 . . . . 0.0 107.728 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -138.62 125.21 20.72 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.67 48.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.921 0.888 . . . . 0.0 109.956 -170.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 pt -72.1 -12.96 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 120.181 -1.574 . . . . 0.0 112.8 -172.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.494 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -128.4 159.29 21.91 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 118.681 0.673 . . . . 0.0 111.578 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -124.81 141.78 51.88 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.3 mt -76.4 112.79 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 161.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -29.67 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 -165.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -144.42 160.23 41.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.313 2.245 . . . . 0.0 107.84 170.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 75.62 60.85 3.09 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 118.55 -1.786 . . . . 0.0 112.037 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -107.82 -36.93 6.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.593 0.711 . . . . 0.0 111.157 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.11 -36.19 48.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.2 6.07 3.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.197 0.999 . . . . 0.0 112.96 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 74.0 mt -86.75 -37.17 18.13 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 111.451 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -4.62 16.78 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.719 -1.238 . . . . 0.0 113.123 -172.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -100.81 -0.95 36.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.25 1.42 . . . . 0.0 112.67 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.48 HD13 ' HB2' ' A' ' 9' ' ' SER . 22.9 mm -80.31 162.37 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.537 0.735 . . . . 0.0 110.635 -167.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -118.31 169.4 9.76 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 127.291 2.236 . . . . 0.0 111.248 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.69 20.67 1.7 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.551 2.34 . . . . 0.0 113.702 -172.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.79 64.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.467 ' H ' ' HB ' ' A' ' 36' ' ' VAL . 6.7 pt-20 -114.37 30.5 7.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -174.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.84 85.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.685 1.594 . . . . 0.0 112.881 171.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 133.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.24 116.01 31.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 164.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -88.37 127.61 41.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 107.39 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -132.53 -179.2 5.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.993 1.717 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -79.25 -3.69 47.08 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.842 0 C-N-CA 125.318 1.447 . . . . 0.0 110.349 -163.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ttp . . . . . 0 CA--C 1.509 -0.602 0 CA-C-O 122.403 1.097 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -71.53 163.25 28.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.363 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.35 113.33 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 5.3 tt0 -86.91 137.85 32.04 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.075 -1.015 . . . . 0.0 108.41 -175.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.3 mt -115.8 97.9 6.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.705 0.684 . . . . 0.0 110.196 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 148.08 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.416 1.087 . . . . 0.0 109.246 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -135.64 178.83 6.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.232 1.413 . . . . 0.0 108.86 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.59 -16.61 57.2 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.932 0.893 . . . . 0.0 111.937 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -124.26 0.48 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.753 0.821 . . . . 0.0 111.292 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.08 -174.25 43.34 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 124.556 1.074 . . . . 0.0 111.429 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -163.04 149.68 12.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.726 1.21 . . . . 0.0 108.47 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.447 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 1.4 p -137.28 -177.2 4.67 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 125.877 2.751 . . . . 0.0 105.101 171.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 4' ' ' GLU 0.258 3.8 p -136.75 164.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 110.275 -3.148 . . . . 0.0 105.869 167.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 pt -135.91 121.29 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 125.47 1.508 . . . . 0.0 107.252 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.94 117.13 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 115.325 -2.274 . . . . 0.0 110.044 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt -121.03 143.3 49.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.652 2.024 . . . . 0.0 112.649 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -89.54 140.86 29.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 111.315 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.34 8.69 3.16 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -91.7 9.93 30.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.663 -1.898 . . . . 0.0 110.479 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.22 133.34 55.16 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.745 1.618 . . . . 0.0 109.279 -170.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -48.52 -49.84 34.43 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.791 1.636 . . . . 0.0 109.888 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.658 ' HB ' HG21 ' A' ' 51' ' ' VAL . 7.2 p -56.89 -37.3 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 117.673 -1.155 . . . . 0.0 111.5 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t -72.1 -43.75 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 120.315 1.416 . . . . 0.0 109.232 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -59.71 -33.1 71.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.659 0.784 . . . . 0.0 111.827 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.405 HD12 ' CG1' ' A' ' 51' ' ' VAL . 18.7 mt -84.93 -37.19 20.84 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.914 0.886 . . . . 0.0 110.769 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mt -57.03 -35.63 69.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.151 0.98 . . . . 0.0 110.225 172.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -58.5 -30.82 67.31 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 119.291 0.95 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.292 1.037 . . . . 0.0 110.973 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.52 26.24 4.75 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.624 1.569 . . . . 0.0 110.347 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.41 HG23 ' HA ' ' A' ' 31' ' ' PRO . 76.2 mt -126.46 146.59 57.09 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HA ' HG23 ' A' ' 30' ' ' ILE . 10.2 Cg_endo -59.55 157.76 41.91 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 CA-C-N 119.44 0.836 . . . . 0.0 111.646 -12.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -148.77 150.22 32.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -105.02 156.63 17.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.32 175.55 11.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG22 ' C ' ' A' ' 36' ' ' VAL . 2.4 p -55.07 165.95 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.4 1.88 . . . . 0.0 111.204 157.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.598 HG13 HG23 ' A' ' 43' ' ' ILE . 38.0 t -117.51 123.91 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 144.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -106.11 164.68 11.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 162.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.7 p -136.24 151.15 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.427 -0.796 . . . . 0.0 109.66 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -149.98 83.75 1.39 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.965 0.802 . . . . 0.0 108.99 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 57.91 69.48 1.26 Allowed Glycine 0 C--O 1.213 -1.195 0 O-C-N 121.215 -0.928 . . . . 0.0 113.569 170.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.265 6.1 mt-10 65.98 35.64 6.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 127.984 2.514 . . . . 0.0 112.531 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.83 152.45 46.51 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.443 1.897 . . . . 0.0 108.373 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.598 HG23 HG13 ' A' ' 36' ' ' VAL . 9.6 mt -113.84 139.66 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 159.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -136.06 160.22 39.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.34 157.83 42.99 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.32 -0.862 . . . . 0.0 110.317 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -87.91 94.7 9.85 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 p -63.15 151.36 86.77 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.0 -26.58 9.24 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.026 2.484 . . . . 0.0 111.374 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -83.15 146.23 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.163 1.385 . . . . 0.0 107.851 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -133.08 133.57 43.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.658 HG21 ' HB ' ' A' ' 22' ' ' VAL . 5.6 m -141.34 179.15 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.807 2.443 . . . . 0.0 107.66 170.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.82 13.81 3.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.839 0.856 . . . . 0.0 112.311 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -92.8 128.6 38.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 113.116 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.575 ' HA ' HD22 ' A' ' 96' ' ' ASN . 0.0 OUTLIER -133.98 106.18 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.201 1.8 . . . . 0.0 112.805 175.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -79.9 -13.94 59.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.585 1.954 . . . . 0.0 114.085 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -139.32 68.43 39.71 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 119.595 1.089 . . . . 0.0 109.878 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.79 107.97 2.46 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.628 2.219 . . . . 0.0 109.772 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -112.97 140.69 47.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 109.582 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 26.2 mt-10 -89.99 9.27 28.54 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.697 0.799 . . . . 0.0 112.105 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.55 154.16 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 127.555 2.342 . . . . 0.0 109.821 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -143.38 -175.57 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 127.389 2.276 . . . . 0.0 107.861 -172.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -106.05 173.39 6.33 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.0 111.469 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 63' ' ' ILE . 22.3 mt -71.62 11.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.977 2.111 . . . . 0.0 112.238 177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.06 34.18 0.44 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 124.93 1.252 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -109.86 -177.93 3.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.31 164.65 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -146.23 170.33 27.37 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 167.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 143.49 48.28 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 167.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.26 85.87 42.52 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 125.249 1.419 . . . . 0.0 107.414 -174.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.42 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 54.7 Cg_endo -60.62 -35.33 90.2 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.286 1.324 . . . . 0.0 115.037 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 59.5 Cg_endo -72.57 -32.91 9.15 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 CA-C-N 122.785 2.031 . . . . 0.0 109.939 -168.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.19 23.01 17.08 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.682 -1.621 . . . . 0.0 113.295 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt 44.64 63.97 1.51 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.107 1.763 . . . . 0.0 111.555 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.65 157.17 44.32 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.35 0.595 . . . . 0.0 111.995 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 177.39 8.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.536 158.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.3 m -150.14 155.85 40.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.378 1.471 . . . . 0.0 108.474 161.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.0 mt -145.97 108.56 4.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.924 2.09 . . . . 0.0 107.5 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -99.4 112.91 25.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.221 0.608 . . . . 0.0 110.176 -168.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -138.77 28.86 2.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.637 1.175 . . . . 0.0 113.915 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.64 52.07 0.02 OUTLIER Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.83 -1.169 . . . . 0.0 114.282 153.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttm 71.6 175.97 0.28 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.053 2.141 . . . . 0.0 109.534 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.6 OUTLIER -153.3 159.31 32.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -165.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.55 6.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.548 4.165 . . . . 0.0 114.394 -172.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.44 44.93 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.681 1.592 . . . . 0.0 107.871 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -162.61 -179.51 6.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.353 2.261 . . . . 0.0 107.083 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -144.17 -39.9 0.28 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 165.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -89.17 -38.65 14.12 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.323 1.059 . . . . 0.0 111.413 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.76 -164.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 128.027 2.531 . . . . 0.0 107.374 -161.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.06 74.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 120.187 1.358 . . . . 0.0 107.614 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.91 143.47 62.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HG2' ' H ' ' A' ' 94' ' ' ALA . 89.1 Cg_endo -89.32 175.88 3.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.436 3.424 . . . . 0.0 110.715 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.8 -16.88 62.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -169.07 15.41 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -165.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.512 ' H ' ' HG2' ' A' ' 91' ' ' PRO . . . 69.19 82.0 0.17 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.016 1.726 . . . . 0.0 109.102 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.5 -169.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 113.626 -1.624 . . . . 0.0 108.841 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.575 HD22 ' HA ' ' A' ' 54' ' ' MET . 52.6 t-20 -128.32 125.31 38.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.07 45.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.117 0.967 . . . . 0.0 110.112 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 pt -59.18 -14.95 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 117.885 -1.055 . . . . 0.0 113.262 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -129.16 162.04 22.6 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.744 0.688 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -129.42 135.27 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 108.154 167.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.26 85.14 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 13' ' ' VAL . 35.7 m -68.48 -47.74 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.27 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.416 ' H ' HG12 ' A' ' 13' ' ' VAL . 37.7 mt-10 -124.66 159.11 31.55 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.908 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 12' ' ' CYS . . . 65.44 74.33 0.51 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 125.961 2.038 . . . . 0.0 112.471 -176.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -107.39 -48.74 3.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.992 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -90.0 -10.78 43.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.565 0.746 . . . . 0.0 111.877 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.79 -12.62 59.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 112.051 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.37 -21.46 63.8 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 119.033 -2.292 . . . . 0.0 112.422 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -10.06 59.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 171.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -77.65 -26.36 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.796 -1.19 . . . . 0.0 111.093 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 mm -77.3 157.18 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -172.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -116.79 170.14 8.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.537 1.535 . . . . 0.0 109.526 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.91 32.23 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.647 2.379 . . . . 0.0 112.569 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.86 63.9 0.03 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.541 -1.144 . . . . 0.0 110.836 172.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -118.79 13.82 13.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp 47.43 155.14 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -160.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.97 159.44 31.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.865 1.266 . . . . 0.0 107.85 164.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.13 97.6 4.83 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.724 2.809 . . . . 0.0 105.954 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.0 t -82.01 134.72 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.289 1.436 . . . . 0.0 108.095 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -140.46 -170.1 2.92 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.583 1.953 . . . . 0.0 109.141 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 30' ' ' ILE . 41.6 m-85 -98.79 5.25 47.61 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.153 0 C-N-CA 127.224 2.21 . . . . 0.0 112.006 175.436 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttp . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -63.3 162.78 11.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.976 0.893 . . . . 0.0 109.316 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.67 135.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 127.563 2.345 . . . . 0.0 105.332 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 35.4 tt0 -112.78 141.03 47.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.95 120.97 40.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.559 1.944 . . . . 0.0 107.327 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.43 110.91 15.11 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.287 1.435 . . . . 0.0 107.933 -173.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -108.33 167.83 9.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 110.431 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.49 -13.73 62.52 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -115.97 -9.44 11.76 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 -166.34 35.07 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 121.621 2.009 . . . . 0.0 111.326 -168.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.8 149.23 7.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.241 1.521 . . . . 0.0 110.545 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.524 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 65.5 m -149.59 176.15 10.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.629 1.972 . . . . 0.0 109.343 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -140.1 145.75 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 122.522 1.153 . . . . 0.0 108.246 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.68 150.03 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 125.303 1.441 . . . . 0.0 107.302 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.58 121.54 43.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.413 1.885 . . . . 0.0 108.395 -171.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -127.79 124.55 37.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 122.432 1.11 . . . . 0.0 111.312 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.56 122.03 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.401 1.481 . . . . 0.0 111.002 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.4 33.03 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.586 172.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -101.42 -9.13 21.39 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 120.512 -1.367 . . . . 0.0 111.247 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -107.91 138.7 43.7 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.535 0.734 . . . . 0.0 110.101 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.26 -51.12 57.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.845 1.658 . . . . 0.0 112.114 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.87 -26.53 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.497 1.119 . . . . 0.0 112.588 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.63 -47.37 20.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.531 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.97 -36.78 75.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.046 0.538 . . . . 0.0 109.946 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.37 -20.92 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.591 1.156 . . . . 0.0 112.16 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.71 -30.28 62.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.829 1.252 . . . . 0.0 111.093 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -59.79 -23.64 63.46 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.582 0.628 . . . . 0.0 110.558 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -70.5 -16.5 62.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.095 1.358 . . . . 0.0 113.544 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -131.73 39.1 3.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.421 1.488 . . . . 0.0 109.515 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.45 141.98 35.66 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.77 154.85 72.41 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 119.629 0.903 . . . . 0.0 110.521 -7.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CE1' HG11 ' A' ' 119' ' ' VAL . 24.7 p90 -145.1 160.87 40.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.528 0.331 . . . . 0.0 110.275 171.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.95 149.0 49.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 165.55 32.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.3 t -86.58 133.0 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.41 HG13 HG23 ' A' ' 43' ' ' ILE . 13.5 t -81.85 72.68 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -68.38 150.98 47.51 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 p -129.3 157.86 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.731 0.812 . . . . 0.0 110.027 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -156.02 89.83 1.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.77 74.32 0.23 Allowed Glycine 0 C--O 1.213 -1.168 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.396 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 69.03 26.43 5.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.943 1.371 . . . . 0.0 113.189 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.36 152.01 51.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.338 1.855 . . . . 0.0 108.741 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 36' ' ' VAL . 17.4 mt -133.57 135.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -147.69 155.37 41.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -140.24 146.21 38.34 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -85.7 78.68 9.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.528 1.131 . . . . 0.0 108.389 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -56.91 147.89 51.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 111.661 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 -15.66 21.7 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.993 2.462 . . . . 0.0 112.972 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.8 t -76.49 148.02 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.223 0.919 . . . . 0.0 109.372 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.46 99.75 5.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.561 0.744 . . . . 0.0 109.26 173.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.5 t -135.1 153.1 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 70' ' ' PRO . 14.2 mt-30 -131.69 0.75 3.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.357 1.063 . . . . 0.0 113.486 175.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.93 120.57 23.72 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.557 1.143 . . . . 0.0 109.085 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.2 mtt -95.92 135.47 37.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -96.75 -28.39 14.31 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.766 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -146.53 71.26 12.85 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.448 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.93 135.04 39.46 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.716 1.611 . . . . 0.0 110.657 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -108.89 -176.48 3.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 164.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -127.72 7.11 6.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.779 0.831 . . . . 0.0 112.844 166.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.41 153.8 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 129.631 3.172 . . . . 0.0 108.267 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.15 170.96 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.173 1.389 . . . . 0.0 109.534 -170.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.43 161.15 20.43 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.377 -0.827 . . . . 0.0 110.361 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.66 74.26 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 166.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.59 8.46 0.06 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.684 -1.065 . . . . 0.0 113.912 -169.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -111.3 173.01 6.55 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.734 1.767 . . . . 0.0 110.361 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.53 131.04 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.731 1.212 . . . . 0.0 108.402 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.49 158.9 14.56 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.881 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.69 135.8 46.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -104.83 87.69 1.95 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 126.657 1.983 . . . . 0.0 109.552 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 59.4 Cg_endo -63.18 -41.61 26.9 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.498 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 73.3 Cg_endo -73.75 -27.15 12.84 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.55 2.167 . . . . 0.0 110.735 -162.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.13 25.92 7.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.098 1.809 . . . . 0.0 112.43 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt 43.35 65.54 0.96 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.865 1.666 . . . . 0.0 111.826 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.68 177.29 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.843 0.457 . . . . 0.0 111.792 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.557 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 2.2 tp -98.44 -177.37 3.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 110.419 167.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 30.7 m -152.87 146.01 24.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.804 1.638 . . . . 0.0 112.371 154.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.265 6.9 mp -114.9 121.83 44.4 Favored 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.342 4.257 . . . . 0.0 106.634 169.815 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -110.64 113.69 26.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.23 0.923 . . . . 0.0 109.129 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 108' ' ' LEU . 42.6 p90 -136.51 35.55 2.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.16 -127.14 0.88 Allowed Glycine 0 C--O 1.225 -0.453 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 163.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -110.85 -15.1 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.074 0.937 . . . . 0.0 112.745 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 83' ' ' PRO 0.256 11.2 p 57.03 165.56 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 128.553 2.741 . . . . 0.0 112.464 175.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 60.2 Cg_endo -77.91 -28.44 5.05 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.665 1.577 . . . . 0.0 114.215 -165.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.9 mmt -94.41 70.43 3.69 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -157.44 171.49 20.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.756 0.822 . . . . 0.0 109.421 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -143.72 -46.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 156.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -77.16 -56.88 4.18 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.042 0.937 . . . . 0.0 110.035 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 160.03 43.68 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.091 1.356 . . . . 0.0 108.991 -150.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.7 75.79 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 123.937 0.895 . . . . 0.0 109.077 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -75.35 144.09 77.54 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.455 160.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.71 -176.35 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.355 3.37 . . . . 0.0 111.891 171.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.82 74.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.023 169.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.3 t -164.71 170.04 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.847 1.659 . . . . 0.0 107.952 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.48 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.202 1.401 . . . . 0.0 110.742 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 m -102.44 152.64 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -74.21 168.85 18.79 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.637 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.1 t -120.15 44.24 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 123.194 1.473 . . . . 0.0 108.452 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.0 pt -72.24 -18.11 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.582 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.66 159.5 13.78 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.298 0.951 . . . . 0.0 111.404 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -130.27 143.13 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 0.0 107.551 172.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.82 105.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.17 -29.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -163.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.63 163.51 32.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 125.876 1.67 . . . . 0.0 106.574 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.524 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 71.36 64.62 2.69 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 117.778 -2.154 . . . . 0.0 111.457 172.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.2 tp -91.87 -45.99 8.09 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.052 0.926 . . . . 0.0 109.474 164.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -79.93 -20.97 44.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.184 -0.947 . . . . 0.0 112.183 -166.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.7 3.92 17.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.217 1.007 . . . . 0.0 111.381 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 79' ' ' PHE . 6.1 mp -76.8 -43.5 36.41 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.786 1.175 . . . . 0.0 111.277 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -66.12 -24.3 66.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.309 -1.494 . . . . 0.0 113.662 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -78.25 -11.07 59.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.733 1.613 . . . . 0.0 114.208 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 mm -77.67 166.85 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.655 1.116 . . . . 0.0 109.045 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.591 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 8.0 mmtp -118.55 -179.48 3.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.16 1.784 . . . . 0.0 107.803 177.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.14 9.42 3.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.948 1.299 . . . . 0.0 114.467 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.17 72.9 0.14 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 120.636 -1.29 . . . . 0.0 110.548 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.591 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 21.7 mm-40 -132.24 33.48 3.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.984 0.914 . . . . 0.0 111.599 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 43.41 74.14 0.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.969 1.707 . . . . 0.0 111.57 160.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.08 120.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.66 128.73 34.75 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.549 HG11 ' CE1' ' A' ' 32' ' ' PHE . 63.9 t -111.16 124.73 68.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 127.058 2.143 . . . . 0.0 106.014 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.26 168.39 19.85 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.822 1.649 . . . . 0.0 110.66 -171.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.81 -7.15 58.51 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.314 -0.959 0 C-N-CA 127.116 2.166 . . . . 0.0 111.711 -171.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 CA--C 1.503 -0.831 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.51 ' CB ' HH11 ' A' ' 2' ' ' ARG . 0.0 OUTLIER -66.62 148.87 51.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.6 t -151.63 147.25 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.914 2.085 . . . . 0.0 109.605 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 11.4 tt0 -134.6 136.67 43.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.751 2.021 . . . . 0.0 107.636 -175.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.58 100.32 7.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.953 2.501 . . . . 0.0 106.596 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.28 100.42 13.22 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.69 175.53 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.879 0.871 . . . . 0.0 108.869 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.28 -35.58 76.19 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 166.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -91.27 -14.88 30.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -172.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.38 -167.06 33.98 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -155.77 145.93 21.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 168.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.89 166.33 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.656 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.16 104.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -162.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.0 pt -120.55 160.38 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.92 1.288 . . . . 0.0 109.806 -166.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -140.56 139.43 34.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -128.93 124.49 35.27 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.73 137.36 51.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.18 -166.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -81.93 35.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.066 1.346 . . . . 0.0 111.983 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -119.66 3.78 11.13 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.245 2.218 . . . . 0.0 111.919 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -120.28 137.72 54.08 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.545 1.138 . . . . 0.0 109.94 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -44.0 -65.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.534 2.334 . . . . 0.0 107.739 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 68' ' ' TYR . 7.3 p -48.54 -38.16 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.25 -43.35 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.052 1.296 . . . . 0.0 109.427 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -62.78 -38.25 89.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 120.913 -1.117 . . . . 0.0 111.602 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -44.0 69.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mt -51.17 -43.79 61.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -54.31 -23.41 15.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.995 0.816 . . . . 0.0 112.43 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.37 -30.98 17.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.58 0.627 . . . . 0.0 110.84 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.6 -40.23 64.01 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.866 1.266 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.2 140.73 98.0 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.859 1.263 . . . . 0.0 108.699 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.74 149.26 93.8 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.139 0.728 . . . . 0.0 112.594 -9.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.64 176.48 10.05 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.977 1.311 . . . . 0.0 110.103 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -133.17 166.86 21.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.514 1.126 . . . . 0.0 109.314 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -165.06 -177.96 4.89 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.4 129.07 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 C-N-CA 125.981 1.712 . . . . 0.0 107.387 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.466 HG13 HG23 ' A' ' 43' ' ' ILE . 2.5 t -69.5 117.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -102.79 156.89 17.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 160.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -144.93 137.34 26.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.211 0.604 . . . . 0.0 109.596 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -148.93 98.44 2.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -165.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 50.49 45.53 46.25 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 78.01 27.57 0.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 130.787 3.635 . . . . 0.0 114.543 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -108.93 160.71 15.79 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.67 1.588 . . . . 0.0 110.257 161.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.466 HG23 HG13 ' A' ' 36' ' ' VAL . 14.6 mt -128.8 134.99 63.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.689 1.996 . . . . 0.0 105.846 165.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.43 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 49.4 p90 -142.11 168.22 20.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.201 0.6 . . . . 0.0 110.78 164.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.8 154.99 36.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.36 76.99 10.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.549 1.14 . . . . 0.0 111.433 -167.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.7 p -60.04 150.47 70.0 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.088 0.955 . . . . 0.0 112.053 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.1 -6.18 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.526 3.484 . . . . 0.0 113.303 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 p -112.34 113.11 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 125.196 1.398 . . . . 0.0 107.998 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.77 103.73 7.22 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.513 1.925 . . . . 0.0 109.438 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.24 154.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.424 2.29 . . . . 0.0 107.879 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -108.75 7.28 26.28 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.302 -0.874 . . . . 0.0 112.483 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -86.42 136.21 33.2 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.353 0.661 . . . . 0.0 109.495 171.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.47 175.46 5.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.932 2.093 . . . . 0.0 109.854 163.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.46 -35.53 1.73 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.795 1.238 . . . . 0.0 110.382 163.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -137.82 65.1 45.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 109.029 -171.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.76 138.53 23.79 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.522 2.148 . . . . 0.0 110.746 171.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -126.45 154.46 43.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.34 -0.85 . . . . 0.0 111.333 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -95.45 6.02 50.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.331 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.19 150.05 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.168 2.987 . . . . 0.0 109.894 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.08 178.35 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 127.784 2.434 . . . . 0.0 108.038 -170.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -102.26 173.47 6.35 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.106 0.962 . . . . 0.0 112.313 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.08 74.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 165.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.49 29.19 0.17 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.885 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -104.23 175.73 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.16 1.98 . . . . 0.0 109.057 167.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.1 117.94 45.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 108.417 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.76 171.64 26.4 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.891 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 22' ' ' VAL . 61.7 t80 -129.28 123.36 31.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -114.18 85.92 11.03 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.561 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 36.8 Cg_endo -61.46 -33.75 87.47 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.392 2.728 . . . . 0.0 117.072 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.561 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 1.9 Cg_endo -63.46 -52.29 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.841 2.361 . . . . 0.0 109.439 -168.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.74 -6.54 87.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.578 -1.124 . . . . 0.0 114.321 174.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 47.04 90.8 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.158 2.583 . . . . 0.0 113.508 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 44' ' ' TYR . . . -160.32 166.71 28.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.212 0.529 . . . . 0.0 112.407 169.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tp -63.39 178.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.013 0.925 . . . . 0.0 110.314 160.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 32.9 m -150.58 143.7 24.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.699 2.0 . . . . 0.0 108.23 158.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 mt -125.38 135.99 52.98 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.522 2.329 . . . . 0.0 105.67 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.5 105.87 12.1 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.967 0.907 . . . . 0.0 109.299 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -136.13 23.11 3.27 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.82 -140.38 2.86 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 120.277 -1.514 . . . . 0.0 112.449 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.79 90.69 2.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -74.63 159.33 83.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 127.701 2.4 . . . . 0.0 110.8 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.22 72.36 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.344 3.363 . . . . 0.0 113.437 -166.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.64 20.85 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.997 -1.065 . . . . 0.0 112.396 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -152.42 -162.61 1.54 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.714 1.206 . . . . 0.0 108.628 -171.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -43.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.336 1.454 . . . . 0.0 109.053 160.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.47 -55.3 6.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.536 0.684 . . . . 0.0 110.698 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -138.1 -165.1 1.74 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.954 1.702 . . . . 0.0 109.595 -160.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 mt -100.62 77.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.683 1.128 . . . . 0.0 108.47 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -77.75 142.94 66.3 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.47 -0.769 . . . . 0.0 109.415 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.73 177.43 5.55 Favored 'Trans proline' 0 C--N 1.347 0.494 1 C-N-CA 125.539 4.159 . . . . 0.0 113.423 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.06 -19.69 64.63 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -172.32 176.52 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.465 2.306 . . . . 0.0 106.331 158.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.72 86.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.311 0.959 . . . . 0.0 112.812 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -69.11 136.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.995 0.918 . . . . 0.0 109.052 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -58.85 111.42 1.28 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 164.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.81 63.88 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 pt -72.84 -21.12 19.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 118.646 -0.693 . . . . 0.0 112.221 -170.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.19 -177.5 16.48 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.114 0.841 . . . . 0.0 114.325 -170.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -140.43 134.55 30.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.522 1.529 . . . . 0.0 109.442 -170.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 92.5 mt -81.07 87.58 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 165.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.5 -35.54 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 118.174 -0.917 . . . . 0.0 108.683 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.35 160.69 40.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.974 0.806 . . . . 0.0 111.7 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.95 74.61 0.35 Allowed Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.213 1.387 . . . . 0.0 110.897 -167.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.44 -63.24 1.28 Allowed 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.45 -22.11 60.28 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.997 -1.064 . . . . 0.0 111.689 -163.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -14.49 59.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 111.667 170.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.38 -31.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.224 -1.548 . . . . 0.0 110.726 169.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -77.55 34.5 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.834 1.254 . . . . 0.0 112.907 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 -16.71 0.84 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.381 -1.449 . . . . 0.0 111.415 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 mm -74.09 154.69 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -113.05 -178.39 3.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.676 0.79 . . . . 0.0 109.441 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -74.19 38.57 0.11 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.738 2.015 . . . . 0.0 111.898 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 151.8 79.9 0.03 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.832 1.206 . . . . 0.0 111.067 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -138.06 29.87 2.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.55 1.54 . . . . 0.0 110.834 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.54 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 128.595 2.758 . . . . 0.0 115.064 -170.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.53 137.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 161.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 104.73 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.942 1.697 . . . . 0.0 106.808 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.67 124.24 50.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 127.443 2.297 . . . . 0.0 106.931 -161.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -138.12 177.0 8.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.647 1.979 . . . . 0.0 110.775 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.96 -6.78 55.51 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.314 -0.947 0 C-N-CA 125.262 1.425 . . . . 0.0 112.922 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttm . . . . . 0 CA--C 1.509 -0.626 0 CA-C-O 121.953 0.882 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -99.89 163.85 12.27 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.539 0.735 . . . . 0.0 109.198 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.3 t -148.47 129.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 2.7 tt0 -111.7 129.26 56.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.121 -1.612 . . . . 0.0 110.509 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -103.44 96.09 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.121 0.962 . . . . 0.0 111.934 174.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.6 142.24 28.41 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 109.057 168.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.51 173.25 11.04 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.751 1.62 . . . . 0.0 110.09 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.45 -27.04 66.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.866 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 m -113.35 0.4 14.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.08 -165.93 37.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 119.793 1.179 . . . . 0.0 111.426 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -162.84 143.85 9.8 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.581 ' CB ' ' HA3' ' A' ' 104' ' ' GLY 0.258 11.8 m -152.54 154.22 35.0 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 3.9 p -122.06 164.97 18.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.485 ' CD1' HD21 ' A' ' 16' ' ' LEU . 1.6 pp -135.59 158.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 166.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -123.71 133.09 53.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 117.648 -1.167 . . . . 0.0 110.537 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 14' ' ' ILE . 81.0 mt -117.32 156.49 27.75 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.758 1.623 . . . . 0.0 111.484 -172.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.631 ' O ' HG21 ' A' ' 23' ' ' VAL . 6.9 t-20 -105.72 118.08 35.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.756 -1.116 . . . . 0.0 108.741 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.61 16.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.18 2.192 . . . . 0.0 115.486 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -102.53 8.2 39.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.443 1.897 . . . . 0.0 110.29 -169.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.624 ' HB2' HG23 ' A' ' 23' ' ' VAL . 54.8 m-85 -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.565 1.146 . . . . 0.0 109.13 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.12 -45.95 53.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.759 1.624 . . . . 0.0 109.116 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.19 -22.57 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 112.557 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 17' ' ' ASN . 3.1 t -81.01 -51.75 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 120.354 1.434 . . . . 0.0 108.009 175.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -57.7 -27.6 63.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.724 1.209 . . . . 0.0 110.496 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.547 HD12 HG11 ' A' ' 51' ' ' VAL . 32.8 mt -92.94 -34.85 13.61 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.835 1.654 . . . . 0.0 111.695 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 49' ' ' VAL . 2.6 mt -61.36 -35.71 78.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 120.141 1.337 . . . . 0.0 110.509 171.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -34.03 51.19 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.893 0.877 . . . . 0.0 110.735 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.98 -15.63 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -120.57 0.82 10.54 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.837 0.855 . . . . 0.0 113.071 -166.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.1 mt -99.28 145.31 29.82 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.235 1.38 . . . . 0.0 108.631 -173.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.26 159.53 81.05 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 CA-C-N 119.039 0.693 . . . . 0.0 113.34 -12.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -148.65 159.76 43.8 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.773 1.229 . . . . 0.0 109.244 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -114.61 159.53 20.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.448 1.099 . . . . 0.0 109.709 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -161.92 172.59 15.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.058 -170.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.32 132.89 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.25 73.16 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -68.64 147.24 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -123.48 136.15 54.43 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.921 0.888 . . . . 0.0 109.449 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' A' ' 92' ' ' ALA . 37.1 t90 -144.82 96.81 2.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 45.02 71.84 0.43 Allowed Glycine 0 C--O 1.211 -1.325 0 O-C-N 124.258 0.974 . . . . 0.0 112.266 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 60.74 31.44 20.11 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.639 1.22 . . . . 0.0 111.792 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -123.73 155.22 38.26 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.82 2.448 . . . . 0.0 108.594 161.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.9 mm -115.47 147.91 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 158.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -144.95 169.34 18.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.111 0.957 . . . . 0.0 108.565 161.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.24 148.24 33.29 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -80.11 77.91 6.79 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 109.537 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -59.73 150.37 67.78 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 122.093 0.949 . . . . 0.0 111.855 -171.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -68.33 -12.24 34.36 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.804 2.336 . . . . 0.0 112.246 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG21 ' HG ' ' A' ' 26' ' ' LEU . 5.7 t -96.77 122.59 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.862 1.665 . . . . 0.0 109.835 -172.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -128.06 30.76 5.19 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.074 1.349 . . . . 0.0 114.003 -167.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG11 HD12 ' A' ' 25' ' ' LEU . 10.6 m -72.65 164.46 3.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.124 1.37 . . . . 0.0 109.731 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -139.51 33.21 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.628 0.771 . . . . 0.0 111.217 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -85.87 148.69 25.68 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.646 0.778 . . . . 0.0 109.177 166.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.88 158.67 44.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 167.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.18 -20.85 1.88 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.773 171.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -117.45 57.11 2.1 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 120.696 1.589 . . . . 0.0 111.819 171.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.66 134.46 35.31 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.065 1.843 . . . . 0.0 112.717 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.474 ' HD2' ' C ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -138.52 169.72 17.29 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.881 0.848 . . . . 0.0 112.714 172.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -122.88 9.21 9.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.263 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' C ' ' HD2' ' A' ' 58' ' ' ARG . 1.6 p -159.99 101.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 125.349 1.46 . . . . 0.0 114.817 174.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 78' ' ' PHE . 31.5 m -100.16 -177.92 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 127.358 2.263 . . . . 0.0 110.137 -168.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -90.09 171.95 9.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.724 -1.235 . . . . 0.0 111.294 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.21 -9.55 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.507 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.31 26.38 2.0 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 125.658 1.599 . . . . 0.0 111.748 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -83.01 -154.86 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 160.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.8 t -137.62 173.89 12.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 130.107 3.363 . . . . 0.0 104.701 162.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.02 154.37 25.87 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 146.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 150.25 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -119.98 87.87 39.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.92 -43.67 56.06 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 121.582 1.521 . . . . 0.0 114.972 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.62 -1.44 11.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.084 2.523 . . . . 0.0 114.902 -155.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.26 5.16 5.98 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 127.01 2.243 . . . . 0.0 112.78 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 55.08 78.16 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.746 2.018 . . . . 0.0 111.942 -167.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.27 176.9 11.12 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.243 0.617 . . . . 0.0 111.893 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.533 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 4.9 tp -90.09 -172.79 3.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.211 1.405 . . . . 0.0 109.919 158.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.533 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 66.8 m -146.85 151.13 36.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.66 3.184 . . . . 0.0 107.734 160.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.37 96.04 3.64 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.547 2.339 . . . . 0.0 105.093 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 61' ' ' VAL . 1.8 m-85 -82.11 132.09 35.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 172.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -147.47 16.08 1.14 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.41 -82.49 0.04 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 165.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -151.39 -13.71 0.21 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 57.43 166.71 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 -1.06 8.01 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.681 2.254 . . . . 0.0 113.241 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.16 39.39 2.44 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.597 1.159 . . . . 0.0 109.299 -169.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -136.24 178.9 6.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.789 1.636 . . . . 0.0 108.617 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -138.47 -47.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 165.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.512 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 26.4 t0 -118.97 -13.39 9.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -163.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 87' ' ' ASP . 3.2 pttt -167.64 164.49 14.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.758 1.623 . . . . 0.0 109.221 -166.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.0 mp -81.65 77.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 122.798 1.285 . . . . 0.0 108.739 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -69.98 144.68 93.29 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.455 163.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.44 -174.46 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.847 3.698 . . . . 0.0 111.329 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HB2' ' CH2' ' A' ' 39' ' ' TRP . . . -85.71 -11.54 53.42 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 t -166.37 170.21 13.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 167.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.51 98.5 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.793 0.837 . . . . 0.0 110.62 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.84 -178.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.736 1.214 . . . . 0.0 109.43 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -130.95 118.9 21.33 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG21 ' NE ' ' A' ' 58' ' ' ARG . 21.4 t -76.72 47.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 123.025 1.393 . . . . 0.0 112.63 -171.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.55 -28.71 37.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 126.874 2.069 . . . . 0.0 113.841 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.421 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -128.57 168.16 20.5 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.184 1.849 . . . . 0.0 112.341 -174.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -141.95 129.05 20.87 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.665 1.986 . . . . 0.0 108.252 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.9 mt -65.08 103.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 164.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 13' ' ' VAL . 33.4 m -75.47 -61.9 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 165.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.451 ' HB2' HG12 ' A' ' 13' ' ' VAL . 6.6 mt-10 -113.03 158.31 20.47 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 88.62 61.61 1.44 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.403 176.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.53 -20.66 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.05 -33.09 7.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.269 1.027 . . . . 0.0 108.671 -173.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -10.01 59.08 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.244 -0.91 . . . . 0.0 111.516 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.414 HD21 ' SG ' ' A' ' 12' ' ' CYS . 53.6 mt -72.41 -20.67 61.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.652 -1.28 . . . . 0.0 112.458 172.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -64.7 -31.68 73.01 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.889 -1.132 . . . . 0.0 110.504 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.76 10.38 41.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.188 2.595 . . . . 0.0 114.213 -172.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.36 159.95 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 120.975 -1.078 . . . . 0.0 109.276 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.56 174.58 5.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.362 1.865 . . . . 0.0 109.746 173.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.06 16.48 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.703 2.001 . . . . 0.0 113.637 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -179.92 65.16 0.07 OUTLIER Glycine 0 CA--C 1.525 0.684 0 O-C-N 119.644 -1.91 . . . . 0.0 113.787 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -94.57 24.97 4.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.642 1.177 . . . . 0.0 112.71 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.9 mttt 43.99 71.98 0.22 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 130.075 3.35 . . . . 0.0 112.629 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -69.29 119.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.54 103.6 16.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 168.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 5' ' ' LEU . 75.6 t -72.42 125.75 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 168.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -136.49 -175.98 4.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.307 1.843 . . . . 0.0 109.203 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.63 8.85 34.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 117.93 2.567 . . . . 0.0 117.93 -168.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 129.983 3.313 . . . . 0.0 111.275 -165.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ttm . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 54.0 mtt180 -84.85 173.03 10.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 173.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 72.8 t -147.78 141.06 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.072 1.749 . . . . 0.0 106.5 169.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 36.1 tt0 -125.26 131.13 53.16 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.786 2.034 . . . . 0.0 107.18 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.82 102.94 10.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.478 1.911 . . . . 0.0 106.773 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.26 136.67 32.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -125.91 170.23 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.994 1.318 . . . . 0.0 109.747 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.97 -27.47 66.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.415 -0.803 . . . . 0.0 113.093 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 m -111.26 -3.74 15.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.27 20.81 Favored Glycine 0 N--CA 1.464 0.527 0 CA-C-O 118.08 -1.4 . . . . 0.0 110.1 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.55 161.04 23.77 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.74 1.77 . . . . 0.0 111.869 -167.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.7 p -143.81 174.83 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.793 0.837 . . . . 0.0 110.32 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.1 128.2 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 pt -117.11 148.79 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -120.24 128.51 53.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.251 -0.906 . . . . 0.0 111.015 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD23 ' CA ' ' A' ' 99' ' ' GLY . 42.3 mt -119.89 169.56 10.05 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 123.523 1.63 . . . . 0.0 111.912 -175.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -128.38 114.9 17.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.99 2.116 . . . . 0.0 109.505 -167.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -72.67 52.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.789 2.036 . . . . 0.0 112.326 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -130.63 -34.15 1.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.317 1.447 . . . . 0.0 110.905 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -74.69 151.02 39.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -57.91 -46.35 85.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.865 0.866 . . . . 0.0 109.076 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 51' ' ' VAL . 1.6 t -61.09 -38.08 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -170.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.82 -46.14 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -52.46 -46.76 66.63 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.094 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.619 HD12 HG12 ' A' ' 51' ' ' VAL . 29.1 mt -74.5 -32.91 62.68 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.741 0.816 . . . . 0.0 111.1 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -39.0 91.63 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.748 1.219 . . . . 0.0 110.184 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -53.68 -41.53 66.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.468 0.707 . . . . 0.0 109.805 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -62.21 -20.64 64.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.185 0.994 . . . . 0.0 111.918 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -111.31 -1.64 15.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 116.893 -1.527 . . . . 0.0 113.003 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -99.3 143.3 26.16 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 121.405 1.911 . . . . 0.0 109.106 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -70.15 159.65 90.53 Favored 'Cis proline' 0 C--N 1.351 0.662 0 CA-C-N 119.109 0.718 . . . . 0.0 113.242 -11.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -146.97 172.23 14.03 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 126.138 1.775 . . . . 0.0 109.722 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -124.52 167.33 14.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 109.784 167.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.34 178.09 3.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.411 0.685 . . . . 0.0 112.046 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.8 t -82.53 138.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 125.385 1.474 . . . . 0.0 109.342 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 111' ' ' ILE . 10.3 t -94.29 71.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.133 0.973 . . . . 0.0 108.379 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -70.13 152.11 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 p -123.01 152.18 41.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.266 0.626 . . . . 0.0 109.997 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -156.89 79.63 0.92 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.718 0.807 . . . . 0.0 109.757 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 83' ' ' PRO . . . 87.19 55.02 2.44 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 119.856 -1.777 . . . . 0.0 113.118 175.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 52.28 40.93 30.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.157 1.383 . . . . 0.0 109.569 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.24 166.03 24.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.81 2.044 . . . . 0.0 107.858 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -132.47 124.28 51.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 108.266 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -127.41 149.26 50.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.396 1.093 . . . . 0.0 109.636 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -136.63 148.45 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 108.446 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.93 74.77 3.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.007 1.723 . . . . 0.0 111.445 -165.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.4 p -63.03 145.52 96.59 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.191 -0.943 . . . . 0.0 112.7 -164.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.68 -1.97 11.21 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.056 3.171 . . . . 0.0 113.096 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.72 136.51 37.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -132.63 82.36 2.0 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.51 0.724 . . . . 0.0 111.768 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.619 HG12 HD12 ' A' ' 25' ' ' LEU . 3.0 m -91.92 173.04 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 O-C-N 121.509 -0.744 . . . . 0.0 110.568 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -132.54 13.93 4.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.292 1.437 . . . . 0.0 112.212 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -111.69 123.19 49.72 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.812 1.187 . . . . 0.0 111.641 -167.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.4 122.7 26.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.291 1.836 . . . . 0.0 110.245 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.44 -37.28 10.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.295 0.638 . . . . 0.0 110.208 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.14 60.07 1.28 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.82 1.648 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -65.31 145.05 82.66 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.224 1.949 . . . . 0.0 110.513 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -143.58 146.56 33.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.228 1.011 . . . . 0.0 108.996 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.16 -5.29 24.59 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.094 1.358 . . . . 0.0 111.391 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.05 149.77 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 127.845 2.458 . . . . 0.0 108.895 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.674 HG21 ' CD1' ' A' ' 78' ' ' PHE . 20.8 m -132.78 -178.72 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.958 1.703 . . . . 0.0 108.587 -173.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.87 176.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.251 1.024 . . . . 0.0 109.472 172.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.6 mt -78.73 -4.54 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.196 0.998 . . . . 0.0 111.128 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.43 37.81 1.94 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.863 1.221 . . . . 0.0 111.083 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -116.85 174.77 5.91 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.1 165.87 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 95' ' ' VAL . . . -141.72 179.19 19.98 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 165.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.986 ' H ' HG13 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -128.82 129.64 45.89 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 -170.28 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . 0.297 2.9 t90 -118.57 86.62 29.46 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-N 120.135 1.334 . . . . 0.0 109.876 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 69.6 Cg_endo -70.78 -26.33 22.87 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 116.834 1.821 . . . . 0.0 116.834 -171.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.455 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 95.4 Cg_endo -77.55 -17.59 14.29 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.955 2.437 . . . . 0.0 112.395 -172.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.45 -2.56 50.52 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.88 1.705 . . . . 0.0 112.79 167.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 52.25 65.49 1.49 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.228 1.811 . . . . 0.0 110.973 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.58 177.51 10.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.75 0.786 . . . . 0.0 111.153 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -88.92 -177.75 5.56 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 126.213 1.805 . . . . 0.0 112.074 175.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 65.7 m -152.94 127.93 9.66 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.638 1.575 . . . . 0.0 109.205 156.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.61 105.12 15.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.393 2.277 . . . . 0.0 105.965 168.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.674 ' CD1' HG21 ' A' ' 61' ' ' VAL . 39.4 m-85 -86.8 132.53 33.82 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -150.25 27.31 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.48 0.582 . . . . 0.0 112.419 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.38 0.09 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-O 118.212 -1.327 . . . . 0.0 112.331 168.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 136.36 4.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.686 1.195 . . . . 0.0 111.3 165.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.56 165.44 30.38 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.277 2.231 . . . . 0.0 113.118 -172.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 85.7 Cg_endo -80.59 -17.8 9.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.65 2.9 . . . . 0.0 114.404 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.21 57.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.432 0.693 . . . . 0.0 111.997 -173.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -172.11 1.85 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.138 2.175 . . . . 0.0 109.839 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.53 -49.97 0.32 Allowed 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 158.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.457 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 8.1 m-20 -72.12 -54.99 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.883 -0.511 . . . . 0.0 110.261 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -139.4 179.71 6.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.677 2.391 . . . . 0.0 109.489 -153.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.7 74.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 121.519 1.963 . . . . 0.0 110.291 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -84.52 142.58 40.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.561 -0.712 . . . . 0.0 109.911 166.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -74.96 -178.57 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.494 3.462 . . . . 0.0 113.72 160.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.08 -12.9 43.4 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t 180.0 -177.95 0.4 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.886 2.074 . . . . 0.0 106.848 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.16 96.06 1.74 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 124.533 2.111 . . . . 0.0 109.609 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.986 HG13 ' H ' ' A' ' 68' ' ' TYR 0.308 46.9 t -58.59 -172.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 CA-C-N 110.945 -2.843 . . . . 0.0 111.199 140.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.679 ' H ' HG12 ' A' ' 95' ' ' VAL . 63.8 t-20 -142.54 130.39 21.68 Favored 'General case' 0 N--CA 1.438 -1.044 1 C-N-CA 132.677 4.391 . . . . 0.0 105.207 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.07 82.71 2.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 22' ' ' VAL . 8.2 pt -77.4 -65.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.968 172.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.469 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -95.59 173.92 31.48 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.848 1.213 . . . . 0.0 111.464 -178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -134.5 141.51 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.611 1.964 . . . . 0.0 108.203 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.84 100.18 2.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 102.339 -3.208 . . . . 0.0 102.339 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -83.72 -38.73 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.363 0.529 . . . . 0.0 110.236 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.74 159.66 41.57 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.557 1.143 . . . . 0.0 109.973 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.0 70.51 1.16 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 tp -87.85 -64.09 1.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.4 -29.14 68.57 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.584 -0.697 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -12.78 24.19 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.38 1.072 . . . . 0.0 111.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.65 -34.91 22.95 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.213 1.405 . . . . 0.0 111.875 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.36 -21.93 66.25 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.08 -1.012 . . . . 0.0 112.361 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.71 10.32 33.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.495 1.518 . . . . 0.0 112.494 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.426 HG21 HG11 ' A' ' 36' ' ' VAL . 23.5 mm -95.37 138.66 20.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.263 0.938 . . . . 0.0 108.983 176.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -85.14 175.08 9.21 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.809 1.244 . . . . 0.0 110.281 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.69 16.4 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 129.652 3.181 . . . . 0.0 114.914 174.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.93 80.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 O-C-N 120.334 -1.479 . . . . 0.0 109.463 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -133.53 31.41 3.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt 46.03 70.11 0.4 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 128.046 2.538 . . . . 0.0 112.347 162.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.44 129.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.58 107.75 20.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.049 1.74 . . . . 0.0 106.992 164.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.5 t -88.57 121.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 128.131 2.572 . . . . 0.0 107.695 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 25.6 mtm180 -138.66 174.13 10.86 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.128 1.371 . . . . 0.0 110.116 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -78.66 -9.44 59.39 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 122.228 2.285 . . . . 0.0 117.036 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.064 0 C-N-CA 126.335 1.854 . . . . 0.0 112.06 -164.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 C--O 1.236 0.378 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.74 157.39 24.4 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 t -155.23 140.43 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.701 1.6 . . . . 0.0 107.646 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 122' ' ' ALA . 43.7 tt0 -123.1 117.96 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.928 2.091 . . . . 0.0 106.476 177.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.87 110.28 19.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.987 1.715 . . . . 0.0 106.448 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.8 122.28 39.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.363 1.465 . . . . 0.0 107.268 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -114.14 170.51 8.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.622 1.169 . . . . 0.0 109.588 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.49 -17.79 62.97 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.406 -1.434 . . . . 0.0 112.358 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 m -113.68 -0.58 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 114.16 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.17 -157.19 28.42 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 119.999 1.272 . . . . 0.0 109.927 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -158.59 166.71 31.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.47 0.708 . . . . 0.0 109.371 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -144.38 179.42 7.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.433 0.693 . . . . 0.0 109.304 166.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.05 126.74 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.19 153.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 122.691 1.234 . . . . 0.0 107.831 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -116.51 126.44 53.36 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 125.842 1.657 . . . . 0.0 106.983 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.35 133.19 51.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.182 0.901 . . . . 0.0 109.546 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.86 137.42 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.15 -18.95 63.23 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.017 0.927 . . . . 0.0 112.591 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.84 -19.5 59.97 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.496 1.043 . . . . 0.0 113.518 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -92.33 126.96 37.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.163 1.385 . . . . 0.0 110.092 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -45.96 -54.76 7.78 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 126.193 1.797 . . . . 0.0 110.915 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -54.98 -32.95 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.143 -1.408 . . . . 0.0 113.998 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.0 t -69.41 -38.75 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.772 1.624 . . . . 0.0 109.379 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -63.41 -42.7 98.75 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.799 0.84 . . . . 0.0 110.759 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -43.99 84.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -54.27 -28.07 39.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.226 1.41 . . . . 0.0 112.8 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -65.29 -27.25 68.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.014 0.824 . . . . 0.0 110.496 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.79 -20.59 63.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.593 0.711 . . . . 0.0 110.817 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -118.29 18.33 13.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.95 2.1 . . . . 0.0 110.753 -165.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.5 mt -121.29 139.97 30.47 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.678 1.581 . . . . 0.0 107.456 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.89 156.99 83.01 Favored 'Cis proline' 0 N--CA 1.458 -0.6 0 C-N-CA 125.089 -0.796 . . . . 0.0 112.053 -9.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.491 ' CE1' HG11 ' A' ' 119' ' ' VAL . 20.5 p90 -143.72 165.17 28.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.578 1.174 . . . . 0.0 109.947 165.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.96 155.32 41.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -162.05 166.3 26.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.819 0.848 . . . . 0.0 111.471 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.57 127.97 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.845 HG13 HG23 ' A' ' 43' ' ' ILE . 98.9 t -80.38 98.54 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 171.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -90.75 156.06 18.34 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -144.45 149.45 36.03 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.161 0.585 . . . . 0.0 110.253 -168.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -146.62 82.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 83' ' ' PRO . . . 79.18 -84.98 1.23 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -142.03 38.62 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.58 1.552 . . . . 0.0 109.181 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.68 165.32 26.66 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.21 172.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.845 HG23 HG13 ' A' ' 36' ' ' VAL . 30.3 mt -131.95 123.19 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -121.18 176.35 5.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.071 0.939 . . . . 0.0 109.751 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.43 161.15 38.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.915 2.086 . . . . 0.0 106.679 173.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p -94.57 85.41 4.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.666 HG21 HD23 ' A' ' 75' ' ' LEU . 40.2 p -59.12 150.21 63.37 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -166.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.87 -25.16 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.287 1.992 . . . . 0.0 111.263 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.88 143.8 10.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.152 0.981 . . . . 0.0 109.938 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -138.87 101.13 4.23 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.395 1.478 . . . . 0.0 108.202 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.8 160.19 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.626 1.57 . . . . 0.0 108.022 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -123.37 2.65 9.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.69 1.196 . . . . 0.0 113.123 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -71.95 157.98 36.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.051 0.841 . . . . 0.0 109.107 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 46.4 mtm -147.59 158.38 43.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.565 1.546 . . . . 0.0 106.939 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -126.64 -51.69 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.533 1.533 . . . . 0.0 108.819 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -123.89 54.41 7.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.297 1.039 . . . . 0.0 111.641 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.77 134.37 27.81 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 120.264 1.13 . . . . 0.0 110.516 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -127.9 148.6 50.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.387 0.675 . . . . 0.0 109.33 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -92.89 5.75 50.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.843 0.857 . . . . 0.0 112.304 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -148.39 153.41 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.034 2.134 . . . . 0.0 106.59 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 78' ' ' PHE . 27.3 m -146.2 -178.74 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.542 2.337 . . . . 0.0 107.207 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.48 172.15 7.67 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.489 -0.757 . . . . 0.0 111.335 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -72.14 71.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.954 . . . . 0.0 107.215 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.73 11.74 0.16 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.813 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -105.07 -177.74 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.399 2.1 . . . . 0.0 108.7 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -131.65 148.34 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.638 1.175 . . . . 0.0 108.463 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -134.09 149.9 19.86 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.462 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 6.7 m-85 -120.24 120.51 36.31 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -105.06 87.97 2.18 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.536 1.934 . . . . 0.0 110.35 -167.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.06 -52.0 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.104 2.536 . . . . 0.0 114.844 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.67 -28.6 7.98 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.939 2.426 . . . . 0.0 111.212 -161.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.66 87.39 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.57 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 47.24 67.62 0.77 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 108.924 -162.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.0 157.2 45.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.629 0.728 . . . . 0.0 111.702 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.666 HD23 HG21 ' A' ' 47' ' ' THR . 0.2 OUTLIER -80.5 -175.62 5.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.663 159.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 t -164.09 154.54 15.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.62 1.168 . . . . 0.0 109.278 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -136.09 142.14 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 107.12 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD2' HG21 ' A' ' 61' ' ' VAL . 56.7 m-85 -120.66 106.38 11.68 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 119.929 1.241 . . . . 0.0 110.829 -170.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.25 52.52 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.328 1.061 . . . . 0.0 112.42 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.36 -98.94 0.13 Allowed Glycine 0 CA--C 1.506 -0.47 0 O-C-N 120.368 -1.457 . . . . 0.0 111.095 159.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.411 ' HA ' HG13 ' A' ' 89' ' ' ILE . 11.6 tttt -135.08 -15.38 1.98 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 167.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 55.72 165.63 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.232 1.813 . . . . 0.0 112.136 -174.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 71.9 Cg_endo -72.64 5.43 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.185 2.59 . . . . 0.0 113.16 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.19 88.26 2.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 p 174.18 172.94 0.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.369 2.668 . . . . 0.0 107.223 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -147.21 -47.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 158.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.83 -53.49 7.85 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.737 0.78 . . . . 0.0 109.429 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -149.82 152.05 34.53 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 128.682 2.793 . . . . 0.0 107.527 -161.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 89' ' ' ILE . 5.4 mp -54.47 122.19 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -138.9 143.4 37.19 Favored Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.501 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -82.71 171.45 11.98 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.625 2.883 . . . . 0.0 113.331 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.12 52.31 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.72 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.9 m -173.02 -175.36 1.2 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.105 2.562 . . . . 0.0 107.089 166.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.9 104.99 0.61 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.433 1.015 . . . . 0.0 108.678 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -106.83 138.83 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -66.21 106.74 1.74 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.292 1.437 . . . . 0.0 108.707 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.21 61.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 122.469 1.128 . . . . 0.0 109.154 -168.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.77 -13.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.194 0.998 . . . . 0.0 112.933 -167.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.11 164.41 17.41 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -129.13 137.72 51.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.72 90.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -73.5 -30.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.704 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -148.98 162.77 39.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.225 0.536 . . . . 0.0 110.801 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.57 70.74 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.261 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -54.66 44.45 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.378 1.089 . . . . 0.0 109.922 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.25 -18.35 61.24 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.045 -1.035 . . . . 0.0 110.624 -167.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.85 -13.26 61.4 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.161 -0.962 . . . . 0.0 111.781 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.62 -29.1 56.35 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.112 -1.617 . . . . 0.0 113.23 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.39 81.16 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 120.308 -1.495 . . . . 0.0 111.872 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -67.38 -11.14 56.99 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.0 164.33 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 126.866 2.067 . . . . 0.0 109.6 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 110' ' ' LYS . 5.7 mmtp -120.86 175.31 6.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.977 1.711 . . . . 0.0 109.488 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.13 44.68 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.0 2.12 . . . . 0.0 112.899 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.77 83.15 0.04 OUTLIER Glycine 0 C--N 1.333 0.366 0 O-C-N 120.721 -1.237 . . . . 0.0 110.94 168.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.5 31.11 5.05 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.264 1.026 . . . . 0.0 111.798 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.1 mttt 47.35 89.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.32 2.248 . . . . 0.0 115.225 171.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.54 152.95 5.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.49 119.14 33.65 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.467 1.907 . . . . 0.0 106.878 159.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.491 HG11 ' CE1' ' A' ' 32' ' ' PHE . 75.9 t -98.48 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 127.496 2.318 . . . . 0.0 107.192 -174.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -130.99 163.17 28.14 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.694 -1.253 . . . . 0.0 110.395 -171.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.92 -18.17 64.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 4' ' ' GLU . . . . . . . . 0 C--N 1.308 -1.228 1 C-N-CA 131.974 4.11 . . . . 0.0 107.375 152.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 7.7 mtt180 -74.86 159.4 31.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.446 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.1 t -153.74 120.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.459 1.903 . . . . 0.0 106.031 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -100.23 136.56 39.94 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.71 -1.244 . . . . 0.0 109.007 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.78 103.11 10.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.679 1.592 . . . . 0.0 106.906 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 143.13 30.64 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.54 -178.72 4.34 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.641 1.976 . . . . 0.0 107.67 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.44 -52.51 38.62 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.808 1.243 . . . . 0.0 110.387 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 m -70.67 -33.35 70.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.004 -0.435 . . . . 0.0 111.858 -173.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.23 -150.45 8.15 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -161.21 164.53 30.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.715 1.257 . . . . 0.0 110.658 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.8 p -146.8 175.47 10.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.564 . . . . 0.0 108.965 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.02 141.98 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.5 pt -129.93 147.73 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -132.94 125.88 30.8 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.26 131.1 53.75 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 125.265 1.603 . . . . 0.0 109.47 -163.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -69.94 122.07 18.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.947 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.86 9.35 1.54 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.138 1.375 . . . . 0.0 114.067 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.02 -6.52 56.57 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.091 -1.005 . . . . 0.0 110.39 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.22 132.96 55.93 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.255 1.022 . . . . 0.0 109.702 -164.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.88 -44.09 70.16 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.274 1.429 . . . . 0.0 111.159 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -54.06 -43.09 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.591 1.156 . . . . 0.0 112.358 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.56 -44.79 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.51 1.504 . . . . 0.0 108.643 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -61.3 -40.23 93.42 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.365 0.666 . . . . 0.0 111.041 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -79.01 -29.41 43.67 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.972 0.909 . . . . 0.0 111.046 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mt -60.97 -24.58 66.21 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.228 1.411 . . . . 0.0 111.363 168.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -64.33 -20.13 65.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.345 0.975 . . . . 0.0 111.177 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -81.89 -14.97 55.46 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.068 0.947 . . . . 0.0 112.251 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -124.33 28.93 6.51 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.294 1.038 . . . . 0.0 111.414 -166.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -131.81 141.26 40.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.0 158.35 74.35 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.075 1.063 . . . . 0.0 112.332 -8.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -150.31 166.0 31.33 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.31 0.644 . . . . 0.0 110.003 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.48 166.93 12.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.3 163.19 17.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.702 0.763 . . . . 0.0 111.736 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.96 131.85 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 164.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.6 99.96 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -85.59 154.85 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.4 p -129.6 150.91 50.72 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.627 1.171 . . . . 0.0 108.681 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -149.31 98.22 2.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.43 -87.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.2 29.61 1.81 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.292 1.837 . . . . 0.0 110.327 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -133.11 161.83 33.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.436 1.094 . . . . 0.0 108.589 168.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -127.3 143.22 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -148.69 166.9 26.99 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 2.5 p90 -154.38 155.64 35.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.759 -1.213 . . . . 0.0 108.584 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -83.02 86.55 6.98 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.541 0.737 . . . . 0.0 109.511 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.0 p -58.15 150.88 49.58 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 122.663 0.385 . . . . 0.0 111.874 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.85 -13.31 13.06 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.277 2.651 . . . . 0.0 112.647 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.81 158.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-N 119.092 0.86 . . . . 0.0 108.904 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.32 103.83 4.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.229 1.412 . . . . 0.0 107.879 172.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.55 147.12 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -125.47 -7.45 6.92 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -65.17 146.7 54.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.723 1.209 . . . . 0.0 107.778 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 18.0 ptp -144.81 104.35 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.24 1.416 . . . . 0.0 110.304 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.66 -30.34 59.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.156 -1.018 . . . . 0.0 113.221 -172.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -133.29 72.9 74.87 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 119.432 1.015 . . . . 0.0 110.522 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 56.3 Cg_endo -69.48 150.67 70.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.75 2.967 . . . . 0.0 112.113 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -140.13 173.36 11.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.494 1.917 . . . . 0.0 108.384 170.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.27 10.67 8.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 112.657 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.72 154.11 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 131.001 3.72 . . . . 0.0 107.004 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.14 -174.48 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.23 1.412 . . . . 0.0 109.575 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -90.94 175.84 6.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.698 0.761 . . . . 0.0 110.935 166.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.456 ' O ' HD11 ' A' ' 105' ' ' LEU . 56.5 mt -75.58 5.23 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.923 1.289 . . . . 0.0 110.68 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.17 30.91 1.6 Allowed Glycine 0 C--N 1.337 0.615 0 O-C-N 120.692 -1.255 . . . . 0.0 112.949 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -115.79 169.92 8.85 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.049 0.924 . . . . 0.0 109.462 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -136.99 140.99 41.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.703 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -127.03 176.82 17.64 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.875 1.226 . . . . 0.0 110.987 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -111.4 143.01 42.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 165.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -104.77 86.06 1.36 Allowed Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 125.631 1.572 . . . . 0.0 107.667 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.05 -43.39 42.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.359 2.039 . . . . 0.0 115.054 -172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.74 -22.65 43.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.639 2.226 . . . . 0.0 111.482 -165.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -115.76 15.13 16.95 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.763 1.649 . . . . 0.0 113.751 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 47.56 37.96 7.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.755 2.278 . . . . 0.0 113.024 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.83 160.95 15.34 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.724 -1.235 . . . . 0.0 110.531 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -80.07 -179.14 6.87 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 161.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.6 m -139.15 163.93 31.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.796 0.838 . . . . 0.0 109.777 154.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.5 mt -151.05 101.49 2.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 129.36 3.064 . . . . 0.0 105.066 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -99.97 119.88 38.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.73 1.56 2.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.14 -178.74 34.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 166.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -83.25 106.88 15.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -59.71 165.43 4.38 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 125.465 1.506 . . . . 0.0 110.961 169.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.41 1.48 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.333 2.022 . . . . 0.0 114.165 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ttp -107.17 58.31 0.63 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 120.208 1.367 . . . . 0.0 110.182 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 p -159.83 -178.63 7.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 122.161 0.982 . . . . 0.0 110.501 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.93 -62.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 154.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.39 -43.54 40.18 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.046 0.538 . . . . 0.0 112.022 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -149.68 161.98 41.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.957 1.303 . . . . 0.0 108.6 -162.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.78 80.54 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -167.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -79.85 141.85 55.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -89.26 177.29 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 124.494 3.463 . . . . 0.0 112.935 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.78 16.16 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.4 t -164.86 173.86 11.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.029 1.286 . . . . 0.0 109.783 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.57 78.8 0.58 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.8 148.92 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 25.7 p30 -64.97 158.59 25.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.213 0.53 . . . . 0.0 112.177 164.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.56 99.32 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 166.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.2 pt -113.47 -16.38 9.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.511 1.124 . . . . 0.0 111.408 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.1 175.56 20.03 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-O 122.061 0.811 . . . . 0.0 112.413 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -135.86 134.0 38.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 105' ' ' LEU . 52.7 mt -73.76 95.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 165.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -76.62 -24.2 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.365 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -148.66 158.68 44.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 110.421 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.78 42.34 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.371 1.462 . . . . 0.0 112.569 160.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 63' ' ' ILE . 1.8 tp -67.63 -11.81 59.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -162.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -107.18 -35.27 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 119.258 0.935 . . . . 0.0 110.331 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.56 -18.21 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.484 0.713 . . . . 0.0 111.316 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mp -66.76 -29.09 68.97 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.088 -1.007 . . . . 0.0 112.314 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -67.22 -22.79 65.69 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.818 1.644 . . . . 0.0 112.87 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -99.16 5.77 46.69 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.932 -171.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.86 165.37 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 119.744 1.157 . . . . 0.0 108.741 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -109.39 172.84 6.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.29 35.8 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 112.735 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.45 51.97 0.04 OUTLIER Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.804 -1.185 . . . . 0.0 112.93 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -103.4 24.92 10.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.016 1.408 . . . . 0.0 113.302 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.6 mttt 44.19 88.25 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.452 1.901 . . . . 0.0 113.258 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.75 142.38 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -125.06 94.49 4.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.443 1.897 . . . . 0.0 106.826 162.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.28 140.39 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 128.724 2.81 . . . . 0.0 109.1 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -140.97 177.06 8.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.999 2.12 . . . . 0.0 109.61 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -78.71 -2.32 38.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . 55.61 -164.67 0.13 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.831 -160.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . 0.342 10.3 p 47.18 16.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 129.771 3.229 . . . . 0.0 116.868 -175.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.249 1.029 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 132.902 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.977 0.894 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.433 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 1.3 mmt-85 -62.57 160.59 13.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.932 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 2' ' ' ARG . 36.8 t -151.11 149.69 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.494 1.518 . . . . 0.0 109.075 166.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -116.54 139.86 50.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.423 2.289 . . . . 0.0 106.229 166.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.428 HD22 HG22 ' A' ' 119' ' ' VAL . 42.8 mt -112.08 119.49 38.61 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 170.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 3.5 tt -121.49 141.01 51.45 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -164.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.73 ' CE1' HG12 ' A' ' 117' ' ' VAL . 18.8 m-85 -128.98 166.45 19.15 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.3 1.409 . . . . 0.0 108.616 -172.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.11 -19.16 62.71 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.244 -0.91 . . . . 0.0 111.543 171.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -25.76 12.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -172.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.5 -156.37 18.11 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 126.379 1.942 . . . . 0.0 108.274 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 13.0 pttp -168.02 157.54 9.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.174 1.487 . . . . 0.0 111.695 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HB3' HD21 ' A' ' 108' ' ' LEU . 14.3 p -136.31 175.24 9.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.36 1.064 . . . . 0.0 111.043 170.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 127.22 56.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.6 pt -121.65 129.01 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -96.14 133.65 40.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.127 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.4 mt -124.62 130.53 52.6 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.588 1.085 . . . . 0.0 110.574 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -71.35 135.97 47.58 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.868 1.667 . . . . 0.0 111.375 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -90.96 45.35 1.25 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 112.854 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -129.05 30.15 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.094 -1.628 . . . . 0.0 108.964 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.434 ' CE2' HG22 ' A' ' 98' ' ' ILE . 23.0 m-85 -132.53 139.47 47.9 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.012 -1.055 . . . . 0.0 109.034 175.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -45.0 -62.76 1.11 Allowed 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 126.373 1.869 . . . . 0.0 109.609 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.33 -39.64 28.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 121.071 -1.018 . . . . 0.0 113.17 -171.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.8 -44.77 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.513 1.125 . . . . 0.0 109.247 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -52.05 -53.57 40.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -43.94 97.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.863 0.865 . . . . 0.0 109.424 -170.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.21 -29.05 20.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.392 1.877 . . . . 0.0 112.866 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -59.98 -29.44 68.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.009 0.822 . . . . 0.0 110.895 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -74.07 -35.62 64.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.04 0.448 . . . . 0.0 109.935 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.35 21.05 3.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.648 2.779 . . . . 0.0 111.407 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -128.26 137.71 31.45 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 121.187 1.812 . . . . 0.0 107.733 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.93 153.14 97.39 Favored 'Cis proline' 0 C--N 1.348 0.518 0 CA-C-N 119.161 0.736 . . . . 0.0 112.428 -5.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CE1' HG11 ' A' ' 119' ' ' VAL . 23.2 p90 -139.75 167.48 22.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 122.667 0.387 . . . . 0.0 111.377 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.15 155.06 46.84 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 t -166.74 161.62 15.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.5 128.2 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.804 HG22 HG13 ' A' ' 117' ' ' VAL . 2.8 t -75.66 73.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -65.29 153.48 40.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -139.46 161.03 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.95 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -160.54 92.62 0.97 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.37 84.34 0.03 OUTLIER Glycine 0 C--O 1.212 -1.248 0 CA-C-O 119.194 -0.781 . . . . 0.0 114.577 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.36 25.23 7.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.095 2.958 . . . . 0.0 113.252 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -128.8 149.38 50.76 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.468 1.107 . . . . 0.0 109.099 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.7 mt -125.04 141.35 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.59 172.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 168.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -156.71 151.36 25.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -74.11 98.33 3.1 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.9 p -66.95 149.8 98.26 Favored Pre-proline 0 N--CA 1.437 -1.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.06 -3.03 12.87 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.389 3.392 . . . . 0.0 112.102 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.2 149.79 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 108.141 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.02 15.79 6.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.84 117.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 123.978 0.911 . . . . 0.0 110.019 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 70' ' ' PRO . 48.6 mt-30 -94.73 2.04 55.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -81.61 96.39 7.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.498 2.319 . . . . 0.0 110.29 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.8 ptp -86.57 123.42 31.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.508 1.123 . . . . 0.0 110.378 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.88 -23.88 16.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -137.9 70.69 50.06 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.2 146.75 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.282 2.655 . . . . 0.0 109.87 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -135.76 174.92 10.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 164.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -125.3 7.05 7.76 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.223 1.009 . . . . 0.0 111.503 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -144.74 137.06 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -142.9 -179.56 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.057 1.343 . . . . 0.0 109.722 -173.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.37 -167.56 1.52 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.977 2.111 . . . . 0.0 111.438 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.19 45.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.429 1.891 . . . . 0.0 107.545 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.03 38.2 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.24 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -110.28 176.04 5.2 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.41 134.33 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.89 148.16 18.88 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -86.75 139.14 31.02 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 168.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -104.89 85.21 1.15 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.484 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 63.9 Cg_endo -64.39 -36.68 43.47 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.167 1.245 . . . . 0.0 114.837 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.484 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 60.5 Cg_endo -74.05 -21.04 18.61 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.266 1.977 . . . . 0.0 110.599 -167.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 22.17 7.58 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 118.05 -1.416 . . . . 0.0 113.352 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 46.21 49.59 12.56 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.766 1.783 . . . . 0.0 111.995 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.97 175.46 9.35 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 111.286 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.438 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 1.3 tp -93.18 -169.66 2.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.141 1.376 . . . . 0.0 111.06 166.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -166.13 140.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.554 1.542 . . . . 0.0 110.371 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -137.36 124.12 21.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.413 2.285 . . . . 0.0 107.538 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.62 119.63 40.09 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.248 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -140.94 14.7 2.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.54 48.32 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 CA-C-N 119.755 1.161 . . . . 0.0 114.327 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.8 tttt 62.24 177.44 0.13 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.64 1.976 . . . . 0.0 109.844 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 43.2 p -149.25 165.54 17.42 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 120.119 1.327 . . . . 0.0 109.925 -172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 96.5 Cg_endo -77.62 64.73 8.12 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.377 3.384 . . . . 0.0 111.462 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.23 -44.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.719 1.608 . . . . 0.0 108.753 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.79 154.74 23.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.479 1.511 . . . . 0.0 108.227 -159.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.73 -58.03 1.6 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.4 -49.42 55.41 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.194 0.521 . . . . 0.0 110.926 -167.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -135.89 166.09 24.12 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 127.005 2.122 . . . . 0.0 108.109 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.73 115.91 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -125.6 144.78 49.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.115 0.966 . . . . 0.0 111.139 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.479 ' HG3' HG22 ' A' ' 95' ' ' VAL . 57.9 Cg_endo -74.5 173.56 14.08 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.305 3.336 . . . . 0.0 112.975 170.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.268 1.427 . . . . 0.0 114.346 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -147.86 173.37 12.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.569 1.547 . . . . 0.0 107.679 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.11 85.59 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.479 HG22 ' HG3' ' A' ' 91' ' ' PRO . 15.5 m -90.93 150.02 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -75.32 175.22 8.58 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.9 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.42 44.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.434 HG22 ' CE2' ' A' ' 20' ' ' TYR . 35.7 pt -64.65 -39.96 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.312 -1.492 . . . . 0.0 110.927 -174.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.82 169.08 16.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -138.47 132.71 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.9 mt -73.62 90.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 103.687 -2.708 . . . . 0.0 103.687 167.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.9 m -72.65 -25.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.511 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 155.1 36.76 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.586 0.755 . . . . 0.0 112.23 -165.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.6 20.17 62.38 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.888 1.232 . . . . 0.0 113.897 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.02 -38.03 87.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.745 1.273 . . . . 0.0 111.542 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -76.39 -1.17 25.62 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.25 1.96 26.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.871 0.868 . . . . 0.0 113.024 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' A' ' 12' ' ' CYS . 23.1 mt -84.31 -41.97 16.28 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.622 1.169 . . . . 0.0 113.68 -172.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.55 -23.41 64.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.61 1.671 . . . . 0.0 111.135 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -69.07 -10.55 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.543 -1.348 . . . . 0.0 111.212 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -92.44 157.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 120.334 1.425 . . . . 0.0 109.634 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.51 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 16.5 mmtp -102.08 172.4 6.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.767 1.627 . . . . 0.0 108.013 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.31 25.24 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 128.492 2.717 . . . . 0.0 113.649 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.85 65.16 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 120.337 -1.477 . . . . 0.0 111.992 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 1.5 mm-40 -125.12 38.16 4.25 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.964 1.306 . . . . 0.0 110.465 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 mttt 42.24 87.26 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.542 1.937 . . . . 0.0 110.597 164.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.804 HG13 HG22 ' A' ' 36' ' ' VAL . 19.5 m -64.0 178.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -150.47 90.36 1.64 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 171.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 32' ' ' PHE . 91.8 t -70.42 125.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -137.55 170.9 15.28 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.509 1.05 . . . . 0.0 109.69 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.11 -11.52 60.33 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . 62.03 115.72 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 128.652 2.781 . . . . 0.0 110.783 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.8 m -110.68 82.37 1.58 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.009 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.413 0.625 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -72.38 167.44 20.51 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 25.4 t -147.62 130.19 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.15 1.38 . . . . 0.0 108.599 167.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -98.74 128.61 45.04 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 119' ' ' VAL . 1.2 mm? -100.61 105.1 16.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.5 31.54 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 169.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.93 175.09 8.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.93 1.292 . . . . 0.0 109.383 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.97 -29.64 67.9 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.503 -1.373 . . . . 0.0 112.057 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.8 m -103.53 -3.0 25.87 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.31 -166.76 39.6 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 119.712 1.142 . . . . 0.0 111.266 -173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 150.34 25.53 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.808 0.304 . . . . 0.0 110.397 168.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.8 p -132.85 172.87 12.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.598 0.713 . . . . 0.0 109.385 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -135.06 146.85 29.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.5 pt -128.13 156.97 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -111.02 135.15 51.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.29 134.69 55.21 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.076 1.351 . . . . 0.0 108.781 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -86.66 118.53 26.12 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.778 0.831 . . . . 0.0 109.478 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -66.21 20.05 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.028 2.131 . . . . 0.0 114.64 -171.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.86 24.17 5.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.39 1.876 . . . . 0.0 109.511 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -129.92 147.81 51.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.438 2.295 . . . . 0.0 108.311 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.77 -46.49 59.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.701 2.0 . . . . 0.0 110.157 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.07 -46.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.337 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -72.16 -43.91 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -165.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -60.89 -24.62 66.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.966 1.307 . . . . 0.0 111.715 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 25' ' ' LEU . 20.5 mt -90.18 -25.8 20.46 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.48 1.112 . . . . 0.0 112.501 176.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.469 ' HG ' HG21 ' A' ' 49' ' ' VAL . 1.4 mt -70.11 -28.82 65.71 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 121.065 -1.022 . . . . 0.0 110.804 172.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.66 -36.68 47.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.337 0.655 . . . . 0.0 111.044 175.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -71.36 -17.51 62.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 112.17 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -123.13 12.46 9.59 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.902 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -106.01 135.76 19.39 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 121.003 1.729 . . . . 0.0 108.109 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.86 164.32 79.83 Favored 'Cis proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.911 1.004 . . . . 0.0 112.824 -6.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CE1' HG11 ' A' ' 119' ' ' VAL . 47.4 p90 -147.54 168.58 21.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.713 1.258 . . . . 0.0 109.403 165.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 116' ' ' LYS . 47.3 mp0 -130.71 154.51 47.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.174 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -165.2 -175.46 3.66 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.905 0.882 . . . . 0.0 111.551 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 t -93.26 142.19 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 128.017 2.527 . . . . 0.0 107.891 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -97.11 91.33 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -86.79 159.64 19.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.6 p -132.4 149.32 52.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.03 0.932 . . . . 0.0 110.561 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.0 t90 -166.91 103.3 0.56 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -172.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.41 20.09 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 160.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.357 17.2 pt-20 47.71 50.91 14.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.966 1.707 . . . . 0.0 111.234 -159.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -140.01 159.56 41.89 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 126.962 2.105 . . . . 0.0 107.615 168.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.99 139.64 50.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 127.513 2.325 . . . . 0.0 106.478 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -155.34 150.02 26.36 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.962 1.363 . . . . 0.0 111.263 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 2.7 p90 -135.64 151.76 50.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.163 1.385 . . . . 0.0 108.204 -174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -88.82 83.34 6.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -166.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 48' ' ' PRO . 16.5 p -53.98 152.29 10.8 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.256 0.622 . . . . 0.0 111.971 -168.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 47' ' ' THR . 42.4 Cg_endo -79.2 4.93 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.505 1 C-N-CA 125.41 4.073 . . . . 0.0 112.505 175.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.469 HG21 ' HG ' ' A' ' 26' ' ' LEU . 94.0 t -107.98 131.53 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.071 1.348 . . . . 0.0 110.421 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.46 66.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.31 1.444 . . . . 0.0 107.19 -171.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -110.49 128.99 66.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 124.48 1.112 . . . . 0.0 108.297 -175.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.98 45.07 2.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.584 1.153 . . . . 0.0 111.264 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -127.69 146.35 50.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.457 1.503 . . . . 0.0 108.405 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.62 110.48 2.45 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.154 1.782 . . . . 0.0 108.329 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -87.36 -25.48 23.83 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.633 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -123.35 65.68 31.51 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 120.138 1.336 . . . . 0.0 110.147 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.26 114.63 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.048 2.499 . . . . 0.0 110.391 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 131.42 55.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.544 1.537 . . . . 0.0 108.087 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -93.12 5.27 52.1 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -160.86 149.28 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 128.095 2.558 . . . . 0.0 109.648 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 78' ' ' PHE . 17.0 m -140.95 174.18 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.053 1.741 . . . . 0.0 109.39 -165.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -94.51 170.03 9.77 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.86 0.838 . . . . 0.0 110.708 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.74 -7.42 8.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 124.965 1.306 . . . . 0.0 112.237 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.11 27.22 4.59 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.681 1.61 . . . . 0.0 112.596 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -103.8 175.78 5.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.016 0.908 . . . . 0.0 109.331 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.507 HG23 HG13 ' A' ' 101' ' ' ILE . 42.4 t -135.42 133.86 52.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.709 0.804 . . . . 0.0 109.639 166.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.74 156.66 21.54 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -103.64 143.37 32.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 163.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -109.33 85.66 3.69 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 124.699 1.2 . . . . 0.0 108.552 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.65 -29.84 90.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.265 1.31 . . . . 0.0 114.671 172.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -77.75 -9.0 17.07 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.509 2.139 . . . . 0.0 111.917 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.59 8.95 4.0 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 118.411 -1.216 . . . . 0.0 115.583 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 44.65 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.741 1.27 . . . . 0.0 109.971 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.49 165.69 20.22 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.534 -0.729 . . . . 0.0 111.611 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 5.3 tp -84.0 178.15 7.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.409 166.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -151.26 108.93 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.082 1.753 . . . . 0.0 108.39 165.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.21 105.29 17.11 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.436 ' CD2' HG21 ' A' ' 61' ' ' VAL . 91.1 m-85 -80.35 133.59 35.94 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -152.84 22.18 0.59 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.946 0.898 . . . . 0.0 110.955 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.2 -139.66 2.76 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.41 103.01 4.78 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -58.52 156.11 24.96 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.487 1.915 . . . . 0.0 111.166 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -3.0 11.89 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.059 3.173 . . . . 0.0 113.459 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.426 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 3.0 tpt -73.09 -8.79 57.33 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.777 -1.202 . . . . 0.0 112.336 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t -132.54 -177.46 4.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.497 1.142 . . . . 0.0 109.914 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -144.35 -42.68 0.25 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.96 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -71.5 -56.81 5.19 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.57 1.176 . . . . 0.0 108.147 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -133.11 -164.84 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.177 2.191 . . . . 0.0 107.41 -153.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.95 77.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.538 1.517 . . . . 0.0 107.662 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 42.5 mt-30 -76.14 142.74 72.51 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 168.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' HG3' HG22 ' A' ' 95' ' ' VAL . 51.0 Cg_endo -77.59 179.74 6.22 Favored 'Trans proline' 0 CA--C 1.533 0.449 1 C-N-CA 126.925 5.083 . . . . 0.0 113.665 170.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HA ' ' HG2' ' A' ' 84' ' ' MET . . . -70.37 -14.01 62.39 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.32 -172.07 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.89 97.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG22 ' HG3' ' A' ' 91' ' ' PRO . 24.4 m -90.0 172.67 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -126.55 124.5 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.47 55.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.586 1.184 . . . . 0.0 109.256 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.6 pt -80.05 -14.57 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.236 1.014 . . . . 0.0 111.381 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.12 155.89 16.82 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -135.88 140.83 44.42 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.879 0.872 . . . . 0.0 108.659 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.507 HG13 HG23 ' A' ' 66' ' ' VAL . 97.1 mt -79.63 93.95 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 123.814 1.768 . . . . 0.0 108.634 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.48 -23.68 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.002 -163.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.04 159.71 44.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.252 2.621 . . . . 0.0 108.716 171.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.53 69.2 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-O 117.927 -1.485 . . . . 0.0 115.277 167.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.69 -49.99 73.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.188 1.994 . . . . 0.0 111.212 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.3 -25.6 66.11 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.814 -0.554 . . . . 0.0 110.956 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.9 -5.97 34.75 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.754 1.222 . . . . 0.0 112.164 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.5 mt -80.7 -44.41 18.77 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 119.028 0.831 . . . . 0.0 111.46 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -57.53 -22.92 47.32 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.03 -1.044 . . . . 0.0 113.147 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -91.82 16.59 10.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.386 1.474 . . . . 0.0 112.978 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.3 mm -113.3 148.13 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 121.156 1.798 . . . . 0.0 109.922 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -89.16 171.98 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.667 1.587 . . . . 0.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.05 40.14 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 130.127 3.371 . . . . 0.0 112.724 167.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.87 12.67 0.03 OUTLIER Glycine 0 CA--C 1.522 0.522 0 O-C-N 120.452 -1.405 . . . . 0.0 116.156 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.53 22.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.607 1.704 . . . . 0.0 114.34 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.538 ' HE2' ' HB3' ' A' ' 33' ' ' GLU . 0.1 OUTLIER 64.87 152.95 0.05 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.003 2.121 . . . . 0.0 112.373 167.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.51 148.26 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 O-C-N 120.435 -1.416 . . . . 0.0 109.048 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.06 108.47 15.27 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.492 2.317 . . . . 0.0 107.14 160.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 32' ' ' PHE . 48.8 t -86.51 124.38 40.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.788 2.435 . . . . 0.0 107.792 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 48.7 mtt180 -140.67 179.76 6.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.571 1.532 . . . . 0.0 110.17 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -81.31 -10.33 59.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 62.0 108.55 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 127.545 2.338 . . . . 0.0 111.266 -169.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 92.6 p -89.53 -11.19 43.56 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.257 1.47 0 C-N-CA 128.49 2.716 . . . . 0.0 115.677 -169.327 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttp . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.62 152.14 39.72 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 50.8 t -153.82 147.85 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.546 1.939 . . . . 0.0 108.132 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.619 ' CB ' ' HB2' ' A' ' 122' ' ' ALA . 42.1 tt0 -131.81 137.41 48.11 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.479 1.911 . . . . 0.0 107.528 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.1 mt -108.57 104.62 13.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.678 1.991 . . . . 0.0 105.857 -174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.67 103.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.56 173.45 9.57 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.931 0.892 . . . . 0.0 108.985 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.77 -42.22 95.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -80.82 -17.08 51.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.62 -161.79 34.09 Favored Glycine 0 N--CA 1.464 0.565 0 CA-C-N 121.11 1.777 . . . . 0.0 110.252 -165.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -159.33 159.92 34.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.203 1.501 . . . . 0.0 111.668 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.8 p -142.84 178.41 7.67 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.195 0.998 . . . . 0.0 109.877 170.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -132.92 129.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.62 144.71 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.401 1.08 . . . . 0.0 108.309 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -136.01 128.97 31.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 121.314 -0.866 . . . . 0.0 112.858 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.59 123.79 42.81 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 125.084 1.49 . . . . 0.0 108.824 -164.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.22 138.58 57.9 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.608 1.563 . . . . 0.0 111.462 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -97.2 50.26 1.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.518 0.727 . . . . 0.0 112.0 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.35 17.75 3.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.144 1.378 . . . . 0.0 111.85 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.68 144.76 50.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.376 1.47 . . . . 0.0 112.438 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -53.24 -50.58 64.47 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.326 1.451 . . . . 0.0 111.829 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HA ' HG11 ' A' ' 51' ' ' VAL . 3.6 t -57.22 -44.74 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -175.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.0 -34.17 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -66.53 -48.94 68.13 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.17 0.988 . . . . 0.0 111.016 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 51' ' ' VAL . 67.5 mt -70.96 -21.78 62.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.691 0.796 . . . . 0.0 110.515 -173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.2 -41.97 80.57 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.852 2.061 . . . . 0.0 111.608 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -56.0 -36.72 68.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.362 0.983 . . . . 0.0 110.0 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.86 -29.54 70.83 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -108.39 2.25 22.33 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.992 1.317 . . . . 0.0 112.04 -168.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG22 ' CE2' ' A' ' 121' ' ' PHE . 60.6 mt -98.12 142.17 24.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.26 160.43 83.03 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 CA-C-N 119.421 0.829 . . . . 0.0 112.941 -7.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.86 175.45 12.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.933 1.693 . . . . 0.0 109.874 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 177.47 7.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.12 2.168 . . . . 0.0 110.728 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -162.63 -154.73 0.32 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.293 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 t -120.39 134.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.877 1.671 . . . . 0.0 107.661 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -88.09 77.03 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 118.995 0.816 . . . . 0.0 109.379 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.62 150.93 34.84 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.681 -1.262 . . . . 0.0 109.239 171.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.8 p -124.69 142.53 51.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.082 1.353 . . . . 0.0 108.886 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -153.36 107.26 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.87 22.13 70.01 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.939 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 75.52 28.38 0.96 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.846 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -115.47 153.26 31.43 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 155.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -124.48 123.97 67.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -138.24 132.4 31.69 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.088 1.755 . . . . 0.0 108.284 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -136.8 156.83 47.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.459 -1.401 . . . . 0.0 107.483 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.72 115.76 7.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.1 p -80.73 153.34 73.01 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 160.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.7 -0.77 10.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.12 3.213 . . . . 0.0 112.53 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 51' ' ' VAL . 26.2 t -80.78 163.94 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 126.578 1.951 . . . . 0.0 108.722 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -143.07 21.93 1.92 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.579 HG11 ' HA ' ' A' ' 22' ' ' VAL . 7.4 p -60.83 155.71 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -135.13 -4.88 2.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.699 0.8 . . . . 0.0 112.445 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HE2' ' OE2' ' A' ' 55' ' ' GLU . 74.0 tttt -70.44 140.52 52.02 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.041 1.291 . . . . 0.0 109.914 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.24 131.01 46.97 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.345 1.458 . . . . 0.0 107.299 167.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' OE2' ' HE2' ' A' ' 53' ' ' LYS . 71.8 mm-40 -87.45 -38.07 16.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.218 0.532 . . . . 0.0 109.679 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.42 ' ND2' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.65 62.02 12.83 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.344 1.857 . . . . 0.0 108.085 -161.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.87 125.75 15.35 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 108.022 -1.568 . . . . 0.0 108.022 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -117.22 145.77 43.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.221 1.009 . . . . 0.0 109.018 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.77 -1.64 27.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.883 1.273 . . . . 0.0 111.905 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.66 146.96 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 129.026 2.931 . . . . 0.0 108.438 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.98 -173.0 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 109.488 -166.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -105.43 159.09 16.19 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.16 1.384 . . . . 0.0 111.31 171.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.401 HG23 ' HA ' ' A' ' 79' ' ' PHE . 58.7 mt -73.37 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.36 0.82 0.5 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 119.033 -0.87 . . . . 0.0 113.975 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -100.48 175.57 5.64 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.764 1.782 . . . . 0.0 109.11 170.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -136.24 134.02 49.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.519 1.127 . . . . 0.0 108.157 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.78 -172.26 31.72 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -133.78 156.38 48.1 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 146.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -121.0 86.77 42.57 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.83 -46.39 31.87 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.253 1.968 . . . . 0.0 114.875 -167.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 -23.76 46.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.809 2.34 . . . . 0.0 111.636 -165.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.57 12.26 46.86 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.757 1.646 . . . . 0.0 113.983 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.489 ' HE3' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER 44.45 48.08 8.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.701 2.0 . . . . 0.0 110.776 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.41 157.03 27.96 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.09 0.948 . . . . 0.0 111.066 -172.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.53 172.56 12.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.641 161.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.53 105.27 3.29 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.872 1.669 . . . . 0.0 109.836 169.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -86.57 120.28 27.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 107.865 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -105.46 105.69 15.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.991 0.814 . . . . 0.0 109.325 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' HA ' HG23 ' A' ' 63' ' ' ILE . 45.2 p90 -136.25 9.24 3.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -175.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.46 -121.21 1.02 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 119.782 1.173 . . . . 0.0 110.65 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -156.56 121.77 4.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.375 1.087 . . . . 0.0 108.517 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -98.14 155.86 36.51 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.996 2.519 . . . . 0.0 112.079 -165.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.61 3.12 6.7 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.489 2.793 . . . . 0.0 115.39 -170.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.5 mmt -81.99 -32.16 30.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.596 1.544 . . . . 0.0 111.289 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.491 ' HB3' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -90.96 175.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.565 0.746 . . . . 0.0 110.087 -176.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 -62.77 0.44 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.16 -26.27 61.12 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.246 0.546 . . . . 0.0 112.395 -165.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -167.9 162.38 13.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 128.359 2.664 . . . . 0.0 107.119 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -75.76 84.19 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 119.534 1.061 . . . . 0.0 109.211 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 85' ' ' SER . 11.1 mt-30 -75.77 144.41 76.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.508 159.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.18 -177.36 3.82 Favored 'Trans proline' 0 C--N 1.346 0.44 1 C-N-CA 125.382 4.055 . . . . 0.0 112.003 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.701 167.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 t -166.36 179.85 5.38 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 126.099 1.76 . . . . 0.0 106.781 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.11 102.36 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.635 1.174 . . . . 0.0 112.17 -171.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.21 149.07 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.96 109.04 15.95 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.42 HG12 ' ND2' ' A' ' 56' ' ' ASN . 1.3 p -80.61 33.06 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 122.548 1.166 . . . . 0.0 112.347 -162.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.3 pt -63.88 -12.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.633 2.373 . . . . 0.0 115.431 -159.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.73 13.61 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 122.571 1.095 . . . . 0.0 111.825 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -117.42 140.81 49.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 163.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.4 mt -72.51 94.82 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 157.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -77.4 -32.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.725 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -153.77 163.45 40.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.821 0.819 . . . . 0.0 111.385 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.62 31.41 54.14 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.283 0.944 . . . . 0.0 112.361 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.77 -54.01 51.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.619 1.209 . . . . 0.0 111.268 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.72 -17.41 59.11 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.766 -0.584 . . . . 0.0 112.141 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.4 -11.75 25.39 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 124.008 0.923 . . . . 0.0 110.828 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.9 -25.76 32.17 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.704 1.138 . . . . 0.0 112.428 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.95 -20.79 62.42 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.711 -1.243 . . . . 0.0 111.485 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.57 28.85 5.23 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.634 2.773 . . . . 0.0 111.108 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.92 166.43 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 127.895 2.478 . . . . 0.0 107.276 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -127.27 -169.51 2.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.323 -1.486 . . . . 0.0 111.264 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -78.43 11.87 2.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.561 1.544 . . . . 0.0 113.854 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.89 79.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.576 0 O-C-N 120.423 -1.423 . . . . 0.0 111.496 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -130.52 40.14 3.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.95 2.1 . . . . 0.0 109.584 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 43.77 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.162 2.585 . . . . 0.0 114.047 163.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.5 p -81.8 111.14 17.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.7 13.4 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.1 t -86.17 126.16 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 127.717 2.407 . . . . 0.0 107.674 -168.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -135.92 172.12 13.47 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.533 1.97 . . . . 0.0 111.428 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.457 ' CE2' HG22 ' A' ' 30' ' ' ILE . 42.0 m-85 -72.24 -11.1 60.57 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.619 ' HB2' ' CB ' ' A' ' 4' ' ' GLU . . . 55.71 58.82 4.21 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 125.517 1.527 . . . . 0.0 114.249 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.2 m -71.32 50.55 0.16 Allowed 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 126.861 2.065 . . . . 0.0 111.457 167.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.094 0 C-N-CA 126.48 1.912 . . . . 0.0 110.158 -169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpp . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 121.359 0.599 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 2.4 mmt-85 -78.9 163.62 25.12 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 123.067 0.547 . . . . 0.0 109.582 173.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.3 t -148.02 146.29 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.518 168.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 14.6 tt0 -120.77 131.62 54.59 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.488 1.915 . . . . 0.0 105.844 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.551 HD11 HD13 ' A' ' 14' ' ' ILE . 54.3 mt -108.71 121.28 44.72 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 7' ' ' PHE . 1.6 tt -123.66 142.13 51.35 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -167.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.834 ' HE1' HG12 ' A' ' 117' ' ' VAL . 5.9 m-85 -134.32 172.13 13.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 119.674 1.125 . . . . 0.0 110.438 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.207 -0.308 . . . . 0.0 110.71 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 m -101.4 -5.65 25.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.02 -163.58 33.82 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 120.931 1.696 . . . . 0.0 111.476 -169.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HA ' ' CD2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -160.42 165.1 31.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.7 1.25 . . . . 0.0 110.261 173.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.7 p -146.73 178.0 8.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.469 1.108 . . . . 0.0 111.529 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 t -133.85 130.18 55.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.141 0.976 . . . . 0.0 108.585 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.551 HD13 HD11 ' A' ' 5' ' ' LEU . 35.9 pt -128.01 147.08 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.435 0.694 . . . . 0.0 109.173 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -131.11 127.77 38.78 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 116.188 1.921 . . . . 0.0 116.188 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -124.91 126.24 45.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.433 1.708 . . . . 0.0 111.563 -161.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -69.6 122.54 19.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.185 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.95 6.6 1.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -85.89 -5.82 59.17 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 120.943 -1.098 . . . . 0.0 110.57 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -105.24 143.14 33.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.09 0.956 . . . . 0.0 109.932 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -45.36 -58.84 3.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.889 1.676 . . . . 0.0 109.427 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.92 -35.87 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.749 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -63.42 -42.99 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.489 1.041 . . . . 0.0 108.909 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -61.53 -44.32 97.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.685 0.794 . . . . 0.0 111.599 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -37.61 78.38 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.338 -1.476 . . . . 0.0 110.905 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.76 -39.83 65.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.842 1.657 . . . . 0.0 110.483 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -62.43 -31.79 72.55 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 123.037 0.535 . . . . 0.0 111.368 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -72.17 -8.92 57.4 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.37 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -131.05 30.25 4.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.93 1.692 . . . . 0.0 110.296 -173.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.43 144.27 52.17 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -63.84 158.96 67.78 Favored 'Cis proline' 0 N--CA 1.459 -0.503 0 CA-C-N 119.029 0.689 . . . . 0.0 113.604 -8.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -150.16 160.85 43.36 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 124.068 0.947 . . . . 0.0 110.682 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -114.45 160.21 19.44 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.187 0.995 . . . . 0.0 108.356 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.56 172.5 10.68 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.536 -0.727 . . . . 0.0 110.297 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 t -76.15 124.03 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.965 HG22 HG13 ' A' ' 117' ' ' VAL . 3.0 t -81.57 74.97 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 123.574 0.749 . . . . 0.0 110.356 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -68.07 163.94 21.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.858 0.754 . . . . 0.0 110.251 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.489 HG22 HG12 ' A' ' 43' ' ' ILE . 72.3 p -137.51 155.64 49.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.42 . . . . 0.0 110.197 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -155.6 99.19 2.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.41 -62.27 2.69 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 124.25 0.928 . . . . 0.0 115.18 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -168.75 40.56 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.958 1.703 . . . . 0.0 109.246 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.78 167.05 31.65 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 38' ' ' THR . 57.8 mt -135.39 133.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.027 1.331 . . . . 0.0 109.357 -176.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.95 159.25 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.968 0.907 . . . . 0.0 109.648 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 3.4 p90 -145.27 157.72 43.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.795 -1.191 . . . . 0.0 108.882 172.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -76.3 98.01 4.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.048 0.939 . . . . 0.0 109.4 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.1 p -68.93 144.79 96.16 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.142 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.7 -28.95 7.62 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.001 2.467 . . . . 0.0 111.003 175.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -67.25 140.21 19.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -121.66 114.98 21.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.94 154.18 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -134.71 21.37 3.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.604 0.761 . . . . 0.0 112.861 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -94.48 119.61 33.45 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.13 1.372 . . . . 0.0 110.94 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.81 112.87 14.02 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.588 1.155 . . . . 0.0 111.84 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.04 -25.95 36.74 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.504 1.122 . . . . 0.0 113.138 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -133.94 60.55 46.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 119.037 0.835 . . . . 0.0 110.675 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.4 95.38 0.61 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.924 2.416 . . . . 0.0 108.876 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.7 mtt-85 -85.35 169.31 13.84 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -123.94 4.71 8.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.743 0.417 . . . . 0.0 111.679 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.7 t -139.92 151.37 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.91 1.684 . . . . 0.0 106.659 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.47 -175.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.323 1.849 . . . . 0.0 109.503 -172.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -114.98 -179.3 3.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.272 1.029 . . . . 0.0 110.303 167.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 63' ' ' ILE . 70.6 mt -77.13 10.15 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 126.649 1.98 . . . . 0.0 110.999 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.39 32.26 1.87 Allowed Glycine 0 CA--C 1.524 0.65 0 O-C-N 120.165 -1.584 . . . . 0.0 112.371 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -123.5 169.74 11.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.35 1.075 . . . . 0.0 109.66 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -139.91 114.76 7.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 -177.46 48.69 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.103 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -131.11 138.7 49.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -116.46 82.63 12.37 Favored Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.406 ' HD2' ' CD ' ' A' ' 71' ' ' PRO . 4.0 Cg_exo -57.55 -47.25 22.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.669 2.246 . . . . 0.0 114.449 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' CD ' ' HD2' ' A' ' 70' ' ' PRO . 56.3 Cg_endo -68.26 -22.45 40.17 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.167 2.578 . . . . 0.0 111.141 -165.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.53 26.43 6.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.522 1.058 . . . . 0.0 113.165 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mttt 46.25 50.92 11.77 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.417 1.487 . . . . 0.0 112.174 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.7 -177.86 4.75 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.061 0.544 . . . . 0.0 110.973 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.405 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 2.7 tp -104.8 -170.96 1.84 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.047 1.739 . . . . 0.0 109.296 172.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.32 153.13 28.54 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.191 1.796 . . . . 0.0 110.05 158.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.57 102.37 4.59 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.986 2.514 . . . . 0.0 105.15 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -91.06 116.11 28.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.216 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.469 ' CD1' HD23 ' A' ' 108' ' ' LEU . 48.9 p90 -141.88 15.23 2.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.06 -146.1 4.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 104.75 8.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -69.28 166.27 31.19 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.502 2.321 . . . . 0.0 113.284 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.98 6.52 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 125.248 3.965 . . . . 0.0 113.419 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.89 136.38 53.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.164 1.785 . . . . 0.0 107.061 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 75.73 163.52 0.25 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 128.834 2.854 . . . . 0.0 109.679 -171.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.67 -42.51 2.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.97 -81.25 0.1 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.428 0.632 . . . . 0.0 111.223 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -98.94 153.84 18.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 127.334 2.254 . . . . 0.0 107.859 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.9 126.81 15.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 124.358 1.063 . . . . 0.0 109.05 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 18.2 mt-30 -126.96 150.42 71.8 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.16 0.984 . . . . 0.0 113.064 167.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.3 -174.43 2.2 Favored 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 126.315 4.677 . . . . 0.0 113.284 174.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.03 -10.1 59.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 t -173.84 -176.52 1.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.86 1.264 . . . . 0.0 108.806 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.28 73.81 0.5 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.414 1.486 . . . . 0.0 111.766 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.4 141.56 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.548 . . . . 0.0 110.31 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -74.76 125.47 28.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.91 49.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.78 -21.77 29.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.684 -172.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.45 164.03 13.44 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 119.631 1.105 . . . . 0.0 112.275 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -129.65 145.63 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.528 1.131 . . . . 0.0 108.352 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mt -76.09 101.67 2.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.83 -22.23 6.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.972 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -155.63 159.07 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.908 0.883 . . . . 0.0 111.652 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.96 11.02 70.93 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 118.746 -1.03 . . . . 0.0 115.145 169.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 tp -51.74 -48.25 63.74 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.005 1.403 . . . . 0.0 111.369 -172.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -70.2 -19.37 63.17 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 120.785 -1.197 . . . . 0.0 111.971 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.2 -0.67 32.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.247 1.019 . . . . 0.0 111.784 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 79' ' ' PHE . 4.9 mp -74.89 -39.01 61.73 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 119.954 -1.717 . . . . 0.0 111.567 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -63.68 -23.74 67.5 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.995 -1.066 . . . . 0.0 111.91 -172.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -94.45 23.0 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 0.0 112.679 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.46 165.63 2.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.397 1.479 . . . . 0.0 107.168 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -125.86 171.08 11.0 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.91 1.684 . . . . 0.0 108.095 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.01 1.91 2.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.218 2.207 . . . . 0.0 114.738 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.41 74.79 0.12 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.74 29.98 5.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.056 2.143 . . . . 0.0 110.029 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.4 mttt 43.07 101.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.611 2.764 . . . . 0.0 113.937 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.965 HG13 HG22 ' A' ' 36' ' ' VAL . 28.0 m -68.2 167.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 116.126 -2.23 . . . . 0.0 105.325 174.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -135.47 109.82 8.42 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 154.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.9 t -78.53 126.26 38.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 125.337 1.455 . . . . 0.0 107.087 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 mtm105 -128.92 176.04 8.18 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 0.0 110.231 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -72.53 -6.94 47.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 58.23 -166.38 0.16 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 126.81 2.044 . . . . 0.0 112.419 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . 0.288 12.0 p 62.97 -11.9 0.08 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.908 3.283 . . . . 0.0 116.961 170.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.257 1.492 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.189 174.151 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 ttm . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -68.4 160.88 28.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.048 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 16' ' ' LEU . 26.1 t -152.94 143.48 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 126.613 1.965 . . . . 0.0 107.126 170.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 41.0 tt0 -135.93 112.55 10.06 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 119.889 -1.757 . . . . 0.0 108.499 -171.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.57 92.26 9.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 131.412 3.885 . . . . 0.0 108.631 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.61 152.4 40.56 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 164.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -131.63 177.82 7.22 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.879 1.672 . . . . 0.0 107.62 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.18 -44.56 83.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.418 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m -86.16 -15.4 41.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -172.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.93 -165.49 34.0 Favored Glycine 0 N--CA 1.467 0.717 0 CA-C-N 120.734 1.606 . . . . 0.0 110.942 -166.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 138.01 8.94 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.915 1.358 . . . . 0.0 110.259 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.575 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 24.1 m -140.11 164.2 30.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.607 1.163 . . . . 0.0 111.772 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.29 112.67 21.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.428 1.091 . . . . 0.0 108.64 -167.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 pt -101.63 139.28 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.12 110.34 21.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 3' ' ' VAL . 25.0 mt -109.82 122.78 48.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.534 1.134 . . . . 0.0 109.708 -167.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.465 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 49.6 t30 -84.64 125.3 32.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.52 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.54 -1.82 12.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.597 1.559 . . . . 0.0 113.538 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.2 -21.14 64.88 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.139 0.881 . . . . 0.0 109.638 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 16.2 m-85 -92.79 124.63 36.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.321 1.448 . . . . 0.0 110.049 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -47.4 -53.91 12.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.241 1.817 . . . . 0.0 111.495 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -44.65 -40.43 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -71.76 -42.09 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.023 1.283 . . . . 0.0 109.958 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -59.26 -37.73 78.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.662 0.785 . . . . 0.0 110.085 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.49 -34.9 54.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.007 1.323 . . . . 0.0 109.983 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.97 -23.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.493 1.117 . . . . 0.0 112.052 172.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -14.4 50.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.742 1.156 . . . . 0.0 111.993 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -86.57 -14.37 43.07 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 120.723 -1.236 . . . . 0.0 112.25 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -124.93 4.58 8.02 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.433 1.093 . . . . 0.0 113.205 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.6 mt -104.6 141.33 22.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 120.1 1.318 . . . . 0.0 107.507 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.32 159.35 94.26 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.294 -0.711 . . . . 0.0 112.589 -6.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 119' ' ' VAL . 34.6 p90 -140.21 164.62 29.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 122.125 -0.359 . . . . 0.0 110.055 165.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -124.26 150.4 45.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.3 161.91 37.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.006 -172.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.01 123.07 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.69 98.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -85.77 155.14 21.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 165.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -131.79 144.55 51.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 108.731 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -154.1 102.63 2.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.47 19.76 79.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 116.45 -2.306 . . . . 0.0 116.674 154.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 76.94 37.96 0.27 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.851 2.826 . . . . 0.0 112.566 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 6.2 tt0 -131.71 163.74 27.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.612 1.965 . . . . 0.0 106.187 150.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.0 mt -127.79 146.24 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 127.009 2.124 . . . . 0.0 107.097 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -134.95 169.32 17.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 122.678 1.228 . . . . 0.0 109.715 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -149.99 150.55 31.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -88.75 82.79 6.74 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -167.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.782 HG21 HD23 ' A' ' 75' ' ' LEU . 11.0 p -65.26 147.92 98.28 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -165.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.19 -26.22 12.86 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.623 2.216 . . . . 0.0 112.072 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.3 136.46 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -122.66 100.02 6.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.733 1.613 . . . . 0.0 107.38 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.04 171.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 129.034 2.934 . . . . 0.0 104.669 165.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.94 3.14 2.0 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 166.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -44.81 118.84 1.74 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.918 1.287 . . . . 0.0 111.053 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtm -108.72 90.59 3.34 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.78 2.032 . . . . 0.0 106.042 -171.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -67.94 -26.88 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.455 -0.778 . . . . 0.0 111.466 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -153.7 54.83 1.2 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.141 1.776 . . . . 0.0 113.692 -167.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.58 162.97 19.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.762 1.642 . . . . 0.0 111.993 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -146.63 -175.71 4.9 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 128.331 2.652 . . . . 0.0 106.489 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -120.28 1.15 10.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.322 1.049 . . . . 0.0 112.916 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.62 159.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.269 2.227 . . . . 0.0 108.998 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.6 m -141.3 -179.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.809 2.044 . . . . 0.0 109.233 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -88.76 178.56 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 120.722 -1.236 . . . . 0.0 110.844 163.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.674 ' O ' HD11 ' A' ' 105' ' ' LEU . 38.7 mt -76.56 4.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.489 1.516 . . . . 0.0 110.261 173.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 43.07 0.67 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -111.78 -154.47 0.54 Allowed 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 129.368 3.067 . . . . 0.0 103.412 161.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.917 HG11 ' HA3' ' A' ' 99' ' ' GLY . 4.9 p -158.72 177.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -143.89 152.26 24.06 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 119.641 -1.912 . . . . 0.0 111.55 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -105.22 123.84 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.321 1.048 . . . . 0.0 109.189 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.401 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 8.1 t90 -104.76 88.29 2.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 127.403 2.281 . . . . 0.0 109.246 -172.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD2' ' CD ' ' A' ' 71' ' ' PRO . 73.5 Cg_endo -61.64 -31.15 86.55 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.033 1.822 . . . . 0.0 115.366 -171.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD2' ' C ' ' A' ' 69' ' ' TRP . 50.7 Cg_endo -67.17 -36.7 20.65 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 123.48 2.278 . . . . 0.0 109.463 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.93 64.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.138 -1.368 . . . . 0.0 113.501 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 45.78 55.63 6.7 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.388 2.094 . . . . 0.0 108.904 -166.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.83 157.83 44.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.782 HD23 HG21 ' A' ' 47' ' ' THR . 3.5 mm? -90.55 176.16 6.79 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.32 124.54 7.5 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.871 1.268 . . . . 0.0 108.855 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' GLU . 8.0 mp -106.19 115.17 29.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.72 2.408 . . . . 0.0 107.553 174.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -107.73 110.45 22.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.862 1.21 . . . . 0.0 108.204 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -125.77 11.24 7.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.695 0.798 . . . . 0.0 112.826 -170.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.64 -128.6 0.96 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 165.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -132.77 107.91 8.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.119 1.459 . . . . 0.0 110.584 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -64.85 165.51 15.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 126.655 1.982 . . . . 0.0 113.383 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.93 7.49 1.31 Allowed 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.889 4.393 . . . . 0.0 114.523 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.1 mmt -116.08 81.37 1.6 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.529 -1.357 . . . . 0.0 109.505 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 p 174.92 -177.03 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.041 2.137 . . . . 0.0 107.632 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -127.94 -59.51 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 143.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -81.4 -37.34 28.3 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.43 162.36 34.65 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.427 1.491 . . . . 0.0 107.733 -165.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.13 83.97 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 121.373 1.897 . . . . 0.0 108.334 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.68 146.29 52.69 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 126.768 2.027 . . . . 0.0 109.923 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.53 -175.34 1.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.932 3.755 . . . . 0.0 112.043 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -38.98 61.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.145 1.378 . . . . 0.0 113.751 168.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -173.24 174.25 3.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 125.661 1.584 . . . . 0.0 109.118 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.37 103.02 0.05 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.6 1.56 . . . . 0.0 111.31 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 93' ' ' SER . 17.2 m -112.21 142.7 23.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.446 1.099 . . . . 0.0 109.734 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -79.58 125.45 29.62 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -90.06 71.06 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.5 pt -87.4 -32.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.917 ' HA3' HG11 ' A' ' 66' ' ' VAL . . . -75.74 169.41 54.77 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 161.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.63 147.56 35.23 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 101.948 -3.352 . . . . 0.0 101.948 131.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.99 83.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 156.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.4 -41.0 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 120.558 -1.339 . . . . 0.0 111.016 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.49 150.09 46.07 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 125.739 1.615 . . . . 0.0 108.713 -169.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 78.35 78.08 0.83 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.674 HD11 ' O ' ' A' ' 63' ' ' ILE . 2.0 tp -108.77 -60.52 1.73 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.164 1.786 . . . . 0.0 110.108 172.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.49 -23.22 58.83 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.47 -0.769 . . . . 0.0 110.439 -172.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -24.11 54.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.415 1.086 . . . . 0.0 111.085 173.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.46 -29.57 56.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.399 0.999 . . . . 0.0 112.027 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -72.4 17.85 0.1 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.952 -1.092 . . . . 0.0 112.74 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -147.85 23.34 1.1 Allowed 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 126.124 1.77 . . . . 0.0 112.437 -178.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.2 mm -105.82 141.05 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 43.3 mmtt -85.18 174.73 9.44 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.4 1.48 . . . . 0.0 109.842 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.61 43.2 0.73 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.674 1.59 . . . . 0.0 112.643 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.43 64.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.385 0 O-C-N 120.12 -1.613 . . . . 0.0 111.91 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 6.2 mm-40 -122.22 24.64 9.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.025 1.73 . . . . 0.0 112.405 -172.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mttp 43.41 86.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.632 2.373 . . . . 0.0 113.494 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.69 104.81 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.804 -0.56 . . . . 0.0 109.522 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.71 96.8 7.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.824 1.65 . . . . 0.0 109.59 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.411 HG11 ' CE1' ' A' ' 32' ' ' PHE . 79.1 t -77.42 117.64 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.779 2.432 . . . . 0.0 108.177 174.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.494 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -130.7 173.74 10.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.92 1.288 . . . . 0.0 109.821 177.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -79.55 -10.6 59.83 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 121.547 1.976 . . . . 0.0 115.602 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 66.92 102.76 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.016 2.126 . . . . 0.0 111.067 -175.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.69 35.02 2.9 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.086 -1.009 . . . . 0.0 110.368 168.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.977 1.711 . . . . 0.0 110.568 -177.251 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttm . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.674 1.225 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.502 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 46.9 mtm-85 -67.2 161.19 25.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.66 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 t -146.73 105.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.521 1.128 . . . . 0.0 107.978 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.635 ' HA ' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -80.78 142.15 34.05 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.636 -1.29 . . . . 0.0 109.403 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.98 97.69 5.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.044 0.938 . . . . 0.0 111.48 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 148.41 25.51 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.98 175.94 8.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.946 1.698 . . . . 0.0 110.36 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -78.2 -5.12 50.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -132.85 5.17 3.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -167.87 39.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -158.95 163.69 36.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.45 1.1 . . . . 0.0 108.25 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 p -161.73 179.87 7.78 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 130.198 3.399 . . . . 0.0 103.862 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -149.68 150.85 13.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 112.126 -2.306 . . . . 0.0 105.115 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 25.1 pt -129.79 114.99 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 124.675 1.19 . . . . 0.0 109.246 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -89.45 107.52 19.12 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.7 -170.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.59 138.61 46.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.768 0.713 . . . . 0.0 110.586 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -87.98 149.51 23.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.742 -0.599 . . . . 0.0 109.69 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.38 -0.66 53.51 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.622 1.169 . . . . 0.0 114.135 -164.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -96.21 5.72 50.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.134 1.374 . . . . 0.0 109.024 -167.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -111.53 133.29 53.91 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.014 2.126 . . . . 0.0 109.178 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.71 -51.7 66.4 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.402 1.081 . . . . 0.0 110.218 -170.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -49.74 -36.06 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.452 1.501 . . . . 0.0 114.456 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.07 -39.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 119.786 1.175 . . . . 0.0 109.283 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.38 -37.5 80.97 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 0.0 110.427 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.0 -36.23 30.93 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.936 0.894 . . . . 0.0 110.735 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.08 -28.32 66.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.361 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -58.52 -26.91 64.0 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.677 0.671 . . . . 0.0 111.591 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -68.12 -26.13 65.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.989 0.813 . . . . 0.0 110.541 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -124.22 24.3 8.13 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 120.952 -1.093 . . . . 0.0 112.614 -160.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.7 mt -115.61 153.38 47.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.449 1.477 . . . . 0.0 108.335 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.26 160.83 23.75 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.067 -1.222 . . . . 0.0 111.341 -24.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' CE1' HG11 ' A' ' 119' ' ' VAL . 33.0 p90 -146.85 171.34 15.35 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.224 1.41 . . . . 0.0 109.756 169.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -122.25 162.58 21.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.252 1.021 . . . . 0.0 109.408 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 -179.92 6.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.063 0.545 . . . . 0.0 109.807 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.15 142.26 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 117' ' ' VAL . 18.3 t -91.65 76.35 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.943 1.297 . . . . 0.0 107.803 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -69.82 156.48 38.98 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.899 -1.126 . . . . 0.0 108.912 175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.5 p -136.45 137.81 40.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.281 1.032 . . . . 0.0 109.956 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 92' ' ' ALA . 67.9 t90 -142.58 75.6 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.454 1.502 . . . . 0.0 108.163 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.13 81.53 0.19 Allowed Glycine 0 C--O 1.218 -0.847 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.987 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 51.6 63.44 2.24 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 118.367 1.084 . . . . 0.0 109.253 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.9 154.87 15.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -131.66 144.09 38.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -148.74 170.62 17.79 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.332 1.453 . . . . 0.0 109.945 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.42 144.13 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.291 1.036 . . . . 0.0 109.256 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -74.85 84.95 2.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.796 2.038 . . . . 0.0 109.384 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 p -61.78 152.32 76.25 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-O 121.413 0.625 . . . . 0.0 111.869 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -81.18 0.23 10.11 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.13 3.22 . . . . 0.0 112.584 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 51' ' ' VAL . 16.9 t -105.55 134.19 47.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 125.12 1.368 . . . . 0.0 108.541 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -114.97 18.03 16.59 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.92 0.888 . . . . 0.0 112.589 -168.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 49' ' ' VAL . 8.3 p -69.33 150.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.739 0.781 . . . . 0.0 112.354 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -135.76 40.9 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.758 2.423 . . . . 0.0 108.586 -172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.411 ' H ' HG22 ' A' ' 51' ' ' VAL . 58.5 tttp -121.61 105.84 10.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.105 2.162 . . . . 0.0 111.165 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -93.19 130.79 38.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.359 1.463 . . . . 0.0 109.716 171.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.32 -44.88 8.48 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.683 -0.636 . . . . 0.0 110.864 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -114.46 60.67 1.09 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.121 0.968 . . . . 0.0 109.581 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.12 144.67 42.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.36 2.04 . . . . 0.0 112.593 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -143.64 164.97 28.91 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.533 0.733 . . . . 0.0 109.751 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.07 12.98 18.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.414 1.886 . . . . 0.0 110.51 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -166.78 150.93 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 129.987 3.315 . . . . 0.0 110.016 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.09 -175.49 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.94 1.296 . . . . 0.0 111.74 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -94.58 175.48 6.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.821 1.248 . . . . 0.0 110.817 170.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 63' ' ' ILE . 51.7 mt -81.44 33.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.692 1.597 . . . . 0.0 111.074 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.508 ' HA2' HD21 ' A' ' 105' ' ' LEU . . . -167.96 34.67 0.2 Allowed Glycine 0 CA--C 1.511 -0.207 0 O-C-N 120.369 -1.457 . . . . 0.0 111.888 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -121.6 -175.28 3.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.214 1.006 . . . . 0.0 108.35 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.7 t -139.12 164.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.182 1.793 . . . . 0.0 107.6 -168.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -165.34 129.12 1.89 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.49 144.5 49.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -114.34 86.79 12.57 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.486 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 68.8 Cg_endo -65.98 -22.23 55.68 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.243 2.629 . . . . 0.0 117.512 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.486 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 42.7 Cg_endo -80.48 -19.1 9.15 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 CA-C-N 123.007 2.11 . . . . 0.0 112.096 -171.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.35 -9.67 11.41 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.615 1.579 . . . . 0.0 114.137 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 58.83 84.28 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.094 2.157 . . . . 0.0 111.299 -164.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.28 175.92 13.23 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.14 -172.42 3.95 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.687 1.595 . . . . 0.0 110.928 162.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 15.8 t -158.22 149.8 21.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.866 1.666 . . . . 0.0 109.09 161.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.46 128.86 47.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.99 2.516 . . . . 0.0 109.448 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.05 112.91 24.01 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 125.011 1.324 . . . . 0.0 109.363 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -134.33 5.55 3.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.767 2.427 . . . . 0.0 113.459 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.18 -168.32 40.43 Favored Glycine 0 CA--C 1.52 0.405 0 O-C-N 119.978 -1.701 . . . . 0.0 110.707 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.08 102.27 14.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -163.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.8 p -74.79 166.33 46.22 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 110.824 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.5 -19.88 48.31 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.362 2.708 . . . . 0.0 113.334 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.7 tpt -97.41 50.69 1.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.229 1.011 . . . . 0.0 110.317 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.0 p -158.93 177.84 10.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.147 0.579 . . . . 0.0 110.26 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.52 -62.46 0.87 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 148.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.05 -49.04 21.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.116 0.96 . . . . 0.0 111.912 -166.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -136.7 158.7 43.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.239 1.816 . . . . 0.0 108.205 -164.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mt -79.6 83.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.56 143.64 59.61 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.807 1.643 . . . . 0.0 111.398 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -81.97 174.99 9.67 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.436 3.424 . . . . 0.0 112.284 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.528 ' HB2' ' CH2' ' A' ' 39' ' ' TRP . . . -66.97 -20.5 65.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 m -156.93 170.35 22.7 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.81 2.444 . . . . 0.0 108.892 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.3 99.11 0.51 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.852 0.751 . . . . 0.0 109.848 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.89 -165.62 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 128.275 2.63 . . . . 0.0 107.396 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -139.8 127.37 21.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 112.511 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 32.75 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.432 -1.418 . . . . 0.0 111.1 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -61.25 -15.63 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 119.68 -1.887 . . . . 0.0 113.698 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.73 165.83 15.32 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 33.3 tptt -134.7 126.18 28.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 170.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.78 93.17 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 166.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.564 ' CG2' HG13 ' A' ' 13' ' ' VAL . 30.8 m -76.42 -63.32 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.612 ' HB2' HG12 ' A' ' 13' ' ' VAL . 1.1 mm-40 -93.07 166.03 12.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -172.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.38 16.57 80.62 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-N 115.241 -0.89 . . . . 0.0 114.793 158.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -54.88 -62.61 1.55 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.162 0.985 . . . . 0.0 109.276 -173.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.35 -21.2 62.92 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.176 -167.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.5 -19.83 64.55 Favored 'General case' 0 C--O 1.225 -0.23 0 O-C-N 121.67 -0.644 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.61 -18.52 65.38 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.618 -1.301 . . . . 0.0 113.44 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -59.11 -29.54 67.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.086 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 27.86 9.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.653 1.115 . . . . 0.0 112.879 -163.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.61 150.55 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -92.84 170.67 9.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.92 15.81 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.643 2.377 . . . . 0.0 112.932 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.71 54.67 0.09 OUTLIER Glycine 0 CA--C 1.533 1.173 0 O-C-N 119.206 -2.184 . . . . 0.0 114.758 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.424 ' CG ' ' H ' ' A' ' 112' ' ' LYS . 13.6 mm-40 -100.3 32.35 3.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.938 1.295 . . . . 0.0 113.274 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.8 mttp 42.03 74.78 0.1 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.309 1.844 . . . . 0.0 112.619 171.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.574 ' HB ' HG22 ' A' ' 36' ' ' VAL . 7.5 p -68.14 105.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.25 88.91 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.39 1.476 . . . . 0.0 107.185 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.511 HG11 ' CE1' ' A' ' 32' ' ' PHE . 90.6 t -71.51 134.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 126.704 2.002 . . . . 0.0 108.648 -173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -141.93 -172.21 3.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.231 1.812 . . . . 0.0 110.332 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -99.9 0.1 40.62 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . 60.72 82.56 0.16 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 126.989 2.116 . . . . 0.0 112.718 -169.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.59 24.43 1.97 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.139 165.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.253 1.286 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 160.177 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.236 0.363 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 152.92 42.83 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.9 t -150.91 130.98 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.267 1.427 . . . . 0.0 107.613 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 22.2 tt0 -115.56 120.53 39.77 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.516 2.326 . . . . 0.0 107.01 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 117' ' ' VAL . 11.2 mp -98.25 109.34 22.11 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 126.884 2.074 . . . . 0.0 106.903 172.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 126.94 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -110.11 173.03 6.51 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.069 0.948 . . . . 0.0 108.445 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.55 -17.66 62.3 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.247 -0.908 . . . . 0.0 111.046 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -115.48 4.59 14.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.594 1.557 . . . . 0.0 114.666 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.75 -164.98 38.38 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.642 -1.286 . . . . 0.0 110.724 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -157.83 158.63 35.53 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.067 0.947 . . . . 0.0 109.079 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -145.38 177.31 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.998 0.919 . . . . 0.0 108.971 174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 t -135.11 133.29 53.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.0 pt -122.66 166.32 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -144.7 135.99 25.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -125.32 114.93 19.55 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 126.686 1.994 . . . . 0.0 108.627 -168.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.92 132.25 52.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.381 0.673 . . . . 0.0 110.411 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.68 21.05 0.21 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.311 1.444 . . . . 0.0 113.842 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.0 10.24 22.16 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.329 1.052 . . . . 0.0 110.454 -173.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -122.72 137.33 54.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.589 1.156 . . . . 0.0 108.938 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.94 -53.67 30.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.963 0.905 . . . . 0.0 110.458 -173.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.37 -32.25 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.36 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.26 -50.45 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.855 1.262 . . . . 0.0 107.886 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -58.71 -43.83 90.19 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.155 0.582 . . . . 0.0 110.942 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -41.97 90.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.766 0.826 . . . . 0.0 109.351 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.34 -28.6 54.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.93 1.292 . . . . 0.0 111.112 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -60.74 -29.96 69.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.713 0.688 . . . . 0.0 110.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -72.35 -14.42 61.72 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.595 0.758 . . . . 0.0 111.863 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -125.29 24.47 7.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.769 1.628 . . . . 0.0 110.982 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mt -121.56 136.86 26.33 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.26 164.97 57.82 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 N-CA-C 114.772 1.028 . . . . 0.0 114.772 -7.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.26 165.49 35.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.686 0.794 . . . . 0.0 112.136 166.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -121.78 160.11 25.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.366 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -163.57 -159.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.432 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.12 134.49 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.075 1.35 . . . . 0.0 108.606 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.38 76.34 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 124.884 1.274 . . . . 0.0 108.111 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -69.31 144.96 53.39 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.256 -1.527 . . . . 0.0 107.615 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.5 p -129.07 147.31 50.92 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.624 0.647 . . . . 0.0 110.215 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -151.79 64.32 0.86 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.725 0.81 . . . . 0.0 109.685 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 82' ' ' THR . . . 70.91 77.72 0.48 Allowed Glycine 0 C--O 1.211 -1.298 0 O-C-N 120.98 -1.075 . . . . 0.0 111.581 170.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 62.06 23.0 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.106 1.453 . . . . 0.0 112.333 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -126.49 145.98 50.29 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.649 2.38 . . . . 0.0 107.317 171.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 mt -122.73 144.48 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 163.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -147.08 158.17 43.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 166.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -141.89 153.85 44.7 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.2 t -79.91 104.54 10.55 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -68.43 149.64 97.96 Favored Pre-proline 0 N--CA 1.447 -0.588 0 O-C-N 121.813 -0.554 . . . . 0.0 110.008 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.72 -36.85 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.076 2.518 . . . . 0.0 110.793 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 149.36 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -132.2 121.87 24.35 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.539 1.936 . . . . 0.0 106.048 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.9 143.81 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -128.54 36.37 4.26 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.3 1.04 . . . . 0.0 111.31 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -128.91 114.87 17.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.093 2.557 . . . . 0.0 107.623 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 162.27 13.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.443 1.097 . . . . 0.0 109.933 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.2 -39.8 3.56 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.996 1.719 . . . . 0.0 110.517 166.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -122.0 60.85 12.65 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.174 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.61 131.49 29.74 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.007 1.138 . . . . 0.0 110.61 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -129.79 124.94 34.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -90.19 0.48 57.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.339 0.518 . . . . 0.0 111.919 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -137.29 135.58 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.65 173.27 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.959 -167.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -115.65 168.02 10.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.937 0.875 . . . . 0.0 112.866 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.2 mt -78.52 68.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.789 2.035 . . . . 0.0 106.85 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.77 -1.14 0.16 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.406 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.3 174.54 7.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.306 2.053 . . . . 0.0 109.564 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.29 146.55 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.181 1.392 . . . . 0.0 107.941 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.64 161.03 26.18 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.316 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -81.21 146.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 168.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.422 ' HE1' ' HG ' ' A' ' 93' ' ' SER . 6.5 t90 -121.03 85.43 40.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.897 1.279 . . . . 0.0 108.382 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.05 -38.96 84.57 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.382 2.055 . . . . 0.0 115.854 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.5 -28.5 32.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.673 2.249 . . . . 0.0 109.814 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.82 4.52 75.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.028 -1.429 . . . . 0.0 114.535 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.96 25.84 4.29 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.47 2.135 . . . . 0.0 112.728 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.44 178.1 7.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.08 -158.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.3 -172.97 4.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.166 166.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.7 m -148.25 158.37 44.04 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.888 2.475 . . . . 0.0 107.02 161.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mt -146.62 114.25 6.4 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.138 1.775 . . . . 0.0 109.488 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -102.73 106.22 16.81 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.103 0.961 . . . . 0.0 110.335 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -138.28 18.25 2.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.47 -134.25 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.148 0.885 . . . . 0.0 111.514 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -127.64 94.44 3.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 40' ' ' GLY . 0.7 OUTLIER -64.67 154.26 85.42 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.86 1.664 . . . . 0.0 111.222 -175.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.97 5.36 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 125.087 3.858 . . . . 0.0 113.685 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.98 24.75 12.3 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.379 1.472 . . . . 0.0 109.212 175.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.46 166.63 23.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.552 1.541 . . . . 0.0 107.985 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -153.17 -68.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -170.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.407 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 19.3 t70 -73.69 -50.83 18.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 122.206 1.003 . . . . 0.0 111.106 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -129.77 177.57 7.15 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 130.369 3.467 . . . . 0.0 107.187 -173.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -80.89 141.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.99 1.268 . . . . 0.0 108.62 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -141.46 144.87 35.43 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.02 0.928 . . . . 0.0 110.236 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.1 169.58 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.501 3.467 . . . . 0.0 113.911 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.16 64.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.422 ' HG ' ' HE1' ' A' ' 69' ' ' TRP . 81.7 p -164.52 -168.86 1.61 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.475 1.11 . . . . 0.0 108.195 165.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 76.9 0.12 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.697 0.761 . . . . 0.0 111.567 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.52 169.84 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.765 1.226 . . . . 0.0 109.242 165.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -114.71 129.16 56.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.866 1.266 . . . . 0.0 109.729 171.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.83 86.13 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.6 pt -103.73 -22.64 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 110.504 170.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.03 163.64 12.51 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -128.41 145.32 51.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.246 1.018 . . . . 0.0 108.596 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 91.9 mt -74.08 102.39 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 158.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -27.88 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 112.783 -2.008 . . . . 0.0 107.293 -167.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -155.86 161.45 40.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.022 2.529 . . . . 0.0 112.299 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.85 30.78 37.79 Favored Glycine 0 C--O 1.221 -0.674 0 CA-C-O 118.205 -1.331 . . . . 0.0 113.284 172.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.73 -41.36 97.53 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.142 1.971 . . . . 0.0 113.17 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.81 -19.87 47.46 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.121 -0.987 . . . . 0.0 111.246 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.3 -22.72 63.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.705 1.202 . . . . 0.0 110.371 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.04 -34.42 77.65 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.167 1.787 . . . . 0.0 110.285 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -67.56 -2.62 6.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -100.9 -16.03 17.35 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 123.929 0.892 . . . . 0.0 112.01 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.02 165.27 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.01 0.823 . . . . 0.0 109.65 -165.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -113.69 -179.76 3.73 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.202 1.401 . . . . 0.0 108.449 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.16 22.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.028 2.131 . . . . 0.0 114.876 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.99 26.81 0.03 OUTLIER Glycine 0 C--N 1.338 0.666 0 O-C-N 119.817 -1.802 . . . . 0.0 115.907 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.06 49.05 1.04 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.806 1.803 . . . . 0.0 112.052 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.2 mttt 42.98 82.53 0.03 OUTLIER 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.263 2.225 . . . . 0.0 114.161 157.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.515 HG21 HD23 ' A' ' 5' ' ' LEU . 4.8 p -76.73 104.09 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.415 1.486 . . . . 0.0 107.699 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.37 101.07 13.21 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.72 134.01 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 128.58 2.752 . . . . 0.0 107.632 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -138.98 175.36 9.62 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.194 2.598 . . . . 0.0 109.634 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -73.6 -10.2 59.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 121.025 1.739 . . . . 0.0 114.884 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 63.97 162.96 0.12 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 126.097 1.759 . . . . 0.0 111.105 -154.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.6 m -141.6 2.19 1.59 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.944 2.098 . . . . 0.0 110.212 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.252 1.196 0 C-N-CA 125.489 1.516 . . . . 0.0 108.763 173.806 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpp . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -112.82 179.68 3.9 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.51 1.924 . . . . 0.0 107.706 162.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.5 t -147.59 150.31 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.274 2.229 . . . . 0.0 106.838 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 27.5 tt0 -125.23 145.71 49.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.705 2.002 . . . . 0.0 107.256 173.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.8 mt -121.98 111.96 17.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.99 122.17 44.05 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -106.8 172.08 7.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.4 -23.82 67.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.588 0.755 . . . . 0.0 111.562 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -125.26 8.74 7.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -167.79 40.84 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-O 119.527 -0.596 . . . . 0.0 111.816 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -159.2 153.66 24.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.831 0.815 . . . . 0.0 111.117 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.0 p -136.8 179.42 6.38 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.426 0.691 . . . . 0.0 110.595 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.61 135.22 49.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.51 124.45 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -96.31 117.89 31.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.986 1.314 . . . . 0.0 107.754 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -128.12 135.72 50.18 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 118.848 0.749 . . . . 0.0 109.715 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -101.04 106.78 18.1 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.01 1.71 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 1 C-N-CA 131.836 4.054 . . . . 0.0 117.151 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.76 -44.21 64.45 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.635 -1.29 . . . . 0.0 107.953 164.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -62.6 139.69 58.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 110.194 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.74 -56.35 16.19 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.283 1.833 . . . . 0.0 107.28 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.441 HG12 HD23 ' A' ' 26' ' ' LEU . 1.5 t -57.45 -38.64 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.042 -173.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.36 -35.62 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.001 -170.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -61.25 -47.32 86.57 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.876 -0.515 . . . . 0.0 111.008 170.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -32.25 71.36 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.719 1.208 . . . . 0.0 110.417 -171.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.773 ' CD2' HG11 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -59.94 -40.99 90.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.389 1.876 . . . . 0.0 109.825 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -50.42 -36.19 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.897 0.879 . . . . 0.0 110.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -69.89 -23.83 63.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.615 0.766 . . . . 0.0 111.622 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -113.13 -10.35 13.43 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 111.336 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -83.21 143.57 45.47 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -70.17 149.72 90.02 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 125.47 -0.637 . . . . 0.0 112.229 -10.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -139.48 168.33 20.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.124 0.97 . . . . 0.0 109.802 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -114.13 166.0 12.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.32 161.24 39.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.603 -0.685 . . . . 0.0 109.928 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.76 128.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 43' ' ' ILE . 35.5 t -77.62 107.45 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 167.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -96.61 151.23 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 163.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.4 p -122.46 149.97 43.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.214 1.006 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -149.43 92.88 1.99 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.2 -88.17 0.49 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 123.646 0.641 . . . . 0.0 111.758 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HB2' ' H ' ' A' ' 82' ' ' THR . 98.0 mt-10 -141.43 36.74 1.68 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.972 1.709 . . . . 0.0 107.944 -173.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -133.17 163.84 28.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 109.681 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.507 HG23 HG13 ' A' ' 36' ' ' VAL . 20.0 mt -123.07 142.59 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -136.46 161.56 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.588 1.555 . . . . 0.0 107.303 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.39 142.83 27.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -75.2 93.33 2.81 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.566 1.146 . . . . 0.0 109.325 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.1 p -62.29 150.92 83.51 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -67.9 -39.04 11.91 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.107 2.538 . . . . 0.0 110.914 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.773 HG11 ' CD2' ' A' ' 26' ' ' LEU . 11.9 p -67.24 155.25 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.595 -0.69 . . . . 0.0 109.673 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -154.63 56.11 0.68 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.329 0.652 . . . . 0.0 112.464 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.12 173.3 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 0.0 110.103 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.0 14.03 2.26 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -69.94 127.76 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -136.03 93.99 2.99 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.827 1.251 . . . . 0.0 110.205 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -75.33 -43.54 50.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -117.19 66.35 4.25 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 111.635 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.31 155.39 69.46 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 120.759 0.972 . . . . 0.0 111.212 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -144.61 157.72 44.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.605 1.162 . . . . 0.0 108.911 168.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -119.63 5.48 11.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.85 1.26 . . . . 0.0 111.892 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.3 145.05 27.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.15 179.45 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.805 0.842 . . . . 0.0 110.115 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -87.88 -168.59 2.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 0.0 111.139 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.408 ' O ' HD11 ' A' ' 105' ' ' LEU . 13.7 mt -90.79 -8.62 10.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 124.803 1.241 . . . . 0.0 110.917 161.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.68 83.22 0.25 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 105.663 -2.975 . . . . 0.0 105.663 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -141.15 -175.18 4.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.74 3.216 . . . . 0.0 105.884 152.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.96 163.3 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 131.312 3.845 . . . . 0.0 109.443 -166.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.91 144.25 9.3 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.87 163.52 27.19 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.169 0.984 . . . . 0.0 109.771 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -136.66 87.31 20.86 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 109.973 -172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.58 -27.53 69.6 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 121.465 1.443 . . . . 0.0 115.201 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.79 -28.39 16.88 Favored 'Trans proline' 0 C--N 1.354 0.822 0 CA-C-N 123.787 2.388 . . . . 0.0 111.362 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.28 9.93 26.63 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.736 -1.035 . . . . 0.0 113.737 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm 46.17 55.84 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.697 1.599 . . . . 0.0 110.814 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.93 176.94 7.47 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.699 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.0 174.49 6.53 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 125.784 1.633 . . . . 0.0 109.929 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.61 137.2 23.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.565 1.946 . . . . 0.0 109.861 162.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.64 109.7 14.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.745 3.618 . . . . 0.0 106.079 172.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.23 49.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.647 1.112 . . . . 0.0 108.632 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -147.01 34.57 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.93 -120.94 0.55 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.877 2.18 . . . . 0.0 108.135 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.81 5.8 7.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.667 1.733 . . . . 0.0 113.302 170.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 41' ' ' GLU 0.298 0.0 OUTLIER 62.93 167.72 0.1 Allowed Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.68 1.127 . . . . 0.0 113.858 167.948 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -91.41 6.15 3.7 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.973 3.115 . . . . 0.0 113.527 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -132.54 62.86 1.64 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.7 1.136 . . . . 0.0 108.277 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -156.62 175.0 14.62 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.343 1.457 . . . . 0.0 109.633 -174.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -148.38 -50.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 154.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.41 -58.98 2.97 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -132.2 168.46 18.0 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.228 2.611 . . . . 0.0 108.502 -167.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.73 122.06 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -129.77 144.32 52.51 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 123.413 0.445 . . . . 0.0 110.479 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.02 173.26 14.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.136 3.224 . . . . 0.0 112.717 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.12 -33.29 75.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.76 175.03 10.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.154 1.382 . . . . 0.0 107.511 172.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 100.33 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.18 -173.46 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -130.92 125.14 32.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.266 2.4 t -90.39 61.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.838 -163.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.3 pt -77.14 -10.48 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.715 2.006 . . . . 0.0 112.398 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.18 167.18 12.58 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 130.423 3.868 . . . . 0.0 112.268 -166.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -148.14 129.04 14.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.825 2.05 . . . . 0.0 106.751 150.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.8 mt -56.98 100.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 101.536 -3.505 . . . . 0.0 101.536 155.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 m -76.57 -36.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 118.903 0.774 . . . . 0.0 110.869 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -149.97 164.13 36.28 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.29 1.036 . . . . 0.0 111.142 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.5 33.05 71.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.994 1.283 . . . . 0.0 112.59 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 63' ' ' ILE . 55.0 tp -58.74 -52.33 66.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.332 1.053 . . . . 0.0 112.288 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.48 -21.26 56.06 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.001 -0.437 . . . . 0.0 111.316 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -9.89 6.63 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.021 1.328 . . . . 0.0 111.75 175.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.9 mt -79.78 -41.23 26.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.808 1.643 . . . . 0.0 111.611 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -65.23 -12.2 48.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.825 -1.172 . . . . 0.0 113.142 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -102.96 14.17 32.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.566 1.146 . . . . 0.0 112.125 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -107.3 127.47 63.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.253 1.421 . . . . 0.0 107.727 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -70.27 174.34 5.71 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.287 1.035 . . . . 0.0 110.471 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.34 49.57 0.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.929 1.692 . . . . 0.0 111.624 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.03 88.54 0.07 OUTLIER Glycine 0 C--O 1.231 -0.074 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -138.5 26.68 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 -173.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 mttm 43.41 75.33 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.013 2.125 . . . . 0.0 111.746 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.75 105.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.72 102.35 10.68 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.95 123.5 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 126.423 1.889 . . . . 0.0 107.669 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -132.97 172.43 12.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.14 1.336 . . . . 0.0 109.139 164.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -70.76 -12.49 61.58 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 55.66 99.43 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.122 1.369 . . . . 0.0 109.969 -162.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 87.5 p 59.09 -13.16 0.03 OUTLIER 'General case' 0 C--N 1.335 -0.061 0 N-CA-C 119.101 3.0 . . . . 0.0 119.101 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.247 0.931 0 CA-C-N 119.107 0.867 . . . . 0.0 109.133 -147.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttp . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -94.72 164.91 12.75 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.206 1.002 . . . . 0.0 109.821 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -149.27 132.5 7.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 35.0 tt0 -113.06 140.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 mp -114.15 99.97 8.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.38 142.44 33.01 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -133.96 165.91 23.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.42 -17.16 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.912 -1.118 . . . . 0.0 112.332 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 m -115.61 -6.01 12.19 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.44 -169.01 39.93 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 120.633 1.56 . . . . 0.0 109.511 -172.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -169.95 113.29 0.48 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.002 0.906 . . . . 0.0 111.578 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.542 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 30.7 m -119.46 171.69 8.17 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.961 1.304 . . . . 0.0 108.713 -169.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 t -139.9 133.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -166.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.5 pt -123.36 160.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 123.386 1.565 . . . . 0.0 108.371 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.433 ' CA ' HD22 ' A' ' 16' ' ' LEU . 11.9 p-10 -145.96 128.18 15.74 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.555 -164.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -129.85 149.19 51.69 Favored 'General case' 0 C--O 1.246 0.887 0 O-C-N 125.08 1.487 . . . . 0.0 110.291 -166.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -87.01 22.34 2.06 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 24.1 mt-10 46.27 14.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.844 2.058 . . . . 0.0 116.215 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -116.18 10.53 14.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.013 -1.055 . . . . 0.0 110.084 -166.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -125.71 135.68 52.35 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -171.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -47.34 -51.31 19.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 110.152 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.279 7.5 p -48.86 -56.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.678 1.991 . . . . 0.0 112.376 172.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.74 -45.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 121.797 2.09 . . . . 0.0 110.74 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 18' ' ' GLU . 79.9 mttt -65.51 -43.15 91.0 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.775 0.83 . . . . 0.0 111.602 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.4 mt -75.43 -30.8 60.14 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.336 1.055 . . . . 0.0 110.222 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.96 -26.11 61.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.321 1.048 . . . . 0.0 110.587 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp -64.91 -9.7 23.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.573 0.749 . . . . 0.0 112.865 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.74 -18.79 22.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.992 1.269 . . . . 0.0 112.159 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -125.92 31.23 5.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.117 1.367 . . . . 0.0 110.217 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.04 141.13 34.96 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 170.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.14 164.87 28.49 Favored 'Cis proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.712 0.933 . . . . 0.0 111.907 -14.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CE1' HG11 ' A' ' 119' ' ' VAL . 22.6 p90 -148.94 165.53 31.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.171 165.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -110.61 158.9 18.07 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 162.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -151.92 -171.79 4.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.007 0.923 . . . . 0.0 108.863 164.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -97.73 138.04 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.774 1.629 . . . . 0.0 107.224 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 117' ' ' VAL . 6.2 t -90.09 64.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.452 1.101 . . . . 0.0 110.127 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -68.66 143.59 54.73 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.476 -1.29 . . . . 0.0 107.524 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 43' ' ' ILE . 18.8 p -111.03 155.33 22.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.971 0.805 . . . . 0.0 109.938 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -147.26 73.19 1.28 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 76.21 0.55 Allowed Glycine 0 C--O 1.218 -0.856 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.808 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.21 25.22 15.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.723 2.009 . . . . 0.0 112.011 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -135.41 157.77 46.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.631 165.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 38' ' ' THR . 34.1 mt -125.15 117.66 50.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.052 1.741 . . . . 0.0 107.247 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -110.9 166.9 10.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.761 1.267 . . . . 0.0 109.718 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.618 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 3.4 p90 -151.04 149.21 29.27 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.2 t -79.0 102.85 8.56 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -79.35 150.57 74.01 Favored Pre-proline 0 N--CA 1.451 -0.417 0 O-C-N 121.765 -0.584 . . . . 0.0 110.969 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.74 -16.48 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.074 3.183 . . . . 0.0 114.601 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.427 HG12 HG12 ' A' ' 51' ' ' VAL . 21.6 t -83.11 107.13 14.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -90.14 51.03 1.96 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 123.413 1.578 . . . . 0.0 109.254 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG12 HG12 ' A' ' 49' ' ' VAL . 4.6 p -80.81 155.86 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.348 1.459 . . . . 0.0 107.716 166.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.05 4.55 2.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 166.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -62.46 102.36 0.31 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.236 1.38 . . . . 0.0 112.333 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.02 124.58 40.09 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.791 0.837 . . . . 0.0 110.308 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.84 -24.42 13.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.518 0.727 . . . . 0.0 112.529 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -114.9 55.73 0.88 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-O 117.49 -1.243 . . . . 0.0 110.044 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.45 126.9 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.217 1.944 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -136.0 127.86 29.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.78 0.45 57.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 118.45 -0.785 . . . . 0.0 111.164 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.1 t -138.88 141.64 36.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.91 174.32 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.175 1.39 . . . . 0.0 109.587 -171.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.62 -177.05 3.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 110.841 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mt -86.43 1.51 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.064 1.345 . . . . 0.0 112.454 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.79 44.55 0.78 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 125.012 1.291 . . . . 0.0 113.128 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' OD1' ' HE2' ' A' ' 100' ' ' LYS . 70.8 m-20 -125.82 174.66 8.2 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.22 147.52 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.25 147.85 19.35 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -93.69 141.6 28.31 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.803 1.301 . . . . 0.0 109.688 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -112.69 85.87 7.99 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.904 1.281 . . . . 0.0 109.946 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -64.32 -33.18 60.02 Favored 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 121.645 1.563 . . . . 0.0 115.264 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.47 -7.23 20.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.504 2.803 . . . . 0.0 112.335 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.52 9.15 8.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.215 1.864 . . . . 0.0 113.569 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.71 32.76 20.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.674 1.237 . . . . 0.0 111.868 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.33 13.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.906 0.775 . . . . 0.0 111.343 -167.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.618 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -80.48 -173.96 4.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.159 0.584 . . . . 0.0 110.153 162.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.415 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 7.5 t -154.91 143.69 20.76 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.22 2.208 . . . . 0.0 106.823 165.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 42' ' ' GLU . 28.4 mt -135.57 103.75 5.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.801 1.64 . . . . 0.0 107.742 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -87.71 135.7 33.26 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.028 1.286 . . . . 0.0 109.9 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -148.4 9.79 0.84 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.74 62.75 0.06 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.114 -1.993 . . . . 0.0 115.224 165.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 75.22 179.07 0.19 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.338 1.855 . . . . 0.0 107.803 -170.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.24 160.0 31.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.8 -27.74 37.27 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.123 2.549 . . . . 0.0 111.435 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.65 31.96 0.2 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.866 1.266 . . . . 0.0 111.219 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -148.75 166.15 29.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.739 -1.225 . . . . 0.0 112.001 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -136.91 -56.52 0.72 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.51 -61.81 1.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.574 1.15 . . . . 0.0 110.476 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -122.82 144.91 48.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.395 1.478 . . . . 0.0 107.103 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.5 mt -59.3 118.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -130.86 145.01 55.85 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 95' ' ' VAL . 38.1 Cg_endo -74.59 175.13 11.5 Favored 'Trans proline' 0 N--CA 1.455 -0.782 1 C-N-CA 126.219 4.613 . . . . 0.0 113.179 171.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.78 -7.04 50.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 t -171.87 -177.66 2.0 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.713 2.005 . . . . 0.0 106.718 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 73.89 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.22 165.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 91' ' ' PRO . 14.7 m -68.84 -177.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 161.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -138.4 124.68 20.42 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.161 -0.962 . . . . 0.0 111.449 -169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.09 72.66 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 122.431 1.11 . . . . 0.0 108.999 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.9 pt -92.77 -14.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.175 1.39 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.66 173.48 23.5 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.428 ' HE2' ' OD1' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -125.93 175.14 7.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.804 1.242 . . . . 0.0 110.415 177.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.47 77.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 122.861 1.315 . . . . 0.0 107.979 166.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -29.32 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.084 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -146.69 158.32 43.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.99 2.516 . . . . 0.0 109.241 168.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.542 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 81.02 61.17 2.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.598 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.16 -60.46 1.67 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -70.3 -27.73 64.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.111 0.957 . . . . 0.0 110.001 -166.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 1.69 5.36 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.786 2.035 . . . . 0.0 112.48 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -87.37 -35.79 18.16 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.842 1.201 . . . . 0.0 111.756 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -14.24 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.523 -1.361 . . . . 0.0 114.472 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.58 0.86 26.9 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.624 2.37 . . . . 0.0 111.7 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mm -83.66 157.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -109.73 172.7 6.7 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.832 1.253 . . . . 0.0 109.118 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.408 ' HA ' HG23 ' A' ' 38' ' ' THR . 0.4 OUTLIER -69.61 11.9 0.23 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.755 2.422 . . . . 0.0 114.286 -175.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.58 75.42 0.05 OUTLIER Glycine 0 C--N 1.333 0.401 0 O-C-N 119.991 -1.693 . . . . 0.0 109.885 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -117.46 37.91 3.75 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.863 1.665 . . . . 0.0 111.242 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.4 mttm 44.04 74.24 0.13 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.869 2.068 . . . . 0.0 112.018 166.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.473 ' HB ' HG22 ' A' ' 36' ' ' VAL . 1.7 p -73.92 101.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.37 100.21 9.85 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.443 HG11 ' CE1' ' A' ' 32' ' ' PHE . 62.0 t -75.99 135.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 126.373 1.869 . . . . 0.0 108.713 173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -140.57 178.59 7.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.773 1.629 . . . . 0.0 109.178 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.95 3.54 11.94 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 123.965 1.84 . . . . 0.0 115.351 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.457 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 56.21 -164.28 0.15 Allowed 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 126.172 1.789 . . . . 0.0 110.728 -156.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 98.8 p 56.24 46.78 20.6 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.567 1.947 . . . . 0.0 111.434 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.856 -1.545 . . . . 0.0 112.436 177.195 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 121.782 0.801 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.484 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -66.08 164.48 15.34 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.97 -1.081 . . . . 0.0 109.444 168.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.25 108.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -81.78 128.83 34.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.169 -1.582 . . . . 0.0 107.657 164.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 119' ' ' VAL . 2.6 mm? -96.59 114.2 25.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.982 1.713 . . . . 0.0 107.257 169.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.11 133.21 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -123.06 178.49 5.06 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.388 1.075 . . . . 0.0 109.572 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -68.27 -27.37 66.27 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.655 -1.278 . . . . 0.0 112.7 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 m -115.42 -10.75 11.94 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.76 -163.79 28.52 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 119.069 0.849 . . . . 0.0 111.237 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -157.08 149.05 22.68 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.125 0.97 . . . . 0.0 110.356 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -126.1 172.37 10.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 103' ' ' GLU . 15.9 t -138.03 126.03 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 160.06 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 123.539 1.638 . . . . 0.0 106.744 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 100' ' ' LYS . 7.4 p-10 -124.18 115.77 21.64 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 129.449 3.1 . . . . 0.0 104.818 -170.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.406 HD23 ' CA ' ' A' ' 99' ' ' GLY . 84.4 mt -119.19 138.73 52.75 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -96.66 139.06 33.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.61 36.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.851 1.26 . . . . 0.0 112.383 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.87 -7.47 14.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 110.481 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -101.28 138.22 38.59 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 120.519 -1.363 . . . . 0.0 111.006 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -49.22 -62.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.199 1.8 . . . . 0.0 108.09 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.605 HG12 HD23 ' A' ' 26' ' ' LEU . 1.5 t -50.98 -40.96 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -173.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.4 t -67.36 -34.48 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -65.06 -50.31 66.69 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 110.85 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -32.59 73.24 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.992 0.814 . . . . 0.0 109.5 -169.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.678 HD22 HG21 ' A' ' 49' ' ' VAL . 3.2 mm? -60.86 -37.8 83.39 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.476 2.311 . . . . 0.0 111.095 172.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -61.78 -24.73 67.03 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.001 1.273 . . . . 0.0 111.468 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.94 -17.06 57.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -127.26 36.82 4.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.124 1.77 . . . . 0.0 110.627 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' A' ' 31' ' ' PRO . 61.4 mt -128.76 145.94 58.3 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 173.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 30' ' ' ILE . 20.1 Cg_endo -63.35 160.11 62.18 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 119.224 0.758 . . . . 0.0 112.163 -9.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.506 ' CE1' HG11 ' A' ' 119' ' ' VAL . 35.2 p90 -149.17 162.21 40.44 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -118.88 165.86 13.53 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.402 0.681 . . . . 0.0 109.732 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.54 175.61 8.83 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.362 0.601 . . . . 0.0 111.382 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.53 131.3 39.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.403 HG11 ' CG2' ' A' ' 111' ' ' ILE . 40.3 t -79.81 71.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -64.2 154.3 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.798 1.181 . . . . 0.0 108.551 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.428 HG22 HG12 ' A' ' 43' ' ' ILE . 34.9 p -137.37 151.32 48.45 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.323 1.049 . . . . 0.0 111.838 -174.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -155.47 88.76 1.15 Allowed 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.2 80.91 0.05 OUTLIER Glycine 0 C--O 1.213 -1.193 0 CA-C-O 118.321 -1.266 . . . . 0.0 114.492 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 67.44 20.45 9.86 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.978 1.889 . . . . 0.0 112.22 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -135.1 146.95 49.36 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.953 0.901 . . . . 0.0 109.532 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 38' ' ' THR . 62.7 mt -130.35 127.76 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.353 1.861 . . . . 0.0 106.547 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -143.62 142.98 31.27 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.067 1.347 . . . . 0.0 109.376 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -131.26 144.78 51.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 120.77 -1.206 . . . . 0.0 109.059 -173.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 m -79.1 79.42 5.5 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.481 1.512 . . . . 0.0 110.728 -168.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.6 p -57.36 152.63 31.4 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.957 0.903 . . . . 0.0 112.896 -170.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.39 -12.74 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.627 2.885 . . . . 0.0 112.212 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.678 HG21 HD22 ' A' ' 26' ' ' LEU . 47.2 t -96.91 140.39 17.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -132.17 89.6 2.69 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -116.33 161.47 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.66 5.51 8.86 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.546 -0.721 . . . . 0.0 112.563 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -74.2 127.18 32.3 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.456 1.903 . . . . 0.0 110.187 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.34 101.85 7.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.177 1.391 . . . . 0.0 109.984 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.46 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.17 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -143.41 81.01 12.69 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 124.055 0.942 . . . . 0.0 111.772 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 65.5 Cg_endo -75.64 143.22 26.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.465 3.443 . . . . 0.0 112.161 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -136.69 169.59 17.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.41 1.084 . . . . 0.0 108.63 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -121.98 4.36 9.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.806 1.243 . . . . 0.0 112.222 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.55 143.19 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 m -132.73 173.12 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 109.14 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -85.31 -176.64 6.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.806 0.812 . . . . 0.0 110.349 164.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.49 -7.58 10.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 124.611 1.165 . . . . 0.0 110.42 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.82 35.82 2.05 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-O 118.64 -1.089 . . . . 0.0 112.311 -168.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . 74.1 m-20 -112.87 173.77 6.22 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.463 1.505 . . . . 0.0 111.355 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.91 135.07 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 120.753 -1.217 . . . . 0.0 110.895 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.24 176.74 16.89 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.909 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -101.55 159.59 15.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.79 1.236 . . . . 0.0 110.334 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.408 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 t90 -132.82 83.06 53.94 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 119.347 0.976 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.17 -24.37 65.93 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.448 2.765 . . . . 0.0 117.936 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HD2' ' C ' ' A' ' 69' ' ' TRP . 22.1 Cg_endo -72.83 -45.06 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.057 2.504 . . . . 0.0 108.982 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.09 -4.36 58.66 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.439 -1.201 . . . . 0.0 114.273 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 55.24 73.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.671 1.988 . . . . 0.0 108.692 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.15 171.46 15.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.727 0.775 . . . . 0.0 112.9 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.08 -178.42 7.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 109.519 157.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 31.5 m -142.95 160.52 40.19 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.875 1.27 . . . . 0.0 109.336 156.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -145.52 97.35 2.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 128.465 2.706 . . . . 0.0 105.273 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -83.52 146.75 28.18 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.14 26.69 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.46 -100.74 0.17 Allowed Glycine 0 C--N 1.333 0.392 0 O-C-N 119.514 -1.991 . . . . 0.0 111.744 165.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -128.14 -13.48 5.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 57.99 165.99 0.07 OUTLIER Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.155 1.782 . . . . 0.0 112.541 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.33 -18.31 9.8 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.563 2.175 . . . . 0.0 112.902 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.79 49.58 0.89 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 122.232 1.015 . . . . 0.0 109.255 -169.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.12 179.51 6.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 121.192 -0.943 . . . . 0.0 110.746 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -142.83 -42.97 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.734 1.214 . . . . 0.0 109.89 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.8 -56.27 2.37 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.25 -0.906 . . . . 0.0 111.538 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -127.93 178.67 6.02 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.553 1.941 . . . . 0.0 109.635 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -77.52 134.44 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 120.231 1.378 . . . . 0.0 108.069 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -123.83 151.33 64.33 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 123.449 0.7 . . . . 0.0 109.311 165.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.89 177.92 7.91 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 124.005 3.137 . . . . 0.0 111.917 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.4 61.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.452 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.4 t -163.22 176.0 10.39 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 120.188 1.358 . . . . 0.0 108.885 -167.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 64.32 0.75 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.732 1.213 . . . . 0.0 110.694 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -66.98 165.46 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.688 1.195 . . . . 0.0 107.918 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 36.1 p30 -94.12 -178.9 4.78 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 120.05 -1.656 . . . . 0.0 109.902 169.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.42 45.19 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 122.878 1.323 . . . . 0.0 108.688 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.9 pt -69.99 -15.12 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.239 -1.538 . . . . 0.0 112.031 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.406 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -121.63 169.82 14.68 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 17.0 tttt -131.84 171.26 13.75 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.454 1.102 . . . . 0.0 108.505 168.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.6 mt -101.92 86.71 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 160.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -30.08 38.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.093 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 3.0 mt-10 -152.8 151.78 30.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 109.061 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.07 58.5 6.66 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.299 -0.876 . . . . 0.0 112.453 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.6 tp -84.43 -52.25 6.31 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.766 -0.844 . . . . 0.0 110.646 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.36 -24.68 57.32 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.339 -0.85 . . . . 0.0 111.089 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -26.61 68.88 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 110.688 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.18 -22.36 39.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.022 0.929 . . . . 0.0 112.288 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -72.6 -21.09 61.18 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.098 -1.626 . . . . 0.0 114.428 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 10.19 6.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 121.498 1.954 . . . . 0.0 112.457 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.403 ' CG2' HG11 ' A' ' 36' ' ' VAL . 28.0 mm -104.31 160.31 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.205 1.002 . . . . 0.0 108.805 -166.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.629 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 10.7 mmtp -131.74 175.03 9.54 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.354 2.262 . . . . 0.0 108.845 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.04 2.79 2.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.837 2.055 . . . . 0.0 115.666 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.49 48.82 0.33 Allowed Glycine 0 CA--C 1.52 0.403 0 O-C-N 120.63 -1.294 . . . . 0.0 110.961 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.629 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 8.6 mm-40 -101.69 30.43 4.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.542 -176.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 mttp 44.25 86.47 0.02 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.445 1.898 . . . . 0.0 113.266 166.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 36' ' ' VAL . 6.4 p -78.52 133.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 176.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.71 111.18 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.574 HG22 HD12 ' A' ' 5' ' ' LEU . 93.5 t -79.13 127.25 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 127.117 2.167 . . . . 0.0 106.716 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -128.42 -166.59 1.65 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.479 1.112 . . . . 0.0 109.421 171.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -95.93 -5.37 41.57 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . . . 75.49 127.23 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 129.243 3.017 . . . . 0.0 110.547 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.1 m -131.75 55.65 1.86 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.666 1.186 . . . . 0.0 109.07 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.249 1.061 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 158.289 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 -67.6 154.08 42.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.305 -0.872 . . . . 0.0 108.912 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.95 147.51 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.398 1.479 . . . . 0.0 108.089 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 40.0 tt0 -123.69 139.9 53.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.019 2.528 . . . . 0.0 106.809 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 4' ' ' GLU . 8.8 mp -118.56 98.53 6.29 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 136.73 33.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -125.35 173.9 8.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.467 1.107 . . . . 0.0 109.142 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -30.36 70.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.948 0.899 . . . . 0.0 111.301 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -93.13 -13.27 28.69 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.11 -159.91 33.12 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 120.834 1.652 . . . . 0.0 109.894 -164.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -158.17 165.09 35.78 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 109.806 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -136.72 178.13 7.31 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.904 0.482 . . . . 0.0 110.276 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.45 128.08 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 16' ' ' LEU . 21.3 pt -116.14 162.18 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 122.628 1.204 . . . . 0.0 109.075 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -120.82 130.36 53.94 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.73 1.612 . . . . 0.0 107.699 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.4 HD21 HD12 ' A' ' 14' ' ' ILE . 55.3 mt -124.81 135.7 53.17 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.474 1.109 . . . . 0.0 109.254 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -76.48 136.47 39.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.081 0.952 . . . . 0.0 110.915 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.33 37.12 1.19 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.42 1.088 . . . . 0.0 113.278 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.08 22.87 11.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.187 -0.946 . . . . 0.0 111.194 170.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.09 133.13 45.36 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.94 0.896 . . . . 0.0 111.216 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -44.5 -55.36 5.15 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.791 2.036 . . . . 0.0 109.248 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.67 -40.24 78.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 116.894 -1.527 . . . . 0.0 113.276 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.06 -30.84 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 121.032 1.742 . . . . 0.0 109.858 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -64.87 -47.21 78.71 Favored 'General case' 0 C--N 1.342 0.263 0 O-C-N 121.608 -0.683 . . . . 0.0 110.383 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB3' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -70.72 -36.7 73.33 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 120.822 -1.174 . . . . 0.0 109.25 -174.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.56 ' CD2' HG11 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -55.91 -38.12 69.81 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.633 1.573 . . . . 0.0 109.721 174.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 tmpt? -59.23 -28.49 66.74 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.363 0.983 . . . . 0.0 111.164 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -69.01 -34.35 75.12 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.095 0.861 . . . . 0.0 110.236 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -107.57 33.54 3.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.346 2.258 . . . . 0.0 110.932 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -129.13 144.2 51.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 172.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -61.03 158.98 49.02 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 119.557 0.878 . . . . 0.0 112.536 -14.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -156.49 162.4 39.96 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.899 0.879 . . . . 0.0 110.817 170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.91 155.57 33.92 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.435 0.694 . . . . 0.0 110.262 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -165.1 172.56 12.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.274 1.03 . . . . 0.0 110.145 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.77 140.59 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.699 1.6 . . . . 0.0 107.535 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 t -96.13 67.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -58.31 138.3 56.52 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -116.51 151.17 36.67 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 108.982 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -157.71 115.9 3.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 -102.7 0.34 Allowed Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -137.39 36.2 2.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.038 2.135 . . . . 0.0 108.413 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -122.72 165.7 16.12 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mt -122.51 147.43 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 171.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.62 175.36 9.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.101 0.953 . . . . 0.0 109.182 160.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -146.86 156.39 43.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -80.49 96.8 6.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -64.21 147.3 97.01 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.78 -39.13 15.67 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.284 1.99 . . . . 0.0 110.007 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.56 HG11 ' CD2' ' A' ' 26' ' ' LEU . 7.7 p -71.69 163.61 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.377 1.471 . . . . 0.0 110.36 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -141.54 38.34 1.68 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 HG22 ' A' ' 49' ' ' VAL . 27.1 t -60.83 153.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.713 0.805 . . . . 0.0 110.781 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.22 -8.46 4.78 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.959 1.304 . . . . 0.0 112.557 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -73.09 126.29 29.65 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.328 0.967 . . . . 0.0 109.404 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 125.63 35.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.781 1.233 . . . . 0.0 109.517 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.72 -33.45 15.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.009 0.924 . . . . 0.0 109.937 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -123.86 61.56 24.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.089 0.956 . . . . 0.0 111.009 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.5 124.19 12.11 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.059 1.839 . . . . 0.0 109.003 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -128.88 149.33 50.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.724 1.209 . . . . 0.0 109.324 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -111.16 -11.03 14.28 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.855 0.462 . . . . 0.0 111.595 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 t -128.38 135.16 63.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.47 -164.01 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.347 1.859 . . . . 0.0 107.513 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -143.63 176.8 8.94 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.55 1.14 . . . . 0.0 111.184 -165.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.4 mt -84.02 11.13 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 126.167 1.787 . . . . 0.0 110.586 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.56 9.81 2.91 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.672 1.606 . . . . 0.0 113.586 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.82 -177.06 4.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 124.33 2.015 . . . . 0.0 108.592 -165.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.453 HG13 HG13 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -153.03 146.66 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 128.454 2.701 . . . . 0.0 105.691 -149.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.34 174.06 22.42 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -131.36 116.49 17.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 127.029 2.131 . . . . 0.0 107.356 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.424 ' HE1' ' HB2' ' A' ' 93' ' ' SER . 8.2 t90 -108.13 87.06 3.61 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 124.582 1.153 . . . . 0.0 109.381 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.86 -43.11 62.48 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.323 2.016 . . . . 0.0 114.969 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.24 -18.19 23.7 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.393 2.062 . . . . 0.0 111.128 -170.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.33 -0.13 70.81 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.443 -1.198 . . . . 0.0 113.29 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 46.68 39.8 7.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.198 1.999 . . . . 0.0 110.623 -166.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.4 146.1 44.68 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -167.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -179.04 1.99 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.572 158.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 55.9 m -145.75 158.87 43.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.302 1.441 . . . . 0.0 108.455 151.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mt -141.46 118.1 10.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 127.752 2.421 . . . . 0.0 106.457 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -114.81 121.29 42.82 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 109.563 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -149.14 7.97 0.72 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.13 0.972 . . . . 0.0 113.458 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.28 -114.06 0.42 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.346 -1.471 . . . . 0.0 112.0 -173.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.61 148.04 26.86 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.87 162.74 55.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.75 1.22 . . . . 0.0 112.077 -167.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.92 -3.07 8.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.164 2.576 . . . . 0.0 113.876 -167.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.87 16.9 14.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.69 1.132 . . . . 0.0 110.804 166.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 90' ' ' GLN . 3.7 t -129.86 178.98 6.12 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -142.07 -34.07 0.47 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.455 1.102 . . . . 0.0 109.848 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.3 -52.27 6.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.302 1.441 . . . . 0.0 112.029 172.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.07 -163.81 1.36 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.564 1.546 . . . . 0.0 109.68 -156.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.99 92.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 170.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.5 ' H ' ' HB2' ' A' ' 85' ' ' SER . 14.0 mt-30 -100.59 146.33 31.86 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 158.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.6 -179.43 5.33 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.229 3.286 . . . . 0.0 113.158 164.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.66 64.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.424 ' HB2' ' HE1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -157.9 -171.87 3.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 84.12 7.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 123.647 1.689 . . . . 0.0 108.265 156.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 95' ' ' VAL 0.332 46.9 t -44.33 161.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 C-N-CA 129.669 3.188 . . . . 0.0 110.668 143.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -98.21 124.62 42.89 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.694 1.597 . . . . 0.0 107.084 171.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.14 107.03 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.5 pt -120.11 -9.74 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.134 2.174 . . . . 0.0 111.351 -173.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.56 171.91 13.95 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 129.752 3.549 . . . . 0.0 112.694 -163.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -144.7 148.83 34.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.851 1.66 . . . . 0.0 108.693 143.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.453 HG13 HG13 ' A' ' 66' ' ' VAL . 16.4 mt -75.01 98.99 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 159.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.0 m -73.74 -36.56 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.526 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.7 163.02 38.54 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 118.798 0.726 . . . . 0.0 110.829 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.41 42.44 73.91 Favored Glycine 0 C--O 1.222 -0.607 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.185 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -56.55 11.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.458 1.129 . . . . 0.0 110.003 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.18 -19.1 64.75 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.958 -0.464 . . . . 0.0 111.088 -168.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.04 -22.96 61.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.173 1.789 . . . . 0.0 110.654 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.33 -41.12 61.63 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.335 -1.478 . . . . 0.0 110.36 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -62.52 -5.29 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.051 1.341 . . . . 0.0 113.412 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.54 6.06 10.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.066 1.746 . . . . 0.0 112.147 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.293 19.2 mm -80.47 164.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.292 0.951 . . . . 0.0 108.875 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.406 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 4.5 mmpt? -121.62 167.85 12.43 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 127.278 2.231 . . . . 0.0 106.472 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.56 -1.63 1.91 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -169.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.01 17.91 1.21 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.605 -1.109 . . . . 0.0 114.168 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 14.7 mm-40 -72.03 23.78 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.274 2.037 . . . . 0.0 113.975 -176.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt 44.75 89.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 128.848 2.859 . . . . 0.0 113.958 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.8 104.36 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -83.62 98.79 9.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 107.899 170.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -75.17 137.34 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.269 1.827 . . . . 0.0 108.589 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -139.75 -177.44 4.97 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.095 2.558 . . . . 0.0 110.096 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -86.62 -4.38 59.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 56.73 76.18 0.32 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 127.524 2.33 . . . . 0.0 112.07 -173.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.6 m -81.45 25.96 0.49 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.869 1.667 . . . . 0.0 112.694 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.814 1.646 . . . . 0.0 107.626 -166.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.38 148.58 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -149.4 142.75 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 27.0 tt0 -117.87 138.09 52.35 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.972 2.109 . . . . 0.0 106.068 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.26 98.94 6.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.972 2.109 . . . . 0.0 106.703 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.56 129.75 46.54 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.957 1.303 . . . . 0.0 109.139 -172.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.18 -176.1 3.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.015 1.326 . . . . 0.0 109.74 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.61 -53.79 36.83 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.928 -0.482 . . . . 0.0 110.467 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 t -76.18 -20.83 57.17 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.502 0.592 . . . . 0.0 111.039 -168.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.05 -152.29 12.73 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -164.73 152.92 12.14 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.525 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 64.7 m -141.26 173.59 11.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.059 0.943 . . . . 0.0 109.009 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 t -140.82 129.7 24.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.6 pt -114.15 166.35 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 122.427 1.108 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -123.42 149.43 45.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 163.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.407 HD23 ' HA3' ' A' ' 99' ' ' GLY . 59.4 mt -139.11 132.11 29.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.694 1.598 . . . . 0.0 110.799 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -84.93 126.43 33.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.633 0.254 . . . . 0.0 110.685 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.76 5.13 14.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.585 1.954 . . . . 0.0 113.961 -169.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -83.41 -11.8 57.17 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.093 -1.004 . . . . 0.0 109.95 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.418 ' CD2' HG22 ' A' ' 98' ' ' ILE . 32.7 m-85 -99.34 141.14 32.51 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.862 2.065 . . . . 0.0 109.688 -174.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -44.87 -59.5 2.52 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.844 1.658 . . . . 0.0 109.365 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.78 -35.53 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.87 -38.61 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.869 1.213 . . . . 0.0 109.819 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -55.72 -45.52 77.92 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.021 0.928 . . . . 0.0 111.066 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -40.06 89.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.03 -1.044 . . . . 0.0 109.511 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.22 -30.52 68.3 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.819 1.248 . . . . 0.0 111.901 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -69.17 -25.15 64.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.276 0.943 . . . . 0.0 109.918 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -78.06 -11.42 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.414 0.685 . . . . 0.0 112.296 171.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -126.1 26.1 6.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.552 1.541 . . . . 0.0 112.077 -166.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.43 143.96 47.85 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -62.04 158.7 56.95 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-N 119.531 0.868 . . . . 0.0 113.202 -10.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -152.79 163.77 39.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.529 0.732 . . . . 0.0 110.354 166.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -119.24 161.99 19.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.244 1.018 . . . . 0.0 110.241 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -168.75 171.36 8.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.673 0.789 . . . . 0.0 112.496 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.28 128.1 47.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.055 1.342 . . . . 0.0 108.852 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 t -91.12 80.88 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -164.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -68.15 151.21 47.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.6 p -126.22 131.61 51.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -134.57 94.71 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 175.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 82' ' ' THR . . . 44.2 82.62 0.03 OUTLIER Glycine 0 C--O 1.214 -1.134 0 C-N-CA 126.304 1.907 . . . . 0.0 115.424 167.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 71.42 21.61 4.5 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.718 1.607 . . . . 0.0 112.609 167.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -140.32 167.9 21.06 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 128.854 2.862 . . . . 0.0 106.395 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mt -132.62 146.09 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 128.003 2.521 . . . . 0.0 108.263 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -146.88 157.61 43.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.758 1.223 . . . . 0.0 111.256 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -150.55 163.05 39.42 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.245 0.618 . . . . 0.0 111.273 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -92.54 88.54 6.38 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.711 0.767 . . . . 0.0 109.825 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.2 p -60.82 148.46 82.84 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.038 0.535 . . . . 0.0 112.184 -170.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.06 -14.57 15.11 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.523 2.815 . . . . 0.0 111.997 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.23 153.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 108.786 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -137.63 119.93 15.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 p -156.92 152.45 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.951 1.3 . . . . 0.0 108.924 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.79 21.58 4.21 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.212 1.805 . . . . 0.0 112.591 -174.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -109.04 148.98 29.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.633 1.973 . . . . 0.0 108.862 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -139.64 157.67 45.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.536 1.134 . . . . 0.0 108.91 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -110.79 -50.09 2.98 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.663 0.785 . . . . 0.0 110.255 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -120.38 68.92 14.74 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.87 1.268 . . . . 0.0 108.042 -172.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 96' ' ' ASN . 72.4 Cg_endo -71.53 156.53 57.87 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.571 2.181 . . . . 0.0 111.799 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.685 ' HG2' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -144.11 158.29 43.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.623 1.569 . . . . 0.0 108.949 177.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -111.32 8.8 21.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 117.411 -1.28 . . . . 0.0 111.043 167.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 p -162.31 154.99 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 120.328 1.422 . . . . 0.0 111.749 173.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.58 HG11 ' CZ ' ' A' ' 58' ' ' ARG . 27.2 m -145.22 -179.85 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.599 1.559 . . . . 0.0 112.498 -174.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.12 171.17 12.23 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 110.31 163.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.29 -13.66 16.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 113.597 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.05 48.51 0.97 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 125.058 1.313 . . . . 0.0 110.446 -168.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.44 ' CG ' ' HZ2' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -120.0 172.55 7.66 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.669 1.188 . . . . 0.0 108.869 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -137.94 136.78 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.99 172.1 18.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.494 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -123.5 137.47 54.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.478 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -116.83 88.23 24.86 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.211 1.804 . . . . 0.0 110.031 -162.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.454 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 91.2 Cg_endo -64.57 -26.61 61.76 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.179 2.586 . . . . 0.0 116.429 -171.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 66.7 Cg_endo -75.05 -32.05 5.64 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 123.579 2.314 . . . . 0.0 110.077 -173.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.28 14.17 21.01 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.687 1.613 . . . . 0.0 114.282 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 44.7 59.59 3.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.277 1.831 . . . . 0.0 111.058 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.4 168.83 18.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.618 1.199 . . . . 0.0 112.127 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.84 163.11 12.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.96 2.104 . . . . 0.0 109.508 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 p -134.79 137.81 43.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 119.63 1.105 . . . . 0.0 112.052 166.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -117.07 113.35 22.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.992 2.517 . . . . 0.0 105.149 170.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -88.22 149.73 23.69 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -158.9 9.99 0.13 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.947 0.794 . . . . 0.0 112.92 169.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.93 -174.84 38.48 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 120.451 -1.406 . . . . 0.0 111.14 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.21 101.17 5.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -69.29 165.11 42.62 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 125.316 1.446 . . . . 0.0 111.095 -178.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.11 5.81 4.75 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.039 3.826 . . . . 0.0 114.121 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -134.31 72.46 1.47 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.71 -174.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.473 2.309 . . . . 0.0 106.537 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -156.11 -66.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -81.49 -44.72 17.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.175 1.39 . . . . 0.0 110.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -143.21 152.89 42.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.637 1.575 . . . . 0.0 108.541 -157.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.6 mt -81.9 81.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -169.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -75.09 143.48 77.4 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 108.231 170.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.9 174.65 12.23 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.646 2.897 . . . . 0.0 111.395 165.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.47 71.01 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -147.71 169.61 19.34 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.608 1.163 . . . . 0.0 107.905 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.67 80.81 0.43 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.952 1.251 . . . . 0.0 110.622 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.528 ' CG2' ' CZ ' ' A' ' 58' ' ' ARG . 2.7 m -77.55 170.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 1.1 p30 -84.47 152.21 24.12 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 120.307 -1.495 . . . . 0.0 112.031 169.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.685 HG23 ' HG2' ' A' ' 58' ' ' ARG . 15.5 t -84.62 112.38 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 152.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.418 HG22 ' CD2' ' A' ' 20' ' ' TYR . 26.6 pt -123.06 -18.28 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.123 0.569 . . . . 0.0 112.184 169.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' A' ' 16' ' ' LEU . . . -138.53 172.05 23.2 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 30.1 tptt -139.83 140.37 36.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.34 90.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -75.19 -34.2 30.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.075 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.55 157.74 43.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.69 1.196 . . . . 0.0 108.73 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 73.47 70.48 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 118.649 -1.739 . . . . 0.0 112.325 -176.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.35 -52.94 2.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 169.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -64.76 -28.6 69.69 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.906 -0.496 . . . . 0.0 111.599 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -71.38 -8.77 55.95 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.337 -0.852 . . . . 0.0 112.801 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -25.9 51.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.859 1.663 . . . . 0.0 113.003 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 5.98 6.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -174.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -129.76 9.97 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.941 2.496 . . . . 0.0 110.839 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.25 157.41 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 106.781 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -117.11 -165.02 1.03 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.765 1.226 . . . . 0.0 110.008 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.83 5.09 26.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.609 0.719 . . . . 0.0 112.644 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -172.16 80.81 0.08 OUTLIER Glycine 0 CA--C 1.523 0.56 0 O-C-N 120.83 -1.169 . . . . 0.0 110.926 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.56 22.45 10.63 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.005 1.722 . . . . 0.0 111.335 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt 44.55 84.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.265 1.826 . . . . 0.0 112.918 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.41 129.02 37.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.73 107.87 19.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.08 126.5 36.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.613 2.365 . . . . 0.0 107.088 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -135.98 169.62 17.3 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.058 1.743 . . . . 0.0 109.744 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -77.32 -3.72 41.41 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 59.06 38.83 23.87 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 126.242 1.817 . . . . 0.0 113.435 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.74 52.54 0.22 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.349 1.859 . . . . 0.0 111.671 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.25 1.093 0 C-N-CA 127.573 2.349 . . . . 0.0 112.938 178.002 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 160.28 33.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 110.513 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.4 t -149.79 142.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 113.008 -1.905 . . . . 0.0 108.546 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 32.0 tt0 -126.83 131.4 51.24 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 127.71 2.404 . . . . 0.0 107.018 -173.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.59 120.29 41.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.533 1.933 . . . . 0.0 107.229 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.99 137.13 48.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -130.28 -176.65 4.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.513 1.125 . . . . 0.0 109.783 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.71 -39.71 43.7 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.875 0.87 . . . . 0.0 109.71 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB2' HD13 ' A' ' 111' ' ' ILE . 9.5 m -93.33 -16.16 24.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.426 1.091 . . . . 0.0 112.587 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.53 -163.38 27.03 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.508 0.575 . . . . 0.0 112.882 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -160.87 146.27 14.41 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.206 1.402 . . . . 0.0 108.378 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.53 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 34.5 m -146.86 174.94 11.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.173 1.789 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -147.98 131.46 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 120.269 -1.519 . . . . 0.0 108.397 -170.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.48 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.04 -1.037 . . . . 0.0 109.983 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.14 119.54 39.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 116.899 -1.524 . . . . 0.0 107.641 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.494 HD23 ' CA ' ' A' ' 99' ' ' GLY . 83.3 mt -119.29 132.19 55.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.212 0.915 . . . . 0.0 111.012 -174.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -88.08 126.27 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.822 -168.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.35 34.64 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.822 1.649 . . . . 0.0 113.943 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -105.49 -9.48 17.46 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.527 -1.358 . . . . 0.0 110.815 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.34 144.2 34.54 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.603 1.561 . . . . 0.0 112.086 -170.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -56.67 -55.76 29.95 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.383 1.073 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 p -44.58 -40.29 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.504 1.522 . . . . 0.0 113.693 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.93 -44.18 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 120.911 1.687 . . . . 0.0 110.014 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -59.65 -38.36 81.22 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.181 0.992 . . . . 0.0 111.228 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.1 mt -72.09 -37.87 69.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.859 0.864 . . . . 0.0 109.689 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -32.52 73.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.853 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -32.96 64.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.158 0.89 . . . . 0.0 109.97 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.3 -13.77 61.99 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.743 0.817 . . . . 0.0 111.953 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -124.16 26.58 7.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.747 2.019 . . . . 0.0 110.833 -173.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -125.06 139.53 33.85 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.11 163.34 68.52 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 119.302 0.786 . . . . 0.0 112.375 -8.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -149.83 169.5 20.96 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.018 0.927 . . . . 0.0 109.473 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.98 155.69 37.76 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.9 170.1 18.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.513 0.673 . . . . 0.0 112.249 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.95 129.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.296 1.438 . . . . 0.0 108.11 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG13 HG23 ' A' ' 43' ' ' ILE . 21.0 t -83.31 76.08 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -68.96 159.39 32.81 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.2 p -140.0 163.51 32.48 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.832 0.853 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -164.3 101.91 0.84 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 47.17 62.87 3.6 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.992 165.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 52.05 78.94 0.11 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.528 2.331 . . . . 0.0 110.655 -159.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -162.23 150.84 14.99 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 161.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.513 HG23 HG13 ' A' ' 36' ' ' VAL . 55.2 mt -127.45 121.19 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 167.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -133.09 151.37 52.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.512 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.69 150.59 52.14 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -70.86 91.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.51 1.524 . . . . 0.0 109.542 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -62.39 146.66 93.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.988 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.35 -3.76 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.424 2.749 . . . . 0.0 111.992 172.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -76.41 163.62 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.269 1.428 . . . . 0.0 109.606 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -148.9 101.68 3.2 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.578 0.751 . . . . 0.0 109.624 170.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG22 ' H ' ' A' ' 53' ' ' LYS . 9.0 p -152.44 154.86 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.176 2.19 . . . . 0.0 108.348 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.83 13.95 6.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.648 1.179 . . . . 0.0 113.139 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 51' ' ' VAL . 15.4 tttt -75.37 125.13 28.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.287 1.835 . . . . 0.0 111.452 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.35 143.3 50.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.603 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -132.73 -30.84 1.38 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.244 1.017 . . . . 0.0 112.601 -169.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -120.13 61.82 8.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.54 150.95 41.36 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.087 1.858 . . . . 0.0 113.201 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -146.51 153.58 40.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.463 1.505 . . . . 0.0 109.773 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -105.44 7.04 32.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.207 1.403 . . . . 0.0 113.221 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.35 152.63 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 129.788 3.235 . . . . 0.0 108.086 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.0 m -147.48 175.14 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.302 1.841 . . . . 0.0 108.414 -167.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.15 169.35 10.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 122.32 1.057 . . . . 0.0 112.363 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 63' ' ' ILE . 44.9 mt -73.16 23.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 0.0 110.779 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.66 16.11 0.07 OUTLIER Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.305 0.955 . . . . 0.0 113.789 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -93.67 -177.22 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -138.34 149.91 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.228 1.011 . . . . 0.0 108.95 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.08 21.59 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 165.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.95 159.85 27.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.006 0.922 . . . . 0.0 108.981 166.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -127.61 85.62 60.38 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.406 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 89.3 Cg_endo -66.2 -28.06 48.34 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.069 1.846 . . . . 0.0 115.391 -174.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 55.4 Cg_endo -69.26 -23.61 32.9 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 123.087 2.138 . . . . 0.0 109.847 -172.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.17 27.47 6.69 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 117.791 -1.561 . . . . 0.0 113.674 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.78 36.9 4.17 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.505 2.153 . . . . 0.0 113.141 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.31 174.16 6.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.274 -1.516 . . . . 0.0 111.398 -167.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -90.77 -178.88 5.37 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.839 161.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 54.0 m -147.33 163.29 36.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.948 2.499 . . . . 0.0 107.441 157.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.22 121.94 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.62 114.3 27.87 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.859 1.264 . . . . 0.0 109.648 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -145.06 27.63 1.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.253 1.821 . . . . 0.0 113.789 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.97 -112.43 0.28 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 120.51 1.504 . . . . 0.0 115.142 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 120.62 2.89 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 129.225 3.01 . . . . 0.0 104.782 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 33.8 p -86.45 165.74 31.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.661 1.119 . . . . 0.0 111.275 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 73.1 Cg_endo -69.2 0.36 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.591 2.861 . . . . 0.0 113.932 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -95.08 -33.01 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.545 1.521 . . . . 0.0 111.967 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 t -79.99 -169.31 1.96 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 161.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.13 -49.13 0.32 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.76 -51.08 9.63 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 126.049 1.74 . . . . 0.0 112.853 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -137.02 -164.18 1.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.302 1.441 . . . . 0.0 109.021 -154.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.414 HD13 ' CG1' ' A' ' 63' ' ' ILE . 13.5 mt -110.28 67.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -172.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -82.32 142.33 46.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.205 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.2 177.21 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 125.158 3.905 . . . . 0.0 112.672 171.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.33 -29.43 68.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.98 -174.26 4.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.476 1.489 . . . . 0.0 109.973 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.03 98.69 0.31 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 m -92.9 -164.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.35 1.46 . . . . 0.0 107.728 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -138.62 125.21 20.72 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.67 48.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.921 0.888 . . . . 0.0 109.956 -170.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 pt -72.1 -12.96 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 120.181 -1.574 . . . . 0.0 112.8 -172.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.494 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -128.4 159.29 21.91 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 118.681 0.673 . . . . 0.0 111.578 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -124.81 141.78 51.88 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.3 mt -76.4 112.79 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 161.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -29.67 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 -165.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -144.42 160.23 41.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.313 2.245 . . . . 0.0 107.84 170.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 75.62 60.85 3.09 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 118.55 -1.786 . . . . 0.0 112.037 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -107.82 -36.93 6.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.593 0.711 . . . . 0.0 111.157 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.11 -36.19 48.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.2 6.07 3.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.197 0.999 . . . . 0.0 112.96 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 74.0 mt -86.75 -37.17 18.13 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 111.451 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -4.62 16.78 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.719 -1.238 . . . . 0.0 113.123 -172.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -100.81 -0.95 36.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.25 1.42 . . . . 0.0 112.67 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.48 HD13 ' HB2' ' A' ' 9' ' ' SER . 22.9 mm -80.31 162.37 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.537 0.735 . . . . 0.0 110.635 -167.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -118.31 169.4 9.76 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 127.291 2.236 . . . . 0.0 111.248 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.69 20.67 1.7 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.551 2.34 . . . . 0.0 113.702 -172.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.79 64.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.467 ' H ' ' HB ' ' A' ' 36' ' ' VAL . 6.7 pt-20 -114.37 30.5 7.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -174.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.84 85.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.685 1.594 . . . . 0.0 112.881 171.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 133.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.24 116.01 31.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 164.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -88.37 127.61 41.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 107.39 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -132.53 -179.2 5.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.993 1.717 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -79.25 -3.69 47.08 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 58.72 -169.74 0.13 Allowed 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 125.318 1.447 . . . . 0.0 110.349 -163.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.5 p -147.95 16.54 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.851 1.66 . . . . 0.0 110.788 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.258 1.509 0 C-N-CA 126.812 2.045 . . . . 0.0 106.581 -160.682 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ttp . . . . . 0 CA--C 1.509 -0.602 0 CA-C-O 122.403 1.097 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -71.53 163.25 28.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.363 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.35 113.33 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 5.3 tt0 -86.91 137.85 32.04 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.075 -1.015 . . . . 0.0 108.41 -175.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.3 mt -115.8 97.9 6.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.705 0.684 . . . . 0.0 110.196 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 148.08 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.416 1.087 . . . . 0.0 109.246 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -135.64 178.83 6.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.232 1.413 . . . . 0.0 108.86 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.59 -16.61 57.2 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.932 0.893 . . . . 0.0 111.937 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -124.26 0.48 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.753 0.821 . . . . 0.0 111.292 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.08 -174.25 43.34 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 124.556 1.074 . . . . 0.0 111.429 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -163.04 149.68 12.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.726 1.21 . . . . 0.0 108.47 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.447 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 1.4 p -137.28 -177.2 4.67 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 125.877 2.751 . . . . 0.0 105.101 171.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 4' ' ' GLU 0.258 3.8 p -136.75 164.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 110.275 -3.148 . . . . 0.0 105.869 167.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 pt -135.91 121.29 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 125.47 1.508 . . . . 0.0 107.252 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.94 117.13 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 115.325 -2.274 . . . . 0.0 110.044 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt -121.03 143.3 49.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.652 2.024 . . . . 0.0 112.649 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -89.54 140.86 29.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 111.315 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.34 8.69 3.16 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -91.7 9.93 30.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.663 -1.898 . . . . 0.0 110.479 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.22 133.34 55.16 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.745 1.618 . . . . 0.0 109.279 -170.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -48.52 -49.84 34.43 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.791 1.636 . . . . 0.0 109.888 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.658 ' HB ' HG21 ' A' ' 51' ' ' VAL . 7.2 p -56.89 -37.3 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 117.673 -1.155 . . . . 0.0 111.5 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t -72.1 -43.75 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 120.315 1.416 . . . . 0.0 109.232 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -59.71 -33.1 71.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.659 0.784 . . . . 0.0 111.827 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.405 HD12 ' CG1' ' A' ' 51' ' ' VAL . 18.7 mt -84.93 -37.19 20.84 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.914 0.886 . . . . 0.0 110.769 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 mt -57.03 -35.63 69.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.151 0.98 . . . . 0.0 110.225 172.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -58.5 -30.82 67.31 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 119.291 0.95 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.292 1.037 . . . . 0.0 110.973 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.52 26.24 4.75 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.624 1.569 . . . . 0.0 110.347 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.41 HG23 ' HA ' ' A' ' 31' ' ' PRO . 76.2 mt -126.46 146.59 57.09 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HA ' HG23 ' A' ' 30' ' ' ILE . 10.2 Cg_endo -59.55 157.76 41.91 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 CA-C-N 119.44 0.836 . . . . 0.0 111.646 -12.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -148.77 150.22 32.71 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -105.02 156.63 17.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.32 175.55 11.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG22 ' C ' ' A' ' 36' ' ' VAL . 2.4 p -55.07 165.95 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.4 1.88 . . . . 0.0 111.204 157.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.598 HG13 HG23 ' A' ' 43' ' ' ILE . 38.0 t -117.51 123.91 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 144.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -106.11 164.68 11.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 162.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.7 p -136.24 151.15 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.427 -0.796 . . . . 0.0 109.66 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -149.98 83.75 1.39 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.965 0.802 . . . . 0.0 108.99 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 57.91 69.48 1.26 Allowed Glycine 0 C--O 1.213 -1.195 0 O-C-N 121.215 -0.928 . . . . 0.0 113.569 170.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.265 6.1 mt-10 65.98 35.64 6.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 127.984 2.514 . . . . 0.0 112.531 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.83 152.45 46.51 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.443 1.897 . . . . 0.0 108.373 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.598 HG23 HG13 ' A' ' 36' ' ' VAL . 9.6 mt -113.84 139.66 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 159.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -136.06 160.22 39.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.34 157.83 42.99 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.32 -0.862 . . . . 0.0 110.317 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -87.91 94.7 9.85 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 p -63.15 151.36 86.77 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.0 -26.58 9.24 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.026 2.484 . . . . 0.0 111.374 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -83.15 146.23 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.163 1.385 . . . . 0.0 107.851 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -133.08 133.57 43.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.658 HG21 ' HB ' ' A' ' 22' ' ' VAL . 5.6 m -141.34 179.15 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.807 2.443 . . . . 0.0 107.66 170.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.82 13.81 3.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.839 0.856 . . . . 0.0 112.311 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -92.8 128.6 38.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 113.116 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.575 ' HA ' HD22 ' A' ' 96' ' ' ASN . 0.0 OUTLIER -133.98 106.18 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.201 1.8 . . . . 0.0 112.805 175.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -79.9 -13.94 59.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.585 1.954 . . . . 0.0 114.085 172.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -139.32 68.43 39.71 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 119.595 1.089 . . . . 0.0 109.878 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.79 107.97 2.46 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.628 2.219 . . . . 0.0 109.772 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -112.97 140.69 47.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 109.582 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 26.2 mt-10 -89.99 9.27 28.54 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.697 0.799 . . . . 0.0 112.105 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.55 154.16 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 127.555 2.342 . . . . 0.0 109.821 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -143.38 -175.57 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 127.389 2.276 . . . . 0.0 107.861 -172.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -106.05 173.39 6.33 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.0 111.469 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 63' ' ' ILE . 22.3 mt -71.62 11.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.977 2.111 . . . . 0.0 112.238 177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.06 34.18 0.44 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 124.93 1.252 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -109.86 -177.93 3.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.31 164.65 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -146.23 170.33 27.37 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 167.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 143.49 48.28 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 167.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.26 85.87 42.52 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 125.249 1.419 . . . . 0.0 107.414 -174.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.42 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 54.7 Cg_endo -60.62 -35.33 90.2 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.286 1.324 . . . . 0.0 115.037 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 59.5 Cg_endo -72.57 -32.91 9.15 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 CA-C-N 122.785 2.031 . . . . 0.0 109.939 -168.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.19 23.01 17.08 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.682 -1.621 . . . . 0.0 113.295 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt 44.64 63.97 1.51 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.107 1.763 . . . . 0.0 111.555 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.65 157.17 44.32 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.35 0.595 . . . . 0.0 111.995 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 177.39 8.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.536 158.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.3 m -150.14 155.85 40.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.378 1.471 . . . . 0.0 108.474 161.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.0 mt -145.97 108.56 4.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.924 2.09 . . . . 0.0 107.5 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -99.4 112.91 25.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.221 0.608 . . . . 0.0 110.176 -168.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -138.77 28.86 2.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.637 1.175 . . . . 0.0 113.915 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.64 52.07 0.02 OUTLIER Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.83 -1.169 . . . . 0.0 114.282 153.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttm 71.6 175.97 0.28 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.053 2.141 . . . . 0.0 109.534 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.6 OUTLIER -153.3 159.31 32.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -165.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.55 6.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.548 4.165 . . . . 0.0 114.394 -172.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.44 44.93 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.681 1.592 . . . . 0.0 107.871 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -162.61 -179.51 6.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.353 2.261 . . . . 0.0 107.083 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -144.17 -39.9 0.28 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 165.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -89.17 -38.65 14.12 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.323 1.059 . . . . 0.0 111.413 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.76 -164.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 128.027 2.531 . . . . 0.0 107.374 -161.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.06 74.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 120.187 1.358 . . . . 0.0 107.614 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.91 143.47 62.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HG2' ' H ' ' A' ' 94' ' ' ALA . 89.1 Cg_endo -89.32 175.88 3.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.436 3.424 . . . . 0.0 110.715 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.8 -16.88 62.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -169.07 15.41 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -165.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.512 ' H ' ' HG2' ' A' ' 91' ' ' PRO . . . 69.19 82.0 0.17 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.016 1.726 . . . . 0.0 109.102 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.5 -169.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 113.626 -1.624 . . . . 0.0 108.841 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.575 HD22 ' HA ' ' A' ' 54' ' ' MET . 52.6 t-20 -128.32 125.31 38.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.07 45.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.117 0.967 . . . . 0.0 110.112 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 pt -59.18 -14.95 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 117.885 -1.055 . . . . 0.0 113.262 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -129.16 162.04 22.6 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.744 0.688 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -129.42 135.27 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 108.154 167.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.26 85.14 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 13' ' ' VAL . 35.7 m -68.48 -47.74 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.27 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.416 ' H ' HG12 ' A' ' 13' ' ' VAL . 37.7 mt-10 -124.66 159.11 31.55 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.908 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 12' ' ' CYS . . . 65.44 74.33 0.51 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 125.961 2.038 . . . . 0.0 112.471 -176.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -107.39 -48.74 3.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.992 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -90.0 -10.78 43.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.565 0.746 . . . . 0.0 111.877 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.79 -12.62 59.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 112.051 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.37 -21.46 63.8 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 119.033 -2.292 . . . . 0.0 112.422 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -10.06 59.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 171.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -77.65 -26.36 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.796 -1.19 . . . . 0.0 111.093 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 mm -77.3 157.18 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -172.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -116.79 170.14 8.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.537 1.535 . . . . 0.0 109.526 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.91 32.23 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.647 2.379 . . . . 0.0 112.569 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.86 63.9 0.03 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.541 -1.144 . . . . 0.0 110.836 172.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -118.79 13.82 13.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp 47.43 155.14 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -160.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.97 159.44 31.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.865 1.266 . . . . 0.0 107.85 164.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.13 97.6 4.83 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.724 2.809 . . . . 0.0 105.954 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.0 t -82.01 134.72 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.289 1.436 . . . . 0.0 108.095 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -140.46 -170.1 2.92 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.583 1.953 . . . . 0.0 109.141 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 124' ' ' SER . 41.6 m-85 -98.79 5.25 47.61 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 64.6 71.7 0.46 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.224 2.21 . . . . 0.0 112.006 175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 t 70.31 3.24 4.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.12 1.768 . . . . 0.0 113.624 -169.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 121' ' ' PHE . 40.4 m . . . . . 0 C--O 1.245 0.83 0 C-N-CA 128.317 2.647 . . . . 0.0 110.404 -168.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttp . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -63.3 162.78 11.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.976 0.893 . . . . 0.0 109.316 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.67 135.96 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 127.563 2.345 . . . . 0.0 105.332 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 35.4 tt0 -112.78 141.03 47.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.95 120.97 40.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.559 1.944 . . . . 0.0 107.327 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.43 110.91 15.11 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.287 1.435 . . . . 0.0 107.933 -173.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -108.33 167.83 9.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 110.431 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.49 -13.73 62.52 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -115.97 -9.44 11.76 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 -166.34 35.07 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 121.621 2.009 . . . . 0.0 111.326 -168.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.8 149.23 7.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.241 1.521 . . . . 0.0 110.545 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.524 ' CB ' ' HA3' ' A' ' 104' ' ' GLY . 65.5 m -149.59 176.15 10.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.629 1.972 . . . . 0.0 109.343 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -140.1 145.75 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 122.522 1.153 . . . . 0.0 108.246 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.68 150.03 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 125.303 1.441 . . . . 0.0 107.302 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.58 121.54 43.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.413 1.885 . . . . 0.0 108.395 -171.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -127.79 124.55 37.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 122.432 1.11 . . . . 0.0 111.312 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.56 122.03 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.401 1.481 . . . . 0.0 111.002 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.4 33.03 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.586 172.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -101.42 -9.13 21.39 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 120.512 -1.367 . . . . 0.0 111.247 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -107.91 138.7 43.7 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.535 0.734 . . . . 0.0 110.101 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.26 -51.12 57.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.845 1.658 . . . . 0.0 112.114 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.87 -26.53 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.497 1.119 . . . . 0.0 112.588 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.63 -47.37 20.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.531 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -58.97 -36.78 75.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.046 0.538 . . . . 0.0 109.946 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.37 -20.92 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.591 1.156 . . . . 0.0 112.16 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.71 -30.28 62.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.829 1.252 . . . . 0.0 111.093 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -59.79 -23.64 63.46 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.582 0.628 . . . . 0.0 110.558 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -70.5 -16.5 62.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.095 1.358 . . . . 0.0 113.544 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -131.73 39.1 3.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.421 1.488 . . . . 0.0 109.515 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.45 141.98 35.66 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.77 154.85 72.41 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 119.629 0.903 . . . . 0.0 110.521 -7.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CE1' HG11 ' A' ' 119' ' ' VAL . 24.7 p90 -145.1 160.87 40.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.528 0.331 . . . . 0.0 110.275 171.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.95 149.0 49.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 165.55 32.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.3 t -86.58 133.0 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.41 HG13 HG23 ' A' ' 43' ' ' ILE . 13.5 t -81.85 72.68 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -68.38 150.98 47.51 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 p -129.3 157.86 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.731 0.812 . . . . 0.0 110.027 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -156.02 89.83 1.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.77 74.32 0.23 Allowed Glycine 0 C--O 1.213 -1.168 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.396 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 69.03 26.43 5.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.943 1.371 . . . . 0.0 113.189 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.36 152.01 51.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.338 1.855 . . . . 0.0 108.741 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 36' ' ' VAL . 17.4 mt -133.57 135.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -147.69 155.37 41.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -140.24 146.21 38.34 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -85.7 78.68 9.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.528 1.131 . . . . 0.0 108.389 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -56.91 147.89 51.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 111.661 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 -15.66 21.7 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.993 2.462 . . . . 0.0 112.972 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.8 t -76.49 148.02 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.223 0.919 . . . . 0.0 109.372 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.46 99.75 5.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.561 0.744 . . . . 0.0 109.26 173.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.5 t -135.1 153.1 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 70' ' ' PRO . 14.2 mt-30 -131.69 0.75 3.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.357 1.063 . . . . 0.0 113.486 175.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.93 120.57 23.72 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.557 1.143 . . . . 0.0 109.085 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.2 mtt -95.92 135.47 37.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -96.75 -28.39 14.31 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.766 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -146.53 71.26 12.85 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.448 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.93 135.04 39.46 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.716 1.611 . . . . 0.0 110.657 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -108.89 -176.48 3.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 164.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -127.72 7.11 6.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.779 0.831 . . . . 0.0 112.844 166.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.41 153.8 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 129.631 3.172 . . . . 0.0 108.267 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.15 170.96 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.173 1.389 . . . . 0.0 109.534 -170.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.43 161.15 20.43 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.377 -0.827 . . . . 0.0 110.361 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.66 74.26 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 166.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.59 8.46 0.06 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.684 -1.065 . . . . 0.0 113.912 -169.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -111.3 173.01 6.55 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.734 1.767 . . . . 0.0 110.361 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.53 131.04 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.731 1.212 . . . . 0.0 108.402 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.49 158.9 14.56 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.881 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.69 135.8 46.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -104.83 87.69 1.95 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 126.657 1.983 . . . . 0.0 109.552 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 59.4 Cg_endo -63.18 -41.61 26.9 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.498 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 73.3 Cg_endo -73.75 -27.15 12.84 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.55 2.167 . . . . 0.0 110.735 -162.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.13 25.92 7.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.098 1.809 . . . . 0.0 112.43 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt 43.35 65.54 0.96 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.865 1.666 . . . . 0.0 111.826 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.68 177.29 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.843 0.457 . . . . 0.0 111.792 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.557 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 2.2 tp -98.44 -177.37 3.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 110.419 167.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 30.7 m -152.87 146.01 24.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.804 1.638 . . . . 0.0 112.371 154.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.265 6.9 mp -114.9 121.83 44.4 Favored 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.342 4.257 . . . . 0.0 106.634 169.815 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -110.64 113.69 26.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.23 0.923 . . . . 0.0 109.129 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 108' ' ' LEU . 42.6 p90 -136.51 35.55 2.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.16 -127.14 0.88 Allowed Glycine 0 C--O 1.225 -0.453 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 163.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -110.85 -15.1 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.074 0.937 . . . . 0.0 112.745 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 83' ' ' PRO 0.256 11.2 p 57.03 165.56 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 128.553 2.741 . . . . 0.0 112.464 175.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 60.2 Cg_endo -77.91 -28.44 5.05 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.665 1.577 . . . . 0.0 114.215 -165.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.9 mmt -94.41 70.43 3.69 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -157.44 171.49 20.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.756 0.822 . . . . 0.0 109.421 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -143.72 -46.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 156.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -77.16 -56.88 4.18 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.042 0.937 . . . . 0.0 110.035 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 160.03 43.68 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.091 1.356 . . . . 0.0 108.991 -150.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.7 75.79 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 123.937 0.895 . . . . 0.0 109.077 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -75.35 144.09 77.54 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.455 160.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.71 -176.35 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.355 3.37 . . . . 0.0 111.891 171.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.82 74.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.023 169.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.3 t -164.71 170.04 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.847 1.659 . . . . 0.0 107.952 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.48 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.202 1.401 . . . . 0.0 110.742 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 m -102.44 152.64 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 171.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -74.21 168.85 18.79 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.637 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.1 t -120.15 44.24 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 123.194 1.473 . . . . 0.0 108.452 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.0 pt -72.24 -18.11 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.582 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.66 159.5 13.78 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.298 0.951 . . . . 0.0 111.404 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -130.27 143.13 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 0.0 107.551 172.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.82 105.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.17 -29.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -163.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.63 163.51 32.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 125.876 1.67 . . . . 0.0 106.574 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.524 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 71.36 64.62 2.69 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 117.778 -2.154 . . . . 0.0 111.457 172.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.2 tp -91.87 -45.99 8.09 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.052 0.926 . . . . 0.0 109.474 164.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -79.93 -20.97 44.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.184 -0.947 . . . . 0.0 112.183 -166.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.7 3.92 17.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.217 1.007 . . . . 0.0 111.381 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 79' ' ' PHE . 6.1 mp -76.8 -43.5 36.41 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.786 1.175 . . . . 0.0 111.277 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -66.12 -24.3 66.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.309 -1.494 . . . . 0.0 113.662 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -78.25 -11.07 59.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.733 1.613 . . . . 0.0 114.208 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 mm -77.67 166.85 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.655 1.116 . . . . 0.0 109.045 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.591 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 8.0 mmtp -118.55 -179.48 3.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.16 1.784 . . . . 0.0 107.803 177.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.14 9.42 3.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.948 1.299 . . . . 0.0 114.467 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -168.17 72.9 0.14 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 120.636 -1.29 . . . . 0.0 110.548 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.591 ' HG3' ' H ' ' A' ' 112' ' ' LYS . 21.7 mm-40 -132.24 33.48 3.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.984 0.914 . . . . 0.0 111.599 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 43.41 74.14 0.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.969 1.707 . . . . 0.0 111.57 160.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.08 120.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.66 128.73 34.75 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.549 HG11 ' CE1' ' A' ' 32' ' ' PHE . 63.9 t -111.16 124.73 68.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 127.058 2.143 . . . . 0.0 106.014 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.26 168.39 19.85 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.822 1.649 . . . . 0.0 110.66 -171.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.81 -7.15 58.51 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 57.61 89.67 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 127.116 2.166 . . . . 0.0 111.711 -171.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.0 m -71.83 0.95 7.8 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.233 -0.917 . . . . 0.0 112.811 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . 0.274 96.7 p . . . . . 0 C--O 1.243 0.73 0 C-N-CA 131.034 3.734 . . . . 0.0 112.161 -167.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 CA--C 1.503 -0.831 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.51 ' CB ' HH11 ' A' ' 2' ' ' ARG . 0.0 OUTLIER -66.62 148.87 51.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.6 t -151.63 147.25 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.914 2.085 . . . . 0.0 109.605 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 11.4 tt0 -134.6 136.67 43.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.751 2.021 . . . . 0.0 107.636 -175.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.58 100.32 7.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.953 2.501 . . . . 0.0 106.596 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.28 100.42 13.22 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.69 175.53 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.879 0.871 . . . . 0.0 108.869 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.28 -35.58 76.19 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 166.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -91.27 -14.88 30.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -172.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.38 -167.06 33.98 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -155.77 145.93 21.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 168.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.89 166.33 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.656 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.16 104.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -162.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.0 pt -120.55 160.38 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 124.92 1.288 . . . . 0.0 109.806 -166.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -140.56 139.43 34.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -128.93 124.49 35.27 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.73 137.36 51.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.18 -166.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -81.93 35.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.066 1.346 . . . . 0.0 111.983 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -119.66 3.78 11.13 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.245 2.218 . . . . 0.0 111.919 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -120.28 137.72 54.08 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.545 1.138 . . . . 0.0 109.94 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -44.0 -65.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.534 2.334 . . . . 0.0 107.739 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 68' ' ' TYR . 7.3 p -48.54 -38.16 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.25 -43.35 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.052 1.296 . . . . 0.0 109.427 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -62.78 -38.25 89.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 120.913 -1.117 . . . . 0.0 111.602 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -44.0 69.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mt -51.17 -43.79 61.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -54.31 -23.41 15.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.995 0.816 . . . . 0.0 112.43 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.37 -30.98 17.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.58 0.627 . . . . 0.0 110.84 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.6 -40.23 64.01 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.866 1.266 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.2 140.73 98.0 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.859 1.263 . . . . 0.0 108.699 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.74 149.26 93.8 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.139 0.728 . . . . 0.0 112.594 -9.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.64 176.48 10.05 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.977 1.311 . . . . 0.0 110.103 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -133.17 166.86 21.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.514 1.126 . . . . 0.0 109.314 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -165.06 -177.96 4.89 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.4 129.07 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 C-N-CA 125.981 1.712 . . . . 0.0 107.387 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.466 HG13 HG23 ' A' ' 43' ' ' ILE . 2.5 t -69.5 117.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -102.79 156.89 17.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 160.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -144.93 137.34 26.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.211 0.604 . . . . 0.0 109.596 -168.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -148.93 98.44 2.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -165.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 50.49 45.53 46.25 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 78.01 27.57 0.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 130.787 3.635 . . . . 0.0 114.543 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -108.93 160.71 15.79 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.67 1.588 . . . . 0.0 110.257 161.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.466 HG23 HG13 ' A' ' 36' ' ' VAL . 14.6 mt -128.8 134.99 63.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.689 1.996 . . . . 0.0 105.846 165.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.43 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 49.4 p90 -142.11 168.22 20.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.201 0.6 . . . . 0.0 110.78 164.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -152.8 154.99 36.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.36 76.99 10.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.549 1.14 . . . . 0.0 111.433 -167.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.7 p -60.04 150.47 70.0 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.088 0.955 . . . . 0.0 112.053 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.1 -6.18 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.526 3.484 . . . . 0.0 113.303 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 p -112.34 113.11 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 125.196 1.398 . . . . 0.0 107.998 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.77 103.73 7.22 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.513 1.925 . . . . 0.0 109.438 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.24 154.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.424 2.29 . . . . 0.0 107.879 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -108.75 7.28 26.28 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.302 -0.874 . . . . 0.0 112.483 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -86.42 136.21 33.2 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.353 0.661 . . . . 0.0 109.495 171.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.47 175.46 5.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.932 2.093 . . . . 0.0 109.854 163.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.46 -35.53 1.73 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.795 1.238 . . . . 0.0 110.382 163.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -137.82 65.1 45.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 109.029 -171.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.76 138.53 23.79 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.522 2.148 . . . . 0.0 110.746 171.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -126.45 154.46 43.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.34 -0.85 . . . . 0.0 111.333 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -95.45 6.02 50.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.331 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.19 150.05 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.168 2.987 . . . . 0.0 109.894 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.08 178.35 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 127.784 2.434 . . . . 0.0 108.038 -170.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -102.26 173.47 6.35 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.106 0.962 . . . . 0.0 112.313 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.08 74.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 165.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.49 29.19 0.17 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.885 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -104.23 175.73 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.16 1.98 . . . . 0.0 109.057 167.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.1 117.94 45.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 108.417 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.76 171.64 26.4 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.891 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 22' ' ' VAL . 61.7 t80 -129.28 123.36 31.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -114.18 85.92 11.03 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.561 ' CD ' ' HD3' ' A' ' 71' ' ' PRO . 36.8 Cg_endo -61.46 -33.75 87.47 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.392 2.728 . . . . 0.0 117.072 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.561 ' HD3' ' CD ' ' A' ' 70' ' ' PRO . 1.9 Cg_endo -63.46 -52.29 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.841 2.361 . . . . 0.0 109.439 -168.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.74 -6.54 87.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.578 -1.124 . . . . 0.0 114.321 174.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 47.04 90.8 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.158 2.583 . . . . 0.0 113.508 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 44' ' ' TYR . . . -160.32 166.71 28.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.212 0.529 . . . . 0.0 112.407 169.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tp -63.39 178.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.013 0.925 . . . . 0.0 110.314 160.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 32.9 m -150.58 143.7 24.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.699 2.0 . . . . 0.0 108.23 158.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 mt -125.38 135.99 52.98 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.522 2.329 . . . . 0.0 105.67 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.5 105.87 12.1 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.967 0.907 . . . . 0.0 109.299 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -136.13 23.11 3.27 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.82 -140.38 2.86 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 120.277 -1.514 . . . . 0.0 112.449 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.79 90.69 2.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -74.63 159.33 83.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 127.701 2.4 . . . . 0.0 110.8 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.22 72.36 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.344 3.363 . . . . 0.0 113.437 -166.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.64 20.85 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.997 -1.065 . . . . 0.0 112.396 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -152.42 -162.61 1.54 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.714 1.206 . . . . 0.0 108.628 -171.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -43.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.336 1.454 . . . . 0.0 109.053 160.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.47 -55.3 6.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.536 0.684 . . . . 0.0 110.698 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -138.1 -165.1 1.74 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.954 1.702 . . . . 0.0 109.595 -160.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 mt -100.62 77.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.683 1.128 . . . . 0.0 108.47 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -77.75 142.94 66.3 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.47 -0.769 . . . . 0.0 109.415 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.73 177.43 5.55 Favored 'Trans proline' 0 C--N 1.347 0.494 1 C-N-CA 125.539 4.159 . . . . 0.0 113.423 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.06 -19.69 64.63 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -172.32 176.52 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.465 2.306 . . . . 0.0 106.331 158.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.72 86.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.311 0.959 . . . . 0.0 112.812 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -69.11 136.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.995 0.918 . . . . 0.0 109.052 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -58.85 111.42 1.28 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 164.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.81 63.88 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 pt -72.84 -21.12 19.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 118.646 -0.693 . . . . 0.0 112.221 -170.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.19 -177.5 16.48 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.114 0.841 . . . . 0.0 114.325 -170.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -140.43 134.55 30.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.522 1.529 . . . . 0.0 109.442 -170.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 92.5 mt -81.07 87.58 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 165.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.5 -35.54 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 118.174 -0.917 . . . . 0.0 108.683 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.35 160.69 40.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.974 0.806 . . . . 0.0 111.7 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.95 74.61 0.35 Allowed Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.213 1.387 . . . . 0.0 110.897 -167.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.44 -63.24 1.28 Allowed 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.45 -22.11 60.28 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.997 -1.064 . . . . 0.0 111.689 -163.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -14.49 59.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 111.667 170.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.38 -31.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.224 -1.548 . . . . 0.0 110.726 169.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -77.55 34.5 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.834 1.254 . . . . 0.0 112.907 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 -16.71 0.84 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.381 -1.449 . . . . 0.0 111.415 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 mm -74.09 154.69 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -113.05 -178.39 3.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.676 0.79 . . . . 0.0 109.441 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -74.19 38.57 0.11 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.738 2.015 . . . . 0.0 111.898 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 151.8 79.9 0.03 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.832 1.206 . . . . 0.0 111.067 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -138.06 29.87 2.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.55 1.54 . . . . 0.0 110.834 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.54 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 128.595 2.758 . . . . 0.0 115.064 -170.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.53 137.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 161.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 104.73 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.942 1.697 . . . . 0.0 106.808 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.67 124.24 50.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 127.443 2.297 . . . . 0.0 106.931 -161.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -138.12 177.0 8.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.647 1.979 . . . . 0.0 110.775 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.96 -6.78 55.51 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 60.87 52.92 4.0 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 125.262 1.425 . . . . 0.0 112.922 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 65.2 m -64.87 34.36 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.417 2.287 . . . . 0.0 114.61 172.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.256 1.402 0 C-N-CA 129.038 2.935 . . . . 0.0 110.995 175.855 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttm . . . . . 0 CA--C 1.509 -0.626 0 CA-C-O 121.953 0.882 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -99.89 163.85 12.27 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.539 0.735 . . . . 0.0 109.198 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.3 t -148.47 129.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 2.7 tt0 -111.7 129.26 56.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.121 -1.612 . . . . 0.0 110.509 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -103.44 96.09 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.121 0.962 . . . . 0.0 111.934 174.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.6 142.24 28.41 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 109.057 168.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.51 173.25 11.04 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.751 1.62 . . . . 0.0 110.09 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.45 -27.04 66.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.866 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 m -113.35 0.4 14.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.08 -165.93 37.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 119.793 1.179 . . . . 0.0 111.426 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -162.84 143.85 9.8 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.581 ' CB ' ' HA3' ' A' ' 104' ' ' GLY 0.258 11.8 m -152.54 154.22 35.0 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 3.9 p -122.06 164.97 18.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.485 ' CD1' HD21 ' A' ' 16' ' ' LEU . 1.6 pp -135.59 158.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 166.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -123.71 133.09 53.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 117.648 -1.167 . . . . 0.0 110.537 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 14' ' ' ILE . 81.0 mt -117.32 156.49 27.75 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.758 1.623 . . . . 0.0 111.484 -172.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.631 ' O ' HG21 ' A' ' 23' ' ' VAL . 6.9 t-20 -105.72 118.08 35.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.756 -1.116 . . . . 0.0 108.741 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.61 16.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.18 2.192 . . . . 0.0 115.486 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -102.53 8.2 39.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.443 1.897 . . . . 0.0 110.29 -169.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.624 ' HB2' HG23 ' A' ' 23' ' ' VAL . 54.8 m-85 -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.565 1.146 . . . . 0.0 109.13 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.12 -45.95 53.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.759 1.624 . . . . 0.0 109.116 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.19 -22.57 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 112.557 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 17' ' ' ASN . 3.1 t -81.01 -51.75 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 120.354 1.434 . . . . 0.0 108.009 175.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -57.7 -27.6 63.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.724 1.209 . . . . 0.0 110.496 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.547 HD12 HG11 ' A' ' 51' ' ' VAL . 32.8 mt -92.94 -34.85 13.61 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.835 1.654 . . . . 0.0 111.695 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 49' ' ' VAL . 2.6 mt -61.36 -35.71 78.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 120.141 1.337 . . . . 0.0 110.509 171.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -34.03 51.19 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.893 0.877 . . . . 0.0 110.735 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.98 -15.63 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -120.57 0.82 10.54 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.837 0.855 . . . . 0.0 113.071 -166.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.1 mt -99.28 145.31 29.82 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.235 1.38 . . . . 0.0 108.631 -173.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.26 159.53 81.05 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 CA-C-N 119.039 0.693 . . . . 0.0 113.34 -12.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -148.65 159.76 43.8 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.773 1.229 . . . . 0.0 109.244 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -114.61 159.53 20.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.448 1.099 . . . . 0.0 109.709 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -161.92 172.59 15.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.058 -170.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.32 132.89 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.25 73.16 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -68.64 147.24 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -123.48 136.15 54.43 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.921 0.888 . . . . 0.0 109.449 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' A' ' 92' ' ' ALA . 37.1 t90 -144.82 96.81 2.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 45.02 71.84 0.43 Allowed Glycine 0 C--O 1.211 -1.325 0 O-C-N 124.258 0.974 . . . . 0.0 112.266 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 60.74 31.44 20.11 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.639 1.22 . . . . 0.0 111.792 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -123.73 155.22 38.26 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.82 2.448 . . . . 0.0 108.594 161.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.9 mm -115.47 147.91 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 158.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -144.95 169.34 18.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.111 0.957 . . . . 0.0 108.565 161.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.24 148.24 33.29 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -80.11 77.91 6.79 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 109.537 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -59.73 150.37 67.78 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 122.093 0.949 . . . . 0.0 111.855 -171.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -68.33 -12.24 34.36 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.804 2.336 . . . . 0.0 112.246 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG21 ' HG ' ' A' ' 26' ' ' LEU . 5.7 t -96.77 122.59 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.862 1.665 . . . . 0.0 109.835 -172.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -128.06 30.76 5.19 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.074 1.349 . . . . 0.0 114.003 -167.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG11 HD12 ' A' ' 25' ' ' LEU . 10.6 m -72.65 164.46 3.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.124 1.37 . . . . 0.0 109.731 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -139.51 33.21 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.628 0.771 . . . . 0.0 111.217 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -85.87 148.69 25.68 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.646 0.778 . . . . 0.0 109.177 166.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.88 158.67 44.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 167.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.18 -20.85 1.88 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.773 171.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -117.45 57.11 2.1 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 120.696 1.589 . . . . 0.0 111.819 171.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.66 134.46 35.31 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.065 1.843 . . . . 0.0 112.717 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.474 ' HD2' ' C ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -138.52 169.72 17.29 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.881 0.848 . . . . 0.0 112.714 172.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -122.88 9.21 9.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.263 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' C ' ' HD2' ' A' ' 58' ' ' ARG . 1.6 p -159.99 101.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.57 0 C-N-CA 125.349 1.46 . . . . 0.0 114.817 174.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 78' ' ' PHE . 31.5 m -100.16 -177.92 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 127.358 2.263 . . . . 0.0 110.137 -168.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -90.09 171.95 9.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.724 -1.235 . . . . 0.0 111.294 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.21 -9.55 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.507 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.31 26.38 2.0 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 125.658 1.599 . . . . 0.0 111.748 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -83.01 -154.86 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 160.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.8 t -137.62 173.89 12.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 130.107 3.363 . . . . 0.0 104.701 162.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.02 154.37 25.87 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 146.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 150.25 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -119.98 87.87 39.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.92 -43.67 56.06 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 121.582 1.521 . . . . 0.0 114.972 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.62 -1.44 11.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.084 2.523 . . . . 0.0 114.902 -155.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.26 5.16 5.98 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 127.01 2.243 . . . . 0.0 112.78 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 55.08 78.16 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.746 2.018 . . . . 0.0 111.942 -167.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.27 176.9 11.12 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.243 0.617 . . . . 0.0 111.893 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.533 ' HG ' ' H ' ' A' ' 76' ' ' CYS . 4.9 tp -90.09 -172.79 3.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.211 1.405 . . . . 0.0 109.919 158.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.533 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 66.8 m -146.85 151.13 36.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.66 3.184 . . . . 0.0 107.734 160.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.37 96.04 3.64 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.547 2.339 . . . . 0.0 105.093 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 61' ' ' VAL . 1.8 m-85 -82.11 132.09 35.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 172.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -147.47 16.08 1.14 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.41 -82.49 0.04 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 165.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -151.39 -13.71 0.21 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 57.43 166.71 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 -1.06 8.01 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.681 2.254 . . . . 0.0 113.241 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.16 39.39 2.44 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.597 1.159 . . . . 0.0 109.299 -169.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -136.24 178.9 6.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.789 1.636 . . . . 0.0 108.617 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -138.47 -47.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 165.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.512 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 26.4 t0 -118.97 -13.39 9.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -163.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 87' ' ' ASP . 3.2 pttt -167.64 164.49 14.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.758 1.623 . . . . 0.0 109.221 -166.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.0 mp -81.65 77.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 122.798 1.285 . . . . 0.0 108.739 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -69.98 144.68 93.29 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.455 163.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.44 -174.46 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.847 3.698 . . . . 0.0 111.329 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HB2' ' CH2' ' A' ' 39' ' ' TRP . . . -85.71 -11.54 53.42 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 t -166.37 170.21 13.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 167.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.51 98.5 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.793 0.837 . . . . 0.0 110.62 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.84 -178.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.736 1.214 . . . . 0.0 109.43 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -130.95 118.9 21.33 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG21 ' NE ' ' A' ' 58' ' ' ARG . 21.4 t -76.72 47.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 123.025 1.393 . . . . 0.0 112.63 -171.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.55 -28.71 37.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 126.874 2.069 . . . . 0.0 113.841 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.421 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -128.57 168.16 20.5 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.184 1.849 . . . . 0.0 112.341 -174.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -141.95 129.05 20.87 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.665 1.986 . . . . 0.0 108.252 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.9 mt -65.08 103.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 164.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 13' ' ' VAL . 33.4 m -75.47 -61.9 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 165.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.451 ' HB2' HG12 ' A' ' 13' ' ' VAL . 6.6 mt-10 -113.03 158.31 20.47 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 12' ' ' CYS . . . 88.62 61.61 1.44 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.403 176.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.53 -20.66 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.05 -33.09 7.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.269 1.027 . . . . 0.0 108.671 -173.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -10.01 59.08 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.244 -0.91 . . . . 0.0 111.516 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.414 HD21 ' SG ' ' A' ' 12' ' ' CYS . 53.6 mt -72.41 -20.67 61.39 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.652 -1.28 . . . . 0.0 112.458 172.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -64.7 -31.68 73.01 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.889 -1.132 . . . . 0.0 110.504 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.76 10.38 41.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.188 2.595 . . . . 0.0 114.213 -172.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.36 159.95 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 120.975 -1.078 . . . . 0.0 109.276 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.56 174.58 5.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.362 1.865 . . . . 0.0 109.746 173.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.06 16.48 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.703 2.001 . . . . 0.0 113.637 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -179.92 65.16 0.07 OUTLIER Glycine 0 CA--C 1.525 0.684 0 O-C-N 119.644 -1.91 . . . . 0.0 113.787 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -94.57 24.97 4.21 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.642 1.177 . . . . 0.0 112.71 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.9 mttt 43.99 71.98 0.22 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 130.075 3.35 . . . . 0.0 112.629 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -69.29 119.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.54 103.6 16.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 168.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 5' ' ' LEU . 75.6 t -72.42 125.75 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 168.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -136.49 -175.98 4.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.307 1.843 . . . . 0.0 109.203 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.63 8.85 34.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 117.93 2.567 . . . . 0.0 117.93 -168.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . . . 55.48 111.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 129.983 3.313 . . . . 0.0 111.275 -165.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.2 t -68.07 -16.41 64.01 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.245 -0.909 . . . . 0.0 111.33 171.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.059 0 C-N-CA 130.677 3.591 . . . . 0.0 111.566 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ttm . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 54.0 mtt180 -84.85 173.03 10.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 173.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 72.8 t -147.78 141.06 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.072 1.749 . . . . 0.0 106.5 169.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . 36.1 tt0 -125.26 131.13 53.16 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.786 2.034 . . . . 0.0 107.18 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.82 102.94 10.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.478 1.911 . . . . 0.0 106.773 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.26 136.67 32.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -125.91 170.23 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.994 1.318 . . . . 0.0 109.747 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.97 -27.47 66.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.415 -0.803 . . . . 0.0 113.093 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 m -111.26 -3.74 15.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.27 20.81 Favored Glycine 0 N--CA 1.464 0.527 0 CA-C-O 118.08 -1.4 . . . . 0.0 110.1 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.55 161.04 23.77 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.74 1.77 . . . . 0.0 111.869 -167.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.7 p -143.81 174.83 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.793 0.837 . . . . 0.0 110.32 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.1 128.2 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 pt -117.11 148.79 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -120.24 128.51 53.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.251 -0.906 . . . . 0.0 111.015 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD23 ' CA ' ' A' ' 99' ' ' GLY . 42.3 mt -119.89 169.56 10.05 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 123.523 1.63 . . . . 0.0 111.912 -175.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -128.38 114.9 17.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.99 2.116 . . . . 0.0 109.505 -167.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -72.67 52.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.789 2.036 . . . . 0.0 112.326 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -130.63 -34.15 1.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.317 1.447 . . . . 0.0 110.905 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -74.69 151.02 39.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -57.91 -46.35 85.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.865 0.866 . . . . 0.0 109.076 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 51' ' ' VAL . 1.6 t -61.09 -38.08 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -170.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.82 -46.14 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -52.46 -46.76 66.63 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.094 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.619 HD12 HG12 ' A' ' 51' ' ' VAL . 29.1 mt -74.5 -32.91 62.68 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.741 0.816 . . . . 0.0 111.1 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -39.0 91.63 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.748 1.219 . . . . 0.0 110.184 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -53.68 -41.53 66.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.468 0.707 . . . . 0.0 109.805 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -62.21 -20.64 64.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.185 0.994 . . . . 0.0 111.918 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -111.31 -1.64 15.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 116.893 -1.527 . . . . 0.0 113.003 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -99.3 143.3 26.16 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 121.405 1.911 . . . . 0.0 109.106 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -70.15 159.65 90.53 Favored 'Cis proline' 0 C--N 1.351 0.662 0 CA-C-N 119.109 0.718 . . . . 0.0 113.242 -11.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -146.97 172.23 14.03 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 126.138 1.775 . . . . 0.0 109.722 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -124.52 167.33 14.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 109.784 167.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.34 178.09 3.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.411 0.685 . . . . 0.0 112.046 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.8 t -82.53 138.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 125.385 1.474 . . . . 0.0 109.342 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 111' ' ' ILE . 10.3 t -94.29 71.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.133 0.973 . . . . 0.0 108.379 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -70.13 152.11 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 p -123.01 152.18 41.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.266 0.626 . . . . 0.0 109.997 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -156.89 79.63 0.92 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.718 0.807 . . . . 0.0 109.757 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 83' ' ' PRO . . . 87.19 55.02 2.44 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 119.856 -1.777 . . . . 0.0 113.118 175.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 52.28 40.93 30.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.157 1.383 . . . . 0.0 109.569 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.24 166.03 24.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.81 2.044 . . . . 0.0 107.858 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -132.47 124.28 51.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 108.266 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -127.41 149.26 50.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.396 1.093 . . . . 0.0 109.636 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -136.63 148.45 47.45 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 108.446 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.93 74.77 3.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.007 1.723 . . . . 0.0 111.445 -165.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.4 p -63.03 145.52 96.59 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.191 -0.943 . . . . 0.0 112.7 -164.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.68 -1.97 11.21 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.056 3.171 . . . . 0.0 113.096 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.72 136.51 37.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -132.63 82.36 2.0 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.51 0.724 . . . . 0.0 111.768 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.619 HG12 HD12 ' A' ' 25' ' ' LEU . 3.0 m -91.92 173.04 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 O-C-N 121.509 -0.744 . . . . 0.0 110.568 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -132.54 13.93 4.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.292 1.437 . . . . 0.0 112.212 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -111.69 123.19 49.72 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.812 1.187 . . . . 0.0 111.641 -167.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.4 122.7 26.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.291 1.836 . . . . 0.0 110.245 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.44 -37.28 10.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.295 0.638 . . . . 0.0 110.208 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.14 60.07 1.28 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.82 1.648 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -65.31 145.05 82.66 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.224 1.949 . . . . 0.0 110.513 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -143.58 146.56 33.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.228 1.011 . . . . 0.0 108.996 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.16 -5.29 24.59 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.094 1.358 . . . . 0.0 111.391 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.05 149.77 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 127.845 2.458 . . . . 0.0 108.895 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.674 HG21 ' CD1' ' A' ' 78' ' ' PHE . 20.8 m -132.78 -178.72 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.958 1.703 . . . . 0.0 108.587 -173.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.87 176.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.251 1.024 . . . . 0.0 109.472 172.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.6 mt -78.73 -4.54 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.196 0.998 . . . . 0.0 111.128 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.43 37.81 1.94 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.863 1.221 . . . . 0.0 111.083 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -116.85 174.77 5.91 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.1 165.87 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 95' ' ' VAL . . . -141.72 179.19 19.98 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 165.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.986 ' H ' HG13 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -128.82 129.64 45.89 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 -170.28 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . 0.297 2.9 t90 -118.57 86.62 29.46 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-N 120.135 1.334 . . . . 0.0 109.876 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HD2' ' HD3' ' A' ' 71' ' ' PRO . 69.6 Cg_endo -70.78 -26.33 22.87 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 116.834 1.821 . . . . 0.0 116.834 -171.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.455 ' HD3' ' HD2' ' A' ' 70' ' ' PRO . 95.4 Cg_endo -77.55 -17.59 14.29 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.955 2.437 . . . . 0.0 112.395 -172.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.45 -2.56 50.52 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.88 1.705 . . . . 0.0 112.79 167.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 52.25 65.49 1.49 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.228 1.811 . . . . 0.0 110.973 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.58 177.51 10.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.75 0.786 . . . . 0.0 111.153 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -88.92 -177.75 5.56 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 126.213 1.805 . . . . 0.0 112.074 175.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 65.7 m -152.94 127.93 9.66 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.638 1.575 . . . . 0.0 109.205 156.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.61 105.12 15.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.393 2.277 . . . . 0.0 105.965 168.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.674 ' CD1' HG21 ' A' ' 61' ' ' VAL . 39.4 m-85 -86.8 132.53 33.82 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -150.25 27.31 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.48 0.582 . . . . 0.0 112.419 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.38 0.09 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-O 118.212 -1.327 . . . . 0.0 112.331 168.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 136.36 4.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.686 1.195 . . . . 0.0 111.3 165.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.56 165.44 30.38 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.277 2.231 . . . . 0.0 113.118 -172.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 85.7 Cg_endo -80.59 -17.8 9.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.65 2.9 . . . . 0.0 114.404 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.21 57.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.432 0.693 . . . . 0.0 111.997 -173.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -172.11 1.85 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.138 2.175 . . . . 0.0 109.839 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.53 -49.97 0.32 Allowed 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.002 -1.061 . . . . 0.0 108.99 158.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.457 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 8.1 m-20 -72.12 -54.99 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.883 -0.511 . . . . 0.0 110.261 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -139.4 179.71 6.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.677 2.391 . . . . 0.0 109.489 -153.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.7 74.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 121.519 1.963 . . . . 0.0 110.291 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -84.52 142.58 40.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.561 -0.712 . . . . 0.0 109.911 166.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -74.96 -178.57 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 124.494 3.462 . . . . 0.0 113.72 160.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.08 -12.9 43.4 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t 180.0 -177.95 0.4 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.886 2.074 . . . . 0.0 106.848 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.16 96.06 1.74 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 124.533 2.111 . . . . 0.0 109.609 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.986 HG13 ' H ' ' A' ' 68' ' ' TYR 0.308 46.9 t -58.59 -172.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 CA-C-N 110.945 -2.843 . . . . 0.0 111.199 140.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.679 ' H ' HG12 ' A' ' 95' ' ' VAL . 63.8 t-20 -142.54 130.39 21.68 Favored 'General case' 0 N--CA 1.438 -1.044 1 C-N-CA 132.677 4.391 . . . . 0.0 105.207 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.07 82.71 2.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 22' ' ' VAL . 8.2 pt -77.4 -65.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.968 172.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.469 ' CA ' HD23 ' A' ' 16' ' ' LEU . . . -95.59 173.92 31.48 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.848 1.213 . . . . 0.0 111.464 -178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -134.5 141.51 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.611 1.964 . . . . 0.0 108.203 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.84 100.18 2.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 102.339 -3.208 . . . . 0.0 102.339 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -83.72 -38.73 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.363 0.529 . . . . 0.0 110.236 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.74 159.66 41.57 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.557 1.143 . . . . 0.0 109.973 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.0 70.51 1.16 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 tp -87.85 -64.09 1.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.4 -29.14 68.57 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.584 -0.697 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -12.78 24.19 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.38 1.072 . . . . 0.0 111.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.65 -34.91 22.95 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.213 1.405 . . . . 0.0 111.875 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.36 -21.93 66.25 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.08 -1.012 . . . . 0.0 112.361 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.71 10.32 33.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.495 1.518 . . . . 0.0 112.494 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.426 HG21 HG11 ' A' ' 36' ' ' VAL . 23.5 mm -95.37 138.66 20.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.263 0.938 . . . . 0.0 108.983 176.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -85.14 175.08 9.21 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.809 1.244 . . . . 0.0 110.281 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.69 16.4 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 129.652 3.181 . . . . 0.0 114.914 174.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.93 80.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 O-C-N 120.334 -1.479 . . . . 0.0 109.463 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -133.53 31.41 3.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt 46.03 70.11 0.4 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 128.046 2.538 . . . . 0.0 112.347 162.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.44 129.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.58 107.75 20.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.049 1.74 . . . . 0.0 106.992 164.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.5 t -88.57 121.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 128.131 2.572 . . . . 0.0 107.695 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 25.6 mtm180 -138.66 174.13 10.86 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.128 1.371 . . . . 0.0 110.116 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -78.66 -9.44 59.39 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 122.228 2.285 . . . . 0.0 117.036 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . . . 62.59 178.21 0.14 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 126.335 1.854 . . . . 0.0 112.06 -164.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.7 m -158.91 36.59 0.22 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.99 2.116 . . . . 0.0 111.055 169.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 C--O 1.247 0.933 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 161.717 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 C--O 1.236 0.378 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.74 157.39 24.4 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 t -155.23 140.43 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.701 1.6 . . . . 0.0 107.646 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 122' ' ' ALA . 43.7 tt0 -123.1 117.96 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.928 2.091 . . . . 0.0 106.476 177.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.87 110.28 19.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.987 1.715 . . . . 0.0 106.448 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.8 122.28 39.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.363 1.465 . . . . 0.0 107.268 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -114.14 170.51 8.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.622 1.169 . . . . 0.0 109.588 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.49 -17.79 62.97 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.406 -1.434 . . . . 0.0 112.358 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 m -113.68 -0.58 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 114.16 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.17 -157.19 28.42 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 119.999 1.272 . . . . 0.0 109.927 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -158.59 166.71 31.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.47 0.708 . . . . 0.0 109.371 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -144.38 179.42 7.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.433 0.693 . . . . 0.0 109.304 166.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.05 126.74 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.19 153.39 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 122.691 1.234 . . . . 0.0 107.831 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -116.51 126.44 53.36 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 125.842 1.657 . . . . 0.0 106.983 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.35 133.19 51.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.182 0.901 . . . . 0.0 109.546 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.86 137.42 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.15 -18.95 63.23 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.017 0.927 . . . . 0.0 112.591 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.84 -19.5 59.97 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.496 1.043 . . . . 0.0 113.518 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -92.33 126.96 37.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.163 1.385 . . . . 0.0 110.092 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -45.96 -54.76 7.78 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 126.193 1.797 . . . . 0.0 110.915 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -54.98 -32.95 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.143 -1.408 . . . . 0.0 113.998 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.0 t -69.41 -38.75 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.772 1.624 . . . . 0.0 109.379 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -63.41 -42.7 98.75 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.799 0.84 . . . . 0.0 110.759 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -43.99 84.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -54.27 -28.07 39.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.226 1.41 . . . . 0.0 112.8 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -65.29 -27.25 68.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.014 0.824 . . . . 0.0 110.496 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.79 -20.59 63.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.593 0.711 . . . . 0.0 110.817 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -118.29 18.33 13.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.95 2.1 . . . . 0.0 110.753 -165.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.5 mt -121.29 139.97 30.47 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.678 1.581 . . . . 0.0 107.456 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.89 156.99 83.01 Favored 'Cis proline' 0 N--CA 1.458 -0.6 0 C-N-CA 125.089 -0.796 . . . . 0.0 112.053 -9.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.491 ' CE1' HG11 ' A' ' 119' ' ' VAL . 20.5 p90 -143.72 165.17 28.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.578 1.174 . . . . 0.0 109.947 165.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.96 155.32 41.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -162.05 166.3 26.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.819 0.848 . . . . 0.0 111.471 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.57 127.97 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.845 HG13 HG23 ' A' ' 43' ' ' ILE . 98.9 t -80.38 98.54 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 171.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -90.75 156.06 18.34 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 p -144.45 149.45 36.03 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.161 0.585 . . . . 0.0 110.253 -168.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -146.62 82.21 1.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 83' ' ' PRO . . . 79.18 -84.98 1.23 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -142.03 38.62 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.58 1.552 . . . . 0.0 109.181 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.68 165.32 26.66 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.21 172.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.845 HG23 HG13 ' A' ' 36' ' ' VAL . 30.3 mt -131.95 123.19 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -121.18 176.35 5.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.071 0.939 . . . . 0.0 109.751 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.43 161.15 38.94 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.915 2.086 . . . . 0.0 106.679 173.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p -94.57 85.41 4.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.666 HG21 HD23 ' A' ' 75' ' ' LEU . 40.2 p -59.12 150.21 63.37 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -166.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.87 -25.16 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.287 1.992 . . . . 0.0 111.263 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.88 143.8 10.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.152 0.981 . . . . 0.0 109.938 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -138.87 101.13 4.23 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.395 1.478 . . . . 0.0 108.202 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.8 160.19 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.626 1.57 . . . . 0.0 108.022 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -123.37 2.65 9.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.69 1.196 . . . . 0.0 113.123 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -71.95 157.98 36.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.051 0.841 . . . . 0.0 109.107 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 46.4 mtm -147.59 158.38 43.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.565 1.546 . . . . 0.0 106.939 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -126.64 -51.69 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.533 1.533 . . . . 0.0 108.819 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -123.89 54.41 7.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.297 1.039 . . . . 0.0 111.641 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.77 134.37 27.81 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 120.264 1.13 . . . . 0.0 110.516 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -127.9 148.6 50.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.387 0.675 . . . . 0.0 109.33 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -92.89 5.75 50.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.843 0.857 . . . . 0.0 112.304 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -148.39 153.41 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.034 2.134 . . . . 0.0 106.59 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 78' ' ' PHE . 27.3 m -146.2 -178.74 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.542 2.337 . . . . 0.0 107.207 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.48 172.15 7.67 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.489 -0.757 . . . . 0.0 111.335 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -72.14 71.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.954 . . . . 0.0 107.215 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.73 11.74 0.16 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.813 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -105.07 -177.74 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.399 2.1 . . . . 0.0 108.7 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -131.65 148.34 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.638 1.175 . . . . 0.0 108.463 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -134.09 149.9 19.86 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.462 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 6.7 m-85 -120.24 120.51 36.31 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -105.06 87.97 2.18 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.536 1.934 . . . . 0.0 110.35 -167.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.06 -52.0 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.104 2.536 . . . . 0.0 114.844 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.67 -28.6 7.98 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.939 2.426 . . . . 0.0 111.212 -161.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.66 87.39 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.57 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 47.24 67.62 0.77 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 108.924 -162.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.0 157.2 45.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.629 0.728 . . . . 0.0 111.702 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.666 HD23 HG21 ' A' ' 47' ' ' THR . 0.2 OUTLIER -80.5 -175.62 5.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.663 159.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 t -164.09 154.54 15.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.62 1.168 . . . . 0.0 109.278 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -136.09 142.14 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 107.12 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD2' HG21 ' A' ' 61' ' ' VAL . 56.7 m-85 -120.66 106.38 11.68 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 119.929 1.241 . . . . 0.0 110.829 -170.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.25 52.52 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.328 1.061 . . . . 0.0 112.42 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.36 -98.94 0.13 Allowed Glycine 0 CA--C 1.506 -0.47 0 O-C-N 120.368 -1.457 . . . . 0.0 111.095 159.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.411 ' HA ' HG13 ' A' ' 89' ' ' ILE . 11.6 tttt -135.08 -15.38 1.98 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 167.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 55.72 165.63 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.232 1.813 . . . . 0.0 112.136 -174.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 71.9 Cg_endo -72.64 5.43 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.185 2.59 . . . . 0.0 113.16 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.19 88.26 2.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 p 174.18 172.94 0.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.369 2.668 . . . . 0.0 107.223 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -147.21 -47.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 158.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.83 -53.49 7.85 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.737 0.78 . . . . 0.0 109.429 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -149.82 152.05 34.53 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 128.682 2.793 . . . . 0.0 107.527 -161.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 89' ' ' ILE . 5.4 mp -54.47 122.19 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -138.9 143.4 37.19 Favored Pre-proline 0 N--CA 1.444 -0.734 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.501 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -82.71 171.45 11.98 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.625 2.883 . . . . 0.0 113.331 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.12 52.31 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.72 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.9 m -173.02 -175.36 1.2 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.105 2.562 . . . . 0.0 107.089 166.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.9 104.99 0.61 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.433 1.015 . . . . 0.0 108.678 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -106.83 138.83 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -66.21 106.74 1.74 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.292 1.437 . . . . 0.0 108.707 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.21 61.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 122.469 1.128 . . . . 0.0 109.154 -168.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.77 -13.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.194 0.998 . . . . 0.0 112.933 -167.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.11 164.41 17.41 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -129.13 137.72 51.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.72 90.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -73.5 -30.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.704 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -148.98 162.77 39.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.225 0.536 . . . . 0.0 110.801 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.57 70.74 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.261 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -54.66 44.45 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.378 1.089 . . . . 0.0 109.922 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.25 -18.35 61.24 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.045 -1.035 . . . . 0.0 110.624 -167.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.85 -13.26 61.4 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.161 -0.962 . . . . 0.0 111.781 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.62 -29.1 56.35 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.112 -1.617 . . . . 0.0 113.23 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.39 81.16 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 120.308 -1.495 . . . . 0.0 111.872 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -67.38 -11.14 56.99 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -173.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.0 164.33 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 126.866 2.067 . . . . 0.0 109.6 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 110' ' ' LYS . 5.7 mmtp -120.86 175.31 6.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.977 1.711 . . . . 0.0 109.488 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.13 44.68 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.0 2.12 . . . . 0.0 112.899 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.77 83.15 0.04 OUTLIER Glycine 0 C--N 1.333 0.366 0 O-C-N 120.721 -1.237 . . . . 0.0 110.94 168.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.5 31.11 5.05 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.264 1.026 . . . . 0.0 111.798 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.1 mttt 47.35 89.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.32 2.248 . . . . 0.0 115.225 171.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.54 152.95 5.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.49 119.14 33.65 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.467 1.907 . . . . 0.0 106.878 159.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.491 HG11 ' CE1' ' A' ' 32' ' ' PHE . 75.9 t -98.48 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 127.496 2.318 . . . . 0.0 107.192 -174.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -130.99 163.17 28.14 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.694 -1.253 . . . . 0.0 110.395 -171.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.92 -18.17 64.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 4' ' ' GLU . . . 173.31 -171.65 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.228 1 C-N-CA 131.974 4.11 . . . . 0.0 107.375 152.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.92 42.26 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.14 -0.975 . . . . 0.0 109.788 162.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 C--O 1.249 1.064 0 C-N-CA 126.617 1.967 . . . . 0.0 107.356 172.853 . . . . . . . . 0 0 . 1 stop_ save_